aspirin has been researched along with Pregnancy in 2247 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effect of aspirin in the prevention of pre-eclampsia in high-risk women." | 10.27 | Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. ( Hämäläinen, E; Kajantie, E; Laivuori, H; Pesonen, AK; Räikkönen, K; Taipale, P; Vainio, M; Villa, PM, 2013) |
| "The APPEC study is a large-population randomized controlled trial in China evaluating the role of low-dose aspirin prophylactic treatment for pre-eclampsia." | 9.69 | Low-dose aspirin in the prevention of pre-eclampsia in China: postpartum hemorrhage in subgroups of women according to their characteristics and potential bleeding risk. ( Chen, J; Huai, J; Li, B; Lin, L; Yang, H; Zhu, Y, 2023) |
| "The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout pregnancy are unknown." | 9.69 | ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. ( Nicolaides, KH; O'Gorman, N; Poon, LC; Rolnik, DL; Syngelaki, A; Wright, D, 2023) |
| "These findings suggest that individuals with twin pregnancies, a history of preeclampsia, or hypertension may not benefit from aspirin to the same extent as those with other complications such as obesity or diabetes." | 9.69 | Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation. ( Corsi, DJ; Dagvadorj, A; Dingwall-Harvey, ALJ; El-Chaár, D; Gaudet, LM; Guo, Y; McLean, C; Muldoon, KA; Rennicks White, R; Rybak, N; Walker, MC; Wen, SW, 2023) |
| "To assess the impact of low-dose aspirin (LDA) starting in early pregnancy on delaying preterm hypertensive disorders of pregnancy." | 9.69 | Aspirin delays the onset of hypertensive disorders of pregnancy among nulliparous pregnant women: A secondary analysis of the ASPIRIN trial. ( Bauserman, M; Bucher, S; Carlo, WA; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hibberd, PL; Hoffman, MK; Jessani, S; Kavi, A; Koso-Thomas, M; Krebs, NF; Lokangaka, A; McClure, EM; Metgud, MC; Moore, J; Mwenechanya, M; Nielsen, E; Patel, A; Saleem, S; Silver, R; Somannavar, MS; Tshefu, A, 2023) |
| "The Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas trial was a landmark study that demonstrated a reduction in preterm birth and hypertensive disorders of pregnancy in nulliparous women who received low-dose aspirin." | 9.69 | The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. ( Achieng, E; Bauserman, M; Bucher, S; Carlo, WA; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hemingway-Foday, J; Hibberd, PL; Hoffman, MK; Jessani, S; Kavi, A; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Moore, J; Nuss, EE; Nyongesa, P; Okitawutshu, J; Saleem, S; Silver, RM; Somannavar, M; Tembo, AM; Tshefu, A, 2023) |
| "To demonstrate the use of ensemble machine learning with augmented inverse probability weighting (AIPW) for per-protocol effect estimation in RCTs and to evaluate the per-protocol effect size of aspirin on pregnancy." | 9.51 | Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial. ( Bodnar, LM; Brooks, MM; Kennedy, EH; Naimi, AI; Zhong, Y, 2022) |
| "Low dose aspirin (LDA) is an effective strategy to reduce preterm birth." | 9.51 | The efficacy of low-dose aspirin in pregnancy among women in malaria-endemic countries. ( Bauserman, M; Bose, CL; Carlo, WA; Chomba, E; Derman, RJ; Esamai, F; Goldenberg, RL; Hemingway-Foday, J; Hoffman, M; Jessani, S; Koso-Thomas, M; Leuba, SI; Liechty, EA; Lokangaka, A; McClure, EM; Meshnick, SR; Moore, J; Nolen, TL; Patterson, J; Saleem, S; Tsehfu, A, 2022) |
| "Daily aspirin, started in the first trimester of pregnancy, is commonly used for the prevention of preeclampsia and fetal growth restriction in multiple gestation." | 9.51 | Aspirin Responsiveness at a Dose of 80 mg and Its Impact on Birth Weight when Used in Twin Pregnancies: The GAP Pilot Randomized Trial. ( Boutin, A; Bujold, E; Camiré, B; Carpentier, C; Guerby, P; Tapp, S, 2022) |
| "Evidence has shown significant benefits of aspirin for preventing pre-eclampsia." | 9.41 | Prevention of pre-eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. ( Ali, R; McDonald, SD; Morfaw, F; Ninan, K, 2023) |
| "This systematic review and meta-analysis investigated whether the use of low-dose aspirin during pregnancy by women with chronic hypertension reduces the odds of superimposed preeclampsia and poor perinatal outcomes." | 9.41 | Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis. ( Giorgione, V; Richards, EMF; Stevens, O; Thilaganathan, B, 2023) |
| " The secondary outcomes included gestational hypertension; fetal growth restriction; preterm birth, either spontaneous or iatrogenic, before 34 weeks of gestation; gestational age at birth; neonatal birthweight; and adverse events secondary to the administration of aspirin, including antepartum and postpartum hemorrhage." | 9.41 | Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis. ( Acuti Martellucci, C; Buca, D; Cerra, C; D'Antonio, F; Fichera, A; Flacco, ME; Herrera, M; Khalil, A; Morelli, R; Orabona, R; Prefumo, F; Rizzo, G, 2023) |
| "To establish the clinical heterogeneity among the clinical practice guidelines (CPGs) on aspirin use in pregnancy and to investigate the quality of these CPGs." | 9.41 | Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review. ( Alameddine, S; D'Antonio, F; Di Girolamo, R; Khalil, A; Liberati, M; Maruotti, GM; Rizzo, G; Santilli, F, 2023) |
| "This study aimed to compare 2 aspirin dosage regimens for the prevention of preterm preeclampsia (PE): 75 to 81 mg vs 150 to 162 mg taken daily starting in the first trimester of pregnancy." | 9.41 | Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis. ( Bujold, E; Foisy, MA; Ghesquiere, L; Guerby, P; Kumar, N; Marchant, I; Roberge, S; Zare, M, 2023) |
| " The aim of this narrative review is to investigate the role of blood pressure (BP) monitoring, physical activity, and prophylactic aspirin to reduce the prevalence of preeclampsia and to improve pregnancy outcome in women with preexisting diabetes." | 9.41 | Prediction and prevention of preeclampsia in women with preexisting diabetes: the role of home blood pressure, physical activity, and aspirin. ( Damm, P; Do, NC; Mathiesen, ER; Nørgaard, SK; Ringholm, L; Vestgaard, M, 2023) |
| "Compared with aspirin alone, low-dose aspirin combined with calcium supplementation was more effective in preventing preeclampsia, reduced the risk of preterm birth and postpartum hemorrhage, and promoted fetal growth." | 9.41 | Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis. ( Chen, WY; Sun, SF, 2023) |
| "A previous large randomized trial indicated that preconception-initiated low-dose aspirin (LDA) therapy did not have a positive effect on pregnancy outcomes." | 9.41 | The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. ( Mumford, SL; Naimi, AI; Perkins, NJ; Platt, RW; Schisterman, EF; Silver, RM; Sjaarda, LA, 2021) |
| "The aim of the study is to evaluate the effects of supplementation with Arginine (L-Arg) 3g, (together with Magnesium (Mg) 350 mg and Salicilate (Sal) 100 mg) on maternal blood pressure (BP), uterine artery doppler PI and neonatal outcomes in women with high-risk pregnancy for chronic hypertension (CH) and other previous placenta vascular disorders (PVD) already treated with low dose of aspirin (LDA), as recommended by guidelines." | 9.41 | Effect of L-arginine supplementation in pregnant women with chronic hypertension and previous placenta vascular disorders receiving Aspirin prophylaxis: a randomized control trial. ( Basile, L; Facchinetti, F; Menichini, D; Monari, F; Neri, I; Pignatti, L, 2021) |
| "To examine the possible risk factors amongst maternal characteristics, medical and obstetric history, pre-eclampsia (PE)-specific biomarkers and estimated-risk group, according to The Fetal Medicine Foundation (FMF) algorithm, that are associated with the development of preterm PE with delivery at < 37 weeks' gestation despite aspirin prophylaxis." | 9.41 | ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis. ( Martinez-Portilla, RJ; Poon, LC; Rolnik, DL; Shen, L, 2021) |
| " Meta-analyses of low-dose aspirin to prevent pre-eclampsia suggest that the incidence of preterm birth might also be decreased, particularly if initiated before 16 weeks of gestation." | 9.34 | Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. ( Achieng, E; Bose, CL; Carlo, WA; Chicuy, J; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Garces, A; Goco, N; Goldenberg, RL; Goudar, SS; Hemingway-Foday, J; Hibberd, PL; Hoffman, MK; Jessani, S; Kodkany, BS; Koso-Thomas, M; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Miodovnik, M; Moore, J; Mwapule, A; Mwenechanya, M; Nolen, TL; Nyongesa, P; Okitawutshu, J; Patel, A; Saleem, S; Silver, R; Somannavar, M; Tshefu, A; Zehra, F, 2020) |
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 9.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "To evaluate the preventive effects of low-dose aspirin on the incidence of preeclampsia and pregnancy outcomes of women at high-risk for preeclampsia." | 9.34 | Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: A randomized controlled trial from Shanghai, China. ( Gu, W; Hou, YY; Huang, HF; Lin, J; Lin, N; Shang, J; Song, MF; Zeng, WJ, 2020) |
| " The subjects of the study were randomly assigned into two groups of intervention and control to receive either 80 mg of aspirin or placebo daily during the pregnancy." | 9.34 | The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia. ( Abdi, N; Alavi, A; Asadi, N; Hessami, K; Kasraeian, M; Rozrokh, A; Vafaei, H; Zare, S, 2020) |
| "We observed no significant difference in UtA-PI between the two doses of aspirin, but we observed low rates of fetal growth restriction and preterm and early-onset preeclampsia (all less than 5%)." | 9.34 | A Pilot Randomized Trial Comparing the Effects of 80 versus 160 mg of Aspirin on Midtrimester Uterine Artery Pulsatility Index in Women with a History of Preeclampsia. ( Bujold, E; Côté, S; Ferreira, E; Girard, M; Guerby, P; Leclair, G; Roberge, S; Tapp, S, 2020) |
| "This study aimed to evaluate the maternal and fetal results in women undergoing antihypertensive therapy (low aspirin or labetalol) with mild to severe chronic hypertension relative to women without medicines." | 9.34 | Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo. ( Wang, F; Xiang, X; Zhao, N; Zhou, Z, 2020) |
| "To evaluate the effect of adjuvant low-dose aspirin therapy on clinical pregnancy rate and uterine perfusion in women undergoing frozen-thawed embryo transfer (FET) cycles." | 9.30 | Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial. ( Ahmadi, F; Bagheri Lankarani, N; Bahmanabadi, A; Jahangiri, N; Madani, T, 2019) |
| "This article evaluates the effect of low-dose aspirin on uterine artery (UtA) Doppler, placental volume, and vascularization flow indices in low-risk pregnancy." | 9.30 | The Impact of Aspirin on Ultrasound Markers of Uteroplacental Flow in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Breathnach, F; Cody, F; Cotter, A; Daly, S; Dicker, P; Dornan, S; Higgins, J; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Morrison, JJ; Mulcahy, C; Tully, E, 2019) |
| "To assess the effect of aspirin use in low-risk pregnancy on: (1) pregnancy-associated plasma protein-A (PAPP-A) and placental-like growth factor (PLGF); (2) urinary albumin-to-creatinine ratio (ACR) and blood pressure; (3) fetal growth parameters; and (4) placental histopathology." | 9.30 | Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Clarke, P; Culliton, M; Downey, P; Fitzgerald, D; Maguire, OC; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Mooney, EE; Mulcahy, C; Tully, E, 2019) |
| "The EAGeR trial randomly assigned 1228 women with a history of pregnancy loss to receive 81 mg aspirin or placebo for up to six menstrual cycles of attempting pregnancy and, if they became pregnant, throughout pregnancy." | 9.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| "There is a reduction in the total drug metabolite concentration of aspirin in pregnancy, and therefore a dose adjustment is potentially required in pregnant women." | 9.30 | A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy. ( Chau, K; Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Makris, A; Münch, G; Shanmugalingam, R; Wang, X; Xu, B, 2019) |
| "Our objective was to determine whether low-dose aspirin reduces the rate of spontaneous preterm birth in nulliparous women without medical comorbidities." | 9.27 | Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. ( Andrikopoulou, M; Gyamfi-Bannerman, C; Handal-Orefice, R; Purisch, SE, 2018) |
| " Trial will be individually randomized with one-to-one ratio (intervention/control) Population: Nulliparous women between the ages of 14 and 40, with a singleton pregnancy between 6 0/7 weeks and 13 6/7 weeks gestational age (GA) confirmed by ultrasound prior to enrollment, no more than two previous first trimester pregnancy losses, and no contraindications to aspirin." | 9.24 | A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study. ( Bose, CL; Carlo, WA; Chomba, E; Derman, RJ; Esamai, F; Garces, A; Goco, N; Goldenberg, RL; Goudar, SS; Hambidge, KM; Hemingway-Foday, JJ; Hibberd, PL; Hoffman, MK; Kodkany, BS; Koso-Thomas, M; Krebs, NF; Liechty, EA; Lokangaka, A; McClure, EM; Miodovnik, M; Mwenechanya, M; Patel, A; Saleem, S; Silver, R; Tshefu, A; Wallace, DD, 2017) |
| " It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia." | 9.24 | Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Gizurarson, S; Janga, D; Jani, JC; Maclagan, K; Meiri, H; Molina, FS; Nicolaides, KH; O'Gorman, N; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Singh, M; Syngelaki, A; Tenenbaum-Gavish, K; Wright, D, 2017) |
| "Among women with a single, recent pregnancy loss, daily preconception low-dose aspirin (LDA) increased the live birth rate with no effect on pregnancy loss." | 9.24 | Low-Dose Aspirin and Sporadic Anovulation in the EAGeR Randomized Trial. ( Chen, Z; Galai, N; Lesher, LL; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Wactawski-Wende, J, 2017) |
| "There is a lack of evidence for pre-eclampsia prophylaxis with aspirin in women with pre-existing diabetes mellitus (DM)." | 9.22 | Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: Systematic review. ( Alahakoon, TI; Cheung, NW; Haider, R; Jesudason, S; Lee, VW; Nolan, CJ; Padmanabhan, S; Peek, M; Simmons, D; Zen, M, 2022) |
| "To examine whether combined treatment with low-molecular-weight heparin (LMWH) and aspirin reduces recurrent hypertensive disorders of pregnancy (HD: pre-eclampsia, eclampsia or HELLP syndrome) in women with antiphospholipid antibodies (aPLA) and a previous delivery for HD and/or small-for-gestational-age (SGA) birthweight before 34 weeks gestation." | 9.22 | Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. ( Bezemer, D; de Vries, JI; Hague, WM; van Hoorn, ME; van Pampus, MG, 2016) |
| "The objective of this study is to determine whether low-dose aspirin (LDA) reduced the rate of preterm birth (PTB) in a cohort of women at high risk for preeclampsia." | 9.22 | The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial. ( Allshouse, AA; Heyborne, KD; Jessel, RH, 2016) |
| "The objective of the study is to evaluate low-dose aspirin (LDA) for pre-eclampsia prevention in twin gestations with elevated maternal serum human chorionic gonadotropin (hCG)." | 9.22 | Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin. ( Allshouse, AA; Euser, AG; Heyborne, KD; Metz, TD, 2016) |
| "We propose a three armed multi-center open-labeled randomized control trial of; (i) routine LDA, (ii) no aspirin, and (iii) LDA on the basis of a positive first trimester pre-eclampsia screening test." | 9.22 | An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol. ( Breathnach, F; Culliton, M; Dicker, P; Downey, P; Malone, FD; McAuliffe, FM; McCormack, D; McParland, P; Mone, F; Mulcahy, C; Stanton, A; Tully, E, 2016) |
| "The aim of this study is to analyze the effect of 100 mg/d regular oral intake of aspirin during pregnancy on high-risk pregnancy-induced hypertension syndrome patients." | 9.22 | Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients. ( Li, L; Liu, FM; Wang, M; Yang, HL; Zhao, M, 2016) |
| "Late timing of intervention and maternal obesity are potential explanations for the modest effect of aspirin for preeclampsia prevention." | 9.20 | Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy? ( Abramovici, AR; Biggio, JR; Cantu, JA; Edwards, RK; Jauk, VR; Owen, J; Tita, AT, 2015) |
| "Aspirin supplementation was associated with worse outcomes related to preterm birth in smokers in a high-risk but not low-risk cohort." | 9.20 | Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth. ( Abramovici, A; Biggio, J; Cantu, J; Edwards, R; Jauk, V; Tita, A; Wetta, L, 2015) |
| "The objective was to determine the effect of preconception-initiated daily low-dose aspirin (LDA; 81 mg/day) treatment on time to pregnancy in women with a history of pregnancy loss." | 9.20 | Preconception low dose aspirin and time to pregnancy: findings from the effects of aspirin in gestation and reproduction randomized trial. ( Chen, Z; Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Stanford, JB; Townsend, JM; Tsai, MY; Wactawski-Wende, J; Zarek, SM, 2015) |
| "To evaluate the association between low-dose aspirin initiated before conception and the risk of preterm birth." | 9.20 | Low-dose aspirin and preterm birth: a randomized controlled trial. ( Ahrens, K; Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L; Townsend, JM; Wactawski-Wende, J; Wong, LF, 2015) |
| "To estimate the effect of early administration of aspirin on the prevention of pre-eclampsia in high-risk women." | 9.20 | Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. ( Goetzinger, KR; Odibo, AO; Odibo, L; Tuuli, MG, 2015) |
| "To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2." | 9.19 | Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014) |
| "To determine the maternal and neonatal efficacy and safety with furosemide, amlodipine or aspirin in women with mild/moderate chronic hypertension during pregnancy." | 9.19 | Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial. ( Dominguez, L; Solis, A; Vigil-De Gracia, P, 2014) |
| "Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed." | 9.19 | Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. ( Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Townsend, JM; Wactawski-Wende, J, 2014) |
| "The aim of the present study was to investigate the clinical value of low‑dose aspirin in combination with Tiao Jing Cu Yun pills in patients with polycystic ovary syndrome (PCOS) by measuring follicular peripheral blood flow parameters and the clinical efficacy." | 9.19 | Effects of combining low‑dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome. ( Du, B; Jiang, X; Ma, M; Shi, L; Zhang, Q; Zhao, Y; Zhou, L, 2014) |
| "Adding low-molecular-weight heparin (LMWH) to aspirin at < 12 weeks gestation reduces the recurrence of HD in women with previous early-onset HD (pre-eclampsia, hemolysis, elevated liver enzymes and low platelets [HELLP] syndrome and eclampsia) and/or SGA, in the context of inheritable thrombophilia without antiphospholipid antibodies." | 9.16 | Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. ( Bezemer, PD; de Vries, JI; Hague, WM; Joosten, JH; van Pampus, MG, 2012) |
| "The present study investigated if acetyl salicylic acid (ASA) and terbutaline in combination increased the clinical pregnancy rate in patients undergoing in vitro fertilisation (IVF)/intra-cytoplasmic sperm injection (ICSI)." | 9.16 | Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF/ICSI? ( Bergh, A; Friberg, M; Hanevik, HI; Haraldsen, C; Kahn, JA, 2012) |
| "It has been suggested in the literature that low-dose aspirin leads to an increased number of oocytes in IVF/ICSI as well as a higher pregnancy rate." | 9.14 | Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial. ( Cabri, P; De Sutter, P; Dhont, M; Dirckx, K; Galajdova, L; Gerris, J; Merien, A, 2009) |
| "To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts." | 9.14 | Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. ( Barrett, J; Clark, CA; Crowther, MR; Gent, M; Ginsberg, JS; Hawker, GA; Kingdom, JC; Laskin, CA; Spitzer, KA, 2009) |
| "To evaluate the effect of low-dose aspirin therapy on ovarian hyperstimulation syndrome (OHSS) in an unselected group of patients undergoing in vitro fertilization (IVF)." | 9.14 | Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. ( Bódis, J; Busznyák, C; Koppán, M; Mánfai, Z; Várnagy, A; Wilhelm, F, 2010) |
| "The use of aspirin during in vitro fertilization (IVF) has been investigated for its effect on pregnancy rates after IVF." | 9.14 | Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. ( Groeneveld, E; Homburg, R; Hompes, PG; Hoozemans, DA; Lambalk, CB; Lambers, MJ; Schats, R, 2009) |
| "To assess whether treatment with enoxaparin and low-dose aspirin, along with intensive pregnancy surveillance, reduces rate of pregnancy loss compared with intensive pregnancy surveillance alone in women with history of 2 or more consecutive previous pregnancy losses, a parallel group, multicenter, randomized controlled trial was performed in the United Kingdom and New Zealand." | 9.14 | SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. ( Clark, P; Crichton, L; Greaves, M; Greer, IA; Langhorne, P; Thomson, A; Walker, ID; Whyte, S, 2010) |
| "Low-dose aspirin therapy could improve remodelling of maternal spiral arteries during early placentation and prevent subsequent pregnancy-related hypertensive disorders." | 9.14 | Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. ( Haapsamo, M; Heinonen, S; Martikainen, H; Nuojua-Huttunen, S; Räsänen, J; Tinkanen, H, 2010) |
| "Diagnosis of preeclampsia; adverse pregnancy health outcomes and complications including eclampsia, perinatal mortality, preterm birth, small for gestational age, and potential bleeding harms or infant/child harms from aspirin exposure." | 9.12 | Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. ( Henderson, JT; Redmond, N; Senger, CA; Thomas, RG; Vesco, KK, 2021) |
| " We included randomized controlled trials reporting on health-related outcomes in children (aged > 28 days) exposed to aspirin versus placebo or no treatment during pregnancy." | 9.12 | Long-term health and neurodevelopment in children after antenatal exposure to low-dose aspirin for the prevention of preeclampsia and fetal growth restriction: A systematic review of randomized controlled trials. ( de Boer, MA; Finken, MJJ; Ket, JCF; Landman, AJEMC; Leemhuis, AG; Oudijk, MA; Painter, RC; van 't Hooft, J; van Limburg Stirum, EVJ, 2021) |
| "The use of low dose aspirin (LDA) has become routine in prenatal care for a variety of diagnoses, most importantly in women with a history of preeclampsia and associated poor pregnancy outcomes." | 9.12 | Low-dose aspirin in pregnancy: who? when? how much? and why? ( Dom, AM; Mather, AR; Thorburg, LL, 2021) |
| " Aspirin prophylaxis substantially lowered the risk of pre-eclampsia, preterm birth, perinatal mortality, and intrauterine growth retardation without elevated bleeding risks." | 9.12 | Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis. ( Choi, YJ; Shin, S, 2021) |
| "Meta-analysis was used to evaluate the efficacy and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome (PCOS)." | 9.12 | Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis. ( Su, F; Wang, M; Wang, Z; Yu, Q, 2021) |
| "Aspirin combined with LMWH for APS may improve live birth rate, and detection of d-dimer levels in APS pregnant women may predict pregnancy complications and guide the use of anticoagulants." | 9.12 | Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels. ( Diao, QZ; Gu, ZD; Shi, T, 2021) |
| "Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA." | 9.12 | Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006) |
| "To verify whether prophylaxis with low-molecular-weight heparin (LMWH) and low-dose aspirin (LDA) could positively affect pregnancy outcome in women with a history of severe preeclampsia." | 9.12 | Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. ( Alessandro, C; Gabriella, F; Giancarlo, P; Giorgia, S; Maria Clara, D; Sergio, F, 2006) |
| "To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women." | 9.12 | Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007) |
| "To determine if aspirin (ASA) therapy reduces the incidence of pre-eclampsia in women at high risk of this condition." | 9.11 | A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. ( Acaia, B; Chiaffarino, F; Del Giudice, A; Facchinetti, F; Marozio, L; Ossola, W; Paladini, D; Parazzini, F, 2004) |
| " Since low doses of aspirin could improve the utero-placental circulation (by shifting the prostacyclin/thromboxane A2 balance), we have evaluated the impact of low-dose aspirin treatment of IUGR during pregnancy on umbilical (UA) and middle cerebral artery (MCA) blood flow." | 9.11 | [The impact of low-dose aspirin therapy on umbilical and middle cerebral artery blood flow in pregnancy complicated by idiopathic intrauterine growth restriction]. ( Gottwald, L; Kalinka, J; Laudański, T; Lech, W; Nowakowski, M; Zdziennicki, A, 2004) |
| "The present results indicate that low-dose aspirin treatment does not have any beneficial effect on ovarian responsiveness, PR and pregnancy outcome in unselected women undergoing IVF/ICSI." | 9.11 | Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. ( Heinonen, S; Hippeläinen, M; Mäkikallio, K; Martikainen, H; Päkkilä, M; Räsänen, J; Tapanainen, JS; Tinkanen, H; Tuomivaara, L, 2005) |
| "To reduce the incidence of pre-eclampsia in nulliparous women, in accordance with the suggestion of a recent meta-analysis that low dose aspirin might decrease this incidence by more than half if used early enough in and at a sufficient dose during pregnancy (more than 75 mg)." | 9.10 | Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1). ( Biausque, S; Breart, G; Churlet, A; Goeusse, P; Lequien, P; Marquis, P; Parmentier, D; Puech, F; Subtil, D; Uzan, S, 2003) |
| "In pregnancies with impaired placentation, as demonstrated by increased impedance to flow in the uterine arteries, the daily administration of 150 mg aspirin after 23 weeks of gestation does not prevent the subsequent development of pre-eclampsia." | 9.10 | Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. ( Nicolaides, KH; Palma Dias, R; Papageorghiou, AT; Parra, M; Yu, CK, 2003) |
| "To determine the effects of low-dose aspirin on ovarian response, uterine and ovarian blood flow velocity, and implantation and pregnancy rates in patients undergoing IVF." | 9.09 | Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. ( Marazzi, A; Polak de Fried, E; Rubinstein, M, 1999) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 9.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "The objectives of the study were to confirm the validity of using oscillometric measurement of MAP in the left lateral position to identify those at high risk for developing pregnancy-induced hypertension (PIH), and to assess and compare the efficacy of prophylaxis with low-dose aspirin or calcium supplementation in high-risk patients." | 9.09 | Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. ( Fung, HY; Hung, CY; Rogers, MS, 1999) |
| "This study extends previous results on the effects of low-dose aspirin on blood pressure in pregnant women at differing risk of developing hypertension in pregnancy and who received aspirin at different times according to their rest-activity cycle." | 9.09 | Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. ( Alonso, I; Ayala, DE; Codesido, J; Fernández, JR; Hermida, RC; Iglesías, M; Mojón, A; Silva, I; Ucieda, R, 1999) |
| "To investigate the effect of low-dose, slow-release aspirin in reducing the incidence and/or severity of pregnancy complications in women identified as high risk of developing problems associated with uteroplacental insufficiency, namely pre-eclampsia or delivering a small-for-gestational age (SGA) baby." | 9.09 | A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks. ( Aquilina, J; Campbell, S; England, P; Harrington, K; Kurdi, W, 2000) |
| "Daily administration of low-dose aspirin during the second and third trimesters of pregnancy does not alter uteroplacental or fetoplacental hemodynamics and does not cause moderate or severe constriction of the ductus arteriosus." | 9.09 | Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. ( Erdmann, M; Grab, D; Kreienberg, R; Lang, D; Muche, R; Oberhoffer, R; Paulus, WE; Terinde, R, 2000) |
| "This preliminary study suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the antiphospholipid syndrome." | 9.09 | Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. ( Birdsall, M; Chamley, LW; Liddell, HS; McDougall, J; Pattison, NS; Zanderigo, AM, 2000) |
| "In patients with aPL syndrome, IVIG treatment improved pregnancy outcome, with significantly lower pregnancy complication rates, when compared with prednisone plus LDA therapy." | 9.09 | Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. ( Cesa, F; Di Pierro, G; Lazzarin, N; Menghini, S; Romanini, C; Valensise, H; Vaquero, E, 2001) |
| " The angiotensin II-sensitive women were randomized to 60 mg of aspirin or placebo as a subset of a large multicenter, randomized, controlled trial of low-dose aspirin therapy in pregnancy." | 9.08 | The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy. ( Buckley, D; de Swiet, M; Kissane, J; Kyle, PM; Redman, CW, 1995) |
| " Whether patients were assigned to aspirin or placebo, birth weight was significantly greater in women who had a twofold or greater reduction in maternal serum thromboxane B2 levels." | 9.08 | Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial. ( Copper, RL; Cutter, GR; Goldenberg, RL; Hauth, JC; Parker, CR, 1995) |
| "Our purpose was to determine the frequency and safety of the use of epidural anesthesia and the correlation between bleeding time and maternal-neonatal bleeding complications in a group of pregnant women who participated in a multicenter trial of low-dose aspirin in pregnancy." | 9.08 | Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. ( Caritis, SN; McNellis, D; Shaw, K; Sibai, BM; Thom, E, 1995) |
| "To determine any benefits or risks, expressed in early childhood, of low dose aspirin treatment in pregnancies at high risk of complications due to pre-eclampsia or intrauterine growth retardation." | 9.08 | Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group. ( , 1995) |
| "To determine the effectiveness of low dose aspirin in women at high risk of adverse outcomes associated with pre-eclampsia." | 9.08 | ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996) |
| "To assess the effect of low dose aspirin on severe pre-eclampsia when given to women identified as high risk by abnormal uterine artery Doppler ultrasound." | 9.08 | Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. ( Bower, SJ; Campbell, S; Harrington, KF; McGirr, C; Schuchter, K, 1996) |
| "The purpose of this study was to investigate the hypothesis that maternal administration of 100mg aspirin each day will improve birth-weight and other measures of neonatal size when given as a treatment to pregnancies complicated by fetal growth restriction and umbilical-placental insufficiency." | 9.08 | Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial. ( Evans, SF; Godfrey, M; Newnham, JP; Phillips, J; Walters, BJ, 1995) |
| "To analyze determinants of the risk of pregnancy-induced hypertension (PIH) with or without proteinuria, we compared characteristics of women enrolled in the Italian Study of Aspirin in Pregnancy who developed PIH and those who did not." | 9.08 | Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. ( Benedetto, C; Bortolus, R; Chatenoud, L; Marozio, L; Parazzini, F; Restelli, S; Ricci, E, 1996) |
| "This study was conducted to determine if lower dose heparin (LD Heparin) combined with aspirin is as efficacious as higher dose heparin (HD Heparin) for the treatment of the antiphospholipid antibody syndrome in women seeking pregnancy." | 9.08 | A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. ( Ermel, LD; Kutteh, WH, 1996) |
| "The purpose of this study was to determine which low dose of low dose aspirin (LDA) optimized the urinary prostacyclin (PGI2)/thromboxane (TXA2) ratio and minimized evidence of platelet aggregation during normal late pregnancy." | 9.08 | Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin/thromboxane ratios in late pregnancy. ( Branch, DW; Martin, C; Mitchell, MD; Rodgers, G; Varner, MW, 1996) |
| "The aims of this prospective study were to explore the changes in platelet angiotensin II (A-II) binding in pregnancy amongst Chinese women at high risk of developing pregnancy-induced hypertension (PIH) and the effects of low-dose aspirin and calcium supplementation on A-II binding." | 9.08 | Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension. ( Arumanayagam, M; Hung, C; Rogers, MS, 1996) |
| "There is evidence that aspirin in low doses favourably influences the course and outcome of pregnancy in women at risk of developing pregnancy-induced hypertension." | 9.08 | Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Center, Dar es Salaam. ( Mgaya, HN; Ramaiya, C, 1995) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 9.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "The use of low-dose aspirin for the prevention and treatment of pre-eclampsia and intrauterine growth restriction has been studied extensively during the last 10 years." | 9.08 | Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study. ( Bar, J; Fisch, B; Hod, M; Kaplan, B; Meizner, I; Pardo, J; Rabinerson, D, 1997) |
| "We found an association between the addition of ketanserin to aspirin and a decrease in the number of cases of pre-eclampsia and severe hypertension, as well as improved pregnancy outcome among patients with mild to moderate midtrimester hypertension." | 9.08 | Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. ( Odendaal, HJ; Steyn, DW, 1997) |
| "To determine whether low-dose aspirin reduces the incidence of pre-eclampsia, reduces perinatal mortality and improves birth weights in pregnant women considered at high risk of developing pre-eclampsia." | 9.08 | A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. ( Byaruhanga, RN; Chipato, T; Rusakaniko, S, 1998) |
| "The results of this study in Barbados do not support the routine use of low dose aspirin for prevention of pre-eclampsia or its complications, confirming results of previous large trials in other settings." | 9.08 | Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. ( Ayers, S; Collins, R; Cruickshank, JK; Duley, L; Farrell, B; Gay, MP; Grant, A; Griffiths, J; Hennis, A; Rotchell, YE; Stewart, A, 1998) |
| "To investigate whether low dose aspirin medication given to primiparous women provides benefit in preventing pre-eclampsia or intrauterine growth retardation." | 9.08 | A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. ( Golding, J, 1998) |
| "The objective of the matched, controlled study was to determine whether low-dose aspirin therapy without heparin improves pregnancy rates following frozen embryo transfer." | 9.08 | A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. ( Check, JH; Chuong, J; Dietterich, C; Lurie, D; Nazari, A, 1998) |
| "Forty-six nulliparous women in third trimester of pregnancy with a raised blood pressure of 30 mm Hg (systolic) or/and 15 mm Hg (diastolic) or both, over baseline values were treated with 75 mg of aspirin per day." | 9.07 | A study of use of low dose aspirin in prevention of pregnancy induced hypertension. ( Pan, S; Roy, UK, 1994) |
| "Meta-analysis of data from several controlled trials has shown that low-dose aspirin reduces the risk of pregnancy-induced hypertension (PIH) and intrauterine growth retardation (IUGR) in women at high risk of these disorders." | 9.07 | Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy. ( , 1993) |
| "Effectiveness of early administered low-dose aspirin in prevention of pregnancy-induced hypertension (PIH) and fetal growth retardation in twin pregnancies was investigated in a randomized placebo controlled, double-blind trial in 47 twin pregnancies." | 9.07 | Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. ( Arieli, S; Bukovski, I; Caspi, E; Raziel, A; Sherman, D; Weinraub, Z, 1994) |
| "To study the effect of daily treatment with 50 mg of aspirin (ASA) on the hypertensive pregnancy complications and on the production prostacyclin (PGI2) and thromboxane A2 (TxA2) in high risk pregnant women and their infants." | 9.07 | Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. ( Hartikainen-Sorri, AL; Hiilesmaa, V; Lumme, R; Viinikka, L; Ylikorkala, O, 1993) |
| "Daily ingestion of 60 mg of aspirin beginning at 24 weeks' gestation significantly reduced the occurrence of preeclampsia." | 9.07 | Low-dose aspirin therapy to prevent preeclampsia. ( Copper, RL; Cutter, GR; DuBard, MB; Goldenberg, RL; Hauth, JC; Parker, CR; Philips, JB, 1993) |
| "Low dose aspirin would appear to be an appropriate agent for the inhibition of platelet reactivity associated with hypertensive pregnancy." | 9.07 | A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. ( Broughton Pipkin, F; Fox, S; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1992) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 9.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia." | 9.07 | Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991) |
| "The effect of low doses of aspirin on women with mild pregnancy-induced hypertension was investigated by means of a prospective, randomized, double-blind trial." | 9.06 | Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. ( Barkai, G; Ben-Baruch, G; Mashiach, S; Schiff, E, 1990) |
| "We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism." | 9.06 | The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. ( Barkai, G; Ben-Baruch, G; Blankstein, J; Goldenberg, M; Peleg, E; Rosenthal, T; Ruppin, E; Schiff, E; Tamarkin, M; Yahal, I, 1989) |
| "There is evidence that aspirin in low doses favorably influences the course of pregnancy-induced hypertension, but the mechanism, although assumed to involve suppression of the production of thromboxane by platelets, has not been established." | 9.06 | Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. ( Ballerini, S; Benigni, A; Chiabrando, C; Fanelli, R; Frusca, T; Gregorini, G; Orisio, S; Piccinelli, A; Pinciroli, V; Valcamonico, A, 1989) |
| "The possibility of preventing pregnancy-induced hypertension (PIH) and pre-eclampsia in primigravidae by suppressing production of thromboxane A2 with low-dose aspirin was investigated in a randomised, placebo-controlled, double-blind trial." | 9.06 | Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. ( Dekker, GA; Makovitz, JW; Rotmans, P; Wallenburg, HC, 1986) |
| "A randomized, placebo-controlled, double-blind trial was carried out to evaluate the fetal benefits of low-dose aspirin (150 mg/day) as a treatment of placental insufficiency during the last trimester of pregnancy." | 9.06 | Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. ( Connelly, A; Cook, CM; Giles, WB; Thompson, RS; Trudinger, BJ, 1988) |
| " Low-dose aspirin and dipyridamole direct prostacyclin/thromboxane A2 balance in pregnancy to the dominance of prostacyclin and may thus prevent idiopathic uteroplacental insufficiency and fetal growth retardation in high-risk patients." | 9.06 | Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. ( Rotmans, N; Wallenburg, HC, 1987) |
| "Since the 1970s, we have known that aspirin can reduce the risk of pre-eclampsia." | 9.05 | Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition? ( Danser, AHJ; Mirabito Colafella, KM; Neuman, RI; Versmissen, J; Visser, W, 2020) |
| "We performed a systematic review and meta-analysis to evaluate the effect of low-dose aspirin initiated at <11 weeks' gestation on the risk of preeclampsia, gestational hypertension, or any hypertensive disorder of pregnancy." | 9.05 | Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia? ( Chaemsaithong, P; Cuenca-Gomez, D; Gil, MM; Plana, MN; Poon, LC, 2020) |
| "For the past decades, growing attention has been given to aspirin use during pregnancy." | 9.05 | Aspirin for prevention of preeclampsia and fetal growth restriction. ( Guerby, P; Hamdi, SM; Loussert, L; Parant, O; Vayssiere, C; Vidal, F, 2020) |
| "Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL)." | 9.05 | Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. ( Goddijn, M; Hamulyák, EN; Marijnen, MC; Middeldorp, S; Scheres, LJ, 2020) |
| "Benefits of aspirin administration on pre-eclampsia and IUGR depend on the gestational age and dose of aspirin administration." | 9.05 | Prophylactic aspirin for preventing pre-eclampsia and its complications: An overview of meta-analyses. ( Banach, M; Ghazanfarpour, M; Jamialahmadi, T; Sahebkar, A; Sathyapalan, T, 2020) |
| " Over the past three decades, studies have investigated the role of aspirin in preeclampsia prevention, yielding some promising results for certain at-risk groups, yet unconvincing evidence of benefit among women with pre-pregnancy diabetes." | 9.05 | The Role of Aspirin for Preeclampsia Prevention in Women with Diabetes. ( Breathnach, FM; Finnegan, C, 2020) |
| "We studied 160 postpartum women having moderate to severe episiotomy pain to determine the efficacy of aspirin analgesia, with 5, 10, and 20 grain doses, as compared to placebo." | 9.05 | Aspirin in the treatment of episiotomy pain. ( Feldman, S; Goldstein, PJ; London, RS; Sundaram, GS, 1983) |
| "In a double-blind, randomized controlled trial among 500 post-partum patients experiencing moderate to severe pain, a single oral dose of an aspirin/caffeine combination (800 mg aspirin, 65 mg caffeine) provided significantly more pain relief at 2 hours than did a higher dose of an acetaminophen/aspirin combination (648 mg acetaminophen, 648 mg aspirin) and a higher dose of acetaminophen alone (1000 mg acetaminophen)." | 9.05 | A double-blind randomized study of an aspirin/caffeine combination versus acetaminophen/aspirin combination versus acetaminophen versus placebo in patients with moderate to severe post-partum pain. ( Rubin, A; Winter, L, 1984) |
| "One investigator at each of 4 institutions followed the requirements of a core protocol designed to evaluate propoxyphene napsylate (50, 100 and 150 mg), fenoprofen calcium (200, 400 and 600 mg) and their combination (50/200, 100/400 and 150/600 mg) in patients reporting postpartum pain." | 9.04 | A multicenter study for analgesia involving fenoprofen, propoxyphene [alone or in combination] with placebo and aspirin controls in postpartum pain. ( Bauer, RO; Bettigole, JB; Gruber, CM; Lash, AF; McDonald, JS, 1979) |
| "The analgesic efficacy of oral naproxen and its sodium salt was compared with that of aspirin and codeine in two separate trials involving 140 and 90 patients, respectively, with postpartum uterine pain in a single-dose, parallel, stratified, randomized, placebo-controlled, double-blind design." | 9.04 | Naproxen, aspirin, and codeine in postpartum uterine pain. ( Barden, TP; Bloomfield, SS; Mitchell, J, 1977) |
| "The analgesic efficacy of fendosal, a new nonsteroidal anti-inflammatory agent structurally related to salicylic acid, was compared with that of aspirin and placebo in 100 patients with postpartum uterine pain in a single oral dose, parallel, stratified, randomized, double-blind design." | 9.04 | Fendosal and aspirin in postpartum uterine pain. ( Barden, TP; Bloomfield, SS; Mitchell, J, 1978) |
| "An improvement of pregnancy outcomes in women with RSA and APS can be achieved by treatment strategies combining low-dose aspirin plus heparin or heparin alone." | 9.01 | Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. ( Jiang, HL; Liu, Y; Lu, C, 2019) |
| "Indications for aspirin during pregnancy are a matter of debate and there is a recent trend to an extended prescription and an overuse of aspirin in pregnancy." | 9.01 | [Aspirin and preeclampsia]. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2019) |
| "We performed a systematic review and metaanalysis that evaluated the prophylactic effect of aspirin during pregnancy." | 8.98 | Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. ( Bujold, E; Nicolaides, KH; Roberge, S, 2018) |
| "We aimed to estimate the effect of aspirin on the risk of placental abruption or antepartum hemorrhage in relation to gestational age at onset of therapy and the dosage of the drug." | 8.98 | Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. ( Bujold, E; Nicolaides, KH; Roberge, S, 2018) |
| "To assess the accuracy of the National Institute of Health and Care Excellence (NICE) and United States Preventive Services Task Force (USPSTF) guidelines for predicting pre-eclampsia in pregnancy to guide aspirin prophylaxis." | 8.98 | Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis. ( Al-Rubaie, ZTA; Askie, LM; Hudson, HM; Jenkins, G; Lord, SJ; Ray, JG, 2018) |
| "We sought to estimate the impact of aspirin dosage on the prevention of preeclampsia, severe preeclampsia, and fetal growth restriction." | 8.95 | The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. ( Bujold, E; Chaillet, N; Demers, S; Hyett, J; Nicolaides, K; Roberge, S, 2017) |
| "To determine in women with hereditary thrombophilia whether the use of the combination of low-molecular-weight heparin (LMWH) and aspirin (ASA) is better than ASA alone." | 8.93 | Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. ( Areia, AL; Areia, M; Fonseca, E; Moura, P, 2016) |
| "The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 8.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
| "To estimate the impact of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin started ≤ 16 weeks' gestation on the prevalence of pre-eclampsia (PE) and the delivery of a small-for-gestational-age (SGA) neonate." | 8.93 | Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. ( Bujold, E; Bureau, M; Côté, S; Demers, S; Nicolaides, KH; Roberge, S, 2016) |
| " Individual patient data meta-analysis indicates that low-dose aspirin causes a 10% risk reduction in pre-eclampsia for women at high individual risk." | 8.93 | Low dose aspirin and pregnancy: how important is aspirin resistance? ( Alfirevic, A; Alfirevic, Z; Navaratnam, K, 2016) |
| "Low-dose aspirin (LDA) is thought to prevent preeclampsia in high-risk pregnancy, but it is not universally used out of concern for its efficacy and safety." | 8.91 | Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis. ( Deng, CY; Huang, GQ; Li, JK; Wang, XD; Xu, TT; Zhou, F, 2015) |
| "In high-risk pregnancies, early aspirin intervention starting before 16 weeks of gestation can prevent PIH, preeclampsia, IUGR, and preterm birth and help to increase the birth weight." | 8.91 | [Early intervention with aspirin for preventing preeclampsia in high-risk women: a meta-analysis]. ( Wu, H; Yao, S; Yu, Y, 2015) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 8.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "The aim of this study is to review literature about the efficacy of low dose aspirin (LDA) and vitamins C/E (VCE) to prevent pre-eclampsia in women at high and low risk." | 8.87 | Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. ( Mullin, PM; Rossi, AC, 2011) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 8.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "To estimate the effect of low-dose aspirin started in early pregnancy on the incidence of preeclampsia and intrauterine growth restriction (IUGR)." | 8.86 | Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. ( Audibert, F; Bujold, E; Bureau, M; Forest, JC; Giguère, Y; Lacasse, Y; Marcoux, S; Roberge, S, 2010) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 8.86 | WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, G, 2010) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia." | 8.85 | Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. ( Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2009) |
| "Investigate cost-effectiveness of first trimester pre-eclampsia screening using the Fetal Medicine Foundation (FMF) algorithm and targeted aspirin prophylaxis in comparison with standard care." | 8.84 | First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study. ( Ammari, C; Casagrandi, D; Hillman, S; Napolitano, R; Nzelu, D; Palmer, T; Pandya, P; Stott, D, 2024) |
| "We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes." | 8.82 | Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003) |
| "The purpose of this study was to determine, on the basis of published reports, whether aspirin use during the first trimester of pregnancy is associated with an increased risk of congenital malformations." | 8.81 | Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. ( Boskovic, R; Costei, A; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2002) |
| " Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication." | 8.81 | Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002) |
| " In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i." | 8.80 | [Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 8.80 | Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, GL, 2000) |
| "To perform a meta-analysis determining the association of low-dose aspirin treatment with subsequent abruptio placentae or perinatal mortality." | 8.79 | Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. ( Cliver, SP; Cutter, GR; Goldenberg, RL; Hauth, JC; Parker, CR, 1995) |
| "Recent surveys of prenatal drug consumption indicate that aspirin is the most frequently consumed drug in pregnancy." | 8.75 | Aspirin in pregnancy: maternal and fetal effects. ( Corby, DG, 1978) |
| "Our results demonstrated that the combination of quercetin and aspirin exerted significantly stronger effects than aspirin alone on decreasing systolic blood pressure and proteinuria, reducing pro-inflammatory cytokine production, and inhibiting M1-type decidual macrophages polarization in an LPS-induced rat model of preeclampsia." | 8.31 | Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide. ( Chen, D; Ding, J; Liu, A; Yang, S, 2023) |
| "This study aimed to investigate the association between low-dose aspirin use and preterm birth among women with a previous preterm birth." | 8.31 | Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Kupka, E; Lomartire, R; Wikström, AK, 2023) |
| "Treatment with curcumin and aspirin combination significantly reduced the systolic blood pressure and proteinuria in the PE rats." | 8.31 | Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats. ( Feng, Y; Hou, X; Ju, Y; Wang, Y; Yang, M; Yang, Y; Zhang, X; Zhu, X, 2023) |
| "The purpose of this study was to assess obstetrician-gynecologist utilization of low-dose aspirin for women at increased risk for hypertensive disorders of pregnancy using guidelines developed by the American College of Obstetricians and Gynecologists and supported by the United States Preventive Services Task Force." | 8.31 | Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention. ( Holmgren, C; Phelps, AJD, 2023) |
| "Hydroxychloroquine combined with low-dose aspirin can effectively improve the pregnancy outcomes of pregnant women with SLE by affecting the levels of T helper (Th) 2 and Th1 cytokines." | 8.31 | Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus. ( Li, Y; Li, YW; Zhang, HX; Zhang, N, 2023) |
| "We demonstrate the estimation of incremental effects in the time-varying setting, using data from the Effects of Aspirin in Gestation and Reproduction trial, which assessed the effect of preconception low-dose aspirin on pregnancy outcomes." | 8.31 | Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy. ( Kennedy, EH; Kim, K; Naimi, AI; Rudolph, JE, 2023) |
| "This study aimed to evaluate whether there is an association between the US Preventive Services Taskforce aspirin guideline hypertensive disorders of pregnancy and the rates of hypertensive disorders of pregnancy and preterm birth in individuals with pregestational diabetes mellitus." | 8.31 | Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus. ( Allshouse, AA; Bruno, AM; Metz, TD; Theilen, LH, 2023) |
| "Many clinical trials have reported that low-dose aspirin decreases the risk of pre-eclampsia in women with prior pre-eclampsia." | 8.31 | Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study. ( Blacher, J; Deneux-Tharaux, C; Gabet, A; Grave, C; Kretz, S; Lailler, G; Olie, V; Plu-Bureau, G; Regnault, N; Tsatsaris, V, 2023) |
| "To investigate the effectiveness of low-dose aspirin (LDA) in the prevention of pre-eclampsia (PE) among otherwise low-risk twin gestations." | 8.31 | Reconsidering the effectiveness of low-dose aspirin in prevention of pre-eclampsia among otherwise low risk twin gestations: A historical cohort study. ( Brantz, Y; Farhi, A; Lerner-Geva, L; Maymon, D; Mazaki-Tovi, S; Meyer, R; Toussia-Cohen, S; Tsur, A; Yinon, Y; Zaslavsky-Paltiel, I, 2023) |
| "Prophylactic low-dose aspirin reduces the rates of preeclampsia, preterm birth, fetal growth restriction, and perinatal death in patients with risk factors for preeclampsia." | 8.31 | Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement. ( Combs, CA; Kumar, NR; Morgan, JL, 2023) |
| "To evaluate the prevalence and perinatal repercussions of preeclampsia (PE) after the implementation of a prophylaxis protocol with aspirin in singleton pregnancy at Maternity School of Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (2015-2106)." | 8.31 | The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin. ( Amim, J; Bornia, RG; Cardoso, FFO; Cardoso, MIMP; Costa Junior, IB; Da Matta, FG; Gama, LB; Rezende, KBC; Saunders, C, 2023) |
| "Adherence to low-dose aspirin is key in preventing pre-eclampsia." | 8.31 | Let's talk aspirin: A survey of barriers and facilitators faced by midwives when engaging in conversations about aspirin with women at risk of pre-eclampsia. ( Araújo-Soares, V; Farnworth, A; Hiu, S; McParlin, C; Smith, V; Vinogradov, R, 2023) |
| "Current guidelines recommend low-dose aspirin for preeclampsia prophylaxis in all women with pregestational (type one and type two) diabetes mellitus." | 8.12 | Associations between aspirin prophylaxis and fetal growth and preeclampsia in women with pregestational diabetes. ( Graham, DF; Shrestha Khatri, N; White, SW, 2022) |
| "To compare the predictive performance for preterm-pre-eclampsia (PE) in first-trimester screening by serum placental growth factor (PlGF) versus pregnancy associated plasma protein-A (PAPP-A), in combination with maternal risk factors, mean arterial pressure (MAP) and uterine artery pulsatility index (UtA-PI), after adjustment for the effect of aspirin in women receiving this treatment." | 8.12 | Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment. ( Nicolaides, KH; O'Gorman, N; Syngelaki, A; Tan, MY; Wright, D, 2022) |
| "To evaluate the association between aspirin use during first pregnancy and later maternal cardiovascular risk." | 8.12 | Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study. ( Bairey Merz, N; Barnes, S; Catov, J; Chung, JH; Greenland, P; Grobman, W; Haas, D; Hoffman, M; Levine, LD; McNeil, R; Mercer, B; Parker, CB; Saade, G; Shanks, A; Silver, RM; Simhan, H; Theilen, LH; Thorsten, V; Varagic, J; Wapner, R, 2022) |
| "To estimate whether low-dose aspirin use is associated with an altered risk of delivering a small-for-gestational age (SGA) neonate among women with a history of having an SGA neonate in a prior pregnancy." | 8.12 | Low-Dose Aspirin for Preventing Birth of a Small-For-Gestational Age Neonate in a Subsequent Pregnancy. ( Bergman, L; Cluver, CA; Hastie, R; Hesselman, S; Kupka, E; Lindquist, A; Tong, S; Walker, SP; Wikström, AK, 2022) |
| "Clinical studies suggest that early pregnancy is the critical window for the prevention of preeclampsia by low-dose aspirin (LDA)." | 8.12 | Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway. ( Feng, L; Jing, S; Xie, H; Zhang, H; Zhang, J, 2022) |
| "The use of 100 mg of aspirin a day before the 20th week of pregnancy in high risk pregnant patients decreased the risk of developing PREEC, regardless the age and risk factors." | 8.12 | [Use of aspirin 100 mg / day to prevent Preeclampsia, in high risk pregnancies, in a cohort from Argentina]. ( Espeche, WG; Minetto, J; Salazar, MR, 2022) |
| "To evaluate the implementation of low-dose aspirin in pregnancy for the prevention of utero-placental complications among gynecologists in the Netherlands between 2016 and 2021." | 8.12 | Improved implementation of aspirin in pregnancy among Dutch gynecologists: Surveys in 2016 and 2021. ( Bij de Weg, JM; de Boer, MA; de Groot, CJM; de Vries, JIP; Oudijk, MA; Visser, L, 2022) |
| "To assess the clinical efficacy of intravenous immunoglobulin G (IVIG) administration combined with low-dose aspirin in women with unexplained recurrent pregnancy loss (RPL)." | 8.12 | Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. ( Chae, HD; Kim, JH; Kim, SH; Ko, Y; Lee, SR; Yang, N, 2022) |
| "The objective of the study was to compare the efficacy of low-molecular weight heparin (LMWH) alone and use in the combination with aspirin in the treatment of fetal growth restriction (FGR) patients." | 8.12 | Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction. ( He, S; Liang, L, 2022) |
| "Aspirin is a common drug for the treatment of pre-eclampsia." | 8.12 | Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome. ( Chen, D; Ding, J; Song, L; Yang, S; Zhang, J; Zhang, Y, 2022) |
| "We retrospectively included a total of 2,763 patients with 2,856 fetuses (2670 singleton births and 93 pairs of twins), among whom 1,684 took low dose aspirin (LDA) during pregnancy (the LDA group) and the other 1,079 were not exposed to LDA (the control group)." | 8.12 | Effect of low dose aspirin application during pregnancy on fetal congenital anomalies. ( Li, C; Qian, H; Sun, S; Wang, Q; Zhao, A, 2022) |
| "In this post hoc study, arachidonic acid (AA)-induced platelet aggregation during pregnancy with and without acetylsalicylic acid (ASA) treatment was studied in 323 women with unexplained recurrent first-trimester miscarriage and in 59 healthy women with normal pregnancies." | 8.12 | Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study. ( Blomqvist, LRF; Hellgren, MSE; Jeppsson, A; Strandell, AM, 2022) |
| "To determine the impact of low-dose aspirin (81 mg) on markers of maternal inflammation and placental function." | 8.12 | The impact of low-dose aspirin on markers of inflammation and placental function: an ancillary study of the ASPIRIN trial. ( Araganji, R; Goudar, SS; Hoffman, MK; Kavi, A; Somannavar, MS; Vernekar, SS, 2022) |
| "To assess the differences in Doppler parameters of endometrial receptivity in unexplained recurrent biochemical pregnancy loss (URBPL) and the therapeutic effect of low-dose aspirin (LDA)." | 8.12 | Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss. ( Bai, W; Guo, F; Wang, Q; Zhang, X; Zhao, A, 2022) |
| "The USPSTF concludes with moderate certainty that there is a substantial net benefit of daily low-dose aspirin use to reduce the risk for preeclampsia, preterm birth, small for gestational age/intrauterine growth restriction, and perinatal mortality in pregnant persons at high risk for preeclampsia." | 8.02 | Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. ( Barry, MJ; Cabana, M; Caughey, AB; Davidson, KW; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Li, L; Mangione, CM; Ogedegbe, G; Pbert, L; Silverstein, M; Simon, MA; Stevermer, J; Tseng, CW; Wong, JB, 2021) |
| " Digital tools such as the MyHealthyPregnancy app might offer an opportunity to improve identification of patients at risk for preeclampsia and communication with these patients about aspirin use." | 8.02 | Use of a Smartphone App to Explore Potential Underuse of Prophylactic Aspirin for Preeclampsia. ( Bernard, M; Davis, AL; Hayani, L; Krishnamurti, T; Rodriguez, S; Simhan, HN, 2021) |
| " Among 932 women, 277 in the First Affiliated Hospital of Chongqing Medical University were routinely treated with aspirin (100 mg daily) from 12 to 16 weeks to 35 weeks of gestational age, while 655 in Chongqing Health Center for Women and Children were not taking aspirin during pregnancy." | 8.02 | Low-dose aspirin for primary prevention of adverse pregnancy outcomes in twin pregnancies: an observational cohort study based on propensity score matching. ( Baker, P; Kilby, MD; Liu, X; Liu, Y; Qi, H; Saffery, R; Tong, C; Wang, L; Wen, L; Ye, Y, 2021) |
| "Aspirin is widely used to prevent pregnancy related vascular disorders such as preeclampsia (PE), intrauterine growth restriction and maternal disorders." | 8.02 | Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis. ( Dorsamy, V; Khaliq, OP; Mkhize, PZ; Moodley, J; Phoswa, WN, 2021) |
| "Decision tree analysis was created using R software to evaluate four approaches to aspirin prophylaxis in the United States: no aspirin, United States Preventive Service Task Force (USPSTF) with Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) hypertension guidelines, USPSTF with ACC/AHA hypertension guidelines, as well as universal aspirin prophylaxis." | 8.02 | The Impact of the New Hypertension Guidelines to Low-Dose Aspirin Prophylaxis Eligibility for the Prevention of Preeclampsia: A Cost-Benefit Analysis. ( Balasooriya, MM; Boscia, AL; Dalkiran, E; Putra, M; Sokol, RJ, 2021) |
| "This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications." | 8.02 | Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Sandström, A; Tong, S; Wikström, AK, 2021) |
| "To evaluate the effects of low-molecular-weight heparin (LMWH) combined with low-dose aspirin (LDA) in pregnant women with a history of pregnancy-related hypertensive disorders." | 8.02 | Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study. ( Chen, Y; Shen, F; Wang, J; Yang, W; Zhang, Y; Zhou, J, 2021) |
| "Aspirin has been shown to reduce prevalence of both early-onset pre-eclampsia (ePET) and fetal growth restriction (FGR)." | 8.02 | Does aspirin prescribed to women deemed high risk for preterm pre-eclampsia at 11-13 ( Emeto, T; Hyett, J; O'Brien, C; Park, F; Phung, J, 2021) |
| "To investigate the therapeutic role of prednisone in patients having unexplained recurrent pregnancy loss (URPL) with positivity of antinuclear antibodies (ANA) and the relationship between ANA titers, prednisone, and pregnancy outcomes." | 8.02 | Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss. ( Chen, C; Guo, F; Kou, X; Li, C; Sun, S; Zhao, A, 2021) |
| "Aspirin is routinely prescribed in high-risk pregnancies to prevent pre-eclampsia; however, there is a paucity of data in women with pre-existing diabetes." | 8.02 | Aspirin and pre-eclampsia prevention in women with pre-existing diabetes: a retrospective study. ( Athayde, N; Cheung, NW; Inglis, E; Lah, S; Lee, V; Padmanabhan, S, 2021) |
| "The objective of the study was to investigate the effects of low-dose aspirin (LDA) during pregnancy on the prevention of preeclampsia in patients with chronic kidney disease (CKD)." | 8.02 | Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy... ( Chen, Q; Chen, S; He, Y; Wang, M; Yang, H; Zhao, M, 2021) |
| "Study the effect of low-dose aspirin on the endometrial receptivity in endometriosis rat models." | 8.02 | Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window. ( Li, C; Li, M; Li, R; Wang, L; Zhang, H; Zhang, J; Zhao, X, 2021) |
| "Despite being key to reducing the occurrence of pre-eclampsia in high-risk women, adherence to aspirin prophylaxis is low, reflecting multifactorial challenges faced by pregnant women." | 8.02 | Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia - A qualitative study. ( Araujo-Soares, V; Robson, SC; Smith, VJ; Vinogradov, R, 2021) |
| "Plasma from women with pre-eclampsia induced TBARS and nitrotyrosine production on endothelial and U937 cells." | 7.96 | Role of aspirin-triggered lipoxin A4, aspirin, and salicylic acid in the modulation of the oxidative and inflammatory responses induced by plasma from women with pre-eclampsia. ( Alvarez, AM; Cadavid J, AP; Gil-Villa, AM; Rojas-López, M; Velásquez-Berrío, M, 2020) |
| "The objective of this study is to investigate possible changes in aspirin resistance during and after pregnancy over time." | 7.96 | Resistance of aspirin during and after pregnancy: A longitudinal cohort study. ( Abheiden, CNH; Bij de Weg, JM; de Boer, MA; de Vries, JIP; Fuijkschot, WW; Harmsze, AM; Thijs, A, 2020) |
| "The current treatment to prevent pregnancy morbidity (PM) associated with antiphospholipid antibodies (aPL) is based on the use of low dose aspirin and low molecular weight heparin (henceforth defined as standard of care (SoC) treatment)." | 7.96 | Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. ( Cecchi, I; Cuadrado, MJ; Radin, M; Roccatello, D; Rubini, E; Schreiber, K; Sciascia, S, 2020) |
| "The study is aimed at understanding the factors, from the women's perspective, that influenced adherence with prophylactic aspirin in their pregnancy." | 7.96 | Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis. ( Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Liamputtong, P; Makris, A; Mengesha, Z; Notaras, S; Shanmugalingam, R, 2020) |
| "To evaluate the effect of low-dose aspirin, which was administered at or before the 16th week of pregnancy due to maternal characteristics and history of a pre-existing medical condition, on prevention of pre-eclampsia, and on the birth of a small-for-gestational-age (SGA) neonate without pre-eclampsia in nulliparas in primary settings." | 7.96 | Effect of current guidelines on prevention of pre-eclampsia with low-dose aspirin in primary settings: A population-based case-control study. ( Kocic, Z; Premru-Srsen, T; Verdenik, I, 2020) |
| "To compare maternal haemodynamics in women at low and high risk for preterm pre-eclampsia (PE), and between those at high risk who are randomised to aspirin or placebo." | 7.96 | Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study. ( Bisquera, A; Jara, PG; Kametas, NA; Ling, HZ; Nicolaides, KH; Poon, LC, 2020) |
| "(1) To evaluate the rates of implementation of the 2016 American College of Obstetricians and Gynecologists guideline over time; and (2) to evaluate the effectiveness of aspirin for the prevention of superimposed preeclampsia and other adverse maternal and neonatal outcomes in women with chronic hypertension before and after this guideline." | 7.96 | Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. ( Banala, C; Berghella, V; Boelig, RC; Cruz, Y; Moreno, S; Roman, A; Saccone, G; Schoen, CN, 2020) |
| "To evaluate differences in Doppler parameters and pregnancy outcomes, if any, and to determine the predictive accuracy of such indices, as well as the effects of low-dose aspirin (LDA) in unexplained recurrent pregnancy loss (URPL)." | 7.96 | Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss. ( He, L; Kang, X; Liu, F; Liu, Z; Wang, T; Zhao, A, 2020) |
| "To elucidate patients' knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP)." | 7.96 | Patients' perspective on aspirin during pregnancy: a survey. ( Abheiden, CNH; Bij de Weg, JM; de Boer, MA; de Groot, C; de Vries, JIP, 2020) |
| "A previous pilot study showed that pravastatin supplementation improved pregnancy outcomes in women with obstetric antiphospholipid syndrome (OAPS) that developed placental insufficiency despite standard of care treatment low molecular weight heparin plus low dose aspirin (LMWH + LDA)." | 7.96 | Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. ( Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K, 2020) |
| "Magnesium sulfate combined with low-dose aspirin can significantly reduce adverse reactions and effectively lower blood pressure in patients with pregnancy induced hypertension, but the overall efficacy and safety of the combination of drugs are not clear." | 7.96 | Efficacy and safety of low dose aspirin and magnesium sulfate in the treatment of pregnancy induced hypertension: A protocol for systematic review and meta-analysis. ( Chen, M; Chen, Y; He, G; Liu, X, 2020) |
| "We designed a decision analysis to compare preeclampsia-related costs and effects of four strategies for aspirin use in pregnancy initiated before 16 weeks of gestation to prevent preeclampsia." | 7.91 | Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis. ( Grobman, W; Mallampati, D; Rouse, DJ; Werner, EF, 2019) |
| "Aspirin use in pregnancy reduces the risks of maternal hypertensive disorders." | 7.91 | Aspirin use during pregnancy and hypertensive disorders in women with various risks. ( Chen, C; Jing, S; Lu, D; Xie, H; Zhang, J; Zhu, J, 2019) |
| "Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 7.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
| "To determine whether hypertensive disorders of pregnancy (HDP) increased long-term stroke risk in women in the California Teachers Study (CTS), a prospective cohort study, and whether aspirin or statin use modified this risk." | 7.91 | Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy. ( Bello, NA; Boehme, AK; Chung, NT; Elkind, MSV; Lacey, JV; Lakshminarayan, K; Miller, EC; Wang, SS; Wapner, R; Willey, JZ; Woo, D; Zhong, C, 2019) |
| " We examined whether mother's use of paracetamol, aspirin or ibuprofen in pregnancy is associated with increased risk of cerebral palsy (CP) in the child." | 7.88 | Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child. ( Andersen, AN; Andersen, GL; Andersen, PK; Liew, Z; Martinussen, T; Olsen, J; Petersen, TG; Rebordosa, C; Strandberg-Larsen, K; Tollånes, MC; Uldall, P; Wilcox, AJ, 2018) |
| "To study women who initiated aspirin in the first trimester for high risk of pre-eclampsia, and compare blood-pressure trends throughout pregnancy between those with normal outcome and those who subsequently developed pre-eclampsia." | 7.88 | Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis. ( Baschat, AA; Blitzer, MG; Block-Abraham, D; Dewberry, D; Miller, JL; Seravalli, V, 2018) |
| "Low-dose aspirin is recommended for prevention of pre-eclampsia in high-risk pregnant women." | 7.88 | Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. ( Alfirevic, A; Alfirevic, Z; Jorgensen, A; Navaratnam, K, 2018) |
| "We sought to examine the effect of prophylactic use of aspirin during pregnancy in women at high risk of preeclampsia on length of stay in the neonatal intensive care unit." | 7.88 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. ( de Alvarado, M; de Paco Matallana, C; Jani, JC; Machuca, M; Mastrodima, S; Molina, FS; Nicolaides, KH; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tan, MY; Wright, D, 2018) |
| "Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia." | 7.88 | ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy. ( , 2018) |
| "Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia." | 7.88 | ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. ( , 2018) |
| "Aspirin use during pregnancy was associated with a reduced risk of hypoxia-related placental pathology in the high-risk population [the adjusted odds ratio and 95% confidence interval in the 1st, 2nd, and 3rd trimesters: 0." | 7.88 | Aspirin use during pregnancy and hypoxia-related placental pathology. ( Chen, C; Chen, Y; Feng, L; Ye, J; Ye, W; Zhang, J; Zhu, J; Zhu, X, 2018) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 7.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| "The FRUIT-RCT concluded that low-molecular-weight heparin added to aspirin compared to treatment with aspirin alone is beneficial in the prevention of early-onset hypertensive disorders of pregnancy (HD) in women with inheritable thrombophilia and prior HD and/or a small-for-gestational age (SGA) infant leading to delivery before 34 weeks gestation." | 7.85 | Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy. ( Abheiden, CNH; Arduç, A; de Boer, MA; de Vries, JIP; Fuijkschot, WW; Harmsze, AM; Thijs, A; van Diemen, JJK, 2017) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 7.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| "In utero exposure to aspirin was associated with an increased risk of childhood asthma (adjusted odds ratio [aORs] = 1." | 7.83 | In Utero Exposure to Aspirin and Risk of Asthma in Childhood. ( Bao, J; Bao, Y; Chu, S; Huang, L; Yu, H; Zhang, J, 2016) |
| "To examine the effect of a combination of screening and treatment with low-dose aspirin on the prevalence of early-onset pre-eclampsia (PE)." | 7.81 | Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. ( Hyett, J; Leung, C; Ogle, R; Park, F; Pelosi, M; Puddephatt, R; Rawashdeh, H; Russo, K; Saaid, R; Walter, M; Williams, P, 2015) |
| "Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation." | 7.81 | Use of ticagrelor in human pregnancy, the first experience. ( Jacquemyn, Y; Mannaerts, D; Muys, J; Verbruggen, M, 2015) |
| " Villous tissue was incubated at 2% O2 (hypoxia), 8% O2 and standard culture conditions (21% O2) or at 2% O2 and 21% O2 with dalteparin or ASA." | 7.80 | Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport. ( Darashchonak, N; Erlenwein, SV; Kleppa, MJ; von Kaisenberg, CS; von Versen-Höynck, F, 2014) |
| " Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy." | 7.80 | Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. ( LeFevre, ML, 2014) |
| "Aspirin treatment compared with untreated control groups led to a significant reduction of preeclampsia in 5 small-scale studies." | 7.78 | -Is prevention of pre-eclampsia with low dosage aspirin possible? Critical assessment of available studies-. ( Lippert, TH; Mück, AO, 1996) |
| "In this retrospective observational study including women with pre-existing hypertension, pre-gestational diabetes or previous placental-mediated complications, we compared the rates of pre-eclampsia, early-onset and severe pre-eclampsia between women who used 81 mg of aspirin (ASA) throughout pregnancy without platelet function analyser (PFA-100®) monitoring ("group ASA no PFA") and those in whom the aspirin dosage was adjusted according to PFA-100® results ("group ASA and PFA")." | 7.77 | Is testing for aspirin response worthwhile in high-risk pregnancy? ( Rey, E; Rivard, GE, 2011) |
| "The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin." | 7.77 | First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. ( Bramham, K; Hunt, BJ; Khamashta, M; Nelson-Piercy, C; Thomas, M, 2011) |
| "Verify that resistance to aspirin may have an impact on pregnancy and neonatal outcome." | 7.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
| " We present critical issues that need to be considered when evaluating and appraising test-treatment combinations, using the example of research on the uterine artery Doppler test to predict, and aspirin to prevent, pre-eclampsia." | 7.76 | How to interpret randomised trials of test-treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia. ( Coomarasamy, A; Fox, C; Khan, KS, 2010) |
| " The use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy was assessed in 3 computer-assisted telephone interviews and 1 self-administered questionnaire." | 7.76 | Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. ( Bonde, JP; Henriksen, TB; Jensen, MS; Olsen, J; Rebordosa, C; Sørensen, HT; Thulstrup, AM; Toft, G, 2010) |
| "Treatment of preeclampsia with prostacyclin appears to be contraindicated because prostacyclin is a potent systemic vasodilator and the clinical outcome of preeclamptic women infused with prostacyclin has been poor." | 7.76 | Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia. ( Walsh, SW, 1989) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 7.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "Two meta-analyses suggest that low-dose aspirin taken daily during pregnancy reduces the incidence of pre-eclampsia in women at risk and reduces mortality among the infants born to mothers at high risk of pre-eclampsia." | 7.75 | Pre-eclampsia: aspirin beneficial. ( , 2009) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 7.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss." | 7.74 | Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. ( Kumagai, K; Nakanishi, T; Ozaki, Y; Sato, T; Sugiura-Ogasawara, M; Suzumori, N, 2008) |
| " The patient had decided to take low-molecular-weight heparin (LMWH) and aspirin throughout her pregnancy." | 7.74 | Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin. ( Curtis, SL; Stuart, AG; Trinder, J, 2008) |
| "Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome." | 7.73 | Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. ( Black, S; Bose, P; Huppertz, B; Kadyrov, M; Neulen, J; Regan, L; Weissenborn, U, 2005) |
| "It is still controversial whether aspirin use during pregnancy increases the risk of certain congenital abnormalities (in particular, neural tube defects, gastroschisis, and cleft lip +/- palate)." | 7.73 | Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. ( Czeizel, AE; Nørgård, B; Puhó, E; Skriver, MV; Sørensen, HT, 2005) |
| " During pregnancy, aspirin prophylaxis was prescribed and followed by steroids after caesarian section." | 7.73 | [Acute myocardial infarction complicating primary antiphospholipid syndrome after aspirin and steroids withdrawal]. ( Galicier, L; Guillevin, L; Meune, C; Salengro, E; Spaulding, C; Wahbi, K; Weber, S, 2005) |
| "Descriptions of salicylate poisoning during pregnancy are rare and unique features of perinatal physiology predict an increased sensitivity of the fetus to aspirin poisoning." | 7.70 | Aspirin poisoning during pregnancy: increased fetal sensitivity. ( Palatnick, W; Tenenbein, M, 1998) |
| "To assess the prevalence of haemostatic abnormalities in patients with an obstetric history of preeclampsia and/or fetal growth restriction and documented thrombophilia, and to evaluate the effects of low-molecular-weight heparin (LMWH) and aspirin on pregnancy outcome." | 7.70 | Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. ( de Vries, JI; Dekker, GA; Huijgens, PC; Leeda, M; Riyazi, N; van Geijn, HP, 1998) |
| "Combined treatment of prednisone for immunosuppression and aspirin as an anti-thrombotic agent, starting before ovulation induction, may improve pregnancy rate in autoantibody seropositive patients who have had repeated IVF-ET failures." | 7.70 | Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. ( Amit, A; Azem, F; Daniel, Y; Geva, E; Lerner-Geva, L; Lessing, JB; Schwartz, T; Yaron, Y; Yovel, I, 2000) |
| "Despite optimism generated by earlier, smaller studies, the Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) trial showed that aspirin is not sufficiently effective to recommend its widespread use for the prevention of pre-eclampsia." | 7.69 | Pre-eclampsia. III: The role of aspirin in prevention. ( de Swiet, M, 1994) |
| "To determine if low dose aspirin therapy improves placental histology in women with a prior complicated pregnancy demonstrating uterine vascular pathology." | 7.69 | Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995) |
| "Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy." | 7.69 | Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. ( Allred, EN; Cohen, A; Epstein, MF; Leviton, A; Pagano, M; Sullivan, KF; Van Marter, LJ, 1996) |
| " Magnesium and dihydralazine effects in pregnancy are not related to altered release of trophoblast vasoactive compounds." | 7.69 | Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion. ( Cervar, M; Desoye, G; Kainer, F; Nelson, DM, 1997) |
| "To describe patterns of prescription in the Netherlands of low-dose aspirin in pregnancy." | 7.68 | Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands. ( Bremer, HA; Wallenburg, HC, 1993) |
| "Low dose Aspirin in pregnancy reduces the incidence of intra uterine growth retardation (IUGR) and pregnancy induced hypertension (PIH) in women at risk for these complications." | 7.68 | Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn. ( Foschini, M; Frusca, T; Soregaroli, M; Tarantini, M; Valcamonico, A, 1993) |
| "To determine whether aspirin therapy in women at risk of pre-eclampsia alters in vitro platelet aggregation." | 7.68 | Changes in platelet reactivity following aspirin treatment for pre-eclampsia. ( Elder, MG; Sullivan, MH, 1993) |
| "To determine whether the beneficial effects of aspirin in the treatment of Doppler umbilical placental insufficiency correlate with the maternal pressor response to angiotensin infusion." | 7.68 | Angiotensin sensitivity predicts aspirin benefit in placental insufficiency. ( Cook, CM; Trudinger, BJ, 1993) |
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 7.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| " Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established." | 7.68 | [A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992) |
| "Urinary excretion of thromboxane B2 metabolites as markers of thromboxane A2 synthesis was measured in eight patients with moderate to severe pregnancy-induced hypertension and in six normotensive pregnant women at term." | 7.68 | Thromboxane A2 synthesis in pregnancy-induced hypertension. ( Fitzgerald, DJ; FitzGerald, GA; Mayo, G; Murray, R; Rocki, W, 1990) |
| "A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0." | 7.68 | [Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990) |
| "The effects of pH and anionic binding inhibitors were used to test the hypothesis that the increased T4 binding affinity of the variant albumin (Alb-FDH) of familial dysalbuminemic hyperthyroxinemia (FDH) is due to an electrostatic bond with the ionized phenolic hydroxyl of the iodothyronine." | 7.68 | Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia. ( Divino, CM; Schussler, GC, 1990) |
| "It has been hypothesized that the ingestion of aspirin by women during pregnancy increases their infants' risk of certain congenital heart defects." | 7.67 | The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. ( Mitchell, AA; Shapiro, S; Werler, MM, 1989) |
| "Recent clinical studies have reported a significant reduction in the incidence of pregnancy-induced hypertension after the ingestion of low-dose aspirin." | 7.67 | Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy. ( Garrido-Calderon, J; O'Sullivan, MJ; Sanchez-Ramos, L, 1987) |
| "The materno-fetal transfer of salicylic acid and its distribution in the fetal organism was investigated in women of early pregnancy." | 7.66 | [Distribution of salicylic acid and hydrolysis of acetylsalicylic acid in the human fetus in early pregnancy]. ( Amon, I; Amon, K; Zschiesche, A, 1983) |
| " The effects of acetaminophen in pregnancy and in the newborn have not been studied extensively; when ingested in usual therapeutic doses, the available data have shown no adverse effects." | 7.66 | Effects of aspirin and acetaminophen in pregnancy and in the newborn. ( Rudolph, AM, 1981) |
| "Pregnant women destined to develop pregnancy-induced hypertension (PIH) lose refractoriness to the pressor effects of infused angiotensin II (A-II) several weeks before the onset of hypertension." | 7.66 | Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1978) |
| " there was no evidence that aspirin taken in pregnancy is a cause of stillbirth, neonatal death, or reduced birth-weight." | 7.65 | Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. ( Heinonen, OP; Kaufman, DW; Monson, RR; Shapiro, S; Siskind, V; Slone, D, 1976) |
| "5 gm of aspirin a day during her entire pregnancy, and to characterize the kinetics of salicylate elimination by the infant." | 7.65 | Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. ( Garrettson, LK; Levy, G; Procknal, JA, 1975) |
| "The incidence of preterm preeclampsia was 1." | 7.30 | Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. ( Alsius, M; Bonacina, E; Caamiña, S; Carreras, E; de Mingo, L; Diaz, S; Ferrer-Costa, R; Garcia, E; Garcia-Manau, P; López, M; Lopez-Quesada, E; Maiz, N; Maroto, A; Martin, L; Mendoza, M; Millán, P; Ocaña, V; Orizales-Lago, C; Pallarols, M; Pérez-Gomez, A; Pintado, E; Puerto, L; Ricart, M; Rodríguez-Zurita, A; Suy, A; Teixidor, M; Vidal-Sagnier, L; Vives, À, 2023) |
| "The main outcome was preeclampsia or a birthweight ≤ 5th percentile." | 7.11 | Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial. ( Arthuis, C; Cheve, MT; Debarge, VH; Delmas, HL; Diguisto, C; Doret, M; Durin, L; Equy, V; Flandrin, A; Gallot, D; Giraudeau, B; Haddad, G; Le Gouge, A; Marchand, MS; Mares, P; Megier, P; Paumier, A; Perrotin, F; Schaub, B; Sentilhes, L; Vayssiere, C; Ville, Y; Winer, N, 2022) |
| "A dosage of 100 mg of aspirin per day, initiated from 12 to 20 gestational weeks until 34 weeks of gestation, did not reduce the incidence of preeclampsia in pregnant women with high-risk factors in China." | 7.11 | A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. ( Chen, D; Chen, J; Cui, S; Ding, H; Huai, J; Juan, J; Li, B; Li, G; Li, X; Lin, L; Ma, Y; Mi, Y; Qi, H; Sun, X; Yang, H; Yu, M; Zhang, H; Zhang, M; Zhang, W; Zhao, X; Zhao, Y; Zhu, Y, 2022) |
| "Preeclampsia is a hypertensive disorder of pregnancy affecting up to 8% of pregnancies." | 7.01 | Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy. ( Costantine, MM; Eid, J; Rood, KM, 2023) |
| "Aspirin was not found to substantially diminish the risk of incidence of preeclampsia, but it did show some beneficial effects." | 7.01 | Role of aspirin in the prevention of preeclampsia in previously hypertensive pregnant women: A Meta-Analysis. ( Ashraf Jahangeer, SM; Khan, AA; Mansoor, M, 2023) |
| "Hydroxychloroquine (HCQ) is an immunomodulatory agent that has been shown in laboratory studies to decrease thrombosis risk, support placentation, and minimize the destructive effects of antiphospholipid antibodies." | 7.01 | Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. ( Bacal, V; Bedaiwy, MA; Hooper, A, 2023) |
| "Pregnancy in sickle cell disease is fraught with many complications including pre-eclampsia (PE) and intrauterine growth restriction (IUGR)." | 7.01 | Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol). ( Adeyemo, TA; Afolabi, BB; Babah, OA; Ezeaka, CV; Nwaiwu, O; Odukoya, OO; Ogunnaike, BA; Oshodi, YA, 2021) |
| "The risk of preeclampsia was not different when comparing the aspirin and placebo groups among the Hispanic, non-Hispanic black, or other ethnicity and race groups." | 6.94 | Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race. ( Aagaard, KM; Mendez-Figueroa, H; Sangi-Haghpeykar, H; Tolcher, MC, 2020) |
| "The Aspirin for Evidence-Based Preeclampsia Prevention trial data are consistent with the hypothesis that aspirin delays the gestational age at delivery with preeclampsia." | 6.90 | Aspirin delays the development of preeclampsia. ( Nicolaides, KH; Wright, D, 2019) |
| "Among women receiving placebo, preeclampsia occurred significantly more often in women with stage 1 hypertension compared with normotensive high-risk women after adjustment for maternal age and body mass index (39." | 6.87 | Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort. ( Caritis, SN; Catov, JM; Hauspurg, A; Sutton, EF, 2018) |
| "Inflammation is linked to causes of infertility." | 6.84 | Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. ( Galai, N; Mitchell, E; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Stanford, JB; Wactawski-Wende, J; Wilcox, B, 2017) |
| "When aspirin was initiated at > 16 weeks, with a dosage of < 100 mg/day aspirin, there was a lesser preventive effect (RR = 0." | 6.82 | The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs. ( Dai, C; He, Q; Huang, X; Lee, W; Li, L; Li, R; Luo, Z; Mok, TN; Yip, KC; Zeng, W, 2022) |
| "Placental insufficiency affects about 10% of pregnancies and can lead to pre-eclampsia, fetal growth restriction, and preterm birth." | 6.82 | The role of melatonin in pregnancies complicated by placental insufficiency: A systematic review. ( Bussolaro, S; Fantasia, I; Rolnik, DL; Stampalija, T, 2022) |
| " These inconsistencies, however, can be largely explained by a high degree of heterogeneity regarding the selection of trial participants, baseline risk of the included women, dosage of aspirin, gestational age of prophylaxis initiation, and preeclampsia definition." | 6.82 | Prevention of preeclampsia with aspirin. ( Nicolaides, KH; Poon, LC; Rolnik, DL, 2022) |
| "Aspirin was associated with a lower rate of late-onset preeclampsia ⩾34w (17." | 6.80 | Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study. ( Allshouse, AA; Galan, HL; Heyborne, KD; Moore, GS; Post, AL, 2015) |
| "The rate of superimposed preeclampsia was 28." | 6.79 | Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. ( Atallah, AN; Kulay, L; Santos, GM; Sass, N; Souza, EV; Torloni, MR, 2014) |
| "In preterm preeclampsia, women assigned at random to 150 mg experienced a significant 62% reduction in risk of preterm preeclampsia (RR = 0." | 6.72 | Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis. ( Flyke, IP; Hennekens, CH; Hoppe, KK; Kim, K; Lasarev, M; Mukhtarova, N; Van Doorn, R, 2021) |
| "It was effective in reducing preterm preeclampsia, but not term preeclampsia, and patient compliance and patient weight were important variables." | 6.72 | The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta. ( Strauss, JF; Walsh, SW, 2021) |
| "Salicylic acid was detected in 1 infant only." | 6.71 | Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. ( Bernert, S; Leonhardt, A; Schmitz-Ziegler, G; Seyberth, HW; Watzer, B, 2003) |
| "The trial enrolled 139 women at risk of preeclampsia or IUGR, with abnormal uterine artery Doppler findings that included the presence of unilateral or bilateral diastolic notch, high resistance index (RI), or high pulsatility index (PI) at 14-16 weeks of gestation." | 6.71 | Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. ( Ebrashy, A; Ibrahim, M; Marzook, A; Yousef, D, 2005) |
| "Whether low-dose aspirin prevents preeclampsia is unclear." | 6.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "Aspirin was not associated with a significant increase in placental haemorrhages or in bleeding during preparation for epidural anaesthesia, but there was a slight increase in use of blood transfusion after delivery." | 6.67 | CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. ( , 1994) |
| "To assess its efficacy in preventing preeclampsia, 60 mg/day aspirin or a matching placebo was administered to women in a double-blind fashion during the second and third trimesters." | 6.67 | Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. ( Arheart, KL; Di Sessa, TG; Khoury, A; Moretti, ML; Pulliam, DA; Sibai, BM, 1994) |
| "The occurrences of IUGR and preeclampsia in the study group (7." | 6.67 | [Prevention of fetal growth retardation by low dose aspirin]. ( Li, WJ; Wang, ZH, 1993) |
| "The incidence of preeclampsia was lower in the aspirin group (69 of 1485 women [4." | 6.67 | Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, SN; Klebanoff, M; McNellis, D; Paul, RH; Rocco, L; Romero, R; Rosen, M; Sibai, BM; Thom, E; Witter, F, 1993) |
| "Chronic hypertension affects 1-5% of women of childbearing age." | 6.66 | Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. ( Haddad, B; Lecarpentier, E, 2020) |
| "Inflammation has been linked to several complications in pregnancy, including pregnancy loss." | 6.61 | The role of aspirin and inflammation on reproduction: the EAGeR trial ( Holland, TL; Kim, K; Levine, LD; Mumford, SL; Schisterman, EF; Sjaarda, LA, 2019) |
| "For the prevention of fetal growth restriction, a recent large-study level meta-analysis and individual patient data meta-analysis confirm that aspirin modestly reduces small-for-gestational-age pregnancy in women at high risk (relative risk, 0." | 6.58 | The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. ( David, AL; Groom, KM, 2018) |
| " Screening modalities, target population, and aspirin dosage are still a matter of debate." | 6.55 | Aspirin for Prevention of Preeclampsia. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2017) |
| "Aspirin has been widely prescribed since the 1980's to prevent pre-eclampsia, intra-uterine growth retardation and fetal death of vascular origin." | 6.55 | [Aspirin: Indications and use during pregnancy]. ( Belhomme, N; Doudnikoff, C; Henriot, B; Isly, H; Jego, P; Polard, E, 2017) |
| "Outcomes included preeclampsia (mild and severe) and SGA neonates." | 6.53 | Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis. ( Bergeron, TS; Bujold, E; Carpentier, C; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Outcomes included preeclampsia, severe preeclampsia, and SGA." | 6.53 | Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials. ( Bujold, E; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Preeclampsia is a hypertensive disorder of pregnancy that remains a significant cause of maternal morbidity and mortality worldwide." | 6.53 | Aspirin vs Heparin for the Prevention of Preeclampsia. ( Kanellopoulou, T; Katsi, V; Makris, T; Nihoyannopoulos, P; Nomikou, E; Tousoulis, D, 2016) |
| "Low-dose aspirin significantly reduced preeclampsia risk in both East Asians (OR = 0." | 6.53 | Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians:A systematic review and meta-analysis. ( Gan, J; He, H; Qi, H, 2016) |
| "Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality." | 6.50 | Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. ( Henderson, JT; O'Connor, E; Rowland, MG; Senger, CA; Thompson, JH; Whitlock, EP, 2014) |
| "The outcomes of interest were preterm preeclampsia (delivery <37 weeks) and term preeclampsia." | 6.48 | Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. ( Bakthi, A; Bujold, E; Ebrashy, A; Giguère, Y; Nicolaides, K; Roberge, S; Vainio, M; Villa, P, 2012) |
| "The outcomes of interest were severe preeclampsia and mild preeclampsia." | 6.48 | Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. ( Bujold, E; Forest, JC; Giguère, Y; Nicolaides, K; Roberge, S; Tapp, S; Vaiman, D; Vainio, M; Villa, P; von Dadelszen, P; von Dadelzen, P, 2012) |
| "The incidence of preeclampsia was 3." | 6.43 | Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials. ( Fontes, RS; Ruano, R; Zugaib, M, 2005) |
| "Aspirin was also associated with a reduction in rates of spontaneous preterm birth (OR 0." | 6.42 | Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. ( Coomarasamy, A; Gee, H; Honest, H; Khan, KS; Papaioannou, S, 2003) |
| " Discrepancies seem largely related to either studying very low-risk populations, or strong differences in aspirin dosage and/or term of introduction." | 6.41 | [Aspirin and prevention of pre-eclampsia]. ( Beaufils, M, 2000) |
| "The baseline risk of preeclampsia in women with abnormal uterine artery Doppler was 16%, and the number of women needed to be treated with aspirin to prevent one case of preeclampsia was 16 (95% CI 8, 316)." | 6.41 | Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. ( Coomarasamy, A; Gee, H; Khan, KS; Papaioannou, S, 2001) |
| "On the basis of the hypothesis that preeclampsia is at least partially caused by an increase in thromboxane A2, some studies attempted to correct this pathologic condition by pharmacologic manipulation with low-dose aspirin." | 6.38 | Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. ( Dekker, GA; Sibai, BM, 1993) |
| "To study the effect of aspirin in the prevention of pre-eclampsia in high-risk women." | 6.27 | Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. ( Hämäläinen, E; Kajantie, E; Laivuori, H; Pesonen, AK; Räikkönen, K; Taipale, P; Vainio, M; Villa, PM, 2013) |
| "To explore the ATF2 expression of preeclampsia patients and investigate whether the level of ATF2 expression impacted the low-dose aspirin treatment of preeclampsia patients." | 5.91 | Low-dose Aspirin may Prevent Preeclampsia by Inhibiting the Expression of ATF2. ( Guo, L; Hu, R; Liu, R; Xiao, S; Zhang, M, 2023) |
| "Premature birth is associated with an increased risk of mortality and morbidity, and strategies to prevent preterm birth are few in number and resource intensive." | 5.91 | Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research. ( Achieng, E; Bose, CL; Bresnahan, BW; Bucher, S; Carlo, WA; Chicuy, J; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hibberd, PL; Hoffman, M; Jessani, S; Kavi, A; Koso-Thomas, M; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Moore, J; Mwapule, A; Mwenechanya, M; Neuwahl, S; Nyongesa, P; Okitawutshu, J; Patel, A; Patterson, JK; Saleem, S; Somannavar, M; Tshefu, A, 2023) |
| " The Royal College of Obstetricians and Gynaecologists recommends 150 mg of aspirin daily, and the National Institute of Health and Care Excellence guidelines suggest risk stratification with a dosage of 75 mg for those at moderate risk of preeclampsia and 150 mg for those at high risk of preeclampsia." | 5.91 | Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? ( Abuhamad, A; Hage Diab, Y; Horgan, R; Saade, G; Waller, J, 2023) |
| " This suggests that use of LDA outside the recommended guidelines should be cautioned and further investigation is needed to determine its ideal dosing and timing of discontinuation." | 5.91 | Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. ( Culhane, JF; Lundsberg, LS; Merriam, AA; Partridge, C; Reddy, UM; Son, M; White, KJ, 2023) |
| "Evidence on the risk of preterm preeclampsia was taken from the Screening programme for pre-eclampsia study, which was a first-trimester screening study for the prediction of preeclampsia." | 5.72 | When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. ( Nicolaides, KH; Tan, MY; Wright, A; Wright, D, 2022) |
| "Preeclampsia is a hypertensive disease unique to pregnancy and has a significant impact on maternal and neonatal morbidity and mortality." | 5.72 | Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence. ( Olson, DN; Ranzini, AC; Russell, T, 2022) |
| "To evaluate the effectiveness of a preeclampsia (PE) screening program using the National Institute for Health and Care Excellence (NICE) guideline in pregnant Thai women." | 5.72 | Low-dose aspirin for prevention of preeclampsia: Implementation of the NICE guideline in Thailand. ( Charernjiratragul, K; Geater, A; Khwankaew, N; Suksai, M; Suntharasaj, T; Suwanrath, C, 2022) |
| "Reportedly, aspirin prevents preeclampsia, specifically early-onset preeclampsia, although findings in decidual arteries in women treated with aspirin therapy remain unclear." | 5.72 | Low-dose aspirin therapy improves decidual arteriopathy in pregnant women with a history of preeclampsia. ( Gi, T; Katsuragi, S; Kodama, Y; Maekawa, K; Sameshima, H; Sato, Y; Tomimori-Gi, K; Yamada, N; Yamashita, A, 2022) |
| "This is a single site sub-study of data collected in conjunction with the Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) Trial, which is listed at ClinicalTrials." | 5.69 | Birth weight and gestational age distributions in a rural Kenyan population. ( Achieng, E; Bucher, S; Ekhaguere, OA; Esamai, FO; Kemboi, M; Liechty, EA; Marete, I; Nowak, K; Nyongesa, P; Otieno, K; Rutto, F; Tenge, C, 2023) |
| "The APPEC study is a large-population randomized controlled trial in China evaluating the role of low-dose aspirin prophylactic treatment for pre-eclampsia." | 5.69 | Low-dose aspirin in the prevention of pre-eclampsia in China: postpartum hemorrhage in subgroups of women according to their characteristics and potential bleeding risk. ( Chen, J; Huai, J; Li, B; Lin, L; Yang, H; Zhu, Y, 2023) |
| "The mechanism by which aspirin prevents pre-eclampsia is poorly understood, and its effects on biomarkers throughout pregnancy are unknown." | 5.69 | ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. ( Nicolaides, KH; O'Gorman, N; Poon, LC; Rolnik, DL; Syngelaki, A; Wright, D, 2023) |
| "These findings suggest that individuals with twin pregnancies, a history of preeclampsia, or hypertension may not benefit from aspirin to the same extent as those with other complications such as obesity or diabetes." | 5.69 | Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation. ( Corsi, DJ; Dagvadorj, A; Dingwall-Harvey, ALJ; El-Chaár, D; Gaudet, LM; Guo, Y; McLean, C; Muldoon, KA; Rennicks White, R; Rybak, N; Walker, MC; Wen, SW, 2023) |
| "To assess the impact of low-dose aspirin (LDA) starting in early pregnancy on delaying preterm hypertensive disorders of pregnancy." | 5.69 | Aspirin delays the onset of hypertensive disorders of pregnancy among nulliparous pregnant women: A secondary analysis of the ASPIRIN trial. ( Bauserman, M; Bucher, S; Carlo, WA; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hibberd, PL; Hoffman, MK; Jessani, S; Kavi, A; Koso-Thomas, M; Krebs, NF; Lokangaka, A; McClure, EM; Metgud, MC; Moore, J; Mwenechanya, M; Nielsen, E; Patel, A; Saleem, S; Silver, R; Somannavar, MS; Tshefu, A, 2023) |
| "The Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas trial was a landmark study that demonstrated a reduction in preterm birth and hypertensive disorders of pregnancy in nulliparous women who received low-dose aspirin." | 5.69 | The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. ( Achieng, E; Bauserman, M; Bucher, S; Carlo, WA; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hemingway-Foday, J; Hibberd, PL; Hoffman, MK; Jessani, S; Kavi, A; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Moore, J; Nuss, EE; Nyongesa, P; Okitawutshu, J; Saleem, S; Silver, RM; Somannavar, M; Tembo, AM; Tshefu, A, 2023) |
| " Low-dose aspirin is used to prevent pre-eclampsia, which has a similar mechanism; hence, the present study aimed to investigate the effect of low-dose aspirin on the prevention of PTD in women with a history of spontaneous PTD." | 5.69 | Evaluation of the Effect of Low-dose Aspirin on the Prevention of Preterm Delivery in Women with a History of Spontaneous Preterm Delivery. ( Azadi, P; Bakhtiyari, M; Dehghani, Z; Khavandegar, A; Mirzamoradi, M; Mohammadi, M, 2023) |
| "· High-risk patients who lack a history preeclampsia were less likely to be advised of aspirin use." | 5.62 | Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study. ( Berghella, V; Boelig, RC; Roman, A; Wanees, M; Zhan, T, 2021) |
| "Our laboratory demonstrated that preeclampsia is associated with high soluble fms-like tyrosine kinase 1 (sFlt-1) and low heme oxygenase-1 (HO1/Hmox1) expression." | 5.62 | MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment. ( Agrawal, S; Ahmad, S; Ahmed, A; Alzahrani, FA; Dias, IH; Rezai, H; Sanchez-Aranguren, L; Sparatore, A; Wang, K, 2021) |
| "Preeclampsia is a severe gestational hypertensive disorder that occurs after 20 weeks' of gestation." | 5.62 | Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia. ( Kuo, PL; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2021) |
| "The use of aspirin for preventing preeclampsia has been practiced recently by fetomaternal specialists in Indonesia." | 5.56 | Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia. ( Karunia, RI; Prasetyadi, FOH; Purnamayanti, A, 2020) |
| "In women who developed severe preeclampsia and delivered preterm, there were significant elevations in non-aspirin-sensitive lipids with biologic actions that could cause preeclampsia." | 5.56 | Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin. ( Al Dulaimi, M; Alam, SMK; Chalfant, CE; Lee, SM; Reep, DT; Springel, EH; Stephenson, DJ; Strauss, JF; Walsh, SW; Washington, SL, 2020) |
| "Early-onset preeclampsia was found in 3 pregnant women (0." | 5.56 | Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year. ( Caeiro, F; Francisco, C; Gomes, H; Lourenço, I; Ribeiro, J; Rocha, P, 2020) |
| "The use of prophylactic treatments against thrombophilia becomes necessary in order to increase the live birth rates in women with RPL." | 5.56 | Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages? ( Aslan, I; Ozyigit, S; Paul, LT; Tosun, O; Tulay, P, 2020) |
| "The benefit of aspirin in preventing preeclampsia is increasingly recognized; however, its mechanism of action remains unclear." | 5.56 | The 15-Epilipoxin-A4 Pathway with Prophylactic Aspirin in Preventing Preeclampsia: A Longitudinal Cohort Study. ( Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Makris, A; Motum, P; Shanmugalingam, R; Wang, X, 2020) |
| "We prospectively recruited women from sites in the Democratic Republic of the Congo (DRC), Kenya, and Zambia who participated in the ASPIRIN (Aspirin Supplementation for Pregnancy Indicated risk Reduction In Nulliparas) trial." | 5.51 | Predictors of Plasmodium falciparum Infection in the First Trimester Among Nulliparous Women From Kenya, Zambia, and the Democratic Republic of the Congo. ( Bauserman, M; Bose, CL; Bucher, SL; Carlo, WA; Chomba, E; Derman, RJ; Esamai, F; Goldenberg, RL; Hemingway-Foday, J; Hoffman, M; Jessani, S; Koso-Thomas, M; Leuba, SI; Liechty, EA; Lokangaka, A; McClure, EM; Moore, J; Nolen, T; Olshan, A; Powers, KA; Saleem, S; Taylor, SM; Tshefu, A; Westreich, D, 2022) |
| "In this study, we observed that low-dose aspirin did not significantly reduce the preterm birth rate in women with a previous spontaneous preterm birth." | 5.51 | Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial. ( Bekker, MN; Boon, J; de Boer, MA; de Groot, CJM; Franssen, MTM; Hemels, MAC; Hermes, W; Huisjes, AJM; Kleiverda, G; Landman, AJEMC; Mol, BW; Naaktgeboren, CN; Nijman, TAJ; Oudijk, MA; Papatsonis, DNM; Sikkema, JM; Sueters, M; van der Ham, DP; van der Weide, MC; van Drongelen, J; van Huizen, ME; van Laar, JOEH; van Pampus, MG; Visser, H; Visser, L; Zwart, JJ, 2022) |
| "To demonstrate the use of ensemble machine learning with augmented inverse probability weighting (AIPW) for per-protocol effect estimation in RCTs and to evaluate the per-protocol effect size of aspirin on pregnancy." | 5.51 | Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial. ( Bodnar, LM; Brooks, MM; Kennedy, EH; Naimi, AI; Zhong, Y, 2022) |
| "Low dose aspirin (LDA) is an effective strategy to reduce preterm birth." | 5.51 | The efficacy of low-dose aspirin in pregnancy among women in malaria-endemic countries. ( Bauserman, M; Bose, CL; Carlo, WA; Chomba, E; Derman, RJ; Esamai, F; Goldenberg, RL; Hemingway-Foday, J; Hoffman, M; Jessani, S; Koso-Thomas, M; Leuba, SI; Liechty, EA; Lokangaka, A; McClure, EM; Meshnick, SR; Moore, J; Nolen, TL; Patterson, J; Saleem, S; Tsehfu, A, 2022) |
| "This is a follow-up study of the Dutch double-blind randomised controlled APRIL trial which assessed the effectiveness of treatment with aspirin (80 mg daily) compared with placebo for the prevention of preterm birth in women with a previous spontaneous preterm birth." | 5.51 | Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial. ( de Boer, MA; Finken, MJJ; Landman, AJEMC; Leemhuis, AG; Oosterlaan, J; Oudijk, MA; Painter, RC; Pajkrt, E; Ravelli, ACJ; Roseboom, TJ; van 't Hooft, J; van Baar, AL; van Limburg Stirum, EVJ; van Wely, M, 2022) |
| "Daily aspirin, started in the first trimester of pregnancy, is commonly used for the prevention of preeclampsia and fetal growth restriction in multiple gestation." | 5.51 | Aspirin Responsiveness at a Dose of 80 mg and Its Impact on Birth Weight when Used in Twin Pregnancies: The GAP Pilot Randomized Trial. ( Boutin, A; Bujold, E; Camiré, B; Carpentier, C; Guerby, P; Tapp, S, 2022) |
| "The aspirin group was associated with earlier delivery at 38." | 5.51 | Effect of early use of low-dose aspirin therapy on late-onset preeclampsia. ( Gillin, AG; Hyett, J; Lan, PG; Pelosi, M; Sandager, P; Tooher, J, 2019) |
| "Aspirin plays an important role in the prevention and therapy of pre-eclampsia." | 5.51 | Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME. ( Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019) |
| "Our novel findings suggest that the preeclampsia prevention effect of aspirin may be exerted through these two mechanisms." | 5.51 | Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia. ( Chen, TY; Kuo, PL; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2019) |
| "Preeclampsia is a hypertensive disorder specific to pregnancy that remains a significant cause of maternal and neonatal morbidity and mortality." | 5.48 | Low-Dose Aspirin for the Prevention of Preeclampsia. ( Fantasia, HC, 2018) |
| "Preeclampsia is a severe pregnancy-related disorder, and patients usually present with high circulating inflammatory factor levels and excessive activation of the nuclear factor-κB (NF-κB) pathway." | 5.48 | The intervention effect of aspirin on a lipopolysaccharide-induced preeclampsia-like mouse model by inhibiting the nuclear factor-κB pathway. ( Li, G; Lin, L; Ma, L; Wang, YL; Yang, H, 2018) |
| "Aspirin treatment significantly decreased the levels of pro-inflammatory cytokines in serum and placenta tissues of preeclampsia rats." | 5.48 | Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway. ( Liu, F; Lu, X; Sun, J; Tang, D; Zhang, H, 2018) |
| "Presumed rates of preeclampsia were 3." | 5.48 | Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women. ( Breathnach, F; Cotter, A; Daly, S; Dicker, P; Higgins, J; Hunter, A; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Morrison, JJ; Mulcahy, C; Normand, C; O'Mahony, JF; Tully, E; Tyrrell, E, 2018) |
| "The cohort of women with a history of preeclampsia were divided into 2 groups, before and after the release of the US Preventive Services Task Force 2014 recommendations." | 5.46 | Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia. ( Aagaard, KM; Chu, DM; Hollier, LM; Mastrobattista, JM; Racusin, DA; Ramin, SM; Sangi-Haghpeykar, H; Tolcher, MC, 2017) |
| "The Aspirin for Evidence-Based Preeclampsia Prevention trial was a multicenter study in women with singleton pregnancies." | 5.46 | Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. ( Carbone, IF; de Alvarado, M; Delgado, JL; Dutemeyer, V; Kapeti, E; Nicolaides, KH; Papantoniou, N; Pazos, A; Plasencia, W; Poon, LC; Rehal, A; Rolnik, DL; Syngelaki, A; Vojtassakova, D; Wright, D, 2017) |
| "Preeclampsia is a multisystem disorder that affects 3% to 5% of pregnant women and remains a significant source of short-term and long-term maternal and neonatal mortality and morbidity." | 5.46 | Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women? ( Costantine, MM; Marrs, CC, 2017) |
| "The estimated rate of preeclampsia would be 4." | 5.42 | A Cost-Benefit Analysis of Low-Dose Aspirin Prophylaxis for the Prevention of Preeclampsia in the United States. ( Hauspurg, AK; Rouse, DJ; Werner, EF, 2015) |
| "We noted a 2." | 5.42 | Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention. ( Allshouse, AA; Galan, HL; Heyborne, KD; Moore, GS; Winn, VD, 2015) |
| "Evidence has shown significant benefits of aspirin for preventing pre-eclampsia." | 5.41 | Prevention of pre-eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. ( Ali, R; McDonald, SD; Morfaw, F; Ninan, K, 2023) |
| "This systematic review and meta-analysis investigated whether the use of low-dose aspirin during pregnancy by women with chronic hypertension reduces the odds of superimposed preeclampsia and poor perinatal outcomes." | 5.41 | Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis. ( Giorgione, V; Richards, EMF; Stevens, O; Thilaganathan, B, 2023) |
| "Low-molecular-weight heparin, vitamin D supplementation, exercise, calcium supplementation, and aspirin reduce the risk of preeclampsia/pregnancy-induced hypertension." | 5.41 | Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials. ( Chen, JY; Duan, CY; He, PC; Li, JQ; Liu, YH; Liu, YX; Lye, S; Tan, N; Wang, ZJ; Wei, YX; Xie, NJ; Xu, XJ; Zhang, YS, 2023) |
| " The secondary outcomes included gestational hypertension; fetal growth restriction; preterm birth, either spontaneous or iatrogenic, before 34 weeks of gestation; gestational age at birth; neonatal birthweight; and adverse events secondary to the administration of aspirin, including antepartum and postpartum hemorrhage." | 5.41 | Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis. ( Acuti Martellucci, C; Buca, D; Cerra, C; D'Antonio, F; Fichera, A; Flacco, ME; Herrera, M; Khalil, A; Morelli, R; Orabona, R; Prefumo, F; Rizzo, G, 2023) |
| "To establish the clinical heterogeneity among the clinical practice guidelines (CPGs) on aspirin use in pregnancy and to investigate the quality of these CPGs." | 5.41 | Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review. ( Alameddine, S; D'Antonio, F; Di Girolamo, R; Khalil, A; Liberati, M; Maruotti, GM; Rizzo, G; Santilli, F, 2023) |
| "The association between aspirin use during pregnancy and the risk of postpartum hemorrhage remains unclear." | 5.41 | Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis. ( Chen, Y; Chen, Z; Ding, W; Du, Y; Fang, C; Feng, L; Gao, P; He, M; Jiang, Y; Su, R; Wang, S; Wei, L; Yu, J; Zhang, H; Zhang, J; Zhou, X; Zhu, S, 2023) |
| "Recent studies have shown a benefit to more aggressive treatment of mild chronic hypertension to a blood pressure goal of <140/90 with oral labetalol and nifedipine remaining first-line agents." | 5.41 | Cardiac medications in obstetric patients. ( Albert-Stone, E; Davis, MB; Spehar, SM, 2023) |
| "This study aimed to compare 2 aspirin dosage regimens for the prevention of preterm preeclampsia (PE): 75 to 81 mg vs 150 to 162 mg taken daily starting in the first trimester of pregnancy." | 5.41 | Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis. ( Bujold, E; Foisy, MA; Ghesquiere, L; Guerby, P; Kumar, N; Marchant, I; Roberge, S; Zare, M, 2023) |
| "Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle, and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre-eclampsia, preterm delivery, and other adverse pregnancy and neonatal outcomes in pregnancies complicated by type 1 diabetes." | 5.41 | Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. ( Battelino, T; Benhalima, K; Beunen, K; Buschur, E; Donovan, LE; Feig, DS; Kudva, YC; Levy, CJ; Mathiesen, ER; Mathieu, C; Murphy, HR; Painter, R; Polsky, S; Ringholm, L; Siegelaar, SE, 2023) |
| " The aim of this narrative review is to investigate the role of blood pressure (BP) monitoring, physical activity, and prophylactic aspirin to reduce the prevalence of preeclampsia and to improve pregnancy outcome in women with preexisting diabetes." | 5.41 | Prediction and prevention of preeclampsia in women with preexisting diabetes: the role of home blood pressure, physical activity, and aspirin. ( Damm, P; Do, NC; Mathiesen, ER; Nørgaard, SK; Ringholm, L; Vestgaard, M, 2023) |
| " The evidence demonstrates that the treatments to consider are first-trimester progesterone administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspirin and heparin in women with antiphospholipid antibodies." | 5.41 | Interventions to prevent miscarriage. ( Coomarasamy, A; Devall, A; Dhillon-Smith, RK; Fox, E; Kaur, R; Melo, P; Woodhead, N, 2023) |
| "Compared with aspirin alone, low-dose aspirin combined with calcium supplementation was more effective in preventing preeclampsia, reduced the risk of preterm birth and postpartum hemorrhage, and promoted fetal growth." | 5.41 | Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis. ( Chen, WY; Sun, SF, 2023) |
| "A previous large randomized trial indicated that preconception-initiated low-dose aspirin (LDA) therapy did not have a positive effect on pregnancy outcomes." | 5.41 | The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial. ( Mumford, SL; Naimi, AI; Perkins, NJ; Platt, RW; Schisterman, EF; Silver, RM; Sjaarda, LA, 2021) |
| "The aim of the study is to evaluate the effects of supplementation with Arginine (L-Arg) 3g, (together with Magnesium (Mg) 350 mg and Salicilate (Sal) 100 mg) on maternal blood pressure (BP), uterine artery doppler PI and neonatal outcomes in women with high-risk pregnancy for chronic hypertension (CH) and other previous placenta vascular disorders (PVD) already treated with low dose of aspirin (LDA), as recommended by guidelines." | 5.41 | Effect of L-arginine supplementation in pregnant women with chronic hypertension and previous placenta vascular disorders receiving Aspirin prophylaxis: a randomized control trial. ( Basile, L; Facchinetti, F; Menichini, D; Monari, F; Neri, I; Pignatti, L, 2021) |
| "To examine the possible risk factors amongst maternal characteristics, medical and obstetric history, pre-eclampsia (PE)-specific biomarkers and estimated-risk group, according to The Fetal Medicine Foundation (FMF) algorithm, that are associated with the development of preterm PE with delivery at < 37 weeks' gestation despite aspirin prophylaxis." | 5.41 | ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis. ( Martinez-Portilla, RJ; Poon, LC; Rolnik, DL; Shen, L, 2021) |
| "The residual risk of preeclampsia in high-risk women on aspirin prophylaxis exceeds that of low-risk populations, and this study aimed to identify first-trimester maternal characteristics associated with aspirin prophylaxis failure." | 5.40 | First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation. ( Atlas, RO; Baschat, AA; Blitzer, MG; Block-Abraham, DM; Doyle, LE; Jenkins, CB; Kopelman, JN; Turan, OM, 2014) |
| "Women with inherited thrombophilia and recurrent miscarriage might benefit from preconceptional antiagreggation with low-dose acetylsalicylic acid (ASA), but concerns about severe adverse reactions may prevent physicians from performing this treatment in patients with ASA hypersensitivity." | 5.38 | Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage. ( Gaspar, A; Livramento, S; Morais-Almeida, M; Sampaio, G; Santos, N, 2012) |
| "Aspirin treatment enhanced LPS-stimulated TNFalpha production by PBML from controls but not cases." | 5.35 | Effect of aspirin treatment on TNFalpha production by women with a history of preterm birth. ( Cooper, C; Esplin, MS; Faux, DS; Hamblin, SD; Peltier, MR; Silver, RM, 2009) |
| " Meta-analyses of low-dose aspirin to prevent pre-eclampsia suggest that the incidence of preterm birth might also be decreased, particularly if initiated before 16 weeks of gestation." | 5.34 | Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. ( Achieng, E; Bose, CL; Carlo, WA; Chicuy, J; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Garces, A; Goco, N; Goldenberg, RL; Goudar, SS; Hemingway-Foday, J; Hibberd, PL; Hoffman, MK; Jessani, S; Kodkany, BS; Koso-Thomas, M; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Miodovnik, M; Moore, J; Mwapule, A; Mwenechanya, M; Nolen, TL; Nyongesa, P; Okitawutshu, J; Patel, A; Saleem, S; Silver, R; Somannavar, M; Tshefu, A; Zehra, F, 2020) |
| "Prospective cohort study as a secondary analysis of the Effects of Aspirin in Gestation and Reproduction randomized controlled trial of preconception-initiated low-dose aspirin among women with one or two prior pregnancy losses." | 5.34 | Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial. ( Freeman, JR; Grewal, J; Mumford, SL; Perkins, NJ; Russo, LM; Schisterman, EF; Schliep, KC; Silver, RM; Sjaarda, LA; Whitcomb, BW, 2020) |
| "To evaluate the preventive effects of low-dose aspirin on the incidence of preeclampsia and pregnancy outcomes of women at high-risk for preeclampsia." | 5.34 | Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: A randomized controlled trial from Shanghai, China. ( Gu, W; Hou, YY; Huang, HF; Lin, J; Lin, N; Shang, J; Song, MF; Zeng, WJ, 2020) |
| " The subjects of the study were randomly assigned into two groups of intervention and control to receive either 80 mg of aspirin or placebo daily during the pregnancy." | 5.34 | The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia. ( Abdi, N; Alavi, A; Asadi, N; Hessami, K; Kasraeian, M; Rozrokh, A; Vafaei, H; Zare, S, 2020) |
| "We observed no significant difference in UtA-PI between the two doses of aspirin, but we observed low rates of fetal growth restriction and preterm and early-onset preeclampsia (all less than 5%)." | 5.34 | A Pilot Randomized Trial Comparing the Effects of 80 versus 160 mg of Aspirin on Midtrimester Uterine Artery Pulsatility Index in Women with a History of Preeclampsia. ( Bujold, E; Côté, S; Ferreira, E; Girard, M; Guerby, P; Leclair, G; Roberge, S; Tapp, S, 2020) |
| " At parturition, cows were blocked by parity [multiparous (MULT) and primiparous (PRIM)] and calving ease [eutocia (EUT) and dystocia (DYS)] and were randomly assigned to 1 of 2 treatment groups: aspirin (ASP; n = 76), in which within 12 h after parturition cows received 4 treatments with acetylsalicylic acid (100 mg/kg; 2 boluses) at 12-h intervals, or placebo (PLC; n = 76), in which within 12 h after parturition cows received 4 consecutive treatments with gelatin capsules (2 capsules) containing water 12 h apart." | 5.34 | Administration of acetylsalicylic acid after parturition in lactating dairy cows under certified organic management: Part II. Biomarkers of nociception, inflammation, and stress. ( Barragan, AA; Bas, S; Bauman, LM; Coetzee, JF; Gonzalez, JDR; Lakritz, J; Menichetti, B; Piñeiro, JM; Schuenemann, GM; Velez, J, 2020) |
| "This study aimed to evaluate the maternal and fetal results in women undergoing antihypertensive therapy (low aspirin or labetalol) with mild to severe chronic hypertension relative to women without medicines." | 5.34 | Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo. ( Wang, F; Xiang, X; Zhao, N; Zhou, Z, 2020) |
| "Aspirin was shown to increase oxygen affinity of hemoglobin via acetylating lysine residues and its general acetylating activity on proteins such as histones makes it also an interesting candidate to activate fetal hemoglobin." | 5.34 | Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale. ( Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K, 2007) |
| "Essential thrombocythemia is a rare disease of unknown origin characterized by abnormal increase in the platelet count." | 5.32 | Pregnancy in essential thrombocythemia during aspirin treatment. ( Cannata, ML; Corrado, F; Ruggeri, Z; Stella, NC, 2003) |
| "Acute fatty liver is a rare but fatal complication of pregnancy." | 5.32 | Acute fatty liver of pregnancy after aspirin intake. ( Deren, O; Durukan, T; Kizilkiliç-Parlakgümüş, A; Onderoğlu, L; Saygan-Karamürsel, B, 2004) |
| "To evaluate the effect of adjuvant low-dose aspirin therapy on clinical pregnancy rate and uterine perfusion in women undergoing frozen-thawed embryo transfer (FET) cycles." | 5.30 | Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial. ( Ahmadi, F; Bagheri Lankarani, N; Bahmanabadi, A; Jahangiri, N; Madani, T, 2019) |
| "This article evaluates the effect of low-dose aspirin on uterine artery (UtA) Doppler, placental volume, and vascularization flow indices in low-risk pregnancy." | 5.30 | The Impact of Aspirin on Ultrasound Markers of Uteroplacental Flow in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Breathnach, F; Cody, F; Cotter, A; Daly, S; Dicker, P; Dornan, S; Higgins, J; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Morrison, JJ; Mulcahy, C; Tully, E, 2019) |
| "To assess the effect of aspirin use in low-risk pregnancy on: (1) pregnancy-associated plasma protein-A (PAPP-A) and placental-like growth factor (PLGF); (2) urinary albumin-to-creatinine ratio (ACR) and blood pressure; (3) fetal growth parameters; and (4) placental histopathology." | 5.30 | Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Clarke, P; Culliton, M; Downey, P; Fitzgerald, D; Maguire, OC; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Mooney, EE; Mulcahy, C; Tully, E, 2019) |
| "To evaluate the efficacy of co-administration of low-dose aspirin (LDA) and tamoxifen on ovulation rates, endometrial thickness and clinical pregnancy rates in anovulatory PCOS women." | 5.30 | A new look at low-dose aspirin: Co-administration with tamoxifen in ovulation induction in anovulatory PCOS women. ( Ahmed, MR; Ahmed, WAS; Aref, NK; Sedik, WF, 2019) |
| "The EAGeR trial randomly assigned 1228 women with a history of pregnancy loss to receive 81 mg aspirin or placebo for up to six menstrual cycles of attempting pregnancy and, if they became pregnant, throughout pregnancy." | 5.30 | Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes. ( Hill, M; Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2019) |
| "There is a reduction in the total drug metabolite concentration of aspirin in pregnancy, and therefore a dose adjustment is potentially required in pregnant women." | 5.30 | A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy. ( Chau, K; Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Makris, A; Münch, G; Shanmugalingam, R; Wang, X; Xu, B, 2019) |
| "Treatment with prednisolone (7." | 5.30 | [A case of antiphospholipid antibody syndrome successfully treated with prednisolone and low-dose aspirin, with subsequent normal pregnancy]. ( Maeda, T; Maesima, E; Yamada, Y; Yamamoto, M; Yukawa, S, 1997) |
| "Pretreatment with aspirin significantly augmented alcohol-induced resorption, IUGR, cleft palate and digital malformations associated with haematomas." | 5.29 | Aspirin-alcohol interaction in the production of cleft palate and limb malformations in the TO mouse. ( Padmanabhan, R; Pallot, DJ, 1995) |
| "Pre-treatment with aspirin (both 150 and 200 mg/kg) on day 8 of gestation resulted in a numerical, though not statistically significant increase in alcohol-induced exencephaly." | 5.29 | Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses. ( Craigmyle, MB; Padmanabhan, R; Wasfi, IA, 1994) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 5.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| "Prophylactic LMW heparin therapy when beginning from before 14 weeks of gestation with aspirin during pregnancy is not associated with an improved angiogenic profile." | 5.27 | Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis. ( Cochery-Nouvellon, E; Gris, JC; Haddad, B; Karumanchi, SA; Lecarpentier, E; Mercier, E; Thadhani, R; Touboul, C, 2018) |
| " We evaluated preconception blood pressure and fecundability, pregnancy loss, and live birth in the EAGeR trial (Effects of Aspirin on Gestational and Reproduction; 2007-2011), a randomized clinical trial of aspirin and reproductive outcomes among 1228 women attempting pregnancy with a history of pregnancy loss." | 5.27 | Preconception Blood Pressure Levels and Reproductive Outcomes in a Prospective Cohort of Women Attempting Pregnancy. ( Kim, K; Mendola, P; Mumford, SL; Naimi, AI; Nobles, CJ; Park, H; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L; Wilcox, B; Yeung, EH, 2018) |
| "Our objective was to determine whether low-dose aspirin reduces the rate of spontaneous preterm birth in nulliparous women without medical comorbidities." | 5.27 | Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. ( Andrikopoulou, M; Gyamfi-Bannerman, C; Handal-Orefice, R; Purisch, SE, 2018) |
| "Evaluate the feasibility and acceptability of routine aspirin in low-risk women, compared with screening-test indicated aspirin for the prevention of pre-eclampsia and fetal growth restriction." | 5.27 | ( Alfirevic, Z; Breathnach, F; Cody, F; Cotter, A; Culliton, M; Daly, S; Dicker, P; Downey, P; Higgins, J; Hunter, A; Malone, FD; McAuliffe, FM; McCormack, D; McParland, P; Mone, F; Morrison, JJ; Mulcahy, C; Stanton, A; Tully, EC, 2018) |
| " Comparing women with stage 1 hypertension and normotensive women receiving low-dose aspirin during pregnancy (n=1,465), no differences in rates of preeclampsia (7." | 5.27 | Maternal Outcomes Associated With Lower Range Stage 1 Hypertension. ( Caritis, SN; Catov, JM; Hauspurg, A; Powers, RW; Sutton, EF, 2018) |
| "Screening results for thrombophilia and antithrombotic treatment with enoxaparin, aspirin, or both and pregnancy outcomes." | 5.27 | The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages. ( Elias, A; Elias, M; Nahas, R; Saliba, W, 2018) |
| "Aspirin was given into jugular vein and caused a significant decrease of blood pressure in both groups of animals during whole time of experiment." | 5.27 | [Changes in the reaction of the cardiovascular system to angiotensin II in pregnancy modified by aspirin]. ( Celewicz, Z; Klinke, R; Paradowski, A, 1986) |
| " Trial will be individually randomized with one-to-one ratio (intervention/control) Population: Nulliparous women between the ages of 14 and 40, with a singleton pregnancy between 6 0/7 weeks and 13 6/7 weeks gestational age (GA) confirmed by ultrasound prior to enrollment, no more than two previous first trimester pregnancy losses, and no contraindications to aspirin." | 5.24 | A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study. ( Bose, CL; Carlo, WA; Chomba, E; Derman, RJ; Esamai, F; Garces, A; Goco, N; Goldenberg, RL; Goudar, SS; Hambidge, KM; Hemingway-Foday, JJ; Hibberd, PL; Hoffman, MK; Kodkany, BS; Koso-Thomas, M; Krebs, NF; Liechty, EA; Lokangaka, A; McClure, EM; Miodovnik, M; Mwenechanya, M; Patel, A; Saleem, S; Silver, R; Tshefu, A; Wallace, DD, 2017) |
| " It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia." | 5.24 | Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Gizurarson, S; Janga, D; Jani, JC; Maclagan, K; Meiri, H; Molina, FS; Nicolaides, KH; O'Gorman, N; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Singh, M; Syngelaki, A; Tenenbaum-Gavish, K; Wright, D, 2017) |
| "To examine the performance of screening for preterm and term pre-eclampsia (PE) in the study population participating in the ASPRE (Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-Based Preeclampsia Prevention) trial." | 5.24 | ASPRE trial: performance of screening for preterm pre-eclampsia. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Janga, D; Jani, JC; Molina, FS; Nicolaides, KH; O'Gorman, N; Papaioannou, G; Persico, N; Plasencia, W; Poon, LCY; Rolnik, DL; Singh, M; Syngelaki, A; Tenenbaum-Gavish, K; Wright, D, 2017) |
| "Among women with a single, recent pregnancy loss, daily preconception low-dose aspirin (LDA) increased the live birth rate with no effect on pregnancy loss." | 5.24 | Low-Dose Aspirin and Sporadic Anovulation in the EAGeR Randomized Trial. ( Chen, Z; Galai, N; Lesher, LL; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Wactawski-Wende, J, 2017) |
| "In women with defective trophoblastic invasion, as reflected by abnormal UtA Doppler, low-dose aspirin started in the first trimester does not have a significant effect on UtA impedance as pregnancy progresses; however, the study was underpowered to detect potential small effects ." | 5.24 | Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study. ( Diaz, D; Figueras, F; González de Agüero, R; Gratacos, E; Meler, E; Oros, D; Ramirez, JC; Ricart, M; Scazzocchio, E, 2017) |
| "LMWH and LMWH combined with aspirin therapy cannot improve the pregnancy outcome of women with uRM and negative aPL." | 5.22 | Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial. ( Li, H; Wang, D; Yan, P; Yan, X, 2022) |
| "There is a lack of evidence for pre-eclampsia prophylaxis with aspirin in women with pre-existing diabetes mellitus (DM)." | 5.22 | Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: Systematic review. ( Alahakoon, TI; Cheung, NW; Haider, R; Jesudason, S; Lee, VW; Nolan, CJ; Padmanabhan, S; Peek, M; Simmons, D; Zen, M, 2022) |
| "To evaluate the association between the use of low-dose aspirin for preeclampsia prophylaxis and risks of gestational diabetes (primary outcome), neonatal hypoglycemia, macrosomia, large for gestational age, birth trauma, and shoulder dystocia (secondary outcomes)." | 5.22 | Association Between Low-Dose Aspirin and Development of Gestational Diabetes: A Systematic Review and Meta-Analysis. ( Burwick, R; Chauhan, SP; Gupta, M; Mendez-Figueroa, H; Murphy, L; Saldanha, IJ; Sawyer, K; Wagner, SM, 2022) |
| " The following were consistently recommended: (1) automated blood pressure measurement with devices validated for pregnancy and preeclampsia, reflecting increasing recognition of the prevalence of white-coat hypertension and the potential usefulness of home blood pressure monitoring; (2) use of dipstick proteinuria testing for screening followed by quantitative testing by urinary protein-to-creatinine ratio or 24-hour urine collection; (3) key definitions and most aspects of classification, including a broad definition of preeclampsia (which includes proteinuria and maternal end-organ dysfunction, including headache and visual symptoms and laboratory abnormalities of platelets, creatinine, or liver enzymes) and a recognition that it can worsen after delivery; (4) preeclampsia prevention with aspirin; (5) treatment of severe hypertension, most commonly with intravenous labetalol, oral nifedipine, or intravenous hydralazine; (6) treatment for nonsevere hypertension when undertaken, with oral labetalol (in particular), methyldopa, or nifedipine, with recommendations against the use of renin-angiotensin-aldosterone inhibitors; (7) magnesium sulfate for eclampsia treatment and prevention among women with "severe" preeclampsia; (8) antenatal corticosteroids for preterm birth but not hemolysis, elevated liver enzymes, and low platelet count syndrome; (9) delivery at term for preeclampsia; (10) a focus on usual labor and delivery care but avoidance of ergometrine; and (11) an appreciation that long-term health complications are increased in incidence, mandating lifestyle change and risk factor modification." | 5.22 | Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. ( Gillon, TE; Magee, LA; Pels, A; Scott, G; von Dadelszen, P, 2022) |
| "To examine whether combined treatment with low-molecular-weight heparin (LMWH) and aspirin reduces recurrent hypertensive disorders of pregnancy (HD: pre-eclampsia, eclampsia or HELLP syndrome) in women with antiphospholipid antibodies (aPLA) and a previous delivery for HD and/or small-for-gestational-age (SGA) birthweight before 34 weeks gestation." | 5.22 | Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT. ( Bezemer, D; de Vries, JI; Hague, WM; van Hoorn, ME; van Pampus, MG, 2016) |
| "The objective of this study is to determine whether low-dose aspirin (LDA) reduced the rate of preterm birth (PTB) in a cohort of women at high risk for preeclampsia." | 5.22 | The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial. ( Allshouse, AA; Heyborne, KD; Jessel, RH, 2016) |
| "The objective of the study is to evaluate low-dose aspirin (LDA) for pre-eclampsia prevention in twin gestations with elevated maternal serum human chorionic gonadotropin (hCG)." | 5.22 | Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin. ( Allshouse, AA; Euser, AG; Heyborne, KD; Metz, TD, 2016) |
| "We propose a three armed multi-center open-labeled randomized control trial of; (i) routine LDA, (ii) no aspirin, and (iii) LDA on the basis of a positive first trimester pre-eclampsia screening test." | 5.22 | An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol. ( Breathnach, F; Culliton, M; Dicker, P; Downey, P; Malone, FD; McAuliffe, FM; McCormack, D; McParland, P; Mone, F; Mulcahy, C; Stanton, A; Tully, E, 2016) |
| "A randomized clinical trial, Effects of Aspirin in Gestation and Reproduction, enrolled women with 1 or 2 prior pregnancy losses at 4 US clinical centers from June 15, 2007, to July 15, 2011." | 5.22 | Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial. ( Galai, N; Grantz, KL; Hinkle, SN; Mitchell, EM; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA, 2016) |
| "The aim of this study is to analyze the effect of 100 mg/d regular oral intake of aspirin during pregnancy on high-risk pregnancy-induced hypertension syndrome patients." | 5.22 | Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients. ( Li, L; Liu, FM; Wang, M; Yang, HL; Zhao, M, 2016) |
| "Late timing of intervention and maternal obesity are potential explanations for the modest effect of aspirin for preeclampsia prevention." | 5.20 | Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy? ( Abramovici, AR; Biggio, JR; Cantu, JA; Edwards, RK; Jauk, VR; Owen, J; Tita, AT, 2015) |
| "Aspirin supplementation was associated with worse outcomes related to preterm birth in smokers in a high-risk but not low-risk cohort." | 5.20 | Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth. ( Abramovici, A; Biggio, J; Cantu, J; Edwards, R; Jauk, V; Tita, A; Wetta, L, 2015) |
| "To evaluate the association between low-dose aspirin initiated before conception and the risk of preterm birth." | 5.20 | Low-dose aspirin and preterm birth: a randomized controlled trial. ( Ahrens, K; Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L; Townsend, JM; Wactawski-Wende, J; Wong, LF, 2015) |
| "To estimate the effect of early administration of aspirin on the prevention of pre-eclampsia in high-risk women." | 5.20 | Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. ( Goetzinger, KR; Odibo, AO; Odibo, L; Tuuli, MG, 2015) |
| "To evaluate the effect of low-dose aspirin in prevention of adverse pregnancy outcomes (APO) in women with second trimester alpha-fetoprotein (AFP) >2." | 5.19 | Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein. ( Alavi, A; Borna, S; Hantoushzadeh, S; Khazardoost, S; Khezerlou, N; Mousavi, S, 2014) |
| "The objectives of this study are to examine the efficacy and safety of low-dose aspirin (LDA) vs LDA plus low-intensity warfarin (LDA + W) in the primary thrombosis prevention of aPL-positive patients with SLE and/or obstetric morbidity and the role of clinical and serological markers in the development of thrombosis." | 5.19 | Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). ( Aguirre, A; Akil, M; Amigo, MC; Bertolaccini, ML; Cuadrado, MJ; Egurbide, MV; Espinosa, G; Galindo, M; Gil, A; Gordon, C; Houssiau, F; Khamashta, MA; Martin, H; McHugh, N; Mico, L; Murru, V; Rahman, A; Ruiz-Irastorza, G; Seed, PT; Tektonidou, MG, 2014) |
| "To determine the maternal and neonatal efficacy and safety with furosemide, amlodipine or aspirin in women with mild/moderate chronic hypertension during pregnancy." | 5.19 | Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial. ( Dominguez, L; Solis, A; Vigil-De Gracia, P, 2014) |
| "Preconception-initiated low-dose aspirin might positively affect pregnancy outcomes, but this possibility has not been adequately assessed." | 5.19 | Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial. ( Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Townsend, JM; Wactawski-Wende, J, 2014) |
| "The aim of the present study was to investigate the clinical value of low‑dose aspirin in combination with Tiao Jing Cu Yun pills in patients with polycystic ovary syndrome (PCOS) by measuring follicular peripheral blood flow parameters and the clinical efficacy." | 5.19 | Effects of combining low‑dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome. ( Du, B; Jiang, X; Ma, M; Shi, L; Zhang, Q; Zhao, Y; Zhou, L, 2014) |
| "Low-dose aspirin (LDA) has been proposed to improve pregnancy outcomes in couples experiencing recurrent pregnancy loss." | 5.17 | A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics. ( Browne, RW; Faraggi, D; Galai, N; Lesher, LL; Lynch, AM; Mumford, SL; Perkins, NJ; Schisterman, EF; Silver, RM; Stanford, JB; Townsend, JM; Wactawski-Wende, J; Whitcomb, BW; White, M, 2013) |
| "Adding low-molecular-weight heparin (LMWH) to aspirin at < 12 weeks gestation reduces the recurrence of HD in women with previous early-onset HD (pre-eclampsia, hemolysis, elevated liver enzymes and low platelets [HELLP] syndrome and eclampsia) and/or SGA, in the context of inheritable thrombophilia without antiphospholipid antibodies." | 5.16 | Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. ( Bezemer, PD; de Vries, JI; Hague, WM; Joosten, JH; van Pampus, MG, 2012) |
| "The present study investigated if acetyl salicylic acid (ASA) and terbutaline in combination increased the clinical pregnancy rate in patients undergoing in vitro fertilisation (IVF)/intra-cytoplasmic sperm injection (ICSI)." | 5.16 | Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF/ICSI? ( Bergh, A; Friberg, M; Hanevik, HI; Haraldsen, C; Kahn, JA, 2012) |
| "With the exception of a reduced risk for infant acute myeloid leukaemias with non-aspirin non-steroidal anti-inflammatory drugs (NSAID) use early in pregnancy (odds ratios=0." | 5.15 | Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study. ( Blair, C; Ognjanovic, S; Robison, LL; Roesler, M; Ross, JA; Spector, LG, 2011) |
| "To determine whether low molecular weight heparin (LMWH) plus low-dose aspirin (LDA) is comparable in efficacy and safety to unfractionated heparin (UFH) plus LDA in the management of pregnant women with a history of recurrent spontaneous abortion secondary to antiphospholipid syndrome (APS)." | 5.15 | Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. ( Abdou, AM; Fouda, IM; Fouda, UM; Ramadan, DI; Sayed, AM; Zaki, MM, 2011) |
| "To analyze whether the administration of low-dose aspirin during IVF treatment improves the uterine blood flow and improves ongoing pregnancy rates for non-tubal factor IVF patients with previous failed conception." | 5.14 | Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial. ( Homburg, R; Hompes, PGA; Hoozemans, DA; Lambalk, CB; Lambers, MJ; Schats, R, 2009) |
| "To compare live birth rates in women with recurrent pregnancy loss (RPL) and either autoantibodies or a coagulation abnormality, treated with low molecular weight heparin plus aspirin (LMWH/ASA) or ASA alone, and to place our results in context with other randomized clinical trials (RCT) with similar cohorts." | 5.14 | Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. ( Barrett, J; Clark, CA; Crowther, MR; Gent, M; Ginsberg, JS; Hawker, GA; Kingdom, JC; Laskin, CA; Spitzer, KA, 2009) |
| "To evaluate the effect of low-dose aspirin therapy on ovarian hyperstimulation syndrome (OHSS) in an unselected group of patients undergoing in vitro fertilization (IVF)." | 5.14 | Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. ( Bódis, J; Busznyák, C; Koppán, M; Mánfai, Z; Várnagy, A; Wilhelm, F, 2010) |
| "The use of aspirin during in vitro fertilization (IVF) has been investigated for its effect on pregnancy rates after IVF." | 5.14 | Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. ( Groeneveld, E; Homburg, R; Hompes, PG; Hoozemans, DA; Lambalk, CB; Lambers, MJ; Schats, R, 2009) |
| "To assess whether treatment with enoxaparin and low-dose aspirin, along with intensive pregnancy surveillance, reduces rate of pregnancy loss compared with intensive pregnancy surveillance alone in women with history of 2 or more consecutive previous pregnancy losses, a parallel group, multicenter, randomized controlled trial was performed in the United Kingdom and New Zealand." | 5.14 | SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. ( Clark, P; Crichton, L; Greaves, M; Greer, IA; Langhorne, P; Thomson, A; Walker, ID; Whyte, S, 2010) |
| " We then randomly assigned them to receive daily 80 mg of aspirin plus open-label subcutaneous nadroparin (at a dose of 2850 IU, starting as soon as a viable pregnancy was demonstrated), 80 mg of aspirin alone, or placebo." | 5.14 | Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. ( Büller, HR; Folkeringa, N; Goddijn, M; Hamulyák, K; Hutten, BA; Kaandorp, SP; Middeldorp, S; Mol, BW; Nahuis, M; Papatsonis, DN; van der Post, JA; van der Veen, F; Verhoeve, HR, 2010) |
| "Low-dose aspirin therapy could improve remodelling of maternal spiral arteries during early placentation and prevent subsequent pregnancy-related hypertensive disorders." | 5.14 | Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. ( Haapsamo, M; Heinonen, S; Martikainen, H; Nuojua-Huttunen, S; Räsänen, J; Tinkanen, H, 2010) |
| "Low-dose aspirin reduces uteroplacental vascular impedance in early and mid pregnancy in unselected IVF/ICSI subjects when medication is started concomitantly with controlled ovarian hyperstimulation." | 5.13 | Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. ( Haapsamo, M; Martikainen, H; Räsänen, J, 2008) |
| "To test whether adjuvant therapy with acetylsalicylic acid (ASA) and prednisolone (ASA+Pred) could improve the outcome of IVF in good-pregnancy prognosis patients." | 5.13 | Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. ( Dolfin, E; Gennarelli, G; Holte, JG; Lantieri, T; Massobrio, M; Revelli, A; Tur-Kaspa, I, 2008) |
| "To compare the use of enoxaparin alone with combination therapy of prednisone, aspirin and progesterone in the treatment of women with idiopathic recurrent miscarriage (IRM) in terms of live births and pregnancy outcome." | 5.13 | Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. ( El-Refaiey, AA; El-Tatongy, M; Fawzy, M; Mosbah, A; Shokeir, T; Warda, O, 2008) |
| "Diagnosis of preeclampsia; adverse pregnancy health outcomes and complications including eclampsia, perinatal mortality, preterm birth, small for gestational age, and potential bleeding harms or infant/child harms from aspirin exposure." | 5.12 | Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. ( Henderson, JT; Redmond, N; Senger, CA; Thomas, RG; Vesco, KK, 2021) |
| " We included randomized controlled trials reporting on health-related outcomes in children (aged > 28 days) exposed to aspirin versus placebo or no treatment during pregnancy." | 5.12 | Long-term health and neurodevelopment in children after antenatal exposure to low-dose aspirin for the prevention of preeclampsia and fetal growth restriction: A systematic review of randomized controlled trials. ( de Boer, MA; Finken, MJJ; Ket, JCF; Landman, AJEMC; Leemhuis, AG; Oudijk, MA; Painter, RC; van 't Hooft, J; van Limburg Stirum, EVJ, 2021) |
| "The most efficacious strategy to manage pregnant patients with antiphospholipid syndrome (APS) refractory to conventional heparin/low-dose aspirin treatment or at high risk of adverse pregnancy outcomes has not been determined with any degree of certainty." | 5.12 | The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies. ( Calligaro, A; Del Ross, T; Favaro, M; Gervasi, MT; Hoxha, A; Ruffatti, A; Ruffatti, AT; Tonello, M, 2021) |
| "The use of low dose aspirin (LDA) has become routine in prenatal care for a variety of diagnoses, most importantly in women with a history of preeclampsia and associated poor pregnancy outcomes." | 5.12 | Low-dose aspirin in pregnancy: who? when? how much? and why? ( Dom, AM; Mather, AR; Thorburg, LL, 2021) |
| " Aspirin prophylaxis substantially lowered the risk of pre-eclampsia, preterm birth, perinatal mortality, and intrauterine growth retardation without elevated bleeding risks." | 5.12 | Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis. ( Choi, YJ; Shin, S, 2021) |
| "Randomized controlled trials (RCTs) and retrospective cohort studies that used aspirin as an adjuvant treatment for endometrial preparation and reported subsequent pregnancy outcomes were included." | 5.12 | Aspirin for Endometrial Preparation in Patients Undergoing IVF: A Systematic Review and Meta-analysis. ( Albaini, O; Antaki, R; Jamal, W; Mourad, A, 2021) |
| "Meta-analysis was used to evaluate the efficacy and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome (PCOS)." | 5.12 | Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis. ( Su, F; Wang, M; Wang, Z; Yu, Q, 2021) |
| "The results did not demonstrate a significant difference amongst low risk nulliparous women in the risks of pre-eclampsia or gestational hypertensive disorders with aspirin administration." | 5.12 | Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: A systematic review and meta-analysis. ( Devani, P; Hodgetts Morton, V; Man, R; Morris, RK, 2021) |
| "Aspirin combined with LMWH for APS may improve live birth rate, and detection of d-dimer levels in APS pregnant women may predict pregnancy complications and guide the use of anticoagulants." | 5.12 | Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels. ( Diao, QZ; Gu, ZD; Shi, T, 2021) |
| "This was a prospective clinical trial conducted at Khartoum Fertility Center, during the period June 2002 to February 2005 to investigate the efficacy of unfractionated heparin and low-dose aspirin as prophylaxis against pregnancy loss in 58 pregnant Sudanese women with recurrent (> or = 3) miscarriages associated with antiphospholipid syndrome (APS)." | 5.12 | Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies. ( A/Magid, YM; A/Rahim, F; Adam, I; Elussein, EA; Omer, MM; Samaan, SI, 2007) |
| "Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA." | 5.12 | Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients. ( Alijotas-Reig, J; Cisteró-Bahíma, A; San Miguel-Moncín, M, 2006) |
| "To examine whether there were any differences in the endocrinological profiles during conception cycle and early pregnancy between a control group and women with a history of recurrent miscarriage that was caused by antiphospholipid syndrome and that was treated with aspirin and low molecular weight heparin." | 5.12 | Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin. ( Laird, S; Ledger, WL; Li, TC; Prakash, A, 2006) |
| "To investigate the effects of short-term low-dose aspirin and/or steroid use on implantation and pregnancy rates in nonselected intracytoplasmic sperm injection (ICSI) cycles." | 5.12 | Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study. ( Atabekoglu, CS; Berker, B; Duvan, CI; Ozmen, B; Satiroglu, H, 2006) |
| "The aim of this study was to compare a low-dose aspirin treatment on placental and perinatal effects in the patients with poor obstetric history such as preeclampsia, intrauterine growth retardation (IUGR) in previous pregnancy." | 5.12 | Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history. ( Bağiş, T; Bal, N; Kayaselcuk, F; Kilicdag, E; Kuscu, E; Tarim, E, 2006) |
| "To compare the effect of aspirin and enoxaparin on live births in women with unexplained recurrent miscarriages, as well as secondary outcomes including birth weight, uterine and umbilical blood flows, and congenital malformations." | 5.12 | A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. ( Brenner, B; Carp, H; Dolitzky, M; Inbal, A; Segal, Y; Weiss, A, 2006) |
| "To verify whether prophylaxis with low-molecular-weight heparin (LMWH) and low-dose aspirin (LDA) could positively affect pregnancy outcome in women with a history of severe preeclampsia." | 5.12 | Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. ( Alessandro, C; Gabriella, F; Giancarlo, P; Giorgia, S; Maria Clara, D; Sergio, F, 2006) |
| "To assess the efficacy of fertility-sparing treatment using medroxyprogesterone acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in young women." | 5.12 | Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. ( Fukunaga, M; Hatae, M; Hiura, M; Iwasaka, T; Kamura, T; Kodama, S; Konishi, I; Nakanishi, T; Saito, T; Saji, F; Sakamoto, A; Sasaki, H; Terakawa, N; Tsuda, H; Ushijima, K; Yaegashi, N; Yahata, H; Yasugi, T; Yoshikawa, H, 2007) |
| " We found elevated values of indices of oxidative stress in the blood serum of pregnant women with IUGR: increased levels of malondialdehyde and 4-hydroxyalkenals, decreased activity of alpha-1-antitrypsin and decreased total antioxidant capacity of the serum, with respect to healthy pregnancy." | 5.12 | Indices of oxidative stress in pregnancy with fetal growth restriction. ( Bartosz, G; Karowicz-Bilinska, A; Kedziora-Kornatowska, K, 2007) |
| " Low-molecular-weight heparin and low-dose aspirin daily during pregnancy were used in 29 selected cases with acquired and inherited thrombophilia." | 5.12 | Thrombophilia and antithrombotic therapy in women with recurrent spontaneous abortions. ( Deligiannidis, A; Mavridis, P; Mavroudi, A; Papastavrou, T; Parapanissiou, E; Tabakoudis, G; Tabakoudis, P, 2007) |
| "To determine if aspirin (ASA) therapy reduces the incidence of pre-eclampsia in women at high risk of this condition." | 5.11 | A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. ( Acaia, B; Chiaffarino, F; Del Giudice, A; Facchinetti, F; Marozio, L; Ossola, W; Paladini, D; Parazzini, F, 2004) |
| " Since low doses of aspirin could improve the utero-placental circulation (by shifting the prostacyclin/thromboxane A2 balance), we have evaluated the impact of low-dose aspirin treatment of IUGR during pregnancy on umbilical (UA) and middle cerebral artery (MCA) blood flow." | 5.11 | [The impact of low-dose aspirin therapy on umbilical and middle cerebral artery blood flow in pregnancy complicated by idiopathic intrauterine growth restriction]. ( Gottwald, L; Kalinka, J; Laudański, T; Lech, W; Nowakowski, M; Zdziennicki, A, 2004) |
| "Women undergoing IVF were randomly assigned to treatment with aspirin 75 mg daily from the day of embryo transfer (ET) until pregnancy test or no treatment in an open study." | 5.11 | Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. ( Hellberg, D; Nilsson, S; Waldenström, U, 2004) |
| "To compare low molecular weight heparin (LMWH), specifically dalteparin, to unfractionated heparin (UFH) for the treatment of antiphospholipid antibody syndrome (APS) in pregnancy." | 5.11 | Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. ( Ballem, PJ; Ensom, MH; Ensworth, S; Houlihan, E; Purkiss, S; Stephenson, MD; Tsang, P, 2004) |
| "To evaluate the use of low-molecular-weight heparin (LMWH) in combination with low-dose aspirin (LDA) for the treatment of antiphospholipid antibody (APA)-associated recurrent pregnancy loss and to compare the results with the use of unfractionated heparin (UFH) plus LDA." | 5.11 | Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. ( Franklin, RD; Herrada, J; Kutteh, WH; Lashey, N; Noble, LS, 2005) |
| "The present results indicate that low-dose aspirin treatment does not have any beneficial effect on ovarian responsiveness, PR and pregnancy outcome in unselected women undergoing IVF/ICSI." | 5.11 | Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. ( Heinonen, S; Hippeläinen, M; Mäkikallio, K; Martikainen, H; Päkkilä, M; Räsänen, J; Tapanainen, JS; Tinkanen, H; Tuomivaara, L, 2005) |
| "The aim of this study was to evaluate the effects of two different prophylactic protocols, low-dose aspirin and fish oil derivates, in the treatment of patients with recurrent pregnancy loss associated with antiphospholipid antibodies (APA) syndrome." | 5.11 | Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates. ( Carta, G; Falciglia, K; Iovenitti, P, 2005) |
| "05) in pregnancy outcomes between the two studied therapeutic protocols, but the therapy with aspirin and low-molecular heparin was cheaper and easier to apply than the therapy with immunoglobulins." | 5.11 | Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. ( Dukanac, J; Gojnić, M; Jeremić, K; Ljubić, A; Pervulov, M; Stojnić, J, 2005) |
| "To compare the efficacy of low-dose aspirin alone versus low-dose aspirin plus low molecular weight heparin in pregnant women with antiphospholipid syndrome and recurrent miscarriage as prophylaxis against pregnancy loss." | 5.10 | Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. ( Farquharson, RG; Greaves, M; Quenby, S, 2002) |
| "To compare the 2 most efficacious therapeutic regimens, intravenous immunoglobulin (IVIG) and anticoagulation with low molecular weight (LMW) heparin plus low-dose aspirin, in women with recurrent pregnancy loss associated with antiphospholipid antibodies (aPL)." | 5.10 | Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. ( Accardo-Palumbo, A; Castelli, A; Ciccia, F; Ferrante, A; Giarratano, A; Licata, G; Perino, A; Triolo, G, 2003) |
| "To reduce the incidence of pre-eclampsia in nulliparous women, in accordance with the suggestion of a recent meta-analysis that low dose aspirin might decrease this incidence by more than half if used early enough in and at a sufficient dose during pregnancy (more than 75 mg)." | 5.10 | Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1). ( Biausque, S; Breart, G; Churlet, A; Goeusse, P; Lequien, P; Marquis, P; Parmentier, D; Puech, F; Subtil, D; Uzan, S, 2003) |
| "To assess the effectiveness of a pre-eclampsia prevention strategy based on routine uterine artery Doppler flow velocity waveform examination during the second trimester of pregnancy, followed by a prescription for 100 mg aspirin in the case of abnormal Doppler findings." | 5.10 | Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2). ( Breart, G; Delcourt, YM; Goeusse, P; Houfflin-Debarge, V; Lequien, P; Malek, YM; Puech, F; Quandalle, F; Subtil, D; Uzan, S, 2003) |
| " These 16 patients with unexplained abortions were treated with aspirin, 80 mg per day, and a successful pregnancy outcome was observed in 10 patients, while 2 patients were in the third trimester of pregnancy." | 5.10 | Prevalence of anticardiolipin antibody IgG in recurrent first trimester abortions and the role of aspirin in its prevention. ( Choudhry, R; Kalra, S; Raheja, S; Tuli, A, 2003) |
| "To investigate whether heparin and low-dose aspirin increase the pregnancy rate in antiphospholipid antibody or antinuclear antibody-seropositive women with IVF implantation failure." | 5.10 | A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. ( Baker, HW; Chamley, L; Hale, L; Norris, H; Stern, C, 2003) |
| "In pregnancies with impaired placentation, as demonstrated by increased impedance to flow in the uterine arteries, the daily administration of 150 mg aspirin after 23 weeks of gestation does not prevent the subsequent development of pre-eclampsia." | 5.10 | Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. ( Nicolaides, KH; Palma Dias, R; Papageorghiou, AT; Parra, M; Yu, CK, 2003) |
| "This is a prospective clinical trial with 11 patients with RSA associated with allo- and autoimmunity not receiving lymphocyte immunizations but only heparin and aspirin preconceptionally and through pregnancy." | 5.09 | Heparin plus aspirin as a "single" therapy for recurrent spontaneous abortion associated with both allo- and autoimmunity. ( Beer, A; Botero, J; Cadavid, A; García, G; Ossa, J; Peña, B; Sánchez, F, 1999) |
| "The treatment with low doses of aspirin reduces the proportion of SGA babies and increases birthweight in the case of a diagnosed fetal growth retardation." | 5.09 | [Evaluation of the effectiveness of a low-dose aspirin in the treatment of intrauterine growth retardation (IUGR)]. ( Hanke, W; Kalinka, J; Laudański, T; Sieroszewski, P; Suzin, J, 1999) |
| " Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound." | 5.09 | Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. ( Backos, M; Baxter, N; Chilcott, IT; Cohen, H; Rai, R; Regan, L, 1999) |
| "The objectives of the study were to confirm the validity of using oscillometric measurement of MAP in the left lateral position to identify those at high risk for developing pregnancy-induced hypertension (PIH), and to assess and compare the efficacy of prophylaxis with low-dose aspirin or calcium supplementation in high-risk patients." | 5.09 | Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. ( Fung, HY; Hung, CY; Rogers, MS, 1999) |
| "This study extends previous results on the effects of low-dose aspirin on blood pressure in pregnant women at differing risk of developing hypertension in pregnancy and who received aspirin at different times according to their rest-activity cycle." | 5.09 | Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. ( Alonso, I; Ayala, DE; Codesido, J; Fernández, JR; Hermida, RC; Iglesías, M; Mojón, A; Silva, I; Ucieda, R, 1999) |
| "This was a prospective observation of pregnancy outcomes among 462 women with pregestational diabetes mellitus (White classes B-F) and singleton pregnancies who were enrolled in a multicenter trial to compare low-dose aspirin with placebo for preeclampsia prevention." | 5.09 | Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Dombrowski, M; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, P; Miodovnik, M; Paul, R; Roberts, J; Sibai, BM; Thurnau, G; VanDorsten, JP, 2000) |
| "To investigate the effect of low-dose, slow-release aspirin in reducing the incidence and/or severity of pregnancy complications in women identified as high risk of developing problems associated with uteroplacental insufficiency, namely pre-eclampsia or delivering a small-for-gestational age (SGA) baby." | 5.09 | A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks. ( Aquilina, J; Campbell, S; England, P; Harrington, K; Kurdi, W, 2000) |
| "Daily administration of low-dose aspirin during the second and third trimesters of pregnancy does not alter uteroplacental or fetoplacental hemodynamics and does not cause moderate or severe constriction of the ductus arteriosus." | 5.09 | Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. ( Erdmann, M; Grab, D; Kreienberg, R; Lang, D; Muche, R; Oberhoffer, R; Paulus, WE; Terinde, R, 2000) |
| " Patients with a history of thromboembolism or positive findings for thrombophilia were prescribed LMWH (enoxaparin sodium, 40 mg daily) in combination with low-dose aspirin (100 mg daily) in the first trimester (group 1, n=14) or the second trimester (group 2, n=17); the remaining 15 patients received low-dose aspirin alone (group 3)." | 5.09 | Low-molecular-weight heparin for thrombophilia in pregnant women. ( Bar, J; Blickstein, D; Cohen-Sacher, B; Hod, M; Lahav, J; Merlob, P, 2000) |
| "Higher pregnancy rate and better endometrial pattern were achieved in patients with thin endometrium after aspirin administration." | 5.09 | Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study. ( Chang, CC; Chen, CL; Hsieh, YY; Lo, HY; Tsai, HD, 2000) |
| "This preliminary study suggests that low-dose aspirin has no additional benefit when added to supportive care for women for whom recurrent early fetal loss is the only sequela of the antiphospholipid syndrome." | 5.09 | Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. ( Birdsall, M; Chamley, LW; Liddell, HS; McDougall, J; Pattison, NS; Zanderigo, AM, 2000) |
| "The aim was to evaluate the effect of aspirin on pregnancy and implantation rates in an unselected group of patients undergoing intracytoplasmic sperm injection (ICSI)." | 5.09 | Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. ( Alatas, C; Balaban, B; Isiklar, A; Mercan, R; Nuhoglu, A; Urman, B, 2000) |
| "In patients with aPL syndrome, IVIG treatment improved pregnancy outcome, with significantly lower pregnancy complication rates, when compared with prednisone plus LDA therapy." | 5.09 | Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin. ( Cesa, F; Di Pierro, G; Lazzarin, N; Menghini, S; Romanini, C; Valensise, H; Vaquero, E, 2001) |
| "To assess whether systematic screening with an uterine artery Doppler in low risk pregnant women followed by the prescription of low dose aspirin in cases with abnormal results reduced the incidence of intrauterine growth restriction and pre-eclampsia." | 5.09 | Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial. ( Aboulker, D; Bréart, G; Bucourt, M; Goffinet, F; Papiernik, E; Paris-Llado, J; Uzan, M, 2001) |
| "Aspirin therapy increased birth weight in all women, especially in women with high human chorionic gonadotropin levels, partly by increasing gestational age at delivery." | 5.08 | The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels. ( DuBard, MB; Goldenberg, RL; Hauth, JC; Lea, C; Wenstrom, KD, 1995) |
| " The angiotensin II-sensitive women were randomized to 60 mg of aspirin or placebo as a subset of a large multicenter, randomized, controlled trial of low-dose aspirin therapy in pregnancy." | 5.08 | The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy. ( Buckley, D; de Swiet, M; Kissane, J; Kyle, PM; Redman, CW, 1995) |
| " Whether patients were assigned to aspirin or placebo, birth weight was significantly greater in women who had a twofold or greater reduction in maternal serum thromboxane B2 levels." | 5.08 | Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial. ( Copper, RL; Cutter, GR; Goldenberg, RL; Hauth, JC; Parker, CR, 1995) |
| "Our purpose was to determine the frequency and safety of the use of epidural anesthesia and the correlation between bleeding time and maternal-neonatal bleeding complications in a group of pregnant women who participated in a multicenter trial of low-dose aspirin in pregnancy." | 5.08 | Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. ( Caritis, SN; McNellis, D; Shaw, K; Sibai, BM; Thom, E, 1995) |
| "Of 186 women with abnormal uteroplacental resistance according to criteria defined previously, 102 agreed to randomization to either low-dose aspirin (100 mg/day) or placebo for the remainder of the pregnancy." | 5.08 | A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. ( Cook, CM; Devonald, KJ; Ellwood, DA; Fay, RA; Morris, JM, 1996) |
| "To determine any benefits or risks, expressed in early childhood, of low dose aspirin treatment in pregnancies at high risk of complications due to pre-eclampsia or intrauterine growth retardation." | 5.08 | Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group. ( , 1995) |
| "To determine the effectiveness of low dose aspirin in women at high risk of adverse outcomes associated with pre-eclampsia." | 5.08 | ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group. ( , 1996) |
| "To assess the effect of low dose aspirin on severe pre-eclampsia when given to women identified as high risk by abnormal uterine artery Doppler ultrasound." | 5.08 | Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. ( Bower, SJ; Campbell, S; Harrington, KF; McGirr, C; Schuchter, K, 1996) |
| "The purpose of this study was to investigate the hypothesis that maternal administration of 100mg aspirin each day will improve birth-weight and other measures of neonatal size when given as a treatment to pregnancies complicated by fetal growth restriction and umbilical-placental insufficiency." | 5.08 | Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial. ( Evans, SF; Godfrey, M; Newnham, JP; Phillips, J; Walters, BJ, 1995) |
| "To analyze determinants of the risk of pregnancy-induced hypertension (PIH) with or without proteinuria, we compared characteristics of women enrolled in the Italian Study of Aspirin in Pregnancy who developed PIH and those who did not." | 5.08 | Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group. ( Benedetto, C; Bortolus, R; Chatenoud, L; Marozio, L; Parazzini, F; Restelli, S; Ricci, E, 1996) |
| "This study was conducted to determine if lower dose heparin (LD Heparin) combined with aspirin is as efficacious as higher dose heparin (HD Heparin) for the treatment of the antiphospholipid antibody syndrome in women seeking pregnancy." | 5.08 | A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. ( Ermel, LD; Kutteh, WH, 1996) |
| "The purpose of this study was to determine which low dose of low dose aspirin (LDA) optimized the urinary prostacyclin (PGI2)/thromboxane (TXA2) ratio and minimized evidence of platelet aggregation during normal late pregnancy." | 5.08 | Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin/thromboxane ratios in late pregnancy. ( Branch, DW; Martin, C; Mitchell, MD; Rodgers, G; Varner, MW, 1996) |
| "The aims of this prospective study were to explore the changes in platelet angiotensin II (A-II) binding in pregnancy amongst Chinese women at high risk of developing pregnancy-induced hypertension (PIH) and the effects of low-dose aspirin and calcium supplementation on A-II binding." | 5.08 | Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension. ( Arumanayagam, M; Hung, C; Rogers, MS, 1996) |
| "There is evidence that aspirin in low doses favourably influences the course and outcome of pregnancy in women at risk of developing pregnancy-induced hypertension." | 5.08 | Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Center, Dar es Salaam. ( Mgaya, HN; Ramaiya, C, 1995) |
| "Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody-associated recurrent pregnancy loss." | 5.08 | Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. ( Kutteh, WH, 1996) |
| "The use of low-dose aspirin for the prevention and treatment of pre-eclampsia and intrauterine growth restriction has been studied extensively during the last 10 years." | 5.08 | Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study. ( Bar, J; Fisch, B; Hod, M; Kaplan, B; Meizner, I; Pardo, J; Rabinerson, D, 1997) |
| "8 mg per kilogram of body weight per day) and aspirin (100 mg per day) or placebo for the duration of the pregnancy." | 5.08 | Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. ( Bombardier, C; Farewell, V; Farine, D; Fielding, L; Hannah, ME; Laskin, CA; Mandel, FP; Ritchie, JW; Soloninka, CA; Spitzer, K; Yeung, M, 1997) |
| " We evaluated the effect of a low-dose aspirin (LDA) on PGI2 and TXA2 production and on pregnancy outcome in RSA women with and without detectable anticardiolipin antibodies (ACA)." | 5.08 | Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. ( Ailus, K; Foudila, T; Marttunen, M; Palosuo, T; Söderstrom-Anttila, V; Tulppala, M; Ylikorkala, O, 1997) |
| "We found an association between the addition of ketanserin to aspirin and a decrease in the number of cases of pre-eclampsia and severe hypertension, as well as improved pregnancy outcome among patients with mild to moderate midtrimester hypertension." | 5.08 | Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. ( Odendaal, HJ; Steyn, DW, 1997) |
| "Clinical pregnancy rates, delivery rates, implantation rates, and change in endometrial thickness were compared in the aspirin and nonaspirin groups." | 5.08 | Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. ( Galen, D; Hammel, J; Hampton, K; Jacobson, A; Weckstein, LN, 1997) |
| "To determine whether low-dose aspirin reduces the incidence of pre-eclampsia, reduces perinatal mortality and improves birth weights in pregnant women considered at high risk of developing pre-eclampsia." | 5.08 | A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. ( Byaruhanga, RN; Chipato, T; Rusakaniko, S, 1998) |
| "The results of this study in Barbados do not support the routine use of low dose aspirin for prevention of pre-eclampsia or its complications, confirming results of previous large trials in other settings." | 5.08 | Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. ( Ayers, S; Collins, R; Cruickshank, JK; Duley, L; Farrell, B; Gay, MP; Grant, A; Griffiths, J; Hennis, A; Rotchell, YE; Stewart, A, 1998) |
| "To investigate whether low dose aspirin medication given to primiparous women provides benefit in preventing pre-eclampsia or intrauterine growth retardation." | 5.08 | A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. ( Golding, J, 1998) |
| "We studied 2503 women with either diabetes mellitus, chronic hypertension, multifetal gestation, or pre-eclampsia in a previous pregnancy who participated in a multicenter study comparing aspirin and placebo in preventing pre-eclampsia." | 5.08 | Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Dombrowski, M; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, M; McNellis, D; Meis, P; Miodovnik, M; Paul, R; Roberts, J; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "The aim of the study was too determine whether, in a low-dose aspirin trial in high-risk pregnancies, a decrease in maternal serum thromboxane B2 level predicted improved pregnancy outcomes." | 5.08 | Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units. ( Caritis, S; Dombrowski, M; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, P; Miodovnik, M; Paul, R; Roberts, JM; Sibai, B; Thurnau, G; VanDorsten, P; Walsh, S, 1998) |
| "Forty-six nulliparous women in third trimester of pregnancy with a raised blood pressure of 30 mm Hg (systolic) or/and 15 mm Hg (diastolic) or both, over baseline values were treated with 75 mg of aspirin per day." | 5.07 | A study of use of low dose aspirin in prevention of pregnancy induced hypertension. ( Pan, S; Roy, UK, 1994) |
| "Meta-analysis of data from several controlled trials has shown that low-dose aspirin reduces the risk of pregnancy-induced hypertension (PIH) and intrauterine growth retardation (IUGR) in women at high risk of these disorders." | 5.07 | Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy. ( , 1993) |
| "Effectiveness of early administered low-dose aspirin in prevention of pregnancy-induced hypertension (PIH) and fetal growth retardation in twin pregnancies was investigated in a randomized placebo controlled, double-blind trial in 47 twin pregnancies." | 5.07 | Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. ( Arieli, S; Bukovski, I; Caspi, E; Raziel, A; Sherman, D; Weinraub, Z, 1994) |
| "Concern has been expressed about possible neonatal side effects after the use of maternal anti-platelet agents in pregnancy, particularly low dose aspirin treatment." | 5.07 | Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. ( Broughton Pipkin, F; Fox, SC; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1994) |
| "To study the effect of daily treatment with 50 mg of aspirin (ASA) on the hypertensive pregnancy complications and on the production prostacyclin (PGI2) and thromboxane A2 (TxA2) in high risk pregnant women and their infants." | 5.07 | Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. ( Hartikainen-Sorri, AL; Hiilesmaa, V; Lumme, R; Viinikka, L; Ylikorkala, O, 1993) |
| "We compared the use of aspirin alone with combined therapy (prednisone plus aspirin) in antiphospholipid antibody-positive obstetric patients with prior adverse pregnancy outcome." | 5.07 | Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. ( Hobart, JM; MacGregor, SN; Neerhof, MG; Ragin, A; Sholl, JS; Silver, RK, 1993) |
| "Daily ingestion of 60 mg of aspirin beginning at 24 weeks' gestation significantly reduced the occurrence of preeclampsia." | 5.07 | Low-dose aspirin therapy to prevent preeclampsia. ( Copper, RL; Cutter, GR; DuBard, MB; Goldenberg, RL; Hauth, JC; Parker, CR; Philips, JB, 1993) |
| "In a prospective, randomized, double-blind study for the prevention of pregnancy-induced hypertension and preeclampsia, 41 primigravidae with positive roll-over test (28th-32nd week of pregnancy) received 80 mg aspirin/day or placebo until the end of the 37th week." | 5.07 | Low-dose aspirin in primigravidae with positive roll-over test. ( Alge, A; Dapunt, O; Daxenbichler, G; Hansen, H; Pastner, E; Schröcksnadel, H; Schwegel, P; Sitte, B; Steckel-Berger, G, 1992) |
| "Low dose aspirin would appear to be an appropriate agent for the inhibition of platelet reactivity associated with hypertensive pregnancy." | 5.07 | A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. ( Broughton Pipkin, F; Fox, S; Heptinstall, S; Louden, KA; Mitchell, JR; O'Callaghan, C; Symonds, EM; Tuohy, P, 1992) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 5.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "A multicentric randomized double-blind trial was realized in order to determine whether a treatment with a low-dose aspirin (150 mg/day) with or without dipyridamole (225 mg/day) was able to prevent the perinatal consequences of pre-eclampsia." | 5.07 | Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group. ( Sureau, C, 1991) |
| "The hypothesis that an enhanced vasopressor response to angiotensin II in pregnancy may be corrected by suppressing production of platelet thromboxane A2 with low-dose aspirin was tested in a randomized, placebo-controlled, double-blind trial." | 5.07 | Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. ( Dekker, GA; Makovitz, JW; Rotmans, N; Wallenburg, HC, 1991) |
| "The effect of low doses of aspirin on women with mild pregnancy-induced hypertension was investigated by means of a prospective, randomized, double-blind trial." | 5.06 | Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. ( Barkai, G; Ben-Baruch, G; Mashiach, S; Schiff, E, 1990) |
| "We carried out a prospective, randomized, double-blind, placebo-controlled study to investigate the capacity of aspirin to prevent pregnancy-induced hypertension and to alter prostaglandin metabolism." | 5.06 | The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. ( Barkai, G; Ben-Baruch, G; Blankstein, J; Goldenberg, M; Peleg, E; Rosenthal, T; Ruppin, E; Schiff, E; Tamarkin, M; Yahal, I, 1989) |
| "There is evidence that aspirin in low doses favorably influences the course of pregnancy-induced hypertension, but the mechanism, although assumed to involve suppression of the production of thromboxane by platelets, has not been established." | 5.06 | Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. ( Ballerini, S; Benigni, A; Chiabrando, C; Fanelli, R; Frusca, T; Gregorini, G; Orisio, S; Piccinelli, A; Pinciroli, V; Valcamonico, A, 1989) |
| "The possibility of preventing pregnancy-induced hypertension (PIH) and pre-eclampsia in primigravidae by suppressing production of thromboxane A2 with low-dose aspirin was investigated in a randomised, placebo-controlled, double-blind trial." | 5.06 | Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. ( Dekker, GA; Makovitz, JW; Rotmans, P; Wallenburg, HC, 1986) |
| "A randomized, placebo-controlled, double-blind trial was carried out to evaluate the fetal benefits of low-dose aspirin (150 mg/day) as a treatment of placental insufficiency during the last trimester of pregnancy." | 5.06 | Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. ( Connelly, A; Cook, CM; Giles, WB; Thompson, RS; Trudinger, BJ, 1988) |
| " Low-dose aspirin and dipyridamole direct prostacyclin/thromboxane A2 balance in pregnancy to the dominance of prostacyclin and may thus prevent idiopathic uteroplacental insufficiency and fetal growth retardation in high-risk patients." | 5.06 | Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. ( Rotmans, N; Wallenburg, HC, 1987) |
| "Since the 1970s, we have known that aspirin can reduce the risk of pre-eclampsia." | 5.05 | Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition? ( Danser, AHJ; Mirabito Colafella, KM; Neuman, RI; Versmissen, J; Visser, W, 2020) |
| "To perform a meta-analysis and meta-regression of randomized controlled trials (RCTs) to evaluate the impact of low-dose aspirin (LDA) on perinatal outcome, independent of its effect on pre-eclampsia (PE), preterm birth and low birth weight." | 5.05 | Impact of low-dose aspirin on adverse perinatal outcome: meta-analysis and meta-regression. ( Hartel, G; Kumar, S; Robertson, NT; Turner, JM, 2020) |
| "We performed a systematic review and meta-analysis to evaluate the effect of low-dose aspirin initiated at <11 weeks' gestation on the risk of preeclampsia, gestational hypertension, or any hypertensive disorder of pregnancy." | 5.05 | Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia? ( Chaemsaithong, P; Cuenca-Gomez, D; Gil, MM; Plana, MN; Poon, LC, 2020) |
| "Literature on the efficacy and safety of enoxaparin for thromboembolism and thromboprophylaxis remains scanty, and therefore efficacy was not assessed; in terms of safety, when including other indications for enoxaparin in pregnancy, we found that enoxaparin was associated with significantly lower complications than aspirin." | 5.05 | Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis. ( Jacobson, B; Leisegang, R; Naidoo, P; Paek, D; Rambiritch, V; Sayre, T; Shan, J, 2020) |
| "For the past decades, growing attention has been given to aspirin use during pregnancy." | 5.05 | Aspirin for prevention of preeclampsia and fetal growth restriction. ( Guerby, P; Hamdi, SM; Loussert, L; Parant, O; Vayssiere, C; Vidal, F, 2020) |
| "Aspirin and heparin are widely used as preventive strategy to reduce the high risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL)." | 5.05 | Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. ( Goddijn, M; Hamulyák, EN; Marijnen, MC; Middeldorp, S; Scheres, LJ, 2020) |
| "Benefits of aspirin administration on pre-eclampsia and IUGR depend on the gestational age and dose of aspirin administration." | 5.05 | Prophylactic aspirin for preventing pre-eclampsia and its complications: An overview of meta-analyses. ( Banach, M; Ghazanfarpour, M; Jamialahmadi, T; Sahebkar, A; Sathyapalan, T, 2020) |
| " Over the past three decades, studies have investigated the role of aspirin in preeclampsia prevention, yielding some promising results for certain at-risk groups, yet unconvincing evidence of benefit among women with pre-pregnancy diabetes." | 5.05 | The Role of Aspirin for Preeclampsia Prevention in Women with Diabetes. ( Breathnach, FM; Finnegan, C, 2020) |
| "We studied 160 postpartum women having moderate to severe episiotomy pain to determine the efficacy of aspirin analgesia, with 5, 10, and 20 grain doses, as compared to placebo." | 5.05 | Aspirin in the treatment of episiotomy pain. ( Feldman, S; Goldstein, PJ; London, RS; Sundaram, GS, 1983) |
| "In a double-blind, randomized controlled trial among 500 post-partum patients experiencing moderate to severe pain, a single oral dose of an aspirin/caffeine combination (800 mg aspirin, 65 mg caffeine) provided significantly more pain relief at 2 hours than did a higher dose of an acetaminophen/aspirin combination (648 mg acetaminophen, 648 mg aspirin) and a higher dose of acetaminophen alone (1000 mg acetaminophen)." | 5.05 | A double-blind randomized study of an aspirin/caffeine combination versus acetaminophen/aspirin combination versus acetaminophen versus placebo in patients with moderate to severe post-partum pain. ( Rubin, A; Winter, L, 1984) |
| "The analgesic response to codeine of patients with postpartum uterine-cramp pain has recently met with controversy." | 5.05 | Codeine and aspirin analgesia in postpartum uterine cramps: qualitative aspects of quantitative assessments. ( Barden, TP; Bloomfield, SS; Cissell, GB; Mitchell, J, 1983) |
| "102 patients at high risk of pre-eclampsia and/or fetal growth retardation were randomly allocated to treatment with 300 mg dipyridamole and 150 mg aspirin daily from 3 months' gestation onwards (group A) or to the control group (group B, no treatment)." | 5.05 | Prevention of pre-eclampsia by early antiplatelet therapy. ( Beaufils, M; Colau, JC; Donsimoni, R; Uzan, S, 1985) |
| "One investigator at each of 4 institutions followed the requirements of a core protocol designed to evaluate propoxyphene napsylate (50, 100 and 150 mg), fenoprofen calcium (200, 400 and 600 mg) and their combination (50/200, 100/400 and 150/600 mg) in patients reporting postpartum pain." | 5.04 | A multicenter study for analgesia involving fenoprofen, propoxyphene [alone or in combination] with placebo and aspirin controls in postpartum pain. ( Bauer, RO; Bettigole, JB; Gruber, CM; Lash, AF; McDonald, JS, 1979) |
| "The analgesic efficacy of oral naproxen and its sodium salt was compared with that of aspirin and codeine in two separate trials involving 140 and 90 patients, respectively, with postpartum uterine pain in a single-dose, parallel, stratified, randomized, placebo-controlled, double-blind design." | 5.04 | Naproxen, aspirin, and codeine in postpartum uterine pain. ( Barden, TP; Bloomfield, SS; Mitchell, J, 1977) |
| "The analgesic efficacy of fendosal, a new nonsteroidal anti-inflammatory agent structurally related to salicylic acid, was compared with that of aspirin and placebo in 100 patients with postpartum uterine pain in a single oral dose, parallel, stratified, randomized, double-blind design." | 5.04 | Fendosal and aspirin in postpartum uterine pain. ( Barden, TP; Bloomfield, SS; Mitchell, J, 1978) |
| "A single-blind, non-crossover study of the effectiveness of paracetamol, compared with aspirin and indomethacin has been carried out in 143 patients suffering from rheumatoid arthritis." | 5.04 | Therapeutic effectiveness of paracetamol in rheumatoid arthritis. ( Anderson, J; Buchanan, W; Lee, P; Watson, M; Webb, J, 1975) |
| "Administering low-dose aspirin to pregnant women led to small-to-moderate benefits, including reductions in pre-eclampsia (16 fewer per 1000 women treated), preterm birth (16 fewer per 1000 treated), the baby being born small-for-gestational age (seven fewer per 1000 treated) and fetal or neonatal death (five fewer per 1000 treated)." | 5.01 | Antiplatelet agents for preventing pre-eclampsia and its complications. ( Askie, LM; Duley, L; Hunter, KE; Meher, S; Seidler, AL, 2019) |
| "An improvement of pregnancy outcomes in women with RSA and APS can be achieved by treatment strategies combining low-dose aspirin plus heparin or heparin alone." | 5.01 | Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. ( Jiang, HL; Liu, Y; Lu, C, 2019) |
| "Indications for aspirin during pregnancy are a matter of debate and there is a recent trend to an extended prescription and an overuse of aspirin in pregnancy." | 5.01 | [Aspirin and preeclampsia]. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2019) |
| "We performed a systematic review and metaanalysis that evaluated the prophylactic effect of aspirin during pregnancy." | 4.98 | Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. ( Bujold, E; Nicolaides, KH; Roberge, S, 2018) |
| "We aimed to estimate the effect of aspirin on the risk of placental abruption or antepartum hemorrhage in relation to gestational age at onset of therapy and the dosage of the drug." | 4.98 | Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. ( Bujold, E; Nicolaides, KH; Roberge, S, 2018) |
| " There is general consensus between guidelines (at least 4 of 6 guidelines in agreement) in early pregnancy risk selection, and use of low-dose aspirin for women with major risk factors for placental insufficiency." | 4.98 | Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. ( Anderson, NH; Figueras, F; McCowan, LM, 2018) |
| "To assess the accuracy of the National Institute of Health and Care Excellence (NICE) and United States Preventive Services Task Force (USPSTF) guidelines for predicting pre-eclampsia in pregnancy to guide aspirin prophylaxis." | 4.98 | Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis. ( Al-Rubaie, ZTA; Askie, LM; Hudson, HM; Jenkins, G; Lord, SJ; Ray, JG, 2018) |
| " We analyzed the outcome of pregnancies in patients with obstetrical APS (Sydney criteria) and previous adverse obstetrical event despite low-dose aspirin and low-molecular weight heparin LMWH (LMWH) conventional treatment who experienced at least one subsequent pregnancy." | 4.95 | Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study. ( Abisror, N; Alijotas-Reig, J; Andreoli, L; Carrat, F; Costedoat-Chalumeau, N; De Carolis, S; Esteve-Valverde, EE; Fain, O; Ferrer-Oliveras, R; Josselin-Mahr, L; Lazzaroni, MG; Maina, A; Masseau, A; Mekinian, A; Morel, N; Nicaise-Roland, P; Ruffatti, A; Tabacco, S; Tincani, A, 2017) |
| "The use of aspirin and heparin has improved the pregnancy outcome in obstetric APS and approximately 70% of pregnant women with APS have a successful pregnancy outcome." | 4.95 | Current insights in obstetric antiphospholipid syndrome. ( Radin, M; Schreiber, K; Sciascia, S, 2017) |
| "Low-dose aspirin (LDA) is advocated for women at high-risk of pre-eclampsia, providing a modest, 10%, reduction in risk." | 4.95 | How important is aspirin adherence when evaluating effectiveness of low-dose aspirin? ( Alfirevic, A; Alfirevic, Z; Navaratnam, K; Pirmohamed, M, 2017) |
| "We sought to estimate the impact of aspirin dosage on the prevention of preeclampsia, severe preeclampsia, and fetal growth restriction." | 4.95 | The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. ( Bujold, E; Chaillet, N; Demers, S; Hyett, J; Nicolaides, K; Roberge, S, 2017) |
| "To determine in women with hereditary thrombophilia whether the use of the combination of low-molecular-weight heparin (LMWH) and aspirin (ASA) is better than ASA alone." | 4.93 | Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials. ( Areia, AL; Areia, M; Fonseca, E; Moura, P, 2016) |
| "The use of low-dose aspirin and heparinoids has improved the pregnancy outcome in obstetric antiphospholipid syndrome (APS)." | 4.93 | The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. ( Branch, DW; Hunt, BJ; Khamashta, M; Levy, RA; Middeldorp, S; Pavord, S; Roccatello, D; Ruiz-Irastorza, G; Schreiber, K; Sciascia, S; Tincani, A, 2016) |
| "To estimate the impact of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin started ≤ 16 weeks' gestation on the prevalence of pre-eclampsia (PE) and the delivery of a small-for-gestational-age (SGA) neonate." | 4.93 | Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. ( Bujold, E; Bureau, M; Côté, S; Demers, S; Nicolaides, KH; Roberge, S, 2016) |
| " Some are beginning to broaden prenatal screening to include pregnancy complications such as pre-eclampsia that can be prevented using soluble low-dose aspirin treatment started before 16 weeks of gestation." | 4.93 | Development of prenatal screening--A historical overview. ( Cuckle, H; Maymon, R, 2016) |
| " Although current treatment regimens including aspirin and low-molecular weight heparin have improved pregnancy outcomes, 30% of affected women have pregnancy complica-tions." | 4.93 | [Antiphospholipid syndrome and pregnancy]. ( Jacobsen, S; Langhoff-Roos, J; Lykke, JA; Nielsen, HS; Schreiber, K, 2016) |
| " Individual patient data meta-analysis indicates that low-dose aspirin causes a 10% risk reduction in pre-eclampsia for women at high individual risk." | 4.93 | Low dose aspirin and pregnancy: how important is aspirin resistance? ( Alfirevic, A; Alfirevic, Z; Navaratnam, K, 2016) |
| " Low-dose aspirin and calcium were identified as candidates for a polypill, with risk reduction estimations for pregnancy-induced hypertension and preeclampsia ranging between 10 and 62 %, depending on patient population characteristics including a priori risk, and gestation age at start of intervention." | 4.93 | Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept. ( Browne, JL; Franx, A; Grobbee, DE; Klipstein-Grobusch, K, 2016) |
| "Risk prediction models may be valuable to identify women at risk of pre-eclampsia to guide aspirin prophylaxis in early pregnancy." | 4.93 | The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. ( Al-Rubaie, Z; Askie, LM; Hudson, HM; Lord, SJ; Ray, JG, 2016) |
| "This review examines the recent literature on the use of low-dose aspirin (LDA) for primary and secondary prevention of cardiovascular disease in women, use of LDA for pre-eclampsia prevention in pregnancy, and the underutilization of aspirin therapy in women as compared to men." | 4.93 | Aspirin Use in Women: Current Perspectives and Future Directions. ( Sarma, A; Scott, NS, 2016) |
| "Currently there is no evidence in favour of routine use of aspirin in order to improve pregnancy rates for a general IVF population." | 4.93 | Aspirin for in vitro fertilisation. ( Basios, G; Pergialiotis, V; Siristatidis, CS; Vogiatzi, P, 2016) |
| "Low-dose aspirin (LDA) is thought to prevent preeclampsia in high-risk pregnancy, but it is not universally used out of concern for its efficacy and safety." | 4.91 | Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis. ( Deng, CY; Huang, GQ; Li, JK; Wang, XD; Xu, TT; Zhou, F, 2015) |
| "In high-risk pregnancies, early aspirin intervention starting before 16 weeks of gestation can prevent PIH, preeclampsia, IUGR, and preterm birth and help to increase the birth weight." | 4.91 | [Early intervention with aspirin for preventing preeclampsia in high-risk women: a meta-analysis]. ( Wu, H; Yao, S; Yu, Y, 2015) |
| " Current treatment of patients with antiphospholipid syndrome (APS) during pregnancy with heparin and aspirin can act by preventing clot formation and improving live birth rates, but other obstetric morbidities remain high, especially in patients with a history of thrombotic events." | 4.90 | Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment? ( de Jesús, GR; de Jesús, NR; Levy, RA; Rodrigues, G, 2014) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two unexplained miscarriages with or without inherited thrombophilia." | 4.90 | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. ( de Jong, PG; Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2014) |
| "Databases were searched for keywords related to aspirin and pregnancy." | 4.89 | Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. ( Bujold, E; Demers, S; Nicolaides, KH; Roberge, S; Villa, P, 2013) |
| " Several studies verify whether prophylaxis with low molecular weight heparins and low dose aspirin could improve pregnancy outcome in preeclampsia." | 4.88 | [The possible options for the prevention of preeclampsia]. ( Fodor, A; Fülesdi, B; Gyorffy, A; Major, T; Váradi, M, 2012) |
| " The use of aspirin did not improve live birth pregnancy rate compared with placebo or no treatment (1." | 4.88 | Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. ( Ageno, W; Dentali, F; Grandone, E; Margaglione, M; Middeldorp, S; Rancan, E; Rezoagli, E; Squizzato, A, 2012) |
| " We sought to review the effect of aspirin, calcium supplementation, antihypertensive agents and magnesium sulphate on risk stillbirths." | 4.87 | Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. ( Bhutta, ZA; Imdad, A; Jabeen, M; Yakoob, MY, 2011) |
| "The aim of this study is to review literature about the efficacy of low dose aspirin (LDA) and vitamins C/E (VCE) to prevent pre-eclampsia in women at high and low risk." | 4.87 | Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. ( Mullin, PM; Rossi, AC, 2011) |
| "The combination of heparin and aspirin was regarded as the 'standard therapy' for patients with recurrent pregnancy loss (RPL) and positive aPL antibodies to enhance live births, but it largely stems from expert opinion." | 4.86 | Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. ( Cheak, AA; Cheung, MW; Ho, RC; Mak, A, 2010) |
| "To estimate the effect of combined heparin and aspirin compared with aspirin monotherapy in pregnant women with antiphospholipid syndrome and recurrent pregnancy loss." | 4.86 | Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. ( Pavlou, M; Voulgarelis, M; Ziakas, PD, 2010) |
| "To estimate the effect of low-dose aspirin started in early pregnancy on the incidence of preeclampsia and intrauterine growth restriction (IUGR)." | 4.86 | Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. ( Audibert, F; Bujold, E; Bureau, M; Forest, JC; Giguère, Y; Lacasse, Y; Marcoux, S; Roberge, S, 2010) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 4.86 | WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, G, 2010) |
| "To evaluate the efficacy and safety of anticoagulant agents, such as aspirin and heparin, in women with a history of at least two miscarriages without apparent causes other than inherited thrombophilia." | 4.85 | Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. ( Di Nisio, M; Goddijn, M; Kaandorp, S; Middeldorp, S, 2009) |
| " Low dose aspirin should be given to every pregnant woman with antiphospholipid antibodies, with the addition of low molecular weight heparin in those with previous thrombosis, previous fetal death or failure of monotherapy with aspirin." | 4.85 | [The antiphospholipid syndrome in the 21st century]. ( Egurbide, MV; Martinez-Berriotxoa, A; Ruiz-Irastorza, G, 2009) |
| " first venous thrombosis) should be treated with warfarin to an INR 2." | 4.85 | Management of antiphospholipid syndrome. ( Khamashta, MA; Tuthill, JI, 2009) |
| " Clinical trials have demonstrated that patients with antiphospholipid antibodies and venous thromboembolism should be treated with vitamin K antagonists (warfarin); that ischemic stroke may be treated with aspirin or warfarin; and that women with recurrent pregnancy loss should receive prophylactic-dose heparin and aspirin." | 4.85 | Antiphospholipid antibody syndrome. ( Lim, W, 2009) |
| "Investigate cost-effectiveness of first trimester pre-eclampsia screening using the Fetal Medicine Foundation (FMF) algorithm and targeted aspirin prophylaxis in comparison with standard care." | 4.84 | First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study. ( Ammari, C; Casagrandi, D; Hillman, S; Napolitano, R; Nzelu, D; Palmer, T; Pandya, P; Stott, D, 2024) |
| "Antiplatelet agents, largely low-dose aspirin, have moderate benefits when used for prevention of pre-eclampsia and its consequences." | 4.84 | Antiplatelet agents for preventing pre-eclampsia and its complications. ( Duley, L; Henderson-Smart, DJ; King, JF; Meher, S, 2007) |
| "Antiplatelet agents, in this review largely low dose aspirin, have small-moderate benefits when used for prevention of pre-eclampsia." | 4.84 | WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia. ( Duley, L; Henderson-Smart, DJ; King, JF; Knight, M, 2007) |
| " Combined aspirin and heparin for antiphospholipid syndrome, and screening and treatment of bacterial vaginosis between ten and 22 weeks of pregnancy with clindamycin, are the only interventions proven to be useful in randomised controlled trials (RCTs)." | 4.84 | Non-surgical interventions for threatened and recurrent miscarriages. ( Tan, TY; Tien, JC, 2007) |
| "A retrospective review was unable to demonstrate improved pregnancy rates when low-dose aspirin was compared with no treatment." | 4.83 | Is there a benefit of low-dose aspirin in assisted reproduction? ( Daya, S, 2006) |
| " Results of the first phase III trial (PT1) that compared anagrelide/aspirin with hydroxyurea/aspirin have sparked an intense discussion, given that the combination of anagrelide and aspirin causes more bleeding complications in the gastrointestinal tract." | 4.83 | Anagrelide: what was new in 2004 and 2005? ( Petrides, PE, 2006) |
| "We assessed the effects and safety of aspirin treatment during pregnancy on fetal and neonatal outcomes." | 4.82 | Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. ( Boskovic, R; Costei, AM; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2003) |
| "NSAIDs or cyclooxygenase inhibitors (COX inhibitors), including aspirin, are widely used to treat pain, fever and the articular symptoms of chronic rheumatic diseases." | 4.82 | Anti-inflammatory pharmacotherapy during pregnancy. ( Skomsvoll, JF; Østensen, ME, 2004) |
| "Although intra-uterine fetal death is considered at high risk of recurrence in case of antiphospholipid syndrome (APS), a uniform management protocol including aspirin and heparin and close obstetrical follow-up led to a favorable outcome in most cases." | 4.82 | Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. ( Bats, AS; Carbonne, B; Cynober, E; Gonzales, M; Lejeune, V; Milliez, J; Safar, E, 2004) |
| " The management of pregnant patients with antiphospholipid syndrome is mainly based on the use of antiaggregant/anticoagulant agents (with aspirin and heparin) to prevent thrombosis in the uteroplacental circulation." | 4.82 | The management of pregnant patients with antiphospholipid syndrome. ( Balasch, J; Cervera, R, 2004) |
| " The recurrent pregnancy loss that is associated with this disease is managed with prophylactic low dose aspirin and heparin therapy." | 4.82 | Immunologic manipulation for the threatened fetus. ( Benson, EM, 2004) |
| " Unfractionated heparin combined with aspirin (two trials; n = 140) significantly reduced pregnancy loss compared to aspirin alone (relative risk (RR) 0." | 4.82 | Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. ( Craig, J; Empson, M; Lassere, M; Scott, J, 2005) |
| " Despite the widespread use of warfarin and unfractionated heparin during pregnancy, the optimal use of anticoagulants during pregnancy remains controversial because of a lack of appropriate prospective randomized clinical trials." | 4.81 | Anticoagulation during pregnancy. ( Foster, E; Naqvi, TZ, 2002) |
| " Aspirin, prednisone and heparin are most commonly utilized but are not clearly proven to outperform expectant management except in case of antiphospholipid syndrome." | 4.81 | [Medical treatment for recurrent miscarriages]. ( Belaisch-Allart, J; Mayenga, JM, 2002) |
| "The purpose of this study was to determine, on the basis of published reports, whether aspirin use during the first trimester of pregnancy is associated with an increased risk of congenital malformations." | 4.81 | Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. ( Boskovic, R; Costei, A; Koren, G; Kozer, E; Nikfar, S; Nulman, I, 2002) |
| "Anticoagulant therapy is indicated during pregnancy for the prevention and treatment of VTE; for the prevention and treatment of systemic embolism in patients with mechanical heart valves; and, often in combination with aspirin, for the prevention of pregnancy loss in women with APLAs or thrombophilia and previous pregnancy losses." | 4.81 | Use of antithrombotic agents during pregnancy. ( Ginsberg, JS; Greer, I; Hirsh, J, 2001) |
| "Antiplatelet drugs, largely low dose aspirin, have small to moderate benefits when used for prevention of pre-eclampsia." | 4.81 | Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. ( Duley, L; Henderson-Smart, D; King, J; Knight, M, 2001) |
| "Combination therapy with aspirin and heparin may reduce pregnancy loss in women with antiphospholipid antibodies by 54%." | 4.81 | Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. ( Craig, JC; Empson, M; Lassere, M; Scott, JR, 2002) |
| " Considering the clear risk of complications during pregnancy -- especially the occurrence of spontaneous abortion in the first trimester -- and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication." | 4.81 | Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature. ( Vanstraelen, D; Vantroyen, B, 2002) |
| " The combination of heparin and low-dose aspirin is effective in significantly increasing the chances of a successful pregnancy in woman with recurrent pregnancy failure associated with antiphospholipid antibodies." | 4.81 | Treatment of the antiphospholipid syndrome. ( Roubey, RA, 2002) |
| "Anticoagulant therapy is indicated during pregnancy for the prevention and treatment of VTE, for the prevention and treatment of systemic embolism in patients with mechanical heart valves, and, in combination with aspirin, for the prevention of pregnancy loss in women with APLA and previous pregnancy losses." | 4.80 | Use of antithrombotic agents during pregnancy. ( Ginsberg, JS; Hirsh, J, 1998) |
| " In patients with arterial or venous thrombosis, there is a high rate of recurrence during the two first years except if high-dose warfarin was used (i." | 4.80 | [Aspirin and antiphospholipid syndrome]. ( Blétry, O; Hachulla, E; Hatron, PY; Piette, AM, 2000) |
| "Aspirin appears to be more effective than chlorpheniramine for relief of itching in pregnancy when no rash is present." | 4.80 | Antihistamines versus aspirin for itching in late pregnancy. ( Jewell, D; Young, GL, 2000) |
| "Antiplatelet agents, in this review largely low dose aspirin, have small-moderate benefits when used for prevention of pre-eclampsia." | 4.80 | Antiplatelet agents for preventing and treating pre-eclampsia. ( Duley, L; Henderson-Smart, DJ; King, JF; Knight, M, 2000) |
| " Hence, in several patient series the use of IVIg either solely or in combination with aspirin/heparin resulted in successful pregnancy outcome in the vast majority of APS patients with recurrent abortions." | 4.80 | Intravenous immunoglobulin therapy of antiphospholipid syndrome. ( Levy, Y; Sherer, Y; Shoenfeld, Y, 2000) |
| " It seems effective for the prevention of recurrent pregnancy losses when conventional strategies using subcutaneous heparin and low-dose aspirin have failed." | 4.80 | [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome]. ( Lê Thi Huong, D; Piette, JC; Wechsler, B, 2000) |
| "To perform a meta-analysis determining the association of low-dose aspirin treatment with subsequent abruptio placentae or perinatal mortality." | 4.79 | Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. ( Cliver, SP; Cutter, GR; Goldenberg, RL; Hauth, JC; Parker, CR, 1995) |
| "The results of four large controlled clinical trials, encompassing over 13,000 pregnant women, indicate that low-dose aspirin is of benefit in the prevention of pre-eclampsia in women at high risk." | 4.79 | Low-dose aspirin therapy in obstetrics. ( Wallenburg, HC, 1995) |
| "The disparate results reported in the literature on the effects of low dose aspirin in preventing pre-eclampsia might be caused by non-compliance in the more recent large trials in low-risk patients." | 4.79 | The pharmacological prevention of pre-eclampsia. ( Dekker, GA, 1995) |
| "We searched 18 medical databases, including MEDLINE since 1964 and EMBASE since 1974, review articles and the references from each retrieved report to identify all studies evaluating the effect of aspirin in pregnancy and including both intrauterine growth retardation and perinatal mortality as outcome measures." | 4.79 | A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. ( Egarter, C; Husslein, P; Kaider, A; Leitich, H; Schemper, M, 1997) |
| "Aspirin has a well established role in the prevention of arterial thrombosis." | 4.79 | Aspirin in essential thrombocythemia: status quo and quo vadis. ( Bangerter, M; Griesshammer, M; Michiels, JJ; van Vliet, HH, 1997) |
| "Current trends of pharmacological research on inflammation are outlined, with particular reference to some agents differing from the aspirin-like and the corticosteroids in their mode and mechanism of action." | 4.77 | Current trends in the research on antiinflammatory agents. ( Bertelli, A; Silvestrini, B, 1985) |
| "Recent surveys of prenatal drug consumption indicate that aspirin is the most frequently consumed drug in pregnancy." | 4.75 | Aspirin in pregnancy: maternal and fetal effects. ( Corby, DG, 1978) |
| "Our results demonstrated that the combination of quercetin and aspirin exerted significantly stronger effects than aspirin alone on decreasing systolic blood pressure and proteinuria, reducing pro-inflammatory cytokine production, and inhibiting M1-type decidual macrophages polarization in an LPS-induced rat model of preeclampsia." | 4.31 | Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide. ( Chen, D; Ding, J; Liu, A; Yang, S, 2023) |
| "This study aimed to investigate the association between low-dose aspirin use and preterm birth among women with a previous preterm birth." | 4.31 | Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Kupka, E; Lomartire, R; Wikström, AK, 2023) |
| "Treatment with curcumin and aspirin combination significantly reduced the systolic blood pressure and proteinuria in the PE rats." | 4.31 | Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats. ( Feng, Y; Hou, X; Ju, Y; Wang, Y; Yang, M; Yang, Y; Zhang, X; Zhu, X, 2023) |
| "The purpose of this study was to assess obstetrician-gynecologist utilization of low-dose aspirin for women at increased risk for hypertensive disorders of pregnancy using guidelines developed by the American College of Obstetricians and Gynecologists and supported by the United States Preventive Services Task Force." | 4.31 | Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention. ( Holmgren, C; Phelps, AJD, 2023) |
| "Hydroxychloroquine combined with low-dose aspirin can effectively improve the pregnancy outcomes of pregnant women with SLE by affecting the levels of T helper (Th) 2 and Th1 cytokines." | 4.31 | Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus. ( Li, Y; Li, YW; Zhang, HX; Zhang, N, 2023) |
| "We demonstrate the estimation of incremental effects in the time-varying setting, using data from the Effects of Aspirin in Gestation and Reproduction trial, which assessed the effect of preconception low-dose aspirin on pregnancy outcomes." | 4.31 | Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy. ( Kennedy, EH; Kim, K; Naimi, AI; Rudolph, JE, 2023) |
| "To analyze the uterine artery blood flow parameters of patients with recurrent spontaneous abortion (RSA) at different gestational ages and to investigate the effects of aspirin and low molecular weight heparin (LMWH) on uterine artery blood flow parameters and pregnancy outcomes." | 4.31 | Analysis of the guidance and predictive value of uterine artery flow parameters in patients with recurrent spontaneous abortion. ( Lian, X; Mao, C; Pan, Z; Xia, F; Zhong, Y; Zhou, W; Zhou, Y, 2023) |
| "l-Arginine, aspirin and vitamin D are promising, high-potential preventative agents for fetal growth restriction." | 4.31 | Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction. ( Ammerdorffer, A; Goldstein, M; Gülmezoglu, AM; Hastie, R; Lim, S; McDougall, ARA; Ricci, C; Rushwan, S; Tong, S; Tuttle, A; Vogel, JP, 2023) |
| "This study aimed to evaluate whether there is an association between the US Preventive Services Taskforce aspirin guideline hypertensive disorders of pregnancy and the rates of hypertensive disorders of pregnancy and preterm birth in individuals with pregestational diabetes mellitus." | 4.31 | Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus. ( Allshouse, AA; Bruno, AM; Metz, TD; Theilen, LH, 2023) |
| "Many clinical trials have reported that low-dose aspirin decreases the risk of pre-eclampsia in women with prior pre-eclampsia." | 4.31 | Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study. ( Blacher, J; Deneux-Tharaux, C; Gabet, A; Grave, C; Kretz, S; Lailler, G; Olie, V; Plu-Bureau, G; Regnault, N; Tsatsaris, V, 2023) |
| " Among SLE group, lower birth weight and smaller gestational age were observed in SLE mothers with disease active during pregnancy, kidney involved, blood system involved and not taking Aspirin during pregnancy." | 4.31 | Association of preterm outcome with maternal systemic lupus erythematosus: a retrospective cohort study. ( Bei, F; Bu, J; Chen, X; Di, W; Hu, Y; Jiang, M; Sun, J; Wu, J; Ye, L, 2023) |
| "To investigate the effectiveness of low-dose aspirin (LDA) in the prevention of pre-eclampsia (PE) among otherwise low-risk twin gestations." | 4.31 | Reconsidering the effectiveness of low-dose aspirin in prevention of pre-eclampsia among otherwise low risk twin gestations: A historical cohort study. ( Brantz, Y; Farhi, A; Lerner-Geva, L; Maymon, D; Mazaki-Tovi, S; Meyer, R; Toussia-Cohen, S; Tsur, A; Yinon, Y; Zaslavsky-Paltiel, I, 2023) |
| "Prophylactic low-dose aspirin reduces the rates of preeclampsia, preterm birth, fetal growth restriction, and perinatal death in patients with risk factors for preeclampsia." | 4.31 | Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement. ( Combs, CA; Kumar, NR; Morgan, JL, 2023) |
| "The Effects of Aspirin in Gestation and Reproduction trial (2007-2011) enrolled 1228 women attempting pregnancy and followed them for up to 6 menstrual cycles and throughout pregnancy if they became pregnant." | 4.31 | The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss. ( Kim, K; Mendola, P; Mumford, SL; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM, 2023) |
| "To evaluate the prevalence and perinatal repercussions of preeclampsia (PE) after the implementation of a prophylaxis protocol with aspirin in singleton pregnancy at Maternity School of Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (2015-2106)." | 4.31 | The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin. ( Amim, J; Bornia, RG; Cardoso, FFO; Cardoso, MIMP; Costa Junior, IB; Da Matta, FG; Gama, LB; Rezende, KBC; Saunders, C, 2023) |
| "Adherence to low-dose aspirin is key in preventing pre-eclampsia." | 4.31 | Let's talk aspirin: A survey of barriers and facilitators faced by midwives when engaging in conversations about aspirin with women at risk of pre-eclampsia. ( Araújo-Soares, V; Farnworth, A; Hiu, S; McParlin, C; Smith, V; Vinogradov, R, 2023) |
| " Our example is an analysis assessing the impact of taking aspirin on pregnancy, 26 weeks after randomization, in the Effects of Aspirin in Gestation and Reproduction trial (United States, 2006-2012)." | 4.12 | The Role of the Natural Course in Causal Analysis. ( Bodnar, LM; Cartus, A; Naimi, AI; Rudolph, JE; Schisterman, EF, 2022) |
| "Current guidelines recommend low-dose aspirin for preeclampsia prophylaxis in all women with pregestational (type one and type two) diabetes mellitus." | 4.12 | Associations between aspirin prophylaxis and fetal growth and preeclampsia in women with pregestational diabetes. ( Graham, DF; Shrestha Khatri, N; White, SW, 2022) |
| "To compare the predictive performance for preterm-pre-eclampsia (PE) in first-trimester screening by serum placental growth factor (PlGF) versus pregnancy associated plasma protein-A (PAPP-A), in combination with maternal risk factors, mean arterial pressure (MAP) and uterine artery pulsatility index (UtA-PI), after adjustment for the effect of aspirin in women receiving this treatment." | 4.12 | Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment. ( Nicolaides, KH; O'Gorman, N; Syngelaki, A; Tan, MY; Wright, D, 2022) |
| "The nonsteroidal anti-inflammatory drug aspirin is an agent of interest for breast cancer prevention." | 4.12 | Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. ( Acheampong, T; Agovino, M; Athilat, S; Lee Argov, EJ; Rodriguez, CB; Tehranifar, P; Terry, MB; Wei, Y, 2022) |
| "(1) To assess the clinical utility of the adjusted global antiphospholipid syndrome score (aGAPSS) to predict new obstetric events during follow-up in primary obstetric antiphospholipid syndrome (POAPS) patients under standard-of-care treatment (SC) based on the use of low-dose aspirin (LDA) + heparin and (2) to study the risk of a first thrombotic event and to evaluate whether stratification according to this score could help to identify POAPS patients who would benefit from long-term thromboprophylaxis." | 4.12 | Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome. ( Alijotas-Reig, J; Aranda, F; Belizna, C; de Larrañaga, G; Esteve-Valverde, E; Fernández-Romero, DS; Latino, JO; Peréz, SM; Udry, S; Wingeyer, SP, 2022) |
| "To evaluate the association between aspirin use during first pregnancy and later maternal cardiovascular risk." | 4.12 | Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study. ( Bairey Merz, N; Barnes, S; Catov, J; Chung, JH; Greenland, P; Grobman, W; Haas, D; Hoffman, M; Levine, LD; McNeil, R; Mercer, B; Parker, CB; Saade, G; Shanks, A; Silver, RM; Simhan, H; Theilen, LH; Thorsten, V; Varagic, J; Wapner, R, 2022) |
| "To estimate whether low-dose aspirin use is associated with an altered risk of delivering a small-for-gestational age (SGA) neonate among women with a history of having an SGA neonate in a prior pregnancy." | 4.12 | Low-Dose Aspirin for Preventing Birth of a Small-For-Gestational Age Neonate in a Subsequent Pregnancy. ( Bergman, L; Cluver, CA; Hastie, R; Hesselman, S; Kupka, E; Lindquist, A; Tong, S; Walker, SP; Wikström, AK, 2022) |
| "Clinical studies suggest that early pregnancy is the critical window for the prevention of preeclampsia by low-dose aspirin (LDA)." | 4.12 | Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway. ( Feng, L; Jing, S; Xie, H; Zhang, H; Zhang, J, 2022) |
| "The use of 100 mg of aspirin a day before the 20th week of pregnancy in high risk pregnant patients decreased the risk of developing PREEC, regardless the age and risk factors." | 4.12 | [Use of aspirin 100 mg / day to prevent Preeclampsia, in high risk pregnancies, in a cohort from Argentina]. ( Espeche, WG; Minetto, J; Salazar, MR, 2022) |
| "To assess the clinical efficacy of intravenous immunoglobulin G (IVIG) administration combined with low-dose aspirin in women with unexplained recurrent pregnancy loss (RPL)." | 4.12 | Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss. ( Chae, HD; Kim, JH; Kim, SH; Ko, Y; Lee, SR; Yang, N, 2022) |
| "The objective of the study was to compare the efficacy of low-molecular weight heparin (LMWH) alone and use in the combination with aspirin in the treatment of fetal growth restriction (FGR) patients." | 4.12 | Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction. ( He, S; Liang, L, 2022) |
| "Aspirin is a common drug for the treatment of pre-eclampsia." | 4.12 | Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome. ( Chen, D; Ding, J; Song, L; Yang, S; Zhang, J; Zhang, Y, 2022) |
| "In this post hoc study, arachidonic acid (AA)-induced platelet aggregation during pregnancy with and without acetylsalicylic acid (ASA) treatment was studied in 323 women with unexplained recurrent first-trimester miscarriage and in 59 healthy women with normal pregnancies." | 4.12 | Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study. ( Blomqvist, LRF; Hellgren, MSE; Jeppsson, A; Strandell, AM, 2022) |
| "To determine the impact of low-dose aspirin (81 mg) on markers of maternal inflammation and placental function." | 4.12 | The impact of low-dose aspirin on markers of inflammation and placental function: an ancillary study of the ASPIRIN trial. ( Araganji, R; Goudar, SS; Hoffman, MK; Kavi, A; Somannavar, MS; Vernekar, SS, 2022) |
| "A retrospective study of 32 women with severe recurrent placenta-mediated complications (preeclampsia with severe features, placental abruption, severe intrauterine growth retardation or intra uterine fetal death) in spite of treatment with low molecular weight heparin and low dose aspirin in previous pregnancy." | 4.12 | Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study. ( Asher-Landsberg, J; Gamzu, R; Kliger, C; Kupferminc, MJ; Rimon, E; Skornick-Rapaport, A; Yogev, Y, 2022) |
| "To assess the differences in Doppler parameters of endometrial receptivity in unexplained recurrent biochemical pregnancy loss (URBPL) and the therapeutic effect of low-dose aspirin (LDA)." | 4.12 | Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss. ( Bai, W; Guo, F; Wang, Q; Zhang, X; Zhao, A, 2022) |
| "The USPSTF concludes with moderate certainty that there is a substantial net benefit of daily low-dose aspirin use to reduce the risk for preeclampsia, preterm birth, small for gestational age/intrauterine growth restriction, and perinatal mortality in pregnant persons at high risk for preeclampsia." | 4.02 | Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. ( Barry, MJ; Cabana, M; Caughey, AB; Davidson, KW; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Li, L; Mangione, CM; Ogedegbe, G; Pbert, L; Silverstein, M; Simon, MA; Stevermer, J; Tseng, CW; Wong, JB, 2021) |
| " Digital tools such as the MyHealthyPregnancy app might offer an opportunity to improve identification of patients at risk for preeclampsia and communication with these patients about aspirin use." | 4.02 | Use of a Smartphone App to Explore Potential Underuse of Prophylactic Aspirin for Preeclampsia. ( Bernard, M; Davis, AL; Hayani, L; Krishnamurti, T; Rodriguez, S; Simhan, HN, 2021) |
| " Among 932 women, 277 in the First Affiliated Hospital of Chongqing Medical University were routinely treated with aspirin (100 mg daily) from 12 to 16 weeks to 35 weeks of gestational age, while 655 in Chongqing Health Center for Women and Children were not taking aspirin during pregnancy." | 4.02 | Low-dose aspirin for primary prevention of adverse pregnancy outcomes in twin pregnancies: an observational cohort study based on propensity score matching. ( Baker, P; Kilby, MD; Liu, X; Liu, Y; Qi, H; Saffery, R; Tong, C; Wang, L; Wen, L; Ye, Y, 2021) |
| "Aspirin is widely used to prevent pregnancy related vascular disorders such as preeclampsia (PE), intrauterine growth restriction and maternal disorders." | 4.02 | Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis. ( Dorsamy, V; Khaliq, OP; Mkhize, PZ; Moodley, J; Phoswa, WN, 2021) |
| "Decision tree analysis was created using R software to evaluate four approaches to aspirin prophylaxis in the United States: no aspirin, United States Preventive Service Task Force (USPSTF) with Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) hypertension guidelines, USPSTF with ACC/AHA hypertension guidelines, as well as universal aspirin prophylaxis." | 4.02 | The Impact of the New Hypertension Guidelines to Low-Dose Aspirin Prophylaxis Eligibility for the Prevention of Preeclampsia: A Cost-Benefit Analysis. ( Balasooriya, MM; Boscia, AL; Dalkiran, E; Putra, M; Sokol, RJ, 2021) |
| "53) with a concurrent increase in targeted aspirin use in women classified as high risk for pre-eclampsia (28." | 4.02 | Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study. ( Buck, E; Diaz Gomez, D; Forenc, K; Guy, GP; Khalil, A; Leslie, K; Thilaganathan, B, 2021) |
| "This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications." | 4.02 | Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. ( Bergman, L; Hastie, R; Hesselman, S; Sandström, A; Tong, S; Wikström, AK, 2021) |
| "To evaluate the effects of low-molecular-weight heparin (LMWH) combined with low-dose aspirin (LDA) in pregnant women with a history of pregnancy-related hypertensive disorders." | 4.02 | Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study. ( Chen, Y; Shen, F; Wang, J; Yang, W; Zhang, Y; Zhou, J, 2021) |
| "Aspirin has been shown to reduce prevalence of both early-onset pre-eclampsia (ePET) and fetal growth restriction (FGR)." | 4.02 | Does aspirin prescribed to women deemed high risk for preterm pre-eclampsia at 11-13 ( Emeto, T; Hyett, J; O'Brien, C; Park, F; Phung, J, 2021) |
| "To investigate the therapeutic role of prednisone in patients having unexplained recurrent pregnancy loss (URPL) with positivity of antinuclear antibodies (ANA) and the relationship between ANA titers, prednisone, and pregnancy outcomes." | 4.02 | Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss. ( Chen, C; Guo, F; Kou, X; Li, C; Sun, S; Zhao, A, 2021) |
| "Aspirin is routinely prescribed in high-risk pregnancies to prevent pre-eclampsia; however, there is a paucity of data in women with pre-existing diabetes." | 4.02 | Aspirin and pre-eclampsia prevention in women with pre-existing diabetes: a retrospective study. ( Athayde, N; Cheung, NW; Inglis, E; Lah, S; Lee, V; Padmanabhan, S, 2021) |
| "The objective of the study was to investigate the effects of low-dose aspirin (LDA) during pregnancy on the prevention of preeclampsia in patients with chronic kidney disease (CKD)." | 4.02 | Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy... ( Chen, Q; Chen, S; He, Y; Wang, M; Yang, H; Zhao, M, 2021) |
| "Study the effect of low-dose aspirin on the endometrial receptivity in endometriosis rat models." | 4.02 | Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window. ( Li, C; Li, M; Li, R; Wang, L; Zhang, H; Zhang, J; Zhao, X, 2021) |
| "Despite being key to reducing the occurrence of pre-eclampsia in high-risk women, adherence to aspirin prophylaxis is low, reflecting multifactorial challenges faced by pregnant women." | 4.02 | Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia - A qualitative study. ( Araujo-Soares, V; Robson, SC; Smith, VJ; Vinogradov, R, 2021) |
| "5%) with a history of pregnancy morbidity alone were treated with prophylactic low molecular weight heparin (LMWH) + low-dose aspirin (LDA, 100 mg) (group I) and 40 (31." | 3.96 | Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study. ( Calligaro, A; Del Ross, T; Favaro, M; Hoxha, A; Infantolino, C; Mattia, E; Ruffatti, A; Ruffatti, AT; Tonello, M, 2020) |
| "Plasma from women with pre-eclampsia induced TBARS and nitrotyrosine production on endothelial and U937 cells." | 3.96 | Role of aspirin-triggered lipoxin A4, aspirin, and salicylic acid in the modulation of the oxidative and inflammatory responses induced by plasma from women with pre-eclampsia. ( Alvarez, AM; Cadavid J, AP; Gil-Villa, AM; Rojas-López, M; Velásquez-Berrío, M, 2020) |
| "The objective of this study is to investigate possible changes in aspirin resistance during and after pregnancy over time." | 3.96 | Resistance of aspirin during and after pregnancy: A longitudinal cohort study. ( Abheiden, CNH; Bij de Weg, JM; de Boer, MA; de Vries, JIP; Fuijkschot, WW; Harmsze, AM; Thijs, A, 2020) |
| "The current treatment to prevent pregnancy morbidity (PM) associated with antiphospholipid antibodies (aPL) is based on the use of low dose aspirin and low molecular weight heparin (henceforth defined as standard of care (SoC) treatment)." | 3.96 | Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score. ( Cecchi, I; Cuadrado, MJ; Radin, M; Roccatello, D; Rubini, E; Schreiber, K; Sciascia, S, 2020) |
| "The study is aimed at understanding the factors, from the women's perspective, that influenced adherence with prophylactic aspirin in their pregnancy." | 3.96 | Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis. ( Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Liamputtong, P; Makris, A; Mengesha, Z; Notaras, S; Shanmugalingam, R, 2020) |
| "To evaluate the effect of low-dose aspirin, which was administered at or before the 16th week of pregnancy due to maternal characteristics and history of a pre-existing medical condition, on prevention of pre-eclampsia, and on the birth of a small-for-gestational-age (SGA) neonate without pre-eclampsia in nulliparas in primary settings." | 3.96 | Effect of current guidelines on prevention of pre-eclampsia with low-dose aspirin in primary settings: A population-based case-control study. ( Kocic, Z; Premru-Srsen, T; Verdenik, I, 2020) |
| "To compare maternal haemodynamics in women at low and high risk for preterm pre-eclampsia (PE), and between those at high risk who are randomised to aspirin or placebo." | 3.96 | Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study. ( Bisquera, A; Jara, PG; Kametas, NA; Ling, HZ; Nicolaides, KH; Poon, LC, 2020) |
| " These patients were grouped into three groups according to their treatment plan including those who received low dose aspirin (LDA) alone (group A), LDA plus LMWH after ovulation therapy (group B), and LDA plus LMWH after pregnancy confirmation (group C)." | 3.96 | D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody. ( Bao, SH; Frempong, ST; Ruan, JL, 2020) |
| "(1) To evaluate the rates of implementation of the 2016 American College of Obstetricians and Gynecologists guideline over time; and (2) to evaluate the effectiveness of aspirin for the prevention of superimposed preeclampsia and other adverse maternal and neonatal outcomes in women with chronic hypertension before and after this guideline." | 3.96 | Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. ( Banala, C; Berghella, V; Boelig, RC; Cruz, Y; Moreno, S; Roman, A; Saccone, G; Schoen, CN, 2020) |
| "To evaluate differences in Doppler parameters and pregnancy outcomes, if any, and to determine the predictive accuracy of such indices, as well as the effects of low-dose aspirin (LDA) in unexplained recurrent pregnancy loss (URPL)." | 3.96 | Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss. ( He, L; Kang, X; Liu, F; Liu, Z; Wang, T; Zhao, A, 2020) |
| "To elucidate patients' knowledge and counseling perspective on aspirin reducing the risk of hypertensive disorders of pregnancy (HDP)." | 3.96 | Patients' perspective on aspirin during pregnancy: a survey. ( Abheiden, CNH; Bij de Weg, JM; de Boer, MA; de Groot, C; de Vries, JIP, 2020) |
| "A previous pilot study showed that pravastatin supplementation improved pregnancy outcomes in women with obstetric antiphospholipid syndrome (OAPS) that developed placental insufficiency despite standard of care treatment low molecular weight heparin plus low dose aspirin (LMWH + LDA)." | 3.96 | Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. ( Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K, 2020) |
| "Magnesium sulfate combined with low-dose aspirin can significantly reduce adverse reactions and effectively lower blood pressure in patients with pregnancy induced hypertension, but the overall efficacy and safety of the combination of drugs are not clear." | 3.96 | Efficacy and safety of low dose aspirin and magnesium sulfate in the treatment of pregnancy induced hypertension: A protocol for systematic review and meta-analysis. ( Chen, M; Chen, Y; He, G; Liu, X, 2020) |
| "We designed a decision analysis to compare preeclampsia-related costs and effects of four strategies for aspirin use in pregnancy initiated before 16 weeks of gestation to prevent preeclampsia." | 3.91 | Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis. ( Grobman, W; Mallampati, D; Rouse, DJ; Werner, EF, 2019) |
| "Aspirin use in pregnancy reduces the risks of maternal hypertensive disorders." | 3.91 | Aspirin use during pregnancy and hypertensive disorders in women with various risks. ( Chen, C; Jing, S; Lu, D; Xie, H; Zhang, J; Zhu, J, 2019) |
| "Women with lupus have an increased risk of preeclampsia and preterm birth, and aspirin 81 mg/day is recommended as a preventative measure for preeclampsia." | 3.91 | Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. ( Clowse, MEB; Eudy, AM; Myers, RA; Voora, D, 2019) |
| "There is recent evidence that prophylaxis with 150 mg of aspirin given before 14-16 weeks significantly reduces preeclampsia rates and may improve pregnancy outcome." | 3.91 | Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies. ( Bot, M; Petca, A; Radu, D; Radu, N; Zvanca, ME, 2019) |
| "To examine whether maternal aspirin use during pregnancy is associated with childhood blood pressure." | 3.91 | Association of intrauterine exposure to aspirin and blood pressure at 7 years of age: a secondary analysis. ( Chen, Y; Wang, B; Zhang, J; Zhang, Y; Zhao, D; Zhu, J, 2019) |
| "To determine whether hypertensive disorders of pregnancy (HDP) increased long-term stroke risk in women in the California Teachers Study (CTS), a prospective cohort study, and whether aspirin or statin use modified this risk." | 3.91 | Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy. ( Bello, NA; Boehme, AK; Chung, NT; Elkind, MSV; Lacey, JV; Lakshminarayan, K; Miller, EC; Wang, SS; Wapner, R; Willey, JZ; Woo, D; Zhong, C, 2019) |
| "Calcium and low-dose aspirin are two potential approaches for primary prevention of hypertensive disorders of pregnancy (HDP)." | 3.91 | Views and preferences of medical professionals and pregnant women about a novel primary prevention intervention for hypertensive disorders of pregnancy: a qualitative study. ( Bekker, MN; Browne, JL; Crombag, NMT; Franx, A; Grobbee, DE; van der Graaf, R; Vestering, A, 2019) |
| "Low-dose aspirin started in early pregnancy significantly reduces the risk of preeclampsia (PE) in high-risk women, especially preterm PE." | 3.88 | Maternal Characteristics for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes (GOS) Study. ( Boutin, A; Bujold, E; Demers, S; Gasse, C; Giguère, Y; Tétu, A, 2018) |
| "Women with antiphospholipid antibodies (aPL) are at risk for pregnancy complications despite treatment with low molecular weight heparin (LMWH) or aspirin (ASA)." | 3.88 | Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies. ( Abrahams, VM; Bryce, E; Chamley, LW; Guller, S; Quao, ZC; Tong, M, 2018) |
| " We examined whether mother's use of paracetamol, aspirin or ibuprofen in pregnancy is associated with increased risk of cerebral palsy (CP) in the child." | 3.88 | Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child. ( Andersen, AN; Andersen, GL; Andersen, PK; Liew, Z; Martinussen, T; Olsen, J; Petersen, TG; Rebordosa, C; Strandberg-Larsen, K; Tollånes, MC; Uldall, P; Wilcox, AJ, 2018) |
| "To study women who initiated aspirin in the first trimester for high risk of pre-eclampsia, and compare blood-pressure trends throughout pregnancy between those with normal outcome and those who subsequently developed pre-eclampsia." | 3.88 | Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis. ( Baschat, AA; Blitzer, MG; Block-Abraham, D; Dewberry, D; Miller, JL; Seravalli, V, 2018) |
| "Low-dose aspirin is recommended for prevention of pre-eclampsia in high-risk pregnant women." | 3.88 | Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia. ( Alfirevic, A; Alfirevic, Z; Jorgensen, A; Navaratnam, K, 2018) |
| "We sought to examine the effect of prophylactic use of aspirin during pregnancy in women at high risk of preeclampsia on length of stay in the neonatal intensive care unit." | 3.88 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. ( de Alvarado, M; de Paco Matallana, C; Jani, JC; Machuca, M; Mastrodima, S; Molina, FS; Nicolaides, KH; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tan, MY; Wright, D, 2018) |
| "To use the Theory of Planned Behavior (TPB) combined with action and coping planning plus global relationship with husband to explain the aspirin adherence in a sample of women with high-risk pregnancy." | 3.88 | Using extended theory of planned behavior to understand aspirin adherence in pregnant women. ( Broström, A; Lin, CY; Nilsen, P; Pakpour, AH, 2018) |
| "To examine the effect of first-trimester screening for pre-eclampsia (PE) on the prediction of delivering a small-for-gestational-age (SGA) neonate and the effect of prophylactic use of aspirin on the prevention of SGA." | 3.88 | Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE. ( Akolekar, R; Cicero, S; de Paco Matallana, C; Greco, E; Janga, D; Jani, JC; Molina, FS; Nicolaides, KH; Papaioannou, G; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Singh, M; Syngelaki, A; Tan, MY; Wright, D, 2018) |
| "Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia." | 3.88 | ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy. ( , 2018) |
| "Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia." | 3.88 | ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. ( , 2018) |
| " Hearing loss was associated with valproic acid and low-dose acetylsalicylic acid exposure during pregnancy." | 3.88 | In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database. ( Araujo, M; Benevent, J; Damase-Michel, C; Durrieu, G; Foch, C; Lacroix, I; Montastruc, JL; Weckel, A, 2018) |
| "Aspirin use during pregnancy was associated with a reduced risk of hypoxia-related placental pathology in the high-risk population [the adjusted odds ratio and 95% confidence interval in the 1st, 2nd, and 3rd trimesters: 0." | 3.88 | Aspirin use during pregnancy and hypoxia-related placental pathology. ( Chen, C; Chen, Y; Feng, L; Ye, J; Ye, W; Zhang, J; Zhu, J; Zhu, X, 2018) |
| "The use of low-dose aspirin in pregnancy should remain a highly targeted indication since its long-term safety has not been established and should be restricted to women at high risk of vascular complications." | 3.85 | [For a targeted use of aspirin]. ( Brun, S; Coatleven, F; Gleyze, M; Lecoq, C; Madar, H; Merlot, B; Nithart, A; Sentilhes, L, 2017) |
| "Combining aspirin, cabergoline, and triggering with low dose of HCG in combination with GnRH agonist produced excellent clinical pregnancy rate, and decreased hospital admissions with severe or critical OHSS." | 3.85 | Combining several interventions to reduce the incidence of OHSS: A prospective cohort study. ( Abdelsalam, EA; Elmahdy, M; Maghraby, HA, 2017) |
| "The beneficial effect of aspirin in the prevention of preterm preeclampsia may not apply in pregnancies with chronic hypertension." | 3.85 | Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. ( Akolekar, R; De Stefani, L; Delgado, JL; Evangelinakis, N; Gonzalez-Vanegas, O; Jani, JC; Leipold, G; Nicolaides, KH; Persico, N; Plasencia, W; Poon, LC; Rolnik, DL; Shearing, S; Syngelaki, A; Tsokaki, T; Wright, D, 2017) |
| " Risk factors for pregnancy complications, including premature delivery before 34 gestational weeks, hypertensive disorders of pregnancy, thrombocytopenia, and light-for-date neonate, were evaluated in 51 women who received low dose aspirin (LDA) plus unfractionated heparin (UFH) and delivered after 24 GW." | 3.85 | Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study. ( Deguchi, M; Fujita, D; Makino, S; Miki, A; Morikawa, M; Murashima, A; Sugiura-Ogasawara, M; Yamada, H, 2017) |
| "Low-dose aspirin has been demonstrated to reduce the incidence of preeclampsia and fetal growth restriction in at-risk populations." | 3.85 | Should we recommend universal aspirin for all pregnant women? ( McAuliffe, FM; McParland, P; Mone, F; Mulcahy, C, 2017) |
| "Women who used naproxen or opioids had slightly lower fecundability than women who did not use any pain-relieving medications; use of acetaminophen, aspirin and ibuprofen was not appreciably associated with fecundability." | 3.85 | Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study. ( Hatch, EE; McInerney, KA; Mikkelsen, EM; Rothman, KJ; Wesselink, AK; Wise, LA, 2017) |
| "The FRUIT-RCT concluded that low-molecular-weight heparin added to aspirin compared to treatment with aspirin alone is beneficial in the prevention of early-onset hypertensive disorders of pregnancy (HD) in women with inheritable thrombophilia and prior HD and/or a small-for-gestational age (SGA) infant leading to delivery before 34 weeks gestation." | 3.85 | Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy. ( Abheiden, CNH; Arduç, A; de Boer, MA; de Vries, JIP; Fuijkschot, WW; Harmsze, AM; Thijs, A; van Diemen, JJK, 2017) |
| "The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody syndrome (APS) includes prolonged treatment with heparin and aspirin, starting from the confirmation of pregnancy and continuing until 6 weeks after birth." | 3.85 | Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study. ( Chi, HB; Liu, P; Qiao, J; Song, Y; Wang, HY, 2017) |
| " She had discontinued Phenprocoumon-treatment in the 5+4 week of pregnancy by herself." | 3.83 | [Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?]. ( Gawaz, M; Klee, K; Meyer-Zürn, CS, 2016) |
| "This prospective study aimed to evaluate pregnancy outcome and complications in women with recurrent pregnancy loss (RPL) and protein S (PS) deficiency, who received low dose aspirin (LDA) or LDA plus heparin (LDA/H) therapies." | 3.83 | Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss. ( Deguchi, M; Ebina, Y; Morizane, M; Shinozaki, N; Tanimura, K; Yamada, H, 2016) |
| " Antecedents of mNEC included mother's identification as Black, consumption of aspirin during the pregnancy, and vaginal bleeding after the 12th week of gestation." | 3.83 | The antecedents and correlates of necrotizing enterocolitis and spontaneous intestinal perforation among infants born before the 28th week of gestation. ( Allred, EN; Grzybowski, M; Leviton, A; Martin, CR; Shah, B; Singh, R, 2016) |
| "In utero exposure to aspirin was associated with an increased risk of childhood asthma (adjusted odds ratio [aORs] = 1." | 3.83 | In Utero Exposure to Aspirin and Risk of Asthma in Childhood. ( Bao, J; Bao, Y; Chu, S; Huang, L; Yu, H; Zhang, J, 2016) |
| "To study the effect of prophylactic use of low dose aspirin and heparin on patients with recurrent unexplained pregnancy loss." | 3.83 | The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion. ( Abdelhafiz, A; El-Nassery, N; Fouad, M; Kotb, A; Maged, AM; Mostafa, WA; Salah, E, 2016) |
| " She was started on 100 mg of aspirin, 20 mg of prednisolone and 20 mg of subcutaneous low-molecular-weight heparin daily for her fourth pregnancy." | 3.83 | Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt. ( Hui, CY; Tan, EL; Tan, LK; Tan, WC, 2016) |
| "Indications for aspirin use during pregnancy were previous HD, FGR, intrauterine fetal death or current maternal disease." | 3.83 | Aspirin adherence during high-risk pregnancies, a questionnaire study. ( Abheiden, CN; de Boer, MA; de Vries, JI; Fuijkschot, WW; Thijs, A; van Reuler, AV, 2016) |
| " Prevention with aspirin or heparin was administered in ten cases during pregnancy, and in all the cases with heparin in postpartum." | 3.81 | [Thrombosis risk during pregnancy after history of cerebral venous thrombosis]. ( Neau, JP; Pierre, F; Pouget-Abadie, JF; Pourrat, O, 2015) |
| "In the final regression model, VFD was associated with maternal consumption of aspirin during the current pregnancy, recurring/persistent acidemia during the first 3 postnatal days, cerebral ventriculomegaly seen on neonatal ultrasound, prethreshold retinopathy of prematurity (ROP), and supplemental oxygen and ventilator dependence at 36 weeks post-menstrual age." | 3.81 | Antecedents and correlates of visual field deficits in children born extremely preterm. ( Allred, E; Dammann, O; Holm, M; Leviton, A; Msall, ME; Skranes, J, 2015) |
| "To examine the effect of a combination of screening and treatment with low-dose aspirin on the prevalence of early-onset pre-eclampsia (PE)." | 3.81 | Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. ( Hyett, J; Leung, C; Ogle, R; Park, F; Pelosi, M; Puddephatt, R; Rawashdeh, H; Russo, K; Saaid, R; Walter, M; Williams, P, 2015) |
| " This study aims to investigate whether calcium channel blockers plus low dosage aspirin therapy can reduce the incidence of complications during pregnancy with chronic hypertension and improve the prognosis of neonates." | 3.81 | The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension. ( Jiang, N; Liu, L; Liu, Q; Yang, WW; Zeng, Y, 2015) |
| "Evidence shows that daily low-dose aspirin during pregnancy can safely lower the risk of preeclampsia and other adverse outcomes." | 3.81 | Another good reason to recommend low-dose aspirin. ( Kirley, K; Oyola, S, 2015) |
| "Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation." | 3.81 | Use of ticagrelor in human pregnancy, the first experience. ( Jacquemyn, Y; Mannaerts, D; Muys, J; Verbruggen, M, 2015) |
| " Villous tissue was incubated at 2% O2 (hypoxia), 8% O2 and standard culture conditions (21% O2) or at 2% O2 and 21% O2 with dalteparin or ASA." | 3.80 | Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport. ( Darashchonak, N; Erlenwein, SV; Kleppa, MJ; von Kaisenberg, CS; von Versen-Höynck, F, 2014) |
| " Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy." | 3.80 | Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. ( LeFevre, ML, 2014) |
| "The effect of low-dose aspirin (LDA) on pregnancy outcome in antiphospholipid (aPL)-positive women not fulfilling the criteria for antiphospholipid antibody syndrome (APS) was evaluated retrospectively." | 3.79 | Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study. ( Calligaro, A; Del Ross, T; Favaro, M; Hoxha, A; Punzi, L; Ruffatti, A; Tonello, M; Visentin, MS, 2013) |
| "Women with persistent aPL on aspirin had pregnancy outcomes that were similar to controls." | 3.79 | Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes. ( Gray, G; Nelson-Piercy, C; Pasupathy, D; Soh, MC, 2013) |
| "To identify patients at very high risk for adverse pregnancy outcome (APO) at the 20- to 23-week scan and to assess the effectiveness of Aspirin (ASS) and low molecular weight heparin (LMWH) starting after this examination." | 3.79 | Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. ( Becker, R; Bittner, U; Fangerau, H; Keller, T; Kiesewetter, H, 2013) |
| " In normal female rats, the sera total thyroxine (TT4) and total triiodothyronine (TT3) levels were detectably increased at day 10 post-partum than those at day 10 of pregnancy." | 3.78 | Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system. ( Abd El-Tawab, SM; Ahmed, OM; Ahmed, RG; El-Bakry, AM; El-Gareib, AW, 2012) |
| "Two study groups were distinguished - with untreated IUGR and with IUGR treated with the acetylsalicylic acid and L-arginine and the control group with correct fetal growth and course of pregnancy Marked microscope preparations from placental samples were made with specific antibodies for MMP-9 and TIMP-2." | 3.78 | [Expression of metalloproteinase MMP-9 and tissue inhibitor of metalloproteinase TIMP-2 in placenta of pregnant women with intrauterine growth restriction]. ( Karowicz-Bilińska, A; Kobos, J; Kowalska-Koprek, U; Pasiński, J; Swierczewski, A, 2012) |
| "Aspirin treatment compared with untreated control groups led to a significant reduction of preeclampsia in 5 small-scale studies." | 3.78 | -Is prevention of pre-eclampsia with low dosage aspirin possible? Critical assessment of available studies-. ( Lippert, TH; Mück, AO, 1996) |
| "Increasing frequency of aspirin use during pregnancy was associated with an increased risk of psychotic experiences (adjusted OR 1." | 3.77 | Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence. ( Gunawardana, L; Gunnell, D; Harrison, G; Hollis, C; Lewis, G; Wolke, D; Zammit, S, 2011) |
| "This data might point to a beneficial effect of aspirin and calcium supplementation in the first trimester of pregnancy and aspirin at the time of disease, although the interaction with the maternal system still needs to be elucidated." | 3.77 | Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants. ( Cohen, A; Gonen, R; Grimpel, YI; Huppertz, B; Kivity, V; Meiri, H; Sammar, M, 2011) |
| " Options include continuing oral anticoagulants (OAC) such as warfarin throughout pregnancy, switching from warfarin to unfractionated heparin or low molecular weight heparin (LMWH) in the first trimester then back to warfarin until close to delivery or taking unfractionated heparin or LMWH throughout pregnancy." | 3.77 | Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. ( McLintock, C, 2011) |
| "In this retrospective observational study including women with pre-existing hypertension, pre-gestational diabetes or previous placental-mediated complications, we compared the rates of pre-eclampsia, early-onset and severe pre-eclampsia between women who used 81 mg of aspirin (ASA) throughout pregnancy without platelet function analyser (PFA-100®) monitoring ("group ASA no PFA") and those in whom the aspirin dosage was adjusted according to PFA-100® results ("group ASA and PFA")." | 3.77 | Is testing for aspirin response worthwhile in high-risk pregnancy? ( Rey, E; Rivard, GE, 2011) |
| "All the patients were treated with low dose aspirin during the pregnancy." | 3.77 | [Pregnancy and essential thrombocytemia]. ( Cambier, N; Depret, S; Deruelle, P; Ducloy, AS; Giraudet, G; Houfflin-Debarge, V; Vaast, P; Wibaut, B, 2011) |
| "The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin." | 3.77 | First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. ( Bramham, K; Hunt, BJ; Khamashta, M; Nelson-Piercy, C; Thomas, M, 2011) |
| " After delivery, aspirin was prescribed to all patients as primary thrombosis prevention." | 3.77 | Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients. ( Bacri, JL; Caron, C; Dubucquoi, S; Hachulla, E; Hatron, PY; Houfflin-Debarge, V; Kyndt, X; Lambert, M; Launay, D; Lefèvre, G; Quemeneur, T; Subtil, D, 2011) |
| "Verify that resistance to aspirin may have an impact on pregnancy and neonatal outcome." | 3.77 | Aspirin resistance may be associated with adverse pregnancy outcomes. ( Huras, H; Jach, R; Musiał, J; Reroń, A; Rytlewski, K; Undas, A; Wilczak, M; Wójtowicz, A, 2011) |
| "The aim of this study was to evaluate whether low doses of aspirin (100 mg per day) administered to a homogeneous population of women early (8-10 weeks) during their first pregnancy improved the outcome of gestation hypertensive disorders." | 3.77 | Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. ( Bakhti, A; Vaiman, D, 2011) |
| "Low molecular weight (LMW) heparin, with or without aspirin (acetylsalicylic acid [ASA]), is used to prevent complications in antiphospholipid syndrome in pregnancy." | 3.77 | Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. ( Abrahams, VM; Brosens, JJ; Chamley, LW; Han, CS; Lockwood, CJ; Mulla, MJ; Paidas, MJ, 2011) |
| "Low-dose aspirin (LDA) given during pregnancy may alter brain development in very preterm infants." | 3.76 | Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. ( Ancel, PY; Arnaud, C; Fresson, J; Kaminski, M; Larroque, B; Marchand, L; Marret, S; Rozé, JC; Thirez, G; Truffert, P, 2010) |
| " A scoring system for VTE risk in pregnant women was developed, each score being associated with a specific treatment: graduated elastic compression stockings, aspirin, prophylactic Low Molecular Weight Heparin (LMWH: variable durations), or adjusted-dose of LMWH through pregnancy and postpartum." | 3.76 | Use of the Delphi method to facilitate antithrombotics prescription during pregnancy. ( Chauleur, C; Decousus, H; Gris, JC; Laporte, S; Mismetti, P; Rancon, F; Varlet, MN, 2010) |
| "To evaluate the clinical and geographical variation in the use of aspirin in women at high risk of pre-eclampsia, and in the use of antihypertensive drugs and magnesium sulphate in women with established pre-eclampsia." | 3.76 | Clinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UK. ( Briley, AL; Chappell, LC; Enye, S; Poston, L; Seed, P; Shennan, AH, 2010) |
| " We present critical issues that need to be considered when evaluating and appraising test-treatment combinations, using the example of research on the uterine artery Doppler test to predict, and aspirin to prevent, pre-eclampsia." | 3.76 | How to interpret randomised trials of test-treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia. ( Coomarasamy, A; Fox, C; Khan, KS, 2010) |
| "5 of pregnancy, each group was respectively treated as follows: a) mice in group C (n = 12, control group) were injected with 100 microl of filtered phosphate-buffered saline into the tail vein every day; b) group PE (n = 15, preeclampsia model group) were injected in the same way with 100 microl of filtered PS/PC vesicle suspension; c) group H (n = 9, group treated with heparin) were injected with 1 unit heparin together with PS/PC vesicle suspension; d) group A (n = 10, group treated with aspirin) were injected with 20 microg/g aspirin-DL lysine as well; e) group LD (n = 10, group treated with low-dose Danshensu) were injected with 10 microg/g Danshensu; and f) group HD (n = 10, group treated with high-dose Danshensu) were injected with 30 microg/g Danshensu." | 3.76 | Effects of Danshensu on maternal syndrome in phosphatidylserine/phosphatidylcholine microvesicle induced-mouse model: is it a candidate for preeclampsia remedy? ( Hu, YL; Shen, Y; Wang, JM; Zhang, Y, 2010) |
| "The USPSTF recommends aspirin for the prevention of stroke and heart attack for those at risk, and screening for major depression and childhood obesity." | 3.76 | USPSTF recommendations you may have missed amid the breast cancer controversy. ( Campos-Outcalt, D, 2010) |
| " When treatment was analyzed, 53/67 (79%) of women with APLAs who had received aspirin and heparin during their pregnancy had a live birth, compared with 64/104 (62%) of women with APLAs who received aspirin only (adjusted OR 2." | 3.76 | Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. ( Cohn, DM; Dawood, F; Farquharson, RG; Goddijn, M; Korevaar, JC; Middeldorp, S, 2010) |
| " The use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy was assessed in 3 computer-assisted telephone interviews and 1 self-administered questionnaire." | 3.76 | Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. ( Bonde, JP; Henriksen, TB; Jensen, MS; Olsen, J; Rebordosa, C; Sørensen, HT; Thulstrup, AM; Toft, G, 2010) |
| "Treatment of preeclampsia with prostacyclin appears to be contraindicated because prostacyclin is a potent systemic vasodilator and the clinical outcome of preeclamptic women infused with prostacyclin has been poor." | 3.76 | Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia. ( Walsh, SW, 1989) |
| "The aim of this retrospective, observational study was to determine the impact of low-dose enoxaparin (20 mg) in conjunction with low-dose aspirin on the pregnancy outcome of women with antiphospholipid syndrome and recurrent miscarriage." | 3.75 | Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin. ( Li, TC; Makris, M; Metwally, M; Mo, D; Saravelos, S, 2009) |
| "Two meta-analyses suggest that low-dose aspirin taken daily during pregnancy reduces the incidence of pre-eclampsia in women at risk and reduces mortality among the infants born to mothers at high risk of pre-eclampsia." | 3.75 | Pre-eclampsia: aspirin beneficial. ( , 2009) |
| " The Task Force has: 1) dropped the age for routine screening for Chlamydia in sexually active women from 25 years and younger to 24 and younger; 2) added a recommendation against the use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer (CRC); 3) changed its recommendation on screening for carotid artery stenosis." | 3.74 | Should you screen--or not? The latest recommendations. ( Campos-Outcalt, D, 2008) |
| "To assess if aspirin improves pregnancy outcome in patients undergoing in vitro fertilization (IVF) with a diagnosis of poor response." | 3.74 | Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. ( Frattarelli, JL; Hill, MJ; McWilliams, GDE; Miller, KA; Scott, RT, 2008) |
| " With a treatment that included aspirin, heparin, and a nitric oxide donor, her third pregnancy ended with a healthy neonate at term." | 3.74 | Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma. ( Cabane, J; Carbonne, B; Cynober, E; Macé, G; Milliez, J, 2007) |
| " Clinical pregnancy rate per ET was significant when low-dose aspirin was compared with no treatment (risk ratio 1." | 3.74 | Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization. ( Collins, TC; Ruopp, MD; Schisterman, EF; Whitcomb, BW, 2008) |
| "To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia." | 3.74 | Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. ( David, M; Dubois, E; Leduc, L; Rey, E; Takser, L, 2007) |
| "It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss." | 3.74 | Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study. ( Kumagai, K; Nakanishi, T; Ozaki, Y; Sato, T; Sugiura-Ogasawara, M; Suzumori, N, 2008) |
| " The patient had decided to take low-molecular-weight heparin (LMWH) and aspirin throughout her pregnancy." | 3.74 | Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin. ( Curtis, SL; Stuart, AG; Trinder, J, 2008) |
| "Management recommendations displayed reasonable consistence: (i) for the use of low-dose aspirin and low-molecular weight heparin during pregnancy and during ovarian stimulation for in vitro fertilization; (ii) against oestrogen-containing oral contraceptives; and (iii) for the use of anticoagulants in the post-partum period." | 3.74 | Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. ( Erkan, D; Gerosa, M; Lockshin, MD; Meroni, PL; Nuzzo, M; Patel, S; Tincani, A, 2008) |
| "We recently found that paracetamol (acetaminophen) use in late pregnancy was associated with an increased risk of early wheezing in the offspring." | 3.73 | Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. ( Headley, JE; Henderson, AJ; Jones, RW; Newson, RB; Shaheen, SO; Strachan, DP; Stratton, FD, 2005) |
| "Live birth rates are increased by treatment with heparin and aspirin in cases of poor pregnancy outcome such as antiphospholipid syndrome." | 3.73 | Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. ( Black, S; Bose, P; Huppertz, B; Kadyrov, M; Neulen, J; Regan, L; Weissenborn, U, 2005) |
| "It is still controversial whether aspirin use during pregnancy increases the risk of certain congenital abnormalities (in particular, neural tube defects, gastroschisis, and cleft lip +/- palate)." | 3.73 | Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. ( Czeizel, AE; Nørgård, B; Puhó, E; Skriver, MV; Sørensen, HT, 2005) |
| "Our results reaffirm previous reports that the use of LMWH in combination with low dose aspirin throughout pregnancy is safe and effective." | 3.73 | Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology. ( Delkos, D; Giannoulis, H; Gkoutzioulis, F; Kalogiros, G; Papaloukas, C; Petropoulos, P; Psarra, A; Tzafettas, J, 2005) |
| " During pregnancy, aspirin prophylaxis was prescribed and followed by steroids after caesarian section." | 3.73 | [Acute myocardial infarction complicating primary antiphospholipid syndrome after aspirin and steroids withdrawal]. ( Galicier, L; Guillevin, L; Meune, C; Salengro, E; Spaulding, C; Wahbi, K; Weber, S, 2005) |
| " aCL were measured in serum by the standardised anticardiolipin enzyme linked immunosorbent assays (ELISA) and beta(2)-glycoprotein 1 assays to determine the seroprevalence of both beta(2) glycoprotein 1 dependent aCL and beta(2)-glycoprotein 1 independent aCL in Jamaican primiparae, to determine whether aCL are associated with abnormal pregnancy outcomes and if treatment with aspirin had any effect on pregnancy outcome in aCL positive primiparae." | 3.73 | Anticardiolipin antibodies in Jamaican primiparae. ( Forrester, T; Kahwa, EK; McCaw-Binns, A; McFarlane-Anderson, N; Sargeant, LA; Smikle, M; Wilks, R, 2006) |
| "Twenty-nine percent of cases and 34% of controls used aspirin during pregnancy." | 3.73 | Aspirin use and miscarriage risk. ( Keim, SA; Klebanoff, MA, 2006) |
| "To elucidate the efficacy of the treatment using a Japanese-modified Chinese herbal medicine, Sairei-to, and low-dose aspirin with or without a corticosteroid hormone for the patients with adverse pregnancy histories positive for anti-phospholipid antibodies." | 3.73 | Prophylactic therapy for patients with reproductive failure who were positive for anti-phospholipid antibodies. ( Ishii, K; Kikuchi, A; Nonaka, T; Ooki, I; Takakuwa, K; Tamura, M; Tamura, N; Tanaka, K, 2006) |
| "We report the cases of two patients who had a favorable outcome with aspirin and corticosteroid therapy during pregnancy for chronic villitis of unknown etiology complicated by labor asphyxia and further intrauterine fetal demise in one gravida 3 patient and for chronic intervillositis of unknown etiology diagnosed after three perinatal deaths in another patient (gravida 4)." | 3.73 | [Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology]. ( Alnoukari, F; Barrier, J; Boog, G; Jossic, F; Le Vaillant, C; Muller, JY, 2006) |
| " Out of the 9 pregnancies with high dose low-molecular-weight heparin and low dose aspirin thromboprophylaxis throughout pregnancy 8 were successful (88." | 3.72 | [Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome]. ( Boda, Z; Kerényi, A; Lakos, G; László, P; Pfliegler, G; Pósán, E; Rázsó, K; Schlammadinger, A, 2003) |
| "The prevention of preeclampsia currently relies on low-dose aspirin started at the beginning of pregnancy." | 3.72 | [Prevention of preeclampsia]. ( Desvaux, D; Haddad, B, 2003) |
| "We treated four pregnancy cases positive for antiphospholipid antibodies (APLs) who had experienced recurrent second trimester fetal or neonatal losses using a Japanese modified Chinese herbal medicine, Sairei-to, low dose aspirin and adrenocorticosteroid hormone." | 3.72 | Effect of sairei-to combined with aspirin and prednisolone on four recurrent reproductive failure women who are positive for anti-phospholipid antibodies. ( Adachi, H; Ishii, K; Kurabayasi, T; Kurata, H; Natsume, N; Takaki, Y; Takakuwa, K; Tamura, M; Tanaka, K, 2003) |
| "The aim of this study was the evaluation of carbonyl group concentration in blood serum in normal pregnancy and in women with IUGR treated by L-arginine and acetylsalicylic acid." | 3.72 | [Plasma carbonyl group concentration in pregnant women with IUGR treated by L-arginine and acetylsalicylic acid]. ( Karowicz-Bilińska, A; Kowalska-Koprek, U; Marszałek, M; Sieroszewski, P; Suzin, J, 2004) |
| "Unfractionated and low-molecular-weight heparin and low-dose aspirin are used for the prevention of pregnancy loss in pregnant women with thrombophilia." | 3.72 | Effects of low-molecular-weight and unfractionated heparin on trophoblast function. ( Cartwright, JE; Mountfield, S; Quenby, S; Vince, G; Whitley, GS, 2004) |
| "To evaluate the pregnancy outcome in patients with abnormal uterine artery Doppler flow velocity waveforms (FVW's) at 19-21 weeks, which were subsequently normal by 24-26 weeks, and to study the effect of low-dose aspirin on these waveforms." | 3.72 | Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. ( Fayyad, A; Harrington, K; Kurdi, W; Thakur, V, 2004) |
| " Fifty-three per cent would advise the use of prophylactic aspirin (75 mg), 49% the use of compression stockings; 4% recommended heparinisation; 44% believed this advice to be applicable only for the 2nd and 3rd trimester, while the RCOG emphasises that the risk of developing venous thromboembolism begins in the 1st trimester." | 3.72 | Thromboembolic disease and air travel in pregnancy: a survey of advice given by obstetricians. ( Cole, R; Iskaros, J; Moriarty, T; Pathak, M; Rodeck, C; Voss, M, 2004) |
| "Heparin prophylaxis at fixed low doses and possibly aspirin could be efficacious in preventing adverse outcomes in women carrying inherited thrombophilia with previous poor obstetric outcomes." | 3.71 | Preventing adverse obstetric outcomes in women with genetic thrombophilia. ( Brancaccio, V; Colaizzo, D; Di Minno, G; Grandone, E; Margaglione, M; Pavone, G; Sciannamé, N, 2002) |
| "We recently reported links between frequent paracetamol (acetaminophen) use and wheezing and asthma in adults and children, but data are lacking on possible effects of prenatal exposure on wheezing in early childhood." | 3.71 | Paracetamol use in pregnancy and wheezing in early childhood. ( Burney, PG; Golding, J; Henderson, AJ; Heron, JE; Newson, RB; Shaheen, SO; Sherriff, A, 2002) |
| "We confirm by meconium analysis the results of previous studies that demonstrated that the use of NSAIDs during pregnancy, particularly aspirin, ibuprofen, and naproxen, is high; is grossly underestimated by maternal history; and is significantly associated with PPHN." | 3.71 | Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn. ( Alano, MA; Konduri, GG; Ngougmna, E; Ostrea, EM, 2001) |
| " If thrombophilia was diagnosed on the basis of hyperhomocysteinemia, the treatment consisted of aspirin, pyridoxine and folic acid, instead." | 3.71 | Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women. ( Aardenburg, R; de Leeuw, PW; Ekhart, TH; Peeters, LL; Spaanderman, ME; van der Heijden, OW; van Eyck, J; van Eyndhoven, HW, 2001) |
| "Although it has been hypothesized that analgesic idiosyncrasy could be acquired by viral infection, there is no evidence that any virus can cause sporadic cases of aspirin-intolerant asthma." | 3.71 | Possible relevance of virus infection for development of analgesic idiosyncrasy. ( Akahori, K; Amayasu, H; Hasegawa, H; Nakabayashi, M; Nakagawa, H; Shoji, T; Yoshida, S, 2001) |
| "This prospective audit reports pregnancy outcomes, anticoagulation complications, and anti-Xa levels in women with mechanical heart valves who were treated with therapeutic enoxaparin plus aspirin during pregnancy." | 3.71 | Enoxaparin treatment in women with mechanical heart valves during pregnancy. ( McCowan, LM; North, RA; Raudkivi, PJ; Rowan, JA, 2001) |
| "The present report shows that in treated APS pregnancies: i) aspirin treatment started preconceptionally is an independent and significant prognostic factor associated with favorable fetal outcome; and ii) abnormal velocity waveforms in the umbilical artery predict adverse outcome of pregnancy." | 3.71 | Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis. ( Azulay, M; Balasch, J; Carmona, F; Cervera, R; Creus, M; Fábregues, F; Font, J; Puerto, B, 2001) |
| "Antenatal intake of low dose aspirin is advised for prevention of pregnancy induced hypertension, intrauterine growth retardation and pre-term labour." | 3.71 | Fetal intracranial hemorrhage due to antenatal low dose aspirin intake. ( Kutty, PM; Sajith, N; Sasidharan, CK, 2001) |
| " A successful pregnancy outcome was achieved by combined therapy with aspirin, low-molecular-weight heparin, prednisone, and enzyme replacement therapy with imiglucerase." | 3.71 | Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome. ( Dulitzki, M; Langevitz, P; Levy, Y; Livneh, A; Sherer, Y; Shoenfeld, Y, 2002) |
| "Authors describe a successful pregnancy outcome after prednisone and aspirin therapy in 19-year-old woman with systemic lupus erythematosus with the history of recurrent urinary tract infections, pericarditis and encephalitis." | 3.71 | [Course of pregnancy in a patient with systemic lupus erythematosus--case report]. ( Goluda, M; Jerzak, MM; Podwysocka, M; Prusek, W, 2002) |
| "Descriptions of salicylate poisoning during pregnancy are rare and unique features of perinatal physiology predict an increased sensitivity of the fetus to aspirin poisoning." | 3.70 | Aspirin poisoning during pregnancy: increased fetal sensitivity. ( Palatnick, W; Tenenbein, M, 1998) |
| "To assess the prevalence of haemostatic abnormalities in patients with an obstetric history of preeclampsia and/or fetal growth restriction and documented thrombophilia, and to evaluate the effects of low-molecular-weight heparin (LMWH) and aspirin on pregnancy outcome." | 3.70 | Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. ( de Vries, JI; Dekker, GA; Huijgens, PC; Leeda, M; Riyazi, N; van Geijn, HP, 1998) |
| " She developed post-dural puncture headache (PDPH) on the third postpartum day which was managed by palliative measures: bed rest (patient's position of choice), increased hydration (water: 3 litres po per day), lysine acetyl salicylate (5." | 3.70 | Unilateral trigeminal and facial nerve palsies associated with epidural analgesia in labour. ( Agustí, M; Carrero, EJ; Fábregas, N; Fernández, C; Valldeoriola, F, 1998) |
| "To our knowledge, this is the first time that a combination of aspirin and glyceryl trinitrate (GTN) has been used in the prophylaxis of preeclampsia and fetal growth retardation, and their use associated with not only Doppler screening of the uterine arteries but also regular Doppler follow-up of the fetal arterial and venous circulation." | 3.70 | A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth. ( Black, RS; Campbell, S; Lees, CC; Oyelese, KO, 1998) |
| " The success rate was higher when treatment was given because of previous poor pregnancy outcomes than when it was given for other indications, and the patients with successful therapy had started aspirin earlier than had those with therapy failure (17." | 3.70 | Effect of aspirin in pregnant women is dependent on increase in bleeding time. ( Beaufils, M; Dumont, A; Flahault, A; Uzan, S; Verdy, E, 1999) |
| "Heparin plus aspirin significantly improves the live birth rate of women with primary antiphospholipid syndrome." | 3.70 | Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study. ( Backos, M; Doré, C; Murphy, M; Rai, R; Regan, L; Thomas, E, 1999) |
| "In general, aspirin is indicated to prevent thrombosis in conditions associated with high shear rates (i." | 3.70 | Warfarin or aspirin: both or others? ( Peverill, RE, 1999) |
| "Combined treatment of prednisone for immunosuppression and aspirin as an anti-thrombotic agent, starting before ovulation induction, may improve pregnancy rate in autoantibody seropositive patients who have had repeated IVF-ET failures." | 3.70 | Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. ( Amit, A; Azem, F; Daniel, Y; Geva, E; Lerner-Geva, L; Lessing, JB; Schwartz, T; Yaron, Y; Yovel, I, 2000) |
| " Aspirin, 75 mg daily was given in addition to enoxaparin to women with antiphospholipid syndrome." | 3.70 | Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. ( Blumenfeld, Z; Brenner, B; Hoffman, R; Weiner, Z; Younis, JS, 2000) |
| "These results support a role for the use of aspirin for antiphospholipid antibody-related pregnancy loss through a mechanism similar to that postulated for preeclampsia, namely, selective inhibition of thromboxane production." | 3.69 | The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant. ( Peaceman, AM; Rehnberg, KA, 1995) |
| " The question of whether anti-GM3 antibodies might exert influence in APLs-positive recurrent pregnancy loss patients who are undergoing prednisolone and aspirin (PSL/ASA) treatment was investigated." | 3.69 | Clinical significance of anti-GM3 antibodies in recurrent pregnancy loss with elevated level of antiphospholipid antibodies. ( Aoki, K; Aoyama, T; Kunimatsu, M; Ozaki, Y, 1995) |
| "Despite optimism generated by earlier, smaller studies, the Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) trial showed that aspirin is not sufficiently effective to recommend its widespread use for the prevention of pre-eclampsia." | 3.69 | Pre-eclampsia. III: The role of aspirin in prevention. ( de Swiet, M, 1994) |
| "This prospective study is an attempt to address the issues of whether or not antiphospholipid antibodies (aPL) constitute a significant risk factor for pregnancy in individuals with systemic lupus erythematosus (SLE) and whether or not combination therapy of high-dose prednisolone (PSL) and low-dose acetylsalicylic acid (ASA) offers efficient control." | 3.69 | A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus. ( Aoki, K; Hayashi, Y; Ogasawara, M, 1995) |
| "To determine if low dose aspirin therapy improves placental histology in women with a prior complicated pregnancy demonstrating uterine vascular pathology." | 3.69 | Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes. ( Campbell, WA; Cusick, W; Ernst, L; Rodis, JF; Salafia, CM; Vintzileos, AM, 1995) |
| "Self-reported use or consumption of tobacco, marijuana, cocaine, aspirin, and other nonsteroidal antiinflammatory drugs during pregnancy." | 3.69 | Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. ( Allred, EN; Cohen, A; Epstein, MF; Leviton, A; Pagano, M; Sullivan, KF; Van Marter, LJ, 1996) |
| " Magnesium and dihydralazine effects in pregnancy are not related to altered release of trophoblast vasoactive compounds." | 3.69 | Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion. ( Cervar, M; Desoye, G; Kainer, F; Nelson, DM, 1997) |
| "The aim of this study was to determine the neonatal outcome in women with well-characterized antiphospholipid syndrome treated during pregnancy with low-dose aspirin." | 3.69 | Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. ( Balasch, J; Botet, F; Carmona, F; Figueras, J; Montagut, P; Romera, G, 1997) |
| " A care of pregnancy complicated by essential thrombocythemia treated with aspirin, antiaggregating agent, throughout pregnancy and with hydroxyurea, a platelet lowering drug is reported." | 3.69 | [Essential thrombocythemia in pregnancy. A case report and general considerations]. ( Catalano, D; Dell'Isola, A; Di Rosa, G, 1997) |
| " In 1982, it was suggested for the first time low doses of aspirin and prednisone for treatment of recurrent fetal death associated to this syndrome, heparin therapy was reported in 1984, recommended a doses of 15,000 U/day during first pregnancy trimester and 20,000 U/day posteriorly." | 3.69 | [Recurrent fetal death and antiphospholipid antibody syndrome. A case report]. ( Bustos López, HH; Hernández Andrade, E; Ramírez Peredo, J; Rojas-Poceros, G, 1997) |
| "To describe patterns of prescription in the Netherlands of low-dose aspirin in pregnancy." | 3.68 | Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands. ( Bremer, HA; Wallenburg, HC, 1993) |
| "Low dose Aspirin in pregnancy reduces the incidence of intra uterine growth retardation (IUGR) and pregnancy induced hypertension (PIH) in women at risk for these complications." | 3.68 | Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn. ( Foschini, M; Frusca, T; Soregaroli, M; Tarantini, M; Valcamonico, A, 1993) |
| "Pregnant rats were treated with ig aspirin (Asp) and acetaminophen (Ace) on d 3 of pregnancy (positive vaginal smear = d 0)." | 3.68 | [Effects of preimplantation treatment with aspirin and acetaminophen on blastocyst and fetus in rats]. ( Lou, YJ; Ying, Y, 1993) |
| "To determine whether aspirin therapy in women at risk of pre-eclampsia alters in vitro platelet aggregation." | 3.68 | Changes in platelet reactivity following aspirin treatment for pre-eclampsia. ( Elder, MG; Sullivan, MH, 1993) |
| "To determine whether the beneficial effects of aspirin in the treatment of Doppler umbilical placental insufficiency correlate with the maternal pressor response to angiotensin infusion." | 3.68 | Angiotensin sensitivity predicts aspirin benefit in placental insufficiency. ( Cook, CM; Trudinger, BJ, 1993) |
| "A patient with systemic lupus erythematosus and elevated cardiolipin antibody levels was given low-dose aspirin therapy prior to and throughout her third pregnancy to minimize the risk of miscarriage." | 3.68 | Anticardiolipin syndrome, aspirin therapy and fetal malformation. ( Chakravarty, K; Merry, P, 1993) |
| "We examined the relation between the spontaneous remission and prednisolone-induced suppression of lupus anticoagulant (LAC) or anticardiolipin antibody (ACA) and pregnancy outcome in 5 LAC-positive women." | 3.68 | Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases. ( Hasegawa, M; Ihara, Y; Inamori, K; Itoh, H; Mandai, M; Mori, T; Niwa, H; Okagaki, A; Sagawa, N, 1993) |
| "Fifteen patients with previous pregnancy losses and positive plasma anticardiolipin antibody (ACA) were treated with prednisone (15 mg/day) and aspirin (80 mg/day)." | 3.68 | Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody. ( Cohen, AW; Forouzan, I; Lindenbaum, C; Samuels, P, 1993) |
| " Further investigation revealed that her mother had taken aspirin throughout pregnancy." | 3.68 | Toxic reaction to salicylate in a newborn infant: similarities to neonatal sepsis. ( Bond, GR; Buck, ML; Grebe, TA, 1993) |
| "We reviewed 82 consecutive pregnancies in 54 women with antiphospholipid syndrome who were treated during pregnancy with the following: 1) prednisone and low-dose aspirin; 2) heparin and low-dose aspirin; 3) prednisone, heparin, and low-dose aspirin; or 4) other combinations of these medications or immunoglobulin." | 3.68 | Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. ( Blackwell, JL; Branch, DW; Reading, JC; Scott, JR; Silver, RM, 1992) |
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 3.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| " She had been treated with prophylactic, subcutaneous heparin and aspirin throughout her pregnancy." | 3.68 | Lupus anticoagulant, paramyotonia congenita and pregnancy. ( Douglas, MJ; Howell, PR, 1992) |
| " Many studies have suggested that treatment with low-dose aspirin and steroids is effective in preventing pregnancy loss or pre-eclampsia, but the mechanism has not been established." | 3.68 | [A trial of low-dose aspirin therapy in high-risk pregnancy]. ( Mochizuki, M; Morikawa, H; Ohashi, M; Takashima, M; Yamasaki, M, 1992) |
| " Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone." | 3.68 | Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. ( Hashimoto, H; Hirose, S; Kobayashi, S; Mokuno, C; Tamura, N; Tsuda, H, 1992) |
| "A 28-year-old women with idiopathic thrombocytosis was treated with melphalan before pregnancy, which resulted in a normal platelet count." | 3.68 | Idiopathic thrombocythemia and pregnancy; a case report. ( Minkhorst, AG; Nováková, IR; van Dongen, PW, 1991) |
| "Urinary excretion of thromboxane B2 metabolites as markers of thromboxane A2 synthesis was measured in eight patients with moderate to severe pregnancy-induced hypertension and in six normotensive pregnant women at term." | 3.68 | Thromboxane A2 synthesis in pregnancy-induced hypertension. ( Fitzgerald, DJ; FitzGerald, GA; Mayo, G; Murray, R; Rocki, W, 1990) |
| "Low-dose Aspirin inhibits thromboxane A2 with minimal effects on prostacyclin and induces clinical improvements in pre-eclampsia." | 3.68 | Treatment of severe pre-eclampsia by acetyl salicylic acid. ( Abd-Rabbo, S; Khowessah, M; Shaala, S; Toppozada, M; Zoheir, A, 1991) |
| " Four of them achieved pregnancy after low-dose aspirin therapy was started, and carried successfully to term." | 3.68 | Antiphospholipid antibodies in unselected patients with repeated abortion. ( Balasch, J; Casals, FJ; Cervera, R; Font, J; Jové, I; López-Soto, A; Vanrell, JA, 1990) |
| "A 27-year-old woman with anti-phospholipid antibody syndrome, whose first pregnancy had ended in intrauterine fetal death, was treated with prednisolone 0." | 3.68 | [Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome]. ( Maruyama, I; Maruyama, Y; Okadome, T; Osame, M; Shimmyozu, K; Tara, M, 1990) |
| "Pregnancy-induced hypertension (PIH) and preeclampsia develop when an imbalance occurs between prostacyclin (PGI2) and thromboxane A2 (TXA2) production." | 3.68 | [Effect of low-dose aspirin therapy on utero-placental blood flow and malondialdehyde (MDA) as an indicator of its therapeutic effect]. ( Iwata, I; Iwata, M; Masuhiro, K; Mitsuda, N; Nishino, E; Takagi, T; Tanizawa, O, 1990) |
| " In five cases, temporary reversal of the HELLP syndrome was achieved using low-dose aspirin and corticosteroids." | 3.68 | Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases. ( Burke, MS; Heyborne, KD; Porreco, RP, 1990) |
| "The effects of pH and anionic binding inhibitors were used to test the hypothesis that the increased T4 binding affinity of the variant albumin (Alb-FDH) of familial dysalbuminemic hyperthyroxinemia (FDH) is due to an electrostatic bond with the ionized phenolic hydroxyl of the iodothyronine." | 3.68 | Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia. ( Divino, CM; Schussler, GC, 1990) |
| "Pregnant rabbits were treated with aspirin (100 mg/kg/day) for ten consecutive days during the last third of the pregnancy." | 3.67 | Maternal aspirin administration inhibits pulmonary arachidonic acid metabolism in fetal rabbits. ( Simberg, N, 1984) |
| " No correlations were found between premenstrual exacerbation of asthma and symptoms of premenstrual tension, consumption of aspirin, use of the contraceptive pill, cycle length, or behaviour of asthma during pregnancy." | 3.67 | Premenstrual exacerbation of asthma. ( Coutts, II; Finnegan, OC; Gibbs, CJ; Lock, R; White, RJ, 1984) |
| "It has been hypothesized that the ingestion of aspirin by women during pregnancy increases their infants' risk of certain congenital heart defects." | 3.67 | The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. ( Mitchell, AA; Shapiro, S; Werler, MM, 1989) |
| "Decreased incidence of proteinuric hypertension after low-dose aspirin therapy is hypothesized to be a consequence of selective thromboxane A2 inhibition and sparing of prostacyclin." | 3.67 | Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. ( Brown, CE; Cox, SM; Gant, NF; Magness, RR; Rosenfeld, CR; Spitz, B, 1988) |
| "The relationship between maternal aspirin use during the first 20 weeks of pregnancy and the child's IQ at 4 years of age was investigated in 19,226 pregnancies occurring from 1959 to 1966 in the Collaborative Perinatal Project." | 3.67 | Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. ( Berendes, HW; Klebanoff, MA, 1988) |
| "Cumulative dose-response curves for histamine induced responses in mesometrial (ME) and antimesometrial (AME) regions of uterine horns isolated from rats at 7th, 16th and 22nd days of pregnancy, were constructed." | 3.67 | Is there a prostaglandin involvement in the positive inotropic action of histamine in isolated pregnant rat uterus, apparently mediated via H1-receptors activation? ( Dveksler, G; Franchi, AM; Gimeno, AL; Gimeno, MF; Viggiano, M, 1987) |
| " Despite preeclampsia our patient successfully completed her 6th pregnancy after treatment with corticosteroids, subcutaneous heparin, and low dose aspirin throughout the pregnancy." | 3.67 | Subclinical autoimmune disease and recurrent spontaneous abortion. ( Andreoli, J; Hakim, C; Maier, D; Parke, A; Randolph, J, 1986) |
| "In a longitudinal prospective study of 1,529 women pregnant in 1974-1975, aspirin and acetaminophen were the two medications most frequently taken during the first half of pregnancy (46 and 41%, respectively)." | 3.67 | Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. ( Barr, HM; Bleyer, WA; Martin, DC; Sampson, PD; Shepard, TH; Streissguth, AP; Treder, RP, 1987) |
| "Normal pregnancy is associated with reduced systemic pressor responses to infused angiotensin II (ANG II); furthermore, the uterine vascular bed is even less responsive to vasoconstriction by ANG II than the systemic vasculature overall." | 3.67 | In vitro prostacyclin production by ovine uterine and systemic arteries. Effects of angiotensin II. ( Magness, RR; Mitchell, MD; Osei-Boaten, K; Rosenfeld, CR, 1985) |
| " During their next pregnancy, the patients were treated with 40 to 50 mg of prednisone per day and 81 mg of aspirin per day." | 3.67 | Obstetric complications associated with the lupus anticoagulant. ( Branch, DW; Hershgold, E; Kochenour, NK; Scott, JR, 1985) |
| "The materno-fetal transfer of salicylic acid and its distribution in the fetal organism was investigated in women of early pregnancy." | 3.66 | [Distribution of salicylic acid and hydrolysis of acetylsalicylic acid in the human fetus in early pregnancy]. ( Amon, I; Amon, K; Zschiesche, A, 1983) |
| " All women were treated with aspirin (1 g daily or 500 mg every 48 hours) during pregnancy, delivery, and the postdelivery period." | 3.66 | Pregnancy in 20 patients with bioprosthetic valve replacement. ( Gil Aguado, M; Larrea, JL; Matorras, R; Minguez, JA; Nuñez, L; Reque, JA, 1983) |
| "Pregnant women with either Type B EPH gestosis or gestosis alone were treated with low dose aspirin if thrombocytopenia were present (platelet counts below 75,000) or had platelet aggregation studies if their platelet counts were above 75,000." | 3.66 | Diagnosis and treatment of pregnancy induced platelet dysfunction. ( Davis, RB; Goodlin, RC, 1983) |
| "The highest pregnancy rate as well as most of all implantates and lowest foetal loss were recorded from the prostaglandin F2 alpha-(PGF2 alpha)-group (84, 84, and 16 per cent), while values following progesterone/oestrone and acetylsalicylic acid treatment were below those obtained from the controls." | 3.66 | [Control of implantation in rats and sows by peroral administration of prostaglandin synthetase inhibitors. 2. Effects of prostaglandin F2 alpha, progesterone/estrone, and acetylsalicylic acid on implantation and various biochemical parameters of amniotic ( Steger, H; Wollenhaupt, K, 1981) |
| "Three antiprostaglandin drugs, acetylsalicylic acid, indomethacin and ibuprofen, were administered intraluminally at different does to pregnant rats on Day 4 of pregnancy." | 3.66 | Effect of intrauterine administration of antiprostaglandin drugs on implantation in the rat. ( Chaudhury, RR; Gupta, U; Malhotra, N; Varma, SK, 1981) |
| " On day 2 post partum, mothers were questioned regarding maternal risk factors, including the use of either aspirin or acetaminophen during the last week of pregnancy." | 3.66 | Neonatal intracranial hemorrhage and maternal use of aspirin. ( Braithwaite, WR; Guggenheim, MA; Johnson, ML; Peterson, RG; Rumack, BH; Rumack, CM, 1981) |
| " The effects of acetaminophen in pregnancy and in the newborn have not been studied extensively; when ingested in usual therapeutic doses, the available data have shown no adverse effects." | 3.66 | Effects of aspirin and acetaminophen in pregnancy and in the newborn. ( Rudolph, AM, 1981) |
| "Pregnant women destined to develop pregnancy-induced hypertension (PIH) lose refractoriness to the pressor effects of infused angiotensin II (A-II) several weeks before the onset of hypertension." | 3.66 | Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1978) |
| "In four patients with clinical and laboratory manifestations of the hemolytic-uremic syndrome, the administration of aspirin and dipyridamole was associated with a dramatic and rapid increase in the platelet count." | 3.66 | The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function. ( Carone, FA; Green, D; Rossi, EC; Thorsen, CA, 1979) |
| "On the 10th-13th days of pregnancy toluene (3600 mg/m3) by inhalation) and on 12th day acetylsalicylic acid (500 mg/kg of body weight per os) were administered to CFY rats and the common effect of these agents was studied." | 3.66 | [Experimental model for the study of the teratogenic interaction of chemical agents and drugs (toluene and acetylsalicylic acid)]. ( Hudák, A; Tátrai, E; Ungváry, G, 1979) |
| ", malformation rates were similar in the children of 35 418 women not exposed to aspirin, 9736 with intermediate exposure, and 5128 women heavily exposed during the first four lunar months of pregnancy." | 3.65 | Aspirin and congenital malformations. ( Heinonen, OP; Kaufman, DW; Monson, RR; Shapiro, S; Siskind, V; Slone, D, 1976) |
| " there was no evidence that aspirin taken in pregnancy is a cause of stillbirth, neonatal death, or reduced birth-weight." | 3.65 | Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. ( Heinonen, OP; Kaufman, DW; Monson, RR; Shapiro, S; Siskind, V; Slone, D, 1976) |
| "5 gm of aspirin a day during her entire pregnancy, and to characterize the kinetics of salicylate elimination by the infant." | 3.65 | Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy. ( Garrettson, LK; Levy, G; Procknal, JA, 1975) |
| " 1159) discussed their demonstration that gestation is prolonged in patients with arthritis taking aspirin in terms of prostaglandin metabolism at the end of pregnancy." | 3.65 | Letter: Aspirin, prostaglandin, and gestation. ( Horan, AH, 1974) |
| "The effect of various doses of clofibrate on the incidence of pregnancy, on the weight of gonads and seminal vesicles, on the estrous cycle, and on the elimination of 17-ketosteroids and estrogen through the urine was studied on the rat and the rabbit." | 3.65 | [Studies of the interactions of clofibrate with the reproductive function]. ( Pantaleoni, GC; Valeri, P, 1974) |
| "The concentrations of free and protein-bound L-tryptophan were measured in sera from normal subjects, patients with rheumatoid arthritis, pregnant women, and patients with jaundice." | 3.65 | Mode of action of antirheumatic drugs. ( Dawkins, PD; Hamilton, EB; McArthur, JN; Smith, MJ, 1971) |
| "The incidence of preterm preeclampsia was 1." | 3.30 | Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. ( Alsius, M; Bonacina, E; Caamiña, S; Carreras, E; de Mingo, L; Diaz, S; Ferrer-Costa, R; Garcia, E; Garcia-Manau, P; López, M; Lopez-Quesada, E; Maiz, N; Maroto, A; Martin, L; Mendoza, M; Millán, P; Ocaña, V; Orizales-Lago, C; Pallarols, M; Pérez-Gomez, A; Pintado, E; Puerto, L; Ricart, M; Rodríguez-Zurita, A; Suy, A; Teixidor, M; Vidal-Sagnier, L; Vives, À, 2023) |
| "The main outcome was preeclampsia or a birthweight ≤ 5th percentile." | 3.11 | Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial. ( Arthuis, C; Cheve, MT; Debarge, VH; Delmas, HL; Diguisto, C; Doret, M; Durin, L; Equy, V; Flandrin, A; Gallot, D; Giraudeau, B; Haddad, G; Le Gouge, A; Marchand, MS; Mares, P; Megier, P; Paumier, A; Perrotin, F; Schaub, B; Sentilhes, L; Vayssiere, C; Ville, Y; Winer, N, 2022) |
| "· Aspirin was not associated with risk of cesarean section." | 3.11 | The Safety of Low-Dose Aspirin on the Mode of Delivery: Secondary Analysis of the Effect of Aspirin in Gestation and Reproduction Randomized Controlled Trial. ( Decherney, AH; Eubanks, AA; Hill, MJ; Kim, K; Mumford, SL; Nobles, CJ; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA; Ye, A, 2022) |
| "A dosage of 100 mg of aspirin per day, initiated from 12 to 20 gestational weeks until 34 weeks of gestation, did not reduce the incidence of preeclampsia in pregnant women with high-risk factors in China." | 3.11 | A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. ( Chen, D; Chen, J; Cui, S; Ding, H; Huai, J; Juan, J; Li, B; Li, G; Li, X; Lin, L; Ma, Y; Mi, Y; Qi, H; Sun, X; Yang, H; Yu, M; Zhang, H; Zhang, M; Zhang, W; Zhao, X; Zhao, Y; Zhu, Y, 2022) |
| "Preeclampsia is a hypertensive disorder of pregnancy affecting up to 8% of pregnancies." | 3.01 | Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy. ( Costantine, MM; Eid, J; Rood, KM, 2023) |
| "Aspirin was not found to substantially diminish the risk of incidence of preeclampsia, but it did show some beneficial effects." | 3.01 | Role of aspirin in the prevention of preeclampsia in previously hypertensive pregnant women: A Meta-Analysis. ( Ashraf Jahangeer, SM; Khan, AA; Mansoor, M, 2023) |
| "Pericardial effusion is the most common manifestation of pericardial diseases during pregnancy." | 3.01 | Pericardial Diseases in Pregnancy. ( Agozzino, F; Bizzi, E; Brucato, A; Dominioni, CC; Imazio, M; Maestroni, S; Mardigyan, V; Negro, E; Nivuori, M; Serati, L; Trotta, L, 2023) |
| "Preeclampsia and gestational hypertension are common pregnancy complications associated with adverse maternal and child outcomes." | 3.01 | Polygenic prediction of preeclampsia and gestational hypertension. ( Antopia, MC; Bhatta, L; Brumpton, BM; Cho, SMJ; Do, R; Gray, KJ; Guerrero, RF; Gupta, RM; Haas, DM; Honigberg, MC; Khan, RR; Koyama, S; Laisk, T; Martin, HC; Nadkarni, GN; Natarajan, P; Patel, AP; Patil, S; Pe'er, I; Saxena, R; Schuermans, A; Selvaraj, MS; Trinder, M; Truong, B; Urbut, SM; van Heel, DA; Vellarikkal, SK; Verma, SS; Vy, HMT; Xiao, B; Yan, Q; Zöllner, S, 2023) |
| "ASA use during pregnancy has benefits beyond reducing the risk of pre-eclampsia." | 3.01 | The Role of Acetylsalicylic Acid in the Prevention of Pre-Eclampsia, Fetal Growth Restriction, and Preterm Birth. ( Berger, R; Hinz, B; Stubert, J, 2023) |
| "Hydroxychloroquine (HCQ) is an immunomodulatory agent that has been shown in laboratory studies to decrease thrombosis risk, support placentation, and minimize the destructive effects of antiphospholipid antibodies." | 3.01 | Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. ( Bacal, V; Bedaiwy, MA; Hooper, A, 2023) |
| "Among 101 women with recurrent miscarriages, overall, 652 pregnancies have been included in the analysis." | 3.01 | Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. ( Antoine, JM; Ben Kraiem, Y; Bornes, M; Chabbert Buffet, N; Cheloufi, M; Cohen, J; Dabi, Y; Darai, E; Dechartres, A; Delhommeau, F; Fain, O; Johanet, C; Kayem, G; Kolanska, K; Ledée, N; Mathieu d'Argent, E; Mekinian, A; Placais, L; Rosefort, A; Selleret, L; Suner, L, 2021) |
| "Pregnancy in sickle cell disease is fraught with many complications including pre-eclampsia (PE) and intrauterine growth restriction (IUGR)." | 3.01 | Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol). ( Adeyemo, TA; Afolabi, BB; Babah, OA; Ezeaka, CV; Nwaiwu, O; Odukoya, OO; Ogunnaike, BA; Oshodi, YA, 2021) |
| "Preeclampsia and gestational hypertension are common complications of pregnancy associated with significant maternal and infant morbidity." | 2.94 | Preconception Blood Pressure and Its Change Into Early Pregnancy: Early Risk Factors for Preeclampsia and Gestational Hypertension. ( Andriessen, VC; Connell, M; Kim, K; Mendola, P; Mumford, SL; Nobles, CJ; Perkins, NJ; Schisterman, EF; Silver, RM; Sjaarda, L, 2020) |
| "The risk of preeclampsia was not different when comparing the aspirin and placebo groups among the Hispanic, non-Hispanic black, or other ethnicity and race groups." | 2.94 | Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race. ( Aagaard, KM; Mendez-Figueroa, H; Sangi-Haghpeykar, H; Tolcher, MC, 2020) |
| "The Aspirin for Evidence-Based Preeclampsia Prevention trial data are consistent with the hypothesis that aspirin delays the gestational age at delivery with preeclampsia." | 2.90 | Aspirin delays the development of preeclampsia. ( Nicolaides, KH; Wright, D, 2019) |
| "Among women receiving placebo, preeclampsia occurred significantly more often in women with stage 1 hypertension compared with normotensive high-risk women after adjustment for maternal age and body mass index (39." | 2.87 | Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort. ( Caritis, SN; Catov, JM; Hauspurg, A; Sutton, EF, 2018) |
| "Inflammation is linked to causes of infertility." | 2.84 | Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. ( Galai, N; Mitchell, E; Mumford, SL; Perkins, NJ; Radin, RG; Schisterman, EF; Silver, RM; Sjaarda, LA; Stanford, JB; Wactawski-Wende, J; Wilcox, B, 2017) |
| "Aspirin was significantly associated with a higher birthweight Z-score (0." | 2.84 | Impact of aspirin on fetal growth in diabetic pregnancies according to White classification. ( Adkins, K; Allshouse, AA; Heyborne, KD; Metz, TD, 2017) |
| " After culture, embryo morphological and developmental parameters were documented using standardized scoring systems at each dosage concentration." | 2.82 | Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system. ( Leung, BW; Leung, TY; Moungmaithong, S; Poon, LC; Sahota, DS; Wang, CC, 2022) |
| "When aspirin was initiated at > 16 weeks, with a dosage of < 100 mg/day aspirin, there was a lesser preventive effect (RR = 0." | 2.82 | The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs. ( Dai, C; He, Q; Huang, X; Lee, W; Li, L; Li, R; Luo, Z; Mok, TN; Yip, KC; Zeng, W, 2022) |
| "Two proteases that are elevated in preeclampsia and activate protease-activated receptor 1 are matrix metalloproteinase-1 and neutrophil elastase." | 2.82 | Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia? ( Strauss, JF; Walsh, SW, 2022) |
| "Given the burden of preeclampsia, the identification of women at high risk in early pregnancy is essential to allow for preventive strategies and close monitoring." | 2.82 | Screening for preeclampsia in twin pregnancies. ( Francisco, C; Gamito, M; Reddy, M; Rolnik, DL, 2022) |
| "Placental insufficiency affects about 10% of pregnancies and can lead to pre-eclampsia, fetal growth restriction, and preterm birth." | 2.82 | The role of melatonin in pregnancies complicated by placental insufficiency: A systematic review. ( Bussolaro, S; Fantasia, I; Rolnik, DL; Stampalija, T, 2022) |
| "It has been reported that preeclampsia initiates from a mismatch between the utero-placental supply and demand, which subsequently triggers the release of placental syncytiotrophoblast stress-derived factors and an imbalance of proangiogenic/antiangiogenic factors, eventually causing maternal systemic endothelial lesions and systemic inflammatory response." | 2.82 | [Latest Findings on Prediction and Prevention of Preeclampsia]. ( Li, XT; Xiao, XR; Xiong, Y; Ye, YZ; Zhou, QJ, 2022) |
| "In addition, treating chronic hypertension neither reduces nor increases fetal or newborn death or morbidity, regardless of the gestational age at which the antihypertensive treatment is started." | 2.82 | Toward personalized management of chronic hypertension in pregnancy. ( Kametas, N; Khalil, A; Magee, LA; von Dadelszen, P, 2022) |
| " These inconsistencies, however, can be largely explained by a high degree of heterogeneity regarding the selection of trial participants, baseline risk of the included women, dosage of aspirin, gestational age of prophylaxis initiation, and preeclampsia definition." | 2.82 | Prevention of preeclampsia with aspirin. ( Nicolaides, KH; Poon, LC; Rolnik, DL, 2022) |
| "When superimposed preeclampsia was present, it developed at an earlier gestational age among the group without GDM (35 ± 5 vs." | 2.82 | Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension. ( Blackwell, SC; Haidar, ZA; Leon, MG; Longo, M; Mendez-Figueroa, H; Moussa, HN; Pedroza, C; Sibai, BM, 2016) |
| "Aspirin was associated with a lower rate of late-onset preeclampsia ⩾34w (17." | 2.80 | Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study. ( Allshouse, AA; Galan, HL; Heyborne, KD; Moore, GS; Post, AL, 2015) |
| "Aspirin and heparin have been shown to have potentially beneficial effects on trophoblast implantation." | 2.79 | Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. ( Adam, I; Ashur, BM; Elbareg, AM; Elmahashi, MO; Essadi, FM, 2014) |
| "The rate of superimposed preeclampsia was 28." | 2.79 | Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. ( Atallah, AN; Kulay, L; Santos, GM; Sass, N; Souza, EV; Torloni, MR, 2014) |
| " The administration of ASA before calving (even at a low dose) in combination with ω-3 FA did not exert any synergistic positive effect on inflammation and performance." | 2.78 | Effects of the precalving administration of omega-3 fatty acids alone or in combination with acetylsalicylic acid in periparturient dairy cows. ( Bertoni, G; Cappelli, FP; Grossi, P; Trevisi, E, 2013) |
| "Thrombophilia has been identified in about 50% of women with recurrent miscarriage and thromboprophylaxis has been suggested as an option of treatment." | 2.76 | Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. ( Bloemenkamp, KW; Helmerhorst, FM; Kaaja, RJ; Lampinen, K; Morin-Papunen, L; Ulander, VM; Visser, J, 2011) |
| "We studied 130 men and 186 women with untreated mild hypertension, 44." | 2.75 | Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. ( Ayala, DE; Hermida, RC, 2010) |
| "In women with a history of recurrent miscarriage, the risk of miscarriage in a subsequent pregnancy is about 30% to 40%." | 2.74 | Use of heparin in women with early and late miscarriages with and without thrombophilia. ( Baumgarten, S; Dörner, T; Kadecki, O; Kiesewetter, H; Monien, S; Salama, A, 2009) |
| "Pregnancy was successfully carried out in 12/12 (100%) SLE-RSA patients with a mean Apgar score of 8." | 2.73 | Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. ( Cipriani, P; De Carolis, C; Fontana, L; Giacomelli, R; Greco, E; Kröegler, B; Perricone, C; Perricone, R, 2008) |
| "Although low-dose aspirin is well established in PV, its indications and dosing regimens are less clear in ET." | 2.72 | Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera. ( Hobbs, G; How, J, 2021) |
| "Pregnancy is a prothrombotic condition, which can be abnormally exaggerated in women with thrombophilia." | 2.72 | Inherited thrombophilia and anticoagulant therapy for women with reproductive failure. ( Han, AR; Han, JW; Lee, SK, 2021) |
| "Development of preeclampsia can be decreased by prescribing low-dose aspirin to high-risk women." | 2.72 | Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review. ( Kay, VR; Smith, GN; Wedel, N, 2021) |
| "The prevention of fetal growth restriction (FGR) is challenging in clinical practice." | 2.72 | Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta-Analysis. ( Avagliano, L; Bettiol, A; Crescioli, G; Emmi, G; Lombardi, N; Ravaldi, C; Urban, ML; Vannacci, A; Virgili, G, 2021) |
| "Hemorrhagic stroke is the most common type of obstetric stroke." | 2.72 | Stroke in Pregnancy: A Multidisciplinary Approach. ( Camargo, EC; Singhal, AB, 2021) |
| "In preterm preeclampsia, women assigned at random to 150 mg experienced a significant 62% reduction in risk of preterm preeclampsia (RR = 0." | 2.72 | Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis. ( Flyke, IP; Hennekens, CH; Hoppe, KK; Kim, K; Lasarev, M; Mukhtarova, N; Van Doorn, R, 2021) |
| "Women with a prior pregnancy affected by FGR have a 20% to 30% risk of recurrence, but effective preventive strategies are lacking." | 2.72 | Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies. ( Blue, NR; Page, JM; Silver, RM, 2021) |
| " Laboratory studies suggest that a twice-daily dosing regimen or evening intake may lead to more efficient platelet inhibition, and the potential clinical benefit of such strategies is currently being explored in ongoing clinical trials." | 2.72 | Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives. ( Christiansen, M; Grove, EL; Hvas, AM, 2021) |
| "It was effective in reducing preterm preeclampsia, but not term preeclampsia, and patient compliance and patient weight were important variables." | 2.72 | The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta. ( Strauss, JF; Walsh, SW, 2021) |
| " Observations collected in two population pharmacokinetic studies, in preterm neonates, investigating amikacin and vancomycin were used to estimate: i) the impact of ibuprofen administration on the clearance of these drugs; and ii) the difference between prophylactic and therapeutic administration of ibuprofen on this clearance." | 2.72 | Impact of ibuprofen administration on renal drug clearance in the first weeks of life. ( Allegaert, K; Anderson, BJ; Rayyan, M, 2006) |
| "Salicylic acid was detected in 1 infant only." | 2.71 | Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation. ( Bernert, S; Leonhardt, A; Schmitz-Ziegler, G; Seyberth, HW; Watzer, B, 2003) |
| "The trial enrolled 139 women at risk of preeclampsia or IUGR, with abnormal uterine artery Doppler findings that included the presence of unilateral or bilateral diastolic notch, high resistance index (RI), or high pulsatility index (PI) at 14-16 weeks of gestation." | 2.71 | Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. ( Ebrashy, A; Ibrahim, M; Marzook, A; Yousef, D, 2005) |
| "The reduction in the incidence of intrauterine growth retardation (2." | 2.70 | Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. ( Iso-Mustajärvi, M; Kujansuu, E; Mäenpää, J; Vainio, M, 2002) |
| "Whether low-dose aspirin prevents preeclampsia is unclear." | 2.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| " Six hundred eighty-seven APA+ women, who were younger than 40 years and who each, completed up to three consecutive IVF/embryo transfer cycles within a 12-month period, were given either H/A alone or H/A in combination with IVIg." | 2.69 | The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. ( Ching, W; Chong, P; Feinman, M; Maassarani, G; Matzner, W; Sher, G; Zouves, C, 1998) |
| "Recurrent miscarriage and later pregnancy complications are in some cases associated with placental thrombosis and infarction." | 2.69 | Recurrent miscarriage--an aspirin a day? ( Backos, M; Baxter, N; Chilcott, I; Rai, R; Regan, L, 2000) |
| "Treatment with aspirin and heparin leads to a significantly higher rate of live births in women with a history of recurrent miscarriage associated with phospholipid antibodies than that achieved with aspirin alone." | 2.68 | Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) ( Cohen, H; Dave, M; Rai, R; Regan, L, 1997) |
| " These studies suggest that during pregnancy changes of the uptake rate and distribution volume modulate the pharmacokinetics of ASA and that this drug given in low dosage to gravidae marginally alters their platelet function." | 2.67 | Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short term treatment on bleeding time. ( Berntorp, E; Gennser, G; Liedholm, H; Melander, A; Nordsjö, P; Rymark, P, 1994) |
| "Aspirin was not associated with a significant increase in placental haemorrhages or in bleeding during preparation for epidural anaesthesia, but there was a slight increase in use of blood transfusion after delivery." | 2.67 | CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. ( , 1994) |
| "To assess its efficacy in preventing preeclampsia, 60 mg/day aspirin or a matching placebo was administered to women in a double-blind fashion during the second and third trimesters." | 2.67 | Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. ( Arheart, KL; Di Sessa, TG; Khoury, A; Moretti, ML; Pulliam, DA; Sibai, BM, 1994) |
| "Aspirin treatment did not affect the relation between the Doppler indices and these outcomes in the logistic regression model." | 2.67 | The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial. ( Atkinson, MW; Copper, RL; Goldenberg, RL; Hauth, JC; Maher, JE; Owen, J, 1994) |
| "The occurrences of IUGR and preeclampsia in the study group (7." | 2.67 | [Prevention of fetal growth retardation by low dose aspirin]. ( Li, WJ; Wang, ZH, 1993) |
| "The incidence of preeclampsia was lower in the aspirin group (69 of 1485 women [4." | 2.67 | Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, SN; Klebanoff, M; McNellis, D; Paul, RH; Rocco, L; Romero, R; Rosen, M; Sibai, BM; Thom, E; Witter, F, 1993) |
| "We studied 14 pregnant women with systemic lupus erythematosus (SLE), of whom six had detectable antiphospholipid antibodies." | 2.67 | Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin. ( Julkunen, H; Kaaja, R; Viinikka, L; Ylikorkala, O, 1993) |
| "Prednisone alone was judged to be effective in 30 patients with mild TTP-HUS (two relapses and two deaths)." | 2.67 | Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. ( Bell, WR; Braine, HG; Kickler, TS; Ness, PM, 1991) |
| "Preeclampsia affects up to 8% of pregnancies worldwide and remains a major cause of maternal and neonatal morbidity and mortality." | 2.66 | Novel Interventions for the Prevention of Preeclampsia. ( Costantine, MM; Kniss, D; Ma'ayeh, M; Rood, KM, 2020) |
| "Preeclampsia is considered a specific disease of pregnancy, but recent theories suggest that women suffering from the condition have greater propensity to develop atherosclerosis, heart disease, and stroke over the years." | 2.66 | Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation. ( Diniz, AD; Diniz, ALD; Paes, MMBM, 2020) |
| "Preeclampsia is an obstetric disorder that affects 3-8% of pregnant women and remains a leading cause of short- and long-term neonatal and maternal morbidity and mortality." | 2.66 | Prevention of preeclampsia. ( Costantine, MM; Ma'ayeh, M, 2020) |
| "To compare the efficacy of heparin combined with aspirin and aspirin alone for URSA." | 2.66 | Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion. ( Gao, YH; Li, J; Li, ZY; Xu, L, 2020) |
| "Chronic hypertension affects 1-5% of women of childbearing age." | 2.66 | Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. ( Haddad, B; Lecarpentier, E, 2020) |
| "Aspirin has been used in the management of postpartum perineal pain, and its effectiveness and safety should be assessed." | 2.66 | Aspirin (single dose) for perineal pain in the early postpartum period. ( Grivell, RM; Shepherd, E, 2020) |
| "Normal pregnancy is a complex and dynamic process that requires significant adaptation from the maternal system." | 2.66 | Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond. ( Doherty, A; Kingdom, JC; McLaughlin, K, 2020) |
| "Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss." | 2.66 | Understanding and Preventing Placenta-Mediated Pregnancy Complications. ( Blondon, M; Ní Áinle, F; Skeith, L, 2020) |
| "Although migraine improves or disappears during pregnancy, a significant association between migraine and hypertension (i." | 2.66 | The Potential Protective Role of Aspirin Against Migraine in Pregnant Women. ( Gong, Y; Liu, X, 2020) |
| "Women with chronic hypertension have a higher incidence of superimposed preeclampsia, cesarean section, preterm delivery before 37 weeks' gestation, birth weight less than 2500 g, neonatal unit admission, and perinatal death." | 2.66 | Hypertension During Pregnancy. ( Agrawal, A; Wenger, NK, 2020) |
| "Preeclampsia is a complex disease affecting 2-8% of pregnancies worldwide." | 2.66 | Novel approaches to combat preeclampsia: from new drugs to innovative delivery. ( Beard, S; Binder, NK; Brownfoot, F; de Alwis, N; Hannan, NJ; Kaitu'u-Lino, TJ; Tong, S, 2020) |
| "Preterm birth is the leading cause of neonatal morbidity and mortality worldwide." | 2.66 | Current Preterm Birth Prevention Strategies. ( Breslin, N; Gyamfi-Bannerman, C, 2020) |
| "The pregnancy was normal in 54% of patients in group A and 23% in group B (p less than 0." | 2.65 | [Controlled trial of preventive treatment of preeclampsia. Preliminary results]. ( Beaufils, M; Colau, JC; Donsimoni, R; Uzan, S, 1984) |
| "Its exact place in the management of ankylosing spondylitis remains to be determined." | 2.64 | Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. ( Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM, 1975) |
| "Myeloproliferative neoplasms (MPNs) are increasingly being identified in women of childbearing potential." | 2.61 | Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis. ( Fazelzad, R; Gupta, V; Kazi, S; Malinowski, AK; Maze, D; Shah, PS; Shehata, N, 2019) |
| "Methods, results: Preeclampsia (PE) is a multisystem disorder complicating pregnancy." | 2.61 | First-trimester screening for preeclampsia. ( Feyereisl, J; Krofta, L; Lošan, P; Lubušký, M; Marková, I; Pilka, R; Roubalová, L; Skřivánek, A; Vojtěch, J, 2019) |
| "Inflammation has been linked to several complications in pregnancy, including pregnancy loss." | 2.61 | The role of aspirin and inflammation on reproduction: the EAGeR trial ( Holland, TL; Kim, K; Levine, LD; Mumford, SL; Schisterman, EF; Sjaarda, LA, 2019) |
| "Compared with control intervention for recurrent miscarriage, enoxaparin treatment has no substantial influence on live births (RR = 1." | 2.61 | Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies. ( Chen, Y; Cheng, X; Li, N; Lin, T; Sheng, X, 2019) |
| "Angiogenic and non-angiogenic preeclampsia are identified by a sFlt-1PlGF≥85 and<85, respectively, with the risk of maternal and fetal complications at two weeks differing between the two." | 2.61 | [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians]. ( Achiche, J; Ahriz Saksi, S; Bailleul, S; Boulanger, H; Drouin, D; Dupuis, E; Ekoukou, D; Lefèvre, G; Sault, C; Stawiarski, N, 2019) |
| "Pregnancy-induced hypertension is a major cause of maternal and fetal morbidity and mortality." | 2.61 | Hypertension and Pregnancy: Management and Future Risks. ( Jim, B; Reddy, S, 2019) |
| " Avoidance of nephrotoxic and teratogenic medications is necessary, and renal dosing of commonly used medications must also be considered." | 2.61 | Chronic Kidney Disease and Pregnancy. ( Hladunewich, MA; Hui, D, 2019) |
| "For the prevention of fetal growth restriction, a recent large-study level meta-analysis and individual patient data meta-analysis confirm that aspirin modestly reduces small-for-gestational-age pregnancy in women at high risk (relative risk, 0." | 2.58 | The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. ( David, AL; Groom, KM, 2018) |
| " Each case showed a marked platelet decrease, from values within normal limits at the time of delivery, with no severe adverse events." | 2.58 | Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review. ( Hasegawa, M; Sakai, K; Ueda, A; Ueda, Y, 2018) |
| "Preterm preeclampsia (PE), occurring at < 37 weeks' gestation, can be predicted from as early as 11-13 weeks and prevented with the use of aspirin." | 2.58 | Prediction of preeclampsia developing at term. ( Huluta, I; Panaitescu, AM, 2018) |
| "It has been now widely accepted that preeclampsia is most a systemic inflammatory and systemic vascular disease during pregnancy and then a lifelong risk factor for subsequent cardiovascular event in women's life." | 2.58 | [Preeclampsia: A challenge also for cardiologists]. ( Cournot, M; Lairez, O; Medzech, B, 2018) |
| "Aspirin has proved its efficacy in primary and secondary pre-eclampsia prevention, especially when it is given at 150mg per day bedtime before 15 weeks of gestation to high-risk women." | 2.58 | [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?] ( de Moreuil, C; Fauchais, AL; Lacut, K; Le Moigne, E; Merviel, P; Pan-Petesch, B; Pasquier, E; Tremouilhac, C, 2018) |
| "Stillbirth affects at least 2." | 2.58 | Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. ( Ellwood, DA; Flenady, V; Heazell, AE; Lassi, ZS; Middleton, P; Murphy, MM; Shepherd, E; Silver, RM; Wilson, T; Wojcieszek, AM, 2018) |
| " Screening modalities, target population, and aspirin dosage are still a matter of debate." | 2.55 | Aspirin for Prevention of Preeclampsia. ( Atallah, A; Doret-Dion, M; Gaucherand, P; Goffinet, F; Lecarpentier, E; Tsatsaris, V, 2017) |
| "Aspirin has been widely prescribed since the 1980's to prevent pre-eclampsia, intra-uterine growth retardation and fetal death of vascular origin." | 2.55 | [Aspirin: Indications and use during pregnancy]. ( Belhomme, N; Doudnikoff, C; Henriot, B; Isly, H; Jego, P; Polard, E, 2017) |
| "The pregnancy was uneventful." | 2.55 | Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review. ( Bohîlţea, RE; Cîrstoiu, MM; Dimitriu, M; Ionescu, CA; Niculescu-Mizil, E; Turcan, N; Vlădăreanu, AM; Voican, I, 2017) |
| "Women at an increased risk of preeclampsia should be offered antiplatelet therapy, regardless of whether they are first seen before or after 16 weeks' gestation." | 2.55 | Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. ( Askie, L; Duley, L; Hunter, K; Meher, S, 2017) |
| "Spontaneous preterm birth is an important cause of neonatal mortality and morbidity." | 2.55 | Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis. ( Askie, LA; Mol, BWJ; Oudijk, MA; van Vliet, EOG, 2017) |
| "Aspirin has been used in the management of postpartum perineal pain and its effectiveness and safety should be assessed." | 2.55 | Aspirin (single dose) for perineal pain in the early postpartum period. ( Grivell, RM; Molakatalla, S; Shepherd, E, 2017) |
| "Outcomes included preeclampsia (mild and severe) and SGA neonates." | 2.53 | Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis. ( Bergeron, TS; Bujold, E; Carpentier, C; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Sixty-eight patients with unexplained recurrent miscarriage were randomized to receive either G-CSF (filgastrim, Neupogen, 1 μ/kg/day SC, n = 35) after the ovulation until the 9th weeks of gestation or placebo (n = 33)." | 2.53 | Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? ( Alijotas-Reig, J; Bornes, M; Carbillon, L; Cohen, J; Daraï, E; Fain, O; Kayem, G; Mekinian, A; Nicaise-Roland, P, 2016) |
| "Outcomes included preeclampsia, severe preeclampsia, and SGA." | 2.53 | Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials. ( Bujold, E; McCaw-Binns, A; Roberge, S; Sibai, B, 2016) |
| "Today, pregnancy is no longer considered impossible in women with lupus." | 2.53 | Pregnancy in women with systemic lupus erythematosus (SLE). ( Moroni, G; Ponticelli, C, 2016) |
| "For a woman with chronic pain, adequate use of pain killers during pregnancy is needed." | 2.53 | Ongoing Pharmacological Management of Chronic Pain in Pregnancy. ( Källén, B; Reis, M, 2016) |
| "Preeclampsia is a hypertensive disorder of pregnancy that remains a significant cause of maternal morbidity and mortality worldwide." | 2.53 | Aspirin vs Heparin for the Prevention of Preeclampsia. ( Kanellopoulou, T; Katsi, V; Makris, T; Nihoyannopoulos, P; Nomikou, E; Tousoulis, D, 2016) |
| "Low-dose aspirin significantly reduced preeclampsia risk in both East Asians (OR = 0." | 2.53 | Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians:A systematic review and meta-analysis. ( Gan, J; He, H; Qi, H, 2016) |
| "Worldwide, preeclampsia is a significant health risk to both pregnant women and their unborn children." | 2.52 | Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia. ( Agrawal, DK; Kirkpatrick, DR; Kovilam, O; Smith, TA, 2015) |
| " Careful attention must be paid to the dosing and potential teratogenicity of medications." | 2.52 | Pregnancy and Lupus Nephritis. ( Garovic, VD; Kattah, AG, 2015) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.50 | Antiphospholipid antibody syndrome. ( Hinote, CD; Kutteh, WH, 2014) |
| "For the prevention of preeclampsia, it is worth considering for women who are at high risk of developing the disease." | 2.50 | [Acetylsalicylic acid and prevention of preeclampsia]. ( Kajantie, E; Laivuori, H; Villa, PM, 2014) |
| "Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality." | 2.50 | Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. ( Henderson, JT; O'Connor, E; Rowland, MG; Senger, CA; Thompson, JH; Whitlock, EP, 2014) |
| "Pregnancy is a specific state of heightened coagulability related to the increase in procoagulant agents and to the reduced fibrinolysis." | 2.50 | Anticoagulant therapy in pregnant patients with metabolic syndrome: a review. ( Kimber-Trojnar, Z; Leszczynska-Gorzelak, B; Mierzynski, R; Oleszczuk, J; Poniedzialek-Czajkowska, E, 2014) |
| "Preeclampsia, intrauterine growth restriction (IUGR), and placental abruption are obstetrical conditions that constitute the syndrome of ischemic placental disease or IPD, the leading cause of indicated preterm birth and an important cause of neonatal morbidity and mortality." | 2.50 | Prediction and prevention of ischemic placental disease. ( Cleary, KL; Friedman, AM, 2014) |
| "Essential thrombocythemia is a chronic myeloproliferative neoplasm characterized by sustained thrombocytosis, bone marrow megakaryocytic hyperplasia and an increased risk of thrombosis and hemorrhage." | 2.49 | [Treatment of essential thrombocythemia]. ( Alvarez-Larrán, A; Besses, C; Cervantes, F, 2013) |
| "Aspirin may cause teratogenicity and fetal toxicity, and perinatal mortality is increased." | 2.49 | Antithrombotic therapy for pregnant women. ( Toyoda, K, 2013) |
| "The outcomes of interest were preterm preeclampsia (delivery <37 weeks) and term preeclampsia." | 2.48 | Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. ( Bakthi, A; Bujold, E; Ebrashy, A; Giguère, Y; Nicolaides, K; Roberge, S; Vainio, M; Villa, P, 2012) |
| "The outcomes of interest were severe preeclampsia and mild preeclampsia." | 2.48 | Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. ( Bujold, E; Forest, JC; Giguère, Y; Nicolaides, K; Roberge, S; Tapp, S; Vaiman, D; Vainio, M; Villa, P; von Dadelszen, P; von Dadelzen, P, 2012) |
| "The optimum treatment for patients with recurrent miscarriage and a confirmed thrombophilia remains a contentious issue." | 2.48 | Recurrent miscarriage and thrombophilia: an update. ( Dawood, F; Farquharson, R; McNamee, K, 2012) |
| "Women treated for preeclampsia also have an increased risk for cardiovascular and renal disease." | 2.48 | Preeclampsia 2012. ( Eiland, E; Faulkner, M; Nzerue, C, 2012) |
| "Over-the-counter antipyretics (acetaminophen, aspirin, ibuprofen) and/or analgesics (acetaminophen, aspirin, diclofenac, ibuprofen, naproxen) are relatively safe for adults." | 2.48 | [Developmental toxicity of the over-the-counter analgetics and antypiretics]. ( Burdan, F; Cendrowska-Pinkosz, M; Dworzańska, A; Dworzański, W; Kubiatowski, T; Starosławska, E; Szumiło, J; Urbańczyk-Zawadzka, M, 2012) |
| "Careful counseling of women with diabetic nephropathy before pregnancy with estimation of the risk for the mother and fetus is important." | 2.48 | Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. ( Clausen, P; Damm, P; Feldt-Rasmussen, B; Mathiesen, ER; Ringholm, L, 2012) |
| "Adequate pregnancy care of women with systemic lupus erythematosus (SLE) rests on three pillars: a coordinated medical-obstetrical care, an agreed and well-defined management protocol and a good neonatal unit." | 2.47 | Lupus and pregnancy: integrating clues from the bench and bedside. ( Khamashta, MA; Ruiz-Irastorza, G, 2011) |
| "Treatment with aspirin and heparin decreases the risk of miscarriages in APS." | 2.47 | Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). ( Burmester, GR; Dörner, T; Hoppe, B, 2011) |
| "Pregnancy has a potentially deleterious affect on moyamoya disease (MMD), a cerebrovascular condition characterized by spontaneous occlusion of the distal internal carotid arteries resulting in the neoangiogenesis of fragile collateral blood vessels." | 2.47 | Moyamoya disease in pregnancy: a case series and review of management options. ( Burlingame, JM; Ma, JC, 2011) |
| "Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings." | 2.47 | Obstetric antiphospholipid syndrome: an update on pathophysiology and management. ( Ernest, JM; Kutteh, WH; Marshburn, PB, 2011) |
| "Aspirin has shown efficacy in preventing PE with a 10 % incidence reduction." | 2.46 | [Prevention of preeclampsia]. ( Coutty, N; Deruelle, P; Girard, JM; Subtil, D, 2010) |
| "The primary outcome was preeclampsia." | 2.45 | Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. ( Bujold, E; Forest, JC; Giguère, Y; Lacasse, Y; Morency, AM; Roberge, S, 2009) |
| "Treatment with aspirin inhibited miR-20b-5p levels, thus restoring primary cilia formation and trophoblast invasion." | 2.44 | Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage. ( Chao, YY; Lin, RC; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2024) |
| "Women with a history of previous preeclampsia are at increased risk of preeclampsia and other adverse pregnancy outcomes in subsequent pregnancies." | 2.44 | Prediction and prevention of recurrent preeclampsia. ( Barton, JR; Sibai, BM, 2008) |
| "Antiphospholipid syndrome is one of the few treatable causes of pregnancy loss, and successful pregnancy rates of 70% or more can be achieved with appropriate treatment." | 2.44 | [Pregnancy and antiphospholipid antibodies]. ( Goffinet, F; Le Guern, V, 2008) |
| " Due to lack of complete randomized investigation about the inclusion of antithrombotic prophylaxis in this group of pregnant women, common scheme of administration and optimal dosage is yet to be established." | 2.44 | [Inherited thrombophilia in women with recurrent miscarriages and pregnancy loss in anamnesis--own experience]. ( Drews, K; Kaluba-Skotarczak, A; Puacz, P; Seremak-Mrozikiewicz, A, 2008) |
| "The antiphospholipid syndrome is an antibody mediated hypercoagulable state characterized by recurrent venous and arterial thromboembolic events." | 2.44 | [The antiphospholipid syndrome, an update]. ( Alonso Santor, JE; Inglada Galiana, L; Pérez Paredes, G, 2007) |
| "The pathophysiology of preeclampsia is still unknown." | 2.44 | [Prophylactic treatment of preeclampsia]. ( Abele, H; Bohlmann, MK; Schauf, B; Wallwiener, D, 2007) |
| "Preventive treatment of preeclampsia consists essentially of low dose aspirin." | 2.44 | [Latest developments: management and treatment of preeclampsia]. ( Tsasaris, V; Winer, N, 2008) |
| "Aspirin has potential risks." | 2.44 | Aspirin and reproductive outcomes. ( Brancazio, LR; James, AH; Price, T, 2008) |
| "Preeclampsia is a pregnancy-associated illness affecting multiple organ systems." | 2.44 | [Anesthetic management of parturients with pre-eclampsia and eclampsia]. ( Bremerich, DH; Fetsch, NI, 2008) |
| "Preeclampsia is accompanied by high fetal and maternal morbidity and mortality and to a high degree responsible for preterm delivery." | 2.43 | [Prevention of preeclampsia]. ( Diedrich, F; Fischer, T; Jacobs, VR; Neumaier-Wagner, P; Paepke, S; Pildner von Steinburg, S; Schneider, KT, 2005) |
| "The antiphospholipid syndrome is currently best treated with anticoagulation." | 2.43 | Anticoagulation therapy in the antiphospholipid syndrome: recent advances. ( Crowther, MA; Ng, HJ, 2005) |
| "The incidence of preeclampsia was 3." | 2.43 | Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials. ( Fontes, RS; Ruano, R; Zugaib, M, 2005) |
| "Women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are subject to several complications during pregnancy, including reactivation of SLE, thrombosis, miscarriage, neonatal lupus, pregnancy-induced hypertension, pulmonary hypertension and drug toxicity." | 2.43 | [Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy]. ( Khamashta, MA; Ruiz-Irastorza, G, 2006) |
| "The choice of therapy for fetal growth restriction (FGR) depends on the nature of the insult that led to the development of FGR." | 2.43 | Prenatal therapy for fetal growth restriction. ( Figueroa, R; Maulik, D, 2006) |
| "Because of the rarity of primary thrombocythemia thus far only two prospectively randomized studies have been carried out to compare cyto- and thromboreductive therapies." | 2.43 | [Primary thrombocythemia: diagnosis and therapy]. ( Petrides, PE, 2006) |
| "Hypertension that complicates preeclampsia in pregnancy is a disorder that requires special consideration in both prevention and pharmacologic treatment." | 2.43 | Pathophysiology and medical management of systemic hypertension in preeclampsia. ( Frishman, WH; Schlocker, SJ; Tejani, N; Veresh, M, 2006) |
| "Recently, the thrombophilias have been revealed as risk factors for severe preeclampsia, abruptio placentae, fetal growth retardation, abortion and still birth as well." | 2.42 | [Anticoagulation and antiaggregation during pregnancy]. ( Biasiutti, FD; Strebel, JK, 2003) |
| "The 'antiphospholipid antibody syndrome' has been described in women with a history of recurrent pregnancy loss or thrombosis with positive APA or lupus anticoagulant on two occasions." | 2.42 | Low molecular weight heparin in immunological recurrent abortion--the incredible cure. ( Allahbadia, GN; Allahbadia, SG, 2003) |
| "Aspirin, which was regarded as the drug of choice for the prevention of such obstetric complications, has proved to be ineffective in a large clinical trial." | 2.42 | Inherited thrombophilia and gestational vascular complications. ( Eldor, A; Kupferminc, MJ, 2003) |
| "Aspirin was also associated with a reduction in rates of spontaneous preterm birth (OR 0." | 2.42 | Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. ( Coomarasamy, A; Gee, H; Honest, H; Khan, KS; Papaioannou, S, 2003) |
| "The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients." | 2.42 | Antiphospholipid syndrome in obstetrics. ( Heilmann, L; Pollow, K; von Tempelhoff, GF, 2003) |
| "Preeclampsia is a multisystem disorder that complicates 6% to 8% of pregnancies, with higher rates in women with preexisting hypertension, diabetes mellitus, or previous history of preeclampsia." | 2.42 | What we have learned about preeclampsia. ( Caritis, S; Hauth, J; Sibai, BM, 2003) |
| "Many authors relate this factor with preeclampsia, intrauterine fetal growth retardation, spontaneous abortion, unexplained cases of still birth, placental abruption, and thromboembolic complications during and after parturition." | 2.42 | [Factor V Leiden mutation and pregnancy complications]. ( Abraitis, V; Mockeviciene, A; Mongirdiene, A, 2003) |
| "Essential thrombocythemia is a distinct clinical entity within the spectrum of myeloproliferative disorders." | 2.42 | Essential thrombocythemia. ( Green, AR; Harrison, CN, 2003) |
| "Preeclampsia is characterized by an imbalance between two cyclooxygenase metabolites of arachidonic acid, thromboxane and prostacyclin, that favors thromboxane." | 2.42 | Eicosanoids in preeclampsia. ( Walsh, SW, 2004) |
| " Unfractionated heparin (UFH) and low molecular weight heparin (LMWH) do not cross the placenta and are safe for the fetus, but long-term treatment with UFH is problematic because of its inconvenient administration, the need to monitor anticoagulant activity and because of its potential side effects, such as heparin-induced thrombocytopenia and osteoporosis." | 2.42 | The safety of antithrombotic therapy during pregnancy. ( Ageno, W; Crotti, S; Turpie, AG, 2004) |
| "Migraine is a typical "women's disease": the fluctuations of sex hormones, in particular estrogens, during woman's reproductive life show a direct and major influence on migraine course." | 2.42 | [Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies]. ( Airola, G; Allais, G; Benedetto, C; Bosio, A; Ciochetto, D; De Lorenzo, C; Mana, O; Quirico, PE; Terzi, MG, 2003) |
| "Preeclampsia is characterized by hypertension and proteinuria." | 2.42 | Pathophysiology of preeclampsia: links with implantation disorders. ( Beaufils, M; Carbillon, L; Challier, JC; Merviel, P; Rabreau, M; Uzan, S, 2004) |
| "Since 1987 the antiphospholipid syndrome has been recognized as a major cause of acquired thrombophilia, whether it is associated with systemic lupus erythematosus or occurs as a free-standing syndrome (primary form)." | 2.41 | [Antiphospholipid syndrome]. ( Arvieux, J; Hachulla, E, 2002) |
| " Discrepancies seem largely related to either studying very low-risk populations, or strong differences in aspirin dosage and/or term of introduction." | 2.41 | [Aspirin and prevention of pre-eclampsia]. ( Beaufils, M, 2000) |
| "Antiphospholipid syndrome is a multisystem disease with the predominant features of venous and arterial thrombosis, recurrent pregnancy loss, foetal death and the presence of antiphospholipid antibodies." | 2.41 | Antiphospholipid syndrome and recurrent miscarriages. ( Cosson, M; Dufour, P; Houpeau, JL; Vinatier, D, 2001) |
| "Cutaneous lupus erythematosus has a variety of clinical presentations, but treatment is similar for the different forms." | 2.41 | Current treatment of cutaneous lupus erythematosus. ( Werth, V, 2001) |
| "If diagnosed and treated early in pregnancy with low-dose aspirin and subcutaneous heparin the outlook for a successful pregnancy is much improved." | 2.41 | A literature review on the antiphospholipid syndrome and the effect on childbearing. ( Vials, JM, 2001) |
| "Arterial and venous thrombosis are the most common and clinically relevant events of the so-called antiphospholipid syndrome; they are reported in approximately one third of patients with the antiphospholipid (aPL) antibodies." | 2.41 | The epidemiology of the antiphospholipid syndrome: who is at risk? ( Finazzi, G, 2001) |
| "The baseline risk of preeclampsia in women with abnormal uterine artery Doppler was 16%, and the number of women needed to be treated with aspirin to prevent one case of preeclampsia was 16 (95% CI 8, 316)." | 2.41 | Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. ( Coomarasamy, A; Gee, H; Khan, KS; Papaioannou, S, 2001) |
| "Essential thrombocythemia is a myeloproliferative disorder characterized by a persistent increase in the platelet count." | 2.40 | Essential thrombocythemia during pregnancy. ( Eliyahu, S; Shalev, E, 1997) |
| "Normal pregnancy is characterized by a marked reduction in peripheral vascular resistance." | 2.40 | Hypertension in pregnancy. ( Bernheim, J, 1997) |
| "Until the pathogenesis of preeclampsia is well defined, prevention of this syndrome with any modality remains unlikely." | 2.40 | Prevention of preeclampsia: a big disappointment. ( Sibai, BM, 1998) |
| "The occurrence of migraine in women is influenced by hormonal changes throughout the lifecycle." | 2.40 | Migraine in pregnancy: what are the safest treatment options? ( Pfaffenrath, V; Rehm, M, 1998) |
| "Essential thrombocythemia is a chronic myeloproliferative disease characterized by persistent thrombocytosis and an increased risk of thromboembolic complications." | 2.40 | [A management program for primary thrombocytopenia]. ( Bruserud, O; Knutsen, H, 1999) |
| "Placental infarction due to thrombosis seems to be the most consistent event." | 2.40 | Fertility, pregnancy and the management of myeloproliferative disorders. ( Bergmann, L; Griesshammer, M; Pearson, T, 1998) |
| "Myocardial infarction is rare in pregnancy." | 2.39 | Myocardial infarction in a parturient. A case report with emphasis on medication and management. ( Haring, P; Hietakorpi, S; Koski, E; Nuutinen, LS; Purhonen, S; Söderlin, MK, 1994) |
| "Autoimmune diseases are relatively common in women, and tend to occur in the childbearing years." | 2.39 | Autoimmune disease and pregnancy. ( Jones, WR, 1994) |
| " We present simple methods for combining dose information from the study of interest with dose-response data from other epidemiologic studies or animal studies to derive plausible hypothesized effect levels." | 2.39 | Resolving discrepancies among studies: the influence of dose on effect size. ( Hertz-Picciotto, I; Neutra, RR, 1994) |
| "The use of drugs for common pregnancy complications like premature labor, hypertensive diseases, and premature rupture of membranes with chorioamnionitis is reviewed." | 2.39 | Drug treatment in pregnancy. ( Schneider, H, 1994) |
| "Insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE) are two common autoimmune disorders that affect women of childbearing age." | 2.39 | Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. ( Ferris, AM; Reece, EA, 1994) |
| "Early-onset preeclampsia appears to be associated with certain disorders that are likely to provoke an arterial thrombotic process by impairing the normal endothelial cell-platelet interactions." | 2.39 | Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives. ( Dekker, GA; van Geijn, HP, 1996) |
| "Aspirin (ASS) was the most frequently used drug in 47 of 93 recorded cases (51%)." | 2.39 | Essential thrombocythemia and pregnancy. ( Griesshammer, M; Heimpel, H; Pearson, TC, 1996) |
| "Preeclampsia is characterized by a functional imbalance between vascular prostacyclin and thromboxane A2 production." | 2.38 | [Acetylsalicylic acid in pregnancy]. ( Egarter, C; Husslein, P; Karas, H, 1993) |
| "On the basis of the hypothesis that preeclampsia is at least partially caused by an increase in thromboxane A2, some studies attempted to correct this pathologic condition by pharmacologic manipulation with low-dose aspirin." | 2.38 | Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. ( Dekker, GA; Sibai, BM, 1993) |
| "Normal mammalian pregnancy is confronted with a great number of self (autoimmune) and foreign (alloimmune) antigens that modulate the immune system of the mother." | 2.38 | Current status of immunologic recurrent pregnancy loss. ( Coulam, CB; Stern, JJ, 1993) |
| "The principle underlying preventive treatment of fetal intrauterine growth retardation can only be considered after defining various groups that are at risk and early screening based on the obstetric history, biological tests, and recently using flow rates with Doppler techniques." | 2.38 | [Fetal growth retardation: prevention. Review of the literature]. ( Boulot, P; Giacalone, PL; Hedon, B; Laffargue, F; Viala, JL, 1992) |
| "The characteristics and treatment of preeclampsia and eclampsia are reviewed." | 2.38 | Treatment of preeclampsia and eclampsia. ( McCombs, J, 1992) |
| "Preeclampsia is a syndrome of unknown etiology characterized by the sequential development of facial and hand edema, hypertension, and proteinuria after the 20th week of gestation." | 2.38 | New concepts in the understanding of hypertensive diseases during pregnancy. An overview. ( Zuspan, FP, 1991) |
| "Preeclampsia is a disease unique to pregnancy." | 2.38 | Prevention of preeclampsia. ( Repke, JT, 1991) |
| " Clinicians who decide to manage complicated or potentially complicated patients with chronic administration of aspirin must continue to study these mothers, fetuses, and neonates intensively and to document their results." | 2.38 | Low-dose aspirin to improve perinatal outcome. ( Barton, JR; Sibai, BM, 1991) |
| " Long-term use of heparin in pregnancy may cause significant osteoporosis, which appears to be reversible." | 2.38 | Drug therapy during pregnancy. ( Niebyl, JR, 1991) |
| "One pregnancy was complicated by superficial thrombophlebitis and a postpartum haemorrhage." | 2.38 | Primary thrombocythaemia in pregnancy. ( Anderson, CC; Beard, J; Hillmen, P; Lewis, SM; Pearson, TC, 1991) |
| " The dosage of ASA in the majority of works has been about 1,000 mg daily while isolated investigations have shown good effect from doses as low as 60 mg daily." | 2.38 | [Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation]. ( Faergeman, O; Fasting, H; Husted, SE; Krusell, LR; Nielsen, HK, 1989) |
| "These defects have been labeled fetal alcohol syndrome or, in a milder form, fetal alcohol effects." | 2.37 | Alcohol, pregnancy, and prostaglandins. ( Anton, RF; Becker, HC; Randall, CL, 1987) |
| "Normal human pregnancy is characterized by vascular refractoriness to AII." | 2.36 | Control of vascular responsiveness during human pregnancy. ( Everett, RB; Gant, NF; MacDonald, PC; Worley, RJ, 1980) |
| " The teratogenic potential of a drug is related to dosage and time of administration." | 2.36 | Analgesics during pregnancy. ( Niederhoff, H; Zahradnik, HP, 1983) |
| "Common complications of systemic lupus erythematosus include nephritis, hematologic complications such as thrombocytopenia, and a variety of neurologic abnormalities." | 1.91 | Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. ( Craigo, S; Kuller, JA; Norton, ME; Osmundson, SS; Porter, F; Silver, R, 2023) |
| "To explore the ATF2 expression of preeclampsia patients and investigate whether the level of ATF2 expression impacted the low-dose aspirin treatment of preeclampsia patients." | 1.91 | Low-dose Aspirin may Prevent Preeclampsia by Inhibiting the Expression of ATF2. ( Guo, L; Hu, R; Liu, R; Xiao, S; Zhang, M, 2023) |
| "Risk for preterm preeclampsia (<37 weeks) was calculated using the Fetal Medicine Foundation algorithm, and individuals with a risk score ≥1 per 100 were recommended to use aspirin (162 mg once daily at bedtime, <16-36 weeks)." | 1.91 | The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study. ( Chada, R; Dwinnell, SJ; Johnson, DW; Johnson, JM; Kuret, VH; Mahallati, H; Maxey, CM; Metcalfe, A; Nerenberg, KA; O'Quinn, CP; Okun, NB; Pastuck, ML; Paterson, K; Paul, H; Schacher, J; Silang, KA; Soliman, N; Somerset, DA; Suchet, IB; Walsh, JD, 2023) |
| "Premature birth is associated with an increased risk of mortality and morbidity, and strategies to prevent preterm birth are few in number and resource intensive." | 1.91 | Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research. ( Achieng, E; Bose, CL; Bresnahan, BW; Bucher, S; Carlo, WA; Chicuy, J; Chomba, E; Das, P; Derman, RJ; Esamai, F; Figueroa, L; Goco, N; Goldenberg, RL; Goudar, SS; Hibberd, PL; Hoffman, M; Jessani, S; Kavi, A; Koso-Thomas, M; Krebs, NF; Kurhe, K; Liechty, EA; Lokangaka, A; McClure, EM; Metgud, M; Moore, J; Mwapule, A; Mwenechanya, M; Neuwahl, S; Nyongesa, P; Okitawutshu, J; Patel, A; Patterson, JK; Saleem, S; Somannavar, M; Tshefu, A, 2023) |
| " In age-adjusted analyses, aspirin plus LMWH regardless of dosage was associated with significantly higher odds of live birth compared with no antithrombotic use (OR = 7." | 1.91 | Management and outcomes of women with antiphospholipid syndrome during pregnancy. ( Adurty, S; D'Angelo, D; DeSancho, MT; Tao, JJ, 2023) |
| "Treatment with aspirin during pregnancy was also recorded." | 1.91 | Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain. ( Adiego, B; Carrillo, MP; Cuenca-Gómez, D; de Paco Matallana, C; Delgado, JL; Gil, MM; Mendoza, M; Molina, FS; Revello, R; Rolle, V; Santacruz, B; Valiño, N; Wright, A, 2023) |
| " The Royal College of Obstetricians and Gynaecologists recommends 150 mg of aspirin daily, and the National Institute of Health and Care Excellence guidelines suggest risk stratification with a dosage of 75 mg for those at moderate risk of preeclampsia and 150 mg for those at high risk of preeclampsia." | 1.91 | Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? ( Abuhamad, A; Hage Diab, Y; Horgan, R; Saade, G; Waller, J, 2023) |
| "Preeclampsia is a multisystemic disorder of pregnancy that affects 250,000 pregnant individuals in the United States and approximately 10 million worldwide per annum." | 1.91 | Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. ( Barton, JR; Beck, S; Bernstein, IM; Buck, TE; Facco, FL; Forgues-Lackie, MA; Gernand, AD; Graves, CR; Hauspurg, A; Jeyabalan, A; King, TL; Manuck, TA; Myatt, L; Myers, JE; Powell, TM; Roberts, JM; Sutton, EF; Tinker, E; Tsigas, E, 2023) |
| " This suggests that use of LDA outside the recommended guidelines should be cautioned and further investigation is needed to determine its ideal dosing and timing of discontinuation." | 1.91 | Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. ( Culhane, JF; Lundsberg, LS; Merriam, AA; Partridge, C; Reddy, UM; Son, M; White, KJ, 2023) |
| "Positive b-hCG, miscarriage, and live birth rates were similar between groups as Group A vs." | 1.91 | Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study. ( Aslan, K; Avci, B; Cakir, C; Cinar, C; Kasapoglu, I; Uncu, G, 2023) |
| "Fifteen (1." | 1.91 | Implementing Preeclampsia Screening in Switzerland (IPSISS): First Results from a Multicentre Registry. ( Amylidi-Mohr, S; Ardabili, S; Challande, P; Hodel, M; Hösli, I; Kohl, J; Manegold-Brauer, G; Mosimann, B; Raio, L; Schönberger, H; Surbek, D; Trottmann, F, 2023) |
| "The risk of preterm preeclampsia (PT PE) can significantly be reduced by starting acetylsalicylic acid ≤ 16 weeks of gestational age." | 1.91 | Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands. ( Beernink, RHJ; Cremers, TIFH; Scherjon, SA; van Asselt, ADI, 2023) |
| "Documentation of preeclampsia risk factors: multifetal gestation, pregestational diabetes, chronic hypertension (high-risk factors) and nulliparity, a body mass index greater than 30, African American race, a maternal age 35 years or older, an interval of more than 10-years since last birth, and having low socioeconomic status (moderate risk factors)." | 1.72 | Estimated Prevalence of Risk Factors for Preeclampsia Among Individuals Giving Birth in the US in 2019. ( Myers, ER; Myers, SO; Swamy, GK; Wheeler, SM, 2022) |
| "Low-dose aspirin for preeclampsia is routinely used." | 1.72 | Antepartum Care of the Uterus Transplant Patient: The Experience of 3 Successful US Centers. ( Gregg, AR; Perni, UC; Wang, EY, 2022) |
| "Analyze secular trends of preeclampsia in Norway based on risk factors." | 1.72 | Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway. ( Laine, K; Räisänen, S; Sole, KB; Staff, AC, 2022) |
| "Evidence on the risk of preterm preeclampsia was taken from the Screening programme for pre-eclampsia study, which was a first-trimester screening study for the prediction of preeclampsia." | 1.72 | When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. ( Nicolaides, KH; Tan, MY; Wright, A; Wright, D, 2022) |
| "Recurrent preeclampsia occurred in 467 (45." | 1.72 | Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia. ( Bijl, RC; Brewer, AN; Cornette, JMJ; Franx, A; Koster, MPH; Tsigas, EZ; Zwart, IF, 2022) |
| "Preeclampsia is a hypertensive disease unique to pregnancy and has a significant impact on maternal and neonatal morbidity and mortality." | 1.72 | Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence. ( Olson, DN; Ranzini, AC; Russell, T, 2022) |
| "To evaluate the effectiveness of a preeclampsia (PE) screening program using the National Institute for Health and Care Excellence (NICE) guideline in pregnant Thai women." | 1.72 | Low-dose aspirin for prevention of preeclampsia: Implementation of the NICE guideline in Thailand. ( Charernjiratragul, K; Geater, A; Khwankaew, N; Suksai, M; Suntharasaj, T; Suwanrath, C, 2022) |
| "Reportedly, aspirin prevents preeclampsia, specifically early-onset preeclampsia, although findings in decidual arteries in women treated with aspirin therapy remain unclear." | 1.72 | Low-dose aspirin therapy improves decidual arteriopathy in pregnant women with a history of preeclampsia. ( Gi, T; Katsuragi, S; Kodama, Y; Maekawa, K; Sameshima, H; Sato, Y; Tomimori-Gi, K; Yamada, N; Yamashita, A, 2022) |
| "Prochlorperazine injection has been upgraded to a highly recommended level because of the rich clinical experience for this treatment." | 1.72 | 2022 Taiwan Guidelines for Acute Treatment of Migraine. ( Lau, CI; Wang, YF, 2022) |
| "Aspirin use was recommended for cases who were at high risk of preterm PE." | 1.72 | Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers. ( Ansbacher-Feldman, Z; Cirkin, R; Louzoun, Y; Meiri, H; Nicolaides, KH; Syngelaki, A, 2022) |
| "· High-risk patients who lack a history preeclampsia were less likely to be advised of aspirin use." | 1.62 | Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study. ( Berghella, V; Boelig, RC; Roman, A; Wanees, M; Zhan, T, 2021) |
| "Our laboratory demonstrated that preeclampsia is associated with high soluble fms-like tyrosine kinase 1 (sFlt-1) and low heme oxygenase-1 (HO1/Hmox1) expression." | 1.62 | MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment. ( Agrawal, S; Ahmad, S; Ahmed, A; Alzahrani, FA; Dias, IH; Rezai, H; Sanchez-Aranguren, L; Sparatore, A; Wang, K, 2021) |
| "Nine pregnancies ended in miscarriages (9/34; 26." | 1.62 | Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety. ( Becker, T; Griesshammer, M; Heidel, FH; Hochhaus, A; Kolatzki, V; Sadjadian, P; Schrickel, L; Wille, K, 2021) |
| "Human pregnancy is associated with a mild proinflammatory state characterized by circulatory neutrophil activation which is further increased in complicated pregnancies, placenta-mediated complications being associated with an increased thrombotic risk." | 1.62 | NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes. ( Bouvier, S; Demattei, C; Fortier, M; Gris, JC; Herzog, M; Letouzey, V; Mercier, E; Mousty, E; Nouvellon, E; Rommelaere, G; Vincent, L, 2021) |
| "Antiphospholipid syndrome is associated with recurrent pregnancy loss." | 1.62 | "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. ( Bates, SM; Gonsalves, C; Karovitch, A; Rodger, MA; Skeith, L; Taylor, TS, 2021) |
| "Preeclampsia is a severe gestational hypertensive disorder that occurs after 20 weeks' of gestation." | 1.62 | Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia. ( Kuo, PL; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2021) |
| "Aspirin-prophylaxis was administered either in 100 mg (n = 229) or 150 mg (n = 90) daily." | 1.62 | Low Dose Aspirin in high-risk pregnancies: The volatile effect of acetylsalicylic acid on the inhibition of platelets uncovered by G. Born's light transmission aggregometry. ( Cervar-Zivkovic, M; Eberhard, K; Kutllovci-Hasani, K; Mayer-Pickel, K; Nanda, M; Prüller, F; Stern, C; Weiss, EC, 2021) |
| "The new pyramid of pregnancy care integrates an early clinic allowing the assessment of biophysical and biochemical markers combined with maternal factors." | 1.62 | Practical approach to the prevention of preeclampsia: from screening to pharmaceutical intervention. ( Ahmed, B; Ayoubi, JM; Rafii Tabrizi, A, 2021) |
| "Among those developing intracranial hemorrhage, limited data are available to guide clinicians with antithrombotic reinitiation." | 1.56 | Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients. ( Bungard, TJ; Butcher, K; Hodgson, M; Schultz, K; Wan, A, 2020) |
| "Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis." | 1.56 | Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary. ( Afshar, Y; Bromley, B; Caughey, AB; Chescheir, N; Copel, JA; Grechukhina, O; Grobman, W; Han, CS; Hobbins, JC; Mallampati, D; Nicolaides, K; Pettker, C; Platt, LD; Saade, G; Sibai, B; Simhan, H; Sonek, J; Werner, E, 2020) |
| "The use of aspirin for preventing preeclampsia has been practiced recently by fetomaternal specialists in Indonesia." | 1.56 | Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia. ( Karunia, RI; Prasetyadi, FOH; Purnamayanti, A, 2020) |
| "In women who developed severe preeclampsia and delivered preterm, there were significant elevations in non-aspirin-sensitive lipids with biologic actions that could cause preeclampsia." | 1.56 | Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin. ( Al Dulaimi, M; Alam, SMK; Chalfant, CE; Lee, SM; Reep, DT; Springel, EH; Stephenson, DJ; Strauss, JF; Walsh, SW; Washington, SL, 2020) |
| "Early-onset preeclampsia was found in 3 pregnant women (0." | 1.56 | Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year. ( Caeiro, F; Francisco, C; Gomes, H; Lourenço, I; Ribeiro, J; Rocha, P, 2020) |
| "The use of prophylactic treatments against thrombophilia becomes necessary in order to increase the live birth rates in women with RPL." | 1.56 | Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages? ( Aslan, I; Ozyigit, S; Paul, LT; Tosun, O; Tulay, P, 2020) |
| "The benefit of aspirin in preventing preeclampsia is increasingly recognized; however, its mechanism of action remains unclear." | 1.56 | The 15-Epilipoxin-A4 Pathway with Prophylactic Aspirin in Preventing Preeclampsia: A Longitudinal Cohort Study. ( Fulcher, I; Hennessy, A; Kumar, R; Lee, G; Makris, A; Motum, P; Shanmugalingam, R; Wang, X, 2020) |
| "In pregnancies with preterm preeclampsia, the mean multiples of the median values of mean arterial pressure and uterine artery pulsatility index were significantly higher (mean arterial pressure, 1." | 1.51 | Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. ( Chaemsaithong, P; Chaiyasit, N; Choolani, M; Hu, Y; Leung, TY; Leung, WC; Ma, R; Naruse, K; Pooh, RK; Poon, LC; Sahota, D; Saito, S; Sekizawa, A; Seshadri, S; Shaw, SW; Tokunaka, M; Wataganara, T; Wright, A; Yeo, GSH; Zheng, M, 2019) |
| "The aspirin group was associated with earlier delivery at 38." | 1.51 | Effect of early use of low-dose aspirin therapy on late-onset preeclampsia. ( Gillin, AG; Hyett, J; Lan, PG; Pelosi, M; Sandager, P; Tooher, J, 2019) |
| "In this series, recurrent miscarriage is the most frequent poor outcome." | 1.51 | The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. ( Alijotas-Reig, J; Arnau, A; Belizna, C; Canti, V; Cervera, R; Chighizola, CB; De Carolis, S; Espinosa, G; Esteve-Valverde, E; Farran-Codina, I; Ferrer-Oliveras, R; Gerosa, M; Gogou, V; Hoxha, A; Latino, O; Lefkou, E; LLurba, E; Lundelin, K; Marozio, L; Martí-Cañamares, A; Mayer-Pickel, K; Mekinian, A; Pengo, V; Reshetnyak, T; Ríos-Garcés, R; Rovere-Querini, P; Ruffatti, A; Ruiz-Hidalgo, D; Sáez-Comet, L; Sos, L; Stojanovich, L; Stoppani, C; Tabacco, S; Tincani, A; Trapé, J; Varoudis, A, 2019) |
| "2." | 1.51 | Management of idiopathic recurrent pericarditis during pregnancy. ( Adler, Y; Brucato, A; Imazio, M; Lucianetti, M; Maestroni, S; Pluymaekers, N; Rampello, S; Tombetti, E; Valenti, A, 2019) |
| "Aspirin plays an important role in the prevention and therapy of pre-eclampsia." | 1.51 | Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME. ( Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019) |
| "Our novel findings suggest that the preeclampsia prevention effect of aspirin may be exerted through these two mechanisms." | 1.51 | Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia. ( Chen, TY; Kuo, PL; Su, MT; Tsai, HL; Tsai, PY; Wang, CY, 2019) |
| "Preeclampsia is a hypertensive disorder specific to pregnancy that remains a significant cause of maternal and neonatal morbidity and mortality." | 1.48 | Low-Dose Aspirin for the Prevention of Preeclampsia. ( Fantasia, HC, 2018) |
| "Preeclampsia is a severe pregnancy-related disorder, and patients usually present with high circulating inflammatory factor levels and excessive activation of the nuclear factor-κB (NF-κB) pathway." | 1.48 | The intervention effect of aspirin on a lipopolysaccharide-induced preeclampsia-like mouse model by inhibiting the nuclear factor-κB pathway. ( Li, G; Lin, L; Ma, L; Wang, YL; Yang, H, 2018) |
| "control)." | 1.48 | Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. ( Akinshina, S; Bitsadze, V; Khamani, N; Khizroeva, J; Makatsariya, A, 2018) |
| "Aspirin treatment significantly decreased the levels of pro-inflammatory cytokines in serum and placenta tissues of preeclampsia rats." | 1.48 | Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway. ( Liu, F; Lu, X; Sun, J; Tang, D; Zhang, H, 2018) |
| "Aspirin treatment improves multiple functions of PE-DMSCs." | 1.48 | Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines. ( Brennecke, SP; Georgiou, HM; Kalionis, B; Khanabdali, R; Murthi, P; Shakouri-Motlagh, A; Wilkinson, S, 2018) |
| "Recurrent spontaneous abortion is one of the common complications in women of childbearing age during pregnancy." | 1.48 | [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. ( Li, XY; Liu, XY; Zhao, JX, 2018) |
| "Presumed rates of preeclampsia were 3." | 1.48 | Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women. ( Breathnach, F; Cotter, A; Daly, S; Dicker, P; Higgins, J; Hunter, A; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Morrison, JJ; Mulcahy, C; Normand, C; O'Mahony, JF; Tully, E; Tyrrell, E, 2018) |
| "Aspirin has antipyretic and anti-inflammatory properties and is frequently used by pregnant and lactating women." | 1.46 | Transfer of Low Dose Aspirin Into Human Milk. ( Baker, T; Datta, P; Hale, TW; Kallem, RR; Rewers-Felkins, K, 2017) |
| "The cohort of women with a history of preeclampsia were divided into 2 groups, before and after the release of the US Preventive Services Task Force 2014 recommendations." | 1.46 | Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia. ( Aagaard, KM; Chu, DM; Hollier, LM; Mastrobattista, JM; Racusin, DA; Ramin, SM; Sangi-Haghpeykar, H; Tolcher, MC, 2017) |
| "The Aspirin for Evidence-Based Preeclampsia Prevention trial was a multicenter study in women with singleton pregnancies." | 1.46 | Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. ( Carbone, IF; de Alvarado, M; Delgado, JL; Dutemeyer, V; Kapeti, E; Nicolaides, KH; Papantoniou, N; Pazos, A; Plasencia, W; Poon, LC; Rehal, A; Rolnik, DL; Syngelaki, A; Vojtassakova, D; Wright, D, 2017) |
| "Preeclampsia is a multisystem disorder that affects 3% to 5% of pregnant women and remains a significant source of short-term and long-term maternal and neonatal mortality and morbidity." | 1.46 | Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women? ( Costantine, MM; Marrs, CC, 2017) |
| "The rate of preeclampsia was much higher at quintile (Q) 5 of VAT depth (9." | 1.46 | Preeclampsia and Preterm Birth Associated With Visceral Adiposity in Early Pregnancy. ( Berger, H; Bujold, E; Connelly, PW; De Souza, LR; Park, AL; Ray, JG, 2017) |
| "Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies." | 1.46 | Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study. ( Berghella, V; Bernabini, D; Dall'Asta, A; Eke, AC; Facchinetti, F; Ghi, T; Hoxha, A; Martinelli, P; Maruotti, GM; Monari, F; Rizzo, G; Rizzo, N; Roman, A; Ruffatti, A; Saccone, G; Sarno, L; Schuit, E; Simonazzi, G; Visentin, S; Xodo, S, 2017) |
| "Obstetrical APS with isolated recurrent miscarriages is mostly associated with isolated anticardiolipids antibodies and have better obstetrical outcome." | 1.46 | [Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?] ( Abisror, N; Bornes, M; Carbillon, L; Cohen, J; Fain, O; Josselin-Mahr, L; Kayem, G; Mekinian, A, 2017) |
| "In univariate analyses, treatment effect on pregnancy losses was similar in patients with APS and non-conventional APS, with odds ratio at 3." | 1.43 | Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies. ( Benbara, A; Bourrienne, MC; Carbillon, L; Chollet-Martin, S; Fain, O; Mekinian, A; Montestruc, F; Nicaise-Roland, P; Noémie, A; Tigaizin, A, 2016) |
| "An autoimmune disease was present in seven (29%) cases." | 1.42 | Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study. ( Botta, A; Bucourt, M; Carbillon, L; Chollet-Martin, S; Chudzinski, A; Cornelis, F; Costedoat-Chalumeau, N; De Carolis, S; Emmanuelli, V; Fain, O; Hachulla, E; Masseau, A; Mekinian, A; Montestruc, F; Nicaise, P; Revaux, A; Subtil, D; Theulin, A, 2015) |
| "Placentas from women with and without preeclampsia were collected." | 1.42 | Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. ( Li, C; Raikwar, NS; Santillan, DA; Santillan, MK; Thomas, CP, 2015) |
| "Of these women, 74 had a history of recurrent miscarriage (1." | 1.42 | Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center. ( Nakanishi, K; Suzuki, S; Terada, K, 2015) |
| "Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm that occurs most commonly in the decade six of life and it is very rare in the young persons." | 1.42 | Management of myelofibrosis during pregnancy: a case report. ( Marisavljević, D; Marković, O; Terzić, T; Tukić, L; Zivković, R, 2015) |
| "The estimated rate of preeclampsia would be 4." | 1.42 | A Cost-Benefit Analysis of Low-Dose Aspirin Prophylaxis for the Prevention of Preeclampsia in the United States. ( Hauspurg, AK; Rouse, DJ; Werner, EF, 2015) |
| "We noted a 2." | 1.42 | Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention. ( Allshouse, AA; Galan, HL; Heyborne, KD; Moore, GS; Winn, VD, 2015) |
| "The number of cases of aPL-related pregnancy complications that physicians have intervened was relatively small." | 1.42 | The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey. ( Amengual, O; Atsumi, T; Bohgaki, T; Horita, T; Kaneko, K; Murashima, A; Nakanishi, I; Nozawa, K; Oku, K; Oomura, K; Sugiura-Ogasawara, M; Yasuda, S, 2015) |
| " The present study was aimed to assess the safety aspect of DLBS1033 in a preclinical setting, which included observation on toxic signs after acute and repeated administrations, and the drug's effect on prenatal development and drug interaction." | 1.40 | Toxicity studies of a bioactive protein with antithrombotic-thrombolytic activity, DLBS1033. ( Adnyana, IK; Anggadireja, K; Sigit, JI; Sukandar, EY; Tjandrawinata, RR, 2014) |
| "The residual risk of preeclampsia in high-risk women on aspirin prophylaxis exceeds that of low-risk populations, and this study aimed to identify first-trimester maternal characteristics associated with aspirin prophylaxis failure." | 1.40 | First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation. ( Atlas, RO; Baschat, AA; Blitzer, MG; Block-Abraham, DM; Doyle, LE; Jenkins, CB; Kopelman, JN; Turan, OM, 2014) |
| "(2) Influence of treatment on the pregnancy outcomes and complications: 24 APS patients were given the treatment of aspirin or aspirin combined with low molecular weight heparin, and 30 patients received no treatment." | 1.40 | [Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study]. ( Deng, XL; Liu, XY; Zheng, XJ, 2014) |
| "The syndrome was recognized as a distinct disorder in 1983 by Holiday and further characterized in the 1980s and 1990s, with Mammen and Bick providing the key findings." | 1.40 | Sticky platelet syndrome: history and future perspectives. ( Holly, P; Kubisz, P; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Stasko, J, 2014) |
| "Previous thrombosis, diagnosis of systemic lupus erythematosus (SLE) and triple antiphospholipid (aPL) antibody positivity have recently been found to be independent factors associated to pregnancy failure during conventional therapy in women with antiphospholipid syndrome (APS)." | 1.40 | Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. ( Alijotas-Reig, J; Andreoli, L; Bertero, MT; Bremme, K; Brucato, A; Canti, V; Caramaschi, P; De Carolis, S; Del Ross, T; Di Poi, E; Galeazzi, M; Gerosa, M; Maina, A; Mekinian, A; Meroni, PL; Mosca, M; Ramoni, V; Ruffatti, A; Salvan, E; Tincani, A; Trespidi, L, 2014) |
| "Superimposed preeclampsia occurred in 49 (23." | 1.39 | Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. ( Cabrol, D; Goffinet, F; Haddad, B; Lecarpentier, E; Sibai, B; Tsatsaris, V, 2013) |
| "Acute myocardial infarction is rare in pregnancy; however, the emerging trend towards advanced maternal age and the rising prevalence of obesity and diabetes suggest that more cases of myocardial infarction are likely to be encountered in pregnancy." | 1.39 | Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy'). ( Dutton, P; Okunoye, GO, 2013) |
| "Women with inherited thrombophilia and recurrent miscarriage might benefit from preconceptional antiagreggation with low-dose acetylsalicylic acid (ASA), but concerns about severe adverse reactions may prevent physicians from performing this treatment in patients with ASA hypersensitivity." | 1.38 | Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage. ( Gaspar, A; Livramento, S; Morais-Almeida, M; Sampaio, G; Santos, N, 2012) |
| "Systemic lupus erythematosus is a chronic autoimmune disorder which affects women with child bearing potential." | 1.38 | [Successful completed pregnancies in patients with systemic lupus erythematosus]. ( Kiss, E; Szegedi, G; Tarr, T; Zeher, M, 2012) |
| "Eptifibatide was stopped for induction of labor." | 1.38 | Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. ( Bauer, ME; Bauer, ST; Mhyre, JM; Rabbani, AB, 2012) |
| "The risk for preeclampsia increased in patients who were positive for multiple antiphospholipid antibodies (aPL) (odds ratio (OR) 3." | 1.38 | Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study. ( Brinks, R; Fischer-Betz, R; Schneider, M; Specker, C, 2012) |
| "Preterm birth was more frequent in study group than general population (21." | 1.38 | Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility. ( Ahn, H; Beaman, K; Gilman-Sachs, A; Han, AR; Kwak-Kim, J; Park, JC; Vu, P, 2012) |
| "Thromboembolism is an infrequent, yet serious cause of both maternal and fetal morbidity and death during pregnancy and the puerperium." | 1.38 | Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia. ( Giannubilo, SR; Tranquilli, AL, 2012) |
| "Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm." | 1.37 | Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome. ( Brost, BC; DeStephano, CC; Meena, M; Watson, WJ, 2011) |
| "To describe the diagnosis and treatment of antiphospholipid syndrome as it relates to spontaneous abortion." | 1.37 | A practical approach to the prevention of miscarriage: part 5--antiphospholipid syndrome as a cause of spontaneous abortion. ( Check, JH, 2011) |
| "Treatment with aspirin and LMWH is associated with improved outcomes for women with previous late fetal loss or early delivery due to placental dysfunction (Group 2)." | 1.36 | Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. ( Bewley, S; Bramham, K; Calatayud, I; Germain, S; Hunt, BJ; Khamashta, M; Nelson-Piercy, C, 2010) |
| "Preterm birth is associated with elevated production of pro-inflammatory cytokines such as TNFalpha at the maternal-fetal interface." | 1.36 | Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. ( Esplin, MS; Faux, DS; Hamblin, SD; Peltier, MR; Silver, RM, 2010) |
| "Thus, in order to diagnose and treat pregnancy-triggered APS in patients with unexplained recurrent miscarriage, screening for APL should also be performed at several time points after conception." | 1.36 | Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages. ( Engel, JB; Häusler, S; Honig, A; Kranke, P; Segerer, SE; Würfel, W, 2010) |
| "The pregnancy was uneventful and the delivery at term." | 1.36 | Treatment of cobalamin C (cblC) deficiency during pregnancy. ( Brunel-Guitton, C; Costa, T; Lambert, M; Mitchell, GA, 2010) |
| "Syphilis is a treatable condition, screening in pregnancy is both cost effective and cost beneficial." | 1.35 | Stroke in pregnancy associated with syphilis. ( Baker, PN; Bowring, J; Mahto, M; Mandal, D, 2008) |
| "The occurrence of superimposed preeclampsia should be detected by appropriate clinical and laboratory evaluation." | 1.35 | [Arterial hypertension in pregnancy]. ( Leeman, M, 2008) |
| "Indomethacin is used to close the patent ductus arteriosus in premature infants and for tocolysis of preterm labor." | 1.35 | Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat. ( Imamura, S; Ito, K; Momma, K; Nakanishi, T; Sugiyama, K; Sun, F; Toyoshima, K, 2009) |
| "Furthermore, the occurrence of a miscarriage in ET might be a marker for a similar event during subsequent pregnancies." | 1.35 | Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. ( Gangat, N; Schwager, S; Tefferi, A; Wolanskyj, AP, 2009) |
| "Aspirin treatment enhanced LPS-stimulated TNFalpha production by PBML from controls but not cases." | 1.35 | Effect of aspirin treatment on TNFalpha production by women with a history of preterm birth. ( Cooper, C; Esplin, MS; Faux, DS; Hamblin, SD; Peltier, MR; Silver, RM, 2009) |
| "Between 20% and 40% of patients with systemic lupus erythematosus (SLE) have positive blood tests for antiphospholipid antibodies (aPLs)." | 1.35 | How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. ( Giles, I; Rahman, A, 2009) |
| "21/29, 72." | 1.35 | Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry. ( Candoni, A; Cascavilla, N; Cedrone, M; Ciancia, R; Comitini, G; Gugliotta, L; Latagliata, R; Martinelli, V; Martino, B; Melillo, L; Palmieri, F; Radaelli, F; Scalzulli, PR; Specchia, G; Tieghi, A; Usala, E; Valente, D; Valvano, MR, 2009) |
| "Aspirin was shown to increase oxygen affinity of hemoglobin via acetylating lysine residues and its general acetylating activity on proteins such as histones makes it also an interesting candidate to activate fetal hemoglobin." | 1.34 | Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale. ( Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K, 2007) |
| " Immunophenotyping analysis using flow cytometry (FCM) indicated that the proportion and number of CD45RA(+) cells increased, and the proportion of CD3(-) NKR-P1A(+) cells decreased in males when dosed with IND at 1." | 1.34 | Effect of prenatal administration of NSAIDs on the immune response in juvenile and adult rats. ( Fujiwara, M; Furusawa, S; Kushima, K; Oda, K; Sakuma, S, 2007) |
| " Unlike general toxicity data, their prenatal toxic effects were not extensively studied before." | 1.33 | Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study. ( Burdan, F, 2005) |
| "The fetal body weight was significantly lower in COX-exposed group of fetuses when compared with untreated control." | 1.33 | Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors. ( Burdan, F; Dudka, J; Klepacz, R; Korobowicz, A; Szumilo, J, 2006) |
| "Antiphospholipid syndrome is a recognized disorder of pregnancy." | 1.33 | Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up. ( Khurshid, M; Naru, T; Nazir, Z, 2006) |
| "Pregnancy is an initiating event for acute thrombotic thrombocytopaenic purpura (TTP)." | 1.33 | Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. ( Cohen, H; Lee, R; Machin, S; Mackie, I; Scully, M; Starke, R, 2006) |
| "Essential thrombocythemia is a rare disease of unknown origin characterized by abnormal increase in the platelet count." | 1.32 | Pregnancy in essential thrombocythemia during aspirin treatment. ( Cannata, ML; Corrado, F; Ruggeri, Z; Stella, NC, 2003) |
| " There are no published ASA studies using the multiple dosing paradigm of GDs 6 to 17." | 1.32 | Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms. ( Cook, JC; Gupta, U; Hurtt, ME; Tassinari, MS, 2003) |
| " The objectives of the current study were to comprehensively define the developmental toxicology profile of ASA in rabbits by using a dosing paradigm encompassing the period of organogenesis and to test the hypothesis that maternal gastrointestinal toxicity after repeated dose administrations hampers the detection of low-incidence malformations with ASA in rabbits by limiting ASA administration to sensitive windows for cardiovascular development and midline closure." | 1.32 | Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development. ( Cappon, GD; Cook, JC; Gupta, U; Hurtt, ME; Tassinari, MS, 2003) |
| "On administration of low-molecular heparin, its dosage weight-adjusted, and 100 mg aspirin daily the discoloration of the finger quickly disappeared, but Raynaud's syndrome remained unchanged until she had stopped breast feeding (left breast only) after 8 months." | 1.32 | [Repeated attacks of pain in the nipple of a pregnant woman. Unusual manifestation of Raynaud's phenomenon]. ( Diehm, C; Lawall, H; Stammler, F, 2003) |
| "Dyslipidemia is associated with macular exudates and vision loss." | 1.32 | Preventing diabetic retinopathy through control of systemic factors. ( Fong, D; Jain, A; Sarraf, D, 2003) |
| "Intrauterine growth restriction is connected with high rate of prematurity and perinatal mortality." | 1.32 | [Analysis of 8-isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR]. ( Karowicz-Bilińska, A; Kowalska-Koprek, U; Sieroszewski, P; Suzin, J, 2003) |
| "Since completion of the recurrent miscarriage analysis, 39 women conceived again." | 1.32 | Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias. ( Dekker, GA; Krabbendam, I, 2004) |
| "Autoimmune diseases are a group of illnesses in which autoantibodies are produced against various organs, presenting with a variety of clinical symptoms." | 1.32 | Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. ( Chen, L; Miller, RK; Ornoy, A; Silver, RM, 2004) |
| "Acute fatty liver is a rare but fatal complication of pregnancy." | 1.32 | Acute fatty liver of pregnancy after aspirin intake. ( Deren, O; Durukan, T; Kizilkiliç-Parlakgümüş, A; Onderoğlu, L; Saygan-Karamürsel, B, 2004) |
| "Both COX inhibitors were toxic to dams in the highest doses evaluated, which caused a significantly greater incidence of intrauterine growth retardation and developmental variations." | 1.32 | Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats. ( Burdan, F, 2004) |
| "Diagnosis of polycythemia vera during pregnancy is a very difficult task due to physiologic changes occurring during gestation." | 1.32 | [Polycythemia vera and pregnancy]. ( Beillat, T; Dreyfus, M; Macro, M, 2004) |
| "There are no reported cases of Kawasaki disease in postpartum patients." | 1.32 | Kawasaki disease in a postpartum patient. ( Fason, JT; Fry, YW; Smith, D, 2004) |
| "Plasmic 6-keto-PGF1a was low." | 1.32 | [Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol]. ( Artem'eva, VB; Gordovskaia, NB; Kozlovskaia, NL; Krylova, MIu; Rogov, VA; Shilov, EM; Sidorova, IS, 2004) |
| "Among the patients treated (n = 38) thrombophilia screening was positive in 16 patients and in the remaining 22 no causative factor was detected." | 1.31 | Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology. ( Anapliotis, A; Klearchou, N; Loufopoulos, A; Mamopoulos, A; Mamopoulos, M; Psarra, A; Tzafettas, J, 2002) |
| "Deferoxamine therapy was continued throughout 2 pregnancies, while in the other it was stopped after 8 weeks: no abnormalities were noted in the children." | 1.31 | High-risk pregnancy in beta-thalassemia major women. Report of three cases. ( De Marzi, CA; Magliari, F; Perniola, R; Rosatelli, MC, 2000) |
| " However, it was not possible to generate dose-response curves whereas significant correlations of uptake values with T50 values were found." | 1.31 | The effect of oxytocin, prostaglandin E2 and acetylsalicylic acid on flow distribution and on the transfer of alanine, glucose and water in isolated perfused guinea pig placentae. ( Goepel, E; Niemax, K; Rybakowski, C; Schröder, HJ, 2000) |
| "Myocardial infarction is rare during pregnancy." | 1.31 | [Myocardial infarction, pregnancy and anesthesia]. ( Diar, N; Rezig, K; Walcker, JL, 2000) |
| "No patients with preeclampsia or other severe complications of pregnancy were observed in the normalised group." | 1.31 | Late normalisation of uterine artery velocimetry in high risk pregnancy. ( Danti, L; Frusca, T; Scalvi, L; Soregaroli, M; Valcamonico, A, 2001) |
| "Previous studies of gastroschisis have suggested that risk is increased for maternal use of vasoactive over-the-counter medications, including specific analgesics and decongestants." | 1.31 | Maternal medication use and risks of gastroschisis and small intestinal atresia. ( Mitchell, AA; Sheehan, JE; Werler, MM, 2002) |
| "We estimated the proportion of miscarriage to be almost doubled, whereas there was no increased risk of congenital abnormalities or prematurity in women exposed to a drug overdose compared with the background population." | 1.31 | Pregnancy outcome after suicide attempt by drug use: a Danish population-based study. ( Flint, C; Larsen, H; Nielsen, GL; Olsen, J; Sørensen, HT, 2002) |
| "Management of ET in pregnancy is still very much individualized." | 1.31 | Four pregnancies in two patients with essential thrombocythaemia--a case report. ( Devendra, K; Koh, LP; Tien, SL, 2002) |
| "When aspirin was added with high folic acid serum, the toxicity on yolk sac decreased or disappeared." | 1.30 | [Antagonism of folic acid on the toxicity of aspirin in yolk sac of rats]. ( Han, M; Wang, X, 1999) |
| "Treatment with prednisolone (7." | 1.30 | [A case of antiphospholipid antibody syndrome successfully treated with prednisolone and low-dose aspirin, with subsequent normal pregnancy]. ( Maeda, T; Maesima, E; Yamada, Y; Yamamoto, M; Yukawa, S, 1997) |
| "Pregnancy was authorized if disease was inactive on 20 mg/day prednisone or less for at least 1 yr." | 1.30 | Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies. ( Blétry, O; Darbois, Y; Godeau, P; Lê Huong, D; Lefèbvre, G; Piette, JC; Seebacher, J; Vauthier-Brouzes, D; Wechsler, B, 1997) |
| "Patients with antiphospholipid syndrome are at high risk of pregnancy loss as well as maternal morbidity, especially thrombo-embolic disease." | 1.30 | Obstetric outcome in antiphospholipid syndrome. ( Farquharson, RG; Granger, KA, 1997) |
| "Pregnancy was confirmed and therapy with platelet aggregation inhibitor was introduced." | 1.30 | Pregnancy in a patient with essential thrombocytosis. ( Appiano, G; Caremani, M; Lapini, L; Rossi, G, 1997) |
| "Isolated cutaneous infarcts have not previously been described in association with SPA." | 1.30 | Cutaneous vascular infarcts secondary to spontaneous platelet aggregation. ( Graham, C; Hutchinson, PE; Lear, JT; Mitchell, V; Pavord, S, 1998) |
| "A newborn had a subdural hematoma detected with a prenatal ultrasonography at 31 weeks' gestation, probably in keeping with the regular treatment of AAS." | 1.30 | [Favorable outcome of a subdural hematoma diagnosed in utero]. ( Daussac, E; Lafont, M; Lamarque, M, 1999) |
| " It is likely that proper selection of patients, as well as the timing and dosage of treatment, are key factors for its efficiency." | 1.30 | [Arterial hypertension of the pregnant woman]. ( Beaufils, M, 1999) |
| "Aspirin-treated P cows had longer PP intervals than either control P, control M, or aspirin-treated M cows." | 1.30 | The effect of aspirin administration and parity on plasma salicylate concentrations and postpartum reproductive parameters in Brahman cows. ( Neuendorff, DA; Randel, RD; Stahringer, RC, 1999) |
| "Pulmonary edema was rare and acute renal failure did not develop in any women." | 1.30 | Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. ( Caritis, SN; Dombrowski, MP; Hauth, JC; Hogg, B; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, PJ; Miodovnik, M; Paul, R; Roberts, JM; Sibai, BM; Thurnau, GR; Van Dorsten, JP, 1999) |
| "We examined 159 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan." | 1.30 | Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan. ( Ihara, T; Kakisita, E; Minami, N; Mori, Y; Omine, M; Shiku, H; Tamaki, S; Wada, H, 1999) |
| "Pretreatment with aspirin significantly augmented alcohol-induced resorption, IUGR, cleft palate and digital malformations associated with haematomas." | 1.29 | Aspirin-alcohol interaction in the production of cleft palate and limb malformations in the TO mouse. ( Padmanabhan, R; Pallot, DJ, 1995) |
| "Increased risk for aplasia cutis congenita should be considered when elevated maternal and amniotic fluid alpha-fetoprotein and a distinct electrophoretic band of acetylcholinesterase are found." | 1.29 | Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band. ( Cohen, RN; Dror, Y; Gelman-Kohan, Z; Hagai, Z; Juster-Reicher, A; Mogilner, B, 1994) |
| "Pre-treatment with aspirin (both 150 and 200 mg/kg) on day 8 of gestation resulted in a numerical, though not statistically significant increase in alcohol-induced exencephaly." | 1.29 | Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses. ( Craigmyle, MB; Padmanabhan, R; Wasfi, IA, 1994) |
| "To study treatment of hypertension in pregnancy in Sweden and compare our results with a similar study published in 1981." | 1.29 | How Swedish obstetricians manage hypertensive disorders in pregnancy. A questionnaire study. ( Ingemarsson, I; Montal, S; Wide-Swensson, D, 1994) |
| "In study 1, compared with control Krebs-Ringer-bicarbonate perfusion, peroxide perfusion significantly increased, in a dose-response manner, placental lipid peroxide secretion." | 1.29 | Secretion of lipid peroxides by the human placenta. ( Walsh, SW; Wang, Y, 1993) |
| "All eight subjects who developed preeclampsia delivered growth-retarded infants before term." | 1.29 | Increased platelet volume and aggregation precede the onset of preeclampsia. ( Elder, MG; Hutt, R; Ogunniyi, SO; Sullivan, MH, 1994) |
| "The patient had experienced hepatic infarction during her first pregnancy and had repeated hepatic infarction during her third pregnancy." | 1.29 | Hepatic infarction during pregnancy complicated by antiphospholipid syndrome. ( Kinoshita, K, 1993) |
| " However, little is known about the dose-response relationship for salicylate-related effects on labor and gestation." | 1.29 | Maternal reproductive effects of oral salicylic acid in Sprague-Dawley rats. ( Daston, GP; Davis, DP; Kraus, AL; Odio, MR; York, RG, 1996) |
| "Thalidomide is a teratogenic sedative-hypnotic drug that is structurally similar to phenytoin, which is thought to be bioactivated by prostaglandin H synthase (PHS) and other peroxidases to a teratogenic reactive intermediate." | 1.29 | Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate. ( Arlen, RR; Wells, PG, 1996) |
| "Women on aspirin, who developed preeclampsia, delivered later in pregnancy [35." | 1.29 | Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. ( Fairley, KF; Ferrier, C; Gamble, G; Kincaid-Smith, P; North, RA, 1995) |
| "One pregnancy was electively terminated after extensive thrombosis in the splanchnic district requiring surgical entero-resection." | 1.29 | Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. ( Arrigoni, L; Muggiasca, ML; Pagliaro, P; Poggio, M; Rossi, E; Russo, U, 1996) |
| "Preeclampsia is a disease which appears only during pregnancy." | 1.29 | [Physiopathology of preeclampsia]. ( Mejía, R; Sarto, A, 1996) |
| "Preeclampsia is a hypertensive disorder of human pregnancy that is a leading cause of premature delivery and fetal growth retardation." | 1.29 | Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas. ( Walsh, SW; Wang, Y, 1995) |
| "Preeclampsia is associated with an imbalance of increased thromboxane and decreased prostacyclin and an abnormal increase of lipid peroxides." | 1.28 | Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women. ( Kay, HH; McCoy, MC; Walsh, SW; Wang, Y, 1992) |
| "Two patients had systemic lupus erythematosus, and the other five fulfilled criteria for the primary antiphospholipid syndrome." | 1.28 | Fetal loss treatment in patients with antiphospholipid antibodies. ( Barquinero, J; Genover, E; Jordana, R; Ordi, J; Selva, A; Tolosa, C; Vilardell, M, 1989) |
| "Thrombotic thrombocytopenic purpura is a severe multisystemic disorder of unknown origin." | 1.28 | Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura. ( Eldor, A; Ezra, Y; Mordel, N; Sadovsky, E; Schenker, JG, 1989) |
| "Dimethadione was given similarly on Days 11 and 12, or 12 and 13, in a dose (900 mg/kg ip) that was equimolar to 1000 mg/kg of trimethadione." | 1.28 | Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds. ( Greco, GS; Nagai, MK; Wells, PG, 1989) |
| "After treatment the pregnancy wastage rate was 55% and 25% in the 2 groups respectively." | 1.28 | Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment. ( Cameron, K; Gatenby, PA; Shearman, RP, 1989) |
| "Fibromuscular dysplasia is an arteriopathy of unknown etiology that affects the intermediate-size branches of the aorta." | 1.28 | Fibromuscular dysplasia of the carotid arteries complicating pregnancy. ( Beyth, Y; Ezra, Y; Kidron, D, 1989) |
| " Cumulative dose-response curves for isoproterenol, norepinephrine and methoxamine were made for the different groups." | 1.27 | In vitro contractile responses of the uterus from 'restricted diet' rats to adrenoceptor agonists. Influence of cyclo-oxygenase inhibitors. ( Gimeno, AL; Gimeno, MA; Goldraij, A; Sterin, AB, 1983) |
| "A clinical diagnosis of systemic lupus erythematosus (SLE) was made in four women." | 1.27 | Lupus anticoagulant in pregnancy. ( Butler, WS; Liggins, GC; Lubbe, WF; Palmer, SJ, 1984) |
| "Aspirin was administered by oral gavage to 25 gravid Sprague-Dawley rats on gestation day 10, as a single dose of 500 mg/kg, in a concentration of 50 mg/ml." | 1.27 | Novel accessory skull bone in fetal rats after exposure to aspirin. ( Boardman, JP; Carrano, RA; Iuliucci, JD; Mitala, JJ, 1984) |
| " These same dosage levels also caused a severe maternal hemolytic anemia following a dramatic decrease in erythrocyte ATP levels." | 1.27 | Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. ( Allen, HL; Bokelman, DL; Clark, RL; Cohen, SM; James, ML; Minsker, DH; Robertson, RT; Tocco, DJ, 1984) |
| " Cumulative dose-response curves for H, in strips isolated from proestrous rats, showed that the agonist inhibited, at all the concentrations tested, spontaneous myometrial contractions, evoking a maximum effect (100% inhibition) at 10(-5)M." | 1.27 | Prostaglandins and ovarian factors as modulators of the negative inotropic action of histamine in the isolated rat uterus. ( Dveksler, G; Franchi, AM; Gimeno, AL; Gimeno, MF; Viggiano, M, 1984) |
| "When aspirin was administered 1 day prior to autopsy, TXB2 production by uterine tissue was 32% of the control uterus." | 1.27 | Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration. ( Blake, DA; Dubin, NH; Ghodgaonkar, RB, 1983) |
| " A similar study was conducted with Dutch-Belted rabbits dosed po daily at 3, 10, 30, or 100 mg of o-toluenediamine/kg body wt/day from Days 6 through 18 of gestation." | 1.27 | Teratogenesis study of o-toluenediamine in rats and rabbits. ( Barbee, SJ; Becci, PJ; Knickerbocker, MJ; Reagan, EL; Wedig, JH, 1983) |
| "Trimethyl phosphite (TMP) is an organophosphorus alkylating agent used primarily in the synthesis of organophosphate compounds." | 1.27 | Teratological evaluation of trimethyl phosphite in the rat. ( Craig, PH; Gallo, MA; Mehlman, MA, 1984) |
| "Toluene was found to potentiate the toxic effect of ASA and to increase both maternal and embryonic toxicity." | 1.27 | Combined embryotoxic action of toluene, a widely used industrial chemical, and acetylsalicylic acid (aspirin). ( Barcza, G; Lõrincz, M; Tátrai, E; Ungváry, G, 1983) |
| " Previous studies have indicated that pregnant animals treated acutely with toxic levels of a variety of pharmacologically unrelated chemicals produced litters without a recognizable syndrome of defects, except for an increased incidence of supernumerary ribs (SNR)." | 1.27 | The potential relationship of maternal toxicity, general stress, and fetal outcome. ( Beyer, PE; Chernoff, N; Kavlock, RJ; Miller, D, 1987) |
| "Mitral valve prolapse is usually a benign condition, however, serious complications have been reported to be associated with it." | 1.27 | Mitral valve prolapse and thromboembolic disease in pregnancy: a case report. ( Bergh, PA; Breen, JL; Gregori, CA; Hollander, D, 1988) |
| "Preeclampsia is characterized by imbalances in the production rates of several arachidonic acid metabolites." | 1.27 | The role of arachidonic acid metabolites in preeclampsia. ( Parisi, VM; Walsh, SW, 1986) |
| "Aspirin treatment was associated with increased lymphocyte thymidine uptake for blastogenesis in pregnant rats fed the normal protein control diet and their offspring." | 1.27 | Effects of aspirin-like drugs on mitogen-stimulated DNA synthesis of lymphocytes from pregnant rats and offspring. ( Ewii, MC; Hyde, BP; Knight, EM; Millis, RM; Offiah, GU, 1988) |
| " A prevention of thromboembolic disease by individual dosage of heparin must be considered in patients at high risk for thromboembolic disease." | 1.27 | [Mortality and morbidity of thromboembolism in drug prevention--5-year analysis]. ( Hopp, A; Hopp, H; Knispel, J, 1988) |
| "Aspirin treatment increased serum globulin levels and decreased serum albumin-globulin ratios in off-spring of dams fed the low-protein diet." | 1.27 | The effects of aspirin-like drugs on the nutritional status of pregnant rats and offspring. ( Ewii, MC; Hyde, BP; Knight, EM; Millis, RM; Offiah, GU, 1988) |
| "Human fetal alcohol syndrome characteristics have been seen in the mouse fetus by several investigators who dosed the dam with only one or two doses of alcohol." | 1.27 | Teratogenic effects on the CD-1 mouse embryo exposed to concurrent doses of ethanol and aspirin. ( Guy, JF; Sucheston, ME, 1986) |
| "Aspirin was continuously administered throughout pregnancy to prevent thrombus formation, but no adverse effects on the delivery or the infant were observed." | 1.27 | Idiopathic thrombocythemia and pregnancy: report of a case. ( Kaibara, M; Kobayashi, T; Matsumoto, S, 1985) |
| "In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis." | 1.26 | Beta 2-microglobulin and other proteins as parameter for tubular function. ( Jaques, G; Keller, M; Mondorf, AW; Prüfer, D; Weise, M, 1981) |
| " If preterm labour was stopped, the dosage had been reduced." | 1.26 | [Clinical study of the labour inhibiting effects an side effects of acetylsalicylic acid (ASA) (author's transl)]. ( Berg, R; Bolte, A; Wolff, F, 1981) |
| "Maternal bleeding was confined to excessive intrapartum or post-partum blood loss." | 1.26 | Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. ( Elrad, H; Graeber, JE; Gross, SJ; Stuart, MJ, 1982) |
| "Aspirin was administered in single oral doses of 500 and 625 mg/kg on d 10; hydroxyurea was injected ip at 500 mg/kg on d 11." | 1.26 | Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains. ( DePass, LR; Weaver, EV, 1982) |
| "Report on 5 patients with thrombotic thrombocytopenic purpura." | 1.26 | [Thrombotic thrombocytopenic purpura: report on 5 cases and current therapy concepts]. ( Cornu, P; Gratwohl, A; Richner, J; Speck, B, 1981) |
| "Aspirin-treated embryos removed on day 12 exhibited a unique pattern of preaxial mesodermal cell death in the hindlimb buds." | 1.26 | Aspirin-induced teratogenesis: a unique pattern of cell death and subsequent polydactyly in the rat. ( Klein, KL; Scott, WJ; Wilson, JG, 1981) |
| " Potencies of estrogens varied greatly, but all compounds tested prevented DIC at adequate dosage levels." | 1.26 | Disseminated intravascular coagulation induced by progesterone in the pregnant rat. Prevention by estogens. ( Stamler, FW, 1977) |
| " During the dosing period, females received 300mg/kg of M73101 showed pronounced body weight depression and decrease in food and water intake." | 1.26 | [Reproduction study of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101) in rabbits. Administration of M73101 during the period of major organogenesis (author's transl)]. ( Kosazuma, T; Obori, R; Tanaka, H; Tanigawa, H; Yoshida, J, 1979) |
| "Two severe anaphylactoid reactions were seen under dextran prophylaxis resulting in the death of one newborn." | 1.26 | [Side effects of drug for thromboembolism prophylaxis. Results from the University Women's Clinic Freiburg/Br]. ( Ardelt, W; Hillemanns, HG; Pasold, K, 1979) |
| "A dosage of 10 mg/kg body weight Na-salicylate has no depressive effect on uterine motility." | 1.26 | [Influence of na-salicylate on uterine motility in labour (author's transl)]. ( Kunath, H; Michels, W; Möller, R; Seewald, HJ; Voigt, R; Zanke, S, 1979) |
| "Beagle bitches were administered aspirin at either 100 or 400 mg/kg/day between Days 15 and 22 or Days 23 and 30 postmating, and corresponding control groups were dosed with vehicle during one of these same time periods." | 1.26 | Aspirin: teratogenic evaluation in the dog. ( Allen, HL; Bokelman, DL; Robertson, RT, 1979) |
| "When thrombotic thrombocytopenic purpura (TTP) occurs in pregnancy, survival of either the mother or fetus is exceedingly rare." | 1.26 | Survival following thrombotic thrombocytopenic purpura in pregnancy. ( Burkhardt, JH; Fitzgibbons, JF; Goodnight, SH; Kirk, PE, 1977) |
| " There are pronounced intersubject differences in salicylate elimination kinetics; dosage must be individualized on the basis of plasma concentration and clinical response." | 1.26 | Clinical pharmacokinetics of aspirin. ( Levy, G, 1978) |
| "Prevention of premature labor is of considerable interest in research and clinics." | 1.25 | The treatment of threatened premature labor by tocolytics, Ca++-Antagonists and anti-inflammatory drugs. ( Mosler, KH, 1975) |
| "Treatment with aspirin prolonged induction-abortion time by about 9 hours and treatment with indomethacin by 30 hours." | 1.25 | Letter to the editor: Non steroid anti-inflammatory drugs and pregnancy. ( Tricomi, V; Waltman, R, 1974) |
| "Aspirin has been proven to inhibit PGs liberation." | 1.25 | [Prostaglandins]. ( , 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 468 (20.83) | 18.7374 |
| 1990's | 464 (20.65) | 18.2507 |
| 2000's | 407 (18.11) | 29.6817 |
| 2010's | 533 (23.72) | 24.3611 |
| 2020's | 375 (16.69) | 2.80 |
| Authors | Studies |
|---|---|
| How, J | 1 |
| Hobbs, G | 1 |
| Sung, N | 1 |
| Khan, SA | 1 |
| Yiu, ME | 1 |
| Jubiz, G | 1 |
| Salazar, MD | 1 |
| Skariah, A | 1 |
| Dambaeva, S | 2 |
| Kwak-Kim, J | 4 |
| Davidson, KW | 1 |
| Barry, MJ | 1 |
| Mangione, CM | 1 |
| Cabana, M | 1 |
| Caughey, AB | 3 |
| Davis, EM | 1 |
| Donahue, KE | 1 |
| Doubeni, CA | 1 |
| Kubik, M | 1 |
| Li, L | 4 |
| Ogedegbe, G | 1 |
| Pbert, L | 1 |
| Silverstein, M | 1 |
| Simon, MA | 1 |
| Stevermer, J | 1 |
| Tseng, CW | 1 |
| Wong, JB | 1 |
| Henderson, JT | 3 |
| Vesco, KK | 1 |
| Senger, CA | 2 |
| Thomas, RG | 1 |
| Redmond, N | 1 |
| Jin, J | 1 |
| Espinoza, J | 1 |
| Giorgione, V | 2 |
| Di Fabrizio, C | 1 |
| Thilaganathan, B | 6 |
| Anthoulakis, C | 1 |
| Mamopoulos, A | 2 |
| Rousso, D | 1 |
| Karagiannis, A | 1 |
| Athanasiadis, A | 1 |
| Grimbizis, G | 1 |
| Athyros, V | 1 |
| Rudolph, JE | 5 |
| Cartus, A | 1 |
| Bodnar, LM | 3 |
| Schisterman, EF | 28 |
| Naimi, AI | 10 |
| Pérez Rodríguez, E | 1 |
| Martínez Tadeo, HA | 1 |
| Hernández Santana, G | 1 |
| Iglesias Souto, FJ | 1 |
| Rodríguez Plata, E | 1 |
| Barrios Recio, J | 1 |
| Callero Viera, A | 1 |
| Shrestha Khatri, N | 1 |
| White, SW | 1 |
| Graham, DF | 2 |
| Krishnamurti, T | 1 |
| Davis, AL | 1 |
| Rodriguez, S | 1 |
| Hayani, L | 1 |
| Bernard, M | 1 |
| Simhan, HN | 3 |
| Lewkowitz, AK | 1 |
| Rouse, DJ | 4 |
| Ghidini, A | 2 |
| Gandhi, M | 1 |
| McCoy, J | 1 |
| Kuller, JA | 3 |
| Yan, X | 1 |
| Wang, D | 1 |
| Yan, P | 1 |
| Li, H | 1 |
| Moungmaithong, S | 1 |
| Leung, BW | 1 |
| Sahota, DS | 1 |
| Wang, CC | 2 |
| Leung, TY | 2 |
| Poon, LC | 16 |
| Ye, Y | 1 |
| Wen, L | 1 |
| Liu, X | 4 |
| Wang, L | 3 |
| Liu, Y | 3 |
| Saffery, R | 1 |
| Kilby, MD | 1 |
| Tong, C | 1 |
| Qi, H | 3 |
| Baker, P | 1 |
| Zen, M | 1 |
| Haider, R | 1 |
| Simmons, D | 1 |
| Peek, M | 1 |
| Nolan, CJ | 1 |
| Padmanabhan, S | 2 |
| Jesudason, S | 1 |
| Alahakoon, TI | 1 |
| Cheung, NW | 2 |
| Lee, VW | 1 |
| Landman, AJEMC | 5 |
| van Limburg Stirum, EVJ | 2 |
| de Boer, MA | 11 |
| van 't Hooft, J | 2 |
| Ket, JCF | 1 |
| Leemhuis, AG | 2 |
| Finken, MJJ | 2 |
| Oudijk, MA | 8 |
| Painter, RC | 2 |
| Gulersen, M | 1 |
| Rochelson, B | 1 |
| Hantoushzadeh, S | 2 |
| Saleh, M | 1 |
| Nouri, B | 1 |
| Panahi, Z | 1 |
| Combs, CA | 7 |
| Zhou, MK | 4 |
| Pandipati, S | 4 |
| Rosario, AD | 1 |
| Ju, Y | 2 |
| Feng, Y | 2 |
| Hou, X | 2 |
| Wu, L | 2 |
| Yang, H | 9 |
| Zhang, H | 6 |
| Ma, Y | 3 |
| Leuba, SI | 2 |
| Westreich, D | 1 |
| Bose, CL | 5 |
| Powers, KA | 1 |
| Olshan, A | 1 |
| Taylor, SM | 1 |
| Tshefu, A | 6 |
| Lokangaka, A | 7 |
| Carlo, WA | 7 |
| Chomba, E | 7 |
| Liechty, EA | 7 |
| Bucher, SL | 1 |
| Esamai, F | 7 |
| Jessani, S | 6 |
| Saleem, S | 7 |
| Goldenberg, RL | 14 |
| Moore, J | 6 |
| Nolen, T | 1 |
| Hemingway-Foday, J | 4 |
| McClure, EM | 7 |
| Koso-Thomas, M | 6 |
| Derman, RJ | 7 |
| Hoffman, M | 4 |
| Bauserman, M | 4 |
| Mone, F | 9 |
| Gupta, JK | 1 |
| Phelan, MM | 2 |
| Meher, S | 5 |
| Lian, LY | 1 |
| Francis, B | 1 |
| Zhang, E | 1 |
| Mulcahy, C | 8 |
| Alfirevic, A | 6 |
| Mcauliffe, FM | 8 |
| Navaratnam, K | 6 |
| Wheeler, SM | 1 |
| Myers, SO | 1 |
| Swamy, GK | 1 |
| Myers, ER | 1 |
| Reis de Carvalho, C | 1 |
| Bigotte Vieira, M | 1 |
| Costa, J | 1 |
| Vaz Carneiro, A | 1 |
| Yip, KC | 1 |
| Luo, Z | 1 |
| Huang, X | 2 |
| Lee, W | 1 |
| Dai, C | 1 |
| Zeng, W | 1 |
| Mok, TN | 1 |
| He, Q | 1 |
| Li, R | 2 |
| Zhu, D | 5 |
| Zou, H | 5 |
| Liu, J | 5 |
| Wang, J | 9 |
| Ma, C | 1 |
| Yin, J | 6 |
| Peng, X | 1 |
| Li, D | 1 |
| Yang, Y | 2 |
| Ren, Y | 4 |
| Zhang, Z | 5 |
| Zhou, P | 5 |
| Wang, X | 9 |
| Cao, Y | 5 |
| Xu, X | 5 |
| Wright, D | 11 |
| Tan, MY | 4 |
| O'Gorman, N | 7 |
| Syngelaki, A | 12 |
| Nicolaides, KH | 26 |
| Acheampong, T | 1 |
| Lee Argov, EJ | 1 |
| Terry, MB | 1 |
| Rodriguez, CB | 1 |
| Agovino, M | 1 |
| Wei, Y | 1 |
| Athilat, S | 1 |
| Tehranifar, P | 1 |
| Perni, UC | 1 |
| Wang, EY | 1 |
| Gregg, AR | 2 |
| Mkhize, PZ | 1 |
| Phoswa, WN | 1 |
| Khaliq, OP | 1 |
| Dorsamy, V | 1 |
| Moodley, J | 3 |
| Ray, JG | 9 |
| Abdulaziz, KE | 1 |
| Berger, H | 3 |
| Visser, L | 3 |
| Nijman, TAJ | 2 |
| Hemels, MAC | 2 |
| Naaktgeboren, CN | 1 |
| van der Weide, MC | 1 |
| Mol, BW | 5 |
| van Laar, JOEH | 1 |
| Papatsonis, DNM | 1 |
| Bekker, MN | 3 |
| van Drongelen, J | 2 |
| van Pampus, MG | 4 |
| Sueters, M | 2 |
| van der Ham, DP | 1 |
| Sikkema, JM | 2 |
| Zwart, JJ | 1 |
| Huisjes, AJM | 1 |
| van Huizen, ME | 1 |
| Kleiverda, G | 1 |
| Boon, J | 1 |
| Franssen, MTM | 2 |
| Hermes, W | 1 |
| Visser, H | 1 |
| de Groot, CJM | 3 |
| Hodgetts Morton, V | 2 |
| Stock, SJ | 1 |
| Vallejo, GM | 1 |
| Uriel, M | 1 |
| Porras-Ramírez, A | 1 |
| Romero, XC | 1 |
| Katler, QS | 1 |
| Kawwass, JF | 1 |
| Hurst, BS | 1 |
| Sparks, AE | 1 |
| McCulloh, DH | 1 |
| Wantman, E | 1 |
| Toner, JP | 1 |
| Sole, KB | 1 |
| Staff, AC | 1 |
| Räisänen, S | 1 |
| Laine, K | 1 |
| Udry, S | 4 |
| Peréz, SM | 1 |
| Belizna, C | 4 |
| Aranda, F | 2 |
| Esteve-Valverde, E | 3 |
| Wingeyer, SP | 2 |
| Fernández-Romero, DS | 1 |
| Latino, JO | 3 |
| de Larrañaga, G | 1 |
| Alijotas-Reig, J | 9 |
| Theilen, LH | 3 |
| Greenland, P | 1 |
| Varagic, J | 1 |
| Catov, J | 1 |
| Shanks, A | 1 |
| Thorsten, V | 1 |
| Parker, CB | 1 |
| McNeil, R | 1 |
| Mercer, B | 1 |
| Wapner, R | 2 |
| Haas, D | 1 |
| Simhan, H | 2 |
| Grobman, W | 3 |
| Chung, JH | 1 |
| Levine, LD | 2 |
| Barnes, S | 1 |
| Bairey Merz, N | 1 |
| Saade, G | 4 |
| Silver, RM | 32 |
| Wright, A | 3 |
| Walsh, SW | 17 |
| Strauss, JF | 5 |
| Bijl, RC | 1 |
| Cornette, JMJ | 1 |
| Brewer, AN | 1 |
| Zwart, IF | 1 |
| Franx, A | 3 |
| Tsigas, EZ | 1 |
| Koster, MPH | 1 |
| Deng, Z | 1 |
| Lu, D | 2 |
| Zhong, Y | 3 |
| Brooks, MM | 1 |
| Kennedy, EH | 5 |
| Hastie, R | 5 |
| Tong, S | 7 |
| Wikström, AK | 3 |
| Walker, SP | 2 |
| Lindquist, A | 1 |
| Cluver, CA | 2 |
| Kupka, E | 2 |
| Bergman, L | 3 |
| Hesselman, S | 3 |
| Zhang, J | 13 |
| Jing, S | 2 |
| Xie, H | 2 |
| Feng, L | 3 |
| Ortiz-Basso, T | 1 |
| Gomez, PV | 1 |
| Boffelli, A | 1 |
| Paladini, A | 1 |
| Espeche, WG | 1 |
| Minetto, J | 1 |
| Salazar, MR | 1 |
| Yao, Q | 1 |
| Zhao, Q | 1 |
| Yang, L | 1 |
| Yu, Y | 4 |
| Xie, J | 1 |
| Feng, C | 1 |
| Zhou, L | 4 |
| Jin, M | 1 |
| Delgado, A | 1 |
| Katz, L | 1 |
| Amorim, MM | 1 |
| Edahiro, Y | 1 |
| Nolen, TL | 2 |
| Tsehfu, A | 1 |
| Patterson, J | 1 |
| Meshnick, SR | 1 |
| Mirabito Colafella, KM | 2 |
| van Dorst, DCH | 1 |
| Neuman, RI | 2 |
| Doorn, LV | 1 |
| Neves, KB | 1 |
| Montezano, AC | 1 |
| Garrelds, IM | 1 |
| van Veghel, R | 1 |
| de Vries, R | 1 |
| Uijl, E | 1 |
| Clahsen-van Groningen, MC | 1 |
| Baelde, HJ | 1 |
| van den Meiracker, AH | 1 |
| Touyz, RM | 1 |
| Visser, W | 3 |
| Danser, AHJ | 2 |
| Versmissen, J | 2 |
| Leeson, C | 1 |
| Odendaal, J | 1 |
| Quenby, S | 5 |
| Francisco, C | 2 |
| Gamito, M | 1 |
| Reddy, M | 2 |
| Rolnik, DL | 17 |
| Chen, D | 3 |
| Yang, S | 3 |
| Ding, J | 2 |
| Liu, A | 1 |
| Olson, DN | 1 |
| Russell, T | 1 |
| Ranzini, AC | 1 |
| Kasraeian, M | 3 |
| Asadi, N | 3 |
| Vafaei, H | 3 |
| Tazang, M | 2 |
| Rahimirad, N | 2 |
| Yousofi, S | 2 |
| Khaleghi, SF | 2 |
| Zare, M | 3 |
| Akalin, EE | 1 |
| Akalin, M | 1 |
| Ayvaci Tasan, H | 1 |
| Koyuncu, K | 1 |
| Murphy, L | 1 |
| Saldanha, IJ | 1 |
| Sawyer, K | 1 |
| Gupta, M | 1 |
| Mendez-Figueroa, H | 4 |
| Burwick, R | 1 |
| Chauhan, SP | 1 |
| Wagner, SM | 1 |
| Ukoha, EP | 1 |
| Snavely, ME | 1 |
| Hahn, MU | 1 |
| Steinauer, JE | 1 |
| Bryant, AS | 1 |
| Bij de Weg, JM | 4 |
| de Vries, JIP | 5 |
| Tani, C | 1 |
| Zucchi, D | 1 |
| Haase, I | 1 |
| Gerosa, M | 7 |
| Larosa, M | 1 |
| Cavagna, L | 1 |
| Bortoluzzi, A | 1 |
| Crisafulli, F | 1 |
| Mucke, J | 1 |
| Strigini, FAL | 1 |
| Baglietto, L | 1 |
| Fornili, M | 1 |
| Monacci, F | 1 |
| Elefante, E | 1 |
| Erra, R | 1 |
| Bellis, E | 1 |
| Padovan, M | 1 |
| Andreoli, L | 9 |
| Coletto, LA | 1 |
| Zanframundo, G | 1 |
| Govoni, M | 1 |
| Iaccarino, L | 1 |
| Tincani, A | 16 |
| Doria, A | 3 |
| Fischer-Betz, R | 3 |
| Mosca, M | 4 |
| Anderson, K | 1 |
| Blaxall, M | 1 |
| Lensen, S | 1 |
| Farquhar, C | 2 |
| Suksai, M | 1 |
| Geater, A | 1 |
| Suntharasaj, T | 1 |
| Suwanrath, C | 1 |
| Charernjiratragul, K | 1 |
| Khwankaew, N | 1 |
| Andrade, JA | 1 |
| Viana Junior, AB | 1 |
| Holanda Moura, SB | 1 |
| Gurgel Alves, JA | 1 |
| Araujo Júnior, E | 2 |
| Carvalho, FH | 1 |
| Kim, JH | 2 |
| Kim, SH | 1 |
| Yang, N | 1 |
| Ko, Y | 1 |
| Lee, SR | 1 |
| Chae, HD | 1 |
| Garza-Galvan, ME | 1 |
| Ferrigno, AS | 1 |
| Campos-Zamora, M | 1 |
| Bain, PA | 1 |
| Easter, SR | 1 |
| Kim, J | 2 |
| Figueras, F | 3 |
| Farber, MK | 2 |
| Lumbreras-Marquez, MI | 1 |
| de Jong, MFC | 1 |
| Komdeur, HM | 1 |
| Salih, M | 1 |
| Meijer, E | 1 |
| Zhang, Y | 6 |
| Song, Y | 2 |
| Xia, X | 1 |
| Qian, Y | 1 |
| Yuan, C | 1 |
| Mao, Y | 1 |
| Diao, F | 1 |
| Ma, X | 2 |
| Benkeser, D | 1 |
| Guo, Y | 2 |
| Zhu, Y | 7 |
| Sun, Y | 1 |
| Tomimori-Gi, K | 1 |
| Katsuragi, S | 1 |
| Kodama, Y | 1 |
| Yamada, N | 1 |
| Sameshima, H | 1 |
| Maekawa, K | 1 |
| Yamashita, A | 1 |
| Gi, T | 1 |
| Sato, Y | 1 |
| Romagano, MP | 2 |
| Sherman, LS | 2 |
| Shadpoor, B | 1 |
| El-Far, M | 1 |
| Souayah, S | 1 |
| Pamarthi, SH | 1 |
| Kra, J | 1 |
| Hood-Nehra, A | 1 |
| Etchegaray, JP | 2 |
| Williams, SF | 2 |
| Rameshwar, P | 2 |
| Foisy, MA | 3 |
| Kingdom, JC | 5 |
| Bujold, E | 36 |
| Nagy, B | 1 |
| Sulyok, E | 1 |
| Várnagy, Á | 3 |
| Barabás, A | 1 |
| Kovács, K | 1 |
| Bódis, J | 3 |
| Moar, L | 1 |
| Simela, C | 1 |
| Nanda, S | 2 |
| Marnerides, A | 1 |
| Al-Adnani, M | 1 |
| Nelson-Piercy, C | 8 |
| Shangaris, P | 1 |
| van Baar, AL | 1 |
| Roseboom, TJ | 1 |
| Ravelli, ACJ | 1 |
| van Wely, M | 1 |
| Oosterlaan, J | 1 |
| Pajkrt, E | 1 |
| Ogoyama, M | 1 |
| Takahashi, H | 2 |
| Suzuki, H | 1 |
| Ohkuchi, A | 1 |
| Fujiwara, H | 1 |
| Takizawa, T | 2 |
| Fu, Z | 1 |
| Ding, X | 1 |
| Wei, D | 1 |
| Li, J | 3 |
| Cang, R | 1 |
| Li, X | 4 |
| Sielhorst, J | 1 |
| Roggel-Buecker, U | 1 |
| Neudeck, KC | 1 |
| Kahler, A | 1 |
| Rohn, K | 1 |
| Luettgenau, J | 1 |
| Bollwein, H | 1 |
| Hollinshead, F | 1 |
| Sieme, H | 1 |
| Pires da Rosa, G | 1 |
| Ferreira, E | 4 |
| Sousa-Pinto, B | 1 |
| Rodríguez-Pintó, I | 1 |
| Brito, I | 1 |
| Mota, A | 1 |
| Cervera, R | 10 |
| Espinosa, G | 5 |
| Sabouni, R | 1 |
| Gorra Al Nafouri, M | 1 |
| Hanafi, I | 1 |
| Al Droubi, I | 1 |
| Alhalabi, M | 1 |
| Silver, R | 4 |
| Craigo, S | 1 |
| Porter, F | 1 |
| Osmundson, SS | 1 |
| Norton, ME | 1 |
| He, S | 3 |
| Liang, L | 1 |
| Lomartire, R | 1 |
| Fantasia, I | 1 |
| Bussolaro, S | 1 |
| Stampalija, T | 2 |
| Ninan, K | 1 |
| Ali, R | 2 |
| Morfaw, F | 1 |
| McDonald, SD | 1 |
| Song, L | 2 |
| Lau, CI | 1 |
| Wang, YF | 1 |
| Pathiraja, PDM | 1 |
| Alrub, NA | 1 |
| Sunanda, G | 1 |
| Richards, EMF | 2 |
| Stevens, O | 1 |
| Diguisto, C | 1 |
| Le Gouge, A | 1 |
| Marchand, MS | 1 |
| Megier, P | 1 |
| Ville, Y | 1 |
| Haddad, G | 1 |
| Winer, N | 4 |
| Arthuis, C | 1 |
| Doret, M | 1 |
| Debarge, VH | 1 |
| Flandrin, A | 1 |
| Delmas, HL | 1 |
| Gallot, D | 1 |
| Mares, P | 4 |
| Vayssiere, C | 2 |
| Sentilhes, L | 4 |
| Cheve, MT | 1 |
| Paumier, A | 1 |
| Durin, L | 1 |
| Schaub, B | 1 |
| Equy, V | 1 |
| Giraudeau, B | 1 |
| Perrotin, F | 1 |
| Liu, YH | 1 |
| Zhang, YS | 1 |
| Chen, JY | 1 |
| Wang, ZJ | 1 |
| Liu, YX | 1 |
| Li, JQ | 1 |
| Xu, XJ | 1 |
| Xie, NJ | 1 |
| Lye, S | 1 |
| Tan, N | 1 |
| Duan, CY | 1 |
| Wei, YX | 1 |
| He, PC | 1 |
| Zhang, X | 3 |
| Zhu, X | 2 |
| Wang, Y | 7 |
| Yang, M | 1 |
| Phelps, AJD | 1 |
| Holmgren, C | 1 |
| Kawaguchi, H | 1 |
| Kanagawa, T | 1 |
| Yamamoto, R | 2 |
| Sasahara, J | 1 |
| Okamoto, Y | 1 |
| Mitsuda, N | 2 |
| Ishii, K | 3 |
| Sun, S | 2 |
| Qian, H | 1 |
| Li, C | 4 |
| Wang, Q | 4 |
| Zhao, A | 6 |
| Ghesquiere, L | 3 |
| Vachon-Marceau, C | 1 |
| Côté, S | 4 |
| Guerby, P | 6 |
| Maheux-Lacroix, S | 1 |
| Xiao, S | 1 |
| Guo, L | 1 |
| Zhang, M | 4 |
| Hu, R | 1 |
| Liu, R | 1 |
| Marchant, I | 2 |
| Lessard, L | 1 |
| Caron, L | 1 |
| Al Dulaimi, M | 2 |
| Ngwira, MM | 3 |
| Gadama, LA | 3 |
| Shanmugalingam, R | 10 |
| Makris, A | 10 |
| Hennessy, A | 10 |
| Johnson, JM | 3 |
| Walsh, JD | 3 |
| Okun, NB | 3 |
| Metcalfe, A | 4 |
| Pastuck, ML | 3 |
| Maxey, CM | 3 |
| Soliman, N | 3 |
| Mahallati, H | 3 |
| Kuret, VH | 3 |
| Dwinnell, SJ | 3 |
| Chada, R | 3 |
| O'Quinn, CP | 3 |
| Schacher, J | 3 |
| Somerset, DA | 3 |
| Paterson, K | 3 |
| Suchet, IB | 3 |
| Silang, KA | 3 |
| Paul, H | 3 |
| Nerenberg, KA | 3 |
| Johnson, DW | 4 |
| D'Antonio, F | 4 |
| Khalil, A | 7 |
| Rizzo, G | 5 |
| Fichera, A | 3 |
| Herrera, M | 3 |
| Buca, D | 3 |
| Morelli, R | 3 |
| Cerra, C | 3 |
| Orabona, R | 3 |
| Acuti Martellucci, C | 3 |
| Flacco, ME | 3 |
| Prefumo, F | 4 |
| Phillips, J | 4 |
| Nathan, E | 3 |
| Graham, D | 3 |
| Ye, YZ | 3 |
| Zhou, QJ | 3 |
| Xiao, XR | 3 |
| Xiong, Y | 3 |
| Li, XT | 3 |
| Zhang, N | 3 |
| Zhang, HX | 3 |
| Li, YW | 3 |
| Li, Y | 5 |
| Ansbacher-Feldman, Z | 3 |
| Meiri, H | 7 |
| Cirkin, R | 3 |
| Louzoun, Y | 3 |
| Kim, K | 10 |
| Del Rosario, A | 3 |
| Wu, X | 3 |
| Yang, W | 4 |
| Hu, Q | 3 |
| Wei, Z | 3 |
| Danjuma, MI | 2 |
| Al-Khulaifi, A | 2 |
| Elshafei, MN | 2 |
| Pyeon, SY | 1 |
| Kwon, BS | 1 |
| Kim, YS | 1 |
| Lee, YJ | 1 |
| Nitsche, JF | 1 |
| Lovell, D | 1 |
| Stephens, N | 1 |
| Conrad, S | 1 |
| Bebeau, K | 1 |
| Brost, BC | 2 |
| Lian, X | 1 |
| Pan, Z | 1 |
| Xia, F | 1 |
| Mao, C | 1 |
| Zhou, W | 2 |
| Zhou, Y | 1 |
| Singh, S | 1 |
| Misra, S | 1 |
| Thijs, A | 4 |
| Harmsze, AM | 3 |
| Di Girolamo, R | 1 |
| Alameddine, S | 1 |
| Santilli, F | 1 |
| Maruotti, GM | 2 |
| Liberati, M | 2 |
| Lim, S | 2 |
| McDougall, ARA | 1 |
| Goldstein, M | 1 |
| Tuttle, A | 1 |
| Ammerdorffer, A | 1 |
| Rushwan, S | 1 |
| Ricci, C | 1 |
| Gülmezoglu, AM | 1 |
| Vogel, JP | 1 |
| Jiang, Y | 1 |
| Chen, Z | 3 |
| Chen, Y | 8 |
| Wei, L | 1 |
| Gao, P | 1 |
| Zhou, X | 1 |
| Zhu, S | 1 |
| Du, Y | 1 |
| Fang, C | 1 |
| Su, R | 1 |
| Wang, S | 1 |
| Yu, J | 1 |
| He, M | 1 |
| Ding, W | 1 |
| Bruno, AM | 1 |
| Allshouse, AA | 6 |
| Metz, TD | 3 |
| Xiao, Y | 1 |
| Ling, Q | 1 |
| Yao, M | 1 |
| Gu, Y | 2 |
| Lan, Y | 2 |
| Liu, S | 1 |
| Ma, Q | 1 |
| Magee, LA | 6 |
| von Dadelszen, P | 8 |
| Patterson, JK | 1 |
| Neuwahl, S | 1 |
| Goco, N | 5 |
| Goudar, SS | 6 |
| Metgud, M | 3 |
| Somannavar, M | 3 |
| Kavi, A | 4 |
| Okitawutshu, J | 3 |
| Mwapule, A | 2 |
| Mwenechanya, M | 4 |
| Chicuy, J | 2 |
| Figueroa, L | 4 |
| Krebs, NF | 5 |
| Kurhe, K | 3 |
| Das, P | 4 |
| Patel, A | 4 |
| Hibberd, PL | 5 |
| Achieng, E | 4 |
| Nyongesa, P | 4 |
| Bucher, S | 4 |
| Bresnahan, BW | 1 |
| Dimitriadis, E | 1 |
| Estrada-Gutierrez, G | 1 |
| Koga, K | 1 |
| Francisco, RPV | 1 |
| Whitehead, C | 1 |
| Hyett, J | 9 |
| da Silva Costa, F | 6 |
| Nicolaides, K | 6 |
| Menkhorst, E | 1 |
| Mendoza, M | 3 |
| Bonacina, E | 1 |
| Garcia-Manau, P | 1 |
| López, M | 1 |
| Caamiña, S | 1 |
| Vives, À | 1 |
| Lopez-Quesada, E | 1 |
| Ricart, M | 2 |
| Maroto, A | 1 |
| de Mingo, L | 1 |
| Pintado, E | 1 |
| Ferrer-Costa, R | 1 |
| Martin, L | 1 |
| Rodríguez-Zurita, A | 1 |
| Garcia, E | 1 |
| Pallarols, M | 1 |
| Vidal-Sagnier, L | 1 |
| Teixidor, M | 1 |
| Orizales-Lago, C | 1 |
| Pérez-Gomez, A | 1 |
| Ocaña, V | 1 |
| Puerto, L | 1 |
| Millán, P | 1 |
| Alsius, M | 1 |
| Diaz, S | 1 |
| Maiz, N | 1 |
| Carreras, E | 2 |
| Suy, A | 2 |
| Eid, J | 1 |
| Rood, KM | 2 |
| Costantine, MM | 7 |
| Ambati, A | 1 |
| Knight, JS | 1 |
| Zuo, Y | 1 |
| Lailler, G | 1 |
| Grave, C | 1 |
| Gabet, A | 1 |
| Regnault, N | 1 |
| Deneux-Tharaux, C | 1 |
| Kretz, S | 1 |
| Tsatsaris, V | 5 |
| Plu-Bureau, G | 1 |
| Blacher, J | 1 |
| Olie, V | 1 |
| Nowak, K | 1 |
| Otieno, K | 1 |
| Tenge, C | 1 |
| Marete, I | 1 |
| Rutto, F | 1 |
| Kemboi, M | 1 |
| Ekhaguere, OA | 1 |
| Esamai, FO | 1 |
| Joudi, N | 1 |
| Rode, M | 1 |
| Chen, J | 5 |
| Huai, J | 3 |
| Lin, L | 6 |
| Li, B | 4 |
| Kou, X | 2 |
| Yang, J | 1 |
| Shen, LX | 1 |
| Wang, ZL | 1 |
| Liona, CP | 1 |
| Tao, JJ | 1 |
| Adurty, S | 1 |
| D'Angelo, D | 1 |
| DeSancho, MT | 2 |
| Chen, X | 3 |
| Di, W | 1 |
| Ye, L | 1 |
| Hu, Y | 3 |
| Jiang, M | 1 |
| Wu, J | 1 |
| Bu, J | 1 |
| Sun, J | 2 |
| Bei, F | 1 |
| Toussia-Cohen, S | 1 |
| Zaslavsky-Paltiel, I | 1 |
| Farhi, A | 1 |
| Brantz, Y | 1 |
| Maymon, D | 1 |
| Meyer, R | 1 |
| Yinon, Y | 1 |
| Lerner-Geva, L | 3 |
| Mazaki-Tovi, S | 1 |
| Tsur, A | 1 |
| Spehar, SM | 1 |
| Albert-Stone, E | 1 |
| Davis, MB | 1 |
| Ashraf Jahangeer, SM | 1 |
| Khan, AA | 1 |
| Mansoor, M | 1 |
| León-Martínez, D | 1 |
| Lynn, T | 1 |
| Abrahams, VM | 3 |
| Strijbos, LTM | 1 |
| Hendrix, MLE | 1 |
| Al-Nasiry, S | 1 |
| Smits, LJM | 3 |
| Scheepers, HCJ | 3 |
| Krishnamoorthy, K | 1 |
| El Far, M | 1 |
| Muldoon, KA | 1 |
| McLean, C | 1 |
| El-Chaár, D | 1 |
| Corsi, DJ | 1 |
| Rybak, N | 1 |
| Dagvadorj, A | 1 |
| Rennicks White, R | 1 |
| Dingwall-Harvey, ALJ | 1 |
| Gaudet, LM | 1 |
| Walker, MC | 1 |
| Wen, SW | 1 |
| Hedley, PL | 1 |
| Hagen, CM | 1 |
| Wilstrup, C | 1 |
| Christiansen, M | 2 |
| Serati, L | 1 |
| Mardigyan, V | 1 |
| Dominioni, CC | 1 |
| Agozzino, F | 1 |
| Bizzi, E | 1 |
| Trotta, L | 1 |
| Nivuori, M | 1 |
| Maestroni, S | 2 |
| Negro, E | 1 |
| Imazio, M | 4 |
| Brucato, A | 5 |
| Cuenca-Gómez, D | 2 |
| de Paco Matallana, C | 5 |
| Rolle, V | 1 |
| Valiño, N | 1 |
| Revello, R | 1 |
| Adiego, B | 1 |
| Molina, FS | 5 |
| Carrillo, MP | 1 |
| Delgado, JL | 3 |
| Santacruz, B | 1 |
| Gil, MM | 2 |
| Yin, M | 1 |
| Qin, X | 1 |
| Stephenson, DJ | 2 |
| MacKnight, HP | 1 |
| Hoeferlin, LA | 1 |
| Washington, SL | 2 |
| Sawyers, C | 1 |
| Archer, KJ | 1 |
| Chalfant, CE | 2 |
| Horgan, R | 1 |
| Hage Diab, Y | 1 |
| Waller, J | 1 |
| Abuhamad, A | 1 |
| Roberts, JM | 5 |
| King, TL | 1 |
| Barton, JR | 3 |
| Beck, S | 1 |
| Bernstein, IM | 1 |
| Buck, TE | 1 |
| Forgues-Lackie, MA | 1 |
| Facco, FL | 1 |
| Gernand, AD | 2 |
| Graves, CR | 1 |
| Jeyabalan, A | 1 |
| Hauspurg, A | 3 |
| Manuck, TA | 1 |
| Myers, JE | 2 |
| Powell, TM | 1 |
| Sutton, EF | 3 |
| Tinker, E | 1 |
| Tsigas, E | 1 |
| Myatt, L | 1 |
| Kumar, N | 1 |
| Roberge, S | 22 |
| Kumar, NR | 1 |
| Morgan, JL | 1 |
| White, KJ | 1 |
| Son, M | 1 |
| Lundsberg, LS | 1 |
| Culhane, JF | 1 |
| Partridge, C | 1 |
| Reddy, UM | 2 |
| Merriam, AA | 1 |
| Honigberg, MC | 1 |
| Truong, B | 1 |
| Khan, RR | 1 |
| Xiao, B | 1 |
| Bhatta, L | 1 |
| Vy, HMT | 1 |
| Guerrero, RF | 1 |
| Schuermans, A | 1 |
| Selvaraj, MS | 1 |
| Patel, AP | 1 |
| Koyama, S | 1 |
| Cho, SMJ | 1 |
| Vellarikkal, SK | 1 |
| Trinder, M | 1 |
| Urbut, SM | 1 |
| Gray, KJ | 2 |
| Brumpton, BM | 1 |
| Patil, S | 1 |
| Zöllner, S | 1 |
| Antopia, MC | 1 |
| Saxena, R | 1 |
| Nadkarni, GN | 1 |
| Do, R | 1 |
| Yan, Q | 1 |
| Pe'er, I | 1 |
| Verma, SS | 1 |
| Gupta, RM | 1 |
| Haas, DM | 1 |
| Martin, HC | 1 |
| van Heel, DA | 1 |
| Laisk, T | 1 |
| Natarajan, P | 1 |
| Aslan, K | 1 |
| Kasapoglu, I | 1 |
| Cinar, C | 1 |
| Cakir, C | 1 |
| Avci, B | 1 |
| Uncu, G | 1 |
| Nobles, CJ | 5 |
| Mendola, P | 4 |
| Mumford, SL | 24 |
| Perkins, NJ | 20 |
| Bangi, EF | 1 |
| Yousuf, MH | 1 |
| Upadhyay, S | 1 |
| Jain, P | 1 |
| Jain, R | 1 |
| Foster, AB | 1 |
| Park, F | 3 |
| Robillard, PY | 1 |
| Dekker, G | 1 |
| Scioscia, M | 1 |
| Bonsante, F | 1 |
| Boukerrou, M | 1 |
| Iacobelli, S | 1 |
| Tran, PL | 1 |
| Benhalima, K | 1 |
| Beunen, K | 1 |
| Siegelaar, SE | 1 |
| Painter, R | 1 |
| Murphy, HR | 1 |
| Feig, DS | 1 |
| Donovan, LE | 1 |
| Polsky, S | 1 |
| Buschur, E | 1 |
| Levy, CJ | 1 |
| Kudva, YC | 1 |
| Battelino, T | 1 |
| Ringholm, L | 3 |
| Mathiesen, ER | 3 |
| Mathieu, C | 1 |
| Parchem, JG | 2 |
| Sibai, BM | 23 |
| Cardoso, MIMP | 1 |
| Rezende, KBC | 1 |
| Da Matta, FG | 1 |
| Saunders, C | 1 |
| Cardoso, FFO | 1 |
| Costa Junior, IB | 1 |
| Gama, LB | 1 |
| Amim, J | 1 |
| Bornia, RG | 1 |
| Regan, L | 10 |
| Rai, R | 8 |
| Saravelos, S | 2 |
| Li, TC | 3 |
| Demuth, B | 1 |
| Stubert, J | 1 |
| Hinz, B | 1 |
| Berger, R | 1 |
| Nzelu, D | 1 |
| Palmer, T | 1 |
| Stott, D | 1 |
| Pandya, P | 1 |
| Napolitano, R | 1 |
| Casagrandi, D | 1 |
| Ammari, C | 1 |
| Hillman, S | 1 |
| Hoffman, MK | 8 |
| Somannavar, MS | 2 |
| Metgud, MC | 1 |
| Nielsen, E | 1 |
| Trottmann, F | 1 |
| Challande, P | 1 |
| Manegold-Brauer, G | 1 |
| Ardabili, S | 1 |
| Hösli, I | 1 |
| Schönberger, H | 1 |
| Amylidi-Mohr, S | 1 |
| Kohl, J | 1 |
| Hodel, M | 1 |
| Surbek, D | 1 |
| Raio, L | 1 |
| Mosimann, B | 1 |
| Granada-Gómez, M | 1 |
| Velásquez-Berrío, M | 2 |
| Molina, CR | 1 |
| Martín, SS | 1 |
| Escudero, C | 1 |
| Alvarez, AM | 3 |
| Cadavid, AP | 2 |
| Nuss, EE | 1 |
| Tembo, AM | 1 |
| Do, NC | 1 |
| Vestgaard, M | 1 |
| Nørgaard, SK | 1 |
| Damm, P | 2 |
| Hooper, A | 1 |
| Bacal, V | 1 |
| Bedaiwy, MA | 1 |
| Dhillon-Smith, RK | 1 |
| Melo, P | 1 |
| Kaur, R | 1 |
| Fox, E | 1 |
| Devall, A | 1 |
| Woodhead, N | 1 |
| Coomarasamy, A | 7 |
| Chen, WY | 1 |
| Sun, SF | 1 |
| Gross, ME | 1 |
| Godecker, A | 1 |
| Hughes, A | 1 |
| Sampene, K | 1 |
| Ayyash, M | 1 |
| Goyert, G | 1 |
| Pitts, D | 1 |
| Khangura, R | 1 |
| Garcia, R | 1 |
| Jacobsen, G | 1 |
| Shaman, M | 1 |
| Beernink, RHJ | 1 |
| Scherjon, SA | 1 |
| Cremers, TIFH | 1 |
| van Asselt, ADI | 1 |
| Singh, N | 1 |
| Shuman, S | 1 |
| Chiofalo, J | 1 |
| Cabrera, M | 1 |
| Smith, A | 1 |
| de Sousa, EF | 1 |
| Miele, MJ | 1 |
| Guida, JP | 1 |
| Rehder, PM | 1 |
| Surita, FG | 1 |
| Costa, ML | 2 |
| Lin, RC | 1 |
| Chao, YY | 1 |
| Su, MT | 3 |
| Tsai, HL | 3 |
| Tsai, PY | 3 |
| Wang, CY | 3 |
| Vinogradov, R | 3 |
| Smith, V | 1 |
| Hiu, S | 1 |
| McParlin, C | 1 |
| Farnworth, A | 1 |
| Araújo-Soares, V | 2 |
| Park, SR | 1 |
| Kim, SR | 1 |
| Min, EK | 1 |
| Oh, BC | 1 |
| Jung, Y | 1 |
| Kim, YH | 1 |
| Lee, HY | 1 |
| Jain, V | 1 |
| Guo, X | 1 |
| Dilidaxi, D | 1 |
| Wang, C | 1 |
| Sang, F | 1 |
| Pei, G | 1 |
| Li, W | 2 |
| Mirzamoradi, M | 1 |
| Dehghani, Z | 1 |
| Azadi, P | 1 |
| Mohammadi, M | 1 |
| Khavandegar, A | 1 |
| Bakhtiyari, M | 1 |
| Mallampati, D | 3 |
| Werner, EF | 3 |
| Wertaschnigg, D | 1 |
| Mol, BWJ | 3 |
| Lazzaroni, MG | 3 |
| Fredi, M | 2 |
| Chighizola, CB | 5 |
| Del Ross, T | 6 |
| Kuzenko, A | 1 |
| Raimondo, MG | 2 |
| Lojacono, A | 2 |
| Ramazzotto, F | 1 |
| Zatti, S | 2 |
| Trespidi, L | 4 |
| Meroni, PL | 7 |
| Pengo, V | 3 |
| Ruffatti, A | 11 |
| Turner, JM | 1 |
| Robertson, NT | 1 |
| Hartel, G | 1 |
| Kumar, S | 2 |
| Zhu, J | 4 |
| Chen, C | 4 |
| Dutta, S | 1 |
| Salomon, C | 1 |
| Chaemsaithong, P | 2 |
| Plana, MN | 1 |
| Orieke, D | 1 |
| Ohaeri, OC | 1 |
| Ijeh, II | 1 |
| Ijioma, SN | 1 |
| Wang, M | 5 |
| Zhang, P | 1 |
| Yu, S | 1 |
| Zhou, G | 1 |
| Lv, J | 1 |
| Nallapothula, D | 1 |
| Guo, C | 1 |
| Singh, RR | 1 |
| Ou, H | 1 |
| Yu, Q | 2 |
| Bao, SH | 3 |
| Chigirin, N | 1 |
| Hoch, V | 1 |
| Ahmed, H | 1 |
| Frempong, ST | 3 |
| Ruan, JL | 2 |
| Karadağ, C | 1 |
| Akar, B | 1 |
| Gönenç, G | 1 |
| Aslancan, R | 1 |
| Yılmaz, N | 1 |
| Çalışkan, E | 1 |
| Ferrer-Oliveras, R | 4 |
| Sáez-Comet, L | 2 |
| Lefkou, E | 3 |
| Mekinian, A | 12 |
| Hoxha, A | 7 |
| Nalli, C | 1 |
| Marozio, L | 4 |
| Maina, A | 3 |
| Ríos-Garcés, R | 2 |
| Carolis, S | 1 |
| Monteleone, G | 1 |
| Latino, O | 2 |
| LLurba, E | 3 |
| Garrido-Gimenez, C | 1 |
| Rovere-Querini, P | 3 |
| Canti, V | 4 |
| Mayer-Pickel, K | 4 |
| Tabacco, S | 3 |
| Arnau, A | 2 |
| Trapé, J | 2 |
| Ruiz-Hidalgo, D | 2 |
| Sos, L | 2 |
| Farran-Codina, I | 2 |
| Maze, D | 1 |
| Kazi, S | 1 |
| Gupta, V | 2 |
| Malinowski, AK | 1 |
| Fazelzad, R | 1 |
| Shah, PS | 1 |
| Shehata, N | 1 |
| Pooh, RK | 1 |
| Zheng, M | 1 |
| Ma, R | 1 |
| Chaiyasit, N | 1 |
| Tokunaka, M | 1 |
| Shaw, SW | 1 |
| Seshadri, S | 1 |
| Choolani, M | 1 |
| Wataganara, T | 1 |
| Yeo, GSH | 1 |
| Leung, WC | 1 |
| Sekizawa, A | 1 |
| Naruse, K | 1 |
| Saito, S | 1 |
| Sahota, D | 1 |
| Putra, M | 1 |
| Balasooriya, MM | 1 |
| Boscia, AL | 1 |
| Dalkiran, E | 1 |
| Sokol, RJ | 1 |
| Favaro, M | 4 |
| Calligaro, A | 4 |
| Ruffatti, AT | 2 |
| Infantolino, C | 1 |
| Tonello, M | 4 |
| Mattia, E | 1 |
| Chimenea, Á | 1 |
| García-Díaz, L | 1 |
| Moreno-De Las Heras, M | 1 |
| Coserria, F | 1 |
| Antiñolo, G | 1 |
| Hybiak, J | 1 |
| Broniarek, I | 1 |
| Kiryczyński, G | 1 |
| Los, LD | 1 |
| Rosik, J | 1 |
| Machaj, F | 1 |
| Sławiński, H | 1 |
| Jankowska, K | 1 |
| Urasińska, E | 1 |
| Jacobson, B | 1 |
| Rambiritch, V | 1 |
| Paek, D | 1 |
| Sayre, T | 1 |
| Naidoo, P | 1 |
| Shan, J | 1 |
| Leisegang, R | 1 |
| Hamdi, SM | 2 |
| Sault, C | 2 |
| Piver, E | 1 |
| Genoux, A | 1 |
| Masson, D | 1 |
| Guibourdenche, J | 1 |
| Mirzakhani, H | 1 |
| McElrath, TF | 1 |
| Weiss, ST | 1 |
| Voutetakis, A | 2 |
| Pervanidou, P | 2 |
| Kanaka-Gantenbein, C | 2 |
| Duley, L | 11 |
| Hunter, KE | 1 |
| Seidler, AL | 2 |
| Askie, LM | 4 |
| Eudy, AM | 1 |
| Voora, D | 1 |
| Myers, RA | 1 |
| Clowse, MEB | 1 |
| Gil-Villa, AM | 1 |
| Rojas-López, M | 1 |
| Cadavid J, AP | 1 |
| Arslan, E | 1 |
| Branch, DW | 12 |
| Jukic, AMZ | 1 |
| Padiyara, P | 1 |
| Bracken, MB | 1 |
| McConnaughey, DR | 1 |
| Steiner, AZ | 1 |
| Lecarpentier, E | 6 |
| Gris, JC | 11 |
| Cochery-Nouvellon, E | 4 |
| Mercier, E | 5 |
| Abbas, H | 1 |
| Thadhani, R | 3 |
| Karumanchi, SA | 4 |
| Haddad, B | 10 |
| van Montfort, P | 2 |
| van Dooren, IMA | 2 |
| Lemmens, SMP | 1 |
| Zelis, M | 2 |
| Zwaan, IM | 2 |
| Spaanderman, MEA | 2 |
| Wan, A | 1 |
| Butcher, K | 1 |
| Hodgson, M | 1 |
| Schultz, K | 1 |
| Bungard, TJ | 1 |
| Copel, JA | 1 |
| Platt, LD | 1 |
| Hobbins, JC | 2 |
| Afshar, Y | 1 |
| Grechukhina, O | 1 |
| Bromley, B | 1 |
| Han, CS | 2 |
| Pettker, C | 1 |
| Sibai, B | 8 |
| Sonek, J | 1 |
| Werner, E | 1 |
| Chescheir, N | 1 |
| Roubalová, L | 1 |
| Vojtěch, J | 1 |
| Feyereisl, J | 1 |
| Krofta, L | 1 |
| Skřivánek, A | 1 |
| Marková, I | 1 |
| Lošan, P | 1 |
| Pilka, R | 1 |
| Lubušký, M | 1 |
| Cuckle, H | 3 |
| Hagen, M | 1 |
| Alchin, J | 1 |
| Abheiden, CNH | 3 |
| Fuijkschot, WW | 3 |
| Qiu, Y | 1 |
| Yu, ED | 1 |
| Xiang, S | 1 |
| Meng, R | 1 |
| Niu, KF | 1 |
| Zhu, H | 1 |
| Karunia, RI | 1 |
| Purnamayanti, A | 1 |
| Prasetyadi, FOH | 1 |
| Meertens, LJE | 1 |
| Loussert, L | 1 |
| Vidal, F | 1 |
| Parant, O | 1 |
| Quinlivan, JA | 1 |
| Kodkany, BS | 2 |
| Garces, A | 2 |
| Zehra, F | 1 |
| Miodovnik, M | 8 |
| He, Y | 2 |
| Chen, L | 3 |
| Liu, C | 1 |
| Han, Y | 2 |
| Liang, C | 1 |
| Xie, Q | 1 |
| Zhou, J | 2 |
| Cheng, Z | 1 |
| Ma'ayeh, M | 2 |
| Kniss, D | 1 |
| Diniz, ALD | 1 |
| Paes, MMBM | 1 |
| Diniz, AD | 1 |
| Ekawati, FM | 1 |
| Emilia, O | 1 |
| Brennecke, S | 1 |
| Gunn, J | 1 |
| Licqurish, S | 1 |
| Lau, P | 1 |
| Radin, M | 2 |
| Cecchi, I | 1 |
| Schreiber, K | 5 |
| Rubini, E | 1 |
| Roccatello, D | 2 |
| Cuadrado, MJ | 2 |
| Sciascia, S | 5 |
| Mengesha, Z | 1 |
| Notaras, S | 1 |
| Liamputtong, P | 1 |
| Fulcher, I | 4 |
| Lee, G | 4 |
| Kumar, R | 4 |
| Young, BC | 1 |
| Motum, P | 2 |
| Premru-Srsen, T | 1 |
| Kocic, Z | 1 |
| Verdenik, I | 1 |
| Ling, HZ | 1 |
| Jara, PG | 1 |
| Bisquera, A | 1 |
| Kametas, NA | 1 |
| Xiang, H | 1 |
| Kalafat, E | 1 |
| Shirazi, A | 1 |
| Banala, C | 1 |
| Moreno, S | 1 |
| Cruz, Y | 1 |
| Boelig, RC | 2 |
| Saccone, G | 2 |
| Berghella, V | 5 |
| Schoen, CN | 1 |
| Roman, A | 5 |
| Russo, LM | 1 |
| Whitcomb, BW | 5 |
| Freeman, JR | 1 |
| Sjaarda, LA | 16 |
| Schliep, KC | 5 |
| Grewal, J | 1 |
| Brentisci, A | 1 |
| Delorme, P | 1 |
| Gu, W | 1 |
| Lin, J | 1 |
| Hou, YY | 1 |
| Lin, N | 1 |
| Song, MF | 1 |
| Zeng, WJ | 1 |
| Shang, J | 1 |
| Huang, HF | 1 |
| Hofmeyr, GJ | 1 |
| Wang, T | 3 |
| Kang, X | 3 |
| He, L | 2 |
| Liu, Z | 3 |
| Liu, F | 2 |
| Kwiatkowski, S | 1 |
| Borowski, D | 1 |
| Kajdy, A | 1 |
| Rokita, W | 1 |
| Wielgos, M | 2 |
| Gavillet, M | 2 |
| Panchaud, A | 1 |
| Baud, D | 2 |
| Yeung, EH | 2 |
| Guan, W | 1 |
| Zeng, X | 1 |
| Salas, LA | 1 |
| de Prado Bert, P | 1 |
| van Meel, ER | 1 |
| Malmberg, A | 1 |
| Sunyer, J | 1 |
| Duijts, L | 1 |
| Felix, JF | 1 |
| Czamara, D | 1 |
| Hämäläinen, E | 4 |
| Binder, EB | 1 |
| Räikkönen, K | 4 |
| Lahti, J | 1 |
| London, SJ | 1 |
| Hamulyák, EN | 1 |
| Scheres, LJ | 1 |
| Marijnen, MC | 1 |
| Goddijn, M | 6 |
| Middeldorp, S | 8 |
| Neykova, K | 2 |
| Dimitrova, V | 3 |
| Dimitrov, R | 3 |
| Campbell, HD | 1 |
| Purdue-Smithe, AC | 1 |
| Radoc, JG | 2 |
| Girling, J | 1 |
| Pregnolato, F | 1 |
| Comerio, C | 1 |
| Bartoli, F | 1 |
| Lonati, PA | 1 |
| Borghi, MO | 1 |
| Acaia, B | 2 |
| Ossola, MW | 1 |
| Ferrazzi, E | 1 |
| Ghazanfarpour, M | 1 |
| Sathyapalan, T | 1 |
| Banach, M | 1 |
| Jamialahmadi, T | 1 |
| Sahebkar, A | 1 |
| Wesselink, AK | 2 |
| Bresnick, KA | 1 |
| Hatch, EE | 2 |
| Rothman, KJ | 3 |
| Mikkelsen, EM | 2 |
| Wang, TR | 1 |
| Huybrechts, KF | 1 |
| Wise, LA | 2 |
| Ramlakhan, KP | 1 |
| Johnson, MR | 1 |
| Roos-Hesselink, JW | 1 |
| Damarany, AI | 1 |
| Ghanem, N | 1 |
| Gao, YH | 1 |
| Xu, L | 1 |
| Li, ZY | 1 |
| Montgomery, DM | 1 |
| Reep, DT | 1 |
| Alam, SMK | 1 |
| Lee, SM | 1 |
| Springel, EH | 1 |
| Lourenço, I | 1 |
| Gomes, H | 1 |
| Ribeiro, J | 1 |
| Caeiro, F | 1 |
| Rocha, P | 1 |
| de Groot, C | 1 |
| Godínez, V | 1 |
| Godínez-Vázquez, VJ | 1 |
| Godínez-Vázquez, PDR | 1 |
| Sosa-Bustamante, GP | 1 |
| Díaz de León-Morales, LV | 1 |
| Guy, GP | 1 |
| Leslie, K | 1 |
| Diaz Gomez, D | 1 |
| Forenc, K | 1 |
| Buck, E | 1 |
| Aslan, I | 1 |
| Ozyigit, S | 1 |
| Paul, LT | 1 |
| Tosun, O | 1 |
| Tulay, P | 1 |
| Gibson, KS | 1 |
| Hameed, AB | 2 |
| Sandström, A | 1 |
| Kametas, N | 1 |
| Shepherd, E | 3 |
| Grivell, RM | 2 |
| Doherty, A | 1 |
| McLaughlin, K | 1 |
| Skeith, L | 3 |
| Blondon, M | 1 |
| Ní Áinle, F | 1 |
| Gong, Y | 1 |
| Andriessen, VC | 1 |
| Connell, M | 1 |
| Sjaarda, L | 4 |
| Abdi, N | 1 |
| Rozrokh, A | 1 |
| Alavi, A | 2 |
| Zare, S | 1 |
| Hessami, K | 1 |
| Scott, G | 1 |
| Gillon, TE | 1 |
| Pels, A | 1 |
| Romero, DSF | 1 |
| Larrañaga, G | 1 |
| Agrawal, A | 1 |
| Wenger, NK | 1 |
| Green, M | 1 |
| Shennan, A | 1 |
| Tapp, S | 6 |
| Girard, M | 1 |
| Leclair, G | 1 |
| Varoudi, K | 1 |
| Pombo, J | 1 |
| Jurisic, A | 1 |
| Jurisic, Z | 1 |
| Contento, G | 1 |
| Girardi, G | 1 |
| Cronqvist, T | 1 |
| Erlandsson, L | 1 |
| Tannetta, D | 1 |
| Hansson, SR | 1 |
| de Alwis, N | 1 |
| Binder, NK | 1 |
| Beard, S | 1 |
| Kaitu'u-Lino, TJ | 1 |
| Brownfoot, F | 1 |
| Hannan, NJ | 1 |
| Barragan, AA | 2 |
| Bauman, L | 1 |
| da Costa, L | 2 |
| Velez, J | 2 |
| Gonzalez, JDR | 2 |
| Schuenemann, GM | 2 |
| Menichetti, B | 2 |
| Piñeiro, J | 1 |
| Bas, S | 2 |
| Bauman, LM | 1 |
| Lakritz, J | 1 |
| Coetzee, JF | 1 |
| Piñeiro, JM | 1 |
| Boag, C | 1 |
| Murphy, P | 2 |
| McGeeney, D | 1 |
| Kunadian, V | 1 |
| Robson, SC | 3 |
| Lanssens, D | 1 |
| Thijs, IM | 1 |
| Gyselaers, W | 1 |
| Eubanks, AA | 1 |
| Hill, MJ | 2 |
| Decherney, AH | 2 |
| Ye, A | 1 |
| Yang, Z | 1 |
| Shen, X | 1 |
| Zhou, C | 1 |
| Wanees, M | 1 |
| Zhan, T | 1 |
| Rezai, H | 1 |
| Ahmad, S | 1 |
| Alzahrani, FA | 1 |
| Sanchez-Aranguren, L | 1 |
| Dias, IH | 1 |
| Agrawal, S | 1 |
| Sparatore, A | 1 |
| Wang, K | 1 |
| Ahmed, A | 1 |
| Schrickel, L | 1 |
| Heidel, FH | 1 |
| Sadjadian, P | 1 |
| Becker, T | 1 |
| Kolatzki, V | 1 |
| Hochhaus, A | 1 |
| Griesshammer, M | 6 |
| Wille, K | 1 |
| Breslin, N | 1 |
| Gyamfi-Bannerman, C | 2 |
| Booker, WA | 1 |
| Kuroda, K | 1 |
| Matsumura, Y | 1 |
| Ikemoto, Y | 1 |
| Segawa, T | 1 |
| Hashimoto, T | 1 |
| Fukuda, J | 1 |
| Nakagawa, K | 1 |
| Uchida, T | 1 |
| Ochiai, A | 1 |
| Horimoto, Y | 1 |
| Arakawa, A | 1 |
| Nojiri, S | 1 |
| Itakura, A | 1 |
| Sugiyama, R | 1 |
| He, G | 2 |
| Chen, M | 2 |
| Han, AR | 2 |
| Han, JW | 1 |
| Lee, SK | 1 |
| Finnegan, C | 1 |
| Breathnach, FM | 1 |
| Breathnach, F | 5 |
| McAuliffe Frcog, FM | 1 |
| Kay, VR | 1 |
| Wedel, N | 1 |
| Smith, GN | 1 |
| Gangat, N | 3 |
| Tefferi, A | 5 |
| Voutsos, L | 1 |
| King, AN | 1 |
| Boelig, R | 2 |
| Ginsberg, NA | 1 |
| Levine, EM | 1 |
| Shen, F | 1 |
| O'Brien, C | 1 |
| Phung, J | 1 |
| Emeto, T | 1 |
| Guo, F | 2 |
| Tolcher, MC | 3 |
| Sangi-Haghpeykar, H | 3 |
| Aagaard, KM | 3 |
| Gervasi, MT | 1 |
| Juan, J | 2 |
| Yu, M | 2 |
| Cross-Barnet, C | 1 |
| Courtot, B | 1 |
| Benatar, S | 1 |
| Hill, I | 1 |
| Bouvier, S | 3 |
| Fortier, M | 1 |
| Vincent, L | 1 |
| Demattei, C | 1 |
| Mousty, E | 2 |
| Herzog, M | 1 |
| Rommelaere, G | 1 |
| Nouvellon, E | 1 |
| Letouzey, V | 2 |
| Bettiol, A | 1 |
| Avagliano, L | 1 |
| Lombardi, N | 1 |
| Crescioli, G | 1 |
| Emmi, G | 1 |
| Urban, ML | 1 |
| Virgili, G | 1 |
| Ravaldi, C | 1 |
| Vannacci, A | 1 |
| Rodger, MA | 1 |
| Bates, SM | 2 |
| Gonsalves, C | 1 |
| Karovitch, A | 1 |
| Taylor, TS | 1 |
| Saravia-Sucaticona, M | 1 |
| Martinez-Garcia, FE | 1 |
| Solar-Cuba, MJ | 1 |
| Platt, RW | 1 |
| Zuo, Q | 1 |
| Zou, Y | 1 |
| Huang, S | 1 |
| Xu, Y | 2 |
| Zhang, T | 1 |
| Ge, Z | 1 |
| Jiang, Z | 1 |
| Lee, EE | 1 |
| Jun, JK | 1 |
| Lee, EB | 1 |
| Jogu, HR | 1 |
| Yarra, P | 1 |
| Camargo, EC | 1 |
| Singhal, AB | 1 |
| Mather, AR | 1 |
| Dom, AM | 1 |
| Thorburg, LL | 1 |
| Blomqvist, LRF | 1 |
| Strandell, AM | 1 |
| Jeppsson, A | 1 |
| Hellgren, MSE | 1 |
| Lah, S | 1 |
| Lee, V | 1 |
| Athayde, N | 1 |
| Inglis, E | 1 |
| Walker, S | 2 |
| Cluver, C | 1 |
| Van Doorn, R | 1 |
| Mukhtarova, N | 1 |
| Flyke, IP | 1 |
| Lasarev, M | 1 |
| Hennekens, CH | 1 |
| Hoppe, KK | 1 |
| Andrade, JAFM | 1 |
| Silva, RMD | 1 |
| Carvalho, FHC | 1 |
| Kolanska, K | 2 |
| Dabi, Y | 1 |
| Dechartres, A | 1 |
| Cohen, J | 4 |
| Ben Kraiem, Y | 1 |
| Selleret, L | 1 |
| Mathieu d'Argent, E | 1 |
| Placais, L | 2 |
| Cheloufi, M | 1 |
| Johanet, C | 2 |
| Rosefort, A | 1 |
| Bornes, M | 4 |
| Suner, L | 1 |
| Delhommeau, F | 1 |
| Ledée, N | 1 |
| Chabbert Buffet, N | 1 |
| Darai, E | 2 |
| Antoine, JM | 1 |
| Fain, O | 9 |
| Kayem, G | 4 |
| Li, G | 4 |
| Wei, W | 1 |
| Suo, L | 1 |
| Zhang, C | 2 |
| Yu, H | 2 |
| Liu, H | 2 |
| Guo, Q | 1 |
| Zhen, X | 1 |
| Choi, YJ | 1 |
| Shin, S | 1 |
| Kuo, PL | 2 |
| Carpentier, C | 2 |
| Camiré, B | 1 |
| Boutin, A | 2 |
| Mourad, A | 1 |
| Antaki, R | 1 |
| Jamal, W | 1 |
| Albaini, O | 1 |
| Chen, S | 1 |
| Zhao, M | 2 |
| Chen, Q | 1 |
| Benito-Garcia, F | 1 |
| Pires, I | 1 |
| Lima, J | 1 |
| Stern, C | 3 |
| Weiss, EC | 1 |
| Kutllovci-Hasani, K | 1 |
| Nanda, M | 1 |
| Eberhard, K | 1 |
| Cervar-Zivkovic, M | 2 |
| Prüller, F | 1 |
| Wang, Z | 2 |
| Su, F | 1 |
| Blue, NR | 1 |
| Page, JM | 1 |
| Zhao, X | 2 |
| Li, M | 1 |
| Monari, F | 2 |
| Menichini, D | 1 |
| Pignatti, L | 1 |
| Basile, L | 1 |
| Facchinetti, F | 3 |
| Neri, I | 1 |
| Shen, L | 1 |
| Martinez-Portilla, RJ | 1 |
| Man, R | 1 |
| Devani, P | 1 |
| Morris, RK | 2 |
| Araganji, R | 1 |
| Vernekar, SS | 1 |
| Rode, L | 1 |
| Ekelund, CK | 1 |
| Riishede, I | 1 |
| Rasmussen, S | 1 |
| Lidegaard, Ø | 1 |
| Tabor, A | 1 |
| Khizroeva, J | 2 |
| Bitsadze, V | 2 |
| Makatsariya, A | 2 |
| Arslanbekova, M | 1 |
| Babaeva, N | 1 |
| Tsibizova, V | 1 |
| Shkoda, A | 1 |
| Makatsariya, N | 1 |
| Tretyakova, M | 1 |
| Solopova, A | 1 |
| Gadaeva, Z | 1 |
| Vorobev, A | 1 |
| Khamani, I | 1 |
| Aslanova, Z | 1 |
| Nakaidze, I | 1 |
| Mischenko, A | 1 |
| Grigoreva, K | 1 |
| Kunesko, N | 1 |
| Egorova, E | 1 |
| Mashkova, T | 1 |
| Chappell, LC | 2 |
| Kingdom, J | 3 |
| Guglielmelli, P | 1 |
| Al-Kali, A | 1 |
| Wolanskyj-Spinner, AP | 1 |
| Camoriano, J | 1 |
| Patnaik, MM | 1 |
| Pardanani, A | 1 |
| Hanson, CA | 1 |
| Vannucchi, AM | 1 |
| Grove, EL | 1 |
| Hvas, AM | 1 |
| Wu, Q | 1 |
| Wei, J | 1 |
| Hu, J | 3 |
| Zheng, S | 1 |
| Smith, VJ | 1 |
| Kupferminc, MJ | 2 |
| Kliger, C | 1 |
| Rimon, E | 1 |
| Asher-Landsberg, J | 1 |
| Skornick-Rapaport, A | 1 |
| Gamzu, R | 1 |
| Yogev, Y | 1 |
| Shi, T | 1 |
| Gu, ZD | 1 |
| Diao, QZ | 1 |
| Chavatza, K | 1 |
| Kostopoulou, M | 1 |
| Nikolopoulos, D | 1 |
| Gioti, O | 1 |
| Togia, K | 1 |
| Aringer, M | 1 |
| Boletis, J | 1 |
| Houssiau, FA | 1 |
| Jayne, D | 1 |
| Svenungsson, E | 1 |
| Bertsias, G | 1 |
| Fanouriakis, A | 1 |
| Boumpas, DT | 1 |
| Huang, J | 2 |
| Zhao, Y | 3 |
| Zhang, W | 3 |
| Xiang, X | 1 |
| Wang, F | 1 |
| Zhao, N | 2 |
| Zhou, Z | 1 |
| Milosavljevic, A | 1 |
| Elsea, SH | 1 |
| Scaglia, F | 1 |
| Cruz-Lemini, M | 1 |
| Vázquez, JC | 1 |
| Ullmo, J | 1 |
| Andresen, JH | 1 |
| Saugstad, OD | 1 |
| Bai, W | 1 |
| Cui, S | 1 |
| Mi, Y | 1 |
| Ding, H | 1 |
| Sun, X | 1 |
| Afolabi, BB | 1 |
| Babah, OA | 1 |
| Adeyemo, TA | 1 |
| Odukoya, OO | 1 |
| Ezeaka, CV | 1 |
| Nwaiwu, O | 1 |
| Oshodi, YA | 1 |
| Ogunnaike, BA | 1 |
| Shopit, A | 1 |
| Radin, RG | 6 |
| Mitchell, E | 1 |
| Wilcox, B | 2 |
| Galai, N | 12 |
| Wactawski-Wende, J | 10 |
| Stanford, JB | 4 |
| Madar, H | 1 |
| Brun, S | 1 |
| Coatleven, F | 1 |
| Nithart, A | 1 |
| Lecoq, C | 1 |
| Gleyze, M | 1 |
| Merlot, B | 1 |
| Elmahdy, M | 1 |
| Abdelsalam, EA | 1 |
| Maghraby, HA | 1 |
| Calhoun, B | 1 |
| Hoover, E | 1 |
| Seybold, D | 1 |
| Broce, M | 1 |
| Hill, A | 1 |
| Schaible, B | 1 |
| Bracero, LA | 1 |
| Käehne, LV | 1 |
| Rørbye, C | 1 |
| Datta, P | 1 |
| Rewers-Felkins, K | 1 |
| Kallem, RR | 1 |
| Baker, T | 1 |
| Hale, TW | 1 |
| Gulati, M | 1 |
| Dixon, CL | 1 |
| Marrs, C | 1 |
| Pacheco, LD | 2 |
| Saade, GR | 2 |
| Chiossi, G | 1 |
| Chu, DM | 1 |
| Hollier, LM | 1 |
| Mastrobattista, JM | 1 |
| Racusin, DA | 1 |
| Ramin, SM | 1 |
| Abdulghani, S | 1 |
| Moretti, F | 1 |
| Gruslin, A | 1 |
| Grynspan, D | 1 |
| Campos-Outcalt, D | 3 |
| Wallace, DD | 1 |
| Hemingway-Foday, JJ | 1 |
| Hambidge, KM | 1 |
| Carrat, F | 2 |
| Costedoat-Chalumeau, N | 5 |
| Masseau, A | 2 |
| Morel, N | 3 |
| Esteve-Valverde, EE | 1 |
| De Carolis, S | 8 |
| Josselin-Mahr, L | 2 |
| Abisror, N | 3 |
| Nicaise-Roland, P | 4 |
| Jackson, JR | 1 |
| Kempen, PM | 1 |
| McMaster-Fay, RA | 1 |
| Hyett, JA | 1 |
| Riancho-Zarrabeitia, L | 1 |
| Daroca, G | 1 |
| Muñoz, P | 1 |
| López-Hoyos, M | 1 |
| Haya, A | 1 |
| Martínez-Taboada, VM | 1 |
| Adkins, K | 1 |
| Heyborne, KD | 7 |
| Viguiliouk, E | 1 |
| Park, AL | 4 |
| Geary, MP | 1 |
| Akolekar, R | 4 |
| Cicero, S | 3 |
| Janga, D | 3 |
| Singh, M | 3 |
| Persico, N | 5 |
| Jani, JC | 5 |
| Plasencia, W | 6 |
| Papaioannou, G | 4 |
| Tenenbaum-Gavish, K | 2 |
| Gizurarson, S | 2 |
| Maclagan, K | 1 |
| Ali, MK | 2 |
| Abbas, AM | 1 |
| Yosef, AH | 1 |
| Bahloul, M | 1 |
| Shiran, A | 1 |
| Adawi, S | 1 |
| Rubinshtein, R | 1 |
| Bardicef, M | 1 |
| Gutterman, E | 1 |
| Bloemenkamp, KWM | 1 |
| Bosmans, JE | 1 |
| Kok, M | 1 |
| van Laar, JO | 1 |
| Scheepers, H | 1 |
| Duvekot, HJJ | 1 |
| van der Post, JAM | 1 |
| Naaktgeboren, C | 1 |
| Iriye, BK | 1 |
| Gregory, KD | 1 |
| Grobman, WA | 1 |
| Brown, HL | 1 |
| Poon, LCY | 1 |
| Tsokaki, T | 1 |
| Leipold, G | 1 |
| Shearing, S | 2 |
| De Stefani, L | 1 |
| Evangelinakis, N | 1 |
| Gonzalez-Vanegas, O | 1 |
| Greene, MF | 1 |
| Solomon, CG | 1 |
| Deguchi, M | 2 |
| Yamada, H | 3 |
| Sugiura-Ogasawara, M | 3 |
| Morikawa, M | 2 |
| Fujita, D | 1 |
| Miki, A | 1 |
| Makino, S | 1 |
| Murashima, A | 4 |
| Abreu, P | 1 |
| Clarke, H | 2 |
| Jorgensen, A | 2 |
| Alfirevic, Z | 7 |
| Himes, KP | 1 |
| Uzan, S | 22 |
| Beaufils, M | 17 |
| Vojtassakova, D | 1 |
| de Alvarado, M | 2 |
| Kapeti, E | 1 |
| Rehal, A | 1 |
| Pazos, A | 1 |
| Carbone, IF | 1 |
| Dutemeyer, V | 1 |
| Papantoniou, N | 1 |
| Rosenberg, K | 1 |
| Zvanca, ME | 1 |
| Bot, M | 1 |
| Radu, D | 1 |
| Radu, N | 1 |
| Petca, A | 1 |
| Miyazaki, M | 1 |
| Kuwabara, Y | 1 |
| Takeshita, T | 1 |
| Sheng, SL | 1 |
| Liao, H | 2 |
| Zhou, Q | 1 |
| Tu, WY | 1 |
| Pirmohamed, M | 1 |
| Connell, MT | 2 |
| Kuhr, D | 1 |
| Plowden, TC | 2 |
| Atallah, A | 2 |
| Goffinet, F | 6 |
| Doret-Dion, M | 2 |
| Gaucherand, P | 2 |
| Xu, B | 3 |
| Chau, K | 2 |
| Pears, S | 1 |
| Gasse, C | 1 |
| Demers, S | 8 |
| Giguère, Y | 8 |
| Tétu, A | 1 |
| Ahmadi, M | 1 |
| Abdolmohammadi-Vahid, S | 1 |
| Ghaebi, M | 1 |
| Aghebati-Maleki, L | 1 |
| Dolati, S | 1 |
| Farzadi, L | 1 |
| Ghasemzadeh, A | 1 |
| Hamdi, K | 1 |
| Younesi, V | 1 |
| Nouri, M | 1 |
| Yousefi, M | 1 |
| Belhomme, N | 1 |
| Doudnikoff, C | 1 |
| Polard, E | 1 |
| Henriot, B | 1 |
| Isly, H | 1 |
| Jego, P | 1 |
| Mecacci, F | 1 |
| Simeone, S | 1 |
| Cirami, CL | 1 |
| Cozzolino, M | 1 |
| Serena, C | 1 |
| Rambaldi, MP | 1 |
| Gallo, P | 1 |
| Emmi, L | 1 |
| Cammelli, D | 1 |
| Mello, G | 1 |
| Matucci Cerinic, M | 1 |
| Quao, ZC | 1 |
| Tong, M | 1 |
| Bryce, E | 1 |
| Guller, S | 1 |
| Chamley, LW | 4 |
| Bohîlţea, RE | 1 |
| Cîrstoiu, MM | 1 |
| Ionescu, CA | 1 |
| Niculescu-Mizil, E | 1 |
| Vlădăreanu, AM | 1 |
| Voican, I | 1 |
| Dimitriu, M | 1 |
| Turcan, N | 1 |
| Petersen, TG | 1 |
| Liew, Z | 1 |
| Andersen, AN | 1 |
| Andersen, GL | 1 |
| Andersen, PK | 1 |
| Martinussen, T | 1 |
| Olsen, J | 4 |
| Rebordosa, C | 3 |
| Tollånes, MC | 1 |
| Uldall, P | 1 |
| Wilcox, AJ | 1 |
| Strandberg-Larsen, K | 1 |
| Lu, C | 2 |
| Jiang, HL | 1 |
| Touboul, C | 1 |
| Groom, KM | 1 |
| David, AL | 2 |
| Azria, E | 2 |
| Schmitz, T | 2 |
| Baschat, AA | 2 |
| Dewberry, D | 1 |
| Seravalli, V | 1 |
| Miller, JL | 1 |
| Block-Abraham, D | 1 |
| Blitzer, MG | 2 |
| Sakai, K | 1 |
| Ueda, A | 1 |
| Hasegawa, M | 2 |
| Ueda, Y | 1 |
| Chen, WL | 1 |
| Liu, YD | 1 |
| Li, XL | 1 |
| Feng, SX | 1 |
| Zhou, XY | 1 |
| Ma, WX | 1 |
| Ye, DS | 1 |
| Chen, SL | 1 |
| de Groot, PG | 4 |
| Devreese, K | 1 |
| Jacobsen, S | 3 |
| Ruiz-Irastorza, G | 10 |
| Salmon, JE | 4 |
| Shoenfeld, Y | 9 |
| Shovman, O | 1 |
| Hunt, BJ | 8 |
| Frusca, T | 4 |
| Valensise, H | 3 |
| Lan, PG | 1 |
| Gillin, AG | 1 |
| Pelosi, M | 2 |
| Tooher, J | 1 |
| Sandager, P | 1 |
| Stanescu, AD | 1 |
| Banica, R | 1 |
| Sima, RM | 1 |
| Ples, L | 1 |
| McCowan, LM | 4 |
| Anderson, NH | 1 |
| Fantasia, HC | 1 |
| Shen, Y | 3 |
| Zuo, C | 1 |
| Machuca, M | 1 |
| Mastrodima, S | 1 |
| Chi, Y | 1 |
| He, P | 1 |
| Lei, L | 1 |
| Meng, Y | 1 |
| Hu, L | 1 |
| Kosinski, P | 1 |
| Sarzynska-Nowacka, U | 1 |
| Fiolna, M | 2 |
| Rosińczuk, J | 1 |
| Dymarek, R | 1 |
| Całkosiński, I | 2 |
| Askie, L | 2 |
| Park, H | 1 |
| Dobrzyński, M | 1 |
| Kaczmarek, U | 1 |
| Kuropka, P | 1 |
| Reichert, P | 1 |
| Grzech-Leśniak, K | 1 |
| Nawathe, A | 1 |
| Lin, CY | 1 |
| Broström, A | 1 |
| Nilsen, P | 1 |
| Pakpour, AH | 1 |
| Ortved, D | 1 |
| Hawkins, TL | 1 |
| Johnson, JA | 1 |
| Greco, E | 2 |
| Ma, L | 1 |
| Wang, YL | 2 |
| El-Messidi, A | 1 |
| Huluta, I | 1 |
| Panaitescu, AM | 1 |
| Cournot, M | 1 |
| Lairez, O | 1 |
| Medzech, B | 1 |
| Catov, JM | 3 |
| Caritis, SN | 6 |
| Aggogeri, E | 1 |
| Bettiga, E | 1 |
| Le Guern, V | 3 |
| Piette, JC | 6 |
| Oh, J | 1 |
| Bae, JY | 1 |
| Andrikopoulou, M | 1 |
| Purisch, SE | 1 |
| Handal-Orefice, R | 1 |
| de Moreuil, C | 1 |
| Fauchais, AL | 1 |
| Merviel, P | 4 |
| Tremouilhac, C | 1 |
| Le Moigne, E | 1 |
| Pasquier, E | 2 |
| Pan-Petesch, B | 1 |
| Lacut, K | 1 |
| Pavlek, L | 1 |
| Kraft, M | 1 |
| Simmons, C | 1 |
| Ryan, M | 1 |
| Prusakov, P | 1 |
| Campbell, A | 1 |
| Brandehoff, N | 1 |
| Ng, PC | 1 |
| Russell, J | 1 |
| Ciciora, SL | 1 |
| Fathi, O | 1 |
| Akinshina, S | 1 |
| Khamani, N | 1 |
| Tang, D | 1 |
| Lu, X | 2 |
| Blomqvist, L | 1 |
| Hellgren, M | 1 |
| Strandell, A | 1 |
| Chahine, KM | 1 |
| Yelnik, CM | 1 |
| Lambert, M | 3 |
| Drumez, E | 1 |
| Bacri, JL | 2 |
| Guerra, MM | 2 |
| Laskin, CA | 6 |
| Sammaritano, LR | 3 |
| Guettrot-Imbert, G | 1 |
| Launay, D | 2 |
| Hachulla, E | 5 |
| Hatron, PY | 4 |
| McParland, P | 8 |
| Downey, P | 3 |
| McCormack, D | 2 |
| Culliton, M | 3 |
| Stanton, A | 2 |
| Cody, F | 2 |
| Morrison, JJ | 3 |
| Daly, S | 3 |
| Higgins, J | 4 |
| Cotter, A | 3 |
| Hunter, A | 2 |
| Tully, EC | 1 |
| Dicker, P | 4 |
| Malone, FD | 5 |
| Gerardi, MC | 1 |
| Fernandes, MA | 1 |
| Kovo, M | 1 |
| Rubinchik-Stern, M | 1 |
| Miremberg, H | 1 |
| Luria, O | 1 |
| Bliecher, I | 1 |
| Mizrachi, Y | 1 |
| Bar, J | 5 |
| Li, YY | 1 |
| Gu, QR | 1 |
| Chen, GR | 1 |
| Quinn, MJ | 2 |
| Govindaswami, B | 1 |
| Jegatheesan, P | 1 |
| Nudelman, M | 1 |
| Narasimhan, SR | 1 |
| Foch, C | 1 |
| Araujo, M | 1 |
| Weckel, A | 1 |
| Damase-Michel, C | 1 |
| Montastruc, JL | 1 |
| Benevent, J | 1 |
| Durrieu, G | 1 |
| Lacroix, I | 1 |
| Murtoniemi, K | 1 |
| Vahlberg, T | 1 |
| Kajantie, E | 4 |
| Pesonen, AK | 3 |
| Taipale, P | 3 |
| Villa, PM | 4 |
| Laivuori, H | 4 |
| Madani, T | 1 |
| Ahmadi, F | 1 |
| Jahangiri, N | 1 |
| Bahmanabadi, A | 1 |
| Bagheri Lankarani, N | 1 |
| Al-Rubaie, ZTA | 1 |
| Hudson, HM | 2 |
| Jenkins, G | 1 |
| Lord, SJ | 2 |
| Powers, RW | 1 |
| Khanabdali, R | 1 |
| Shakouri-Motlagh, A | 1 |
| Wilkinson, S | 1 |
| Murthi, P | 2 |
| Georgiou, HM | 1 |
| Brennecke, SP | 6 |
| Kalionis, B | 2 |
| Chea, M | 1 |
| Ripart, S | 1 |
| Hanss, M | 1 |
| de Mazancourt, P | 1 |
| Reale, SC | 1 |
| Boyer, EW | 1 |
| Arce, DY | 1 |
| Khalid, A | 1 |
| Byrne, BM | 1 |
| Dornan, S | 1 |
| Tully, E | 4 |
| Huang, R | 1 |
| Ye, W | 2 |
| Cunningham, TK | 1 |
| Draper, H | 1 |
| Rajesh, U | 1 |
| Kemp, M | 1 |
| Thomas, W | 1 |
| Gao, H | 1 |
| Zhao, D | 1 |
| Wang, B | 2 |
| Maduro, MR | 1 |
| Nonaka, T | 2 |
| Takahashi, M | 1 |
| Nonaka, C | 1 |
| Haino, K | 1 |
| Yamaguchi, M | 2 |
| Enomoto, T | 1 |
| Takakuwa, K | 6 |
| Ye, J | 1 |
| Carbillon, L | 9 |
| Nicaise Roland, P | 1 |
| Benbara, A | 2 |
| Cacciatore, C | 1 |
| Wojcieszek, AM | 1 |
| Middleton, P | 1 |
| Lassi, ZS | 1 |
| Wilson, T | 1 |
| Murphy, MM | 1 |
| Heazell, AE | 1 |
| Ellwood, DA | 2 |
| Flenady, V | 1 |
| Holland, TL | 1 |
| Li, XY | 1 |
| Zhao, JX | 1 |
| Liu, XY | 2 |
| O'Mahony, JF | 1 |
| Tyrrell, E | 1 |
| Normand, C | 1 |
| Mendel, A | 1 |
| Bernatsky, SB | 1 |
| Hanly, JG | 1 |
| Urowitz, MB | 1 |
| Clarke, AE | 1 |
| Romero-Diaz, J | 1 |
| Gordon, C | 2 |
| Bae, SC | 1 |
| Wallace, DJ | 1 |
| Merrill, JT | 4 |
| Buyon, JP | 3 |
| Isenberg, DA | 1 |
| Rahman, A | 3 |
| Ginzler, EM | 1 |
| Petri, M | 2 |
| Dooley, MA | 1 |
| Fortin, PR | 1 |
| Gladman, DD | 1 |
| Steinsson, K | 1 |
| Ramsey-Goldman, R | 2 |
| Khamashta, MA | 13 |
| Aranow, C | 1 |
| Mackay, M | 1 |
| Alarcón, GS | 1 |
| Manzi, S | 2 |
| Nived, O | 1 |
| Jönsen, A | 1 |
| Zoma, AA | 1 |
| van Vollenhoven, RF | 1 |
| Ramos-Casals, M | 1 |
| Kalunian, KC | 1 |
| Inanc, M | 1 |
| Kamen, DL | 1 |
| Peschken, CA | 1 |
| Askanase, A | 1 |
| Sanchez-Guerrero, J | 2 |
| Bruce, IN | 1 |
| Vinet, É | 1 |
| Miller, EC | 1 |
| Boehme, AK | 1 |
| Chung, NT | 1 |
| Wang, SS | 1 |
| Lacey, JV | 1 |
| Lakshminarayan, K | 1 |
| Zhong, C | 1 |
| Woo, D | 2 |
| Bello, NA | 1 |
| Elkind, MSV | 1 |
| Willey, JZ | 1 |
| Feske, SK | 1 |
| Bushnell, C | 3 |
| Zambon, A | 1 |
| Mayrink, J | 1 |
| Cecatti, JG | 1 |
| Maguire, OC | 1 |
| Mooney, EE | 1 |
| Clarke, P | 1 |
| Fitzgerald, D | 1 |
| Mikolaiczik, K | 1 |
| Praetner, M | 1 |
| Rüth, M | 1 |
| Mark, K | 1 |
| Lin, T | 1 |
| Cheng, X | 1 |
| Li, N | 1 |
| Sheng, X | 1 |
| Snead, CM | 1 |
| Strassberg, E | 1 |
| Overcash, R | 1 |
| Stark, L | 1 |
| Paglia, MJ | 1 |
| Schulkin, J | 1 |
| Jelin, A | 1 |
| Egan, AM | 1 |
| Brassill, MJ | 1 |
| Brosnan, E | 1 |
| Carmody, L | 1 |
| Coogan Kelly, C | 1 |
| Culliney, L | 1 |
| Durkan, M | 1 |
| Fenlon, M | 1 |
| Ferry, P | 1 |
| Hanlon, G | 1 |
| Higgins, T | 1 |
| Hoashi, S | 1 |
| Khamis, A | 1 |
| Kinsley, B | 1 |
| Kinsley, T | 1 |
| Kirwan, B | 1 |
| Liew, A | 1 |
| McGurk, C | 1 |
| McHugh, C | 1 |
| Murphy, MS | 1 |
| O'Halloran, D | 1 |
| O'Mahony, L | 1 |
| O'Sullivan, E | 1 |
| Nolan, M | 1 |
| Peter, M | 1 |
| Roberts, G | 1 |
| Smyth, A | 1 |
| Todd, M | 1 |
| Tuthill, A | 1 |
| Wan Mahmood, WA | 1 |
| Yousif, O | 1 |
| P Dunne, F | 1 |
| Lundelin, K | 1 |
| Reshetnyak, T | 1 |
| Stojanovich, L | 1 |
| Gogou, V | 1 |
| Varoudis, A | 1 |
| Stoppani, C | 1 |
| Martí-Cañamares, A | 1 |
| Pluymaekers, N | 1 |
| Tombetti, E | 1 |
| Rampello, S | 2 |
| Lucianetti, M | 1 |
| Valenti, A | 1 |
| Adler, Y | 2 |
| Xing, H | 1 |
| Xie, Z | 1 |
| Cui, H | 1 |
| Aref, NK | 1 |
| Ahmed, WAS | 1 |
| Ahmed, MR | 1 |
| Sedik, WF | 1 |
| Helgadottir, H | 1 |
| Tropea, T | 1 |
| Mandalà, M | 1 |
| Ayala, NK | 1 |
| Houfflin-Debarge, V | 5 |
| Namavar Jahromi, B | 1 |
| Zolghadri, J | 1 |
| Rahmani, E | 1 |
| Alipour, S | 1 |
| Anvar, Z | 1 |
| Zarei, A | 1 |
| Keramati, P | 1 |
| Boulanger, H | 2 |
| Lefèvre, G | 2 |
| Ahriz Saksi, S | 1 |
| Achiche, J | 1 |
| Bailleul, S | 1 |
| Ekoukou, D | 1 |
| Drouin, D | 1 |
| Stawiarski, N | 1 |
| Dupuis, E | 1 |
| Hill, M | 1 |
| Elli, EM | 1 |
| Diral, E | 1 |
| Gambacorti-Passerini, C | 1 |
| Calori, R | 1 |
| Carmosino, I | 1 |
| Breccia, M | 1 |
| Latagliata, R | 2 |
| Di Veroli, A | 1 |
| Rafii Tabrizi, A | 1 |
| Ayoubi, JM | 1 |
| Ahmed, B | 1 |
| Agrawala, S | 1 |
| Omosigho, UR | 1 |
| Halvorson, LM | 1 |
| Solt, I | 1 |
| Ben David, C | 1 |
| Carp, H | 3 |
| Leavitt, K | 1 |
| Običan, S | 1 |
| Yankowitz, J | 1 |
| Reddy, S | 1 |
| Jim, B | 1 |
| Chung, EYM | 1 |
| Tiku, A | 1 |
| Seeho, S | 1 |
| Mather, A | 1 |
| Vestering, A | 1 |
| Grobbee, DE | 2 |
| van der Graaf, R | 1 |
| Crombag, NMT | 1 |
| Browne, JL | 2 |
| Münch, G | 1 |
| Mitic, D | 1 |
| Milenkovic, JM | 1 |
| Milojkovic, M | 1 |
| Jeremic, M | 1 |
| Petric, A | 1 |
| Basic, M | 1 |
| Shi, X | 1 |
| Hui, D | 1 |
| Hladunewich, MA | 1 |
| Dewarrat, N | 1 |
| Kaiser, J | 1 |
| Alberio, L | 1 |
| Hassan, SS | 1 |
| Gomez-Lopez, N | 1 |
| Alkhammash, S | 1 |
| Saumet, J | 1 |
| Genest, G | 1 |
| Chen, TY | 1 |
| Patel, V | 1 |
| Ramachandran, B | 1 |
| Omar, I | 1 |
| Visentin, MS | 2 |
| Punzi, L | 1 |
| Santos, N | 1 |
| Gaspar, A | 1 |
| Livramento, S | 1 |
| Sampaio, G | 1 |
| Morais-Almeida, M | 1 |
| Lavi, N | 1 |
| Brenner, B | 4 |
| Avivi, I | 1 |
| Alvarez-Larrán, A | 1 |
| Cervantes, F | 1 |
| Besses, C | 1 |
| Akhtar, MA | 2 |
| Eljabu, H | 2 |
| Hopkisson, J | 2 |
| Raine-Fenning, N | 2 |
| Jayaprakasan, K | 2 |
| Grossi, P | 1 |
| Bertoni, G | 1 |
| Cappelli, FP | 1 |
| Trevisi, E | 1 |
| Agcaoili, MS | 1 |
| Aleta, L | 1 |
| Liao, A | 1 |
| Ota, K | 1 |
| Beaman, K | 2 |
| Kim, JW | 1 |
| Gilman-Sachs, A | 3 |
| Groeneveld, E | 2 |
| Lambers, MJ | 3 |
| Lambalk, CB | 3 |
| Broeze, KA | 1 |
| Haapsamo, M | 4 |
| de Sutter, P | 2 |
| Schoot, BC | 1 |
| Schats, R | 3 |
| Hompes, PG | 2 |
| Bloor, M | 1 |
| Paech, M | 2 |
| Vainio, M | 8 |
| Thornton, J | 2 |
| Clark, DA | 2 |
| Cabrol, D | 1 |
| Soh, MC | 1 |
| Pasupathy, D | 1 |
| Gray, G | 1 |
| Sukandar, EY | 1 |
| Anggadireja, K | 1 |
| Sigit, JI | 1 |
| Adnyana, IK | 1 |
| Tjandrawinata, RR | 1 |
| Dodd, JM | 1 |
| McLeod, A | 1 |
| Windrim, RC | 1 |
| Khazardoost, S | 1 |
| Mousavi, S | 1 |
| Borna, S | 1 |
| Khezerlou, N | 1 |
| Okunoye, GO | 1 |
| Dutton, P | 1 |
| Toyoda, K | 1 |
| Pourrat, O | 2 |
| Neau, JP | 1 |
| Pouget-Abadie, JF | 1 |
| Pierre, F | 1 |
| Mazaud-Guittot, S | 2 |
| Nicolas Nicolaz, C | 1 |
| Desdoits-Lethimonier, C | 3 |
| Coiffec, I | 1 |
| Ben Maamar, M | 1 |
| Balaguer, P | 1 |
| Kristensen, DM | 4 |
| Chevrier, C | 1 |
| Lavoué, V | 1 |
| Poulain, P | 1 |
| Dejucq-Rainsford, N | 2 |
| Jégou, B | 4 |
| Chakraborty, P | 1 |
| Banerjee, S | 1 |
| Saha, P | 1 |
| Nandi, SS | 1 |
| Sharma, S | 2 |
| Goswami, SK | 1 |
| Chakravarty, B | 1 |
| Kabir, SN | 1 |
| Zhu, Q | 1 |
| Hu, MH | 1 |
| Tong, XH | 1 |
| Ji, JJ | 1 |
| Liu, YS | 1 |
| Bertolaccini, ML | 1 |
| Seed, PT | 3 |
| Tektonidou, MG | 1 |
| Aguirre, A | 1 |
| Mico, L | 1 |
| Egurbide, MV | 2 |
| Gil, A | 1 |
| Houssiau, F | 1 |
| Martin, H | 1 |
| McHugh, N | 1 |
| Galindo, M | 1 |
| Akil, M | 1 |
| Amigo, MC | 1 |
| Murru, V | 1 |
| Vigil-De Gracia, P | 1 |
| Dominguez, L | 1 |
| Solis, A | 1 |
| Lesher, LL | 9 |
| Faraggi, D | 7 |
| Browne, RW | 1 |
| Townsend, JM | 8 |
| White, M | 1 |
| Lynch, AM | 8 |
| Vlachadis, N | 1 |
| Tsamadias, V | 1 |
| Economou, E | 1 |
| Asemi, Z | 1 |
| Samimi, M | 1 |
| Heidarzadeh, Z | 1 |
| Khorrammian, H | 1 |
| Tabassi, Z | 1 |
| Chapin, J | 1 |
| Carlson, K | 1 |
| Christos, PJ | 1 |
| Kane, SC | 2 |
| de Jesús, GR | 1 |
| Rodrigues, G | 1 |
| de Jesús, NR | 2 |
| Levy, RA | 4 |
| Yasuda, S | 2 |
| Elmahashi, MO | 1 |
| Elbareg, AM | 1 |
| Essadi, FM | 1 |
| Ashur, BM | 1 |
| Adam, I | 2 |
| Gizzo, S | 1 |
| Capuzzo, D | 1 |
| Zicchina, C | 1 |
| Di Gangi, S | 1 |
| Coronella, ML | 1 |
| Andrisani, A | 1 |
| Gangemi, M | 1 |
| Nardelli, GB | 1 |
| Gaul, C | 1 |
| Kutteh, WH | 11 |
| Hinote, CD | 1 |
| Block-Abraham, DM | 1 |
| Turan, OM | 1 |
| Doyle, LE | 1 |
| Kopelman, JN | 1 |
| Atlas, RO | 1 |
| Jenkins, CB | 1 |
| Sammar, M | 2 |
| Herzog, A | 1 |
| Grimpel, YI | 2 |
| Fihaman, G | 1 |
| Cohen, A | 3 |
| Kivity, V | 2 |
| Sharabi-Nov, A | 1 |
| Gonen, R | 2 |
| Chescheir, NC | 1 |
| Goodnight, W | 1 |
| Whitlock, EP | 2 |
| O'Connor, E | 2 |
| Thompson, JH | 1 |
| Rowland, MG | 1 |
| Mierzynski, R | 1 |
| Poniedzialek-Czajkowska, E | 1 |
| Kimber-Trojnar, Z | 1 |
| Leszczynska-Gorzelak, B | 1 |
| Oleszczuk, J | 1 |
| Souza, EV | 1 |
| Torloni, MR | 1 |
| Atallah, AN | 1 |
| Santos, GM | 1 |
| Kulay, L | 2 |
| Sass, N | 1 |
| Zheng, XJ | 1 |
| Deng, XL | 1 |
| Gomaa, MF | 1 |
| Elkholy, AG | 1 |
| El-Said, MM | 1 |
| Abdel-Salam, NE | 1 |
| Friedman, AM | 1 |
| Cleary, KL | 1 |
| Voelker, R | 1 |
| Kleppa, MJ | 1 |
| Erlenwein, SV | 1 |
| Darashchonak, N | 1 |
| von Kaisenberg, CS | 1 |
| von Versen-Höynck, F | 1 |
| Kubisz, P | 1 |
| Ruiz-Argüelles, GJ | 1 |
| Stasko, J | 1 |
| Holly, P | 1 |
| Ruiz-Delgado, GJ | 1 |
| McCullough, L | 1 |
| Campbell, BK | 1 |
| Hernandez-Medrano, J | 1 |
| Onions, V | 1 |
| Pincott-Allen, C | 1 |
| Aljaser, F | 1 |
| Fisher, J | 1 |
| McNeilly, AS | 1 |
| Webb, R | 1 |
| Picton, HM | 1 |
| Grandone, E | 6 |
| Villani, M | 3 |
| Dentali, F | 2 |
| Tiscia, GL | 4 |
| Colaizzo, D | 3 |
| Cappucci, F | 1 |
| Fischetti, L | 1 |
| Ageno, W | 3 |
| Margaglione, M | 4 |
| de Jong, PG | 2 |
| Kaandorp, S | 2 |
| Di Nisio, M | 2 |
| Salvan, E | 1 |
| Bertero, MT | 2 |
| Bremme, K | 2 |
| Ramoni, V | 1 |
| Di Poi, E | 1 |
| Caramaschi, P | 1 |
| Galeazzi, M | 1 |
| Botta, A | 2 |
| Chudzinski, A | 1 |
| Theulin, A | 1 |
| Emmanuelli, V | 1 |
| Revaux, A | 1 |
| Nicaise, P | 1 |
| Cornelis, F | 1 |
| Subtil, D | 6 |
| Montestruc, F | 2 |
| Bucourt, M | 2 |
| Chollet-Martin, S | 3 |
| Cantu, JA | 1 |
| Jauk, VR | 1 |
| Owen, J | 4 |
| Biggio, JR | 1 |
| Abramovici, AR | 1 |
| Edwards, RK | 1 |
| Tita, AT | 1 |
| Lowe, SA | 1 |
| Lust, K | 1 |
| North, RA | 4 |
| McMahon, L | 1 |
| Griffin, C | 1 |
| LeFevre, ML | 1 |
| Greer, IA | 5 |
| Signorelli, F | 1 |
| Du, B | 1 |
| Jiang, X | 1 |
| Ma, M | 1 |
| Shi, L | 1 |
| Zhang, Q | 1 |
| Leeson, P | 1 |
| van den Boom, D | 1 |
| Abramovici, A | 1 |
| Jauk, V | 1 |
| Wetta, L | 1 |
| Cantu, J | 1 |
| Edwards, R | 1 |
| Biggio, J | 1 |
| Tita, A | 1 |
| Moussa, HN | 2 |
| Wu, ZH | 1 |
| Blackwell, SC | 3 |
| Sidaway, P | 1 |
| Bao, S | 1 |
| Shuai, W | 1 |
| Mutlu, I | 1 |
| Mutlu, MF | 1 |
| Biri, A | 1 |
| Bulut, B | 1 |
| Erdem, M | 1 |
| Erdem, A | 1 |
| Arachchillage, DR | 1 |
| Machin, SJ | 1 |
| Mackie, IJ | 1 |
| Cohen, H | 8 |
| Nizamuddin, SL | 1 |
| Broderick, DK | 1 |
| Minehart, RD | 1 |
| Kamdar, BB | 1 |
| Holm, M | 1 |
| Msall, ME | 1 |
| Skranes, J | 1 |
| Dammann, O | 1 |
| Allred, E | 1 |
| Leviton, A | 3 |
| Moore, GS | 2 |
| Post, AL | 1 |
| Galan, HL | 2 |
| Maalej, A | 1 |
| Khallouli, A | 1 |
| Loukil, M | 1 |
| Bellassoued, O | 1 |
| Rannen, R | 1 |
| Kraus, M | 1 |
| Raikwar, NS | 1 |
| Santillan, MK | 1 |
| Santillan, DA | 1 |
| Thomas, CP | 1 |
| Motteram, C | 1 |
| Vollenhoven, B | 1 |
| Hope, N | 1 |
| Osianlis, T | 1 |
| Rombauts, LJ | 1 |
| Russo, K | 1 |
| Williams, P | 1 |
| Puddephatt, R | 1 |
| Walter, M | 1 |
| Leung, C | 1 |
| Saaid, R | 1 |
| Rawashdeh, H | 1 |
| Ogle, R | 1 |
| Matyas, RA | 1 |
| Newman, SL | 1 |
| Hovey, KM | 1 |
| Emerick, L | 1 |
| Mead, B | 1 |
| Stanford, J | 1 |
| Zarek, SM | 4 |
| Tsai, MY | 1 |
| Ahrens, K | 1 |
| Wong, LF | 1 |
| Bartsch, E | 2 |
| Terada, K | 1 |
| Nakanishi, K | 1 |
| Suzuki, S | 1 |
| Xu, TT | 1 |
| Zhou, F | 1 |
| Deng, CY | 1 |
| Huang, GQ | 1 |
| Li, JK | 1 |
| Wang, XD | 1 |
| Jiang, N | 1 |
| Liu, Q | 1 |
| Liu, L | 3 |
| Yang, WW | 1 |
| Zeng, Y | 1 |
| Odibo, AO | 2 |
| Goetzinger, KR | 1 |
| Odibo, L | 1 |
| Tuuli, MG | 1 |
| Patil, R | 2 |
| Ghosh, K | 3 |
| Damania, K | 1 |
| Bansal, V | 1 |
| Satoskar, P | 1 |
| Darekar, A | 1 |
| Shetty, S | 3 |
| Chen, XY | 1 |
| Wang, ZY | 1 |
| Yu, XH | 1 |
| Wei, BX | 1 |
| Wu, XH | 1 |
| Oyola, S | 1 |
| Kirley, K | 1 |
| Abheiden, C | 1 |
| Van Hoorn, ME | 2 |
| Hague, WM | 4 |
| Kostense, PJ | 1 |
| de Vries, J | 1 |
| Zivković, R | 1 |
| Marković, O | 1 |
| Marisavljević, D | 1 |
| Terzić, T | 1 |
| Tukić, L | 1 |
| Areia, AL | 1 |
| Fonseca, E | 1 |
| Areia, M | 1 |
| Moura, P | 1 |
| Smith, TA | 1 |
| Kirkpatrick, DR | 1 |
| Kovilam, O | 1 |
| Agrawal, DK | 1 |
| Yao, S | 1 |
| Wu, H | 1 |
| Shen, W | 1 |
| Savov, A | 1 |
| Pavord, S | 2 |
| Khamashta, M | 6 |
| Papatheodorou, SI | 1 |
| Kim, MY | 1 |
| Rana, S | 1 |
| Zhang, D | 1 |
| Lockshin, MD | 4 |
| Porter, TF | 2 |
| Stephenson, MD | 3 |
| Gao, Q | 1 |
| Bureau, M | 2 |
| Hauspurg, AK | 1 |
| Tannetta, DS | 1 |
| Hunt, K | 1 |
| Jones, CI | 1 |
| Davidson, N | 1 |
| Coxon, CH | 1 |
| Ferguson, D | 1 |
| Redman, CW | 4 |
| Gibbins, JM | 1 |
| Sargent, IL | 1 |
| Tucker, KL | 1 |
| Kattah, AG | 1 |
| Garovic, VD | 1 |
| Winn, VD | 1 |
| Oktay, K | 1 |
| Bedoschi, G | 1 |
| Pacheco, F | 1 |
| Turan, V | 1 |
| Emirdar, V | 1 |
| Verbruggen, M | 1 |
| Mannaerts, D | 1 |
| Muys, J | 1 |
| Jacquemyn, Y | 1 |
| Chinni, E | 1 |
| Bodenizza, C | 1 |
| Cascavilla, N | 2 |
| Mitchell, EM | 2 |
| Bohio, R | 1 |
| Brohi, ZP | 1 |
| Bohio, F | 1 |
| Bergeron, TS | 1 |
| McCaw-Binns, A | 3 |
| Mukherjee, S | 1 |
| Maymon, R | 1 |
| Bezemer, D | 1 |
| de Vries, JI | 5 |
| Ismail, AM | 1 |
| Hamed, AH | 1 |
| Saso, S | 1 |
| Abu-Elhasan, AM | 1 |
| Abu-Elghar, MM | 1 |
| Abdelmeged, AN | 1 |
| Lykke, JA | 1 |
| Langhoff-Roos, J | 1 |
| Nielsen, HS | 1 |
| Truong, A | 1 |
| Sayago, MM | 1 |
| Ke, RW | 1 |
| Etwel, F | 1 |
| Koren, G | 3 |
| Leon, MG | 1 |
| Longo, M | 1 |
| Pedroza, C | 1 |
| Haidar, ZA | 1 |
| Jessel, RH | 1 |
| Klee, K | 1 |
| Gawaz, M | 1 |
| Meyer-Zürn, CS | 1 |
| Shinozaki, N | 1 |
| Ebina, Y | 1 |
| Tanimura, K | 1 |
| Morizane, M | 1 |
| Ahrens, KA | 1 |
| Zarek, S | 1 |
| Euser, AG | 1 |
| Medcalf, KE | 1 |
| Oku, K | 1 |
| Oomura, K | 1 |
| Amengual, O | 1 |
| Bohgaki, T | 1 |
| Horita, T | 1 |
| Kaneko, K | 1 |
| Nakanishi, I | 1 |
| Nozawa, K | 1 |
| Atsumi, T | 2 |
| Moroni, G | 1 |
| Ponticelli, C | 1 |
| Sotiriadis, A | 1 |
| Gaudriault, P | 1 |
| Lesné, L | 3 |
| Serrano, T | 1 |
| Main, KM | 2 |
| Källén, B | 1 |
| Reis, M | 1 |
| Singh, R | 1 |
| Shah, B | 1 |
| Allred, EN | 2 |
| Grzybowski, M | 1 |
| Martin, CR | 1 |
| Klipstein-Grobusch, K | 1 |
| Al-Rubaie, Z | 1 |
| Katsi, V | 1 |
| Kanellopoulou, T | 1 |
| Makris, T | 1 |
| Nihoyannopoulos, P | 1 |
| Nomikou, E | 1 |
| Tousoulis, D | 1 |
| Chu, S | 1 |
| Huang, L | 2 |
| Bao, Y | 1 |
| Bao, J | 1 |
| Gan, J | 1 |
| He, H | 1 |
| Rafi, J | 1 |
| Helou, A | 1 |
| Stewart, K | 1 |
| George, J | 1 |
| Reza Pour, N | 1 |
| Chuah, SC | 1 |
| Vo, TM | 1 |
| Beran, R | 1 |
| Maged, AM | 1 |
| Abdelhafiz, A | 1 |
| Mostafa, WA | 1 |
| El-Nassery, N | 1 |
| Fouad, M | 1 |
| Salah, E | 1 |
| Kotb, A | 1 |
| Bourrienne, MC | 1 |
| Noémie, A | 1 |
| Tigaizin, A | 1 |
| Vakrilova, L | 1 |
| D'Souza, R | 1 |
| Raheemullah, A | 1 |
| Laurence, TN | 1 |
| Abheiden, CN | 2 |
| Blomjous, BS | 1 |
| Kroese, SJ | 1 |
| Bultink, IE | 1 |
| Fritsch-Stork, RD | 1 |
| Lely, AT | 1 |
| Fan, J | 2 |
| Chaillet, N | 2 |
| Hinkle, SN | 1 |
| Grantz, KL | 1 |
| Herrera, CA | 1 |
| Heuser, CC | 1 |
| Baca, KM | 1 |
| Caritis, S | 7 |
| Chitrit, Y | 1 |
| Chauleur, C | 4 |
| Bages, K | 1 |
| Benachi, A | 1 |
| Bretelle, F | 1 |
| Bastuji-Garin, S | 1 |
| Panagodage, S | 1 |
| Yong, HE | 1 |
| Borg, AJ | 1 |
| Nahas, R | 1 |
| Saliba, W | 1 |
| Elias, A | 1 |
| Elias, M | 1 |
| Sarma, A | 1 |
| Scott, NS | 1 |
| Siristatidis, CS | 2 |
| Basios, G | 1 |
| Pergialiotis, V | 1 |
| Vogiatzi, P | 1 |
| Scazzocchio, E | 1 |
| Oros, D | 1 |
| Diaz, D | 1 |
| Ramirez, JC | 1 |
| Meler, E | 1 |
| González de Agüero, R | 1 |
| Gratacos, E | 1 |
| Hunter, K | 1 |
| McInerney, KA | 1 |
| Xu, H | 1 |
| Marrs, CC | 1 |
| Lim, W | 2 |
| Hui, CY | 1 |
| Tan, WC | 1 |
| Tan, EL | 1 |
| Tan, LK | 1 |
| van Reuler, AV | 1 |
| Liu, FM | 1 |
| Yang, HL | 1 |
| De Souza, LR | 1 |
| Connelly, PW | 1 |
| Arduç, A | 1 |
| van Diemen, JJK | 1 |
| Tong, L | 1 |
| Wei, X | 1 |
| Amin, ME | 1 |
| Amin, AF | 1 |
| Abd El Aal, DEM | 1 |
| van Vliet, EOG | 1 |
| Askie, LA | 1 |
| Lee, KS | 1 |
| Lee, DK | 1 |
| Park, M | 1 |
| Choi, S | 1 |
| Park, W | 1 |
| Kim, S | 1 |
| Choi, YK | 1 |
| Hwang, JY | 1 |
| Choe, J | 1 |
| Won, MH | 1 |
| Jeoung, D | 1 |
| Lee, H | 1 |
| Ryoo, S | 1 |
| Ha, KS | 1 |
| Kwon, YG | 1 |
| Kim, YM | 1 |
| Balducchi, JP | 2 |
| Quéré, I | 4 |
| Perez-Martin, A | 1 |
| Balcázar, N | 1 |
| San Martín, S | 1 |
| Markert, UR | 1 |
| Wang, HY | 1 |
| Qiao, J | 1 |
| Liu, P | 1 |
| Chi, HB | 1 |
| Ghi, T | 1 |
| Simonazzi, G | 1 |
| Rizzo, N | 1 |
| Dall'Asta, A | 1 |
| Visentin, S | 1 |
| Sarno, L | 1 |
| Xodo, S | 1 |
| Bernabini, D | 1 |
| Eke, AC | 1 |
| Schuit, E | 1 |
| Martinelli, P | 1 |
| Lakovschek, IC | 1 |
| Csapo, B | 1 |
| Kolovetsiou-Kreiner, V | 1 |
| Reif, P | 1 |
| Ulrich, D | 1 |
| Lang, U | 1 |
| Obermayer-Pietsch, B | 1 |
| Aranda, FM | 1 |
| Perés Wingeyer, SDA | 1 |
| Fernández Romero, DS | 1 |
| de Larrañaga, GF | 1 |
| Molakatalla, S | 1 |
| Roumi, JE | 1 |
| Moukhadder, HM | 1 |
| Graziadei, G | 1 |
| Pennisi, M | 1 |
| Cappellini, MD | 1 |
| Taher, AT | 1 |
| Luo, Y | 1 |
| Huan, Y | 1 |
| Fang, R | 1 |
| Rodger, M | 1 |
| Pabinger, I | 1 |
| Sofaer, S | 1 |
| Hirsh, J | 7 |
| Bowring, J | 1 |
| Mahto, M | 1 |
| Mandal, D | 1 |
| Baker, PN | 4 |
| Struve, S | 1 |
| Barbui, T | 1 |
| Birgegård, G | 1 |
| Cnossen, JS | 1 |
| Langejans, M | 1 |
| Kleijnen, J | 1 |
| Ter Riet, G | 1 |
| van der Post, JA | 2 |
| Khan, KS | 6 |
| Lazzarin, N | 2 |
| Vaquero, E | 2 |
| Exacoustos, C | 1 |
| Bertonotti, E | 1 |
| Romanini, ME | 1 |
| Arduini, D | 1 |
| Vieira-Filho, LD | 1 |
| Lucena-Júnior, JM | 1 |
| Barreto, IS | 1 |
| Angelim, JL | 1 |
| Paixão, AD | 1 |
| Ruan, Y | 1 |
| Bridges, JS | 1 |
| Kumar, K | 1 |
| Raphael, JA | 1 |
| Acharjee, S | 1 |
| Welty, FK | 1 |
| Skrzypczak, J | 2 |
| Biggerstaff, BJ | 1 |
| Jackson, D | 1 |
| Casellas-Caro, M | 1 |
| Llurba-Olive, E | 1 |
| Hermosilla, E | 1 |
| Vilardell-Tarres, M | 1 |
| Cabero-Roura, L | 1 |
| Turtzo, LC | 1 |
| McCullough, LD | 1 |
| Martikainen, H | 4 |
| Räsänen, J | 4 |
| Seremak-Mrozikiewicz, A | 1 |
| Drews, K | 1 |
| Puacz, P | 1 |
| Kaluba-Skotarczak, A | 1 |
| Leeman, M | 1 |
| Hoozemans, DA | 2 |
| Homburg, R | 2 |
| Hompes, PGA | 1 |
| Bernardon, M | 1 |
| Limone, A | 1 |
| Businelli, C | 1 |
| Maso, GP | 1 |
| Piccoli, M | 1 |
| Alberico, S | 1 |
| Dendrinos, S | 2 |
| Sakkas, E | 1 |
| Makrakis, E | 2 |
| d'Ythurbide, G | 1 |
| Rousset, P | 1 |
| Carbonne, B | 4 |
| Cabane, J | 2 |
| Fardet, L | 1 |
| Tiev, K | 1 |
| Kettaneh, A | 1 |
| Dirckx, K | 1 |
| Cabri, P | 1 |
| Merien, A | 1 |
| Galajdova, L | 1 |
| Gerris, J | 1 |
| Dhont, M | 1 |
| Spitzer, KA | 3 |
| Clark, CA | 3 |
| Crowther, MR | 2 |
| Ginsberg, JS | 6 |
| Hawker, GA | 1 |
| Barrett, J | 1 |
| Gent, M | 2 |
| Helms, AK | 1 |
| Drogan, O | 1 |
| Kittner, SJ | 1 |
| Heilmann, L | 3 |
| Schorch, M | 1 |
| Hahn, T | 2 |
| Adasz, G | 1 |
| Schilberz, K | 1 |
| Adiguzel, C | 1 |
| Fareed, J | 2 |
| Momma, K | 2 |
| Toyoshima, K | 1 |
| Ito, K | 1 |
| Sugiyama, K | 1 |
| Imamura, S | 1 |
| Sun, F | 1 |
| Nakanishi, T | 3 |
| Wolanskyj, AP | 1 |
| Schwager, S | 1 |
| Buckingham, KL | 1 |
| Mánfai, Z | 2 |
| Wilhelm, F | 1 |
| Busznyák, C | 2 |
| Koppán, M | 2 |
| Pati, S | 1 |
| Bhattacharya, S | 1 |
| Rakshit, VM | 1 |
| Gelbaya, TA | 1 |
| Nardo, LG | 2 |
| Gaskins, AJ | 1 |
| Curri, S | 1 |
| Palmieri, G | 1 |
| Trinchero, R | 2 |
| Granne, I | 1 |
| Stewart, J | 1 |
| Martinez-Berriotxoa, A | 1 |
| Peltier, MR | 2 |
| Faux, DS | 2 |
| Hamblin, SD | 2 |
| Cooper, C | 1 |
| Esplin, MS | 2 |
| Dodo, T | 1 |
| Fukuta, T | 1 |
| Uchida, K | 1 |
| Mineshima, H | 1 |
| Okuda, Y | 1 |
| Okada, F | 1 |
| Katsutani, N | 1 |
| Hirano, K | 1 |
| Aoki, T | 1 |
| Carp, HJ | 5 |
| Tuthill, JI | 1 |
| Krüger, K | 1 |
| Salomon, O | 1 |
| Dulitzky, M | 2 |
| Apter, S | 1 |
| Giles, I | 1 |
| Sankar, A | 1 |
| Hinshaw, K | 1 |
| Monien, S | 1 |
| Kadecki, O | 1 |
| Baumgarten, S | 1 |
| Salama, A | 1 |
| Dörner, T | 2 |
| Kiesewetter, H | 3 |
| Melillo, L | 1 |
| Tieghi, A | 1 |
| Candoni, A | 1 |
| Radaelli, F | 1 |
| Ciancia, R | 1 |
| Specchia, G | 1 |
| Martino, B | 1 |
| Scalzulli, PR | 1 |
| Palmieri, F | 1 |
| Usala, E | 1 |
| Valente, D | 1 |
| Valvano, MR | 1 |
| Cedrone, M | 1 |
| Comitini, G | 1 |
| Martinelli, V | 1 |
| Gugliotta, L | 1 |
| Mo, D | 1 |
| Metwally, M | 1 |
| Makris, M | 1 |
| Passamonti, F | 2 |
| Beghin, D | 1 |
| Delongeas, JL | 1 |
| Claude, N | 1 |
| Farinotti, R | 1 |
| Forestier, F | 1 |
| Gil, S | 1 |
| Quinn, J | 1 |
| Von Klemperer, K | 1 |
| Brooks, R | 1 |
| Peebles, D | 1 |
| Walker, F | 1 |
| Bramham, K | 2 |
| Germain, S | 1 |
| Calatayud, I | 1 |
| Bewley, S | 2 |
| Rumi, E | 1 |
| Randi, ML | 4 |
| Morra, E | 1 |
| Cazzola, M | 1 |
| Revelli, A | 2 |
| Casano, S | 1 |
| Piane, LD | 1 |
| Grassi, G | 1 |
| Gennarelli, G | 2 |
| Guidetti, D | 1 |
| Massobrio, M | 2 |
| Morency, AM | 1 |
| Lacasse, Y | 2 |
| Forest, JC | 4 |
| Mak, A | 1 |
| Cheung, MW | 1 |
| Cheak, AA | 1 |
| Ho, RC | 1 |
| Marret, S | 2 |
| Marchand, L | 1 |
| Kaminski, M | 1 |
| Larroque, B | 1 |
| Arnaud, C | 1 |
| Truffert, P | 1 |
| Thirez, G | 1 |
| Fresson, J | 1 |
| Rozé, JC | 1 |
| Ancel, PY | 1 |
| Fouladkou, F | 1 |
| Jiang, C | 1 |
| She, Y | 1 |
| Walls, JR | 1 |
| Kawabe, H | 1 |
| Brose, N | 1 |
| Henkelman, RM | 1 |
| Huang, A | 1 |
| Bruneau, BG | 1 |
| Rotin, D | 1 |
| Laporte, S | 2 |
| Rancon, F | 1 |
| Varlet, MN | 2 |
| Decousus, H | 2 |
| Mismetti, P | 2 |
| Caron, N | 1 |
| Rivard, GÉ | 2 |
| Michon, N | 1 |
| Morin, F | 1 |
| Pilon, D | 1 |
| Moutquin, JM | 1 |
| Rey, É | 4 |
| Seed, P | 2 |
| Enye, S | 1 |
| Briley, AL | 1 |
| Poston, L | 4 |
| Shennan, AH | 3 |
| Leroux, P | 1 |
| Hennebert, C | 1 |
| Catteau, J | 1 |
| Legros, H | 1 |
| Hennebert, O | 1 |
| Laudenbach, V | 1 |
| Butwick, AJ | 1 |
| Carvalho, B | 1 |
| Clark, P | 1 |
| Walker, ID | 1 |
| Langhorne, P | 1 |
| Crichton, L | 1 |
| Thomson, A | 1 |
| Greaves, M | 2 |
| Whyte, S | 1 |
| Kaandorp, SP | 1 |
| Hutten, BA | 1 |
| Verhoeve, HR | 1 |
| Hamulyák, K | 1 |
| Folkeringa, N | 1 |
| Nahuis, M | 1 |
| Papatsonis, DN | 1 |
| Büller, HR | 1 |
| van der Veen, F | 1 |
| Deruelle, P | 2 |
| Girard, JM | 1 |
| Coutty, N | 1 |
| Gelber, SE | 1 |
| Ayala, DE | 5 |
| Hermida, RC | 5 |
| Armellino, F | 1 |
| Spodick, DH | 1 |
| Fox, C | 1 |
| Hu, YL | 1 |
| Wang, JM | 1 |
| Ziakas, PD | 1 |
| Pavlou, M | 1 |
| Voulgarelis, M | 1 |
| Audibert, F | 2 |
| Marcoux, S | 1 |
| Calderon, AC | 1 |
| Berezowski, AT | 1 |
| Marcolin, AC | 1 |
| Martins, WP | 1 |
| Duarte, G | 1 |
| Cavalli, RC | 1 |
| A/Magid, YM | 1 |
| Elussein, EA | 1 |
| Omer, MM | 1 |
| Samaan, SI | 1 |
| A/Rahim, F | 1 |
| Ogishima, H | 1 |
| Ito, S | 1 |
| Tsutsumi, A | 1 |
| Sugihara, M | 1 |
| Goto, D | 1 |
| Matsumoto, I | 1 |
| Obata-Yasuoka, M | 1 |
| Hamada, H | 1 |
| Yoshikawa, H | 2 |
| Sumida, T | 1 |
| Cohn, DM | 1 |
| Korevaar, JC | 1 |
| Dawood, F | 2 |
| Farquharson, RG | 4 |
| de Saint Martin, L | 1 |
| Le Gal, G | 1 |
| Naru, T | 2 |
| Khan, RS | 1 |
| Visser, J | 2 |
| Cohen, D | 1 |
| Bloemenkamp, KW | 2 |
| Jensen, MS | 2 |
| Thulstrup, AM | 2 |
| Toft, G | 2 |
| Sørensen, HT | 4 |
| Bonde, JP | 2 |
| Henriksen, TB | 2 |
| Zeng, QL | 1 |
| Yao, MY | 1 |
| Honig, A | 1 |
| Engel, JB | 1 |
| Segerer, SE | 1 |
| Kranke, P | 1 |
| Häusler, S | 1 |
| Würfel, W | 1 |
| Gyte, GM | 1 |
| Brunel-Guitton, C | 1 |
| Costa, T | 1 |
| Mitchell, GA | 1 |
| Tinkanen, H | 2 |
| Heinonen, S | 2 |
| Nuojua-Huttunen, S | 1 |
| Kosar, A | 1 |
| Kasapoglu, B | 1 |
| Kalyoncu, S | 1 |
| Turan, H | 1 |
| Balcik, OS | 1 |
| Gümüs, EI | 1 |
| Hass, U | 1 |
| Lottrup, G | 1 |
| Jacobsen, PR | 1 |
| Boberg, J | 1 |
| Petersen, JH | 1 |
| Toppari, J | 1 |
| Jensen, TK | 1 |
| Brunak, S | 1 |
| Skakkebaek, NE | 1 |
| Nellemann, C | 1 |
| Leffers, H | 2 |
| Young, G | 1 |
| Jewell, D | 2 |
| Ulander, VM | 1 |
| Helmerhorst, FM | 1 |
| Lampinen, K | 1 |
| Morin-Papunen, L | 1 |
| Kaaja, RJ | 2 |
| Barbhaiya, M | 1 |
| Erkan, D | 3 |
| Hughes, GR | 2 |
| Hadlow, N | 1 |
| Tsokos, N | 1 |
| Oates, R | 1 |
| Gunawardana, L | 1 |
| Zammit, S | 1 |
| Lewis, G | 1 |
| Gunnell, D | 1 |
| Hollis, C | 1 |
| Wolke, D | 1 |
| Harrison, G | 1 |
| Ognjanovic, S | 1 |
| Blair, C | 1 |
| Spector, LG | 1 |
| Robison, LL | 1 |
| Roesler, M | 1 |
| Ross, JA | 1 |
| Huppertz, B | 2 |
| Chanprapaph, P | 1 |
| Sun, Q | 1 |
| Xiong, J | 1 |
| Fouda, UM | 1 |
| Sayed, AM | 1 |
| Abdou, AM | 1 |
| Ramadan, DI | 1 |
| Fouda, IM | 1 |
| Zaki, MM | 1 |
| Meena, M | 1 |
| DeStephano, CC | 1 |
| Watson, WJ | 1 |
| McLintock, C | 1 |
| Perneby, C | 1 |
| Vahter, M | 1 |
| Akesson, A | 1 |
| Hjemdahl, P | 1 |
| Deane, KD | 1 |
| Tyler, KN | 1 |
| Tanabe, JL | 1 |
| Oskarrson, BE | 1 |
| Nitka, EE | 1 |
| Brass, E | 1 |
| Davies, JK | 1 |
| Striebich, CC | 1 |
| Hoppe, B | 1 |
| Burmester, GR | 1 |
| Martín de Argila de Prados, C | 1 |
| Ismail, SK | 1 |
| Higgins, JR | 1 |
| Duhig, KE | 1 |
| Schorsch, M | 1 |
| Giraudet, G | 1 |
| Wibaut, B | 1 |
| Ducloy, AS | 1 |
| Depret, S | 1 |
| Cambier, N | 1 |
| Vaast, P | 1 |
| Check, JH | 3 |
| Jabeen, M | 1 |
| Yakoob, MY | 1 |
| Imdad, A | 1 |
| Bhutta, ZA | 1 |
| Thomas, M | 1 |
| Dubucquoi, S | 1 |
| Quemeneur, T | 1 |
| Caron, C | 1 |
| Kyndt, X | 1 |
| Morales-Vidal, S | 1 |
| Schneck, MJ | 1 |
| Flaster, MS | 1 |
| Biller, J | 1 |
| Tate, J | 1 |
| Fraser, WD | 1 |
| Rossi, AC | 1 |
| Mullin, PM | 1 |
| Bontadi, A | 1 |
| Salvi, S | 1 |
| Nuzzo, M | 2 |
| Mitic, G | 1 |
| Boffa, MC | 3 |
| Wójtowicz, A | 1 |
| Undas, A | 1 |
| Huras, H | 1 |
| Musiał, J | 1 |
| Rytlewski, K | 1 |
| Reroń, A | 1 |
| Wilczak, M | 1 |
| Jach, R | 1 |
| Dodd, SR | 1 |
| Drakeley, AJ | 2 |
| Alalaf, S | 1 |
| Pasquier, JC | 1 |
| Bakhti, A | 1 |
| Vaiman, D | 3 |
| Ma, JC | 1 |
| Burlingame, JM | 1 |
| Molinari, N | 1 |
| Fabbro-Peray, P | 1 |
| Lefrant, JY | 1 |
| Dauzat, M | 2 |
| Galarza-Maldonado, C | 1 |
| Kourilovitch, MR | 1 |
| Pérez-Fernández, OM | 1 |
| Gaybor, M | 1 |
| Cordero, C | 1 |
| Cabrera, S | 1 |
| Soroka, NF | 1 |
| Kabisch, M | 1 |
| Ruckes, C | 1 |
| Seibert-Grafe, M | 1 |
| Blettner, M | 1 |
| Mulla, MJ | 1 |
| Brosens, JJ | 1 |
| Paidas, MJ | 2 |
| Lockwood, CJ | 1 |
| Bezemer, PD | 1 |
| Joosten, JH | 1 |
| Ernest, JM | 1 |
| Marshburn, PB | 1 |
| Schrör, K | 1 |
| Fodor, A | 1 |
| Gyorffy, A | 1 |
| Váradi, M | 1 |
| Fülesdi, B | 1 |
| Major, T | 1 |
| Tormene, D | 1 |
| De Stefano, V | 1 |
| Tosetto, A | 1 |
| Palareti, G | 1 |
| Castaman, G | 1 |
| Rossi, E | 3 |
| Ciminello, A | 1 |
| Valdrè, L | 1 |
| Legnani, C | 1 |
| Bafunno, V | 1 |
| Carraro, S | 1 |
| Rodeghiero, F | 1 |
| Simioni, P | 1 |
| Borelli, P | 1 |
| Baldacci, F | 1 |
| Vergallo, A | 1 |
| Del Dotto, P | 1 |
| Lucetti, C | 1 |
| Nuti, A | 1 |
| Bonuccelli, U | 1 |
| Yamashita, E | 1 |
| Okada, H | 1 |
| Yorioka, H | 1 |
| Fujita, S | 1 |
| Nishi, K | 1 |
| Komiyama, Y | 1 |
| Kanzaki, H | 1 |
| Loire-Berson, P | 1 |
| Lachassinne, E | 1 |
| Stirnemann, J | 1 |
| Tarr, T | 1 |
| Kiss, E | 1 |
| Szegedi, G | 1 |
| Zeher, M | 1 |
| Villa, P | 4 |
| Bakthi, A | 1 |
| Ebrashy, A | 2 |
| Marinov, B | 2 |
| Pramatarova, T | 2 |
| Andreeva, A | 2 |
| Iarukova, N | 2 |
| Slavov, A | 2 |
| Gouin, K | 1 |
| von Dadelzen, P | 1 |
| Ying, Y | 3 |
| Zhong, YP | 1 |
| Zhou, CQ | 1 |
| Xu, YW | 1 |
| Wu, HT | 1 |
| Shen, XT | 1 |
| Kovács, M | 1 |
| Hartwig, M | 1 |
| Aleksza, M | 1 |
| Tihanyi, M | 1 |
| Nagy, T | 1 |
| Vajda, G | 1 |
| Daru, J | 1 |
| Gasztonyi, B | 1 |
| Bauer, ME | 1 |
| Bauer, ST | 1 |
| Rabbani, AB | 1 |
| Mhyre, JM | 1 |
| Wijetilleka, S | 1 |
| Scoble, T | 1 |
| Le Fol, V | 1 |
| Ahmed, OM | 1 |
| Ahmed, RG | 1 |
| El-Gareib, AW | 1 |
| El-Bakry, AM | 1 |
| Abd El-Tawab, SM | 1 |
| Specker, C | 1 |
| Brinks, R | 1 |
| Schneider, M | 1 |
| McNamee, K | 1 |
| Farquharson, R | 1 |
| Ames, M | 1 |
| Rueda, J | 1 |
| Ahn, H | 1 |
| Vu, P | 1 |
| Park, JC | 1 |
| Eiland, E | 1 |
| Nzerue, C | 1 |
| Faulkner, M | 1 |
| Giannubilo, SR | 1 |
| Tranquilli, AL | 1 |
| Swierczewski, A | 1 |
| Kobos, J | 1 |
| Pasiński, J | 1 |
| Kowalska-Koprek, U | 4 |
| Karowicz-Bilińska, A | 5 |
| Burdan, F | 5 |
| Starosławska, E | 1 |
| Szumiło, J | 1 |
| Dworzańska, A | 1 |
| Dworzański, W | 1 |
| Kubiatowski, T | 1 |
| Cendrowska-Pinkosz, M | 1 |
| Urbańczyk-Zawadzka, M | 1 |
| Rezoagli, E | 1 |
| Rancan, E | 1 |
| Squizzato, A | 1 |
| Feldt-Rasmussen, B | 1 |
| Clausen, P | 1 |
| Patrono, C | 2 |
| Rocca, B | 1 |
| Specker, Ch | 1 |
| Ucieda, R | 3 |
| Hanevik, HI | 1 |
| Friberg, M | 1 |
| Bergh, A | 1 |
| Haraldsen, C | 1 |
| Kahn, JA | 1 |
| Mravian, SR | 1 |
| Petrukhin, VA | 1 |
| Davydova, TV | 1 |
| Budykina, TS | 1 |
| Tishenina, RS | 1 |
| Pronina, VP | 1 |
| Grishin, VL | 1 |
| Bardage, C | 1 |
| Westerlund, T | 1 |
| Barzi, S | 1 |
| Bernsten, C | 1 |
| Doridot, L | 1 |
| Passet, B | 1 |
| Méhats, C | 1 |
| Rigourd, V | 1 |
| Barbaux, S | 1 |
| Ducat, A | 1 |
| Mondon, F | 1 |
| Vilotte, M | 1 |
| Castille, J | 1 |
| Breuiller-Fouché, M | 1 |
| Daniel, N | 1 |
| le Provost, F | 1 |
| Bauchet, AL | 1 |
| Baudrie, V | 1 |
| Hertig, A | 1 |
| Buffat, C | 1 |
| Simeoni, U | 1 |
| Germain, G | 1 |
| Vilotte, JL | 1 |
| George, EM | 1 |
| Bidwell, GL | 1 |
| Becker, R | 1 |
| Keller, T | 1 |
| Fangerau, H | 1 |
| Bittner, U | 1 |
| Naqvi, TZ | 1 |
| Foster, E | 1 |
| Brancaccio, V | 1 |
| Sciannamé, N | 1 |
| Pavone, G | 1 |
| Di Minno, G | 1 |
| Belaisch-Allart, J | 1 |
| Mayenga, JM | 1 |
| Zunker, P | 1 |
| Golombeck, K | 1 |
| Brossmann, J | 1 |
| Georgiadis, D | 1 |
| Deuschl, G | 1 |
| Vilela, VS | 1 |
| Inbal, A | 2 |
| Shaheen, SO | 2 |
| Newson, RB | 2 |
| Sherriff, A | 1 |
| Henderson, AJ | 2 |
| Heron, JE | 1 |
| Burney, PG | 1 |
| Golding, J | 2 |
| Franklin, RD | 2 |
| Czestochowska, E | 1 |
| Vainio, H | 1 |
| Morgan, G | 1 |
| Elwood, P | 1 |
| Tesarik, J | 1 |
| Mendoza, C | 1 |
| Arvieux, J | 1 |
| Kozer, E | 2 |
| Nikfar, S | 2 |
| Costei, A | 1 |
| Boskovic, R | 2 |
| Nulman, I | 2 |
| Somerset, D | 1 |
| Gee, H | 3 |
| Hickstein, H | 1 |
| Barz, D | 1 |
| Külz, T | 1 |
| Korten, G | 1 |
| Müller, H | 1 |
| Schmidt, R | 1 |
| Leonhardt, A | 1 |
| Bernert, S | 1 |
| Watzer, B | 1 |
| Schmitz-Ziegler, G | 1 |
| Seyberth, HW | 1 |
| Smith, JH | 1 |
| Nesheim, BI | 1 |
| Stone, S | 3 |
| Parmar, K | 1 |
| Iglesias, M | 3 |
| Qureshi, ZP | 1 |
| Schellenberg, JC | 1 |
| Shelling, AN | 1 |
| Van Ee, CC | 1 |
| Triolo, G | 1 |
| Ferrante, A | 1 |
| Ciccia, F | 1 |
| Accardo-Palumbo, A | 1 |
| Perino, A | 1 |
| Castelli, A | 1 |
| Giarratano, A | 1 |
| Licata, G | 1 |
| Tzafettas, J | 2 |
| Anapliotis, A | 1 |
| Loufopoulos, A | 1 |
| Psarra, A | 2 |
| Klearchou, N | 1 |
| Mamopoulos, M | 1 |
| Kent, N | 1 |
| Tsakiris, DA | 1 |
| Biasiutti, FD | 1 |
| Strebel, JK | 1 |
| Allahbadia, GN | 1 |
| Allahbadia, SG | 1 |
| Eldor, A | 4 |
| Han, M | 1 |
| Ahmed, AS | 1 |
| Goeusse, P | 2 |
| Puech, F | 3 |
| Lequien, P | 2 |
| Biausque, S | 1 |
| Breart, G | 13 |
| Marquis, P | 1 |
| Parmentier, D | 1 |
| Churlet, A | 1 |
| Quandalle, F | 1 |
| Delcourt, YM | 1 |
| Malek, YM | 1 |
| Braun, S | 1 |
| Jünger, M | 1 |
| Honest, H | 1 |
| Papaioannou, S | 2 |
| von Tempelhoff, GF | 1 |
| Pollow, K | 1 |
| Kato, EH | 1 |
| Shimada, S | 1 |
| Sakuragi, N | 1 |
| Fujimoto, S | 1 |
| Minakami, H | 1 |
| Kalra, S | 1 |
| Tuli, A | 2 |
| Choudhry, R | 2 |
| Raheja, S | 1 |
| Ruggeri, Z | 1 |
| Cannata, ML | 1 |
| Stella, NC | 1 |
| Corrado, F | 1 |
| Nasonov, EL | 2 |
| Sawdy, R | 1 |
| Pan, H | 1 |
| Sullivan, M | 3 |
| Bennett, P | 1 |
| Gupta, U | 3 |
| Cook, JC | 2 |
| Tassinari, MS | 2 |
| Hurtt, ME | 2 |
| Cappon, GD | 1 |
| Streck, RD | 1 |
| Kumpf, SW | 1 |
| Ozolins, TR | 1 |
| Stedman, DB | 1 |
| Costei, AM | 1 |
| Boda, Z | 1 |
| Schlammadinger, A | 1 |
| László, P | 1 |
| Lakos, G | 1 |
| Kerényi, A | 1 |
| Pfliegler, G | 1 |
| Rázsó, K | 1 |
| Pósán, E | 1 |
| Mertens, D | 1 |
| Langford, K | 2 |
| Riutta, A | 3 |
| Koivisto, AM | 2 |
| Mäenpää, J | 4 |
| Hauth, J | 6 |
| Alarcón-Segovia, D | 2 |
| Branch, W | 1 |
| Gharavi, A | 1 |
| Wilson, W | 1 |
| Roubey, R | 1 |
| Chamley, L | 2 |
| Norris, H | 1 |
| Hale, L | 1 |
| Baker, HW | 1 |
| Li, DK | 1 |
| Odouli, R | 1 |
| Lewandowski, K | 1 |
| Balcerzak, A | 1 |
| Kubiaczyk-Paluch, B | 1 |
| Breborowicz, GH | 1 |
| Agarwal, U | 1 |
| Sangwan, K | 1 |
| Yu, CK | 1 |
| Papageorghiou, AT | 1 |
| Parra, M | 1 |
| Palma Dias, R | 1 |
| Stammler, F | 1 |
| Lawall, H | 1 |
| Diehm, C | 1 |
| DARMAILLACQ, R | 1 |
| PELLET, C | 1 |
| LEROY, P | 1 |
| OBBINK, HJ | 1 |
| DALDERUP, LM | 1 |
| EARLEY, PA | 1 |
| HAYDEN, J | 1 |
| SUREAU, C | 2 |
| FOURNIL, C | 1 |
| BONNET, P | 1 |
| LEROUX, C | 1 |
| CREZE, J | 1 |
| GROSIEUX, P | 1 |
| BONHOMME, Y | 1 |
| VITSE, M | 1 |
| VINCI, SL | 1 |
| HARLEY, JD | 1 |
| LESSEL, B | 1 |
| CLIFFE, EE | 1 |
| PETROV-MASLAKOV, MA | 1 |
| BROWN, RA | 1 |
| WEST, GB | 2 |
| BRUNI, JR | 1 |
| HOLT, RE | 1 |
| LARSSON, KS | 1 |
| BOSTROEM, H | 1 |
| TRASLER, DG | 2 |
| MCCOLL, JD | 2 |
| GLOBUS, M | 1 |
| ROBINSON, S | 1 |
| SCHARDEIN, JL | 2 |
| WOOSLEY, ET | 2 |
| HAMILTON, LE | 1 |
| KAUMP, DH | 2 |
| Lejeune, V | 2 |
| Abraitis, V | 1 |
| Mongirdiene, A | 1 |
| Mockeviciene, A | 1 |
| Braunholtz, D | 1 |
| Song, F | 1 |
| Taylor, R | 1 |
| Harrison, CN | 1 |
| Green, AR | 1 |
| Desvaux, D | 1 |
| Takaki, Y | 1 |
| Natsume, N | 1 |
| Adachi, H | 1 |
| Kurata, H | 1 |
| Tamura, M | 3 |
| Kurabayasi, T | 1 |
| Tanaka, K | 5 |
| Blickstein, D | 2 |
| Hod, M | 4 |
| Jain, A | 1 |
| Sarraf, D | 1 |
| Fong, D | 1 |
| Chernev, T | 1 |
| Koleva, R | 1 |
| Karag'ozova, Zh | 1 |
| Chernev, A | 1 |
| Miller, SM | 1 |
| Suzin, J | 3 |
| Sieroszewski, P | 3 |
| Malinowski, A | 1 |
| Dyński, MA | 1 |
| Maciołek-Blewniewska, G | 1 |
| Głowacka, E | 1 |
| Pawłowski, T | 1 |
| Babula, G | 1 |
| Krabbendam, I | 1 |
| Dekker, GA | 7 |
| Lavigne-Lissalde, G | 1 |
| Hoffet, M | 2 |
| Ripart-Neveu, S | 1 |
| Tailland, ML | 1 |
| Chiaffarino, F | 1 |
| Parazzini, F | 3 |
| Paladini, D | 1 |
| Ossola, W | 1 |
| Del Giudice, A | 1 |
| Henderson-Smart, D | 2 |
| Crotti, S | 1 |
| Turpie, AG | 1 |
| Østensen, ME | 1 |
| Skomsvoll, JF | 1 |
| Uzan, M | 5 |
| Cimaz, R | 1 |
| Meregalli, E | 1 |
| Biggioggero, M | 1 |
| Borghi, O | 1 |
| Motta, M | 1 |
| Airò, P | 1 |
| Allais, G | 1 |
| Bosio, A | 1 |
| Mana, O | 1 |
| Airola, G | 1 |
| Ciochetto, D | 1 |
| Terzi, MG | 1 |
| De Lorenzo, C | 1 |
| Quirico, PE | 1 |
| Benedetto, C | 3 |
| Balasch, J | 8 |
| Marszałek, M | 1 |
| Prakash, A | 2 |
| Ola, B | 1 |
| Bats, AS | 1 |
| Cynober, E | 3 |
| Safar, E | 1 |
| Gonzales, M | 1 |
| Milliez, J | 3 |
| Gromnica-Ihle, E | 1 |
| Kalinka, J | 2 |
| Gottwald, L | 1 |
| Nowakowski, M | 1 |
| Lech, W | 1 |
| Zdziennicki, A | 1 |
| Laudański, T | 2 |
| Konova, E | 1 |
| Ivanova, I | 1 |
| Petrova, P | 1 |
| Popov, I | 1 |
| Andreeva, Kh | 1 |
| Lukanov, Ts | 1 |
| Gecheva, S | 1 |
| Waldenström, U | 1 |
| Hellberg, D | 1 |
| Nilsson, S | 1 |
| Ornoy, A | 1 |
| Miller, RK | 1 |
| Challier, JC | 1 |
| Rabreau, M | 1 |
| Ferrer-Raventos, JC | 1 |
| Mountfield, S | 1 |
| Cartwright, JE | 1 |
| Whitley, GS | 1 |
| Vince, G | 1 |
| Wisløff, F | 1 |
| Crowther, M | 1 |
| Ballem, PJ | 1 |
| Tsang, P | 1 |
| Purkiss, S | 1 |
| Ensworth, S | 1 |
| Houlihan, E | 1 |
| Ensom, MH | 1 |
| Jivraj, S | 1 |
| Saygan-Karamürsel, B | 1 |
| Kizilkiliç-Parlakgümüş, A | 1 |
| Deren, O | 1 |
| Onderoğlu, L | 1 |
| Durukan, T | 1 |
| Durlach, J | 1 |
| Kurdi, W | 2 |
| Fayyad, A | 1 |
| Thakur, V | 1 |
| Harrington, K | 2 |
| Lassere, M | 3 |
| Empson, M | 3 |
| Benson, EM | 1 |
| Niittyvuopio, R | 1 |
| Juvonen, E | 1 |
| Kaaja, R | 4 |
| Oksanen, K | 1 |
| Hallman, H | 1 |
| Timonen, T | 1 |
| Ruutu, T | 1 |
| Beillat, T | 1 |
| Macro, M | 1 |
| Dreyfus, M | 1 |
| Fason, JT | 1 |
| Fry, YW | 1 |
| Smith, D | 1 |
| Wilson, AM | 1 |
| Boyle, AJ | 1 |
| Fox, P | 1 |
| Headley, JE | 1 |
| Stratton, FD | 1 |
| Jones, RW | 1 |
| Strachan, DP | 1 |
| Bose, P | 1 |
| Black, S | 1 |
| Kadyrov, M | 1 |
| Weissenborn, U | 1 |
| Neulen, J | 1 |
| Verspyck, E | 1 |
| Marpeau, L | 1 |
| Soy, M | 1 |
| Sayin, NC | 1 |
| Unlü, E | 1 |
| Rogov, VA | 3 |
| Shilov, EM | 1 |
| Kozlovskaia, NL | 2 |
| Gordovskaia, NB | 1 |
| Sidorova, IS | 2 |
| Krylova, MIu | 1 |
| Artem'eva, VB | 1 |
| Nørgård, B | 1 |
| Puhó, E | 1 |
| Czeizel, AE | 1 |
| Skriver, MV | 1 |
| Noble, LS | 1 |
| Lashey, N | 1 |
| Herrada, J | 1 |
| Cheng, Y | 1 |
| Chen, XS | 1 |
| Klein-Szanto, A | 1 |
| Fitzgerald, GA | 6 |
| Funk, CD | 1 |
| Fischer, T | 1 |
| Pildner von Steinburg, S | 1 |
| Diedrich, F | 1 |
| Neumaier-Wagner, P | 1 |
| Paepke, S | 1 |
| Jacobs, VR | 1 |
| Schneider, KT | 1 |
| Päkkilä, M | 1 |
| Tuomivaara, L | 1 |
| Mäkikallio, K | 1 |
| Hippeläinen, M | 1 |
| Tapanainen, JS | 1 |
| Ezemba, N | 1 |
| Eze, JC | 1 |
| Onah, HE | 1 |
| Anisiuba, BC | 1 |
| Aghaji, MA | 1 |
| Ezike, HA | 1 |
| Huxtable, LM | 1 |
| Tafreshi, MJ | 1 |
| Ondreyco, SM | 1 |
| Craig, J | 1 |
| Scott, J | 1 |
| Carta, G | 1 |
| Iovenitti, P | 1 |
| Falciglia, K | 1 |
| Petropoulos, P | 1 |
| Delkos, D | 1 |
| Papaloukas, C | 1 |
| Giannoulis, H | 1 |
| Kalogiros, G | 1 |
| Gkoutzioulis, F | 1 |
| Taéron, C | 1 |
| Rubboli, A | 1 |
| Di Pasquale, G | 1 |
| Bonaminio, PN | 1 |
| de Regnier, R | 1 |
| Chang, E | 1 |
| Day, N | 1 |
| Jeremić, K | 1 |
| Pervulov, M | 1 |
| Gojnić, M | 1 |
| Dukanac, J | 1 |
| Ljubić, A | 1 |
| Stojnić, J | 1 |
| Ng, HJ | 1 |
| Crowther, MA | 1 |
| Wahbi, K | 1 |
| Salengro, E | 1 |
| Galicier, L | 1 |
| Guillevin, L | 1 |
| Spaulding, C | 1 |
| Weber, S | 1 |
| Meune, C | 1 |
| Nicolas, X | 1 |
| Le Berre, R | 1 |
| Ansart, S | 1 |
| Pennec, YL | 1 |
| Voss, M | 1 |
| Cole, R | 1 |
| Moriarty, T | 1 |
| Pathak, M | 1 |
| Iskaros, J | 1 |
| Rodeck, C | 1 |
| Koscielny, J | 1 |
| Aslan, T | 1 |
| Meyer, O | 1 |
| Jung, F | 1 |
| Mrowietz, C | 1 |
| Latza, R | 1 |
| Ibrahim, M | 1 |
| Marzook, A | 1 |
| Yousef, D | 1 |
| Smith, RA | 1 |
| Urman, B | 2 |
| Yakin, K | 1 |
| Balaban, B | 2 |
| Ruano, R | 2 |
| Fontes, RS | 2 |
| Zugaib, M | 2 |
| Haram, K | 2 |
| Björge, L | 1 |
| Sandset, PM | 1 |
| San Miguel-Moncín, M | 1 |
| Cisteró-Bahíma, A | 1 |
| Laird, S | 1 |
| Ledger, WL | 1 |
| Wu, S | 1 |
| Monastiri, K | 2 |
| Seket, B | 1 |
| Chouchane, S | 1 |
| Samama, MM | 1 |
| Mahjoub, T | 2 |
| Szumilo, J | 1 |
| Dudka, J | 1 |
| Korobowicz, A | 1 |
| Klepacz, R | 1 |
| Søfteland, E | 1 |
| Bukowski, R | 1 |
| Kahwa, EK | 1 |
| Sargeant, LA | 1 |
| McFarlane-Anderson, N | 1 |
| Smikle, M | 1 |
| Forrester, T | 1 |
| Wilks, R | 1 |
| Oricha, BS | 1 |
| Goel, N | 1 |
| Duvan, CI | 1 |
| Ozmen, B | 1 |
| Satiroglu, H | 1 |
| Atabekoglu, CS | 1 |
| Berker, B | 1 |
| Faivre, L | 1 |
| Meerpohl, J | 1 |
| Marie, I | 1 |
| Nouvel, C | 1 |
| Gnekow, A | 1 |
| Bender-Götze, C | 1 |
| Bauters, F | 1 |
| Coiffier, B | 1 |
| Peaud, PY | 1 |
| Rispal, P | 1 |
| Berrebi, A | 1 |
| Berger, C | 1 |
| Flesch, M | 1 |
| Sagot, P | 3 |
| Varet, B | 1 |
| Niemeyer, C | 1 |
| Tchernia, G | 1 |
| Leblanc, T | 1 |
| Tsuda, E | 1 |
| Kawamata, K | 1 |
| Neki, R | 1 |
| Echigo, S | 1 |
| Chiba, Y | 1 |
| Khurshid, M | 1 |
| Nazir, Z | 1 |
| Nitsch, P | 1 |
| Breuer, J | 1 |
| Geipel, A | 1 |
| Bartmann, P | 1 |
| Gembruch, U | 1 |
| Heep, A | 1 |
| Lindqvist, PG | 1 |
| Merlo, J | 1 |
| Vaughan, JE | 1 |
| Ford, GD | 1 |
| Tarim, E | 1 |
| Bal, N | 1 |
| Kilicdag, E | 1 |
| Kayaselcuk, F | 1 |
| Bağiş, T | 1 |
| Kuscu, E | 1 |
| Pereira, TV | 1 |
| Rudnicki, M | 1 |
| Soler, JM | 1 |
| Krieger, JE | 1 |
| Tempfer, CB | 1 |
| Kurz, C | 1 |
| Bentz, EK | 1 |
| Unfried, G | 1 |
| Walch, K | 1 |
| Czizek, U | 1 |
| Huber, JC | 1 |
| Figueroa, R | 1 |
| Maulik, D | 1 |
| Daya, S | 1 |
| Keim, SA | 1 |
| Klebanoff, MA | 2 |
| Dolitzky, M | 1 |
| Segal, Y | 1 |
| Weiss, A | 1 |
| Kuś, E | 1 |
| Frattarelli, JL | 2 |
| Miller, BT | 1 |
| Scott, RT | 2 |
| De Santis, M | 1 |
| Cavaliere, AF | 1 |
| Straface, G | 1 |
| Di Gianantonio, E | 1 |
| Caruso, A | 4 |
| Petrides, PE | 2 |
| Sergio, F | 1 |
| Maria Clara, D | 1 |
| Gabriella, F | 1 |
| Giorgia, S | 1 |
| Giancarlo, P | 1 |
| Alessandro, C | 1 |
| Scully, M | 1 |
| Starke, R | 1 |
| Lee, R | 1 |
| Mackie, I | 1 |
| Machin, S | 1 |
| Yamaguchi, K | 1 |
| Hisano, M | 1 |
| Sakata, M | 1 |
| Minatogawa, Y | 1 |
| Suzuki, T | 1 |
| Ozawa, N | 1 |
| Kitagawa, M | 1 |
| Gunther, K | 1 |
| Ooki, I | 1 |
| Tamura, N | 2 |
| Kikuchi, A | 1 |
| Boog, G | 3 |
| Le Vaillant, C | 1 |
| Alnoukari, F | 1 |
| Jossic, F | 1 |
| Barrier, J | 2 |
| Muller, JY | 2 |
| Hender, J | 1 |
| Harris, D | 1 |
| Richard, B | 1 |
| Dawson, A | 1 |
| Khanna, P | 1 |
| Frishman, WH | 2 |
| Veresh, M | 2 |
| Schlocker, SJ | 2 |
| Tejani, N | 2 |
| Descarries, LM | 1 |
| Leduc, L | 2 |
| Khairy, P | 1 |
| Mercier, LA | 1 |
| Bloom, MS | 1 |
| Iwashita, T | 1 |
| Fujitani, M | 1 |
| Yamamoto, Y | 1 |
| Katsurada, T | 1 |
| Yoshida, Y | 1 |
| Allegaert, K | 1 |
| Rayyan, M | 1 |
| Anderson, BJ | 1 |
| Mégarbane, B | 1 |
| Baud, F | 1 |
| Altinoz, MA | 1 |
| Ozdilli, K | 1 |
| Carin, MN | 1 |
| Gedikoglu, G | 1 |
| Boomsma, CM | 1 |
| Macklon, NS | 1 |
| Kornacka, MK | 1 |
| Bokiniec, R | 1 |
| Derksen, RH | 2 |
| Marinho, SA | 1 |
| Sala, MA | 1 |
| Lopes, RA | 1 |
| de Moraes Grisi, MF | 1 |
| Novaes, AB | 1 |
| de Souza, SL | 1 |
| Taba, M | 1 |
| Aguilera, C | 1 |
| Agustí, A | 1 |
| Kushima, K | 1 |
| Oda, K | 1 |
| Sakuma, S | 1 |
| Furusawa, S | 1 |
| Fujiwara, M | 1 |
| Richter, ON | 1 |
| Rath, W | 1 |
| Stamer, UM | 1 |
| Stüber, F | 1 |
| Walsh, CA | 1 |
| Manias, T | 1 |
| Patient, C | 1 |
| Henderson-Smart, DJ | 4 |
| King, JF | 3 |
| Ateş, U | 1 |
| Baka, M | 1 |
| Turgut, M | 1 |
| Uyanikgil, Y | 1 |
| Ulker, S | 1 |
| Yilmaz, O | 1 |
| Tavmergen, E | 1 |
| Yurtseven, M | 1 |
| Khairy, M | 1 |
| Banerjee, K | 1 |
| El-Toukhy, T | 1 |
| Khalaf, Y | 1 |
| Stewart, LA | 1 |
| Lett, C | 1 |
| Case, A | 1 |
| Baerwald, A | 1 |
| Glasnović, M | 1 |
| Bosnjak, I | 1 |
| Vcev, A | 1 |
| Soldo, I | 1 |
| Kosuta, M | 1 |
| Lenz, B | 1 |
| Glasnović-Horvatić, E | 1 |
| Soldo-Butković, S | 1 |
| Mićunović, N | 1 |
| Ushijima, K | 1 |
| Yahata, H | 1 |
| Konishi, I | 1 |
| Yasugi, T | 1 |
| Saito, T | 2 |
| Sasaki, H | 1 |
| Saji, F | 1 |
| Iwasaka, T | 1 |
| Hatae, M | 1 |
| Kodama, S | 1 |
| Terakawa, N | 1 |
| Yaegashi, N | 1 |
| Hiura, M | 1 |
| Sakamoto, A | 1 |
| Tsuda, H | 2 |
| Fukunaga, M | 1 |
| Kamura, T | 1 |
| McWilliams, GDE | 1 |
| Miller, KA | 1 |
| Knight, M | 3 |
| Srivastava, AR | 1 |
| Modi, P | 1 |
| Sahi, S | 1 |
| Niwariya, Y | 1 |
| Singh, H | 1 |
| Banerjee, A | 1 |
| Kedziora-Kornatowska, K | 1 |
| Bartosz, G | 1 |
| Asghar, F | 1 |
| Zaire, M | 1 |
| Dwyer, MO | 1 |
| Bhuinneain, MN | 1 |
| Macé, G | 1 |
| Deligiannidis, A | 1 |
| Parapanissiou, E | 1 |
| Mavridis, P | 1 |
| Tabakoudis, G | 1 |
| Mavroudi, A | 1 |
| Papastavrou, T | 1 |
| Tabakoudis, P | 1 |
| Reilly, JT | 1 |
| Hossain, N | 1 |
| Ruopp, MD | 1 |
| Collins, TC | 1 |
| Alonso Santor, JE | 1 |
| Inglada Galiana, L | 1 |
| Pérez Paredes, G | 1 |
| Schauf, B | 1 |
| Bohlmann, MK | 1 |
| Wallwiener, D | 1 |
| Abele, H | 1 |
| Dubois, E | 1 |
| Takser, L | 1 |
| David, M | 1 |
| Guan, Q | 1 |
| Ma, HG | 1 |
| Wang, YY | 1 |
| Zhang, F | 1 |
| Zhao, S | 1 |
| Lewis, DF | 1 |
| Kalogirou, I | 1 |
| Theodoridis, T | 1 |
| Mahmound, EA | 1 |
| Christopoulou-Cokkinou, V | 1 |
| Creatsas, G | 1 |
| Poustie, VJ | 1 |
| Dodd, S | 1 |
| Chandiramani, M | 1 |
| Elkarmi, A | 1 |
| Abu-Samak, M | 1 |
| Al-Qaisi, K | 1 |
| Tien, JC | 1 |
| Tan, TY | 1 |
| Tsasaris, V | 1 |
| Dolfin, E | 1 |
| Lantieri, T | 1 |
| Holte, JG | 1 |
| Tur-Kaspa, I | 1 |
| Fawzy, M | 1 |
| Shokeir, T | 1 |
| El-Tatongy, M | 1 |
| Warda, O | 1 |
| El-Refaiey, AA | 1 |
| Mosbah, A | 1 |
| James, AH | 1 |
| Brancazio, LR | 1 |
| Price, T | 1 |
| Vij, M | 1 |
| Mowbray, D | 1 |
| Gauer, R | 1 |
| Atlas, M | 1 |
| Hill, J | 1 |
| Bick, RL | 2 |
| Bessereau, J | 1 |
| Desvignes, O | 1 |
| Huon, B | 1 |
| Roudaut, JY | 1 |
| Picault, L | 1 |
| Blanc, JJ | 1 |
| Fetsch, NI | 1 |
| Bremerich, DH | 1 |
| Trakakis, E | 1 |
| Loghis, C | 1 |
| Laggas, D | 1 |
| Simeonides, G | 1 |
| Vaggopoulos, V | 1 |
| Chrelias, C | 1 |
| Lambos, G | 1 |
| Kassanos, D | 1 |
| Vroom, F | 1 |
| van den Berg, PB | 1 |
| de Jong-van den Berg, LT | 1 |
| Ozaki, Y | 2 |
| Sato, T | 1 |
| Suzumori, N | 1 |
| Kumagai, K | 1 |
| Quenet, S | 1 |
| Seffert, P | 1 |
| Perricone, R | 1 |
| De Carolis, C | 1 |
| Kröegler, B | 1 |
| Giacomelli, R | 1 |
| Cipriani, P | 1 |
| Fontana, L | 1 |
| Perricone, C | 1 |
| Curtis, SL | 1 |
| Trinder, J | 1 |
| Stuart, AG | 1 |
| Dinas, K | 1 |
| Hatzipantelis, E | 1 |
| Karasmanis, K | 1 |
| Zepiridis, L | 1 |
| Mavromatidis, G | 1 |
| Bontis, J | 1 |
| Fernández-Meré, LA | 1 |
| Fernández Rogríguez, S | 1 |
| Alvarez-Blanco, M | 1 |
| Liang, WG | 1 |
| Yang, CM | 1 |
| Bromer, JG | 1 |
| Cetinkaya, MB | 1 |
| Arici, A | 1 |
| Al-Aqeedi, RF | 1 |
| Al-Nabti, AD | 1 |
| Bajocchi, G | 1 |
| Tonon, M | 1 |
| Salvarani, C | 1 |
| Patel, S | 2 |
| Wolff, F | 6 |
| Bolte, A | 4 |
| Berg, R | 5 |
| Vorhees, CV | 2 |
| Klein, KL | 3 |
| Scott, WJ | 4 |
| Reimann, IW | 1 |
| Frölich, JC | 1 |
| Lubbe, WF | 6 |
| Butler, WS | 2 |
| Palmer, SJ | 2 |
| Liggins, GC | 3 |
| Reisner, SH | 1 |
| Eisenberg, NH | 1 |
| Stahl, B | 1 |
| Hauser, GJ | 1 |
| Reid, JD | 1 |
| Voigt, T | 1 |
| Voigt, H | 1 |
| Weise, M | 1 |
| Prüfer, D | 1 |
| Jaques, G | 1 |
| Keller, M | 1 |
| Mondorf, AW | 1 |
| Fahrländer, H | 1 |
| Boccaccio, P | 1 |
| Ghio, R | 1 |
| Ratti, M | 1 |
| Casciaro, S | 1 |
| Rattenni, S | 1 |
| Sergnese, G | 1 |
| Spector, SL | 1 |
| Valone, J | 1 |
| Neame, PB | 1 |
| Wang, WH | 1 |
| Qian, SZ | 1 |
| Chen, LJ | 1 |
| Wang, MY | 1 |
| Sun, WK | 1 |
| Liu, MZ | 1 |
| Marmo, E | 2 |
| Gant, NF | 8 |
| Worley, RJ | 4 |
| Everett, RB | 4 |
| MacDonald, PC | 6 |
| de Gaetano, G | 5 |
| Korman, SH | 1 |
| Berant, M | 1 |
| Alon, U | 1 |
| Robinson, DR | 1 |
| London, RS | 1 |
| Sundaram, GS | 1 |
| Feldman, S | 1 |
| Goldstein, PJ | 1 |
| Syrop, CH | 1 |
| Varner, MW | 2 |
| Niederhoff, H | 1 |
| Zahradnik, HP | 2 |
| Cooper, SA | 1 |
| Wagenberg, B | 1 |
| Eskow, R | 1 |
| Zissu, J | 1 |
| Laska, EM | 1 |
| Sunshine, A | 1 |
| Mueller, F | 1 |
| Elvers, WB | 1 |
| Siegel, C | 1 |
| Rubin, A | 2 |
| Grabowski, CT | 1 |
| Kennedy, BM | 1 |
| Walker, EB | 1 |
| Mehta, J | 1 |
| Roberts, A | 2 |
| Sterin, AB | 1 |
| Goldraij, A | 1 |
| Gimeno, MA | 1 |
| Gimeno, AL | 4 |
| Anggård, E | 1 |
| Berlin, CM | 1 |
| Simberg, N | 1 |
| Donsimoni, R | 3 |
| Colau, JC | 3 |
| Mitala, JJ | 1 |
| Boardman, JP | 1 |
| Carrano, RA | 1 |
| Iuliucci, JD | 1 |
| Bornstein, A | 1 |
| Dalal, P | 1 |
| Tischler, J | 1 |
| Novack, S | 1 |
| Michaelson, S | 1 |
| Mishell, DR | 1 |
| Fisher, HW | 1 |
| Haynes, PJ | 1 |
| Jones, GS | 1 |
| Smith, RP | 1 |
| Yokoyama, A | 3 |
| Takakubo, F | 1 |
| Eto, K | 1 |
| Ueno, K | 4 |
| Igarashi, T | 1 |
| Satoh, T | 1 |
| Kitagawa, H | 4 |
| Clark, RL | 2 |
| Robertson, RT | 2 |
| Minsker, DH | 1 |
| Cohen, SM | 1 |
| Tocco, DJ | 1 |
| Allen, HL | 2 |
| James, ML | 1 |
| Bokelman, DL | 2 |
| Winter, L | 1 |
| Vesterqvist, O | 1 |
| Gréen, K | 1 |
| Vandekerckhove, F | 1 |
| Noens, L | 1 |
| Colardyn, F | 1 |
| Thiery, M | 1 |
| Delbarge, W | 1 |
| Gibbs, CJ | 1 |
| Coutts, II | 1 |
| Lock, R | 1 |
| Finnegan, OC | 1 |
| White, RJ | 1 |
| Clark, KE | 1 |
| Lal, J | 1 |
| Viggiano, M | 2 |
| Dveksler, G | 2 |
| Franchi, AM | 2 |
| Gimeno, MF | 3 |
| Bloomfield, SS | 5 |
| Cissell, GB | 1 |
| Mitchell, J | 5 |
| Barden, TP | 5 |
| Dubin, NH | 1 |
| Ghodgaonkar, RB | 1 |
| Blake, DA | 1 |
| Simonsen, K | 1 |
| Andreasen, PB | 1 |
| Szekeres-Bartho, J | 1 |
| Csernus, V | 1 |
| Hadnagy, J | 1 |
| Pacsa, AS | 1 |
| Amon, I | 1 |
| Zschiesche, A | 1 |
| Amon, K | 1 |
| Todorov, S | 1 |
| Becci, PJ | 1 |
| Reagan, EL | 1 |
| Knickerbocker, MJ | 1 |
| Barbee, SJ | 1 |
| Wedig, JH | 1 |
| Thiessen, JJ | 2 |
| Coceani, F | 2 |
| Olley, PM | 2 |
| Salama, RB | 2 |
| Itami, T | 2 |
| Kanoh, S | 2 |
| Knuppel, RA | 1 |
| Rao, PS | 1 |
| Cavanagh, D | 1 |
| Mehlman, MA | 1 |
| Craig, PH | 1 |
| Gallo, MA | 1 |
| Fournie, A | 1 |
| Boneu, B | 1 |
| Weksler, BB | 1 |
| Colwell, JA | 1 |
| Halushka, PV | 1 |
| Tamura, T | 2 |
| Ventura, S | 1 |
| Catalano, S | 1 |
| Cianci, A | 1 |
| Okazaki, T | 1 |
| Casey, ML | 1 |
| Okita, JR | 1 |
| Johnston, JM | 2 |
| Niebyl, JR | 3 |
| Ollivier-Bousquet, M | 2 |
| Haataja, M | 2 |
| Grönroos, M | 2 |
| Honkonen, E | 2 |
| Paul, R | 7 |
| Nieminen, AL | 1 |
| Anttila, M | 2 |
| Willems, C | 1 |
| Pool, GA | 1 |
| Gonsalvez, MS | 1 |
| Van Aken, WG | 1 |
| Van Mourik, JA | 1 |
| Saito, H | 3 |
| Sakai, T | 3 |
| Shimoto, Y | 1 |
| Takeno, S | 2 |
| Nuñez, L | 1 |
| Larrea, JL | 1 |
| Gil Aguado, M | 1 |
| Reque, JA | 1 |
| Matorras, R | 1 |
| Minguez, JA | 1 |
| Ungváry, G | 3 |
| Tátrai, E | 2 |
| Lõrincz, M | 1 |
| Barcza, G | 1 |
| Goodlin, RC | 3 |
| Davis, RB | 1 |
| Wollenhaupt, K | 3 |
| Rubo, B | 1 |
| Steger, H | 3 |
| Felts, WR | 1 |
| Simon, LS | 1 |
| Mills, JA | 1 |
| Linton, EA | 1 |
| Whitehead, SA | 1 |
| Makatsariia, AD | 1 |
| Limonova, SG | 1 |
| Wessler, S | 1 |
| Stuart, MJ | 1 |
| Gross, SJ | 1 |
| Elrad, H | 1 |
| Graeber, JE | 1 |
| Gerhardt, W | 1 |
| Kallós, P | 1 |
| Lundquist, A | 1 |
| Snellings, WM | 1 |
| Maronpot, RR | 1 |
| Zelenak, JP | 1 |
| Laffoon, CP | 1 |
| Mankes, RF | 1 |
| Rosenblum, I | 1 |
| Benitz, KF | 1 |
| LeFevre, R | 1 |
| Abraham, R | 1 |
| DePass, LR | 1 |
| Weaver, EV | 1 |
| Greenaway, JC | 1 |
| Shepard, TH | 3 |
| Fantel, AG | 1 |
| Juchau, MR | 1 |
| Biale, Y | 1 |
| Cantor, A | 1 |
| Lewenthal, H | 1 |
| Gueron, M | 1 |
| Masumura, H | 1 |
| Pütter, J | 3 |
| Tsuruzaki, T | 1 |
| Watanabe, G | 1 |
| Yamamoto, M | 3 |
| Richner, J | 1 |
| Gratwohl, A | 1 |
| Cornu, P | 1 |
| Speck, B | 1 |
| Anderson, GF | 1 |
| Kawarabayashi, T | 1 |
| Marshall, JM | 1 |
| Furmaniuk, J | 1 |
| Religa, Z | 1 |
| Kiełek, M | 1 |
| Siemiński, R | 1 |
| Koszałkowski, M | 1 |
| Szuba, R | 1 |
| Walkowska, I | 1 |
| Szymonik, Z | 1 |
| Skegg, DC | 1 |
| Doll, R | 1 |
| Wilson, JG | 5 |
| Malhotra, N | 1 |
| Varma, SK | 1 |
| Chaudhury, RR | 1 |
| Rumack, CM | 1 |
| Guggenheim, MA | 1 |
| Rumack, BH | 3 |
| Peterson, RG | 3 |
| Johnson, ML | 1 |
| Braithwaite, WR | 1 |
| Soller, RW | 1 |
| Stander, H | 1 |
| Barbieri, B | 1 |
| Balconi, G | 1 |
| Dejana, E | 1 |
| Donati, MB | 3 |
| Anderson, DF | 2 |
| Phernetton, TM | 2 |
| Rankin, JH | 2 |
| Stein, GH | 1 |
| Cantor, B | 1 |
| Panush, RS | 1 |
| Jackowski, L | 1 |
| Nowakowski, T | 1 |
| Sokal, K | 1 |
| Sadłecki, W | 1 |
| Mikhaĭlenko, ET | 1 |
| Chernega, MIa | 1 |
| Jespersen, J | 1 |
| Bygdeman, M | 1 |
| Machlin, LJ | 1 |
| Gabriel, E | 1 |
| Horn, LR | 1 |
| Filipski, R | 1 |
| Brin, M | 1 |
| Nelson, J | 1 |
| Curtius, JM | 1 |
| Goeckenjan, G | 1 |
| Steyer, M | 1 |
| Hust, M | 1 |
| Rudolph, AM | 3 |
| Wenstrom, KD | 1 |
| Hauth, JC | 8 |
| DuBard, MB | 3 |
| Lea, C | 1 |
| Padmanabhan, R | 2 |
| Pallot, DJ | 1 |
| Peaceman, AM | 2 |
| Rehnberg, KA | 1 |
| Wechsler, B | 6 |
| Généreau, T | 1 |
| Biousse, V | 1 |
| Vauthier-Brouzes, D | 2 |
| Seebacher, J | 2 |
| Dormont, D | 1 |
| Godeau, P | 2 |
| Ron-el, R | 1 |
| Vinder, A | 1 |
| Golan, A | 1 |
| Herman, A | 1 |
| Raziel, A | 2 |
| Caspi, E | 2 |
| Sidi, Y | 1 |
| Bortolus, R | 2 |
| Chatenoud, L | 2 |
| Restelli, S | 2 |
| Dror, Y | 1 |
| Gelman-Kohan, Z | 1 |
| Hagai, Z | 1 |
| Juster-Reicher, A | 1 |
| Cohen, RN | 1 |
| Mogilner, B | 1 |
| Hamid, R | 1 |
| Robson, M | 1 |
| Pearce, JM | 2 |
| Aoki, K | 7 |
| Aoyama, T | 3 |
| Kunimatsu, M | 1 |
| Kyle, PM | 1 |
| Buckley, D | 1 |
| Kissane, J | 1 |
| de Swiet, M | 10 |
| Zahner, J | 1 |
| Wehmeier, A | 1 |
| Schneider, W | 1 |
| Ylikorkala, O | 5 |
| Sasa, H | 2 |
| Ogasawara, M | 4 |
| Kajiura, S | 1 |
| Yagami, Y | 3 |
| Laifer, SA | 1 |
| Parker, CR | 5 |
| Copper, RL | 5 |
| Cutter, GR | 3 |
| Edelman, P | 2 |
| Rouquette, AM | 1 |
| Silver, RK | 3 |
| Adams, DM | 1 |
| Lavanya, R | 1 |
| Pratap, K | 1 |
| Hirahatake, K | 1 |
| Sato, C | 1 |
| Rienhardt, GW | 1 |
| Steyn, PS | 1 |
| Odendaal, HJ | 2 |
| Thom, E | 5 |
| Shaw, K | 1 |
| McNellis, D | 7 |
| Blank, M | 1 |
| Fishman, P | 3 |
| Hayashi, Y | 1 |
| Cliver, SP | 1 |
| Brown, MA | 2 |
| Crowther, CA | 1 |
| King, J | 2 |
| McCowan, L | 1 |
| Morris, J | 1 |
| North, R | 1 |
| Pattison, N | 2 |
| Tippett, C | 1 |
| Radermecker, M | 1 |
| Govaert, P | 1 |
| Staelens, V | 1 |
| Vanhaesebrouch, P | 1 |
| Wallenburg, HC | 12 |
| Williams, K | 1 |
| Söderlin, MK | 1 |
| Purhonen, S | 1 |
| Haring, P | 1 |
| Hietakorpi, S | 1 |
| Koski, E | 1 |
| Nuutinen, LS | 1 |
| Nicoloso, E | 1 |
| d'Ercole, C | 1 |
| Cassel, N | 1 |
| Azoulay, P | 1 |
| Cravello, L | 1 |
| Boubli, L | 1 |
| Blanc, B | 1 |
| Rymark, P | 1 |
| Berntorp, E | 1 |
| Nordsjö, P | 1 |
| Liedholm, H | 1 |
| Melander, A | 1 |
| Gennser, G | 1 |
| Tunbridge, RD | 1 |
| Wada, I | 1 |
| Hsu, CC | 1 |
| Williams, G | 1 |
| Macnamee, MC | 1 |
| Brinsden, PR | 1 |
| Kawano, M | 1 |
| Jones, WR | 1 |
| Gordon, T | 1 |
| Klebanoff, M | 8 |
| Paul, RH | 2 |
| Wasfi, IA | 1 |
| Craigmyle, MB | 1 |
| Bremer, HA | 3 |
| Rotmans, N | 4 |
| Brommer, EJ | 1 |
| Oian, P | 2 |
| Maltau, JM | 1 |
| Darling, M | 2 |
| Hamed, MR | 1 |
| al-Assy, YS | 1 |
| Ezzeldin, E | 1 |
| Roy, UK | 1 |
| Pan, S | 1 |
| Romanini, C | 2 |
| Barron, WM | 1 |
| Wide-Swensson, D | 1 |
| Montal, S | 1 |
| Ingemarsson, I | 1 |
| Di Sessa, TG | 1 |
| Moretti, ML | 1 |
| Khoury, A | 1 |
| Pulliam, DA | 1 |
| Arheart, KL | 1 |
| Christiansen, OB | 4 |
| Lauritsen, JG | 2 |
| Arnout, J | 1 |
| Spitz, B | 3 |
| Wittevrongel, C | 1 |
| Vanrusselt, M | 1 |
| Van Assche, A | 1 |
| Vermylen, J | 2 |
| Kwak, JY | 1 |
| Barini, R | 1 |
| Beaman, KD | 1 |
| Beer, AE | 1 |
| Lindberg, B | 1 |
| Secher, NJ | 1 |
| Lorentzen, B | 2 |
| Henriksen, T | 2 |
| Porreco, RP | 2 |
| Hickok, DE | 1 |
| Williams, MA | 1 |
| Krenning, C | 1 |
| Keirse, MJ | 2 |
| Gonser, M | 1 |
| Marzusch, K | 1 |
| Louden, KA | 6 |
| Crawford, MA | 1 |
| Moya, FR | 1 |
| Germain, A | 1 |
| Karas, H | 1 |
| Egarter, C | 2 |
| Husslein, P | 2 |
| Atkinson, MW | 1 |
| Maher, JE | 3 |
| Carmona, F | 3 |
| López-Soto, A | 3 |
| Font, J | 5 |
| Creus, M | 2 |
| Fábregues, F | 2 |
| Ingelmo, M | 2 |
| Vanrell, JA | 2 |
| Fernandez, H | 2 |
| Fletcher, HM | 1 |
| Wharfe, GH | 1 |
| Thomas, E | 2 |
| Sherman, D | 1 |
| Arieli, S | 1 |
| Bukovski, I | 1 |
| Weinraub, Z | 1 |
| Hertz-Picciotto, I | 2 |
| Neutra, RR | 1 |
| Schneider, H | 2 |
| Broughton Pipkin, F | 3 |
| Heptinstall, S | 3 |
| Fox, SC | 1 |
| Tuohy, P | 2 |
| O'Callaghan, C | 2 |
| Mitchell, JR | 2 |
| Symonds, EM | 2 |
| Beilin, L | 1 |
| Viinikka, L | 5 |
| Hartikainen-Sorri, AL | 1 |
| Lumme, R | 1 |
| Hiilesmaa, V | 1 |
| Valcamonico, A | 3 |
| Foschini, M | 1 |
| Soregaroli, M | 2 |
| Tarantini, M | 1 |
| Silveira, LH | 2 |
| Espinoza, LR | 2 |
| Jesse, R | 1 |
| Goldenberg, R | 1 |
| Lou, YJ | 3 |
| al-Momen, AK | 1 |
| Moghraby, SA | 1 |
| el-Rab, MO | 1 |
| Gader, AM | 1 |
| al-Balla, SR | 1 |
| al-Meshari, AA | 1 |
| al-Nuaim, L | 1 |
| MacGregor, SN | 1 |
| Sholl, JS | 1 |
| Hobart, JM | 1 |
| Neerhof, MG | 1 |
| Ragin, A | 1 |
| Hutt, R | 1 |
| Ogunniyi, SO | 1 |
| Sullivan, MH | 7 |
| Elder, MG | 10 |
| Karlowicz, MG | 1 |
| White, LE | 1 |
| Wang, ZH | 1 |
| Li, WJ | 1 |
| Pollard, JK | 1 |
| Mitchell, MD | 5 |
| Gull, S | 1 |
| Prentice, A | 1 |
| Ferris, AM | 1 |
| Reece, EA | 4 |
| Orlikowski, CE | 3 |
| Rocke, DA | 3 |
| Gatenby, P | 1 |
| Lin, QD | 1 |
| Tian, CH | 1 |
| Skajaa, K | 1 |
| Pardini, S | 1 |
| Dore, F | 1 |
| Murineddu, M | 1 |
| Bontigli, S | 1 |
| Longinotti, M | 1 |
| Grigliotti, B | 1 |
| Spano, B | 1 |
| Shen, J | 1 |
| Wanwimolruk, S | 1 |
| Wilson, PD | 1 |
| Seddon, RJ | 1 |
| Roberts, MS | 1 |
| Kinoshita, K | 1 |
| Stuart, RA | 1 |
| McHugh, NJ | 1 |
| Fiks-Sigaud, M | 1 |
| Audrain, M | 1 |
| Banwatt, D | 1 |
| Chaouat, G | 2 |
| Ngo, VU | 1 |
| Kammoun, M | 1 |
| Bouzaghar, A | 1 |
| Saranti, L | 1 |
| Jeny, R | 1 |
| Meagher, EA | 1 |
| Hirafuji, M | 1 |
| Shinoda, H | 1 |
| Tareeva, IE | 1 |
| Androsova, SO | 1 |
| Katamadze, KT | 1 |
| Nikiforova, OV | 2 |
| Julkunen, H | 3 |
| Ammälä, P | 1 |
| Palosuo, T | 2 |
| Kurki, P | 1 |
| Menashe, Y | 3 |
| Frenkel, Y | 2 |
| Many, A | 4 |
| Nebel, L | 2 |
| Toder, V | 2 |
| Mashiach, S | 6 |
| Ben-Baruch, G | 3 |
| Greenspoon, JS | 1 |
| Rosen, DJ | 1 |
| Rocco, L | 1 |
| Romero, R | 1 |
| Witter, F | 1 |
| Rosen, M | 1 |
| Zuspan, FP | 2 |
| Samuels, P | 2 |
| Cook, CM | 5 |
| Trudinger, BJ | 3 |
| O'Connell, PD | 1 |
| Caplan, MS | 1 |
| Philips, JB | 1 |
| Chakravarty, K | 1 |
| Merry, P | 1 |
| Itoh, H | 1 |
| Ihara, Y | 1 |
| Okagaki, A | 1 |
| Inamori, K | 1 |
| Sagawa, N | 1 |
| Mori, T | 1 |
| Mandai, M | 1 |
| Niwa, H | 1 |
| Stern, JJ | 1 |
| Coulam, CB | 2 |
| Chassagne, M | 1 |
| Barnouin, J | 1 |
| Forouzan, I | 1 |
| Cohen, AW | 2 |
| Lindenbaum, C | 1 |
| Endresen, M | 1 |
| Clausen, T | 1 |
| Williams, HD | 1 |
| Howard, R | 1 |
| O'Donnell, N | 1 |
| Findley, I | 1 |
| Veille, JC | 1 |
| Hanson, R | 1 |
| Sivakoff, M | 1 |
| Swain, M | 1 |
| Henderson, L | 1 |
| Buck, ML | 1 |
| Grebe, TA | 1 |
| Bond, GR | 1 |
| Olson, NA | 1 |
| Morris, JM | 2 |
| Fay, RA | 1 |
| Devonald, KJ | 1 |
| Takanashi, K | 1 |
| Watanabe, K | 1 |
| Yoshizawa, I | 1 |
| McCoy, MC | 2 |
| Coffman, TM | 1 |
| Killam, AP | 1 |
| Kay, HH | 2 |
| Marco, P | 1 |
| Lucas, J | 1 |
| Alonso, A | 1 |
| Pérez Vázquez, J | 1 |
| Fernández, P | 1 |
| Victoria, C | 1 |
| García, MC | 1 |
| Calatayud, R | 1 |
| Cusick, W | 1 |
| Salafia, CM | 1 |
| Ernst, L | 1 |
| Rodis, JF | 1 |
| Campbell, WA | 1 |
| Vintzileos, AM | 1 |
| Ezra, Y | 3 |
| Rose, M | 1 |
| Davis, DP | 1 |
| Daston, GP | 1 |
| Odio, MR | 1 |
| York, RG | 1 |
| Kraus, AL | 1 |
| Buist, RG | 1 |
| Gamble, G | 2 |
| Van Marter, LJ | 1 |
| Pagano, M | 1 |
| Sullivan, KF | 1 |
| Epstein, MF | 1 |
| Lippert, TH | 1 |
| Mück, AO | 1 |
| Arlen, RR | 1 |
| Wells, PG | 3 |
| Delage, R | 1 |
| Demers, C | 1 |
| Cantin, G | 1 |
| Roy, J | 1 |
| Grant, JM | 1 |
| Crowther, C | 1 |
| Judd, A | 1 |
| Lilford, RJ | 1 |
| Onwude, J | 1 |
| Prentice, C | 1 |
| Roberts, J | 3 |
| Walker, J | 1 |
| Bower, SJ | 1 |
| Harrington, KF | 1 |
| Schuchter, K | 1 |
| McGirr, C | 1 |
| Campbell, S | 3 |
| Fahy, BG | 1 |
| Malinow, AM | 1 |
| Ohl, J | 1 |
| Bettahar-Lebugle, K | 1 |
| Dellenbach, P | 1 |
| Berkane, N | 3 |
| Ferrier, C | 1 |
| Fairley, KF | 1 |
| Kincaid-Smith, P | 1 |
| Newnham, JP | 1 |
| Godfrey, M | 1 |
| Walters, BJ | 1 |
| Evans, SF | 1 |
| Ricci, E | 1 |
| Ding, GS | 1 |
| Tu, ZH | 1 |
| Ermel, LD | 1 |
| Rai, RS | 1 |
| Chitolie, A | 1 |
| Donald, JG | 1 |
| van Geijn, HP | 2 |
| Zozulia, OV | 1 |
| Miroshnichenko, NG | 1 |
| Martin, C | 1 |
| Rodgers, G | 1 |
| Pagliaro, P | 1 |
| Arrigoni, L | 1 |
| Muggiasca, ML | 1 |
| Poggio, M | 1 |
| Russo, U | 1 |
| Paniel, BJ | 1 |
| Horn, EH | 1 |
| Hardy, E | 1 |
| Cooper, J | 1 |
| Rubin, PC | 2 |
| Falach-Vaknin, E | 1 |
| Sredni, B | 1 |
| Dicker, D | 1 |
| Edwin, SS | 1 |
| Romero, RJ | 1 |
| Munoz, H | 1 |
| Rogers, MS | 2 |
| Hung, C | 1 |
| Arumanayagam, M | 1 |
| Cowchock, S | 3 |
| Ogola, ES | 1 |
| Ramaiya, C | 1 |
| Mgaya, HN | 1 |
| Leslie, GI | 1 |
| Gallery, ED | 1 |
| Arnold, JD | 1 |
| Ross, MR | 1 |
| Gyory, AZ | 1 |
| Heimpel, H | 2 |
| Pearson, TC | 3 |
| Horbach, DA | 1 |
| Theis, JG | 1 |
| Mazzucconi, MG | 1 |
| Dragoni, F | 1 |
| Chistolini, A | 1 |
| Peraino, M | 1 |
| Paesano, R | 2 |
| Di Prima, M | 1 |
| Di Francesco, F | 1 |
| Masala, C | 1 |
| Pachì, A | 1 |
| Buckshee, K | 1 |
| Chadha, S | 1 |
| Alqadah, F | 1 |
| Garofalo, J | 1 |
| Zheng, XZ | 2 |
| Assimakopoulos, E | 1 |
| Mackworth-Young, C | 1 |
| Dave, M | 1 |
| Cervar, M | 1 |
| Nelson, DM | 4 |
| Kainer, F | 1 |
| Desoye, G | 1 |
| el Kouri, D | 1 |
| Hamidou, M | 1 |
| Mejía, R | 1 |
| Sarto, A | 1 |
| Das, I | 1 |
| Sooranna, SR | 1 |
| Eliyahu, S | 1 |
| Shalev, E | 1 |
| Maesima, E | 1 |
| Yamada, Y | 1 |
| Yukawa, S | 1 |
| Maeda, T | 1 |
| Leitich, H | 1 |
| Kaider, A | 1 |
| Schemper, M | 1 |
| Aulesa, C | 1 |
| Petit, M | 1 |
| Sentis, M | 1 |
| Ortega, JJ | 1 |
| Sen, AP | 1 |
| Dong, Y | 1 |
| Gulati, A | 1 |
| Pardo, J | 1 |
| Fisch, B | 1 |
| Rabinerson, D | 1 |
| Kaplan, B | 1 |
| Meizner, I | 1 |
| Cohen, MD | 1 |
| Conn, DL | 1 |
| Botet, F | 1 |
| Romera, G | 1 |
| Montagut, P | 1 |
| Figueras, J | 1 |
| Dell'Isola, A | 1 |
| Di Rosa, G | 1 |
| Catalano, D | 1 |
| Bombardier, C | 1 |
| Hannah, ME | 1 |
| Mandel, FP | 1 |
| Ritchie, JW | 1 |
| Farewell, V | 1 |
| Farine, D | 1 |
| Spitzer, K | 1 |
| Fielding, L | 1 |
| Soloninka, CA | 1 |
| Yeung, M | 1 |
| Yetman, DL | 1 |
| Chantilis, SJ | 1 |
| Crain, J | 1 |
| Montan, S | 1 |
| Bernheim, J | 1 |
| Herabutya, Y | 1 |
| Jetsawangsri, T | 1 |
| Saropala, N | 1 |
| Johnson, RD | 2 |
| Polakoski, K | 1 |
| Everson, WV | 1 |
| Lê Huong, D | 1 |
| Lefèbvre, G | 1 |
| Blétry, O | 3 |
| Darbois, Y | 1 |
| Granger, KA | 1 |
| Birbari, AE | 1 |
| Tulppala, M | 1 |
| Marttunen, M | 1 |
| Söderstrom-Anttila, V | 1 |
| Foudila, T | 1 |
| Ailus, K | 1 |
| Bangerter, M | 2 |
| van Vliet, HH | 1 |
| Michiels, JJ | 1 |
| Huong, DL | 1 |
| Cai, YX | 1 |
| Willoughby, SJ | 1 |
| Fairhead, S | 1 |
| Woodcock, BE | 1 |
| Mojón, A | 2 |
| Silva, I | 2 |
| Fernández, JR | 2 |
| Rossi, G | 1 |
| Appiano, G | 1 |
| Lapini, L | 1 |
| Caremani, M | 1 |
| Tewari, S | 1 |
| Kaushish, R | 1 |
| Gulati, N | 1 |
| Steyn, DW | 1 |
| Di Simone, N | 1 |
| Ferrazzani, S | 3 |
| Castellani, R | 1 |
| Mancuso, S | 2 |
| González Campos, J | 1 |
| Monedero, M | 1 |
| Vinuesa, M | 1 |
| Alvarez, D | 1 |
| Digón, J | 1 |
| Rodríguez, JM | 1 |
| Weckstein, LN | 1 |
| Jacobson, A | 1 |
| Galen, D | 1 |
| Hampton, K | 1 |
| Hammel, J | 1 |
| Faas, MM | 1 |
| Schuiling, GA | 1 |
| Baller, JF | 1 |
| Valkhof, N | 1 |
| Bakker, WW | 1 |
| Napolitano, PG | 1 |
| Hoeldtke, NJ | 1 |
| Moore, KH | 1 |
| Calhoun, BC | 1 |
| Christensen, ED | 1 |
| Markenson, GR | 1 |
| Hume, RF | 1 |
| Burnog, T | 1 |
| Scott, JR | 4 |
| Pollack, RN | 1 |
| Yaffe, H | 1 |
| Divon, MY | 1 |
| Geva, E | 2 |
| Amit, A | 2 |
| Lessing, JB | 2 |
| Polakoski, KL | 1 |
| Sadovsky, Y | 1 |
| Shekhtman, MM | 1 |
| Rasul'-Zade, IuG | 1 |
| Palatnick, W | 1 |
| Tenenbein, M | 1 |
| Rojas-Poceros, G | 1 |
| Ramírez Peredo, J | 1 |
| Hernández Andrade, E | 1 |
| Bustos López, HH | 1 |
| Lindheimer, MD | 2 |
| VanDorsten, P | 3 |
| Landon, M | 6 |
| Meis, P | 5 |
| Thurnau, G | 5 |
| Barth, W | 1 |
| Arakawa, M | 1 |
| Honda, K | 1 |
| Imai, T | 1 |
| Kurabayashi, T | 2 |
| Tiboni, GM | 1 |
| Iammarrone, E | 1 |
| Piccirillo, G | 1 |
| Bellati, U | 1 |
| Chaieb, A | 1 |
| Skouri, H | 1 |
| Slama, A | 1 |
| Chebil, S | 1 |
| Maaroufi, R | 1 |
| Nouira, M | 1 |
| Mokni, M | 1 |
| Zanina, R | 1 |
| Saidi, H | 1 |
| Ben Amor, F | 1 |
| Bibi, M | 1 |
| Kortas, M | 1 |
| Snoussi, N | 1 |
| Khairi, H | 1 |
| Byaruhanga, RN | 1 |
| Chipato, T | 1 |
| Rusakaniko, S | 1 |
| Rotchell, YE | 1 |
| Cruickshank, JK | 1 |
| Gay, MP | 1 |
| Griffiths, J | 1 |
| Stewart, A | 2 |
| Farrell, B | 1 |
| Ayers, S | 1 |
| Hennis, A | 1 |
| Grant, A | 1 |
| Collins, R | 1 |
| Ural, S | 1 |
| Nagey, DA | 1 |
| Cyrkowicz, A | 1 |
| Przybycień, J | 1 |
| Katano, K | 2 |
| Suzumori, K | 2 |
| Sher, G | 3 |
| Maassarani, G | 3 |
| Zouves, C | 3 |
| Feinman, M | 3 |
| Sohn, S | 1 |
| Matzner, W | 3 |
| Chong, P | 3 |
| Ching, W | 3 |
| Cohn, GM | 1 |
| Ikeda, Y | 1 |
| Kawahata, M | 1 |
| Togashi, H | 1 |
| Arishima, K | 1 |
| Masaoka, T | 1 |
| Clark, NA | 1 |
| Moreno González, A | 1 |
| Brown, NL | 1 |
| Alvi, SA | 1 |
| Bennett, PR | 1 |
| Regan, CL | 1 |
| McAdam, BF | 1 |
| Boylan, PC | 1 |
| Fitzgerald, DJ | 2 |
| Cook, JL | 1 |
| Randall, CL | 7 |
| Johns, KR | 1 |
| Littlejohn, GO | 1 |
| Lear, JT | 1 |
| Graham, C | 1 |
| Mitchell, V | 1 |
| Hutchinson, PE | 1 |
| Riyazi, N | 1 |
| Leeda, M | 1 |
| Huijgens, PC | 1 |
| Hughes, G | 1 |
| Alexander, RE | 1 |
| Lindheimer, M | 4 |
| Dombrowski, M | 3 |
| Ware Branch, D | 1 |
| Hatasaka, HH | 1 |
| Carrero, EJ | 1 |
| Agustí, M | 1 |
| Fábregas, N | 1 |
| Valldeoriola, F | 1 |
| Fernández, C | 1 |
| MacPherson, C | 4 |
| Walsh, S | 1 |
| Denis, E | 1 |
| Dufour, P | 2 |
| Vinatier, D | 2 |
| Valat, AS | 1 |
| Pfaffenrath, V | 1 |
| Rehm, M | 1 |
| Sebastian, C | 1 |
| Scherlag, M | 1 |
| Kugelmass, A | 1 |
| Schechter, E | 1 |
| Hasegawa, I | 2 |
| Yamanoto, Y | 1 |
| Suzuki, M | 1 |
| Murakawa, H | 1 |
| Leinonen, PJ | 1 |
| Dietterich, C | 1 |
| Lurie, D | 1 |
| Nazari, A | 1 |
| Chuong, J | 1 |
| Oyelese, KO | 1 |
| Black, RS | 1 |
| Lees, CC | 1 |
| Dumont, A | 3 |
| Flahault, A | 1 |
| Verdy, E | 1 |
| Ylitalo, P | 1 |
| Ala-Fossi, SL | 1 |
| Tuimala, R | 1 |
| Christian, R | 1 |
| Sungani, FC | 1 |
| Malata, A | 1 |
| Masanjika, R | 1 |
| Witlin, AG | 1 |
| Luzzatto, G | 1 |
| Fabris, F | 3 |
| Dasari, R | 1 |
| Narang, A | 1 |
| Vasishta, K | 1 |
| Garewal, G | 1 |
| Rubinstein, M | 1 |
| Marazzi, A | 1 |
| Polak de Fried, E | 1 |
| Li, DJ | 1 |
| Li, CJ | 1 |
| Cadavid, A | 1 |
| Peña, B | 1 |
| García, G | 1 |
| Botero, J | 1 |
| Sánchez, F | 1 |
| Ossa, J | 1 |
| Beer, A | 1 |
| Hanke, W | 1 |
| Wakatsuki, A | 1 |
| Izumiya, C | 1 |
| Okatani, Y | 1 |
| Sagara, Y | 1 |
| Costa, M | 1 |
| Backos, M | 3 |
| Baxter, N | 2 |
| Chilcott, IT | 1 |
| Emeagi, J | 1 |
| Patni, S | 1 |
| Tikum, HM | 1 |
| Mander, AM | 1 |
| Harding, J | 1 |
| Barker, S | 1 |
| Ford, C | 1 |
| Reznikoff-Etievant, MF | 1 |
| Cayol, V | 1 |
| Zou, GM | 1 |
| Abuaf, N | 1 |
| Robert, A | 1 |
| Norwitz, ER | 1 |
| Robinson, JN | 1 |
| Repke, JT | 3 |
| Fung, HY | 1 |
| Hung, CY | 1 |
| Elder, M | 1 |
| Lafont, M | 1 |
| Lamarque, M | 1 |
| Daussac, E | 1 |
| Alonso, I | 1 |
| Codesido, J | 1 |
| Murphy, M | 1 |
| Doré, C | 1 |
| Knutsen, H | 1 |
| Bruserud, O | 1 |
| Peverill, RE | 1 |
| Stahringer, RC | 1 |
| Neuendorff, DA | 1 |
| Randel, RD | 1 |
| Hogg, B | 2 |
| Van Dorsten, JP | 1 |
| Meis, PJ | 1 |
| Thurnau, GR | 1 |
| Dombrowski, MP | 1 |
| Canales, MA | 1 |
| Sevilla, J | 1 |
| Hernández, D | 1 |
| Hernández Navarro, F | 1 |
| Acevedo, CG | 1 |
| Rojas, S | 1 |
| Bravo, I | 1 |
| Rossi, C | 2 |
| Girolami, A | 2 |
| Jouhikainen, T | 1 |
| Vikhliaeva, EM | 1 |
| Gaudet, R | 1 |
| Bergmann, L | 1 |
| Pearson, T | 1 |
| Perniola, R | 1 |
| Magliari, F | 1 |
| Rosatelli, MC | 1 |
| De Marzi, CA | 1 |
| Le Thi Huong, D | 2 |
| Rybakowski, C | 1 |
| Niemax, K | 1 |
| Goepel, E | 1 |
| Schröder, HJ | 1 |
| VanDorsten, JP | 2 |
| Yaron, Y | 1 |
| Daniel, Y | 1 |
| Schwartz, T | 1 |
| Azem, F | 1 |
| Yovel, I | 1 |
| Mori, Y | 1 |
| Wada, H | 1 |
| Tamaki, S | 1 |
| Minami, N | 1 |
| Shiku, H | 1 |
| Ihara, T | 1 |
| Omine, M | 1 |
| Kakisita, E | 1 |
| Younis, JS | 2 |
| Ohel, G | 1 |
| Haddad, S | 1 |
| Lanir, N | 1 |
| Ben-Ami, M | 1 |
| Lévesque, H | 2 |
| Lafont, O | 1 |
| Tanasescu, S | 1 |
| Thuillez, C | 1 |
| Piette, AM | 1 |
| Aquilina, J | 1 |
| England, P | 1 |
| Grab, D | 1 |
| Paulus, WE | 1 |
| Erdmann, M | 1 |
| Terinde, R | 1 |
| Oberhoffer, R | 1 |
| Lang, D | 1 |
| Muche, R | 1 |
| Kreienberg, R | 1 |
| Young, GL | 1 |
| Marcondes, S | 1 |
| Lafay, M | 1 |
| Brohard-Bohn, B | 1 |
| de Nucci, G | 1 |
| Rendu, F | 1 |
| Sherer, Y | 2 |
| Levy, Y | 2 |
| Hoffman, R | 1 |
| Blumenfeld, Z | 1 |
| Weiner, Z | 1 |
| Trudinger, B | 2 |
| Cohen-Sacher, B | 2 |
| Lahav, J | 2 |
| Merlob, P | 1 |
| Kaburaki, J | 1 |
| Kuwana, M | 1 |
| Karabulut, AK | 2 |
| Ulger, H | 2 |
| Pratten, MK | 1 |
| Hsieh, YY | 1 |
| Tsai, HD | 1 |
| Chang, CC | 1 |
| Lo, HY | 1 |
| Chen, CL | 1 |
| Rezig, K | 1 |
| Diar, N | 1 |
| Walcker, JL | 1 |
| Chilcott, I | 1 |
| Güthner, C | 1 |
| Beneke, H | 1 |
| Hildebrand, A | 1 |
| Grünewald, M | 1 |
| Macchi, L | 1 |
| Sarfati, R | 1 |
| Guicheteau, M | 1 |
| Chamlian, V | 1 |
| Gruel, Y | 1 |
| Magnin, G | 1 |
| Brizard, A | 1 |
| Boinot, C | 1 |
| Curi, AL | 1 |
| Jacks, A | 1 |
| Pavesio, C | 1 |
| Pattison, NS | 1 |
| Birdsall, M | 2 |
| Zanderigo, AM | 1 |
| Liddell, HS | 1 |
| McDougall, J | 1 |
| Coller, B | 1 |
| Dalen, JE | 1 |
| Fuster, V | 1 |
| Roth, G | 1 |
| Greer, I | 1 |
| Pratten, M | 1 |
| Mercan, R | 1 |
| Alatas, C | 1 |
| Isiklar, A | 1 |
| Nuhoglu, A | 1 |
| Alano, MA | 1 |
| Ngougmna, E | 1 |
| Ostrea, EM | 1 |
| Konduri, GG | 1 |
| Mashiah, R | 1 |
| Orvieto, R | 1 |
| Ben-Rafael, Z | 1 |
| Scalvi, L | 1 |
| Danti, L | 1 |
| Menghini, S | 1 |
| Di Pierro, G | 1 |
| Cesa, F | 1 |
| Roberts, N | 1 |
| Ross, D | 1 |
| Flint, SK | 1 |
| Arya, R | 1 |
| Blott, M | 1 |
| Colomina, MT | 1 |
| Albina, ML | 1 |
| Sanchez, DJ | 1 |
| Domingo, JL | 1 |
| Spaanderman, ME | 1 |
| Aardenburg, R | 1 |
| Ekhart, TH | 1 |
| van Eyndhoven, HW | 1 |
| van der Heijden, OW | 1 |
| van Eyck, J | 1 |
| de Leeuw, PW | 1 |
| Peeters, LL | 1 |
| Rittenhouse, L | 1 |
| Cosson, M | 1 |
| Houpeau, JL | 1 |
| Briere, J | 1 |
| Guilmin, F | 1 |
| Werth, V | 1 |
| Wright, CA | 1 |
| Kruszka, S | 1 |
| Kruszka, P | 1 |
| Aboulker, D | 1 |
| Paris-Llado, J | 1 |
| Papiernik, E | 1 |
| Vials, JM | 1 |
| Verrotti, C | 1 |
| Fieni, S | 1 |
| Gualdi, M | 1 |
| Cavatorta, E | 1 |
| Yazici, Y | 1 |
| Sammaritano, L | 1 |
| Narumiya, S | 1 |
| Nakagawa, H | 1 |
| Yoshida, S | 1 |
| Nakabayashi, M | 1 |
| Akahori, K | 1 |
| Shoji, T | 1 |
| Hasegawa, H | 1 |
| Amayasu, H | 1 |
| Finazzi, G | 1 |
| Yagi, K | 1 |
| Nakamura, A | 1 |
| Sekine, A | 1 |
| Watanabe, H | 1 |
| Kalashnikova, LA | 1 |
| Aleksandrova, EN | 1 |
| Kosheleva, NM | 1 |
| Reshetniak, TM | 1 |
| Salozhin, KV | 1 |
| Strizhakov, AN | 1 |
| Musaev, ZM | 1 |
| Timokhina, TF | 1 |
| Rowan, JA | 1 |
| Raudkivi, PJ | 1 |
| Sansom, OJ | 1 |
| Stark, LA | 1 |
| Dunlop, MG | 1 |
| Clarke, AR | 1 |
| Amsalhem, P | 1 |
| Gaudouen, Y | 1 |
| Krivitzky, A | 1 |
| Azulay, M | 1 |
| Puerto, B | 1 |
| Sasidharan, CK | 1 |
| Kutty, PM | 1 |
| Sajith, N | 1 |
| Werler, MM | 2 |
| Sheehan, JE | 1 |
| Mitchell, AA | 2 |
| Pauzner, R | 1 |
| Dulitzki, M | 2 |
| Langevitz, P | 3 |
| Livneh, A | 2 |
| Kenett, R | 1 |
| Craig, JC | 1 |
| Maharaj, R | 1 |
| Kujansuu, E | 1 |
| Iso-Mustajärvi, M | 1 |
| Fayyad, AM | 1 |
| Brummitt, DR | 1 |
| Barker, HF | 1 |
| Spooner, SF | 1 |
| Lédée-Bataille, N | 1 |
| Doumerc, S | 1 |
| Olivennes, F | 1 |
| Kadoch, J | 1 |
| Frydman, R | 1 |
| Soriano, D | 1 |
| Seidman, DS | 1 |
| Schiff, E | 4 |
| Proia, A | 1 |
| Torcia, F | 1 |
| Annino, L | 1 |
| Capria, S | 1 |
| Ferrari, A | 1 |
| Ferrazza, G | 1 |
| Pacifici, E | 1 |
| Pantalissi, A | 1 |
| Meloni, G | 1 |
| Vantroyen, B | 1 |
| Vanstraelen, D | 1 |
| Roubey, RA | 1 |
| Espiridião, S | 1 |
| Oliveira-Filho, RM | 1 |
| Simões, MJ | 1 |
| Mamede, JA | 1 |
| Woo, YL | 1 |
| Allard, S | 1 |
| Letsky, E | 1 |
| Jerzak, MM | 1 |
| Prusek, W | 1 |
| Podwysocka, M | 1 |
| Goluda, M | 1 |
| Flint, C | 1 |
| Larsen, H | 1 |
| Nielsen, GL | 1 |
| Diejomaoh, MF | 1 |
| Al-Azemi, MM | 1 |
| Bandar, A | 1 |
| Egbase, PE | 1 |
| Jirous, J | 1 |
| Al-Othman, S | 1 |
| Bukhadour, N | 1 |
| Al-Sweih, N | 1 |
| Kwek, K | 1 |
| Yeo, GS | 1 |
| Koh, LP | 1 |
| Devendra, K | 1 |
| Tien, SL | 1 |
| Rote, NS | 1 |
| Adhikari, M | 1 |
| Pillay, T | 1 |
| Nathoo, N | 1 |
| Béguin, F | 1 |
| Huskisson, EC | 1 |
| Glusa, E | 1 |
| Castellanos, JM | 1 |
| Aranda, M | 1 |
| Cararach, J | 1 |
| Cararach, V | 1 |
| Adlercreutz, H | 1 |
| Slone, D | 2 |
| Siskind, V | 2 |
| Heinonen, OP | 3 |
| Monson, RR | 2 |
| Kaufman, DW | 2 |
| Shapiro, S | 3 |
| Collins, E | 1 |
| Turner, G | 1 |
| Stamler, FW | 1 |
| Haesslein, HO | 1 |
| Fleming, J | 1 |
| Crandon, AJ | 1 |
| Isherwood, DM | 1 |
| Buchan, PC | 1 |
| Macdonald, HN | 1 |
| Chand, S | 1 |
| Bulmash, JM | 1 |
| Charbonnel, B | 1 |
| Ardelt, W | 2 |
| Bove, KE | 1 |
| Bhathena, D | 1 |
| Wyatt, RJ | 2 |
| Lucas, BA | 1 |
| Holland, NH | 1 |
| Mosler, KH | 3 |
| Garrettson, LK | 2 |
| Procknal, JA | 1 |
| Levy, G | 3 |
| Rausch, KD | 1 |
| Linka, F | 2 |
| McQueen, EG | 1 |
| Gruber, CM | 4 |
| Bauer, RO | 2 |
| Bettigole, JB | 1 |
| Lash, AF | 1 |
| McDonald, JS | 1 |
| Rainsford, KD | 1 |
| Tanigawa, H | 2 |
| Obori, R | 2 |
| Tanaka, H | 2 |
| Yoshida, J | 2 |
| Kosazuma, T | 2 |
| Sagy, M | 1 |
| Birenbaum, E | 1 |
| Brish, M | 1 |
| Bowie, EJ | 1 |
| Owen, CA | 1 |
| Karim, SM | 1 |
| Jain, AK | 1 |
| McMahon, FG | 1 |
| Ryan, JR | 1 |
| Unger, D | 1 |
| Richard, W | 1 |
| De Vroey, P | 1 |
| Meier, U | 1 |
| Klingspohr, HJ | 1 |
| Corby, DG | 2 |
| Gutová, M | 1 |
| Dyck, WP | 1 |
| Ritter, EJ | 1 |
| Fradkin, R | 1 |
| Köln, RB | 1 |
| Dipalma, JR | 1 |
| Heymann, MA | 2 |
| Babenerd, J | 1 |
| Kyriakidis, K | 1 |
| Pasold, K | 1 |
| Hillemanns, HG | 1 |
| Thorsen, CA | 1 |
| Rossi, EC | 1 |
| Green, D | 1 |
| Carone, FA | 1 |
| van Kessel, PH | 1 |
| Zanke, S | 1 |
| Seewald, HJ | 1 |
| Michels, W | 1 |
| Kunath, H | 1 |
| Voigt, R | 1 |
| Möller, R | 1 |
| Latour, JG | 1 |
| Leger-Gauthier, C | 1 |
| Hudák, A | 1 |
| Fitzgibbons, JF | 1 |
| Goodnight, SH | 1 |
| Burkhardt, JH | 1 |
| Kirk, PE | 1 |
| Warnes, GM | 1 |
| Amato, F | 1 |
| Seamark, RF | 1 |
| Plum, H | 1 |
| Schrager, GO | 1 |
| Garattini, S | 2 |
| Woo, DC | 1 |
| McClain, RM | 1 |
| Hoar, RM | 1 |
| Aznar, J | 1 |
| Martínez-Sausor, V | 1 |
| Valles, J | 1 |
| Fuller, WE | 1 |
| Brancadoro, V | 3 |
| Somma, A | 1 |
| Tinelli, F | 1 |
| Capasso, A | 1 |
| Cuocolo, R | 3 |
| Palm, PE | 1 |
| Arnold, EP | 1 |
| Rachwall, PC | 1 |
| Leyczek, JC | 1 |
| Teague, KW | 1 |
| Kensler, CJ | 1 |
| Marlowe, FI | 1 |
| Yaffe, SJ | 2 |
| Moggian, G | 3 |
| Palombi, L | 1 |
| Tamburini, E | 3 |
| Visonà, E | 1 |
| Williams, KI | 1 |
| Vane, JR | 1 |
| Dry, J | 1 |
| Smith, MT | 1 |
| Levin, HM | 1 |
| Bare, WW | 1 |
| Berry, FN | 1 |
| Miller, JM | 1 |
| Mercier-Parot, L | 1 |
| Tuchmann-Duplessis, H | 3 |
| Lubawy, WC | 1 |
| Garrett, RJ | 1 |
| Fenton, LJ | 1 |
| Beresford, ME | 1 |
| Keenan, WJ | 1 |
| Beall, JR | 1 |
| Klein, MF | 1 |
| O'Dell, BL | 1 |
| Reynolds, G | 1 |
| Reeves, PG | 1 |
| Domula, M | 1 |
| Weissbach, G | 1 |
| Lenk, H | 1 |
| Keller, J | 1 |
| Read, MD | 1 |
| Kakkar, VV | 1 |
| Cooperman, EM | 1 |
| Gupta, JD | 1 |
| Waltman, R | 6 |
| Tricomi, V | 6 |
| Tavakoli, FM | 1 |
| Takeuchi, K | 2 |
| Okabe, S | 2 |
| Takagi, K | 2 |
| Kuhl, H | 1 |
| Frey, W | 1 |
| Rosniatowski, C | 1 |
| Sioe-Eng Dericks-Tan, J | 1 |
| Taubert, HD | 1 |
| Fritz, H | 1 |
| Lynd, PA | 1 |
| Andreasen, AC | 1 |
| Granström, E | 1 |
| Kindahl, H | 1 |
| Mellin, TN | 1 |
| Busch, RD | 1 |
| Kartasheva, VE | 1 |
| Balika, IuD | 1 |
| Blasubramanian, A | 1 |
| Ramakrishnan, S | 1 |
| Fossati, C | 1 |
| Di Lieto, A | 1 |
| De Martino, G | 1 |
| Nanda, R | 1 |
| Brogden, RN | 1 |
| Pinder, RM | 1 |
| Sawyer, PR | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Kalendovsky, Z | 1 |
| Austin, J | 1 |
| Steele, P | 1 |
| Chaudhury, MR | 1 |
| Hiss, D | 1 |
| Mottot, G | 1 |
| Rosner, I | 1 |
| Ben Ismail, M | 1 |
| Ghariani, M | 1 |
| Jais, JM | 1 |
| Lewis, CT | 1 |
| Molland, EA | 1 |
| Marshall, VR | 1 |
| Tresidder, GC | 1 |
| Blandy, JP | 1 |
| Smith, ID | 1 |
| Temple, DM | 1 |
| Shearman, RP | 2 |
| Faivre, J | 1 |
| Faivre, M | 1 |
| Lery, N | 1 |
| Lee, P | 2 |
| Watson, M | 1 |
| Webb, J | 1 |
| Anderson, J | 1 |
| Buchanan, W | 1 |
| Mukherjee, AB | 1 |
| Chan, M | 1 |
| Waite, R | 1 |
| Metzger, MI | 1 |
| Yaffee, SJ | 1 |
| Miller, JJ | 1 |
| Fries, JF | 1 |
| Brenner, WE | 1 |
| Dingfelder, R | 1 |
| Staurovsky, LG | 1 |
| Bell, DP | 1 |
| Gibson, JG | 1 |
| McCarroll, AM | 1 |
| McClean, GA | 1 |
| Boulot, P | 1 |
| Giacalone, PL | 1 |
| Hedon, B | 1 |
| Laffargue, F | 1 |
| Viala, JL | 1 |
| Schröcksnadel, H | 4 |
| Sitte, B | 3 |
| Alge, A | 3 |
| Steckel-Berger, G | 2 |
| Daxenbichler, G | 2 |
| Dapunt, O | 2 |
| Chow, EY | 1 |
| Haley, LP | 1 |
| Vickars, LM | 1 |
| Passaleva, A | 1 |
| Massai, G | 1 |
| D'Elios, MM | 1 |
| Livi, C | 1 |
| Abbate, R | 1 |
| Solal-Céligny, P | 1 |
| Tertian, G | 1 |
| Sedano, M | 1 |
| Palma, S | 1 |
| González, P | 1 |
| Neira, O | 1 |
| Abumohor, P | 1 |
| Cerda, C | 1 |
| Guzmán, L | 1 |
| Williamson, JG | 1 |
| Murray, FE | 1 |
| Cole, AT | 1 |
| Hudson, N | 1 |
| Hawkey, CJ | 1 |
| Paris, J | 2 |
| Ho, HN | 2 |
| Melinda, S | 1 |
| Lin, HH | 1 |
| Hwang, JL | 2 |
| Hsieh, CY | 2 |
| Lee, TY | 1 |
| Payne, AJ | 1 |
| Blackwell, JL | 1 |
| Reading, JC | 1 |
| Hubble, CL | 1 |
| Jara, LJ | 1 |
| Saway, S | 1 |
| Martínez-Osuna, P | 1 |
| Seleznick, MJ | 1 |
| Angel, J | 1 |
| O'Brien, W | 1 |
| Diss, EM | 1 |
| Gabbe, SG | 1 |
| Moore, JW | 1 |
| Kniss, DA | 1 |
| Schwegel, P | 2 |
| Pastner, E | 1 |
| Hansen, H | 1 |
| van Hof, AC | 1 |
| Ubachs, JM | 1 |
| van Wersch, JW | 1 |
| Howell, PR | 1 |
| Douglas, MJ | 1 |
| Baume, P | 1 |
| Shuev, BV | 1 |
| Dotts, IB | 1 |
| Tatlok, RK | 1 |
| Laraki, R | 1 |
| Cosserat, J | 1 |
| Elliott, JP | 1 |
| Radin, TG | 1 |
| Takashima, M | 1 |
| Yamasaki, M | 1 |
| Ohashi, M | 1 |
| Morikawa, H | 1 |
| Mochizuki, M | 1 |
| Reubinoff, BE | 1 |
| Laufer, N | 1 |
| Sadovsky, E | 2 |
| Yoshida, A | 2 |
| Morozumi, K | 2 |
| Koyama, K | 1 |
| Fukuda, M | 1 |
| Oikawa, T | 1 |
| Fusi, L | 1 |
| Brosens, J | 1 |
| Katzman, GH | 1 |
| Kobayashi, S | 1 |
| Mokuno, C | 1 |
| Hashimoto, H | 1 |
| Hirose, S | 1 |
| Landy, HJ | 1 |
| Kessler, C | 2 |
| Kelly, WK | 1 |
| Weingold, AB | 1 |
| Goto, S | 1 |
| Yamada, K | 1 |
| Sekizuka, N | 1 |
| Kanazawa, K | 1 |
| Vener, AM | 1 |
| Krupka, LR | 1 |
| Engelmann, MD | 1 |
| Norris, LA | 1 |
| Sheppard, BL | 1 |
| Bonnar, J | 1 |
| McCombs, J | 1 |
| Aune, B | 1 |
| Fox, S | 1 |
| Rozdzinski, E | 1 |
| Hertenstein, B | 1 |
| Schmeiser, T | 1 |
| Seifried, E | 1 |
| Kurrle, E | 1 |
| Saleh, AA | 1 |
| Bottoms, SF | 1 |
| Mammen, EF | 1 |
| King, JA | 1 |
| Davila-Garcia, M | 1 |
| Azmitia, EC | 1 |
| Strand, FL | 1 |
| Pallarés, L | 1 |
| Navarro, M | 1 |
| Bosch, X | 1 |
| Bazin, B | 2 |
| Capitant, C | 1 |
| Davies, NJ | 1 |
| Walkinshaw, Sa | 1 |
| Fay, TN | 1 |
| Mallett, SV | 1 |
| Platt, M | 1 |
| Lanzone, A | 1 |
| Toppozada, M | 2 |
| Darwish, EA | 1 |
| Osman, YF | 1 |
| Abd-Rabbo, MS | 1 |
| Kubow, S | 1 |
| Wallenburg, CS | 1 |
| Wise, LD | 1 |
| Vetter, CM | 1 |
| Anderson, CA | 1 |
| Antonello, JM | 1 |
| Anton, RF | 6 |
| Becker, HC | 6 |
| Hale, RL | 1 |
| Ekblad, U | 1 |
| Tikkanen, J | 1 |
| Dürig, P | 1 |
| Correy, JF | 1 |
| Newman, NM | 1 |
| Collins, JA | 1 |
| Burrows, EA | 1 |
| Burrows, RF | 1 |
| Curran, JT | 1 |
| Cheng, WW | 1 |
| Zhang, ZJ | 1 |
| Dildy, GA | 1 |
| Clark, SL | 1 |
| Imperiale, TF | 1 |
| Petrulis, AS | 1 |
| Minkhorst, AG | 1 |
| Nováková, IR | 1 |
| van Dongen, PW | 1 |
| Barkai, G | 3 |
| Cornélissen, G | 2 |
| Halberg, F | 1 |
| Prikryl, P | 1 |
| Danková, E | 1 |
| Siegelová, J | 1 |
| Dusek, J | 1 |
| Baxi, LV | 1 |
| Pearlstone, MM | 1 |
| Rocki, W | 1 |
| Murray, R | 1 |
| Mayo, G | 1 |
| Chamberlain, GV | 1 |
| Pineo, GF | 1 |
| Blahey, WB | 1 |
| Macdonald, R | 1 |
| Ahmed, Y | 1 |
| Beard, J | 1 |
| Hillmen, P | 1 |
| Anderson, CC | 1 |
| Lewis, SM | 1 |
| Makovitz, JW | 2 |
| Bell, WR | 1 |
| Braine, HG | 1 |
| Ness, PM | 1 |
| Kickler, TS | 1 |
| Khowessah, M | 1 |
| Shaala, S | 1 |
| Abd-Rabbo, S | 1 |
| Zoheir, A | 1 |
| Jové, I | 1 |
| Casals, FJ | 1 |
| Gabrielli, S | 1 |
| Cullen, MT | 1 |
| Harris, EN | 1 |
| Gaffney, RC | 1 |
| Rice, GE | 1 |
| Takao, A | 1 |
| Seneviratne, HR | 1 |
| Weerasinghe, WM | 1 |
| Shimmyozu, K | 1 |
| Okadome, T | 1 |
| Maruyama, Y | 1 |
| Maruyama, I | 1 |
| Osame, M | 1 |
| Tara, M | 1 |
| de Jong, PC | 1 |
| Zielhuis, GA | 1 |
| Gabreëls, F | 1 |
| Hillman, D | 1 |
| Di Giglio, R | 1 |
| Vercillo Martino, I | 1 |
| Pometti, A | 1 |
| Tocci, A | 1 |
| Kato, J | 1 |
| Munro, CD | 1 |
| Hahn, L | 1 |
| Hutton, JD | 1 |
| Wilkinson, AM | 1 |
| Neale, J | 1 |
| Brown, CE | 2 |
| Cox, K | 1 |
| Rosenfeld, CR | 3 |
| Magness, RR | 3 |
| Sumiya, M | 1 |
| Nishino, E | 1 |
| Takagi, T | 1 |
| Masuhiro, K | 1 |
| Iwata, I | 1 |
| Iwata, M | 1 |
| Tanizawa, O | 1 |
| Hopenhayn-Rich, C | 1 |
| Golub, M | 1 |
| Hooper, K | 1 |
| Herschman, Z | 1 |
| Klapholz, A | 1 |
| Burke, MS | 1 |
| Raub, W | 1 |
| Abignente, E | 1 |
| Arena, F | 1 |
| Luraschi, E | 1 |
| De Caprariss, P | 1 |
| Vitagliano, S | 1 |
| Donnoli, D | 1 |
| McCarthy, L | 1 |
| Kotylo, P | 1 |
| Lister, K | 1 |
| Divino, CM | 1 |
| Schussler, GC | 1 |
| Wehrmacher, WH | 1 |
| Messmore, HL | 1 |
| Gendron, RL | 1 |
| Farookhi, R | 1 |
| Baines, MG | 1 |
| Lundin-Schiller, S | 1 |
| Gibb, W | 1 |
| MacLennan, SJ | 1 |
| McGrath, JC | 1 |
| Whittle, MJ | 1 |
| Zubovits, JT | 1 |
| Wong, ST | 1 |
| Molinari, LM | 1 |
| Ali, S | 1 |
| Ordi, J | 1 |
| Barquinero, J | 1 |
| Vilardell, M | 1 |
| Jordana, R | 1 |
| Tolosa, C | 1 |
| Selva, A | 1 |
| Genover, E | 1 |
| Huang, LW | 1 |
| Shen, MC | 1 |
| Hachicha, J | 1 |
| Ammous, A | 1 |
| Damak, J | 1 |
| Hammami, M | 1 |
| Ghorbel, A | 1 |
| Rekik, S | 1 |
| Jarraya, A | 1 |
| Sarkar, AK | 1 |
| Chakraborti, A | 1 |
| Saha, UK | 1 |
| Bose, SK | 1 |
| Sengupta, D | 2 |
| Mordel, N | 1 |
| Schenker, JG | 1 |
| Giles, WB | 2 |
| Connelly, AJ | 1 |
| Thompson, RS | 2 |
| Wapner, RJ | 1 |
| Cowchock, FS | 1 |
| Shapiro, SS | 1 |
| Nagai, MK | 1 |
| Greco, GS | 1 |
| Gatenby, PA | 1 |
| Cameron, K | 1 |
| Serr, DM | 1 |
| Danays, T | 1 |
| Peleg, E | 1 |
| Goldenberg, M | 1 |
| Rosenthal, T | 1 |
| Ruppin, E | 1 |
| Tamarkin, M | 1 |
| Yahal, I | 1 |
| Blankstein, J | 1 |
| Benigni, A | 1 |
| Gregorini, G | 1 |
| Chiabrando, C | 1 |
| Ballerini, S | 1 |
| Orisio, S | 1 |
| Piccinelli, A | 1 |
| Pinciroli, V | 1 |
| Fanelli, R | 1 |
| Nielsen, HK | 1 |
| Husted, SE | 1 |
| Krusell, LR | 1 |
| Fasting, H | 1 |
| Faergeman, O | 1 |
| Kidron, D | 1 |
| Beyth, Y | 1 |
| White, NM | 1 |
| Cunningham, FG | 1 |
| Mirro, R | 1 |
| Chesney, CM | 1 |
| Leffler, C | 1 |
| Rotmans, P | 1 |
| Howden, CW | 1 |
| Chernoff, N | 1 |
| Kavlock, RJ | 1 |
| Beyer, PE | 1 |
| Miller, D | 1 |
| Robertson, A | 1 |
| Elder, MA | 1 |
| Flloyd, E | 1 |
| Hawkins, DF | 1 |
| Thompson, R | 1 |
| Giles, W | 1 |
| Connelly, A | 2 |
| Bergh, PA | 1 |
| Hollander, D | 1 |
| Gregori, CA | 1 |
| Breen, JL | 1 |
| Druzin, ML | 1 |
| Qamar, T | 1 |
| Gancel, A | 1 |
| Courtois, H | 1 |
| Doucet, J | 1 |
| Schrub, JC | 1 |
| Le Bouedec, G | 1 |
| Fondrinier, E | 1 |
| Sauvezie, B | 1 |
| Bruhat, MA | 1 |
| Rick, ME | 1 |
| Williams, SB | 1 |
| Sacher, RA | 1 |
| McKeown, LP | 1 |
| Parisi, VM | 1 |
| Tanfin, Z | 1 |
| Harbon, S | 1 |
| Köpernick, H | 1 |
| Mest, HJ | 1 |
| Schwarz, B | 1 |
| Thorp, JA | 1 |
| Brath, PC | 1 |
| Lacroix, MC | 1 |
| Bochner, F | 1 |
| Lloyd, J | 1 |
| Steiner, T | 1 |
| Witter, FR | 1 |
| Ritter, JM | 1 |
| Rodin, A | 1 |
| Thom, MH | 1 |
| Horn, L | 1 |
| Cox, SM | 1 |
| Suganuma, T | 1 |
| Shinmura, I | 1 |
| Fujinami, T | 1 |
| Andersen, ES | 1 |
| Grunnet, N | 1 |
| Neubert, D | 1 |
| Stahlmann, R | 1 |
| Millis, RM | 2 |
| Ewii, MC | 2 |
| Offiah, GU | 2 |
| Hyde, BP | 2 |
| Knight, EM | 2 |
| Berendes, HW | 1 |
| Hopp, H | 1 |
| Hopp, A | 1 |
| Knispel, J | 1 |
| Rigby, PG | 1 |
| Cissell, G | 1 |
| Mäkilä, UM | 1 |
| Kääpä, P | 1 |
| Hoffmann, P | 1 |
| Bartels, T | 1 |
| Heinemann, S | 1 |
| Beitz, J | 1 |
| Taube, C | 1 |
| Parke, A | 1 |
| Maier, D | 1 |
| Hakim, C | 1 |
| Randolph, J | 1 |
| Andreoli, J | 1 |
| Isada, N | 1 |
| Larsen, J | 1 |
| Weingold, A | 1 |
| Zeller, G | 1 |
| Dudenhausen, JW | 1 |
| Streissguth, AP | 1 |
| Treder, RP | 1 |
| Barr, HM | 1 |
| Bleyer, WA | 3 |
| Sampson, PD | 1 |
| Martin, DC | 1 |
| Falconer, J | 1 |
| Pineo, G | 1 |
| Blahey, W | 1 |
| Bowen, T | 1 |
| Docksteader, B | 1 |
| Jadusingh, I | 1 |
| Walker, JJ | 1 |
| Forbes, CD | 1 |
| Calder, AA | 1 |
| Unsworth, J | 1 |
| d'Assis-Fonseca, A | 1 |
| Beswick, DT | 1 |
| Blake, DR | 1 |
| Sengupta, T | 1 |
| Datta, C | 1 |
| Dasgupta, J | 1 |
| De, K | 1 |
| Saha, U | 1 |
| Quaas, L | 1 |
| Göppinger, A | 1 |
| Cunningham, MD | 1 |
| Ellison, RC | 1 |
| Zierler, S | 2 |
| Kanto, WP | 1 |
| Miettinen, OS | 1 |
| Nadas, AS | 1 |
| Sautter, RD | 1 |
| Paradowski, A | 1 |
| Celewicz, Z | 1 |
| Klinke, R | 1 |
| Guy, JF | 1 |
| Sucheston, ME | 1 |
| Sanchez-Ramos, L | 1 |
| O'Sullivan, MJ | 1 |
| Garrido-Calderon, J | 1 |
| Agapitos, M | 1 |
| Georgiou-Theodoropoulou, M | 1 |
| Koutselinis, A | 1 |
| Papacharalampus, N | 1 |
| Fernandez-Pardal, J | 1 |
| Seymour, RA | 1 |
| Reimers, TJ | 1 |
| Ullmann, MB | 1 |
| Hansel, W | 1 |
| Weiner, CP | 1 |
| Dryburgh, DR | 1 |
| Rákóczi, I | 1 |
| Tihanyi, K | 1 |
| Demeter, J | 1 |
| Gáti, I | 1 |
| Needs, CJ | 1 |
| Brooks, PM | 1 |
| Bertelli, A | 1 |
| Silvestrini, B | 1 |
| Osei-Boaten, K | 1 |
| James, MJ | 1 |
| Walsh, JA | 1 |
| Buchanan, MR | 1 |
| Butt, RW | 1 |
| Magas, Z | 1 |
| van Ryn, J | 1 |
| Nazir, DJ | 1 |
| Kochenour, NK | 1 |
| Hershgold, E | 1 |
| Robbins, G | 1 |
| Snethlage, W | 1 |
| Ten Cate, JW | 1 |
| Kaibara, M | 1 |
| Kobayashi, T | 1 |
| Matsumoto, S | 1 |
| Strickland, MA | 1 |
| Bates, GW | 1 |
| Whitworth, NS | 1 |
| Martin, JN | 1 |
| Weintraub, SJ | 1 |
| Naulty, JS | 1 |
| Derbes, SJ | 1 |
| deShazo, RD | 1 |
| Rejent, TA | 1 |
| Baik, S | 1 |
| Ambrose, A | 1 |
| Welham, RT | 1 |
| Cefalo, RC | 1 |
| Kollenberg, LO | 1 |
| Hudyma, EO | 1 |
| Robbins, JM | 1 |
| Jankowski, A | 1 |
| Skublicki, S | 1 |
| Wichliński, LM | 1 |
| Szymański, W | 1 |
| Verstraete, M | 1 |
| Sheffield, PA | 1 |
| Turner, JS | 1 |
| Tothill, A | 1 |
| Bamford, D | 1 |
| Draper, J | 1 |
| Wood, L | 1 |
| Lewis, RB | 1 |
| Schulman, JD | 1 |
| Horan, AH | 1 |
| Landesman, R | 1 |
| Fuchs, F | 1 |
| O'Brien, JR | 1 |
| Cenedella, RJ | 1 |
| Crouthamel, WG | 1 |
| Andresen, O | 1 |
| Dornhöfer, W | 1 |
| Vaisrub, S | 1 |
| Kolendorf, K | 1 |
| Siersbaek-Nielsen, K | 1 |
| Hansen, MJ | 1 |
| Friis, T | 1 |
| Santangelo, G | 1 |
| Barberi, I | 1 |
| Maccarrone, N | 1 |
| Palumbo, A | 1 |
| Courtney, KD | 1 |
| Valerio, DA | 1 |
| Crossland, J | 1 |
| Santos, AA | 1 |
| Hermier, C | 1 |
| Netter, A | 1 |
| Nakano, J | 1 |
| Gavan, JA | 1 |
| Stenlake, JB | 1 |
| Williams, WD | 1 |
| Davidson, AG | 1 |
| Downie, W | 1 |
| Whaley, K | 1 |
| Mehta, BC | 1 |
| Jhaveri, K | 1 |
| Patel, JC | 1 |
| Tubaro, E | 1 |
| Bulgini, MJ | 1 |
| Del Grande, P | 1 |
| Monai, A | 1 |
| Nelson, MM | 1 |
| Forfar, JO | 1 |
| Eriksson, M | 2 |
| Pochedly, C | 1 |
| Ente, G | 1 |
| Chatterjee, A | 1 |
| Biswas, L | 1 |
| Pal, AK | 1 |
| Brown, AK | 1 |
| Schultz, FM | 1 |
| Duenhoelter, JH | 1 |
| Jimenez, JM | 1 |
| Pritchard, JA | 1 |
| Porter, JC | 1 |
| Satravaha, P | 1 |
| Stockhausen, H | 1 |
| Huntsman, RG | 1 |
| Lehmann, H | 1 |
| Palmer, AK | 1 |
| Kriegel, H | 2 |
| Butcher, RE | 1 |
| Kimmel, CA | 2 |
| Eyring, EJ | 1 |
| Grosfeld, JL | 1 |
| Connelly, PA | 1 |
| Shabanah, EH | 1 |
| Arenas, R | 1 |
| Cervellati, I | 2 |
| Aiken, JW | 1 |
| Chester, R | 1 |
| Dukes, M | 1 |
| Slater, SR | 1 |
| Walpole, AL | 1 |
| Baptisti, A | 3 |
| Bergquist, JR | 1 |
| Tanimura, T | 1 |
| Pickles, VR | 1 |
| Koshakji, RP | 1 |
| Schulert, AR | 1 |
| Caldwell, BV | 1 |
| Auletta, FJ | 1 |
| Speroff, L | 1 |
| Grintzalis, TP | 1 |
| Bedi, SS | 1 |
| Marsh, GN | 1 |
| Beliles, RP | 1 |
| Jewett, JF | 1 |
| Palav, A | 1 |
| Krasner, J | 1 |
| Tjälve, H | 1 |
| Sjöstrand, E | 1 |
| Hansson, E | 1 |
| Dacie, JV | 1 |
| Maickel, RP | 1 |
| Snodgrass, WR | 1 |
| Cobo, E | 1 |
| Rodriguez, A | 1 |
| De Villamizar, M | 1 |
| Reeves, JT | 1 |
| Daoud, FS | 1 |
| Estridge, M | 1 |
| Stone, WH | 1 |
| McGARY, D | 1 |
| Pantaleoni, GC | 1 |
| Valeri, P | 1 |
| Brazelton, TB | 1 |
| Miller, RR | 1 |
| Feingold, A | 1 |
| Paxinos, J | 1 |
| Hagedorn, B | 1 |
| Lambelin, G | 1 |
| Roba, J | 1 |
| Gillet, C | 1 |
| Gautier, M | 1 |
| Buu-Hoï, NP | 1 |
| Guimbretière, J | 1 |
| Dehorne, M | 1 |
| Guimbretière, L | 1 |
| Frohberg, H | 1 |
| Davison, C | 1 |
| Casteels-van Daele, M | 1 |
| Jaeken, J | 1 |
| Eggermont, E | 1 |
| Vermijlen, J | 1 |
| Presl, J | 1 |
| Adebahr, G | 1 |
| Kiplinger, GF | 1 |
| Nava Negrete, A | 1 |
| Fisch, L | 1 |
| Costello, JM | 1 |
| Shannon, FT | 1 |
| Breckenridge, RT | 1 |
| Lasagna, L | 1 |
| Davis, M | 1 |
| Pearson, JW | 1 |
| Sharley, CB | 1 |
| Devereux, WP | 1 |
| Au, WY | 1 |
| Lange, WA | 1 |
| Raisz, LG | 1 |
| Crombie, DL | 1 |
| Pinsent, RJ | 1 |
| Slater, BC | 1 |
| Fleming, D | 1 |
| Cross, KW | 1 |
| Warkany, J | 2 |
| Schumacher, HJ | 1 |
| McArthur, JN | 1 |
| Dawkins, PD | 1 |
| Smith, MJ | 1 |
| Hamilton, EB | 1 |
| Eliason, BC | 1 |
| Posner, HS | 1 |
| Schulman, I | 1 |
| Mandelcorn, MS | 1 |
| Merin, S | 1 |
| Cardarelli, J | 1 |
| Pap, AG | 1 |
| Tarakhovskiĭ, ML | 1 |
| Uhlenbroock, K | 1 |
| von Freier, G | 1 |
| Takacs, E | 1 |
| Wajcner, G | 1 |
| Guedon, J | 1 |
| Chapman, A | 1 |
| Blatz, AT | 1 |
| Palmisano, PA | 1 |
| Cassady, G | 1 |
| Rothfield, NF | 1 |
| Chernish, SM | 1 |
| Baba, T | 1 |
| Nagahama, M | 1 |
| Akiyama, N | 1 |
| Miki, T | 1 |
| Weinberg, MS | 1 |
| Goldhamer, RE | 1 |
| Carson, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Best Practice Alert (BPA) for Low Dose Aspirin Recommendation in High-risk Pregnancies: a Randomized Controlled Trial[NCT05802940] | 640 participants (Anticipated) | Interventional | 2023-06-19 | Not yet recruiting | |||
| Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity[NCT05757167] | Phase 4 | 2,500 participants (Anticipated) | Interventional | 2023-11-06 | Recruiting | ||
| The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.[NCT00467363] | 1,228 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| Implementing Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks - a Randomized Controlled Trial[NCT06108947] | 300 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial[NCT05580523] | 3,000 participants (Anticipated) | Interventional | 2023-07-03 | Recruiting | |||
| 162 mg of Aspirin for Prevention of Preeclampsia[NCT05221164] | Phase 4 | 200 participants (Anticipated) | Interventional | 2021-07-06 | Recruiting | ||
| Low Molecular Weight Heparin, Enoxaparin, to Prevent Adverse Maternal and Perinatal Outcomes in Women With Previous Severe Preeclampsia at Less Than 34 Weeks' Gestation. A Prospective Randomized Trial[NCT00986765] | Phase 3 | 257 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)[NCT02409680] | 11,976 participants (Actual) | Interventional | 2016-03-23 | Completed | |||
| Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia[NCT04797949] | Phase 4 | 156 participants (Anticipated) | Interventional | 2021-03-03 | Recruiting | ||
| Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome[NCT02303171] | Phase 4 | 100 participants (Anticipated) | Interventional | 2014-11-30 | Recruiting | ||
| Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS[NCT00180778] | Phase 1/Phase 2 | 90 participants (Anticipated) | Interventional | 2005-10-31 | Not yet recruiting | ||
| Low-molecular-weight Heparin Versus Unfractionated Heparin in Pregnant Women With History of Recurrent Abortion Secondary to Antiphospholipid Syndrome. A Randomized Controlled Trial[NCT01051778] | Phase 2 | 60 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| A Randomized Controlled Trial Comparing Low Molecular Weight Heparin and Aspirin to Aspirin Alone in Women With Unexplained Recurrent Pregnancy Loss[NCT00564174] | 88 participants (Actual) | Interventional | 2000-03-31 | Terminated (stopped due to interim analysis found no difference in LB rate and lower than expected event rate) | |||
| A Pilot Study Assessing the Feasibility of a Randomized Controlled Trial Evaluating Aspirin Versus Low-molecular-weight Heparin (LMWH) and Aspirin in Women With Antiphospholipid Syndrome and Pregnancy Loss[NCT03100123] | Early Phase 1 | 1 participants (Actual) | Interventional | 2017-11-06 | Terminated (stopped due to Pilot deemed not feasible by Steering Committee due to recruitment rate.) | ||
| Role of LMWH (Enoxaparine) With or Without Aspirin in the Prevention of Habitual Abortion; Special Attention to the Thrombophilic Status of the Mother[NCT00959621] | Phase 3 | 220 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin[NCT02144064] | Phase 3 | 200 participants (Anticipated) | Interventional | 2019-06-23 | Recruiting | ||
| A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS)[NCT01661439] | 316 participants (Anticipated) | Observational | 2012-03-31 | Recruiting | |||
| PEPPI Study: Identification of Women at Risk for Placental Dysfunction During the First and Third Trimesters of Pregnancy[NCT06115122] | 3,000 participants (Anticipated) | Observational [Patient Registry] | 2022-02-15 | Recruiting | |||
| PREMOM II: Pregnancy Remote Monitoring of Women With Gestational Hypertensive Disorders[NCT04031430] | 6,107 participants (Anticipated) | Interventional | 2019-06-18 | Recruiting | |||
| Genetic, Laboratory and Clinical Factors Associated With Low-dose Aspirin Failure in the Prevention of Preeclampsia- An Exploratory Protocol[NCT05709483] | Early Phase 1 | 130 participants (Anticipated) | Interventional | 2023-04-13 | Recruiting | ||
| Preeclampsia Intervention 4 - A Triple Blind Phase III Randomised Controlled Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia[NCT06033131] | Phase 3 | 294 participants (Anticipated) | Interventional | 2024-01-22 | Not yet recruiting | ||
| Low Dose Aspirin in the Prevention of Preeclampsia in Chinese Pregnant Women.[NCT02797249] | Phase 3 | 1,000 participants (Actual) | Interventional | 2016-12-07 | Completed | ||
| Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial[NCT03871491] | Phase 3 | 34,000 participants (Anticipated) | Interventional | 2020-09-01 | Active, not recruiting | ||
| A Randomized Controlled Trial Comparing Low Doses Of Aspirin In The Prevention Of Preeclampsia (ASAPP)[NCT04070573] | Phase 3 | 400 participants (Anticipated) | Interventional | 2019-10-21 | Enrolling by invitation | ||
| Role of Aspirin in Maternal Endothelial Dysfunction and Uterine Artery Blood Flow in Women at Risk for Preeclampsia[NCT03893630] | Phase 2 | 250 participants (Anticipated) | Interventional | 2019-04-25 | Recruiting | ||
| IMPACT - Study for Improving Maternal, Pregnancy and Child Outcomes[NCT03831490] | 13,000 participants (Actual) | Observational [Patient Registry] | 2018-11-09 | Active, not recruiting | |||
| First-trimester Placental Ultrasound Study (First PLUS): an Observational Cohort Study to Assess the Clinical Utility of the OxNNet Toolkit for the Prediction of Adverse Pregnancy Outcomes.[NCT05326191] | 4,000 participants (Actual) | Observational | 2022-03-15 | Completed | |||
| The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population[NCT05089175] | 4,500 participants (Anticipated) | Observational [Patient Registry] | 2021-11-30 | Recruiting | |||
| A Pragmatic Randomized Study Comparing 81 mg Aspirin Versus 162 mg Aspirin in the Prevention of Preeclampsia During Pregnancy[NCT04158830] | Phase 4 | 0 participants (Actual) | Interventional | 2020-06-01 | Withdrawn (stopped due to PI is no longer at this University.) | ||
| STUDY PROTOCOL FOR A PROSPECTIVE, MULTICENTRE, COHORT STUDY: Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of Pregnancy (CRISP STUDY)[NCT04767438] | 6,560 participants (Anticipated) | Observational | 2021-03-31 | Not yet recruiting | |||
| Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension: A Pilot Study[NCT04908982] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-05-28 | Recruiting | ||
| Implementation of First-trimester Screening and Prevention of Preeclampsia: a Stepped Wedge Cluster-randomized Trial in Asia[NCT03941886] | 42,454 participants (Actual) | Interventional | 2019-07-31 | Completed | |||
| Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE): a Randomized Controlled Trial[NCT05253781] | Phase 3 | 476 participants (Anticipated) | Interventional | 2020-07-01 | Recruiting | ||
| Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes[NCT04801121] | 100 participants (Anticipated) | Observational [Patient Registry] | 2020-11-01 | Enrolling by invitation | |||
| First-trimester Preeclampsia Screening: Women's Perspectives[NCT05123560] | 750 participants (Anticipated) | Observational | 2022-04-01 | Not yet recruiting | |||
| Fetal, Obstetrics and Reproduction Genomics[NCT05720169] | 400 participants (Anticipated) | Observational | 2023-10-01 | Not yet recruiting | |||
| A Randomized Trial of Transplacental Aspirin Therapy for Early Onset Fetal Growth[NCT04557475] | Phase 3 | 0 participants (Actual) | Interventional | 2022-06-11 | Withdrawn (stopped due to We are modifying this trial's protocol and will resubmit a new application at a later date.) | ||
| A Prospective Muti-center Study of Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort[NCT04631627] | Phase 4 | 1,500 participants (Anticipated) | Interventional | 2020-11-16 | Not yet recruiting | ||
| Correlation Between Pulmonary Artery Doppler And Other Ultrasonographic Markers With Neonatal Outcome In Placenta Accreta Spectrum Patients[NCT04911322] | 71 participants (Actual) | Observational | 2021-08-15 | Completed | |||
| Correlation Between Pulmonary Artery Doppler And Neonatal Outcome In Hypertensive Disorders Of Pregnancy[NCT05793125] | 72 participants (Anticipated) | Observational | 2023-04-03 | Recruiting | |||
| Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)[NCT00198068] | 700 participants (Anticipated) | Observational | 2003-09-30 | Recruiting | |||
| Acetylsalicylic Acid for Postpartum Preeclampsia: A Pilot Randomized Trial[NCT05924971] | Phase 2 | 86 participants (Anticipated) | Interventional | 2023-07-26 | Recruiting | ||
| Prevention of Preeclampsia With Aspirin Administered From the Beginning of Pregnancy in Recipients of Donated Oocytes.[NCT02174328] | Phase 3 | 81 participants (Actual) | Interventional | 2014-05-21 | Terminated (stopped due to Halted prematurely due to low recruitment rate.) | ||
| Low Dose Aspirin and Low-molecular-weight Heparin in the Treatment of Pregnant Libyan Women With Recurrent Miscarriage[NCT01917799] | Phase 4 | 150 participants (Anticipated) | Interventional | 2009-01-31 | Recruiting | ||
| Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss[NCT04558268] | Phase 2/Phase 3 | 242 participants (Anticipated) | Interventional | 2020-12-31 | Not yet recruiting | ||
| A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174] | 420 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
| Pravastatin to Prevent Preeclampsia and Reduce Maternal-Neonatal Mortality and Morbidity in High Risk Preeclampsia Patients[NCT03648970] | Phase 2 | 280 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | ||
| Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss ,Double Blinded Randomized Controlled Trial .[NCT05237843] | Phase 1 | 70 participants (Anticipated) | Interventional | 2022-03-01 | Not yet recruiting | ||
| Early Prediction and Aspirin for Prevention of Preeclampsia[NCT01547390] | 104 participants (Actual) | Interventional | 2012-03-31 | Terminated (stopped due to Terminated after Aspirin was recommended by the USPTF to Prevent Preeclampsia.) | |||
| A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome[NCT04624269] | Phase 4 | 384 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial[NCT04855513] | 414 participants (Anticipated) | Interventional | 2022-03-24 | Not yet recruiting | |||
| Assessment of the Cardiovascular Risk Profile of Infants Exposed to Pre-eclampsia in Utero[NCT05091827] | 234 participants (Anticipated) | Observational | 2021-11-30 | Not yet recruiting | |||
| The Copenhagen Analgesic Study[NCT04369222] | 600 participants (Anticipated) | Observational | 2020-03-01 | Recruiting | |||
| An Open-label Randomized-Controlled Trial of Early Screening Test for Pre-eclampsia and Growth Restriction[NCT03674606] | Phase 4 | 546 participants (Actual) | Interventional | 2014-02-01 | Completed | ||
| A Randomized Blinded Placebo Controlled Trial Assessing Ketorolac (Toradol) at Oocyte Retrieval[NCT06026553] | Phase 1 | 400 participants (Anticipated) | Interventional | 2022-08-10 | Recruiting | ||
| [NCT02696577] | Phase 2 | 68 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Thromboelastography to Assess Age-Related Coagulation Differences in Patients Undergoing Elective Cesarean Delivery.[NCT01416454] | 46 participants (Actual) | Observational | 2010-10-31 | Completed | |||
| Does Low-Dose Aspirin Improve Outcome in IVF/ICSI? A Prospective, Randomized, Double Blind Placebo Controlled Trial[NCT00644085] | Phase 3 | 201 participants (Actual) | Interventional | 2000-04-30 | Completed | ||
| The Significance of Low-Dose Aspirin on Ovarian Responsiveness, Uterine Hemodynamics and Pregnancy Outcome in in Vitro Fertilization and in Intracytoplasmic Sperm Injection: A Randomized, Placebo-Controlled Double-Blind Study[NCT00683202] | 374 participants (Actual) | Interventional | 2001-03-31 | Completed | |||
| Efficacy L-arginine + L-citrulline as a Dietary Supplement vs Placebo for Weight Gain in Fetus With a Decrease in Their Growth Curve in the Third Trimester of Pregnancy[NCT05029778] | Phase 4 | 41 participants (Anticipated) | Interventional | 2021-10-20 | Not yet recruiting | ||
| Prospective Multicentric Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women With a Risk of Thromboembolism and/or a Risk of Placental Vascular Complication, Strategy Determined With a Risk Score.[NCT00745212] | 2,280 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| Effects of Aspirin and Intrauterine Balloon on the Post-operative Uterine Endometrial Repair and Reproductive Prognosis in Patients With Severe Intrauterine Adhesion: a Prospective Cohort Study[NCT02744716] | 114 participants (Actual) | Interventional | 2011-05-31 | Completed | |||
| Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses[NCT01828697] | Phase 4 | 1,110 participants (Actual) | Interventional | 2013-04-24 | Completed | ||
| Prospective Validation of Prediction Algorithms for Preeclampsia in the First-trimester of Pregnancy[NCT03554681] | 10,935 participants (Actual) | Observational | 2016-12-31 | Completed | |||
| Early Versus Late Post Caesarean Section Oral Anticoagulation Initiation and Risk of Maternal Complications in Patients With Mechanical Heart Valve Prosthesis[NCT04855110] | 114 participants (Anticipated) | Interventional | 2021-04-19 | Recruiting | |||
| Association Between Preeclampsia, Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure, Systemic Arterial Pressure and Cardiovascular Function.[NCT05679206] | 900 participants (Anticipated) | Observational | 2022-12-20 | Recruiting | |||
| Investigation Of The Utility Of Home Blood Pressure Measurements Towards Improving The Management Of Hypertension In Patients In Stage 3 And 4 Chronic Kidney Disease[NCT03588520] | 70 participants (Anticipated) | Interventional | 2018-06-02 | Recruiting | |||
| Evaluation of the Benefit of Adjuvant Treatment With Hydroxychloroquine to the Usual Medical Management for Obtaining an Uncomplicated Term Pregnancy in Primary Obstetric Antiphospholipid Syndrome[NCT04275778] | Phase 2 | 110 participants (Anticipated) | Interventional | 2021-07-09 | Recruiting | ||
| Use of Sildenafil Citrate in Management of Mild Pre-eclampsia: A Randomized Controlled Trial[NCT03262961] | Phase 2/Phase 3 | 80 participants (Anticipated) | Interventional | 2016-09-15 | Recruiting | ||
| Diagnostic Value of microRNA 210 In Preeclampsia[NCT03193554] | 80 participants (Anticipated) | Observational [Patient Registry] | 2019-01-01 | Recruiting | |||
| Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers[NCT01729468] | Phase 4 | 1,106 participants (Actual) | Interventional | 2012-06-27 | Completed | ||
| A Multi-center, Double-Blind Randomized, Cross-over, Active-control, Comparative Clinical Study to Evaluate the Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-Controlled Hypertensive Patients (Phase IV)[NCT00386529] | Phase 4 | 191 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| Effect of Low-Molecular-Weight-Heparin (LMWH) on Pregnancy Outcome in Women With Multiple Failures of IVF-ET[NCT03701750] | Phase 4 | 240 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting | ||
| Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy[NCT00287651] | Phase 2/Phase 3 | 150 participants (Actual) | Interventional | 2005-11-30 | Terminated (stopped due to Administrative) | ||
| Influence of Local Biopsy of the Endometrium Prior to Controlled Ovarian Stimulation for IVF or ICSI Procedure on the Rates of Embryo Implantation, Clinical Pregnancy and Live Birth in ART[NCT01064193] | Phase 3 | 190 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Value of Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Fertility-preserving Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma[NCT03463252] | Phase 2/Phase 3 | 224 participants (Anticipated) | Interventional | 2018-04-01 | Recruiting | ||
| Induction of Labor at Term Versus Expectant Management Among Women With Abnormal Maternal Serum Biochemical Markers: A Randomized Controlled Trial[NCT02754635] | 320 participants (Anticipated) | Interventional | 2016-03-31 | Recruiting | |||
| Acute Headache Treatment in Pregnancy: Improvement in Pain Scores With Occipital Nerve Block vs PO Acetaminophen With Caffeine A Randomized Controlled Trial[NCT03951649] | Phase 4 | 62 participants (Actual) | Interventional | 2020-02-10 | Completed | ||
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants[NCT01755728] | Phase 3 | 19 participants (Actual) | Interventional | 2013-01-01 | Completed | ||
| Serum Assessment of Preterm Birth: Outcomes Compared to Historical Controls[NCT03151330] | 2,110 participants (Anticipated) | Interventional | 2018-06-15 | Active, not recruiting | |||
| A Comparison of Fetal Hemodynamic Measurements Between Pregnant Women Taking Anti-hypertensive Medication and Controls[NCT00759278] | 0 participants (Actual) | Observational | 2008-08-31 | Withdrawn (stopped due to No participants) | |||
| A Placebo-Controlled, Double-Blind, Randomized Study of the Potential Interaction Between Aspirin and Ibuprofen or Celecoxib.[NCT00565500] | Phase 4 | 24 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)[NCT05262881] | 50 participants (Anticipated) | Observational | 2022-03-01 | Not yet recruiting | |||
| Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus in Premature Infants: A Pilot Study[NCT03103022] | Phase 1 | 20 participants (Actual) | Interventional | 2017-06-12 | Completed | ||
| A Study of the Pharmacology of 17-Hydroxyprogesterone Caproate in Pregnancy[NCT00409825] | Phase 2 | 61 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Partial or complete abruption (ie, premature separation of the placenta) (NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 7 |
| Placebo | 5 |
(NCT00467363)
Timeframe: 8-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 374 |
| Placebo | 346 |
Implantation failures (NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 28 |
| Placebo | 27 |
(NCT00467363)
Timeframe: within 6 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 3 |
| Placebo | 3 |
(NCT00467363)
Timeframe: until 40 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 4 |
| Placebo | 6 |
(NCT00467363)
Timeframe: within 8-weeks of gestation
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 394 |
| Placebo | 363 |
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff . (NCT00467363)
Timeframe: after delivery
| Intervention | livebirths (Number) |
|---|---|
| Aspirin | 309 |
| Placebo | 286 |
(NCT00467363)
Timeframe: 8 weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 0 |
| Placebo | 0 |
(NCT00467363)
Timeframe: until delivery
| Intervention | participants (Number) |
|---|---|
| Aspirin | 32 |
| Placebo | 30 |
Includes preembryonic and embryonic losses (exclusive of implantation failures) (NCT00467363)
Timeframe: less than 10-weeks
| Intervention | pregnancy (Number) |
|---|---|
| Aspirin | 56 |
| Placebo | 53 |
(NCT00467363)
Timeframe: until delivery
| Intervention | infants (Number) |
|---|---|
| Aspirin | 22 |
| Placebo | 31 |
birthweight (NCT00467363)
Timeframe: until delivery
| Intervention | grams (Mean) |
|---|---|
| Aspirin | 3327 |
| Placebo | 3315 |
(NCT00467363)
Timeframe: 40 weeks
| Intervention | participants (Number) |
|---|---|
| Aspirin | 2 |
| Placebo | 2 |
- Early preterm delivery (<34 weeks) (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 189 |
| Placebo Arm | 230 |
- Birth weight <2500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1078 |
| Placebo Arm | 1153 |
- Birth weight <1500g (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 78 |
| Placebo Arm | 101 |
- Incidence of Fetal Loss (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 303 |
| Placebo Arm | 353 |
- Incidence of Spontaneous Abortion (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 134 |
| Placebo Arm | 152 |
- Incidence of All stillbirth (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 141 |
| Placebo Arm | 166 |
- Incidence of Medical Termination of Pregnancy (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 42 |
| Placebo Arm | 30 |
- Hypertensive disorders of pregnancy is defined by the characterization of evidence of a hypertensive disorder, including either preeclampsia or eclampsia occurring during the pregnancy. (NCT02409680)
Timeframe: Evidence of hypertensive disorder during the pregnancy (prior to delivery/birth)
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 352 |
| Placebo Arm | 325 |
- Incidence of Perinatal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 264 |
| Placebo Arm | 309 |
The primary outcome of this study is incidence of preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks. This will be determined based on actual date of delivery in comparison to the projected estimated due date (EDD), independent of whether or not the preterm delivery is indicated or spontaneous. (NCT02409680)
Timeframe: At delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 668 |
| Placebo Arm | 754 |
- Small for gestational age (SGA) as defined by the INTERGROWTH-21st standard (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 1506 |
| Placebo Arm | 1564 |
- Vaginal bleeding (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 214 |
| Placebo Arm | 246 |
- Antepartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 26 |
| Placebo Arm | 25 |
- Postpartum hemorrhage (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 54 |
| Placebo Arm | 43 |
- Incidence of Maternal Mortality (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 9 |
| Placebo Arm | 12 |
- Incidence of Late Abortion (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 23 |
| Placebo Arm | 30 |
Hemoglobin < 7.0 gm/dl at 26-30 weeks gestation or a drop of 3.5+ gm/dl from screening to 26-30 weeks gestation (NCT02409680)
Timeframe: At enrollment, 4 weeks post enrollment, and 26-30 weeks GA.
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 290 |
| Placebo Arm | 333 |
Early preterm delivery (<34 weeks) and hypertensive disorders (i.e.: preeclampsia) (NCT02409680)
Timeframe: At delivery or at Day 42 after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Arm | 8 |
| Placebo Arm | 21 |
Live birth occurs when a fetus (> 24 weeks ) , exits the maternal body and subsequently shows signs of life, such as voluntary movement, heartbeat, or pulsation of the umbilical cord. (NCT01051778)
Timeframe: pregnancy > 24weeks gestation
| Intervention | Percentage of pregnancies (Number) |
|---|---|
| Enoxaparin 40 mg /Day Plus Low Dose Aspirin | 24 |
| Heparin Calcium 5,000 U Twice Daily Plus Low Dose Aspirin | 20 |
Proportion of eligible subjects who provide consent. (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Consented Eligible Patients | 1 |
Crossover rate between standard of care and experimental study arms. (NCT03100123)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Crossover Rate | 0 |
Proportion of screened patients who meet eligibility criteria (i.e. patients who meet inclusion criteria and are also eligible based on exclusion criteria). (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Screened Patients Who Met Eligibility Criteria | 4 |
Proportion of sites requiring >18 months to obtain all required approvals/contracts from time of delivery of all study documents. (NCT03100123)
Timeframe: 18 months
| Intervention | Sites (Number) |
|---|---|
| Approval Timeline | 1 |
Level of compliance with study drug through patient recall and patient medication diary. (NCT03100123)
Timeframe: 52 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Standard of Care Arm | 0 |
| Experimental Arm | 1 |
The primary feasibility outcome of the pilot trial is the mean recruitment rate per center per month. (NCT03100123)
Timeframe: 24 months
| Intervention | participants (Number) |
|---|---|
| Experimental Arm | 1 |
Proportion of withdrawals/loss to follow-up among randomized patients. (NCT03100123)
Timeframe: 24 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Withdrawal/Lost to Follow-up | 0 |
Preeclampsia diagnosed per ACOG criteria: Blood pressure greater than 140/90 on 2 occasions 6 hrs apart and significant proteinuria (greater than 300mg in 24hrs). (NCT01547390)
Timeframe: within 3 months prior to delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 3 |
| Aspirin | 3 |
"Intrauterine growth restriction (IUGR) - estimated fetal weight less than 10th percentile early preeclampsia - preeclampsia delivered prior to 34 weeks severe preeclampsia - blood pressure greater then 160/110 gestational hypertension - hypertension without features of preeclampsia preterm birth, stillbirth, placental abruption, antepartum hemorrhage, neonatal death, NICU admission, miscarriage.~Statistical significance not reported due to the low recruitment and poor patient compliance." (NCT01547390)
Timeframe: within 3 months of delivery
| Intervention | participants (Number) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small for gestational age (IUGR) | Gestational hypertension | Early preeclampsia | Severe preeclampsia | Preterm birth | Stillbirth | Placental abruption | antepartum hemorrhage | neonatal death | NICU admission | miscarriage | |
| Aspirin | 1 | 2 | 1 | 3 | 1 | 0 | 0 | 0 | 0 | 2 | 0 |
| Placebo | 1 | 0 | 1 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
(NCT03951649)
Timeframe: 7 days
| Intervention | days (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 9 |
| Oral Acetaminophen/Caffeine Group | 4 |
(NCT03951649)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 7 |
| Oral Acetaminophen/Caffeine Group | 2 |
Other: Pain at injection site (NCT03951649)
Timeframe: 7 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 0 |
| Oral Acetaminophen/Caffeine Group | 2 |
(NCT03951649)
Timeframe: 7 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 0 |
| Oral Acetaminophen/Caffeine Group | 0 |
(NCT03951649)
Timeframe: 4 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 9 |
| Oral Acetaminophen/Caffeine Group | 14 |
(NCT03951649)
Timeframe: 5 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 4 |
| Oral Acetaminophen/Caffeine Group | 2 |
Emergency department for treatment of headache since treatment asked at 28 day follow up (NCT03951649)
Timeframe: 28 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 5 |
| Oral Acetaminophen/Caffeine Group | 1 |
(NCT03951649)
Timeframe: 120 min
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 5 |
| Oral Acetaminophen/Caffeine Group | 5 |
Based on guidelines from the International Headache Society the primary outcome is the portion of women who experience resolution of headache or improvement of headache to mild range (VRS ≤ 3) at 2 hours following treatment with Occipital nerve block as compared to acetaminophen/caffeine cocktail. (NCT03951649)
Timeframe: 60-300 min
| Intervention | Participants (Count of Participants) |
|---|---|
| Occipital Nerve Block | 20 |
| Oral Acetaminophen/Caffeine Group | 16 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 60 min
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 3 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 180min
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6 |
| Oral Acetaminophen/Caffeine Group | 4 |
"Visual/verbal Rating Score (VRS). VRS is used to assess pain in patients. With 0 representing no pain at all and 10 representing worst possible pain.~Total Minimum score=0 Total Maximum score=10~Higher values represent worse pain. If VRS=0, then the headache pain is considered resolved." (NCT03951649)
Timeframe: 2 hrs
| Intervention | score on a scale (Median) |
|---|---|
| Occipital Nerve Block | 6.0 |
| Oral Acetaminophen/Caffeine Group | 6.5 |
"Change in the area under the concentration vs. time curve in the second and third trimesters of pregnancy.~We compared AUC at each PK study visit. Measurements were obtained at 0, 1, 2, 3, 4, 5, 6, 7 days." (NCT00409825)
Timeframe: Second and third trimesters of pregnancy
| Intervention | ng/ML/day (Mean) | |
|---|---|---|
| AUC -1 | AUC - 2 | |
| Part 1 | 115 | 136 |
532 reviews available for aspirin and Pregnancy
| Article | Year |
|---|---|
Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera.
Topics: Animals; Aspirin; Disease Management; Female; Humans; Phlebotomy; Platelet Aggregation Inhibitors; P | 2021 |
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Infant, Newborn; Infant, Small for | 2021 |
Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Female; Heparin; Heparin, | 2022 |
Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Ibuprofen; | 2022 |
Aspirin for the prevention of pre-eclampsia in women with pre-existing diabetes: Systematic review.
Topics: Aspirin; Diabetes Mellitus; Female; Humans; Pre-Eclampsia; Pregnancy | 2022 |
Long-term health and neurodevelopment in children after antenatal exposure to low-dose aspirin for the prevention of preeclampsia and fetal growth restriction: A systematic review of randomized controlled trials.
Topics: Aspirin; Child; Female; Fetal Growth Retardation; Humans; Infant; Infant, Newborn; Parturition; Pre- | 2021 |
Platelet response to aspirin in UK and Irish pregnancy cohorts: a genome-wide approach.
Topics: Aspirin; Cross-Sectional Studies; Female; Genome-Wide Association Study; Humans; Platelet Aggregatio | 2022 |
The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs.
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Postpartum Hemorrhage; Pr | 2022 |
Low-dose aspirin for the prevention of preterm birth: More questions than answers.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Infant, Newbor | 2022 |
Vanquishing multiple pregnancy in in vitro fertilization in the United States-a 25-year endeavor.
Topics: Acetaminophen; Aspirin; Female; Fertilization in Vitro; Humans; Infant, Low Birth Weight; Infant, Ne | 2022 |
Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?
Topics: Aspirin; Female; Fibrinolytic Agents; Humans; Neutrophil Infiltration; Placenta; Pre-Eclampsia; Preg | 2022 |
Letter by Lu et al regarding article, "the role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs".
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2022 |
Concerning the article "The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta‑analysis of RCTs".
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Treatment options and pregnancy management for patients with PV and ET.
Topics: Aspirin; Female; Humans; Hydroxyurea; Janus Kinase 2; Janus Kinase Inhibitors; Myeloproliferative Di | 2022 |
Screening for preeclampsia in twin pregnancies.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy Trimeste | 2022 |
Association Between Low-Dose Aspirin and Development of Gestational Diabetes: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Diabetes, Gestational; Female; Gestational Age; Humans; Hypoglycemia; Infant, Newborn; Pre- | 2022 |
Toward the elimination of race-based medicine: replace race with racism as preeclampsia risk factor.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Racism; Risk Factors | 2022 |
Low-dose aspirin use in the first trimester of pregnancy and odds of congenital anomalies: A meta-analysis of randomized controlled trials.
Topics: Aspirin; Female; Humans; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topi | 2023 |
The role of platelets in reproduction
Topics: Aspirin; Blood Platelets; Female; Hemostasis; Humans; Ovarian Hyperstimulation Syndrome; Placenta; P | 2022 |
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis.
Topics: Abortion, Spontaneous; Adalimumab; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxych | 2022 |
Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; MicroRNAs; Pre-Eclampsia; Pregnancy; Pregnancy | 2022 |
Impact of subchorionic hematoma on pregnancy outcomes in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Aspirin; Female; Hematoma; Humans; Pregnancy; Pregnancy Complications; Pregnancy | 2023 |
Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Outcome; Thrombosis; Venous | 2022 |
The role of melatonin in pregnancies complicated by placental insufficiency: A systematic review.
Topics: Antioxidants; Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Melatonin; Placent | 2022 |
Prevention of pre-eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence.
Topics: Aspirin; Female; Humans; Infant, Newborn; Perinatal Death; Pre-Eclampsia; Pregnancy | 2023 |
Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Perinatal Death; Pre-Eclampsia; Pregnancy; P | 2023 |
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials.
Topics: Aspirin; Bayes Theorem; Calcium; Female; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pregna | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; In | 2023 |
[Latest Findings on Prediction and Prevention of Preeclampsia].
Topics: Aspirin; Female; Humans; Placenta; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Trophoblasts | 2022 |
[Latest Findings on Prediction and Prevention of Preeclampsia].
Topics: Aspirin; Female; Humans; Placenta; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Trophoblasts | 2022 |
[Latest Findings on Prediction and Prevention of Preeclampsia].
Topics: Aspirin; Female; Humans; Placenta; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Trophoblasts | 2022 |
[Latest Findings on Prediction and Prevention of Preeclampsia].
Topics: Aspirin; Female; Humans; Placenta; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Trophoblasts | 2022 |
Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Placenta; Placenta Diseases; Platelet Aggregation | 2023 |
Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis.
Topics: Aspirin; Female; Humans; Postpartum Hemorrhage; Pregnancy; Pregnancy Outcome | 2023 |
Pre-eclampsia.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Perinatal Death; Pre-Eclampsia; Pregnancy; P | 2023 |
Aspirin and Pravastatin for Preeclampsia Prevention in High-Risk Pregnancy.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Pravastatin; Pre-Eclampsia; Pregnancy; Pregn | 2023 |
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; P | 2023 |
Aspirin in pregnancy: a review of indications, timing, dosing and efficacy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Ag | 2023 |
[Important Considerations of Low-Dose Aspirin in the Prevention of Preeclampsia].
Topics: Aspirin; China; Female; Humans; Pre-Eclampsia; Pregnancy | 2023 |
Cardiac medications in obstetric patients.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Agents; Female; Hematologic Agents; Humans; Hyperte | 2023 |
Role of aspirin in the prevention of preeclampsia in previously hypertensive pregnant women: A Meta-Analysis.
Topics: Aspirin; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pr | 2023 |
Pericardial Diseases in Pregnancy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiac Tamponade; Female; Humans; Pericardial Eff | 2023 |
Meta-Analysis of the Efficacy of Low Molecular Weight Heparin and Aspirin in the Treatment of Thrombosis During Pregnancy and Effects on Coagulation Function.
Topics: Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Thrombophilia; Th | 2023 |
Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis.
Topics: Aspirin; Female; Gestational Age; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Ecla | 2023 |
Polygenic prediction of preeclampsia and gestational hypertension.
Topics: Aspirin; Child; Eclampsia; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Pre-Eclamp | 2023 |
Comprehensive Review of Hypertensive Disorders Related to Pregnancy.
Topics: Aspirin; Eclampsia; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Placenta; Pre- | 2023 |
Do first-trimester screening algorithms for preeclampsia aligned to use of preventative therapies reduce the prevalence of pre-term preeclampsia: A systematic review and meta-analysis.
Topics: Algorithms; Aspirin; Female; Humans; Maternal Health Services; Pre-Eclampsia; Pregnancy; Pregnancy T | 2023 |
Preeclampsia in 2023: Time for preventing early onset- and term preeclampsia: The paramount role of gestational weight gain.
Topics: Aspirin; Body Mass Index; Female; Gestational Weight Gain; Humans; Infant, Newborn; Obesity; Pre-Ecl | 2023 |
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets.
Topics: Antihypertensive Agents; Aspirin; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, T | 2023 |
The Role of Acetylsalicylic Acid in the Prevention of Pre-Eclampsia, Fetal Growth Restriction, and Preterm Birth.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Premat | 2023 |
The great obstetrical syndromes and the placenta.
Topics: Aspirin; Female; Humans; Infant, Newborn; Inflammation; Placenta; Pre-Eclampsia; Pregnancy; Prematur | 2023 |
Prediction and prevention of preeclampsia in women with preexisting diabetes: the role of home blood pressure, physical activity, and aspirin.
Topics: Aspirin; Blood Pressure; Diabetes Mellitus, Type 2; Exercise; Female; Humans; Pre-Eclampsia; Pregnan | 2023 |
Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Birth Rate; | 2023 |
Interventions to prevent miscarriage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; Female; Heparin; Humans; Hypothyroidism; Pregnan | 2023 |
Clinical efficacy of low-dose aspirin combined with calcium in preventing preeclampsia: A systematic review and meta-analysis.
Topics: Aspirin; Calcium; Calcium, Dietary; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn | 2023 |
Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition?
Topics: Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; | 2020 |
Evidence-Based Prevention of Preeclampsia: Commonly Asked Questions in Clinical Practice.
Topics: Aspirin; Evidence-Based Medicine; Female; Humans; Pre-Eclampsia; Pregnancy; Prenatal Care; Risk Asse | 2019 |
Impact of low-dose aspirin on adverse perinatal outcome: meta-analysis and meta-regression.
Topics: Abruptio Placentae; Apgar Score; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retardation; Hum | 2020 |
Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy.
Topics: Animals; Aspirin; Biomarkers; Exosomes; Extracellular Vesicles; Female; Humans; Molecular Targeted T | 2019 |
Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2020 |
Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis.
Topics: Antineoplastic Agents; Aspirin; Birth Rate; Female; Fibrinolytic Agents; Heparin; Humans; Interferon | 2019 |
Aspirin and its pleiotropic application.
Topics: Animals; Aspirin; Female; Humans; Mental Disorders; Neoplasms; Platelet Aggregation Inhibitors; Pre- | 2020 |
Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Hemorrhage; Humans; Pregnancy; Pregnancy Complications; | 2020 |
[Preeclampsia: Should screening and pronostic biomarkers be used in common clinical practice?]
Topics: Angiogenic Proteins; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Female; Humans; P | 2019 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Matern | 2019 |
Antiphospholipid syndrome: Diagnosis and management in the obstetric patient.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy | 2020 |
Aspirin for CVD, Scabies, Intimate Partner Violence, Maternal Vaccines, Caregiver Burden.
Topics: Adaptation, Psychological; Aspirin; Cardiovascular Diseases; Caregivers; Cyclooxygenase Inhibitors; | 2019 |
First-trimester screening for preeclampsia.
Topics: Aspirin; Biomarkers; Female; Humans; Mass Screening; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, | 2019 |
Nonprescription drugs recommended in guidelines for common pain conditions.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2020 |
Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta-analysis.
Topics: Abortion, Spontaneous; Animals; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-W | 2020 |
Aspirin for prevention of preeclampsia and fetal growth restriction.
Topics: Angiogenesis Inducing Agents; Anticoagulants; Aspirin; Female; Fetal Growth Retardation; Gestational | 2020 |
Novel Interventions for the Prevention of Preeclampsia.
Topics: Animals; Aspirin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Pre- | 2020 |
Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation.
Topics: Aspirin; Atherosclerosis; Female; Humans; Hypertension; Inflammation; Placenta; Placentation; Pre-Ec | 2020 |
Opportunities for improving hypertensive disorders of pregnancy (HDP) management in primary care settings: A review of international published guidelines in the context of pregnancy care in Indonesia.
Topics: Aspirin; Calcium; Calcium-Regulating Hormones and Agents; Communication; Female; General Practice; H | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2020 |
Prophylactic aspirin for preventing pre-eclampsia and its complications: An overview of meta-analyses.
Topics: Abruptio Placentae; Aspirin; Female; Fetal Growth Retardation; Hemorrhage; Humans; Hypertension, Pre | 2020 |
Prevention of preeclampsia.
Topics: Aspirin; Female; Fibrinolytic Agents; Humans; Hypertension; Pre-Eclampsia; Pregnancy | 2020 |
Pregnancy and cardiovascular disease.
Topics: Acute Coronary Syndrome; Antihypertensive Agents; Aortic Dissection; Arrhythmias, Cardiac; Aspirin; | 2020 |
Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gestational Age | 2020 |
Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension.
Topics: Aspirin; Female; France; Humans; Hypertension; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complic | 2020 |
Toward personalized management of chronic hypertension in pregnancy.
Topics: Antihypertensive Agents; Aspirin; Blood Pressure Monitoring, Ambulatory; Calcium; Chronic Disease; C | 2022 |
Aspirin (single dose) for perineal pain in the early postpartum period.
Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Episiotomy; Female; Humans; Obstetric | 2020 |
Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retarda | 2020 |
Understanding and Preventing Placenta-Mediated Pregnancy Complications.
Topics: Abruptio Placentae; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2020 |
The Potential Protective Role of Aspirin Against Migraine in Pregnant Women.
Topics: Aspirin; Drug Administration Schedule; Drug Dosage Calculations; Endothelium, Vascular; Female; Huma | 2020 |
Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Calcium; Delivery, Obstetric; Female; Glucocortic | 2022 |
Prevention of preeclampsia with aspirin.
Topics: Aspirin; Cost-Benefit Analysis; Female; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibit | 2022 |
Hypertension During Pregnancy.
Topics: Aspirin; Cesarean Section; Female; Humans; Hypertension; Infant, Newborn; Pre-Eclampsia; Pregnancy; | 2020 |
Novel approaches to combat preeclampsia: from new drugs to innovative delivery.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Drug Delivery Systems; Female; Humans; Molecular Target | 2020 |
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin, | 2021 |
Current Preterm Birth Prevention Strategies.
Topics: Administration, Intravaginal; Aspirin; Cerclage, Cervical; Cervical Length Measurement; Female; Fert | 2020 |
Hypertensive Disorders of Pregnancy.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Chronic Disease; Delivery, Obstetric; Eclampsia; | 2020 |
Inherited thrombophilia and anticoagulant therapy for women with reproductive failure.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Blood Coagulation; Female; Heparin; Humans; Infertility | 2021 |
The Role of Aspirin for Preeclampsia Prevention in Women with Diabetes.
Topics: Aspirin; Diabetes Mellitus, Type 2; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; | 2020 |
Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review.
Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Humans; Hypertension; Pre-Eclam | 2021 |
Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Aspirin; Combined Modality Therapy; Femal | 2021 |
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2021 |
Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta-Analysis.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Fetal Growth Retardation; Hemorrhage; He | 2021 |
Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, L | 2021 |
Stroke in Pregnancy: A Multidisciplinary Approach.
Topics: Aspirin; Brain Diseases; Cardiomyopathies; Cesarean Section; Eclampsia; Embolism, Paradoxical; Femal | 2021 |
Low-dose aspirin in pregnancy: who? when? how much? and why?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregna | 2021 |
Aspirin to prevent pre-eclampsia.
Topics: Aspirin; Drug Administration Schedule; Female; Hemorrhage; Humans; Platelet Aggregation Inhibitors; | 2021 |
Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Dru | 2021 |
Aspirin Prophylaxis During Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Female; Gestational Age; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy Outco | 2021 |
Aspirin for Endometrial Preparation in Patients Undergoing IVF: A Systematic Review and Meta-analysis.
Topics: Abortion, Spontaneous; Aspirin; Female; Fertilization in Vitro; Humans; Live Birth; Ovulation Induct | 2021 |
Effectiveness and safety of aspirin combined with letrozole in the treatment of polycystic ovary syndrome: a systematic review and meta-analysis.
Topics: Aspirin; China; Female; Humans; Letrozole; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy | 2021 |
Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies.
Topics: Adult; Anticoagulants; Aspirin; Delivery, Obstetric; Female; Fetal Growth Retardation; Gestational A | 2021 |
Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: A systematic review and meta-analysis.
Topics: Aspirin; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Pre-Eclampsia; Pregnanc | 2021 |
Pre-eclampsia.
Topics: Aspirin; Calcium; Calcium-Regulating Hormones and Agents; Female; Humans; Platelet Aggregation Inhib | 2021 |
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Female; Humans; Platelet Aggregation; Platelet Ag | 2021 |
Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2021 |
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.
Topics: Animals; Aspirin; Biomarkers; Disease Management; Disease Susceptibility; Female; Gene Expression; H | 2021 |
Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Fetal Growth Retardation; Gestational Ag | 2022 |
Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2021 |
[Treatment with low-dose acetylsalicylic acid can reduce risk of pre-eclampsia in high-risk pregnant women].
Topics: Aspirin; Early Medical Intervention; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Peri | 2017 |
Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, L | 2017 |
Updates on the Recognition, Prevention and Management of Hypertension in Pregnancy.
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregation Inhibitors; Pregnancy | 2017 |
Current insights in obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2017 |
How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?
Topics: Aspirin; Cardiology; Female; Fibrinolytic Agents; Humans; Medication Adherence; Obstetrics; Pre-Ecla | 2017 |
The Effects of Aspirin in Gestation and Reproduction (EAGeR) Trial: A Story of Discovery.
Topics: Adolescent; Adult; Aspirin; C-Reactive Protein; Female; Humans; Pregnancy; Pregnancy Complications; | 2017 |
Aspirin for Prevention of Preeclampsia.
Topics: Aspirin; Female; Humans; Incidence; Pre-Eclampsia; Pregnancy; Primary Prevention; Risk Factors; Seco | 2017 |
[Aspirin: Indications and use during pregnancy].
Topics: Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy, | 2017 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Gestational Age; Humans; Pre-Eclampsia; Pregnancy | 2018 |
Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review.
Topics: Adult; Aspirin; Cesarean Section; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin, L | 2017 |
Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid | 2019 |
The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Topics: Anticoagulants; Aspirin; Female; Fetal Growth Retardation; Genetic Therapy; Heparin; Heparin, Low-Mo | 2018 |
Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Platelet Count; Pregnan | 2018 |
Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage.
Topics: Abruptio Placentae; Aspirin; Female; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Pre-Eclamp | 2018 |
Antiphospholipid syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiph | 2018 |
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
Topics: Aspirin; Biomarkers; Canada; Consensus; Evidence-Based Medicine; Female; Fetal Growth Retardation; F | 2018 |
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
Topics: Aspirin; Biomarkers; Canada; Consensus; Evidence-Based Medicine; Female; Fetal Growth Retardation; F | 2018 |
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
Topics: Aspirin; Biomarkers; Canada; Consensus; Evidence-Based Medicine; Female; Fetal Growth Retardation; F | 2018 |
Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
Topics: Aspirin; Biomarkers; Canada; Consensus; Evidence-Based Medicine; Female; Fetal Growth Retardation; F | 2018 |
The practical use of acetylsalicylic acid in the era of the ASPRE trial. Update and literature review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnanc | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Optimal aspirin dosing for preeclampsia prevention.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregation Inhibitors; Pre-Ecla | 2018 |
Prophylaxis and treatment of foetal growth restriction.
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diet, Healthy; Female; | 2018 |
Prediction of preeclampsia developing at term.
Topics: Adult; Aspirin; Biomarkers; Early Diagnosis; Female; Humans; Pre-Eclampsia; Predictive Value of Test | 2018 |
[Preeclampsia: A challenge also for cardiologists].
Topics: Anticoagulants; Aspirin; Biomarkers; Cardiovascular Diseases; Exercise; Female; Heparin, Low-Molecul | 2018 |
[Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?]
Topics: Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Pre-Eclampsia; Precision Medicine; Pregnancy | 2018 |
Obstetric Anti-phospholipid Syndrome: State of the Art.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; H | 2018 |
Prevention of Prematurity: Advances and Opportunities.
Topics: Anti-Infective Agents; Aspirin; Cerclage, Cervical; Cesarean Section; Female; Humans; Indomethacin; | 2018 |
Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.
Topics: Aspirin; Female; Humans; Parity; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pre- | 2018 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2018 |
Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis.
Topics: Anticoagulants; Aspirin; Birth Weight; Female; Heparin, Low-Molecular-Weight; Humans; Placenta; Pre- | 2020 |
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.
Topics: Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Parent | 2018 |
The role of aspirin and inflammation on reproduction: the EAGeR trial
Topics: Animals; Aspirin; Female; Humans; Inflammation; Pregnancy; Pregnancy Outcome; Reproduction | 2019 |
Management of pregnant women with antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Combinations; Female; Heparin | 2019 |
Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction.
Topics: ADAM12 Protein; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Bi | 2018 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: A meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Live Birth; Pre-Eclampsia; | 2019 |
[Aspirin and preeclampsia].
Topics: Aspirin; Chronobiology Phenomena; Contraindications, Drug; Cyclooxygenase Inhibitors; Drug Utilizati | 2019 |
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Topics: Adult; Aspirin; Biomarkers; Endoglin; Endothelium, Vascular; Female; Humans; Immune Tolerance; Infla | 2019 |
Treatment and Prevention of Hypertensive Disorders During Pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Chronic Dis | 2019 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Human | 2019 |
Chronic Kidney Disease and Pregnancy.
Topics: Aspirin; Female; Glomerular Filtration Rate; Humans; Hypertension, Pregnancy-Induced; Infant, Newbor | 2019 |
Aspirin for the Prevention of Preeclampsia and Potential Consequences for Fetal Brain Development.
Topics: Aspirin; Brain; Cyclooxygenase Inhibitors; Female; Fetal Growth Retardation; Humans; Infant, Newborn | 2019 |
[Treatment of essential thrombocythemia].
Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Cell Transformation, Neoplastic; Disease Progress | 2013 |
Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2013 |
Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data.
Topics: Adult; Aspirin; Female; Fertilization in Vitro; Humans; Hypertension, Pregnancy-Induced; Logistic Mo | 2013 |
Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspir | 2013 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low | 2013 |
Antithrombotic therapy for pregnant women.
Topics: Aspirin; Contraindications; Cooperative Behavior; Dose-Response Relationship, Drug; Drug Labeling; F | 2013 |
New directions in the prediction of pre-eclampsia.
Topics: Aspirin; Biomarkers; Calcium; Female; Humans; Pre-Eclampsia; Pregnancy; Risk Factors; Ultrasonograph | 2014 |
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retarda | 2014 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome].
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2013 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrin | 2014 |
[Acetylsalicylic acid and prevention of preeclampsia].
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pr | 2014 |
Anticoagulant therapy in pregnant patients with metabolic syndrome: a review.
Topics: Animals; Anticoagulants; Aspirin; Female; Fondaparinux; Heparin; Humans; Metabolic Syndrome; Polysac | 2014 |
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Placenta Diseases; Placentation; Pregnanc | 2014 |
Prediction and prevention of ischemic placental disease.
Topics: Abruptio Placentae; Anticoagulants; Ascorbic Acid; Aspirin; Calcium, Dietary; Dietary Supplements; F | 2014 |
Pre-eclampsia: an update.
Topics: Aspirin; Blood Pressure; Female; Humans; Magnesium; Pre-Eclampsia; Pregnancy; Risk | 2014 |
Antiphospholipid antibody syndrome and reproduction.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans | 2014 |
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Heparin, | 2014 |
Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; | 2015 |
Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Birth Weight; Female; Gestational Age; Heparin, Low-Mol | 2016 |
Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Practice Guidelines as Topic; Pre- | 2015 |
[Early intervention with aspirin for preventing preeclampsia in high-risk women: a meta-analysis].
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pre-Eclampsia; Pre | 2015 |
Aspirin and heparin in pregnancy.
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans; Pregnancy; Pregnancy Complica | 2015 |
Committee Opinion Summary No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia.
Topics: Advisory Committees; Age of Onset; Aspirin; Early Diagnosis; Evidence-Based Medicine; Female; Follow | 2015 |
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Female; Heparin; H | 2016 |
Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
Topics: Aspirin; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Pre-Eclampsia; Pr | 2016 |
Pregnancy and Lupus Nephritis.
Topics: Abortion, Spontaneous; Anticoagulants; Antihypertensive Agents; Antiphospholipid Syndrome; Aspirin; | 2015 |
Prevention of Preeclampsia with Aspirin in Multiple Gestations: A Systematic Review and Meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Small f | 2016 |
Development of prenatal screening--A historical overview.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Cell-Free System; DNA; Down Syndrome; | 2016 |
[Antiphospholipid syndrome and pregnancy].
Topics: Anticoagulants; Antimalarials; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-We | 2016 |
Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
Topics: Abortion, Habitual; Adalimumab; Aspirin; Embryo Implantation; Etanercept; Female; Heparin; Humans; I | 2016 |
When positive studies of novel therapies are subsequently nullified: cumulative meta-analyses in preeclampsia.
Topics: Antioxidants; Aspirin; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Journal Impact | 2015 |
Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Small f | 2016 |
Low dose aspirin and pregnancy: how important is aspirin resistance?
Topics: Aspirin; Bleeding Time; Blood Platelets; Dose-Response Relationship, Drug; Drug Resistance; Female; | 2016 |
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
Topics: Aspirin; Body Mass Index; Chronic Disease; Cohort Studies; Early Diagnosis; Female; Humans; Hyperten | 2016 |
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
Topics: Aspirin; Body Mass Index; Chronic Disease; Cohort Studies; Early Diagnosis; Female; Humans; Hyperten | 2016 |
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
Topics: Aspirin; Body Mass Index; Chronic Disease; Cohort Studies; Early Diagnosis; Female; Humans; Hyperten | 2016 |
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
Topics: Aspirin; Body Mass Index; Chronic Disease; Cohort Studies; Early Diagnosis; Female; Humans; Hyperten | 2016 |
Pregnancy in women with systemic lupus erythematosus (SLE).
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2016 |
Analgesic use - prevalence, biomonitoring and endocrine and reproductive effects.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Commerce; | 2016 |
Ongoing Pharmacological Management of Chronic Pain in Pregnancy.
Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chr | 2016 |
Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept.
Topics: Antihypertensive Agents; Aspirin; Calcium, Dietary; Drug Therapy, Combination; Female; Humans; Hyper | 2016 |
The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
Topics: Aspirin; Blood Pressure; Decision Support Techniques; Female; Fertilization; Humans; Hypertension; M | 2016 |
Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction.
Topics: Aspirin; Female; Fetal Growth Retardation; Heparin; Humans; Pre-Eclampsia; Pregnancy | 2016 |
Aspirin vs Heparin for the Prevention of Preeclampsia.
Topics: Aspirin; Female; Heparin; Humans; Hypertension; Placenta Diseases; Pre-Eclampsia; Pregnancy | 2016 |
Preventing preeclampsia and its fetal complications with low-dose aspirin in East Asians and non-East Asians:A systematic review and meta-analysis.
Topics: Asian People; Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pr | 2016 |
Vertebral artery dissection in hypertensive disorders of pregnancy: a case series and literature review.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure; Computed Tomography Angiography; Female; Hu | 2016 |
Preventing deaths due to the hypertensive disorders of pregnancy.
Topics: Aspirin; Birth Intervals; Calcium; Cardiotocography; Dietary Supplements; Eclampsia; Female; Food Su | 2016 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
Aspirin Use in Women: Current Perspectives and Future Directions.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Primary Preventi | 2016 |
Aspirin for in vitro fertilisation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Female; Fertiliz | 2016 |
Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis.
Topics: Aspirin; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Perinatal Death; Platel | 2017 |
Prevention of thrombosis in antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Humans; Male; Pregnancy; Pregnancy | 2016 |
Meta-analysis of aspirin-heparin therapy for un-explained recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Female; Heparin; Humans; Pregnancy; Publication Bias | 2016 |
Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis.
Topics: Adult; Aspirin; Dipyridamole; Female; Gestational Age; Humans; Logistic Models; Platelet Aggregation | 2017 |
Aspirin (single dose) for perineal pain in the early postpartum period.
Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Obstetric Labor Compli | 2017 |
Anticoagulants to prevent recurrent placenta-mediated pregnancy complications: Is it time to put the needles away?
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Placent | 2017 |
Antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolyt | 2017 |
Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Polycythemi | 2008 |
Long-term management of thrombocytosis in essential thrombocythaemia.
Topics: Algorithms; Antineoplastic Agents; Aspirin; Female; Fibrinolytic Agents; Humans; Hydroxyurea; Interf | 2009 |
Prediction and prevention of recurrent preeclampsia.
Topics: Adult; Antihypertensive Agents; Aspirin; Calcium, Dietary; Female; Fetal Growth Retardation; Heparin | 2008 |
Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.
Topics: alpha-Fetoproteins; Aspirin; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Fetal Growth Retar | 2008 |
[The management of pregnant women with antiphospholipid syndrome].
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; | 2007 |
Sex differences in stroke.
Topics: Acute Disease; Age Factors; Animals; Aspirin; Atrial Fibrillation; Carotid Stenosis; Cerebrovascular | 2008 |
[Pregnancy and antiphospholipid antibodies].
Topics: Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Complemen | 2008 |
[Inherited thrombophilia in women with recurrent miscarriages and pregnancy loss in anamnesis--own experience].
Topics: Abortion, Habitual; Adult; Aspirin; Factor V; Female; Fibrinolytic Agents; Heparin, Low-Molecular-We | 2008 |
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecul | 2009 |
Thromboprophylaxis and obstetric management of the antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Catastrophic Illness; Drug Therapy, Combi | 2009 |
Effects of low-dose aspirin in in-vitro fertilization.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Fertilization in Vitro | 2009 |
Medical adjuncts in IVF: evidence for clinical practice.
Topics: Aspirin; Chemotherapy, Adjuvant; Embryo Implantation; Estradiol; Estrogens; Female; Fertilization in | 2009 |
[The antiphospholipid syndrome in the 21st century].
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Tri | 2009 |
Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss--a review of literature of various therapeutic protocols.
Topics: Abortion, Spontaneous; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Aspirin; Clinical Tri | 2009 |
Aspirin in recurrent miscarriage: is there an indication?
Topics: Abortion, Habitual; Aspirin; Contraindications; Cyclooxygenase Inhibitors; Female; Humans; Pregnancy | 2009 |
Management of antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolyt | 2009 |
[Management of antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Enzyme | 2009 |
Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 2009 |
Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2010 |
Antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Blood Transfus | 2009 |
Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.
Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Anticoagulants; Aspirin; Clopidogrel; Female; Fibrinoly | 2010 |
[Prevention of preeclampsia].
Topics: Adolescent; Adult; Anticoagulants; Antioxidants; Aspirin; Calcium Compounds; Diuretics; Female; Hepa | 2010 |
Management of pericardial diseases during pregnancy.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Colchicine; Contraindications; Cyclooxyg | 2010 |
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fibrinoly | 2010 |
Management of pregnancy after stillbirth.
Topics: alpha-Fetoproteins; Aspirin; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Female; Fetal | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Incidence; Platelet Aggregation | 2010 |
[Progress of integrative medical treatment of recurrent natural abortion induced by immune factor].
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Drug Therapy, Combination; Drugs, Chinese | 2010 |
Utero-placental Doppler ultrasound for improving pregnancy outcome.
Topics: Aspirin; Female; Fibrinolytic Agents; Humans; Placenta; Platelet Aggregation Inhibitors; Pregnancy; | 2010 |
WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy.
Topics: Antipruritics; Aspirin; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Pregnancy; Pregn | 2010 |
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Ma | 2011 |
Lupus and pregnancy: integrating clues from the bench and bedside.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseli | 2011 |
Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Dr | 2011 |
Hemostasis in pre-eclampsia.
Topics: Aspirin; Female; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pregnancy-Induced; | 2011 |
Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths.
Topics: Antihypertensive Agents; Aspirin; Calcium; Dietary Supplements; Eclampsia; Female; Humans; Magnesium | 2011 |
Pregnancy and stroke risk in women.
Topics: Aspirin; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Hypertension, Pregnancy-Induced; Plate | 2011 |
Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis.
Topics: Antioxidants; Ascorbic Acid; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia | 2011 |
Aspirin for in vitro fertilisation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Female; Fertiliz | 2011 |
Moyamoya disease in pregnancy: a case series and review of management options.
Topics: Adult; Aspirin; Cerebral Revascularization; Female; Hawaii; Humans; Infant, Newborn; Moyamoya Diseas | 2011 |
Obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Antibody-Dependent Cell Cytotoxicity; Ant | 2012 |
Randomized controlled trials: part 17 of a series on evaluation of scientific publications.
Topics: Abortion, Spontaneous; Aspirin; Biomarkers; Drug Approval; Drug Therapy, Combination; Female; Fibrin | 2011 |
Obstetric antiphospholipid syndrome: an update on pathophysiology and management.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Hepari | 2011 |
Testing for inherited thrombophilia in recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Preg | 2011 |
[The possible options for the prevention of preeclampsia].
Topics: Anticoagulants; Antioxidants; Aspirin; Calcium; Calcium Compounds; Dietary Supplements; Female; Hepa | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Chi-Square Distribution; Drug Administration Schedule; Evidence-Based Medicine; Female; Ges | 2012 |
Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Severity of Illn | 2012 |
Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotei | 2012 |
Recurrent miscarriage and thrombophilia: an update.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Evidence-Based Medicine; Fem | 2012 |
Ambulatory management of chronic hypertension in pregnancy.
Topics: Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Disease | 2012 |
Preeclampsia 2012.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antioxidants; Aspirin; Biomarkers; Calcium | 2012 |
Preeclampsia 2012.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antioxidants; Aspirin; Biomarkers; Calcium | 2012 |
Preeclampsia 2012.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antioxidants; Aspirin; Biomarkers; Calcium | 2012 |
Preeclampsia 2012.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antioxidants; Aspirin; Biomarkers; Calcium | 2012 |
[Developmental toxicity of the over-the-counter analgetics and antypiretics].
Topics: Adult; Analgesics; Antipyretics; Aspirin; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, N | 2012 |
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature.
Topics: Abortion, Spontaneous; Adult; Aspirin; Embryo Implantation; Female; Fertility Agents; Fertilization | 2012 |
Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.
Topics: Albuminuria; Antihypertensive Agents; Aspirin; Counseling; Diabetes Mellitus, Type 1; Diabetes Melli | 2012 |
Aspirin and Other COX-1 inhibitors.
Topics: Animals; Aspirin; Atherosclerosis; Atrial Fibrillation; Cyclooxygenase 1; Cyclooxygenase Inhibitors; | 2012 |
[Antiphospholipid-syndrome - when to treat?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; As | 2012 |
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.
Topics: Adolescent; Adult; Aspirin; Double-Blind Method; Female; Finland; Humans; Platelet Aggregation Inhib | 2013 |
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.
Topics: Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Perinatal Mortality; Platelet Aggreg | 2013 |
Anticoagulation during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Humans; Practice Guidelines | 2002 |
[Medical treatment for recurrent miscarriages].
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulant | 2002 |
Prevention of thrombosis during pregnancy.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation Tests; B | 2002 |
[Antithrombotic prophylaxis in pregnancy].
Topics: Aspirin; Factor V; Female; Fibrinolytic Agents; Humans; Mutation; Pregnancy; Pregnancy Complications | 2001 |
The public health potential of aspirin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Colonic Neoplasms; Female | 2002 |
[Antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2002 |
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Aspirin; Case-Control Studies; Cohort Studies; Congenital Abnormalities | 2002 |
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Aspirin; Case-Control Studies; Cohort Studies; Congenital Abnormalities | 2002 |
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Aspirin; Case-Control Studies; Cohort Studies; Congenital Abnormalities | 2002 |
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.
Topics: Abnormalities, Drug-Induced; Aspirin; Case-Control Studies; Cohort Studies; Congenital Abnormalities | 2002 |
Current management of hypertensive disease in pregnancy.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Calcium, Dietary; Delivery, Obstetric; Female; Hu | 2002 |
[Anticoagulation and antiaggregation during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abruptio Placentae; Administration, Oral; Adult; | 2003 |
Low molecular weight heparin in immunological recurrent abortion--the incredible cure.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 2003 |
Inherited thrombophilia and gestational vascular complications.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pregnanc | 2003 |
[Traveler's thrombosis].
Topics: Adult; Age Factors; Aged; Aircraft; Anticoagulants; Aspirin; Case-Control Studies; Clinical Trials a | 2003 |
Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review.
Topics: Aspirin; Birth Weight; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Obstetr | 2003 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Annexin A5; Antibodies, Anticardiolipin; Anticoagu | 2003 |
Treatment of pregnancy loss in Hughes syndrome: a critical update.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Heparin; H | 2002 |
Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; | 2003 |
Antibody-mediated thrombosis and pregnancy loss.
Topics: Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination | 2003 |
What we have learned about preeclampsia.
Topics: Aspirin; Female; Gestational Age; Humans; National Institutes of Health (U.S.); Platelet Aggregation | 2003 |
Prophylaxis of the antiphospholipid syndrome: a consensus report.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; P | 2003 |
[Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
Topics: Abortion, Habitual; Adrenal Cortex Hormones; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Hu | 2003 |
[Factor V Leiden mutation and pregnancy complications].
Topics: Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; Factor V; Fem | 2003 |
Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making.
Topics: Aspirin; Decision Making; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2003 |
Essential thrombocythemia.
Topics: Aspirin; Diagnosis, Differential; Female; Humans; Pregnancy; Pregnancy Complications, Hematologic; R | 2003 |
Eicosanoids in preeclampsia.
Topics: Antioxidants; Aspirin; Eicosanoids; Epoprostenol; Female; Humans; Lipid Peroxidation; Oxidative Stre | 2004 |
The safety of antithrombotic therapy during pregnancy.
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Practic | 2004 |
Anti-inflammatory pharmacotherapy during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 2004 |
[Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies].
Topics: Abnormalities, Drug-Induced; Acetaminophen; Acupuncture Points; Acupuncture Therapy; Adult; Analgesi | 2003 |
Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Arteries; Aspirin; Female; Fetal Deat | 2004 |
Pathophysiology of preeclampsia: links with implantation disorders.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Embryo Implantation; Female; Humans; Pre-Eclampsia | 2004 |
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Ev | 2004 |
The management of pregnant patients with antiphospholipid syndrome.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pla | 2004 |
Treatment of antiphospholipid syndrome in pregnancy--a systematic review of randomized therapeutic trials.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; | 2004 |
Immunologic manipulation for the threatened fetus.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; B-Lymphocytes; Complement C1 Inactivator Pro | 2004 |
Pregnancy in essential thrombocythaemia: experience with 40 pregnancies.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Eclampsia; Female; Fetal Death; Finland; Humans; Pla | 2004 |
[Thrombophilias and vascular placental pathology. A survey of the literature].
Topics: Activated Protein C Resistance; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cohort Studies; | 2005 |
[Prevention of preeclampsia].
Topics: Aspirin; Diet, Sodium-Restricted; Female; Fibrinolytic Agents; Humans; Pre-Eclampsia; Pregnancy | 2005 |
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; Fibrin | 2005 |
Anticoagulation therapy in the antiphospholipid syndrome: recent advances.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Kidney Transplantation; Pregnanc | 2005 |
Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple.
Topics: Aneuploidy; Antibodies, Antiphospholipid; Aspirin; Blade Implantation; Embryo Culture Techniques; Em | 2005 |
Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials.
Topics: Aspirin; Drug Administration Schedule; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsi | 2005 |
Obstetrical antiphospholipid syndrome.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Fem | 2006 |
Intrauterine growth restriction.
Topics: Adrenal Cortex Hormones; Amniotic Fluid; Aspirin; Bed Rest; Female; Fetal Development; Fetal Growth | 2006 |
[Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy].
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Disease Progression; Female; Humans; Immunosuppr | 2006 |
Prenatal therapy for fetal growth restriction.
Topics: Adrenergic beta-Agonists; Aspirin; Bed Rest; Calcium Channel Blockers; Calcium, Dietary; Diet, Sodiu | 2006 |
Is there a benefit of low-dose aspirin in assisted reproduction?
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Reproductive Techniques, Assist | 2006 |
Inherited and acquired thrombophilia: pregnancy outcome and treatment.
Topics: Abortion, Spontaneous; Abruptio Placentae; Anticoagulants; Aspirin; Female; Fetal Growth Retardation | 2006 |
Anagrelide: what was new in 2004 and 2005?
Topics: Antineoplastic Agents; Aspirin; Blood Platelets; Clinical Trials, Phase III as Topic; Drug Therapy, | 2006 |
[Primary thrombocythemia: diagnosis and therapy].
Topics: Adult; Aged; Aspirin; Child; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; | 2006 |
Pathophysiology and medical management of systemic hypertension and pre-eclampsia in pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure Determination; Calcium, Dietary; Chronic Dis | 2006 |
Pathophysiology and medical management of systemic hypertension in preeclampsia.
Topics: Adrenergic beta-Antagonists; Aspirin; Calcium; Calcium Channel Blockers; Cerebral Hemorrhage; Female | 2006 |
[Acute poisoning: general management and main causes].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Alcoholic Intoxication; Amphetamines; Analgesics; | 2006 |
What can the clinician do to improve implantation?
Topics: Aromatase Inhibitors; Ascorbic Acid; Aspirin; Embryo Implantation; Embryo Transfer; Enzyme Inhibitor | 2006 |
[Newborn from mother with antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Female; Fet | 2006 |
[Fetus monitoring of a mother suffering from the antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2006 |
The obstetric antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Heparin | 2008 |
[Thromboembolic diseases in pregnancy].
Topics: Algorithms; Anticoagulants; Aspirin; Contraindications; Coumarins; Female; Heparin; Heparin, Low-Mol | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Antiplatelet agents for preventing pre-eclampsia and its complications.
Topics: Aspirin; Female; Fetal Death; Humans; Obstetric Labor, Premature; Platelet Aggregation Inhibitors; P | 2007 |
Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis.
Topics: Aspirin; Female; Fertilization in Vitro; Humans; Pregnancy; Pregnancy Rate; Sperm Injections, Intrac | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
Topics: Aspirin; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors | 2007 |
WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Randomized Contr | 2007 |
Anticoagulation for pregnant patients with mechanical heart valves.
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Drug Administration Schedule; Female; Fetal Diseases | 2007 |
Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies.
Topics: Anticoagulants; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Heparin; Humans; Immunoglobu | 2007 |
[The antiphospholipid syndrome, an update].
Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphosph | 2007 |
[Prophylactic treatment of preeclampsia].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Female; Fibrinolytic Agents; Germany; Heparin; Hu | 2007 |
Low-dose aspirin for in vitro fertilisation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Female; Fertilization i | 2007 |
Non-surgical interventions for threatened and recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Threatened; Antiphospholipid Syndrome; Aspirin; Bed Rest; Chorionic Go | 2007 |
[Latest developments: management and treatment of preeclampsia].
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Aspirin; Calcium; Calcium Channel Blockers; Female | 2008 |
Aspirin and reproductive outcomes.
Topics: Abnormalities, Drug-Induced; Antibodies, Antiphospholipid; Aspirin; Cyclooxygenase Inhibitors; Dose- | 2008 |
Clinical inquiries. Does low-dose aspirin reduce preeclampsia and other maternal-fetal complications?
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pre-Eclampsi | 2008 |
Antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2008 |
[Anesthetic management of parturients with pre-eclampsia and eclampsia].
Topics: Adult; Anesthesia, Obstetrical; Aspirin; Blood Volume; Cesarean Section; Eclampsia; Female; Humans; | 2008 |
Pretreatments before the induction of ovulation in assisted reproduction technologies: evidence-based medicine in 2007.
Topics: Adrenal Cortex Hormones; Aspirin; Contraceptives, Oral; Evidence-Based Medicine; Female; Fertilizati | 2008 |
Pre-pregnancy counselling of patients with vasculitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Contraception; Counseling; Female; | 2008 |
[Risks of simultaneous tocolytic treatment with beta adrenergic and PG inhibiting agents].
Topics: Adrenergic beta-Antagonists; Aspirin; Drug Interactions; Drug Therapy, Combination; Female; Humans; | 1981 |
Maternal medications and breast-feeding.
Topics: Anti-Anxiety Agents; Aspirin; Benzodiazepines; Breast Feeding; Chlorpromazine; Contraceptives, Oral; | 1983 |
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; | 1982 |
Reciprocal relationship between pregnancy and pulmonary disease. State of the art.
Topics: Adrenergic beta-Agonists; Alcohol Drinking; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Infecti | 1984 |
Proliferative diabetic retinopathy and patient age: presentation, prognosis, and management.
Topics: Adolescent; Adult; Age Factors; Anticoagulants; Aspirin; Diabetes Mellitus, Type 1; Diabetic Retinop | 1984 |
Increased platelet destruction.
Topics: Aspirin; beta-Thromboglobulin; Blood Platelets; Bone Marrow; Cell Membrane; Cell Survival; Chromium | 1982 |
[Untoward side effects of acetylsalicylic acid].
Topics: Adolescent; Adult; Angioedema; Aspirin; Asthma; Child; Child, Preschool; Female; Fetus; Gastrointest | 1984 |
Control of vascular responsiveness during human pregnancy.
Topics: 20-alpha-Dihydroprogesterone; Angiotensin II; Aspirin; Blood Vessels; Cyclic AMP; Female; Humans; Hy | 1980 |
Platelets, prostaglandins and thrombotic disorders.
Topics: Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Calcium; Coronary Disease; Cyclic AMP | 1981 |
Review: prostaglandins in diarrheal states.
Topics: Aspirin; Bacterial Infections; Child; Cholera Toxin; Colonic Diseases; Cyclic AMP; Diarrhea; Dinopro | 1981 |
Prostaglandins and anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Central Nervous System Diseases; Cyclic AMP; Drug Hypers | 1983 |
Systemic lupus erythematosus.
Topics: Abnormalities, Drug-Induced; Abortion, Therapeutic; Adrenal Cortex Hormones; Aspirin; Azathioprine; | 1983 |
Analgesics during pregnancy.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Female; Fetal Death; | 1983 |
The electrocardiogram of fetal and newborn rats and dysrhythmias induced by toxic exposure.
Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Aspirin; Dose-Response Relationship, Drug; Electroc | 1983 |
Aspirin and surgery--a review.
Topics: Adult; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Epoprostenol; Ethanol; Female; Hemo | 1984 |
Advances in pediatric pharmacology and toxicology.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Attention Deficit Disorder with Hyperactivity; Biological A | 1983 |
Prostacyclin.
Topics: Adenylyl Cyclases; Adult; Animals; Arteriosclerosis; Aspirin; Blood Platelet Disorders; Blood Platel | 1982 |
Platelet function in diabetes mellitus.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Diabetes Mellitus; D | 1980 |
Preterm parturition. Prostaglandin synthetase inhibitors.
Topics: Amniotic Fluid; Animals; Aspirin; Cyclooxygenase Inhibitors; Ductus Arteriosus; Ductus Arteriosus, P | 1981 |
Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts).
Topics: Anti-Inflammatory Agents; Arthritis; Aspirin; Child; Drug Tolerance; Female; Gastric Mucosa; Gastrit | 1980 |
[Anticoagulants and pregnancy].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coumarins; Disseminated Intravascular Coagulation; Female; | 1981 |
[Pregnancy in essential thrombocythemia. Manifestation time and risk for mother and child].
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Fetal Death; Growth Disorders; Humans; Infant, Newbor | 1995 |
Aspirin for the prevention of pre-eclampsia: where do we stand now?
Topics: Abruptio Placentae; Aspirin; Drug Evaluation; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Tr | 1995 |
Evaluation of the obstetrical risks of the antiphospholipid syndrome and therapeutic management.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Glucocorticoids; Heparin; | 1995 |
Understanding prostaglandin metabolites and platelet-activating factor in the pathophysiology and treatment of the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Humans; Platelet Activating Factor; | 1995 |
[Aspirin and pregnancy: present data and future perspectives].
Topics: Aspirin; Controlled Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Placent | 1995 |
Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.
Topics: Animals; Antiphospholipid Syndrome; Aspirin; Disease Models, Animal; Drug Therapy, Combination; Fema | 1995 |
Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality.
Topics: Abruptio Placentae; Aspirin; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Incidenc | 1995 |
[Therapeutic strategy in asthma: special cases and pseudo-asthma].
Topics: Adrenergic beta-Antagonists; Aspirin; Asthma; Asthma, Exercise-Induced; Cardiovascular System; Femal | 1995 |
Perinatal intracranial hemorrhage due to maternal salicylate ingestion.
Topics: Aspirin; Cerebral Hemorrhage; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; P | 1995 |
Low-dose aspirin therapy in obstetrics.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Randomized Controlled T | 1995 |
Hypertension in pregnancy.
Topics: Antihypertensive Agents; Aspirin; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, | 1995 |
Myocardial infarction in a parturient. A case report with emphasis on medication and management.
Topics: Adult; Aspirin; Atenolol; Delivery, Obstetric; Drug Therapy, Combination; Female; Humans; Myocardial | 1994 |
[Serious forms of arterial pregnancy-related hypertension].
Topics: Aspirin; Diagnosis, Differential; Female; Humans; Infant Mortality; Infant, Newborn; Maternal Mortal | 1994 |
The management of pregnancy in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure; Congenital Abnormalities; Female; Humans; H | 1994 |
Autoimmune disease and pregnancy.
Topics: Aspirin; Autoimmune Diseases; Embryonic and Fetal Development; Female; Heparin; Humans; Maternal-Fet | 1994 |
Is low-dose aspirin effective in preventing hypertension in pregnancy?
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovasc | 1994 |
[Acetylsalicylic acid in pregnancy].
Topics: Aspirin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; E | 1993 |
[Pregnancy nephropathies].
Topics: Adult; Antihypertensive Agents; Aspirin; Epoprostenol; Female; Hemostasis; Humans; Hypertension; Kid | 1993 |
Resolving discrepancies among studies: the influence of dose on effect size.
Topics: Aspirin; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Ethylene Oxide; Female; | 1994 |
Pregnancy-induced hypertensive disorders.
Topics: Antihypertensive Agents; Aspirin; Endothelium, Vascular; Female; Fetal Monitoring; Humans; Pre-Eclam | 1994 |
Drug treatment in pregnancy.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Antiviral Agents; Aspirin; Female; Humans; Magnesium | 1994 |
[Therapeutic management of antiphospholipid antibody syndrome in pregnancy].
Topics: Adrenal Cortex Hormones; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pre | 1993 |
Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes.
Topics: Adult; Aspirin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Humans; Lactation Disorders; | 1994 |
[Advances in the prevention and treatment of pregnancy-induced hypertension].
Topics: Antihypertensive Agents; Aspirin; Female; Humans; Magnesium Sulfate; Pre-Eclampsia; Pregnancy | 1993 |
[Pre-eclampsia. Etiology--physiopathology--treatment].
Topics: Aspirin; Female; Fish Oils; Hemodynamics; Humans; Minerals; Pre-Eclampsia; Pregnancy | 1993 |
[Antiphospholipid syndrome. Proposition for management].
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Immunoglobulins, Intravenous; Mass Scre | 1993 |
Disordered eicosanoid formation in pregnancy-induced hypertension.
Topics: Aspirin; Eicosanoids; Epoprostenol; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications | 1993 |
[Pathogenesis on infertility; its immunological aspects].
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Autoimmune Diseases; Cytokines; Female | 1993 |
Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials.
Topics: Angiotensin II; Aspirin; Clinical Trials as Topic; Epoprostenol; Female; Fetal Growth Retardation; H | 1993 |
[Does a preventive treatment of pregnancy toxemia exist: the role of aspirin].
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Risk Factors | 1993 |
Current status of immunologic recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antilymphocyte Serum; Aspirin; Autoimmune Diseases | 1993 |
Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Combined Modality Therapy; Diagnostic Errors; Dipyridamole; | 1996 |
-Is prevention of pre-eclampsia with low dosage aspirin possible? Critical assessment of available studies-.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Platelet Aggregation Inh | 1996 |
Treatment of essential thrombocythemia during pregnancy with interferon-alpha.
Topics: Adult; Aspirin; Female; Humans; Infant, Newborn; Interferon-alpha; Male; Platelet Aggregation Inhibi | 1996 |
[Can nitrogen monoxide replace aspirin in the prevention of preeclampsia?].
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Humans; Nitric Oxide; Pre-Eclampsia; Pregnancy | 1996 |
Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives.
Topics: Antibodies, Anticardiolipin; Aspirin; Endothelium, Vascular; Female; Fibrinolytic Agents; Homocystei | 1996 |
[Uterine velocimetry and vascular pregnancy pathologies prevented with low-dose aspirin].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Incidence; Odds Ratio; Patient Selection; Platele | 1996 |
The pharmacological prevention of pre-eclampsia.
Topics: Aspirin; Epoprostenol; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Ra | 1995 |
Prevention of fetal death in the antiphospholipid antibody syndrome.
Topics: Adrenal Cortex Hormones; Animals; Antiphospholipid Syndrome; Aspirin; Female; Fetal Death; Heparin; | 1996 |
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Di | 1996 |
Essential thrombocythemia during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Platelet Aggregation Inhibito | 1997 |
A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fetal Growth Retardation; Humans; Infant M | 1997 |
Benefits of low-dose corticosteroids in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Hypertension in pregnancy.
Topics: Adult; Animals; Antihypertensive Agents; Aspirin; Disease Models, Animal; Eclampsia; Endothelium, Va | 1997 |
Aspirin in essential thrombocythemia: status quo and quo vadis.
Topics: Abortion, Habitual; Aspirin; Cerebrovascular Disorders; Cohort Studies; Contraindications; Erythrome | 1997 |
Therapy for intrauterine growth restriction: current options and future directions.
Topics: Adrenergic beta-Agonists; Aspirin; Atrial Natriuretic Factor; Bed Rest; Cyclooxygenase Inhibitors; D | 1997 |
[Late pregnancy toxicosis developing against a background of extragenital pathology and its prevention (a review)].
Topics: Adult; Aspirin; Female; Humans; Hypertension; Obesity; Pre-Eclampsia; Pregnancy; Risk Factors; Weigh | 1997 |
[Intra-uterine fetal death syndrome--not only a gynecologic problem].
Topics: Adrenocorticotropic Hormone; Aspirin; Blood Coagulation Disorders; Female; Fetal Death; Heparin; Hum | 1997 |
ACOG educational bulletin. Antiphospholipid syndrome. Number 244, February 1998. American College of Obstetricians and Gynecologists.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; H | 1998 |
The antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Huma | 1998 |
Treatment of the antiphospholipid syndrome in pregnancy.
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagula | 1998 |
Prevention of thromboembolism in pregnancy.
Topics: Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibit | 1998 |
Antiphospholipid antibodies and infertility: fact or fallacy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antip | 1998 |
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1998 |
Use of antithrombotic agents during pregnancy.
Topics: Administration, Oral; Antibodies, Antiphospholipid; Aspirin; Female; Fetus; Fibrinolytic Agents; Hea | 1998 |
Prevention of preeclampsia: a big disappointment.
Topics: Antihypertensive Agents; Aspirin; Cyclooxygenase Inhibitors; Dietary Supplements; Female; Humans; Pr | 1998 |
[Current obstetrical management of antiphospholipid antibody syndrome: review of the literature apropos of 20 cases].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 1998 |
Migraine in pregnancy: what are the safest treatment options?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Female; Humans; Migraine Disorders; Pregnancy; Pre | 1998 |
Antiphospholipid syndrome and pregnancy loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 1998 |
Low-dose aspirin therapy in the treatment of preeclampsia.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Humans; Nurse Practitioners; Pre-Eclampsia; Pregnancy; R | 1999 |
Pre-eclampsia/eclampsia: a literature review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Eclampsia; Female; Humans; Magnes | 1998 |
Counseling for women with preeclampsia or eclampsia.
Topics: Aspirin; Calcium; Chronic Disease; Counseling; Eclampsia; Female; HELLP Syndrome; Humans; Hypertensi | 1999 |
Prevention of preeclampsia: is it possible?
Topics: Aspirin; Cyclooxygenase Inhibitors; Dietary Supplements; Female; Humans; Mass Screening; Pre-Eclamps | 1999 |
Chronic hypertension in pregnancy.
Topics: Abruptio Placentae; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin | 1999 |
[A management program for primary thrombocytopenia].
Topics: Adult; Aged; Anticoagulants; Aspirin; Female; Guidelines as Topic; Humans; Hydroxyurea; Interferon T | 1999 |
[Phospholipid antigens, thrombosis and repeated fetal death].
Topics: Abortion, Habitual; Adult; Antigens; Aspirin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; | 1996 |
[Pharmacological prevention of gestation complications].
Topics: Aspirin; Calcium, Dietary; Fatty Acids, Unsaturated; Female; Humans; Hypertension; Placental Insuffi | 1999 |
[Risk factors in pre-eclampsia].
Topics: Aspirin; Evidence-Based Medicine; Female; Fibrinolytic Agents; Humans; Pre-Eclampsia; Pregnancy; Ris | 1999 |
Fertility, pregnancy and the management of myeloproliferative disorders.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Alkylating Agents; Animals; Aspirin; Bone Marrow | 1998 |
[Effect of pregnancy, menopause and hormone substitution therapy on disseminated systemic lupus erythematosus].
Topics: Aspirin; Estrogen Replacement Therapy; Female; Heparin; Humans; Lupus Erythematosus, Systemic; Ovula | 2000 |
[Aspirin throughout the ages: a historical review].
Topics: Adult; Analgesia, Obstetrical; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Cyclooxygena | 2000 |
[Pharmacology of aspirin].
Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Br | 2000 |
[Aspirin and prevention of pre-eclampsia].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Controlled Clinical Trials | 2000 |
[Aspirin and antiphospholipid syndrome].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndrome; Arteriosc | 2000 |
Antihistamines versus aspirin for itching in late pregnancy.
Topics: Antipruritics; Aspirin; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Pregnancy; Pregn | 2000 |
Antiplatelet agents for preventing and treating pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Randomized Contr | 2000 |
[Antiphospholipid antibody syndrome in adverse pregnancy].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; A | 2000 |
Intravenous immunoglobulin therapy of antiphospholipid syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antiph | 2000 |
[Diagnosis and management for antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2000 |
[Aspirin: a return to the source rather than a big disappointment].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications | 2000 |
[Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Femal | 2000 |
Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Topics: Aspirin; Female; Humans; MEDLINE; Placebos; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Risk | 2000 |
Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Blood Platelet Disorders; Coagulation | 2000 |
Prevention of pre-eclampsia: status and perspectives 2000.
Topics: Antioxidants; Aspirin; Calcium; Diet; Female; Humans; Life Style; Pre-Eclampsia; Pregnancy | 2001 |
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Female; Fibrinolytic Agents; Humans; Platelet Aggr | 2001 |
Use of antithrombotic agents during pregnancy.
Topics: Aspirin; Female; Fetus; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregn | 2001 |
Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review.
Topics: Aspirin; Female; Fetal Death; Humans; Infant, Newborn; Obstetric Labor, Premature; Platelet Aggregat | 2001 |
Antiphospholipid syndrome and recurrent miscarriages.
Topics: Abortion, Habitual; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Antibodies, Antiphospholip | 2001 |
Management of patients with essential thrombocythemia: current concepts and perspectives.
Topics: Adult; Aged; Aspirin; Case Management; Clinical Trials as Topic; Diagnosis, Differential; Disease Pr | 2001 |
Current treatment of cutaneous lupus erythematosus.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Antimalarials; Aspirin; Diagnosis, Differen | 2001 |
A single institutional experience with 43 pregnancies in essential thrombocythemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulf | 2001 |
Update on the management of the pregnant patient with antiphospholipid antibody.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complicatio | 2001 |
A literature review on the antiphospholipid syndrome and the effect on childbearing.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Embolism; Female; Fetal Death; Fetal Diseases; F | 2001 |
[Prevention of preeclampsia with low-dose acetyl salicylic acid: critical assessment].
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Humans; Pre-Eclampsia; Pregnancy | 1999 |
Genetic and pharmacological analysis of prostanoid receptor function.
Topics: Animals; Aspirin; Biological Transport; Bone Resorption; Cell Nucleus; Colonic Neoplasms; Cyclooxyge | 2001 |
The epidemiology of the antiphospholipid syndrome: who is at risk?
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antibodies, Anticardiolipin; Antibodies, Antiphosphol | 2001 |
Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Ultrasonography, | 2001 |
[Prenatal effects of acetylsalicylic acid].
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Huma | 2001 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2002 |
Do acetylsalicylic acid and other antiplatelet drugs prevent preeclampsia?
Topics: Aspirin; Autoimmune Diseases; Clinical Trials as Topic; Diabetes Complications; Dose-Response Relati | 2001 |
Hypertensive diseases and eclampsia.
Topics: Antihypertensive Agents; Antioxidants; Aspirin; Eclampsia; Endothelial Growth Factors; Endothelium, | 2002 |
Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literature.
Topics: Adult; Aspirin; Disease Management; Female; Heparin; Humans; Practice Guidelines as Topic; Pregnancy | 2002 |
Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.
Topics: Abortion, Spontaneous; Aspirin; Blood Component Removal; Female; Fetal Death; Gestational Age; Human | 2002 |
Treatment of the antiphospholipid syndrome.
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Humans; Nerv | 2002 |
Current understanding of pre-eclampsia.
Topics: Anticoagulants; Aspirin; Biomarkers; Delivery, Obstetric; Disease Progression; Female; Humans; Mass | 2002 |
Autoimmune factors in assisted reproduction.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Ant | 2002 |
Antiinflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents; Apazone; Arthritis, Rheumatoid; Aspirin; Benzylidene Compounds; Chi | 1977 |
[Inhibition of blood platelet function].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antimalarials; Aspirin; Chloroquine; Dipy | 1979 |
Vascular reactivity to angiotensin II in human pregnancy.
Topics: Adolescent; Angiotensin II; Animals; Aspirin; Blood Pressure; Blood Volume; Dogs; Female; Haplorhini | 1978 |
Systemic lupus erythematosus and pregnancy.
Topics: Antimalarials; Aspirin; Autoantibodies; B-Lymphocytes; Complement System Proteins; Female; Glucocort | 1978 |
[Clinical pharmacology in obstetrics: regulation of the uterus].
Topics: Adrenergic beta-Agonists; Aspirin; Ergotamine; Female; Humans; Indomethacin; Methylergonovine; Obste | 1975 |
Hemostatic failure in clinical medicine.
Topics: Acute Disease; Amyloidosis; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Vessels; Chroni | 1977 |
Zinc and parturition.
Topics: Animals; Aspirin; Blood Pressure; Body Temperature; Female; Labor, Obstetric; Maternal Behavior; Pre | 1977 |
On the use of blockers of prostaglandin synthesis in the control of labor.
Topics: Animals; Aspirin; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Indome | 1978 |
Aspirin in pregnancy: maternal and fetal effects.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Birth Weight; Cleft Lip; Cleft Palate; Female; Fetal | 1978 |
[Clinical pharmacology of acetylsalicylic acid].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Asthma; Female; Humans; Hydrolysis; Intestinal Absorp | 1979 |
[Acetylsalicyl acid (ASA) and prostaglandins].
Topics: Arthritis, Rheumatoid; Aspirin; Asthma; Chemical Phenomena; Chemistry; Collagen; Drug Interactions; | 1977 |
Inhibition of uterine motility: the possible role of the prostaglandins and aspirin-like drugs.
Topics: Abortion, Induced; Abortion, Spontaneous; Animals; Aspirin; Depression, Chemical; Dogs; Endotoxins; | 1975 |
[Fetal growth retardation: prevention. Review of the literature].
Topics: Adrenergic beta-Agonists; Aspirin; Evaluation Studies as Topic; Female; Fetal Growth Retardation; ga | 1992 |
[Pregnancy in patients with essential thrombocythemia. Three cases].
Topics: Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Platelet Count; Postpartum Period; Pr | 1992 |
[Prediction and prevention of pre-eclampsia. Importance of new epidemiological methods].
Topics: Aspirin; Case-Control Studies; Cohort Studies; Epidemiologic Methods; Female; Humans; Incidence; Met | 1992 |
Use of antithrombotic agents during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Fetal Diseases; Hemorrhage; Humans; Oste | 1992 |
Drug supplementation in pregnancy.
Topics: Aspirin; Cations, Divalent; Female; Humans; Iron; Pregnancy; Prenatal Care; Vitamins | 1992 |
Principles and applications of manipulation of prostaglandin synthesis in pregnancy.
Topics: Aspirin; Diet; Dietary Fats; Epoprostenol; Fatty Acids, Unsaturated; Female; Humans; Indomethacin; P | 1992 |
Aspirin is good for you.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Humans; Musculoskeletal Disease | 1992 |
[Aspirin as a cyclooxygenase inhibitor in various complications of the gestational period].
Topics: Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Female; Fetal Gr | 1992 |
[Role of antiphospholipid antibodies in fetal loss].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Antibodies, Anticardiolipin; Antibodies, Antiphospho | 1992 |
Treatment of preeclampsia and eclampsia.
Topics: Antihypertensive Agents; Aspirin; Diazepam; Eclampsia; Female; Humans; Magnesium Sulfate; Phenytoin; | 1992 |
[Preventive low dosage treatment and pre-eclampsia].
Topics: Aspirin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Pre-Eclampsia; | 1992 |
An aspirin a day to prevent prematurity.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Health Status Indicators; Humans; Obstetric | 1992 |
Prenatal care, screening, and complications.
Topics: alpha-Fetoproteins; Aspirin; Blood Transfusion, Autologous; Female; Humans; Mass Screening; Neural T | 1991 |
[Is prevention of pre-eclampsia possible?].
Topics: Antihypertensive Agents; Aspirin; Diuretics; Eclampsia; Female; Fetal Growth Retardation; Humans; Hy | 1991 |
New concepts in the understanding of hypertensive diseases during pregnancy. An overview.
Topics: Aspirin; Bed Rest; Blood Pressure Determination; Calcium, Dietary; Causality; Clinical Trials as Top | 1991 |
Prevention of preeclampsia.
Topics: Aspirin; Calcium, Dietary; Female; Hemodynamics; Humans; Nutritional Physiological Phenomena; Pre-Ec | 1991 |
[Etiology and early detection of pregnancy-induced hypertension, possibilities for pharmacologic modification of disordered prostaglandin balance].
Topics: Aspirin; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Prostag | 1991 |
[Pathophysiology and prevention of pre-eclampsia].
Topics: Aspirin; Blood Coagulation Factors; Endothelium, Vascular; Epoprostenol; Female; Fetal Hypoxia; Huma | 1991 |
Recent developments in pregnancy-induced hypertension.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Diagnosis, Differential; Female; Humans; Hyperten | 1991 |
A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease.
Topics: Aspirin; Cesarean Section; Clinical Trials as Topic; Female; Humans; Hypertension; Infant, Low Birth | 1991 |
Low-dose aspirin to prevent pregnancy-induced hypertensive disease.
Topics: Aspirin; Female; Humans; Hypertension; Meta-Analysis as Topic; Pregnancy; Pregnancy Complications, C | 1991 |
Low-dose aspirin to improve perinatal outcome.
Topics: Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Female; Fetal Growth Retardation; Fetu | 1991 |
Pregnancy-induced hypertension: pathogenesis and management.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1991 |
Diagnosis and management of chronic hypertension in pregnancy.
Topics: Abruptio Placentae; Antihypertensive Agents; Aspirin; Blood Pressure Determination; Female; Humans; | 1991 |
Drug therapy during pregnancy.
Topics: Anticonvulsants; Aspirin; Female; Fetus; Heparin; Humans; Osteoporosis; Pregnancy; Tocolytic Agents | 1991 |
Antiphospholipid syndrome: laboratory concerns, fetal loss, and pregnancy management.
Topics: Adrenal Cortex Hormones; Aspirin; Autoimmune Diseases; Female; Fetal Death; Heparin; Humans; Phospho | 1991 |
[Acetylsalicylic acid and pregnancy hypertension].
Topics: Aspirin; Epoprostenol; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complicatio | 1991 |
Arachidonic acid metabolism in the pathophysiology and prevention of preeclampsia--a review.
Topics: Arachidonic Acid; Aspirin; Female; Fish Oils; Humans; Pre-Eclampsia; Pregnancy; Risk | 1991 |
Primary thrombocythaemia in pregnancy.
Topics: Abortion, Incomplete; Adult; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Hematologi | 1991 |
Recurrent adverse pregnancy outcome and antiphospholipid antibodies.
Topics: Adrenal Cortex Hormones; Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Female; Human | 1990 |
Physiology of low-dose aspirin therapy for the prevention of preeclampsia.
Topics: Aspirin; Female; Fetus; Humans; Pre-Eclampsia; Pregnancy; Prostaglandins; Thromboxanes | 1990 |
Prevention of preeclampsia by low dose aspirin.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1990 |
Platelet anti-aggregatory therapy in pregnancy: another role for low dose aspirin?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 1990 |
Acetylsalicylic acid and the balance between prostacyclin and thromboxane A2.
Topics: Arteriosclerosis; Aspirin; Clinical Trials as Topic; Drug Administration Schedule; Epoprostenol; Fem | 1990 |
The risks and benefits of taking aspirin during pregnancy.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Fetus; Hemorrhage; Humans; Infant, Newborn; P | 1990 |
Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
Topics: Aspirin; Clinical Trials as Topic; Epoprostenol; Female; Humans; Maternal-Fetal Exchange; Pre-Eclamp | 1989 |
[Acetylsalicylic acid in the treatment of arterial thromboembolytic diseases. 2. Clinical documentation].
Topics: Aspirin; Cardiac Surgical Procedures; Diabetic Angiopathies; Female; Glomerulonephritis, Membranopro | 1989 |
Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?
Topics: Aspirin; Blood Platelets; Blood Vessels; Chemistry, Pharmaceutical; Clinical Trials as Topic; Cycloo | 1986 |
[Drug prescriptions in pregnancy. Current status].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; R | 1988 |
Low-dose aspirin in prevention of toxaemia of pregnancy. Does it have a place?
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1987 |
Alcohol, pregnancy, and prostaglandins.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Brain; Chick Embryo; Cricetinae; Dinoprost; Embryonic | 1987 |
Consequences associated with nonnarcotic analgesics in the fetus and newborn.
Topics: Acetaminophen; Adolescent; Adult; Animals; Aspirin; Blood Pressure; Cardiac Output; Child; Child, Pr | 1985 |
Consequences associated with nonnarcotic analgesics in the fetus and newborn.
Topics: Acetaminophen; Adolescent; Adult; Animals; Aspirin; Blood Pressure; Cardiac Output; Child; Child, Pr | 1985 |
Consequences associated with nonnarcotic analgesics in the fetus and newborn.
Topics: Acetaminophen; Adolescent; Adult; Animals; Aspirin; Blood Pressure; Cardiac Output; Child; Child, Pr | 1985 |
Consequences associated with nonnarcotic analgesics in the fetus and newborn.
Topics: Acetaminophen; Adolescent; Adult; Animals; Aspirin; Blood Pressure; Cardiac Output; Child; Child, Pr | 1985 |
Diagnosis and management of thromboembolic disease during pregnancy.
Topics: Acute Disease; Aspirin; Bacterial Infections; Female; Heparin; Humans; Ovary; Phlebography; Plethysm | 1985 |
Antipyretics and analgesics in children.
Topics: Acetaminophen; Acid-Base Equilibrium; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child | 1985 |
Vitamin C and chiropractic.
Topics: Age Factors; Alcoholism; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ascorbic Acid; As | 1985 |
Antirheumatic medication during lactation.
Topics: Anti-Inflammatory Agents; Aspirin; Breast Feeding; Diclofenac; Female; Half-Life; Humans; Indoleacet | 1985 |
Current trends in the research on antiinflammatory agents.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzydam | 1985 |
Lupus anticoagulant and pregnancy.
Topics: Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Fetal Death; Fetal Diseases; Fetal Growt | 1985 |
Control of uterine activity and prevention of premature birth.
Topics: Adrenergic beta-Antagonists; Aspirin; Blood Pressure; Diazoxide; Epinephrine; Ethanol; Female; Fetal | 1974 |
[Prostaglandins, a review (author's transl)].
Topics: Abortion, Induced; Animals; Arachidonic Acids; Aspirin; Blood Pressure; Corpus Luteum; Depression, C | 1973 |
[New pathogenetic aspects of platelet pathology in childhood].
Topics: Aspirin; Autoantibodies; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Female; Human | 1972 |
Modern views on pharmacology. X. Angiotensin, kinins and prostaglandins.
Topics: Angiotensin II; Animals; Aspirin; Cardiovascular System; Female; Humans; Kinins; Male; Muscle, Smoot | 1971 |
The prostaglandins: their significance in clinical practice.
Topics: Abortion, Induced; Anemia, Hemolytic; Animals; Aspirin; Asthma; Chemical Phenomena; Chemistry; Cycli | 1974 |
Adverse hematologic effects of drugs.
Topics: Anemia, Hemolytic; Anemia, Macrocytic; Anti-Bacterial Agents; Anticonvulsants; Antidepressive Agents | 1972 |
Present status of drugs as teratogens in man.
Topics: Abnormalities, Drug-Induced; Alkylating Agents; Anti-Bacterial Agents; Anticonvulsants; Antiemetics; | 1973 |
Prostaglandins in the control of ovulation, corpus luteum function, and parturition.
Topics: Animals; Aspirin; Corpus Luteum; Cricetinae; Estrogens; Female; Haplorhini; Humans; Hysterectomy; In | 1973 |
Effect of prenatal drugs on the behavior of the neonate.
Topics: Aspirin; Barbiturates; Behavior; Body Weight; Depression, Chemical; Diet; Female; Fetus; Genotype; G | 1970 |
Propoxyphene hydrochloride. A critical review.
Topics: Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Dextropropoxyphene; Female; Headac | 1970 |
[Present position of the toxicology of drugs].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Amantadine; Aminopterin; Animals; Animals, Newbo | 1970 |
Salicylate metabolism in man.
Topics: Acylation; Adolescent; Aminopyrine; Animals; Antipyrine; Aspirin; Biotransformation; Brain; Dogs; Ep | 1971 |
350 trials available for aspirin and Pregnancy
| Article | Year |
|---|---|
Predictors of Plasmodium falciparum Infection in the First Trimester Among Nulliparous Women From Kenya, Zambia, and the Democratic Republic of the Congo.
Topics: Aspirin; Democratic Republic of the Congo; Female; Humans; Kenya; Malaria; Malaria, Falciparum; Plas | 2022 |
Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial.
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Netherlands; | 2022 |
Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortion, Spontaneous; Adult; Aspirin; Double-Blind Method; Female; Humans; Machine Learning; Male; | 2022 |
The efficacy of low-dose aspirin in pregnancy among women in malaria-endemic countries.
Topics: Aspirin; Female; Humans; Infant, Newborn; Malaria; Perinatal Death; Perinatal Mortality; Pregnancy; | 2022 |
The effect of 150 and 80 mg doses of aspirin on preventing preterm birth in high-risk pregnant women.
Topics: Aspirin; Female; Humans; Infant, Newborn; Iran; Placenta; Pre-Eclampsia; Pregnancy; Pregnant Women; | 2022 |
Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population.
Topics: Algorithms; Aspirin; Brazil; Female; Humans; Perinatology; Pre-Eclampsia; Pregnancy; Pregnancy Trime | 2023 |
Long-term outcomes following antenatal exposure to low-dose aspirin: study protocol for the 4-year follow-up of the APRIL randomised controlled trial.
Topics: Aspirin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pre | 2022 |
Effect of Acetylsalicylic Acid on Uterine Blood Flow, Gestation Length, Foal Birth Weight and Placental Weight in Pregnant Thoroughbred Mares - A Clinical Pilot Study.
Topics: Animals; Aspirin; Birth Weight; Female; Horses; Parturition; Pilot Projects; Placenta; Placental Cir | 2022 |
Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial.
Topics: Aspirin; Birth Weight; Female; Humans; Infant, Newborn; Male; Pre-Eclampsia; Pregnancy; Pregnancy Tr | 2022 |
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial.
Topics: Adult; Aspirin; Biomarkers; Female; Hemorrhage; Humans; Infant, Newborn; Peripartum Period; Placenta | 2023 |
Birth weight and gestational age distributions in a rural Kenyan population.
Topics: Age Distribution; Aspirin; Birth Weight; Female; Gestational Age; Humans; Infant; Infant, Newborn; I | 2023 |
Low-dose aspirin in the prevention of pre-eclampsia in China: postpartum hemorrhage in subgroups of women according to their characteristics and potential bleeding risk.
Topics: Adult; Aspirin; Female; Humans; Incidence; Maternal Age; Postpartum Hemorrhage; Pre-Eclampsia; Pregn | 2023 |
Labetalol, Low-dose Aspirin, and Vitamin E and Calcium for Gestational Hypertension and Influence on MicroRNA-126 and PLGF Levels.
Topics: Aspirin; Calcium; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; MicroRNA | 2023 |
ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy.
Topics: Arterial Pressure; Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre | 2023 |
Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation.
Topics: Aspirin; Female; Folic Acid; Humans; Hypertension; Infant, Newborn; Obesity; Pre-Eclampsia; Pregnanc | 2023 |
Aspirin delays the onset of hypertensive disorders of pregnancy among nulliparous pregnant women: A secondary analysis of the ASPIRIN trial.
Topics: Aspirin; Child; Child Health; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Indu | 2023 |
The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Male; Perinatal Death; Pr | 2023 |
Evaluation of the Effect of Low-dose Aspirin on the Prevention of Preterm Delivery in Women with a History of Spontaneous Preterm Delivery.
Topics: Aspirin; Female; Gestational Age; Humans; Incidence; Infant, Newborn; Pre-Eclampsia; Pregnancy; Prem | 2023 |
Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fi | 2019 |
Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Administration Schedule; Drug Therapy, Comb | 2020 |
Urinary Placental Growth Factor for Prediction of Placental Adverse Outcomes in High-Risk Pregnancies.
Topics: Adult; Aspirin; Biomarkers; Female; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Placenta | 2019 |
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Delivery, Obstetric; Developing Countries; Double-Blind | 2020 |
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Delivery, Obstetric; Developing Countries; Double-Blind | 2020 |
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Delivery, Obstetric; Developing Countries; Double-Blind | 2020 |
Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Delivery, Obstetric; Developing Countries; Double-Blind | 2020 |
Physical activity and incidence of subclinical and clinical pregnancy loss: a secondary analysis in the effects of aspirin in gestation and reproduction randomized trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Asymptomatic Diseases; Cohort Studies; Exercise; | 2020 |
Effects of low-dose aspirin on the prevention of preeclampsia and pregnancy outcomes: A randomized controlled trial from Shanghai, China.
Topics: Adult; Aspirin; China; Dose-Response Relationship, Drug; Female; Humans; Incidence; Platelet Aggrega | 2020 |
Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels: a longitudinal study and meta-analysis.
Topics: Adult; Aspirin; C-Reactive Protein; CpG Islands; DNA Methylation; Epigenesis, Genetic; Female; Fetal | 2020 |
Effect of flunixin meglumine and aspirin administration on conception rate and estrous cycle characteristics of Egyptian Baladi cows during hot season.
Topics: Animals; Aspirin; Cattle; Clonixin; Egypt; Estrous Cycle; Female; Pregnancy; Progesterone; Seasons | 2020 |
Preconception Blood Pressure and Its Change Into Early Pregnancy: Early Risk Factors for Preeclampsia and Gestational Hypertension.
Topics: Adult; Aspirin; Blood Pressure Determination; Drug Monitoring; Early Diagnosis; Female; Humans; Hype | 2020 |
The effect of aspirin on preeclampsia, intrauterine growth restriction and preterm delivery among healthy pregnancies with a history of preeclampsia.
Topics: Adult; Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Pregnancy-Associ | 2020 |
A Pilot Randomized Trial Comparing the Effects of 80 versus 160 mg of Aspirin on Midtrimester Uterine Artery Pulsatility Index in Women with a History of Preeclampsia.
Topics: Aspirin; Canada; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Infant, | 2020 |
Administration of acetylsalicylic acid after parturition in lactating dairy cows under certified organic management: Part I. Milk yield, milk components, activity patterns, fertility, and health.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Behavior, Animal; Cattle; Cattle Diseases | 2020 |
Administration of acetylsalicylic acid after parturition in lactating dairy cows under certified organic management: Part II. Biomarkers of nociception, inflammation, and stress.
Topics: Animals; Aspirin; Biomarkers; Cattle; Cattle Diseases; Dystocia; Female; Haptoglobins; Hydrocortison | 2020 |
Design of the Pregnancy REmote MOnitoring II study (PREMOM II): a multicenter, randomized controlled trial of remote monitoring for gestational hypertensive disorders.
Topics: Adult; Aspirin; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Hypertension, Pregnancy-In | 2020 |
The Safety of Low-Dose Aspirin on the Mode of Delivery: Secondary Analysis of the Effect of Aspirin in Gestation and Reproduction Randomized Controlled Trial.
Topics: Aspirin; Cesarean Section; Delivery, Obstetric; Female; Humans; Live Birth; Pregnancy; Pregnancy Out | 2022 |
Assessing measures of aspirin adherence in pregnancy: Secondary analysis of the TEST randomized controlled trial.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2021 |
Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.
Topics: Aspirin; Ethnicity; Female; Humans; Infant, Newborn; Placenta; Pre-Eclampsia; Pregnancy; Premature B | 2020 |
Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension.
Topics: Aspirin; China; Female; Humans; Hypertension; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnant Wo | 2021 |
The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth : Per Protocol Analysis of a Randomized Trial.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Gonadotrop | 2021 |
Low-dose acetylsalicylic acid does not modify maternal vascular reactivity in nulliparas.
Topics: Aspirin; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Female; Humans; Pregnancy; Vas | 2022 |
Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
Topics: Abortion, Habitual; Adult; Aspirin; Biomarkers; Female; Heparin, Low-Molecular-Weight; Humans; Immun | 2021 |
Aspirin Responsiveness at a Dose of 80 mg and Its Impact on Birth Weight when Used in Twin Pregnancies: The GAP Pilot Randomized Trial.
Topics: Aspirin; Birth Weight; Female; Humans; Infant, Newborn; Pilot Projects; Platelet Aggregation Inhibit | 2022 |
Effect of L-arginine supplementation in pregnant women with chronic hypertension and previous placenta vascular disorders receiving Aspirin prophylaxis: a randomized control trial.
Topics: Arginine; Aspirin; Child; Dietary Supplements; Female; Humans; Hypertension; Infant; Infant, Newborn | 2021 |
ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Topics: Adult; Algorithms; Arterial Pressure; Aspirin; Biomarkers; Blood Pressure; Female; Gestational Age; | 2021 |
Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Blood Pressure; Do | 2020 |
A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China.
Topics: Adult; Aspirin; China; Female; Humans; Incidence; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pr | 2022 |
Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol).
Topics: Anemia, Sickle Cell; Aspirin; Female; Fetal Growth Retardation; Humans; Nigeria; Placenta; Pre-Eclam | 2021 |
Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Rate; C-Reacti | 2017 |
Effect of Low-Dose Aspirin on the Time of Onset of Preeclampsia and Time of Delivery.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Logistic Models; Multivariate Analysis; Pre-Eclamps | 2017 |
A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Developing Countries; Double-Bl | 2017 |
A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Developing Countries; Double-Bl | 2017 |
A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Developing Countries; Double-Bl | 2017 |
A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Developing Countries; Double-Bl | 2017 |
Impact of aspirin on fetal growth in diabetic pregnancies according to White classification.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Development; Fetal Macrosomia; Humans; Infant, Newborn; | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Intention to Treat | 2017 |
The effect of low-dose aspirin on fetal weight of idiopathic asymmetrically intrauterine growth restricted fetuses with abnormal umbilical artery Doppler indices: a randomized clinical trial.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibit | 2018 |
Low dose aspirin in the prevention of recurrent spontaneous preterm labour - the APRIL study: a multicenter randomized placebo controlled trial.
Topics: Adolescent; Adult; Aspirin; Cost-Benefit Analysis; Double-Blind Method; Female; Gestational Age; Hum | 2017 |
ASPRE trial: performance of screening for preterm pre-eclampsia.
Topics: Adult; Algorithms; Aspirin; Biomarkers; Double-Blind Method; Female; Humans; Mass Screening; Placent | 2017 |
Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
Topics: Adult; Aspirin; Drug Administration Schedule; Female; Humans; Maternal Serum Screening Tests; Placen | 2019 |
Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combina | 2017 |
Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis.
Topics: Adult; Angiogenesis Inducing Agents; Aspirin; Early Diagnosis; Female; France; Gestational Age; Hepa | 2018 |
Low dose aspirin for preventing fetal growth restriction: a randomised trial.
Topics: Adult; Aspirin; Birth Weight; Drug Administration Schedule; Female; Fetal Growth Retardation; Gestat | 2018 |
Transdermal estrogen gel and oral aspirin combination therapy improves fertility prognosis via the promotion of endometrial receptivity in moderate to severe intrauterine adhesion.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aspirin; Drug Therapy, Combination; Endometr | 2018 |
Preconception Blood Pressure Levels and Reproductive Outcomes in a Prospective Cohort of Women Attempting Pregnancy.
Topics: Abortion, Spontaneous; Adult; Aspirin; Blood Pressure; Blood Pressure Determination; Cohort Studies; | 2018 |
Aspirin Effect on Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a High-Risk Cohort.
Topics: Adult; Aspirin; Blood Pressure; Body Mass Index; Cyclooxygenase Inhibitors; Dose-Response Relationsh | 2018 |
Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women.
Topics: Administration, Oral; Adolescent; Aspirin; Female; Gestational Age; Humans; Parity; Platelet Aggrega | 2018 |
Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial.
Topics: Abortion, Habitual; Adult; Aspirin; Double-Blind Method; Drug Administration Schedule; Female; Follo | 2018 |
Topics: Adult; Aspirin; Chemoprevention; Feasibility Studies; Female; Gestational Age; Humans; Ireland; Medi | 2018 |
The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort.
Topics: Administration, Oral; Adult; Aspirin; Cohort Studies; Female; Finland; Gestational Age; Humans; Long | 2018 |
Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cryopreservation; Double-Blind Method; Embryo Implantation; E | 2019 |
Maternal Outcomes Associated With Lower Range Stage 1 Hypertension.
Topics: Adolescent; Adult; Aspirin; Female; Fibrinolytic Agents; Humans; Infant, Newborn; Pregnancy; Pregnan | 2018 |
The Impact of Aspirin on Ultrasound Markers of Uteroplacental Flow in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT.
Topics: Aspirin; Female; Humans; Placenta; Placental Circulation; Pre-Eclampsia; Pregnancy; Pregnancy Trimes | 2019 |
Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial.
Topics: Adult; Aspirin; Data Collection; Data Interpretation, Statistical; Female; Humans; Middle Aged; Mult | 2018 |
Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT.
Topics: Adult; Albuminuria; Aspirin; Biomarkers; Creatinine; Female; Fetal Development; Humans; Placenta; Pl | 2019 |
Aspirin delays the development of preeclampsia.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pre | 2019 |
A new look at low-dose aspirin: Co-administration with tamoxifen in ovulation induction in anovulatory PCOS women.
Topics: Adult; Anovulation; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Egypt; End | 2019 |
Effect of low-dose aspirin on the development of ovarian hyperstimulation syndrome and outcomes of assisted reproductive techniques in the women with PCOS, a randomized double-blinded clinical trial.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; | 2019 |
Metabolic Syndrome and the Effectiveness of Low-dose Aspirin on Reproductive Outcomes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Drug A | 2019 |
Effect of preconception low dose aspirin on pregnancy and live birth according to socioeconomic status: A secondary analysis of a randomized clinical trial.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Live Birth; Preconception Care; Pregnancy; Pregnancy Rat | 2019 |
A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy.
Topics: Adult; Area Under Curve; Aspirin; Case-Control Studies; Dose-Response Relationship, Drug; Drug Chron | 2019 |
Effects of the precalving administration of omega-3 fatty acids alone or in combination with acetylsalicylic acid in periparturient dairy cows.
Topics: Acute-Phase Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cattle; Dietary Sup | 2013 |
Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein.
Topics: Adult; alpha-Fetoproteins; Aspirin; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy; Pregnancy | 2014 |
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune | 2014 |
Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial.
Topics: Adult; Amlodipine; Antihypertensive Agents; Aspirin; Diuretics; Female; Furosemide; Humans; Hyperten | 2014 |
A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Double-Blind Method; Female; Hu | 2013 |
A randomized controlled clinical trial investigating the effect of calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress and insulin resistance in pregnant women at risk for pre-eclampsia.
Topics: Aspirin; Blood Glucose; C-Reactive Protein; Calcium; Dietary Supplements; Dose-Response Relationship | 2012 |
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Aspirin; Birth Weight; Embryo Implantation; Enoxaparin; Female; Fibrinoly | 2014 |
Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin.
Topics: Adolescent; Adult; Aspirin; Biomarkers; Blood Pressure; Female; Galectins; Humans; Middle Aged; Pre- | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Weight; Double-Blind Method; Drug Adm | 2014 |
Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial.
Topics: Adult; Aspirin; Brazil; Calcium, Dietary; Chronic Disease; Double-Blind Method; Drug Combinations; F | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial.
Topics: Abortion, Habitual; Administration, Oral; Adult; Aspirin; CD56 Antigen; Double-Blind Method; Drug Th | 2014 |
Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Female; Gestational Age; H | 2015 |
Effects of combining low‑dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome.
Topics: Adult; Aspirin; Drug Therapy, Combination; Drugs, Chinese Herbal; Endometrium; Female; Fertility Age | 2014 |
Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth.
Topics: Adolescent; Adult; Aspirin; Cohort Studies; Double-Blind Method; Female; Humans; Infant, Newborn; In | 2015 |
Customized versus Population Fetal Growth Norms and Adverse Outcomes Associated with Small for Gestational Age Infants in a High-Risk Cohort.
Topics: Aspirin; Birth Weight; Cesarean Section; Cyclooxygenase Inhibitors; Female; Fetal Development; Fetal | 2015 |
Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.
Topics: Adult; Aspirin; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Pre-Eclampsia; Pregn | 2015 |
Recruitment for longitudinal, randomised pregnancy trials initiated preconception: lessons from the effects of aspirin in gestation and reproduction trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cost-Benefit Analysis; Double-Blind Method; | 2015 |
Preconception low dose aspirin and time to pregnancy: findings from the effects of aspirin in gestation and reproduction randomized trial.
Topics: Adolescent; Adult; Aspirin; Double-Blind Method; Female; Gestational Age; Humans; Platelet Aggregati | 2015 |
Low-dose aspirin and preterm birth: a randomized controlled trial.
Topics: Adult; Aspirin; Cyclooxygenase Inhibitors; Female; Folic Acid; Humans; Intention to Treat Analysis; | 2015 |
Risk threshold for starting low dose aspirin in pregnancy to prevent preeclampsia: an opportunity at a low cost.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Risk | 2015 |
Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.
Topics: Adult; Aspirin; Double-Blind Method; Female; Gestational Age; Humans; Platelet Aggregation Inhibitor | 2015 |
Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
Topics: Adult; Anticoagulants; Aspirin; Birth Weight; Blood Flow Velocity; Drug Therapy, Combination; Female | 2016 |
Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; | 2015 |
Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Mullerian Hormone; Aspirin; Biomarkers; Cohort Studie | 2016 |
Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Pregnancy; P | 2016 |
Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Australia; Drug Therapy, Co | 2016 |
Randomized controlled study of pre-conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Egypt; Eno | 2016 |
Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension.
Topics: Adult; Aspirin; Diabetes, Gestational; Female; Gestational Age; Humans; Hypertension; Infant, Newbor | 2016 |
The impact of low-dose aspirin on preterm birth: secondary analysis of a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; F | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Complications and Safety of Preconception Low-Dose Aspirin Among Women With Prior Pregnancy Losses.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn | 2016 |
Low-dose aspirin for pre-eclampsia prevention in twins with elevated human chorionic gonadotropin.
Topics: Adult; Aspirin; Chorionic Gonadotropin; Double-Blind Method; Female; Humans; Pre-Eclampsia; Pregnanc | 2016 |
Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
Topics: Adolescent; Adult; Aspirin; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; L | 2016 |
An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): Trial protocol.
Topics: Aspirin; Early Diagnosis; Female; Fetal Growth Retardation; Humans; Mass Screening; Medication Adher | 2016 |
Combined treatment of prednisone and aspirin, starting before ovulation induction, may improve reproductive outcomes in ANA-positive patients.
Topics: Adult; Antibodies, Antinuclear; Aspirin; Controlled Before-After Studies; Drug Therapy, Combination; | 2016 |
Association of Nausea and Vomiting During Pregnancy With Pregnancy Loss: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarke | 2016 |
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Topics: Abruptio Placentae; Adult; Aspirin; Drug Therapy, Combination; Enoxaparin; Female; Humans; Pre-Eclam | 2016 |
Low-Dose Aspirin and Sporadic Anovulation in the EAGeR Randomized Trial.
Topics: Adolescent; Adult; Anovulation; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Humans; Liv | 2017 |
The Prevalence of Thrombophilia in Women With Recurrent Fetal Loss and Outcome of Anticoagulation Therapy for the Prevention of Miscarriages.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Middle A | 2018 |
Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study.
Topics: Adult; Aspirin; Cell Movement; Female; Humans; Infant, Small for Gestational Age; Pre-Eclampsia; Pre | 2017 |
Effect of regular oral intake of aspirin during pregnancy on pregnancy outcome of high-risk pregnancy-induced hypertension syndrome patients.
Topics: Aspirin; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Pr | 2016 |
Evaluation of the effectiveness of low-dose aspirin and omega 3 in treatment of asymmetrically intrauterine growth restriction: A randomized clinical trial.
Topics: Adult; Aspirin; Fatty Acids, Omega-3; Female; Fetal Growth Retardation; Fetal Weight; Fibrinolytic A | 2017 |
Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Mol | 2017 |
Low-dose aspirin and omega-3 fatty acids improve uterine artery blood flow velocity in women with recurrent miscarriage due to impaired uterine perfusion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Arteries; Aspirin; Blood Flow Velocity; Cyclooxyge | 2009 |
Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
Topics: Adult; Arteries; Aspirin; Blood Flow Velocity; Double-Blind Method; Female; Fibrinolytic Agents; Hum | 2008 |
Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial.
Topics: Adult; Arteries; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Embryo Implantation | 2009 |
Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Resp | 2009 |
Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Humans; Male; Oocytes; Ovulatio | 2009 |
Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study.
Topics: Adult; Aspirin; Blood Flow Velocity; Double-Blind Method; Embryo Transfer; Endometrium; Female; Fert | 2009 |
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Topics: Abortion, Habitual; Adult; Antibodies, Antinuclear; Anticoagulants; Antiphospholipid Syndrome; Aspir | 2009 |
Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; F | 2010 |
Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Humans; Hypertension, Pregnancy | 2009 |
Use of heparin in women with early and late miscarriages with and without thrombophilia.
Topics: Abortion, Habitual; Adult; Age Factors; Aspirin; Biomarkers; Case-Control Studies; Dalteparin; Drug | 2009 |
Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience.
Topics: Anticoagulants; Aspirin; Factor Xa Inhibitors; Female; Heart Valve Prosthesis; Hemorrhage; Heparin, | 2009 |
Low-dose ASA response using the PFA-100 in women with high-risk pregnancy.
Topics: Adult; Aspirin; Blood Platelets; Cohort Studies; Female; Humans; Platelet Function Tests; Pregnancy; | 2009 |
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Infant, Newborn; Pla | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Contusions; Drug Therapy, Combination; Female; H | 2010 |
Sex differences in the administration-time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects.
Topics: Actigraphy; Adult; Aspirin; Blood Pressure; Drug Administration Schedule; Female; Humans; Hypertensi | 2010 |
Heparin and aspirin in pregnant Sudanese women with recurrent miscarriage associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2007 |
Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fertilization in Vitro; Humans; Hypertension, Pregnancy | 2010 |
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Earl | 2011 |
Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study.
Topics: Adolescent; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Inf | 2011 |
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2011 |
Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Embryo Loss; Female; Heparin, Low-Mol | 2012 |
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial.
Topics: Anticoagulants; Aspirin; Cohort Studies; Disease Progression; Enoxaparin; Female; Follow-Up Studies; | 2011 |
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.
Topics: Aspirin; Drug Therapy, Combination; Female; Gestational Age; Heparin, Low-Molecular-Weight; Humans; | 2012 |
Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
Topics: Adult; Aspirin; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Drug A | 2013 |
Do acetyl salicylic acid and terbutaline in combination increase the probability of a clinical pregnancy in patients undergoing IVF/ICSI?
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug T | 2012 |
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.
Topics: Adolescent; Adult; Aspirin; Double-Blind Method; Female; Finland; Humans; Platelet Aggregation Inhib | 2013 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Confidence | 2002 |
Post-partum cerebral angiopathy: repetitive TCD, MRI, MRA, and EEG examinations.
Topics: Acetates; Adult; Amines; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Brain Ed | 2002 |
Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Cohort Studies; Dr | 2002 |
Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence.
Topics: Adult; Aspirin; Cell Count; Embryo Implantation; Embryo Transfer; Embryo, Mammalian; Estradiol; Fema | 2002 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Gestatio | 2002 |
Antiphospholipid syndrome in pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Female; Gestational Age; He | 2002 |
Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation.
Topics: Aspirin; Blood Platelets; Dinoprostone; Epoprostenol; Female; Fetal Blood; Humans; Infant, Newborn; | 2003 |
Administration time-dependent influence of aspirin on blood pressure in pregnant women.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; | 2003 |
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Topics: Abortion, Habitual; Adolescent; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Ther | 2003 |
Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1).
Topics: Adult; Aspirin; Blood Transfusion; Double-Blind Method; Female; Hemorrhage; Humans; Parity; Platelet | 2003 |
Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 2).
Topics: Adult; Arteries; Aspirin; Female; Fetal Growth Retardation; Humans; Placental Circulation; Platelet | 2003 |
Prevalence of anticardiolipin antibody IgG in recurrent first trimester abortions and the role of aspirin in its prevention.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Aspirin; F | 2003 |
9 alpha,11 beta-prostaglandin F2 in pregnancies at high risk for hypertensive disorders of pregnancy, and the effect of acetylsalicylic acid.
Topics: Aspirin; Dinoprost; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, | 2003 |
A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies.
Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Cross-Over St | 2003 |
Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.
Topics: Adult; Arteries; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2003 |
[Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; A | 2003 |
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Topics: Aspirin; Birth Weight; Enoxaparin; Female; Fetal Death; Folic Acid; Heparin, Low-Molecular-Weight; H | 2004 |
A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia.
Topics: Administration, Oral; Adult; Aspirin; Chi-Square Distribution; Dose-Response Relationship, Drug; Dru | 2004 |
[The impact of low-dose aspirin therapy on umbilical and middle cerebral artery blood flow in pregnancy complicated by idiopathic intrauterine growth restriction].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; Dose-Response Relation | 2004 |
[Effect of intravenous gamma-globulin therapy on lymphocyte population in pregnant women with antiphospholipid antibodies].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; beta | 2004 |
Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study.
Topics: Adult; Anticoagulants; Aspirin; Birth Rate; Confidence Intervals; Dose-Response Relationship, Drug; | 2004 |
Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dalteparin; Female; Heparin; Humans; Pilo | 2004 |
Treatment of antiphospholipid syndrome in pregnancy--a systematic review of randomized therapeutic trials.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Hype | 2004 |
Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Drug Therapy, Comb | 2005 |
Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study.
Topics: Adult; Aspirin; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Fertilization in Vitro; Huma | 2005 |
Recurrent miscarriage associated with antiphospholipid antibodies: prophylactic treatment with low-dose aspirin and fish oil derivates.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Docosahexaenoic Acids; Dose-Response | 2005 |
Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2005 |
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
Topics: Aspirin; Case-Control Studies; Echocardiography, Doppler; Female; Fetal Growth Retardation; Humans; | 2005 |
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
Topics: Aspirin; Case-Control Studies; Echocardiography, Doppler; Female; Fetal Growth Retardation; Humans; | 2005 |
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
Topics: Aspirin; Case-Control Studies; Echocardiography, Doppler; Female; Fetal Growth Retardation; Humans; | 2005 |
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
Topics: Aspirin; Case-Control Studies; Echocardiography, Doppler; Female; Fetal Growth Retardation; Humans; | 2005 |
Aspirin desensitization in the treatment of antiphospholipid syndrome during pregnancy in ASA-sensitive patients.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Desensitization, Immunologic; Female; Fetal Death; Follow | 2006 |
Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Topics: Abortion, Habitual; Activins; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Case-Contro | 2006 |
The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Anticoagulants; Apgar Score; Aspirin; Birth | 2006 |
Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Rel | 2006 |
Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history.
Topics: Adult; Aspirin; Chorionic Villi; Female; Fetus; Humans; Infant, Newborn; Placenta; Pregnancy; Retros | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.
Topics: Abortion, Habitual; Abortion, Induced; Adult; Anticoagulants; Aspirin; Birth Rate; Birth Weight; Eno | 2006 |
Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weigh | 2006 |
Impact of ibuprofen administration on renal drug clearance in the first weeks of life.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Aspirin; Betamethasone; Birth Weight; Cyclooxygenase I | 2006 |
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.
Topics: Adult; Aspirin; Carcinoma; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fertil | 2007 |
Indices of oxidative stress in pregnancy with fetal growth restriction.
Topics: Adult; alpha 1-Antitrypsin; Arginine; Aspirin; Biomarkers; Female; Fetal Growth Retardation; Humans; | 2007 |
Thrombophilia and antithrombotic therapy in women with recurrent spontaneous abortions.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Factors; Female; Fibrinolytic Agents; Greece; | 2007 |
[Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles].
Topics: Aspirin; Embryo Transfer; Female; Fertilization in Vitro; Growth Hormone; Humans; Infertility, Femal | 2007 |
Safety and effectiveness of tinzaparin sodium in the management of recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Huma | 2007 |
Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study.
Topics: Adult; Anti-Inflammatory Agents; Arteries; Aspirin; Embryo Implantation; Female; Fertility Agents, F | 2008 |
Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; Enoxaparin; | 2008 |
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antibodies | 2008 |
Aspirin in the treatment of episiotomy pain.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Episiotomy; Female; Humans; Pain; Pregnancy; P | 1983 |
Double-blind evaluation of suprofen and aspirin in the treatment of periodontal pain.
Topics: Acetaminophen; Adult; Aspirin; Clinical Trials as Topic; Codeine; Double-Blind Method; Female; Human | 1983 |
Caffeine as an analgesic adjuvant.
Topics: Acetaminophen; Adjuvants, Pharmaceutic; Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Dou | 1984 |
[Controlled trial of preventive treatment of preeclampsia. Preliminary results].
Topics: Adult; Aspirin; Blood Volume; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardati | 1984 |
A double-blind randomized study of an aspirin/caffeine combination versus acetaminophen/aspirin combination versus acetaminophen versus placebo in patients with moderate to severe post-partum pain.
Topics: Acetaminophen; Adolescent; Adult; Aspirin; Caffeine; Double-Blind Method; Drug Combinations; Drug Ev | 1984 |
Codeine and aspirin analgesia in postpartum uterine cramps: qualitative aspects of quantitative assessments.
Topics: Adolescent; Adult; Analgesics; Aspirin; Codeine; Double-Blind Method; Drug Evaluation; Female; Human | 1983 |
Influence of treatment with prostaglandin synthesis inhibitor or progesterone on cytotoxic activity and progesterone binding capacity of lymphocytes during pregnancy.
Topics: 17-alpha-Hydroxyprogesterone; Aspirin; Cytotoxicity, Immunologic; Female; Humans; Hydroxyprogesteron | 1983 |
Drug prophylaxis for arterial thromboembolism--1981.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coumarins; Decision M | 1981 |
The effect of low-dose aspirin on pregnancies complicated by elevated human chorionic gonadotropin levels.
Topics: Adolescent; Adult; Aspirin; Birth Weight; Chi-Square Distribution; Chorionic Gonadotropin; Double-Bl | 1995 |
Follow-up of children in the Italian Study of Aspirin in Pregnancy.
Topics: Abnormalities, Drug-Induced; Aspirin; Developmental Disabilities; Female; Follow-Up Studies; Humans; | 1994 |
Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental circulation.
Topics: Adult; alpha-Fetoproteins; Aspirin; Female; Humans; Infant Mortality; Infant, Low Birth Weight; Infa | 1994 |
The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy.
Topics: Angiotensin II; Aspirin; Blood Pressure; Female; Gestational Age; Humans; Mass Screening; Parity; Pl | 1995 |
Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
Topics: Aspirin; Birth Weight; Double-Blind Method; Embryonic and Fetal Development; Female; Humans; Obstetr | 1995 |
Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network.
Topics: Analysis of Variance; Anesthesia, Epidural; Anesthesia, Obstetrical; Aspirin; Bleeding Time; Blood C | 1995 |
Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short term treatment on bleeding time.
Topics: Aspirin; Bleeding Time; Female; Humans; Male; Pregnancy; Pregnancy Trimester, Third | 1994 |
Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Abortion, Induced; Abortion, Spontaneous; Aspirin; Blood Pressure; Female; Humans; Logistic Models; | 1995 |
Effect of low-dose aspirin during pregnancy on fibrinolytic variables before and after parturition.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Female; Fibrinolysis; Humans; Plasminogen Activator In | 1995 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
Topics: Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant Mortalit | 1994 |
A study of use of low dose aspirin in prevention of pregnancy induced hypertension.
Topics: Aspirin; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy | 1994 |
Uterine Doppler in the identification of patients at risk for hypertension and IUGR.
Topics: Aspirin; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newbor | 1994 |
Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy.
Topics: Aspirin; Double-Blind Method; Echocardiography; Echocardiography, Doppler; Female; Fetal Heart; Gest | 1994 |
[Comments: low-dose aspirin in pregnant women].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy | 1994 |
Low-dose aspirin and hypertension in pregnancy.
Topics: Aspirin; Double-Blind Method; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Card | 1993 |
Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy.
Topics: Adolescent; Adult; Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; P | 1993 |
The predictive value of umbilical artery Doppler studies for preeclampsia or fetal growth retardation in a preeclampsia prevention trial.
Topics: Adult; Aspirin; Diastole; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Logistic Mo | 1994 |
Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report.
Topics: Adult; Aspirin; Double-Blind Method; Embryonic and Fetal Development; Female; Humans; Hypertension; | 1994 |
Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
Topics: Adult; Aspirin; Double-Blind Method; Female; Fetal Blood; Humans; Hypertension; In Vitro Techniques; | 1994 |
Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn.
Topics: Adult; Aspirin; Drug Administration Schedule; Epoprostenol; Female; Humans; Hypertension; Pre-Eclamp | 1993 |
The effect of low-dose aspirin on fetal urine output and amniotic fluid volume.
Topics: Adult; Amniotic Fluid; Analysis of Variance; Aspirin; Chi-Square Distribution; Double-Blind Method; | 1993 |
The effect of low-dose aspirin on umbilical artery Doppler measurements.
Topics: Aspirin; Blood Pressure; Double-Blind Method; Female; Fetus; Follow-Up Studies; Humans; Maternal-Fet | 1993 |
Are pill counts valid measures of compliance in clinical obstetric trials?
Topics: Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Patient Compliance; | 1993 |
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; F | 1993 |
[Prevention of fetal growth retardation by low dose aspirin].
Topics: Adolescent; Adult; Aspirin; Blood Flow Velocity; Double-Blind Method; Female; Fetal Growth Retardati | 1993 |
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, C | 1993 |
Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Abruptio Placentae; Adult; Aspirin; Double-Blind Method; Female; Humans; Hypertension; Incidence; Pa | 1993 |
Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Chromatography, High Pressure Liquid; Epoprostenol; Fe | 1993 |
Low-dose aspirin therapy to prevent preeclampsia.
Topics: Adult; Aspirin; Eclampsia; Female; Humans; Hypertension; Parity; Pre-Eclampsia; Pregnancy; Pregnancy | 1993 |
The effect of low dose aspirin on bleeding times.
Topics: Aspirin; Bleeding Time; Blood Coagulation; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy | 1993 |
A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow.
Topics: Adult; Arteries; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregna | 1996 |
Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group.
Topics: Aspirin; Body Height; Body Weight; Canada; Cohort Studies; Developmental Disabilities; Double-Blind | 1995 |
[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy].
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 1995 |
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.
Topics: Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; Follow-Up Studies; Humans; Obs | 1996 |
-Is prevention of pre-eclampsia with low dosage aspirin possible? Critical assessment of available studies-.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Platelet Aggregation Inh | 1996 |
Prediction of pre-eclampsia by abnormal uterine Doppler ultrasound and modification by aspirin.
Topics: Adolescent; Adult; Aspirin; Blood Flow Velocity; Female; Humans; Platelet Aggregation Inhibitors; Pr | 1996 |
Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial.
Topics: Adult; Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Placent | 1995 |
Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial.
Topics: Adult; Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Placent | 1995 |
Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial.
Topics: Adult; Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Placent | 1995 |
Low dose aspirin for the treatment of fetal growth restriction: a randomized controlled trial.
Topics: Adult; Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Placent | 1995 |
Risk factors for pregnancy-induced hypertension in women at high risk for the condition. Italian Study of Aspirin in Pregnancy Group.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Educational Status; Female | 1996 |
A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Dose-Response Relationship, Immuno | 1996 |
A prospective randomized placebo-controlled trial of low-dose aspirin for prevention of intra-uterine growth retardation.
Topics: Adolescent; Adult; Aspirin; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Placenta; | 1996 |
Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin/thromboxane ratios in late pregnancy.
Topics: Adolescent; Adult; Aspirin; Bleeding Time; Blood Coagulation; Dose-Response Relationship, Drug; Epop | 1996 |
Platelet angiotensin II receptor status during pregnancy in Chinese women at high-risk of developing pregnancy-induced hypertension.
Topics: Adolescent; Adult; Angiotensin II; Aspirin; Blood Platelets; Calcium; Cohort Studies; Female; Food, | 1996 |
Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Center, Dar es Salaam.
Topics: Aspirin; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Incidence; Pre-Eclampsia; P | 1995 |
Neonatal outcome in a randomized, controlled trial of low-dose aspirin in high-risk pregnancies.
Topics: Aspirin; Chronic Disease; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Kidney | 1995 |
The presence of anti-beta 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Dose-Response Relationship, Drug; Drug | 1996 |
Randomized trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combinati | 1996 |
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1997 |
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; He | 1996 |
Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnan | 1997 |
Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study.
Topics: Adult; Aspirin; Blood Circulation; Female; Fetal Blood; Fetal Growth Retardation; Fetus; Humans; Pla | 1997 |
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Autoantibodies; Female; Fetal Membranes, Premature R | 1997 |
Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; Embryo Implantation; Embr | 1997 |
The use of low-dose aspirin to prevent preeclampsia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; H | 1996 |
Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production.
Topics: Abortion, Habitual; Adult; Aspirin; Autoimmune Diseases; Blood Platelets; Epoprostenol; Female; Huma | 1997 |
Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Pre-Eclampsia; Preg | 1997 |
Role of low dose aspirin in prevention of pregnancy induced hypertension.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Drug Admi | 1997 |
Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
Topics: Adult; Antihypertensive Agents; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Hum | 1997 |
Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study.
Topics: Adult; Aspirin; Embryo Implantation; Embryo Transfer; Endometrium; Female; Fertilization in Vitro; H | 1997 |
Prevention of early pregnancy loss in autoantibody seropositive women.
Topics: Abortion, Spontaneous; Aspirin; Autoantibodies; Embryo Transfer; Female; Fertilization in Vitro; Hum | 1998 |
Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Adult; Aspirin; Chronic Disease; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Hyp | 1998 |
A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia.
Topics: Adult; Aspirin; Birth Weight; Confidence Intervals; Dose-Response Relationship, Drug; Female; Follow | 1998 |
Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
Topics: Adult; Aspirin; Barbados; Birth Weight; Delayed-Action Preparations; Female; Fetal Death; Gestationa | 1998 |
A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group.
Topics: Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Follow-Up Studies; Hum | 1998 |
The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies.
Topics: Adult; Aspirin; Embryo Transfer; Female; Fertilization in Vitro; Heparin; Humans; Immunoglobulin G; | 1998 |
A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Combined Modality Therapy; Drug Therapy, Combination; | 1998 |
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Cyclooxygenase Inhibitors; Delayed-Action Preparations | 1998 |
The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Case-Control Studies; Drug Therapy, C | 1998 |
Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Adult; Aspirin; Blood Pressure; Female; Gestational Age; Humans; Hypertension; Parity; Placebos; Pre | 1998 |
Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; H | 1998 |
A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters.
Topics: Antibodies, Antiphospholipid; Aspirin; Chorionic Gonadotropin, beta Subunit, Human; Embryo Implantat | 1998 |
In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies.
Topics: Aspirin; Epoprostenol; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pregnancy; Pre | 1999 |
Effect of maternal low dose aspirin on neonatal platelet function.
Topics: Aspirin; Blood Platelets; Female; Fetal Blood; Humans; Infant, Newborn; Platelet Aggregation Inhibit | 1998 |
Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay.
Topics: Adult; Aspirin; Blood Flow Velocity; Double-Blind Method; Embryo Implantation; Female; Fertilization | 1999 |
Heparin plus aspirin as a "single" therapy for recurrent spontaneous abortion associated with both allo- and autoimmunity.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Autoantibodies; Female; Heparin; Humans; Immunot | 1999 |
[Evaluation of the effectiveness of a low-dose aspirin in the treatment of intrauterine growth retardation (IUGR)].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; F | 1999 |
Antiphospholipid antibodies and pregnancy.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Birth Rate; Female; Fetal | 1999 |
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Dru | 1999 |
Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial.
Topics: Adult; Aspirin; Birth Weight; Double-Blind Method; Female; Fetal Growth Retardation; Humans; Platele | 1999 |
Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension.
Topics: Analysis of Variance; Aspirin; Calcium; Chi-Square Distribution; Dietary Supplements; Female; Humans | 1999 |
Administration time-dependent effects of aspirin in women at differing risk for preeclampsia.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Doubl | 1999 |
L-arginine transport at the fetal side of human placenta: effect of aspirin in pregnancy.
Topics: Adult; Amino Acids; Arginine; Aspirin; Biological Transport; Chile; Female; Humans; Hydrogen-Ion Con | 1999 |
Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Aspirin; Birth Weight; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; | 2000 |
A prospective management study of slow-release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Aspirin; Delayed-Action Preparations; Fema | 2000 |
Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; Cyclooxygenase Inhibitors; Do | 2000 |
Low-molecular-weight heparin for thrombophilia in pregnant women.
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weigh | 2000 |
Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study.
Topics: Adult; Aspirin; Endometrium; Female; Humans; Infertility, Female; Insemination, Artificial, Homologo | 2000 |
Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Topics: Aspirin; Female; Humans; MEDLINE; Placebos; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Risk | 2000 |
Recurrent miscarriage--an aspirin a day?
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Birth Rate; | 2000 |
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Double-Blind Method; Female; Humans; Pregnancy; Pregnancy | 2000 |
Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study.
Topics: Adult; Age Factors; Aspirin; Dose-Response Relationship, Drug; Embryo Implantation; Female; Humans; | 2000 |
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Immunoglobulins, I | 2001 |
Does antiplatelet therapy prevent preeclampsia and its complications?
Topics: Aspirin; Female; Guidelines as Topic; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Ecl | 2001 |
Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial.
Topics: Adult; Algorithms; Aspirin; Female; Fetal Growth Retardation; Fibrinolytic Agents; Humans; Pre-Eclam | 2001 |
Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodies.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndr | 2001 |
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
Topics: Adult; Arteries; Aspirin; Birth Weight; Blood Flow Velocity; Double-Blind Method; Female; Fetal Grow | 2002 |
Enoxaparin sodium improves pregnancy outcome in aspirin-resistant antiphospholipid/antiprotein antibody syndromes.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Resistance; Enoxaparin; | 2002 |
Management and outcome of pregnancy in women with thrombophylic disorders and past cerebrovascular events.
Topics: Adult; Anticoagulants; Aspirin; Birth Weight; Cerebrovascular Disorders; Cohort Studies; Female; Fib | 2002 |
A multicenter study for analgesia involving fenoprofen, propoxyphene [alone or in combination] with placebo and aspirin controls in postpartum pain.
Topics: Analgesia; Aspirin; Dextropropoxyphene; Drug Interactions; Drug Therapy, Combination; Female; Fenopr | 1979 |
Naproxen, aspirin, and codeine in postpartum uterine pain.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Codeine; Delivery, Obstetric; Drug Evaluation; | 1977 |
Fendosal and aspirin in postpartum uterine pain.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Doubl | 1978 |
On the use of blockers of prostaglandin synthesis in the control of labor.
Topics: Animals; Aspirin; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Indome | 1978 |
Aspirin and aspirin-caffeine in postpartum pain relief.
Topics: Adolescent; Adult; Aspirin; Caffeine; Clinical Trials as Topic; Double-Blind Method; Drug Combinatio | 1978 |
A double-blind comparison of diflunisal and aspirin in the treatment of post-operative pain after episiotomy.
Topics: Adolescent; Adult; Analgesics; Aspirin; Biphenyl Compounds; Clinical Trials as Topic; Episiotomy; Fe | 1978 |
[Effect of fenoterol (Partusisten) on the oxygen dissociation curve in pregnant women (author's transl)].
Topics: Acid-Base Equilibrium; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Erythrocytes; E | 1978 |
[Clinical trial of a new analgesic (lysine acetylsalicylate) in labor].
Topics: Anesthesia, Obstetrical; Aspirin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Labor, | 1976 |
Asprin and codeine in two postpartum pain models.
Topics: Adult; Aspirin; Clinical Trials as Topic; Codeine; Episiotomy; Female; Humans; Models, Theoretical; | 1976 |
Acetaminophen extra strength capsules versus propoxphene compound-65 versus placebo: a double-blind study of effectiveness and safety.
Topics: Acetaminophen; Adolescent; Adult; Aspirin; Caffeine; Capsules; Clinical Trials as Topic; Dextropropo | 1975 |
Naproxen: a review of its pharmacological properties and therapeutic efficacy and use.
Topics: Animals; Arthritis, Rheumatoid; Aspirin; Blood Coagulation; Clinical Trials as Topic; Collagen; Dogs | 1975 |
Therapeutic effectiveness of paracetamol in rheumatoid arthritis.
Topics: Acetaminophen; Analysis of Variance; Arthritis, Rheumatoid; Aspirin; Drug Evaluation; Female; Humans | 1975 |
[Low-dose aspirin in prevention and therapy of hypertension in pregnancy].
Topics: Aspirin; Austria; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertensio | 1992 |
[Prevention of intrauterine growth retardation and pre-eclampsia by small doses of aspirin. Results of the french multicenter trial EPREDA and comparison with data in the literature; value of uterine Doppler].
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Growth Retardat | 1992 |
Low-dose aspirin in primigravidae with positive roll-over test.
Topics: Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Male; P | 1992 |
Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody.
Topics: Abortion, Habitual; Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; Drug Evalua | 1992 |
Hypertension in pregnancy.
Topics: Angiotensin II; Aspirin; Blood Flow Velocity; Female; Fetus; Humans; Hypertension; Placenta; Pre-Ecl | 1992 |
A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.
Topics: Adult; Arachidonic Acid; Aspirin; Collagen; Female; Humans; Hypertension; Platelet Aggregation; Plat | 1992 |
Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.
Topics: Adult; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug | 1991 |
Low-dose aspirin and nulliparae.
Topics: Aspirin; Birth Weight; Cesarean Section; Double-Blind Method; Female; Fetal Growth Retardation; Huma | 1991 |
Low dose acetyl salicylic acid in severe preeclampsia.
Topics: Albuminuria; Aspirin; Blood Pressure; Edema; Female; Humans; Pre-Eclampsia; Pregnancy | 1991 |
Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group.
Topics: Abruptio Placentae; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Combinations; Fem | 1991 |
[Experience with the roll-over test in gestosis screening].
Topics: Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infant, Newborn; Mas | 1991 |
[Low-dose aspirin preventing pregnancy induced hypertension].
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Double-Blind Method; Female; Fibronectins; Humans; Pre-Eclamp | 1991 |
Arachidonic acid metabolism in the pathophysiology and prevention of preeclampsia--a review.
Topics: Arachidonic Acid; Aspirin; Female; Fish Oils; Humans; Pre-Eclampsia; Pregnancy; Risk | 1991 |
Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension.
Topics: Administration, Oral; Adult; Aspirin; Blood Platelets; Drug Administration Schedule; Drug Evaluation | 1990 |
Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin II; Aspirin; Blood Pressure; Double-Blind Metho | 1991 |
Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Transfusion; Dipyridamole; Female; Hemolytic-Uremic Syndrome | 1991 |
Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnan | 1990 |
Poor participation of nulliparous women in a low dose aspirin study to prevent preeclampsia.
Topics: Adult; Aspirin; Drug Administration Schedule; Evaluation Studies as Topic; Fear; Female; Humans; Par | 1990 |
Low-dose aspirin and twin pregnancy.
Topics: Aspirin; Drug Evaluation; Embryonic and Fetal Development; Female; Humans; Pregnancy; Pregnancy Trim | 1989 |
Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Fetal Growth Ret | 1989 |
Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
Topics: Aspirin; Clinical Trials as Topic; Epoprostenol; Female; Humans; Maternal-Fetal Exchange; Pre-Eclamp | 1989 |
The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies.
Topics: Adult; Aspirin; Clinical Trials as Topic; Double-Blind Method; Epoprostenol; Female; Humans; Hyperte | 1989 |
Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Epoprostenol; Female; Fetus; Humans; | 1989 |
Low-dose aspirin in pregnancy.
Topics: Alprostadil; Apgar Score; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Ductus Arterio | 1989 |
Prevention of pre-eclampsia by early antiplatelet therapy.
Topics: Adult; Aspirin; Dipyridamole; Female; Humans; Pre-Eclampsia; Pregnancy | 1985 |
Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.
Topics: Adolescent; Adult; Angiotensin II; Aspirin; Blood Pressure; Clinical Trials as Topic; Double-Blind M | 1986 |
Low-dose aspirin improves fetal weight in umbilical placental insufficiency.
Topics: Aspirin; Female; Fetus; Humans; Placenta Diseases; Placental Insufficiency; Pregnancy | 1988 |
Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency.
Topics: Adult; Aspirin; Birth Weight; Blood Flow Velocity; Clinical Trials as Topic; Double-Blind Method; Fe | 1988 |
Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardation; Humans; Pa | 1986 |
Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?
Topics: Aspirin; Blood Platelets; Blood Vessels; Chemistry, Pharmaceutical; Clinical Trials as Topic; Cycloo | 1986 |
Inhibition of arachidonic acid metabolism in the perinatal period: pharmacology, clinical application, and potential adverse effects.
Topics: Administration, Oral; Arachidonic Acid; Arachidonic Acids; Aspirin; Clinical Trials as Topic; Cycloo | 1986 |
Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole.
Topics: Adult; Aspirin; Birth Weight; Clinical Trials as Topic; Dipyridamole; Epoprostenol; Female; Fetal Gr | 1987 |
Flurbiprofen, aspirin, codeine, and placebo for postpartum uterine pain.
Topics: Adult; Aspirin; Clinical Trials as Topic; Codeine; Double-Blind Method; Female; Flurbiprofen; Humans | 1986 |
[Indications for tocolysis. A prospective study].
Topics: Aspirin; Betamethasone; Clenbuterol; Drug Therapy, Combination; Ethanol; Ethanolamines; Female; Feno | 1986 |
Effect of acetylsalicylic acid on prostacyclin production in trophoblast.
Topics: Adult; Aspirin; Epoprostenol; Female; Humans; Pregnancy; Pregnancy Trimester, First; Trophoblasts | 1985 |
[Critical study of the post-partum pain by means of a clinical pharmacology experiment].
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Humans; Methylphenidate; Pain; Phenobarbital; Plac | 1972 |
[Comparative study of a psychostimulating drug in the treatment of post-partum pain].
Topics: Adult; Analgesics; Aspirin; Clinical Trials as Topic; Female; Humans; Methylphenidate; Pain; Phenoba | 1973 |
Evaluation of propoxyphene napsylate compound in post partum uterine cramping.
Topics: Administration, Oral; Aspirin; Caffeine; Clinical Trials as Topic; Dextropropoxyphene; Female; Human | 1974 |
The relief of postpartum pain with Fiorinal.
Topics: Administration, Oral; Aspirin; Barbiturates; Clinical Trials as Topic; Episiotomy; Female; Hemorrhoi | 1972 |
Propoxyphene hydrochloride. A critical review.
Topics: Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Dextropropoxyphene; Female; Headac | 1970 |
Von Willebrand's disease.
Topics: Adult; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Transfusion; Chromosome Aberration | 1971 |
Relief of postpartum uterine cramping with propoxyphene and aspirin.
Topics: Administration, Oral; Analgesia; Analysis of Variance; Aspirin; Capsules; Chlorides; Dextropropoxyph | 1971 |
A comparison of acetophenetidin and acetaminophen. I. Analgesic effects in postpartum patients.
Topics: Acetaminophen; Analgesia; Aspirin; Clinical Trials as Topic; Female; Humans; Phenacetin; Placebos; P | 1967 |
1374 other studies available for aspirin and Pregnancy
| Article | Year |
|---|---|
Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Topics: Abortion, Habitual; Adolescent; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Female; Fe | 2021 |
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Infant, Newborn; Infant, Small for | 2021 |
Use of Aspirin During Pregnancy to Prevent Preeclampsia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Practice Guidelines as Topic; Pre- | 2021 |
Low-Dose Aspirin for the Prevention of Preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2021 |
Re: ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Topics: Aspirin; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Risk | 2021 |
Arterial Stiffness as a Cardiovascular Risk Factor for the Development of Preeclampsia and Pharmacopreventive Options.
Topics: Aspirin; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Humans; Pre-Eclampsia; Pregnan | 2022 |
The Role of the Natural Course in Causal Analysis.
Topics: Adult; Aspirin; Causality; Female; Humans; Models, Theoretical; Pregnancy; Pregnancy Complications; | 2022 |
Multitool Approach for High-Risk Aspirin Desensitization in a Pregnant Woman.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Desensitization, Immunologic; Drug Hypersensitivit | 2022 |
Associations between aspirin prophylaxis and fetal growth and preeclampsia in women with pregestational diabetes.
Topics: Analgesics; Aspirin; Diabetes Mellitus; Female; Fetal Development; Humans; Pre-Eclampsia; Pregnancy; | 2022 |
Use of a Smartphone App to Explore Potential Underuse of Prophylactic Aspirin for Preeclampsia.
Topics: Adolescent; Adult; Aspirin; Cohort Studies; Female; Humans; Logistic Models; Mobile Applications; Pr | 2021 |
Miscommunication About Low-Dose Aspirin for Preeclampsia Prevention-Further Support for Universal Prophylaxis.
Topics: Aspirin; Communication; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2021 |
Society for Maternal-Fetal Medicine Consult Series #60: Management of pregnancies resulting from in vitro fertilization.
Topics: Aspirin; Female; Fertilization in Vitro; Humans; Perinatology; Placenta; Pregnancy; Prenatal Diagnos | 2022 |
Low-dose aspirin for primary prevention of adverse pregnancy outcomes in twin pregnancies: an observational cohort study based on propensity score matching.
Topics: Adult; Aspirin; China; Cohort Studies; Female; Humans; Infant, Small for Gestational Age; Pre-Eclamp | 2021 |
Aspirin for preeclampsia prevention: does diet play a role?
Topics: Aspirin; Diet; Female; Gestational Age; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Preg | 2022 |
Is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?
Topics: Aspirin; COVID-19; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk F | 2022 |
Prevalence of preeclampsia risk factors: implications for low-dose aspirin prophylaxis.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prevalence | 2022 |
Combined apocyanin and aspirin treatment activates the PI3K/Nrf2/HO-1 signaling pathway and ameliorates preeclampsia symptoms in rats.
Topics: Animals; Aspirin; Female; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinases; Placenta; Pre-Ecla | 2022 |
More evidence for low-dose aspirin in preventing pre-eclampsia.
Topics: Advisory Committees; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2022 |
Estimated Prevalence of Risk Factors for Preeclampsia Among Individuals Giving Birth in the US in 2019.
Topics: Adult; Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Prevalenc | 2022 |
[Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2021 |
Inhibition of HMGB1 Ameliorates the Maternal-Fetal Interface Destruction in Unexplained Recurrent Spontaneous Abortion by Suppressing Pyroptosis Activation.
Topics: Abortion, Habitual; Adult; Animals; Aspirin; Biomarkers; Decidua; Disease Management; Disease Models | 2021 |
Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; Pregnan | 2022 |
Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use.
Topics: Adult; Aspirin; Breast Density; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Hydroxyme | 2022 |
Antepartum Care of the Uterus Transplant Patient: The Experience of 3 Successful US Centers.
Topics: Aspirin; Cesarean Section; Female; Humans; Pre-Eclampsia; Pregnancy; Prenatal Care; Uterus | 2022 |
Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis.
Topics: Aspirin; Female; Humans; Meta-Analysis as Topic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; | 2021 |
Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Hypertension; Length of Stay; Obesity; Pre-Eclampsia; Pr | 2022 |
Could Aspirin Treatment Modify the Assessment of the Uterine Arteries?
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Prospective Studies; Pulsatile Flow; Retrospectiv | 2022 |
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway.
Topics: Aspirin; Cohort Studies; Female; Humans; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; | 2022 |
Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; P | 2022 |
Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study.
Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Heart Disease Risk Factors; Hum | 2022 |
When to give aspirin to prevent preeclampsia: application of Bayesian decision theory.
Topics: Aspirin; Bayes Theorem; Clinical Decision-Making; Female; Humans; Platelet Aggregation Inhibitors; P | 2022 |
Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia.
Topics: Aspirin; Female; Humans; Infant, Newborn; Male; Patient Reported Outcome Measures; Placenta; Pre-Ecl | 2022 |
Low-Dose Aspirin for Preventing Birth of a Small-For-Gestational Age Neonate in a Subsequent Pregnancy.
Topics: Aspirin; Birth Weight; Cohort Studies; Female; Fetal Growth Retardation; Gestational Age; Humans; In | 2022 |
Low-dose aspirin prevents LPS-induced preeclampsia-like phenotype via AQP-1 and the MAPK/ERK 1/2 pathway.
Topics: Animals; Aquaporin 1; Aspirin; Cell Movement; Female; Lipopolysaccharides; MAP Kinase Signaling Syst | 2022 |
[Assessment of a teleophthalmology program for the prevention of diabetes blindness in a rural area of Argentina.]
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Ri | 2022 |
[Use of aspirin 100 mg / day to prevent Preeclampsia, in high risk pregnancies, in a cohort from Argentina].
Topics: Adult; Argentina; Aspirin; Cohort Studies; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy, High | 2022 |
IVF/ICSI outcomes of euthyroid infertile women with thyroid autoimmunity: does treatment with aspirin plus prednisone matter?
Topics: Aspirin; Autoimmunity; Female; Fertilization in Vitro; Humans; Infertility, Female; Prednisone; Preg | 2022 |
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality.
Topics: Aspirin; Female; Humans; Morbidity; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk | 2022 |
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage.
Topics: Angiogenesis Inhibitors; Animals; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Endothelin-1; Epopros | 2022 |
Re: Serum PlGF compared to PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; Pregnan | 2023 |
Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Disease Models, Animal; Female; Flavonoids; Humans; Lipo | 2023 |
Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence.
Topics: Aspirin; Autoimmune Diseases; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pre- | 2022 |
Short-term effects of first trimester low-dose aspirin therapy on uterine artery flow in women at high risk for preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, | 2022 |
Improved implementation of aspirin in pregnancy among Dutch gynecologists: Surveys in 2016 and 2021.
Topics: Aspirin; Female; Gynecology; Humans; Obstetrics; Placenta; Pregnancy; Surveys and Questionnaires | 2022 |
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study.
Topics: Aspirin; Female; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Pre-Eclampsia; Pregnancy; P | 2022 |
Surveys of clinician and patient attitudes to an add-on for in vitro fertilisation.
Topics: Anti-Bacterial Agents; Aspirin; Attitude; Female; Fertilization in Vitro; Humans; Live Birth; Pregna | 2022 |
Low-dose aspirin for prevention of preeclampsia: Implementation of the NICE guideline in Thailand.
Topics: Aspirin; Female; Humans; Maternal Health Services; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Fi | 2022 |
Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
Topics: Abortion, Habitual; Aspirin; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infant, | 2022 |
Bleeding risk in patients with autosomal dominant polycystic kidney disease treated with acetylsalicylic acid: implications for prevention of preeclampsia.
Topics: Aspirin; Female; Humans; Polycystic Kidney, Autosomal Dominant; Pre-Eclampsia; Pregnancy | 2022 |
A retrospective study on IVF/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Aspir | 2022 |
Estimation of the Average Causal Effect in Longitudinal Data With Time-Varying Exposures: The Challenge of Nonpositivity and the Impact of Model Flexibility.
Topics: Aspirin; Causality; Female; Humans; Incidence; Models, Statistical; Pregnancy; Probability | 2022 |
The preventive effect of low-dose aspirin in a PPAR-γ antagonist treated mouse model of preeclampsia.
Topics: Animals; Aspirin; Disease Models, Animal; Female; Mice; Placenta; PPAR gamma; Pre-Eclampsia; Pregnan | 2022 |
Low-dose aspirin therapy improves decidual arteriopathy in pregnant women with a history of preeclampsia.
Topics: Aspirin; Female; Gestational Age; Humans; Infant; Placenta; Placenta Diseases; Pre-Eclampsia; Pregna | 2022 |
Aspirin-Mediated Reset of Preeclamptic Placental Stem Cell Transcriptome - Implication for Stabilized Placental Function.
Topics: Aspirin; Female; Humans; Inflammation; Mesenchymal Stem Cells; Placenta; Pre-Eclampsia; Pregnancy; S | 2022 |
Reply to: Aspirin for the prevention of preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2022 |
Optimal Timing and Aspirin Dose for the Prevention of Preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2022 |
Activated protein C resistance impact on Syrian candidates for in vitro fertilisation and the benefit of anticoagulation therapy: a retrospective cohort study.
Topics: Activated Protein C Resistance; Anticoagulants; Aspirin; Canada; Female; Fertilization in Vitro; Hep | 2022 |
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Wei | 2023 |
Comparison of Low Molecular Weight Heparin Used alone or Combined with Aspirin in the Treatment of Fetal Growth Restriction.
Topics: Aspirin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; I | 2022 |
Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study.
Topics: Aspirin; Cohort Studies; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pregnancy | 2023 |
Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome.
Topics: Animals; Aspirin; Caspase 1; Dietary Supplements; Female; Humans; Inflammasomes; Lipopolysaccharides | 2022 |
2022 Taiwan Guidelines for Acute Treatment of Migraine.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Caffeine; Calcitonin G | 2022 |
Indications for commencing aspirin for the prevention of pregnancy-induced hypertension and pre-eclampsia spectrum disorders.
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy | 2022 |
Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats.
Topics: Animals; Aspirin; Curcumin; Female; Humans; NF-kappa B; Placenta; Placenta Growth Factor; Pre-Eclamp | 2023 |
Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prescriptions; R | 2023 |
Efficacy of discontinuing the use of low-dose aspirin at 28 weeks of gestation for preventing preeclampsia.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Postpartum Hemorrh | 2022 |
Effect of low dose aspirin application during pregnancy on fetal congenital anomalies.
Topics: Aspirin; Female; Fetus; Humans; Pregnancy; Pregnancy Trimester, First; Prenatal Care; Retrospective | 2022 |
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?
Topics: Aspirin; Female; Humans; Infant, Newborn; Placenta; Platelet Aggregation Inhibitors; Pre-Eclampsia; | 2022 |
Low-dose Aspirin may Prevent Preeclampsia by Inhibiting the Expression of ATF2.
Topics: Activating Transcription Factor 2; Aspirin; Female; Humans; Hypertension; Interleukin-6; Interleukin | 2023 |
Aspirin for the prevention of preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2022 |
Aspirin Inhibits the Inflammatory Response of Protease-Activated Receptor 1 in Pregnancy Neutrophils: Implications for Treating Women with Preeclampsia.
Topics: Aspirin; Bicyclic Monoterpenes; Cyclooxygenase 2; Female; Humans; Inflammation; Neutrophils; Peptide | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
Health care workers and key policy informant's knowledge of the use of calcium and low dose aspirin for prevention of preeclampsia in Malawian women.
Topics: Aspirin; Calcium; Calcium, Dietary; Cross-Sectional Studies; Female; Health Personnel; Humans; Polic | 2022 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Preeclampsia in women with lupus - Influence of aspirin and hydroxychloroquine on pregnancy outcome.
Topics: Aspirin; Australia; Female; Humans; Hydroxychloroquine; Pre-Eclampsia; Pregnancy; Pregnancy Complica | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Benefits of Hydroxychloroquine Combined with Low-Dose Aspirin on Pregnancy Outcomes and Serum Cytokines in Pregnant Women with Systemic Lupus Erythematosus.
Topics: Antirheumatic Agents; Aspirin; Cytokines; Female; Humans; Hydroxychloroquine; Infant, Newborn; Lupus | 2023 |
Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Machine Learning; Placenta Growth Factor; Pre- | 2022 |
Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Machine Learning; Placenta Growth Factor; Pre- | 2022 |
Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Machine Learning; Placenta Growth Factor; Pre- | 2022 |
Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Machine Learning; Placenta Growth Factor; Pre- | 2022 |
Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy.
Topics: Aspirin; Female; Humans; Incidence; Nausea; Odds Ratio; Pregnancy; Probability | 2023 |
Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy.
Topics: Aspirin; Female; Humans; Incidence; Nausea; Odds Ratio; Pregnancy; Probability | 2023 |
Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy.
Topics: Aspirin; Female; Humans; Incidence; Nausea; Odds Ratio; Pregnancy; Probability | 2023 |
Estimation of the Time-Varying Incremental Effect of Low-dose Aspirin on Incidence of Pregnancy.
Topics: Aspirin; Female; Humans; Incidence; Nausea; Odds Ratio; Pregnancy; Probability | 2023 |
Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia.
Topics: Aspirin; Checklist; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia.
Topics: Aspirin; Checklist; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia.
Topics: Aspirin; Checklist; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia.
Topics: Aspirin; Checklist; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
Low-dose aspirin protects unexplained recurrent spontaneous abortion
Topics: Abortion, Spontaneous; Animals; Aspirin; Down-Regulation; Female; HMGB1 Protein; Humans; Infant; Inf | 2022 |
The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study. A letter to the Editor.
Topics: Aspirin; Double-Blind Method; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregna | 2023 |
The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study. A letter to the Editor.
Topics: Aspirin; Double-Blind Method; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregna | 2023 |
The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study. A letter to the Editor.
Topics: Aspirin; Double-Blind Method; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregna | 2023 |
The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study. A letter to the Editor.
Topics: Aspirin; Double-Blind Method; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregna | 2023 |
Diagnostic efficacy of aneuploidy markers correlated with early onset preeclampsia.
Topics: alpha-Fetoproteins; Aneuploidy; Aspirin; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, | 2022 |
The effects of heparin, aspirin, and maternal clinical factors on the rate of nonreportable cell-free DNA results: a retrospective cohort study.
Topics: Aspirin; Cell-Free Nucleic Acids; Female; Heparin; Humans; Pregnancy; Prenatal Diagnosis; Retrospect | 2023 |
Reply: Low dose aspirin prophylaxis in pregnant women with chronic hypertension: more questions than answers.
Topics: Aspirin; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pr | 2023 |
Analysis of the guidance and predictive value of uterine artery flow parameters in patients with recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Retrospective | 2023 |
Low-dose aspirin prophylaxis in pregnant women with chronic hypertension: more questions than answers.
Topics: Aspirin; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pr | 2023 |
Authors' response to Letter to the Editor on The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy | 2023 |
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction.
Topics: Arginine; Aspirin; Female; Fetal Growth Retardation; Humans; Maternal Health; Pregnancy; Pregnancy C | 2023 |
Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus.
Topics: Aspirin; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hypertension, Pregnancy-Induced | 2023 |
Aspirin 75 mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China.
Topics: Aspirin; Female; Humans; Male; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Pregnancy, High | 2023 |
Aspirin from early pregnancy to reduce preterm birth.
Topics: Aspirin; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Bir | 2023 |
Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research.
Topics: Aspirin; Child; Child Health; Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Perinatal Deat | 2023 |
Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study.
Topics: Aspirin; Cohort Studies; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
[Update on pregnancy in inflammatory rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Female; Humans; Infant, New | 2023 |
Management and outcomes of women with antiphospholipid syndrome during pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; | 2023 |
Association of preterm outcome with maternal systemic lupus erythematosus: a retrospective cohort study.
Topics: Aspirin; Birth Weight; Child; China; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Lup | 2023 |
Reconsidering the effectiveness of low-dose aspirin in prevention of pre-eclampsia among otherwise low risk twin gestations: A historical cohort study.
Topics: Aspirin; Body Mass Index; Cohort Studies; Female; Humans; Infant, Newborn; Odds Ratio; Pre-Eclampsia | 2023 |
Cell-free fetal DNA impairs trophoblast migration in a TLR9-dependent manner and can be reversed by hydroxychloroquine.
Topics: Aspirin; Cell Line; Cell-Free Nucleic Acids; DNA; Female; Humans; Hydroxychloroquine; Placenta; Pre- | 2023 |
Which first-trimester risk assessment method for preeclampsia is most suitable? A model-based impact study.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Trimes | 2023 |
Low dose acetyl salicylic acid (LDA) mediates epigenetic changes in preeclampsia placental mesenchymal stem cells similar to cells from healthy pregnancy.
Topics: Aspirin; Epigenesis, Genetic; Female; Humans; Mesenchymal Stem Cells; Placenta; Pre-Eclampsia; Pregn | 2023 |
The use of artificial intelligence and machine learning methods in early pregnancy pre-eclampsia screening: A systematic review protocol.
Topics: Artificial Intelligence; Aspirin; Cross-Sectional Studies; Female; Humans; Machine Learning; Meta-An | 2023 |
Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
Topics: Arterial Pressure; Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre | 2023 |
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy.
Topics: Aspirin; Biomarkers; Cross-Sectional Studies; Eicosanoids; Female; Humans; Infant, Newborn; Placenta | 2023 |
Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?
Topics: Aspirin; Female; Gestational Age; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2023 |
Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up.
Topics: Aspirin; Educational Status; Female; Follow-Up Studies; Humans; Pre-Eclampsia; Pregnancy; Risk Facto | 2023 |
Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement.
Topics: Aspirin; Female; Humans; Infant, Newborn; Perinatology; Pre-Eclampsia; Pregnancy; Premature Birth; Q | 2023 |
Low-Dose Aspirin during Pregnancy and Postpartum Bleeding.
Topics: Adult; Anticoagulants; Aspirin; Female; Humans; Postpartum Hemorrhage; Postpartum Period; Pregnancy; | 2023 |
Low Molecular Weight Heparin-Aspirin-Prednisolone Combination Does Not Increase the Live Birth Rate in Recurrent Implantation Failure: A Retrospective Cohort Study.
Topics: Abortion, Spontaneous; Aspirin; Birth Rate; Female; Fertilization in Vitro; Heparin, Low-Molecular-W | 2023 |
The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss.
Topics: Abortion, Spontaneous; Aspirin; Female; Fertility; Humans; Isoprostanes; Pregnancy | 2023 |
Aspirin Discontinuation in Pregnancies at High Risk of Preterm Preeclampsia-Reply.
Topics: Aspirin; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy, High-Risk; Premature | 2023 |
Aspirin Discontinuation in Pregnancies at High Risk of Preterm Preeclampsia.
Topics: Aspirin; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Pregnancy, High-Risk; Premature | 2023 |
The prevalence and perinatal repercussions of preeclampsia after the implementation of a prophylaxis protocol with aspirin.
Topics: Aspirin; Brazil; Female; Fetal Death; Fetal Growth Retardation; Gestational Age; Humans; Infant, New | 2023 |
Recurrent MiscarriageGreen-top Guideline No. 17.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Male; Pregnancy; Pr | 2023 |
Optimal dose of aspirin for the prevention of preterm preeclampsia.
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2023 |
First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study.
Topics: Aspirin; Cohort Studies; Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Pre-Eclampsia; Preg | 2024 |
Implementing Preeclampsia Screening in Switzerland (IPSISS): First Results from a Multicentre Registry.
Topics: Aspirin; Biomarkers; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; Pregnan | 2023 |
Modulation of the activation of endothelial nitric oxide synthase and nitrosative stress biomarkers by aspirin triggered lipoxins: A possible mechanism of action of aspirin in the antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Human Umbilical Vein Endothelial Cells; Humans; Immunogl | 2023 |
Leveraging quality improvement to promote health equity: standardization of prenatal aspirin recommendations.
Topics: Aspirin; Female; Health Promotion; Humans; Pre-Eclampsia; Pregnancy; Quality Improvement; Reference | 2023 |
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Retrospective Studies; Risk Factors | 2023 |
Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands.
Topics: Aspirin; Cost-Effectiveness Analysis; Female; Humans; Infant, Newborn; Netherlands; Pre-Eclampsia; P | 2023 |
Missed opportunities in aspirin prescribing for preeclampsia prevention.
Topics: Aspirin; Female; Humans; Hypertension; Maternal Mortality; Morbidity; Pre-Eclampsia; Pregnancy; Retr | 2023 |
Nutricional intake, maternal outcomes and knowledge on preeclampsia prevention: Was there impact during the COVID-19 pandemic among women with hypertension?
Topics: Adult; Aspirin; Calcium; COVID-19; Female; Humans; Hypertension; Pandemics; Pre-Eclampsia; Pregnancy | 2023 |
Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage.
Topics: Abortion, Habitual; Aspirin; Autophagy; Cell Movement; Cell Proliferation; Female; Humans; MicroRNAs | 2024 |
Let's talk aspirin: A survey of barriers and facilitators faced by midwives when engaging in conversations about aspirin with women at risk of pre-eclampsia.
Topics: Aspirin; Cross-Sectional Studies; Female; Humans; Midwifery; Pre-Eclampsia; Pregnancy; Pregnant Wome | 2023 |
Unveiling the potential effects of acetylsalicylic acid: insights into regeneration in endometrial stem cells.
Topics: Animals; Aspirin; Cell Differentiation; Endometrium; Female; Humans; Mice; Pregnancy; Signal Transdu | 2023 |
Screening for preeclampsia risk and prophylaxis with acetylsalicylic acid.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2023 |
Aspirin protects human trophoblast HTR-8/SVneo cells from H
Topics: Apoptosis; Aspirin; Cell Movement; Female; Humans; Hydrogen Peroxide; Infant, Newborn; NADP; Oxidati | 2023 |
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.
Topics: Adult; Aspirin; Biomarkers; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Plat | 2019 |
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Drug | 2019 |
Aspirin use during pregnancy and hypertensive disorders in women with various risks.
Topics: Adult; Aspirin; China; Cohort Studies; Female; Humans; Hypertension, Pregnancy-Induced; Platelet Agg | 2019 |
Gastrointestinal and uterine smooth muscles relaxant and anti-inflammatory effects of corchorus olitorius leaf extract in laboratory animal models.
Topics: Abortion, Spontaneous; Animals; Anti-Inflammatory Agents; Antidiarrheals; Aspirin; Corchorus; Diarrh | 2020 |
Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: A cohort study.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; China; Drug Therapy, Combination; Female; | 2020 |
Uterine Radial Artery Resistance Index Predicts Reproductive Outcome in Women with Recurrent Pregnancy Losses and Thrombophilia.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Live Bir | 2019 |
Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Live Birth; | 2020 |
Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
Topics: Adult; Arterial Pressure; Asian People; Aspirin; Bayes Theorem; Female; Gestational Age; Humans; Pla | 2019 |
The Impact of the New Hypertension Guidelines to Low-Dose Aspirin Prophylaxis Eligibility for the Prevention of Preeclampsia: A Cost-Benefit Analysis.
Topics: American Heart Association; Aspirin; Blood Pressure; Cost-Benefit Analysis; Eligibility Determinatio | 2021 |
Upgrading Therapy Strategy Improves Pregnancy Outcome in Antiphospholipid Syndrome: A Cohort Management Study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Drug Dosage | 2020 |
Giant right atrial aneurysm. Prenatal diagnosis and outcome of a rare congenital abnormality.
Topics: Adult; Aspirin; Conservative Treatment; Echocardiography; Female; Heart Aneurysm; Heart Atria; Human | 2020 |
Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder.
Topics: Aspirin; Brain; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimest | 2020 |
Vital Considerations for Aspirin in Prevention of Preeclampsia, a Multifaceted Pregnancy Disorder-Reply.
Topics: Aspirin; Brain; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimest | 2020 |
Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.
Topics: Adult; Aspirin; Female; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Lupu | 2019 |
Role of aspirin-triggered lipoxin A4, aspirin, and salicylic acid in the modulation of the oxidative and inflammatory responses induced by plasma from women with pre-eclampsia.
Topics: Acetylation; Adolescent; Adult; Aspirin; Cell Adhesion; Cyclooxygenase 2; Female; Human Umbilical Ve | 2020 |
Analgesic use at ovulation and implantation and human fertility.
Topics: Acetaminophen; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Embryo Implantat | 2020 |
Implementing a Preeclampsia Prediction Model in Obstetrics: Cutoff Determination and Health Care Professionals' Adherence.
Topics: Adult; Aspirin; Clinical Decision Rules; Cohort Studies; Female; Guideline Adherence; Health Personn | 2020 |
Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Blood Coagulation Factors; Cer | 2020 |
Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary.
Topics: Aspirin; Consensus; Cost-Benefit Analysis; Female; Gestational Age; Humans; Hypertension, Pregnancy- | 2020 |
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.
Topics: Aspirin; Cost-Benefit Analysis; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Preg | 2020 |
Response to Letter.
Topics: Aspirin; Cost-Benefit Analysis; Female; Humans; Pre-Eclampsia; Pregnancy | 2020 |
Resistance of aspirin during and after pregnancy: A longitudinal cohort study.
Topics: Adult; Aspirin; Cohort Studies; Drug Resistance; Female; Humans; Hypertension, Pregnancy-Induced; Lo | 2020 |
Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; G | 2020 |
Low-dose-aspirin usage among women with an increased preeclampsia risk: A prospective cohort study.
Topics: Adult; Aspirin; Counseling; Female; Humans; Medication Adherence; Netherlands; Platelet Aggregation | 2020 |
Simple and safe: preventing preterm birth with aspirin.
Topics: Aspirin; Double-Blind Method; Female; Humans; Infant, Newborn; Parity; Pregnancy; Premature Birth | 2020 |
Aspirin modulates STOX1 expression and reverses STOX1-induced insufficient proliferation and migration of trophoblast cells.
Topics: Apoptosis; Aspirin; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; H | 2020 |
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents | 2020 |
Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis.
Topics: Adult; Aspirin; Australia; Communication; Female; Humans; Medication Adherence; Pre-Eclampsia; Pregn | 2020 |
Aspirin to Prevent Preterm Preeclampsia: More Progress.
Topics: Aspirin; Cohort Studies; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclam | 2020 |
Clinical Influence of Nonadherence With Prophylactic Aspirin in Preventing Preeclampsia in High-Risk Pregnancies: A Multicenter, Prospective, Observational Cohort Study.
Topics: Adult; Aspirin; Female; Humans; Incidence; Medication Adherence; Platelet Aggregation Inhibitors; Pr | 2020 |
Effect of current guidelines on prevention of pre-eclampsia with low-dose aspirin in primary settings: A population-based case-control study.
Topics: Adult; Aspirin; Case-Control Studies; Female; Guideline Adherence; Humans; Infant, Newborn; Infant, | 2020 |
Maternal cardiac function in women at high risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study.
Topics: Adult; Arterial Pressure; Aspirin; Cardiac Output; Female; Gestational Age; Humans; Longitudinal Stu | 2020 |
D-Dimer Assay May Guide LMWH Treatment in Repeated Biochemical Pregnancy Losses in Women with Positive Antiphospholipid Antibody.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Fibrin | 2020 |
Destruction in maternal-fetal interface of URSA patients via the increase of the HMGB1-RAGE/TLR2/TLR4-NF-κB signaling pathway.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antigens, Neoplasm; Aspirin; Female; Fetus; Gene Expressi | 2020 |
The role of aspirin in prevention of preeclampsia in twin pregnancies: does the dose matter?
Topics: Aspirin; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Pre-Eclampsia; Pregnancy; | 2020 |
Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension.
Topics: Adult; Aspirin; Cohort Studies; Female; Humans; Hypertension; Incidence; Philadelphia; Platelet Aggr | 2020 |
[Can low dose aspirin be proposed to reduce preterm birth, if started in the early pregnancy?]
Topics: Aspirin; Female; Humans; Infant, Newborn; Pre-Eclampsia; Pregnancy; Premature Birth | 2020 |
Aspirin and pre-eclampsia: the heart of the matter?
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2020 |
Low-dose aspirin improves endometrial receptivity in the midluteal phase in unexplained recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; China; Endometrium; Female; Humans; Pregna | 2020 |
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; | 2020 |
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Vi | 2020 |
The effect of antithrombotic therapy on the recurrence of placenta-mediated diseases in pregnancy.
Topics: Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Placenta; Pre-Eclampsia | 2022 |
Platelet activation and placenta-mediated adverse pregnancy outcomes: an ancillary study to the Effects of Aspirin in Gestation and Reproduction trial.
Topics: Abruptio Placentae; Adult; Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension, Pregnanc | 2020 |
Low-dose aspirin for prevention of pre-eclampsia: when over the counter just isn't.
Topics: Aspirin; Female; Humans; Nonprescription Drugs; Pre-Eclampsia; Pregnancy | 2020 |
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies.
Topics: Adult; Algorithms; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; beta 2-Glycop | 2021 |
Association Between Male Use of Pain Medication and Fecundability.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Birth Rate; Cohort Studies; | 2020 |
Society for Maternal-Fetal Medicine Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin.
Topics: Aspirin; Checklist; Female; Gestational Age; Health Plan Implementation; Humans; Mass Screening; Pre | 2020 |
Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin.
Topics: Adult; Aspirin; Eicosanoids; Female; Humans; Mass Spectrometry; Placenta; Pre-Eclampsia; Pregnancy; | 2020 |
Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Incidence; Mass Screening; Pre-Ecl | 2020 |
Patients' perspective on aspirin during pregnancy: a survey.
Topics: Adult; Aspirin; Female; Health Knowledge, Attitudes, Practice; Humans; Hypertension, Pregnancy-Induc | 2020 |
[Acetylsalicylic acid in prevention of pre-eclampsia].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; R | 2019 |
Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.
Topics: Adult; Algorithms; Aspirin; Female; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Pre-Eclamps | 2021 |
Thrombophilia associated gene polymorphisms: Does use of medication, including anti-coagulants, minerals or folic acid, prevent the miscarriages?
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Dietary Supplements; Female; Folic Acid; Humans; | 2020 |
Society for Maternal-Fetal Medicine Special Statement: Checklist for postpartum discharge of women with hypertensive disorders.
Topics: Aspirin; Blood Pressure Monitoring, Ambulatory; Checklist; Exercise; Female; Humans; Hypertension, P | 2020 |
Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Vit | 2020 |
Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Female; Humans; Postpartum | 2021 |
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Hy | 2020 |
Society for Maternal-Fetal Medicine Special Statement: Updated checklist for antepartum care of pregestational diabetes mellitus.
Topics: Aspirin; Checklist; Delivery, Obstetric; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disea | 2020 |
Aspirin should be targeted to those who need it.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnanc | 2021 |
Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticoagulants; A | 2020 |
The 15-Epilipoxin-A4 Pathway with Prophylactic Aspirin in Preventing Preeclampsia: A Longitudinal Cohort Study.
Topics: Adult; Aspirin; Case-Control Studies; Chemoprevention; Cohort Studies; Female; Humans; Lipoxins; Lon | 2020 |
Placental syncytiotrophoblast extracellular vesicles enter primary endothelial cells through clathrin-mediated endocytosis.
Topics: Adult; Aspirin; Clathrin; Endocytosis; Endothelial Cells; Extracellular Vesicles; Female; Gene Expre | 2020 |
Aspirin non-response in pregnant women at increased risk of pre-eclampsia.
Topics: Aspirin; Cohort Studies; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2020 |
Improving Utilization of Aspirin for Prevention of Preeclampsia in a High-Risk Urban Cohort: A Prospective Cohort Study.
Topics: Adult; Aspirin; Cohort Studies; Drug Administration Schedule; Female; Gestational Age; Humans; Plate | 2021 |
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.
Topics: Animals; Aspirin; Female; Heme Oxygenase-1; Hydrogen Sulfide; Membrane Proteins; Mice; Pre-Eclampsia | 2021 |
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Interferon-alp | 2021 |
Analysis of the risk factors and treatment for repeated implantation failure: OPtimization of Thyroid function, IMmunity, and Uterine Milieu (OPTIMUM) treatment strategy.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Aspirin; Autoantibodies; Embryo Implantation; Endometr | 2021 |
Efficacy and safety of low dose aspirin and magnesium sulfate in the treatment of pregnancy induced hypertension: A protocol for systematic review and meta-analysis.
Topics: Aspirin; Clinical Protocols; Female; Humans; Hypertension, Pregnancy-Induced; Magnesium Sulfate; Met | 2020 |
81-mg aspirin: a dosing dilemma.
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy | 2021 |
81 mg aspirin: a dosing dilemma response.
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy | 2021 |
Impact of aspirin on preeclampsia response.
Topics: Aspirin; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Ri | 2021 |
Impact of aspirin on preeclampsia.
Topics: Aspirin; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Ri | 2021 |
Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Cohort Studies; Female; Gestational Age; Heparin | 2021 |
Does aspirin prescribed to women deemed high risk for preterm pre-eclampsia at 11-13
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Small f | 2021 |
Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Antinuclear; Aspirin; Female; Humans; Infant, Newborn; Prednisone; P | 2021 |
Preeclampsia Risk and Prevention among Pregnant Medicaid Beneficiaries.
Topics: Aspirin; Female; Humans; Infant, Newborn; Medicaid; Mothers; Pre-Eclampsia; Pregnancy; Risk; United | 2020 |
NETosis Markers in Pregnancy: Effects Differ According to Histone Subtypes.
Topics: Adult; Apoptosis; Aspirin; Cell Line; Cell Movement; Enoxaparin; Extracellular Traps; Female; France | 2021 |
"Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome.
Topics: Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Attitude of Health Person | 2021 |
The timing of aspirin administration in pregnancy is important to prevent preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2021 |
The timing of aspirin administration in pregnancy is important to prevent preeclampsia.
Topics: Aspirin; Ethnicity; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk | 2021 |
Summary for Patients: The Effect of Preconception-Initiated Low-Dose Aspirin on Human Chorionic Gonadotropin-Detected Pregnancy, Pregnancy Loss, and Live Birth.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Gonadotrop | 2021 |
Aspirin reduces sFlt-1-mediated apoptosis of trophoblast cells in preeclampsia.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Aspirin; Cell Line; Female; Humans; I-kappa B Prot | 2021 |
Risk of aspirin among pregnant women.
Topics: Aspirin; Female; Humans; Pregnancy; Pregnancy Trimester, First; Pregnant Women; Prenatal Diagnosis | 2022 |
Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study.
Topics: Abortion, Habitual; Adult; Arachidonic Acid; Aspirin; Case-Control Studies; Female; Humans; Platelet | 2022 |
Aspirin and pre-eclampsia prevention in women with pre-existing diabetes: a retrospective study.
Topics: Aspirin; Diabetes Mellitus; Female; Humans; Placenta; Pre-Eclampsia; Pregnancy; Retrospective Studie | 2021 |
Low-Dose Aspirin Prevents Kidney Damage in LPS-Induced Preeclampsia by Inhibiting the WNT5A and NF-κB Signaling Pathways.
Topics: Animals; Apoptosis; Aspirin; Blood Pressure; Blood Proteins; Cell Line; Cells, Cultured; Disease Mod | 2021 |
Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia.
Topics: Adult; Antigens, CD; Aspirin; Cadherins; Cell Line; Cell Movement; Cell Proliferation; Epithelial-Me | 2021 |
Competing risks model for prediction of preeclampsia in women who took aspirin prophylaxis in a previous pregnancy.
Topics: Aspirin; Female; Gravidity; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2021 |
Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study : This is the study for kidney and pregnancy...
Topics: Aspirin; Female; Humans; Kidney; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnanc | 2021 |
Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women.
Topics: Antiphospholipid Syndrome; Aspirin; Desensitization, Immunologic; Female; Humans; Pre-Eclampsia; Pre | 2021 |
Low Dose Aspirin in high-risk pregnancies: The volatile effect of acetylsalicylic acid on the inhibition of platelets uncovered by G. Born's light transmission aggregometry.
Topics: Adult; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Female; Humans; Platelet Aggregat | 2021 |
Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window.
Topics: Animals; Aspirin; Embryo Implantation; Endometriosis; Endometrium; Female; Infertility, Female; Leuk | 2021 |
The impact of low-dose aspirin on markers of inflammation and placental function: an ancillary study of the ASPIRIN trial.
Topics: alpha-Fetoproteins; Aspirin; Biomarkers; Case-Control Studies; Female; Humans; Inflammation; Placent | 2022 |
Prediction of preterm pre-eclampsia according to NICE and ACOG criteria: descriptive study of 597 492 Danish births from 2008 to 2017.
Topics: Adult; Aspirin; Denmark; Female; Gestational Age; Humans; Incidence; Infant, Newborn; Obstetrics; Pr | 2021 |
Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Endothelial Cells; | 2022 |
Pregnancy in patients with myelofibrosis: Mayo-Florence series of 24 pregnancies in 16 women.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Diabetes, Gestational; Female; Fetal Death; Hemo | 2021 |
Effects of aspirin, vitamin D3, and progesterone on pregnancy outcomes in an autoimmune recurrent spontaneous abortion model.
Topics: Abortion, Habitual; Animals; Aspirin; Cholecalciferol; Female; Humans; Mice; Placenta; Pregnancy; Pr | 2021 |
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia - A qualitative study.
Topics: Adult; Aspirin; Female; Humans; Interviews as Topic; Patient Compliance; Patient Education as Topic; | 2021 |
Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
Topics: Abruptio Placentae; Aspirin; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; Humans | 2022 |
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antirheumatic Agents; Aspirin; Drug Tapering; Europe; Fema | 2021 |
The preventive effects of aspirin on preeclampsia based on network pharmacology and bioinformatics.
Topics: Aspirin; Computational Biology; Female; Gene Regulatory Networks; Humans; Molecular Docking Simulati | 2022 |
Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Metabolome; Pre-Eclampsia; Pregnancy | 2021 |
50 Years Ago in TheJournalofPediatrics: Neonatal Platelet Aggregation: Effects of Antenatal Aspirin.
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation; Platelet Aggregation Inhibitors; Pre | 2021 |
Low-dose aspirin improves blood perfusion of endometrium of unexplained recurrent biochemical pregnancy loss.
Topics: Abortion, Habitual; Aspirin; China; Endometrium; Female; Humans; Perfusion; Pregnancy; Retrospective | 2022 |
[For a targeted use of aspirin].
Topics: Abnormalities, Drug-Induced; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pre-Eclampsia; Preg | 2017 |
Combining several interventions to reduce the incidence of OHSS: A prospective cohort study.
Topics: Adult; Aspirin; Cabergoline; Chorionic Gonadotropin; Drug Therapy, Combination; Ergolines; Female; G | 2017 |
Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
Topics: Adult; Anticoagulants; Aspirin; Case-Control Studies; Comorbidity; Female; Fetal Growth Retardation; | 2018 |
Transfer of Low Dose Aspirin Into Human Milk.
Topics: Adult; Aspirin; Breast Feeding; Chromatography, Liquid; Female; Humans; Lactation; Middle Aged; Milk | 2017 |
Early Identification of Pregnant Women at Risk for Preeclampsia: USPSTF Recommendations on Screening for Preeclampsia.
Topics: Aspirin; Blood Pressure Determination; Early Diagnosis; Female; Gynecology; Humans; Mass Screening; | 2017 |
Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Diabetes Mellitus, Type 2; | 2017 |
Recurrent Massive Perivillous Fibrin Deposition and Chronic Intervillositis Treated With Heparin and Intravenous Immunoglobulin: A Case Report.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Chorionic Villi; Daltepar | 2017 |
USPSTF recommendations: A 2017 roundup.
Topics: Advisory Committees; Aspirin; Breast Feeding; Cardiovascular Diseases; Colorectal Neoplasms; Dose-Re | 2017 |
Essential Thrombocytosis and Labor Epidural Placement While on Aspirin: Assessing Hemorrhagic Risks: A Case Report.
Topics: Adult; Anesthesia, Epidural; Aspirin; Bupivacaine; Female; Fentanyl; Humans; Labor, Obstetric; Lidoc | 2017 |
Comment on: Preventing preeclampsia with aspirin: does dose or timing matter?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 2017 |
Serological evolution in women with positive antiphospholipid antibodies.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; | 2017 |
Low Rates of Aspirin Use for the Prevention of Preeclampsia.
Topics: Aspirin; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Pre-Eclampsia; Pregnancy; Retrosp | 2017 |
Non-invasive management of post-partum spontaneous left main coronary artery dissection using cardiac computed tomography angiography.
Topics: Adult; Aspirin; Bisoprolol; Cesarean Section; Clopidogrel; Computed Tomography Angiography; Conserva | 2017 |
Quality measures in high-risk pregnancies: Executive Summary of a Cooperative Workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists.
Topics: Antibiotic Prophylaxis; Aspirin; Cesarean Section; Congresses as Topic; Female; Fetal Growth Retarda | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Topics: Adult; Algorithms; Aspirin; Body Mass Index; Evidence-Based Medicine; Female; Gestational Age; Human | 2017 |
Aspirin to Prevent Preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2017 |
Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Hy | 2017 |
Pre-eclampsia: Screening and aspirin therapy for prevention of pre-eclampsia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Mass Screening; Patient Selection; | 2017 |
Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.
Topics: Aspirin; Early Diagnosis; Female; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as To | 2017 |
Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.
Topics: Aspirin; Early Diagnosis; Female; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as To | 2017 |
Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.
Topics: Aspirin; Early Diagnosis; Female; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as To | 2017 |
Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.
Topics: Aspirin; Early Diagnosis; Female; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as To | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Ethnicity; Evidence-Based Medicine; Female; Humans; Logistic Mo | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Ethnicity; Evidence-Based Medicine; Female; Humans; Logistic Mo | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Ethnicity; Evidence-Based Medicine; Female; Humans; Logistic Mo | 2017 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia.
Topics: Adult; Aspirin; Double-Blind Method; Ethnicity; Evidence-Based Medicine; Female; Humans; Logistic Mo | 2017 |
Aspirin Lowers the Risk of Preeclampsia.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; Platelet Aggreg | 2017 |
Impact of early supplementation with low-dose aspirin on functional first trimester parameters in low-risk pregnancies.
Topics: Adult; Aspirin; Case-Control Studies; Female; Humans; Placentation; Platelet Aggregation Inhibitors; | 2019 |
Influence of perinatal low-dose acetylsalicylic acid therapy on fetal hemodynamics evaluated by determining the acceleration-time/ejection-time ratio in the ductus arteriosus.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ductus Arteriosus; Female; Gestational Age; | 2018 |
The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Communication; Cells, Cultured; Coculture Tec | 2017 |
Maternal Characteristics for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes (GOS) Study.
Topics: Adult; Aspirin; Body Mass Index; Female; Humans; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk | 2018 |
Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.
Topics: Adult; Aspirin; Cytokines; Embryo Implantation; Embryo Transfer; Female; Fertilization in Vitro; Gen | 2017 |
Preeclampsia in pregnancies complicated by systemic lupus erythematosus (SLE) nephritis: prophylactic treatment with multidisciplinary approach are important keys to prevent adverse obstetric outcomes.
Topics: Adult; Antibodies, Antiphospholipid; Aspirin; Case-Control Studies; Creatinine; Female; Fibrinolytic | 2019 |
Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Cells, Cult | 2018 |
Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Aspirin; Cerebral Palsy; Cohort Studies; Female; Hum | 2018 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Aspirin; Female; Humans; Infant, Newborn; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; | 2017 |
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Topics: Aspirin; Female; Humans; Hypertension; Infant, Newborn; Pre-Eclampsia; Pregnancy; Risk | 2017 |
Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis.
Topics: Adult; Aspirin; Blood Pressure Determination; Case-Control Studies; Female; Humans; Maternal Age; Mi | 2018 |
[Pregnancy outcome in a woman with premature ovarian insufficiency complicated by systemic lupus erythematosus during pregnancy: a case report].
Topics: Aspirin; Cesarean Section; Embryo Transfer; Female; Fertilization in Vitro; Humans; Lupus Erythemato | 2017 |
Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia.
Topics: Adult; Aspirin; Female; Fetal Death; Humans; Middle Aged; Platelet Aggregation Inhibitors; Pre-Eclam | 2018 |
Acetylsalicylic acid in pregnant women with chronic hypertension.
Topics: Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovasc | 2018 |
Effect of early use of low-dose aspirin therapy on late-onset preeclampsia.
Topics: Adult; Aspirin; Case-Control Studies; Delivery, Obstetric; Female; Gestational Age; Humans; Infant, | 2019 |
Low-Dose Aspirin for the Prevention of Preeclampsia.
Topics: Adult; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Risk Factors | 2018 |
Aspirin Ameliorates Preeclampsia Induced by a Peroxisome Proliferator-Activated Receptor Antagonist.
Topics: Animals; Aspirin; Benzamides; Blood Pressure; Cyclooxygenase Inhibitors; Disease Models, Animal; Fem | 2018 |
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.
Topics: Adult; Aspirin; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature; Intensi | 2018 |
The protective action of tocopherol and acetylsalicylic acid on the behavior of rats treated with dioxins.
Topics: Animals; Animals, Newborn; Aspirin; Behavior, Animal; Brain; Central Nervous System; Dioxins; Female | 2018 |
Tooth development disorders in infants of rat dams exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and protective role of tocopherol and acetylsalicylic acid.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Environme | 2017 |
[Is universal first trimester screening for high risk of preterm preeclampsia clinically meaningful?]
Topics: Aspirin; Biomarkers; Female; Humans; Mass Screening; Placenta Growth Factor; Pre-Eclampsia; Pregnanc | 2018 |
Using extended theory of planned behavior to understand aspirin adherence in pregnant women.
Topics: Adaptation, Psychological; Adult; Aspirin; Cardiovascular Agents; Female; Health Knowledge, Attitude | 2018 |
Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
Topics: Adult; Algorithms; Aspirin; Cost-Benefit Analysis; Decision Trees; Female; Humans; Mass Screening; P | 2019 |
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Topics: Adult; Aspirin; Biomarkers; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newbo | 2018 |
The intervention effect of aspirin on a lipopolysaccharide-induced preeclampsia-like mouse model by inhibiting the nuclear factor-κB pathway.
Topics: Animals; Aspirin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Inter | 2018 |
Excerpts from the World Medical Literature: Obstetrics.
Topics: Aspirin; Female; Humans; Infant, Newborn; Obstetrics; Pre-Eclampsia; Pregnancy; Premature Birth; Vit | 2018 |
Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Carrier State; Female; Foll | 2018 |
Postpartum spontaneous renal blood vessel rupture followed by pulmonary artery thromboembolism associated with protein C deficiency.
Topics: Adult; Aspirin; Cesarean Section; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnanc | 2019 |
ACOG Committee Opinion No. 743 Summary: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
Topics: Adult; Aspirin; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregati | 2018 |
Acetaminophen and Acetylsalicylic Acid Exposure in a Preterm Infant after Maternal Overdose.
Topics: Acetaminophen; Antidepressive Agents; Antidotes; Aspirin; Cystine; Drug Overdose; Female; Humans; In | 2019 |
Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.
Topics: Adult; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Moscow; Pregnanc | 2018 |
Ameliorative effects of aspirin against lipopolysaccharide-induced preeclampsia-like symptoms in rats by inhibiting the pro-inflammatory pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cytokines; Disease Models, Animal; Down-R | 2018 |
Chronic Hypertension in Pregnancy: New Concepts for Classification and Management.
Topics: Adult; Antihypertensive Agents; Aspirin; Chronic Disease; Female; Humans; Hypertension; Hypertension | 2019 |
Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Loss, Surgical; Blood Transfusion; | 2018 |
The ASPRE pre-eclampsia trial: implications for basic research and clinical practice.
Topics: Aspirin; Blood Pressure; Cardiovascular Agents; Evidence-Based Medicine; Female; Humans; Pre-Eclamps | 2018 |
The effect of aspirin on placental vessels reactivity using the ex-vivo placental perfusion model.
Topics: Aspirin; Extracorporeal Circulation; Female; Humans; Perfusion; Placenta; Pregnancy | 2018 |
Preventing preterm preeclampsia.
Topics: Aspirin; Female; Humans; Infant, Newborn; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Prem | 2018 |
In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Case-Control Studies; Child, Pres | 2018 |
Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; Humans; | 2019 |
Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; Humans; | 2019 |
Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; Humans; | 2019 |
Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Female; Humans; | 2019 |
Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines.
Topics: Adult; Aspirin; Cell Adhesion; Cell Proliferation; Cytokines; Decidua; Female; Humans; Male; Mesench | 2018 |
Successful Pregnancy under Fibrinogen Substitution with Heparin and Aspirin in a Woman with Dysfibrinogenemia Revealed by Placental Abruption.
Topics: Abruptio Placentae; Afibrinogenemia; Aspirin; Cesarean Section; Consanguinity; Female; Fibrinogen; G | 2018 |
Toxic Ingestion of Acetaminophen and Acetylsalicylic Acid in a Parturient at 33 Weeks Gestation: A Case Report.
Topics: Acetaminophen; Acetylcysteine; Adult; Aspirin; Cesarean Section; Charcoal; Drug Overdose; Female; Fe | 2019 |
Aspirin In The Prevention Of Pre-Eclampsia: Where Are We Now?
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Endothelium; Epoprost | 2018 |
A prophylactic low-dose aspirin earlier than 12 weeks until delivery should be considered to prevent preeclampsia.
Topics: Anti-Inflammatory Agents; Aspirin; Endothelium, Vascular; Epoprostenol; Female; Humans; Obstetrics; | 2018 |
Management of a pregnancy with underlying fibromuscular dysplasia with a history of stroke and carotid artery dissection.
Topics: Adult; Aortic Dissection; Aspirin; Carotid Artery Diseases; Female; Fibromuscular Dysplasia; Humans; | 2019 |
ACOG Practice Bulletin No. 201 Summary: Pregestational Diabetes Mellitus.
Topics: Administration, Oral; Aspirin; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; | 2018 |
Association of intrauterine exposure to aspirin and blood pressure at 7 years of age: a secondary analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Child; Female; Humans; Hypertensio | 2019 |
Aspirin in Preeclampsia and Its Molecular Intermediators.
Topics: Aspirin; Female; Humans; Peroxisome Proliferator-Activated Receptors; Platelet Aggregation Inhibitor | 2018 |
Treatment for patients with recurrent fetal losses positive for anti-cardiolipin beta2 glycoprotein I antibody using Sairei-to (Chai-ling-tang) and low-dose aspirin.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; beta 2-Glycoprotein I; Cardiolipins; Drug Therap | 2019 |
Aspirin use during pregnancy and hypoxia-related placental pathology.
Topics: Adult; Aspirin; Case-Control Studies; Female; Humans; Hypoxia; Middle Aged; Placenta; Placental Insu | 2018 |
Obstetrical morbidity related to anti-SSA antibodies: Data from a French monocentric retrospective study.
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Aspirin; Databases, Factual; Female; Fran | 2019 |
[Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome].
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 2018 |
Preeclampsia Prevention Using Routine Versus Screening Test-Indicated Aspirin in Low-Risk Women.
Topics: Aspirin; Cost-Benefit Analysis; Female; Humans; Mass Screening; Models, Theoretical; Platelet Aggreg | 2018 |
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Platelet Agg | 2019 |
Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy.
Topics: Adult; Age Factors; Aspirin; Female; Fibrinolytic Agents; Follow-Up Studies; Hospitalists; Humans; H | 2019 |
Stroke prevention: How low can you go?
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Pregnancy; Stroke | 2019 |
Delayed hemolysis, elevated liver enzymes, low platelet count syndrome in succession of switches of preventive anticoagulant treatment in a 41-year-old patient with a history of recurrent assisted implantation failures: a case report.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Female; HELLP Syndrome; Heparin, Low-Molecular-Wei | 2019 |
Obstetricians' knowledge and practices regarding the management of preeclampsia.
Topics: Aspirin; Female; Humans; Obstetrics; Physicians; Pre-Eclampsia; Pregnancy; Prospective Studies; Unit | 2020 |
An Irish National Diabetes in Pregnancy Audit: aiming for best outcomes for women with diabetes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cesarean Section; Clinical Audit; Delivery of Health Care; De | 2020 |
An aspirin a day in pregnancy keeps childhood hypertension away?
Topics: Aspirin; Blood Pressure; Child; Female; Humans; Hypertension; Platelet Aggregation Inhibitors; Pregn | 2019 |
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cohort | 2019 |
Management of idiopathic recurrent pericarditis during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Disease Management; Female; | 2019 |
Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis.
Topics: Aspirin; Female; Heparin; Humans; Infant, Newborn; Network Meta-Analysis; Pre-Eclampsia; Pregnancy; | 2019 |
Aspirin causes endothelium-dependent vasodilation of resistance arteries from non-gravid and gravid rats.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Mesenteric Arteries; Placenta; P | 2019 |
A Nudge Toward Universal Aspirin for Preeclampsia Prevention.
Topics: Aspirin; Attitude of Health Personnel; Female; Guideline Adherence; Humans; Platelet Aggregation Inh | 2019 |
Antagonists of TNFα for recurrent miscarriages: 2 Illustrative cases.
Topics: Abortion, Habitual; Adalimumab; Adult; Anti-Inflammatory Agents; Aspirin; Drug Therapy, Combination; | 2019 |
Management and outcome of 11 pregnancies in women with polycythemia vera.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Disease Management; Drug Th | 2019 |
Practical approach to the prevention of preeclampsia: from screening to pharmaceutical intervention.
Topics: Aspirin; Female; Humans; Mass Screening; Pharmaceutical Preparations; Pre-Eclampsia; Pregnancy; Pren | 2021 |
Enoxaparin (or plus aspirin) for the prevention of recurrent miscarriage: a meta-analysis of randomized controlled studies.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Pregnancy; Prospective Stud | 2019 |
Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Cell Hypoxia; Cell Line; Cell Mo | 2019 |
Significant infrarenal aortic stenosis in pregnancy: a case report.
Topics: Adult; Aortic Valve Stenosis; Aspirin; Calcium; Calcium-Regulating Hormones and Agents; Cesarean Sec | 2019 |
Views and preferences of medical professionals and pregnant women about a novel primary prevention intervention for hypertensive disorders of pregnancy: a qualitative study.
Topics: Adult; Aspirin; Attitude of Health Personnel; Calcium; Decision Making; Female; General Practitioner | 2019 |
Short-term dexamethasone plus acetylsalicylic acid treatment during in vitro fertilization procedure.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Case-Control Studies; Dexamethasone; Embryo Implantation; | 2019 |
Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME.
Topics: Animals; Aspirin; Blood Pressure; Cytokines; Dietary Supplements; Disease Models, Animal; Female; In | 2019 |
Low-dose aspirin as a promising agent for the prevention of spontaneous preterm birth.
Topics: Aspirin; Female; Humans; Infant, Newborn; Parity; Pregnancy; Premature Birth | 2019 |
Pregnancy with Chuvash Polycythaemia and Other Congenital Erythrocytosis.
Topics: Adult; Aspirin; Female; Ferritins; Heparin, Low-Molecular-Weight; Homozygote; Humans; Iron; Polycyth | 2020 |
Reducing maternal mortality: can elabela help in this fight?
Topics: Age of Onset; Animals; Aspirin; Female; Global Health; Health Promotion; Humans; Maternal Health; Ma | 2019 |
Infertility and pregnancy in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: More than just primary ovarian failure?
Topics: Aspirin; Female; Fertilization in Vitro; Humans; Hypertension; Immunoglobulins, Intravenous; Immunol | 2019 |
Aspirin enhances trophoblast invasion and represses soluble fms-like tyrosine kinase 1 production: a putative mechanism for preventing preeclampsia.
Topics: Aspirin; Cell Line; Cells, Cultured; Female; Humans; Pre-Eclampsia; Pregnancy; Trophoblasts; Vascula | 2019 |
Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Aspirin; Diagnosis, Differential; Factor V; Female; Hea | 2019 |
Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Fema | 2013 |
Aspirin desensitization in a woman with inherited thrombophilia and recurrent miscarriage.
Topics: Abortion, Habitual; Administration, Oral; Adult; Anaphylaxis; Aspirin; Desensitization, Immunologic; | 2012 |
Management of pregnant women with myeloproliferative neoplasms.
Topics: Adult; Aspirin; Blood Viscosity; Female; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Inc | 2013 |
Aspirin and heparin as adjuvants during IVF do not improve live birth rates in unexplained implantation failure.
Topics: Adult; Aspirin; Birth Rate; Embryo Implantation; Female; Fertilization in Vitro; Heparin; Humans; In | 2013 |
Aspirin in the prevention of pre-eclampsia in high-risk women.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2013 |
Initiation of aspirin in early gestation for the prevention of pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2013 |
Initiation of aspirin in early gestation for the prevention of pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2013 |
Aspirin and heparin to improve live birth rate in IVF for unexplained implantation failure?
Topics: Aspirin; Birth Rate; Embryo Implantation; Female; Fertilization in Vitro; Heparin; Humans; Male; Pre | 2013 |
Aspirin for pre-eclampsia: beware of subgroup meta-analysis.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Outcome | 2013 |
Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Female; Humans; Hypertension; Pre-Eclampsia; Pregnancy; Pre | 2013 |
Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Case | 2013 |
Toxicity studies of a bioactive protein with antithrombotic-thrombolytic activity, DLBS1033.
Topics: Analysis of Variance; Animals; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Evaluati | 2014 |
Acute myocardial infarction in pregnancy following unlicensed use of methylenedioxymethamphetamine ('Ecstasy').
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Adult; Aspirin; Bisoprolol; Ch | 2013 |
[Thrombosis risk during pregnancy after history of cerebral venous thrombosis].
Topics: Adult; Anticoagulants; Aspirin; Chemoprevention; Family Health; Female; Humans; Intracranial Thrombo | 2015 |
Paracetamol, aspirin, and indomethacin induce endocrine disturbances in the human fetal testis capable of interfering with testicular descent.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Acetaminophen; Analgesics, Non-Narcotic; Androgens; | 2013 |
Aspirin and low-molecular weight heparin combination therapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Heparin, Low- | 2013 |
A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antinuclear; Aspirin; Female; Fertilization in Vitro; Huma | 2013 |
Response: aspirin to improve IVF unexplained implantation rates: time for an individualized approach.
Topics: Aspirin; Embryo Implantation; Embryo Transfer; Female; Fertilization in Vitro; Heparin; Humans; Prec | 2014 |
Aspirin to improve IVF unexplained implantation rates: time for an individualized approach.
Topics: Aspirin; Birth Rate; Embryo Implantation; Female; Fertilization in Vitro; Heparin; Humans; Male; Pre | 2014 |
Anti-phospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Autoimmune Diseases; Female; Humans; Male; Pr | 2014 |
Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle | 2015 |
Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition?
Topics: Adult; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Fem | 2014 |
[Aspirin for migraine in pregnancy. This recommendation seems questionable].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraindications; Female; Humans; Ibuprofen; Infa | 2013 |
First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation.
Topics: Adolescent; Adult; Aspirin; Blood Pressure; Body Mass Index; Decision Support Techniques; Drug Admin | 2014 |
Improving livebirth rates: a role for preconception aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Live Birth; Preconception Care; Pr | 2014 |
[Pregnancy outcome in 54 patients with antiphospholipid syndrome: a retrospective clinical study].
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retardation; Heparin | 2014 |
USPSTF: Low-dose aspirin may help reduce risk of preeclampsia.
Topics: Advisory Committees; Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibit | 2014 |
Low-dose aspirin for the prevention of adverse pregnancy outcomes in women with elevated alpha-fetoprotein.
Topics: alpha-Fetoproteins; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications | 2015 |
Hypoxia and the anticoagulants dalteparin and acetylsalicylic acid affect human placental amino acid transport.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Transport System A; Amino Acid Transport System L; | 2014 |
Sticky platelet syndrome: history and future perspectives.
Topics: Aspirin; Blood Platelet Disorders; Female; History, 20th Century; History, 21st Century; Humans; Mal | 2014 |
Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline.
Topics: American Heart Association; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Practice Guide | 2014 |
Restoration of ovarian function and natural fertility following the cryopreservation and autotransplantation of whole adult sheep ovaries.
Topics: Animals; Anti-Mullerian Hormone; Anticoagulants; Aspirin; Cryopreservation; Drug Therapy, Combinatio | 2014 |
Low-dose aspirin for prevention of preeclampsia.
Topics: Aspirin; Drug Approval; Female; Fibrinolytic Agents; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Low-molecular -weight heparin in pregnancies after ART -a retrospective study-.
Topics: Adult; Anticoagulants; Aspirin; Embryo Implantation; Female; Heparin, Low-Molecular-Weight; Humans; | 2014 |
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Europe; Female; Heparin; Hu | 2014 |
Chronic histiocytic intervillositis: outcome, associated diseases and treatment in a multicenter prospective study.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cell Movement; Chorionic Vi | 2015 |
Caution regarding first trimester screening for pre-eclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Re: New directions in the prediction of pre-eclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Re: New directions in the prediction of pre-eclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
Topics: Aspirin; Biomedical Research; Cost of Illness; Female; Humans; Platelet Aggregation Inhibitors; Pre- | 2014 |
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
Topics: Aspirin; Biomedical Research; Cost of Illness; Female; Humans; Platelet Aggregation Inhibitors; Pre- | 2014 |
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
Topics: Aspirin; Biomedical Research; Cost of Illness; Female; Humans; Platelet Aggregation Inhibitors; Pre- | 2014 |
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
Topics: Aspirin; Biomedical Research; Cost of Illness; Female; Humans; Platelet Aggregation Inhibitors; Pre- | 2014 |
Summaries for patients: aspirin to prevent preeclampsia-related complications and death: U.S. Preventive Services Task Force recommendation statement.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Outcom | 2014 |
Preconception-initiated, low-dose aspirin did not increase live birth after 1 or 2 pregnancy losses.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Live Birth; Preconception Care; Pr | 2014 |
Antithrombotic therapy for pregnancy complications: let's not throw the baby out with the bath water.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Live Birth; Preconception Care; Pr | 2015 |
Patient-health care provider relationship: how can it impact on APS (Hughes' syndrome) adherence to treatment?
Topics: Antiphospholipid Syndrome; Aspirin; Female; Health Personnel; Heparin, Low-Molecular-Weight; Humans; | 2014 |
Updated review identifies no adverse impact on mother or offspring during the perinatal period of aspirin use for prevention of preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2015 |
Maternal plasma cell-free DNA in the prediction of pre-eclampsia.
Topics: Adult; Aspirin; Biomarkers; Case-Control Studies; Cell-Free System; Crown-Rump Length; DNA; Female; | 2015 |
Pre-eclampsia: low-dose aspirin for pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2014 |
Successful pregnancy outcome with comprehensive treatment after 13 consecutive pregnancy losses.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Hu | 2014 |
Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
Topics: Abortion, Habitual; Anticoagulants; Apgar Score; Aspirin; Birth Weight; Blood Coagulation Factors; D | 2015 |
Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Drug T | 2015 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Low-dose aspirin for prevention of morbidity and mortality from preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2014 |
Therapy: Low-dose aspirin to reduce the risk of pre-eclampsia?
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2015 |
Spontaneous coronary artery dissection in a parturient with Nail-Patella syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antidiuretic | 2015 |
Antecedents and correlates of visual field deficits in children born extremely preterm.
Topics: Acidosis; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cerebral Ventricles; Child Develo | 2015 |
[Post-contusive subfoveolar hematoma in a pregnant women taking aspegic].
Topics: Adult; Aspirin; Contusions; Eye Injuries; Female; Fovea Centralis; Hematoma; Humans; Lysine; Papille | 2015 |
Identifying risks for early onset pre-eclampsia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Early Diagnosis; Early Medical Intervention; Femal | 2015 |
Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cell Hypoxia; Cell Line | 2015 |
Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study.
Topics: Adult; Aspirin; Birth Rate; Case-Control Studies; Combined Modality Therapy; Doxycycline; Embryo Tra | 2015 |
Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.
Topics: Adult; Aspirin; Australia; Cohort Studies; Female; Gestational Age; Humans; Infant, Newborn; Platele | 2015 |
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomized trial.
Topics: Abortion, Spontaneous; Aspirin; Birth Rate; Female; Humans; Ireland; Live Birth; Pre-Eclampsia; Preg | 2015 |
Low-dose aspirin reduces morbidity and mortality in pregnant women at high-risk for preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2015 |
Clinical characteristics of pregnancies with a history of recurrent miscarriage at a Japanese perinatal center.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Case-Control Studies; Cesarean Section; Female; | 2015 |
The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension.
Topics: Adult; Amlodipine; Aspirin; Birth Weight; Blood Pressure; Calcium Channel Blockers; China; Female; H | 2015 |
Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Case-Control Studies; Cell-Derived Microparticle | 2015 |
Effects of modified Shoutaiwai recipe on integrin β3 and leukemia-inhibitory factor in endometrium of controlled ovarian hyperstimulation mice during the implantation window.
Topics: Animals; Aspirin; Diet; Diet Therapy; Drugs, Chinese Herbal; Embryo Implantation; Endometrium; Femal | 2015 |
Another good reason to recommend low-dose aspirin.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 2015 |
Management of myelofibrosis during pregnancy: a case report.
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinolytic | 2015 |
Prothrombotic state of patients with unexplained recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Aspirin; China; Female; Fibrin Fibrinogen Degradation Products; Fibrinoly | 2015 |
[INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Bulgaria; Female; Heparin; Heparin, Low-Molecula | 2015 |
Re: Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. A. O. Odibo, K. R. Goetzinger, L. Odibo and M. G. Tuuli. Ultrasound Obstet Gynecol 2015; 46: 414-418.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2015 |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Anticoagulants; Antige | 2016 |
A Cost-Benefit Analysis of Low-Dose Aspirin Prophylaxis for the Prevention of Preeclampsia in the United States.
Topics: Administration, Oral; Aspirin; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Rel | 2015 |
Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function.
Topics: Adult; Aspirin; Blood Platelets; Case-Control Studies; Extracellular Vesicles; Female; Humans; Micro | 2015 |
Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Double-Blind Method; Female; Hu | 2015 |
First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery.
Topics: Adolescent; Adult; Angiogenesis Inducing Agents; Animals; Aspirin; Cryopreservation; Embryo Transfer | 2016 |
Use of ticagrelor in human pregnancy, the first experience.
Topics: Adenosine; Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Myocardial Infarction; Platele | 2015 |
Postpartum haemorrhage in a woman with essential thrombocythemia carrying calreticulin mutation: a case report.
Topics: Adult; Aspirin; Calreticulin; Female; Fibrinolytic Agents; Humans; Mutation; Postpartum Hemorrhage; | 2016 |
Utilization of over the counter medication among pregnant women; a cross-sectional study conducted at Isra University Hospital, Hyderabad.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; | 2016 |
Does consumption of platelet-derived microparticles in the fibrin clot explain the decrease in their percentage during pregnancy?
Topics: Abortion, Spontaneous; Anticoagulants; Aspirin; Blood Platelets; Cell-Derived Microparticles; Female | 2016 |
Subchorionic hematomas are increased in early pregnancy in women taking low-dose aspirin.
Topics: Adult; Aspirin; Chorion; Cohort Studies; Female; Hematoma; Humans; Middle Aged; Pregnancy; Pregnancy | 2016 |
[Mechanic valve prosthesis and pregnancy: Is Phenprocoumon replaceable?].
Topics: Abortion, Missed; Adult; Aortic Valve; Aspirin; Drug Substitution; Drug Therapy, Combination; Female | 2016 |
Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Birth Weight; Comorbidity; Drug Th | 2016 |
Investigating the role of aspirin resistance in obstetrics may optimise prevention of pre-eclampsia.
Topics: Aspirin; Female; Humans; Obstetrics; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2016 |
The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Female | 2015 |
Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe.
Topics: Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; | 2016 |
The antecedents and correlates of necrotizing enterocolitis and spontaneous intestinal perforation among infants born before the 28th week of gestation.
Topics: Adult; Aspirin; Birth Weight; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, N | 2016 |
In Utero Exposure to Aspirin and Risk of Asthma in Childhood.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Child; Cohort Studies; Female; Foll | 2016 |
Pre-eclampsia paper raises dilemma for clinicians starting aspirin in high risk women.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2016 |
Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?
Topics: Adult; Antihypertensive Agents; Aspirin; Chronic Disease; Female; Guideline Adherence; Humans; Hyper | 2017 |
The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Case-Control Studies; Drug Therapy, Combination; Female; Fibrino | 2016 |
Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: Prevalence and treatment efficacy in pregnancies.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Hep | 2016 |
Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy | 2016 |
[ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION].
Topics: Anticoagulants; Aspirin; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Heparin, L | 2016 |
Preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Risk Factors | 2016 |
Repeated Thrombosis After Synthetic Cannabinoid Use.
Topics: Adult; Anticoagulants; Aspirin; Cannabinoids; Enoxaparin; Female; Humans; Infarction; Platelet Aggre | 2016 |
Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Databases, Factual; Female; Heparin, Low- | 2017 |
Should we recommend universal aspirin for all pregnant women?
Topics: Aspirin; Blood Pressure; Drug Resistance; Female; Fetal Growth Retardation; Humans; Medication Adher | 2017 |
Stillbirth: the impact of antiphospholipid syndrome?
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Infant, Newborn; Lupus Coagulation Inhi | 2017 |
Vitamin D, pre-eclampsia, and preterm birth among pregnancies at high risk for pre-eclampsia: an analysis of data from a low-dose aspirin trial.
Topics: Adult; Aspirin; Female; Fibrinolytic Agents; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complicatio | 2017 |
Low-Dose Acetylsalicylic Acid Treatment Modulates the Production of Cytokines and Improves Trophoblast Function in an in Vitro Model of Early-Onset Preeclampsia.
Topics: Apoptosis; Aspirin; Cell Line; Cytokines; Female; Giant Cells; Humans; Placenta; Placenta Growth Fac | 2016 |
Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study.
Topics: Acetaminophen; Adult; Analgesics; Analgesics, Opioid; Aspirin; Female; Humans; Ibuprofen; Internet; | 2017 |
Effect of Low-Dose Aspirin on Midluteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; | 2016 |
Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?
Topics: Aspirin; Female; Fibrinolytic Agents; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Risk Factors | 2017 |
Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.
Topics: Abortion, Induced; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal Growth Retardation; Gene | 2016 |
Aspirin adherence during high-risk pregnancies, a questionnaire study.
Topics: Adult; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Health Knowledge, Attitudes, Practice | 2016 |
Preeclampsia and Preterm Birth Associated With Visceral Adiposity in Early Pregnancy.
Topics: Adult; Aspirin; Body Mass Index; Chronic Disease; Female; Humans; Hypertension; Intra-Abdominal Fat; | 2017 |
Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy.
Topics: Adult; Aspirin; Drug Resistance; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Hypertensio | 2017 |
Aspirin prevents TNF-α-induced endothelial cell dysfunction by regulating the NF-κB-dependent miR-155/eNOS pathway: Role of a miR-155/eNOS axis in preeclampsia.
Topics: Adult; Aspirin; Endothelial Cells; Female; Human Umbilical Vein Endothelial Cells; Humans; MicroRNAs | 2017 |
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.
Topics: Anticoagulants; Aspirin; Enoxaparin; Female; Humans; Placenta; Platelet Aggregation Inhibitors; Preg | 2017 |
Modulation of antiphospholipid antibodies-induced trophoblast damage by different drugs used to prevent pregnancy morbidity associated with antiphospholipid syndrome.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blotting, W | 2017 |
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2017 |
Preventing preeclampsia with aspirin: does dose or timing matter?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 2017 |
Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; beta 2-Glyc | 2017 |
Comparison of two-risk assessment algorithms for preeclampsia in first trimester with consecutive intake of low-dose aspirin in the high-risk group - an observational study.
Topics: Algorithms; Aspirin; Decision Support Techniques; Female; Humans; Platelet Aggregation Inhibitors; P | 2018 |
Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospho | 2017 |
[Obstetrical APS: Is there a place for additional treatment to aspirin-heparin combination?]
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; | 2017 |
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; beta-Thalassemia; Birth Weight; Cesarean Section | 2017 |
Effects of Aspirin and Intrauterine Balloon on Endometrial Repair and Reproductive Prognosis in Patients with Severe Intrauterine Adhesion: A Prospective Cohort Study.
Topics: Adult; Aspirin; Endometrium; Female; Humans; Hysteroscopy; Menstruation; Postoperative Care; Pregnan | 2017 |
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Antibodies, Antiphospholipid; Antithrombin III Deficiency; Aspirin; Evidence-Based Medicine; Female; | 2008 |
Stroke in pregnancy associated with syphilis.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Female; Gestational Age; Humans; Magnetic Resonance Imaging; | 2008 |
Should you screen--or not? The latest recommendations.
Topics: Adult; Alcohol Drinking; Anemia, Sickle Cell; Aspirin; Chlamydia Infections; Colorectal Neoplasms; F | 2008 |
Repercussion of acetylsalicylic acid during fetal development on later renal hemodynamics of rats.
Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Female; Fetal Development; Fetal Weight | 2008 |
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Fem | 2008 |
The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis.
Topics: Aspirin; Biometry; Confidence Intervals; Diuretics; Esophageal and Gastric Varices; Female; Glycerol | 2008 |
Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants | 2008 |
[Arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Calcium; Dietary Sup | 2008 |
Acute myocardial infarction in pregnancy.
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Apgar Score; Aspirin; Cesarean Section; Coron | 2008 |
[Liver infarcts with early HELLP syndrome and probable catastrophic antiphospholipid syndrome].
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Co | 2009 |
First trimester stroke prophylaxis in pregnant women with a history of stroke.
Topics: Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Health Care Surveys; Heparin, Low-Molecular-We | 2009 |
Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
Topics: Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Heparin, L | 2008 |
Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibito | 2009 |
Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.
Topics: Abortion, Spontaneous; Adolescent; Adult; Aspirin; Female; Humans; Janus Kinase 2; Leukocyte Count; | 2009 |
A critical assessment of the role of antiphospholipid antibodies in infertility.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Drug T | 2009 |
Pregnancy complicated by Budd-Chiari syndrome and antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Budd-Chiari Syndrome; Cesarean Section; Drug The | 2009 |
Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization.
Topics: Aspirin; Female; Fertilization in Vitro; Humans; Meta-Analysis as Topic; Pregnancy | 2009 |
Medical treatment of pericarditis during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Glucocor | 2010 |
Effect of aspirin treatment on TNFalpha production by women with a history of preterm birth.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Cells; Case-Control Studies; Cells, C | 2009 |
A comparative investigation of fetal skeletal anomalies in rats induced by acetylsalicylic acid with single- and double-staining techniques.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone and Bon | 2009 |
[Recurrent spontaneous abortion--is heparin expendable to recurrence prophylaxis?].
Topics: Abortion, Habitual; Adult; Antibodies, Antinuclear; Anticoagulants; Antiphospholipid Syndrome; Aspir | 2009 |
New observations in postpartum ovarian vein thrombosis: experience of single center.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Early Diagnosis; Enoxaparin; Female; Humans; Incid | 2010 |
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
Topics: Algorithms; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female | 2009 |
Livedoid vasculopathy and pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Cicatrix; Dose-Response Relationship, Drug; Female; Humans; Pregnanc | 2009 |
Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Interferon Type I; Italy; Janus Kinase 2; Middle Aged; M | 2009 |
Treatment of recurrent miscarriage and antiphospholipid syndrome with low-dose enoxaparin and aspirin.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relatio | 2009 |
Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Interferon Type I; Pregnancy; P | 2009 |
Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models.
Topics: Animals; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Dose-Res | 2010 |
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Infant, Ne | 2010 |
Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies.
Topics: Aspirin; Female; Genotype; Humans; Janus Kinase 2; Mutation; Phenotype; Platelet Aggregation Inhibit | 2010 |
A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments.
Topics: Adolescent; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Case-Control Studies; Chemotherapy, | 2009 |
Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth.
Topics: Aspirin; Cytokines; Escherichia coli; Female; Humans; Interleukin-10; Interleukin-1beta; Interleukin | 2010 |
Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm.
Topics: Aspirin; Cerebral Palsy; Child Behavior Disorders; Child, Preschool; Cohort Studies; Confidence Inte | 2010 |
The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of thrombospondin-1.
Topics: Animals; Aspirin; Endosomal Sorting Complexes Required for Transport; Female; Fibroblasts; Heart; He | 2010 |
Pre-eclampsia: aspirin beneficial.
Topics: Aspirin; Female; Fetal Mortality; Humans; Infant Mortality; Infant, Newborn; Male; Maternal Mortalit | 2009 |
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Clinical Trials as Topic; Female; Gestati | 2010 |
Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.
Topics: Anticoagulants; Aspirin; Delphi Technique; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; | 2010 |
Clinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UK.
Topics: Adult; Anticonvulsants; Antihypertensive Agents; Aspirin; Female; Humans; Magnesium Sulfate; Platele | 2010 |
Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.
Topics: Acetaminophen; Adrenal Cortex Hormones; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Ste | 2010 |
Antithrombotic therapy for recurrent miscarriage?
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Humans; Nadroparin; | 2010 |
Autoimmunity: effectiveness of treatments for pregnant women with APS.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Autoimmunity; Dose-Re | 2010 |
How to interpret randomised trials of test-treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia.
Topics: Aspirin; Female; Humans; Observer Variation; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnan | 2010 |
Effects of Danshensu on maternal syndrome in phosphatidylserine/phosphatidylcholine microvesicle induced-mouse model: is it a candidate for preeclampsia remedy?
Topics: Animals; Anticoagulants; Aspirin; Disease Models, Animal; Female; Heparin; Lactates; Mice; Mice, Inb | 2010 |
USPSTF recommendations you may have missed amid the breast cancer controversy.
Topics: Adolescent; Age Factors; Aspirin; Breast Neoplasms; Breast Self-Examination; Child; Depression; Depr | 2010 |
Ultrasonography in pregnant women with antiphospholipid syndrome using salicylic acid and heparin.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans; Infant, Newborn; M | 2011 |
High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Blood Coagulation; Cesarean Section; Drug Monito | 2010 |
Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; An | 2010 |
Antithrombotic medications and recurrent miscarriage.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Bias; Double-Blind Method; Female; Heparin, Low-Molecul | 2010 |
Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Chi-Square Distribution; Dru | 2010 |
Antithrombotic medications and recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; M | 2010 |
Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism.
Topics: Acetaminophen; Adult; Aspirin; Cryptorchidism; Cyclooxygenase Inhibitors; Denmark; Female; Humans; I | 2010 |
Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; | 2010 |
Treatment of cobalamin C (cblC) deficiency during pregnancy.
Topics: Amino Acid Metabolism, Inborn Errors; Aspirin; Carnitine; Carrier Proteins; Cells, Cultured; Combine | 2010 |
Uterine artery Doppler and low-dose aspirin to predict and prevent preeclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Ultrasonography, | 2010 |
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Aspirin; | 2010 |
Favorable maternal and fetal effects of danshensu in an experimental mice model of preeclampsia.
Topics: Animals; Anticoagulants; Aspirin; Blood Pressure; Disease Models, Animal; Drugs, Chinese Herbal; Fem | 2011 |
Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
Topics: Adult; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy | 2011 |
Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat.
Topics: Acetaminophen; Analgesics; Animals; Aspirin; Cohort Studies; Cryptorchidism; Female; Humans; Ibuprof | 2011 |
Hughes syndrome (the antiphospholipid syndrome): a disease of our time.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Arterial Occlusive D | 2011 |
A case of hypertension with virilisation during pregnancy.
Topics: Adult; Aspirin; Brenner Tumor; Calcium; Cesarean Section; Dehydroepiandrosterone Sulfate; Dietary Su | 2010 |
Examining the association between maternal analgesic use during pregnancy and risk of psychotic symptoms during adolescence.
Topics: Acetaminophen; Analgesics; Aspirin; Child; Cohort Studies; Confounding Factors, Epidemiologic; Delus | 2011 |
Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Calcium; Cells, Cultured; F | 2011 |
Update in pre-eclampsia.
Topics: Antihypertensive Agents; Antioxidants; Ascorbic Acid; Aspirin; Blood Pressure; Female; Humans; Hyper | 2004 |
Blank control setting and protein detection method on low-dose aspirin-treated mice during implantation window.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Control Groups; Embryo Implantation; Fema | 2011 |
Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Chest Pain; Dyspnea; Female; Heparin; H | 2011 |
LMWH have no place in recurrent pregnancy loss: debate-against the motion.
Topics: Abortion, Habitual; Anticoagulants; Aspirin; Embryo Loss; Female; Fetus; Heparin, Low-Molecular-Weig | 2011 |
Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option.
Topics: Anticoagulants; Aspirin; Female; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Hum | 2011 |
Opinion & hypothesis could early aspirin prophylaxis prevent against preterm birth?
Topics: Aspirin; Female; Fibrinolytic Agents; Humans; Meta-Analysis as Topic; Pregnancy; Premature Birth | 2011 |
Thromboxane metabolite excretion during pregnancy--influence of preeclampsia and aspirin treatment.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Thromboxanes | 2011 |
Susac syndrome and pregnancy: disease management.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Aspirin; Cyclophosphamide; D | 2011 |
[Security of proton pump inhibitors].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Chronic Disease; Drug Interactions; | 2011 |
Antiplatelet agents for the prevention of pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prenatal Care; R | 2011 |
Antiphospholipid syndrome and pre-eclampsia.
Topics: Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Femal | 2011 |
Is testing for aspirin response worthwhile in high-risk pregnancy?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Canada; Diabetes Complications; Dose-Respon | 2011 |
[Pregnancy and essential thrombocytemia].
Topics: Adult; Aspirin; Female; Hospitals, University; Humans; Platelet Aggregation Inhibitors; Pregnancy; P | 2011 |
A practical approach to the prevention of miscarriage: part 5--antiphospholipid syndrome as a cause of spontaneous abortion.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspi | 2011 |
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Anticoagulants | 2011 |
Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
Topics: Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; F | 2011 |
Stroke- and pregnancy-induced hypertensive syndromes.
Topics: Adult; Antihypertensive Agents; Aspirin; Female; Fibrinolytic Agents; Humans; Hypertension, Pregnanc | 2011 |
Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fetal Growth Retardation; Humans; Patient | 2011 |
Analgesics during pregnancy and cryptorchidism: additional analyses.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Cryptorchidism; Cyclooxygenase Inhibitors; Female; | 2011 |
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.
Topics: Abortion, Spontaneous; Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Biomarkers; C | 2011 |
Aspirin resistance may be associated with adverse pregnancy outcomes.
Topics: Adult; Aspirin; Cesarean Section; Drug Resistance; Female; Fetal Distress; Humans; Infant, Newborn; | 2011 |
Aspirin resistance and adverse pregnancy outcomes.
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Outcome | 2011 |
Prevention of perinatal death with low-dose aspirin in developing countries.
Topics: Aspirin; Female; Humans; Hypertension, Pregnancy-Induced; Platelet Aggregation Inhibitors; Pre-Eclam | 2011 |
Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation.
Topics: Adult; Aspirin; Birth Weight; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fetal | 2011 |
The importance of sonographic endometrial parameters in influencing success following embryo transfer in the modern era and therapeutic options--part 1: the importance of late proliferative phase endometrial thickness.
Topics: Aspirin; Embryo Transfer; Endometrium; Estrogens; Female; Fibrinolytic Agents; Humans; Menstrual Cyc | 2011 |
Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function.
Topics: Angiogenic Proteins; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Cell Line; Ce | 2011 |
Bloody mess.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Heparin; H | 2011 |
Bloody tests.
Topics: Abortion, Spontaneous; Antibodies, Anticardiolipin; Aspirin; Female; Fibrinolytic Agents; Hematologi | 2011 |
[Essential acetylsalicylic acid: over 100 years old and still good for surprises (interview by Dr. med. Jochen Aumiller)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Dose-Response Relationship, | 2011 |
Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
Topics: Abortion, Spontaneous; Adult; Aspirin; Case-Control Studies; Drug Therapy, Combination; Factor V; Fe | 2012 |
Bilateral thalamic infarct caused by spontaneous vertebral artery dissection in pre-eclampsia with HELLP syndrome: a previously unreported association.
Topics: Adult; Aspirin; Cerebral Angiography; Cerebral Infarction; Female; HELLP Syndrome; Humans; Postpartu | 2012 |
Successful management of pregnancy-associated thrombotic thrombocytopenic purpura by monitoring ADAMTS13 activity.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers | 2012 |
Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Comorbi | 2012 |
[Successful completed pregnancies in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Azathioprine; Birth Weight; Female; Follow-Up Studies; Gest | 2012 |
[Our experience with management of inherited thrombophilia during pregnancy. Preliminary report].
Topics: Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Co | 2011 |
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal.
Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pre-Eclampsia; Pregnancy; Thrombophilia | 2012 |
[Our experience with management of inherited thrombophilia during pregnancy: preliminary report].
Topics: Aspirin; Factor V; Female; Fibrinolytic Agents; Genetic Testing; Heparin, Low-Molecular-Weight; Huma | 2011 |
A retrospective study on IVF outcome in patients with anticardiolipin antibody: effects of methylprednisolone plus low-dose aspirin adjuvant treatment.
Topics: Adult; Antibodies, Anticardiolipin; Aspirin; Chemotherapy, Adjuvant; Embryo Implantation; Female; Fe | 2012 |
Antiphospholipid antibodies in relation to sterility/infertility.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; | 2012 |
Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction.
Topics: Adult; Analgesia, Obstetrical; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Eptifibatide; F | 2012 |
Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis.
Topics: Acetaminophen; Androgen Antagonists; Animals; Arachidonic Acid; Aspirin; Cryptorchidism; Endocrine D | 2012 |
Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system.
Topics: Age Factors; alpha-Tocopherol; Analysis of Variance; Animals; Animals, Newborn; Antioxidants; Ascorb | 2012 |
Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
Topics: Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Brain Ische | 2012 |
Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Diabetes, Gestational; Female | 2012 |
Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
Topics: Anticoagulants; Aspirin; Bone Density; Breast Feeding; Chondroitin Sulfates; Dermatan Sulfate; Femal | 2012 |
[Expression of metalloproteinase MMP-9 and tissue inhibitor of metalloproteinase TIMP-2 in placenta of pregnant women with intrauterine growth restriction].
Topics: Adult; Arginine; Aspirin; Female; Fetal Growth Retardation; Humans; Matrix Metalloproteinase 9; Plac | 2012 |
Current controversies in prenatal diagnosis 4: pregnancy complications due to placental vascular disease (pre-eclampsia, FGR): are we ready for prevention?
Topics: Aspirin; Calcium; Female; Fetal Growth Retardation; Gestational Age; Humans; Placenta; Placenta Dise | 2013 |
[Peculiarities of pregnancy management after multiple stenting of coronary arteries].
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Cesarean Section; Coronary Vessels; Diagnosis, Diffe | 2012 |
Non-prescription medicines for pain and fever--a comparison of recommendations and counseling from staff in pharmacy and general sales stores.
Topics: Acetaminophen; Analgesics; Antipyretics; Aspirin; Child; Commerce; Contraindications; Counseling; Fe | 2013 |
Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Carrier Proteins | 2013 |
STOX1: a new player in preeclampsia?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Carrier Proteins | 2013 |
Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.
Topics: Algorithms; Anticoagulants; Aspirin; Body Mass Index; Female; Fetal Death; Fetal Growth Retardation; | 2013 |
Preventing adverse obstetric outcomes in women with genetic thrombophilia.
Topics: Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Pregnancy; Pregnancy Complication | 2002 |
Management of thrombosis during pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Aspirin; Blood Coagulation Tests; Drug The | 2002 |
Paracetamol use in pregnancy and wheezing in early childhood.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Aspirin; Asthma; Eczema; Female; Humans; Infant; Longitudin | 2002 |
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
Topics: Animals; Arteries; Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitor | 2002 |
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
Topics: Arteries; Aspirin; Female; Fetal Growth Retardation; Humans; Platelet Aggregation Inhibitors; Pre-Ec | 2002 |
Protein A immunoadsorption in a pregnant woman with habitual abortion.
Topics: Abortion, Habitual; Abortion, Spontaneous; Activated Protein C Resistance; Adult; Anticoagulants; An | 2002 |
Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
Topics: Arteries; Aspirin; Female; Fetal Growth Retardation; Humans; Meta-Analysis as Topic; Platelet Aggreg | 2002 |
[Acetylsalicylic acid against pre-eclampsia?].
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Risk Factors | 2002 |
Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy.
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Biomarkers; Dalteparin; Endothelium, Vascular; F | 2003 |
Activity, synthesis, storage, and messenger RNA of cyclooxygenase in intrauterine tissues of guinea pigs near term and during labor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Dinop | 2003 |
Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cohort Studies; Drug Administration Schedule; Fe | 2002 |
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Ran | 2003 |
[New antiaggregants and their importance for the practitioner].
Topics: Abciximab; Administration, Oral; Adult; Anesthesia, Spinal; Antibodies, Monoclonal; Aspirin; Cardiov | 2003 |
[Antagonism of folic acid on the toxicity of aspirin in yolk sac of rats].
Topics: Animals; Aspirin; Embryonic and Fetal Development; Female; Folic Acid; Male; Pregnancy; Rats; Rats, | 1999 |
Pre-eclampsia: prevention.
Topics: Aspirin; Female; Humans; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; United Kingdom | 2003 |
Live birth rate varies with gestational history and etiology in women experiencing recurrent spontaneous abortion.
Topics: Abortion, Habitual; Aspirin; Chromosome Aberrations; Corpus Luteum; Female; Humans; Immunoglobulins, | 2003 |
Pregnancy in essential thrombocythemia during aspirin treatment.
Topics: Adult; Aspirin; Cesarean Section; Drug Administration Schedule; Female; Humans; Infant, Newborn; Mal | 2003 |
[Current approaches to prevention and treatment of antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Contraceptives, Oral; Enzyme Inhibitors; | 2003 |
Effect of selective vs. non-selective cyclo-oxygenase inhibitors on fetal membrane prostaglandin synthesis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cycloox | 2003 |
Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Weight; | 2003 |
Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Weight; | 2003 |
Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2, during organogenesis.
Topics: Animals; Aspirin; Carbonic Anhydrase IV; Cyclooxygenase 1; Cyclooxygenase 2; DNA Primers; Female; Ge | 2003 |
[Successful high-dose low-molecular-weight heparin thromboprophylaxis in pregnant women with antiphospholipid syndrome].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Administration Schedule; Female; Fib | 2003 |
Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and in healthy pregnancy.
Topics: Abortion, Spontaneous; Abruptio Placentae; Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal | 2003 |
Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.
Topics: Abortion, Spontaneous; Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studi | 2003 |
[Successful pregnancy outcome in the woman with thrombophilia and multiple miscarriages].
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Cesarean Section; Factor V; Female; Heterozygote | 2003 |
Successful perinatal outcome following recurrent idiopathic cerebrovascular strokes in pregnancy: a case report.
Topics: Adult; Aspirin; Cerebral Infarction; Delivery, Obstetric; Diagnosis, Differential; Drug Therapy, Com | 2003 |
[Repeated attacks of pain in the nipple of a pregnant woman. Unusual manifestation of Raynaud's phenomenon].
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Fingers; Heparin; Humans; Ni | 2003 |
[Severe ulcerous hemorrhage after aspirin injection in a pregnant woman].
Topics: Aspirin; Female; Hemorrhage; Humans; Injections; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pregnancy; P | 1957 |
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL MICE AND RATS.
Topics: Abnormalities, Drug-Induced; Animals, Newborn; Aspirin; Fetus; Mice; Pregnancy; Pregnancy, Animal; R | 1964 |
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL RABBITS.
Topics: Abnormalities, Drug-Induced; Aspirin; Female; Fetal Death; Fetus; Humans; Maternal-Fetal Exchange; P | 1964 |
[USE OF A PROTEOLYTIC ENZYME-ACETYLSALICYLIC ACID COMBINATION IN OBSTETRICS AND COMPARISON OF THE THERAPEUTIC RESULTS WITH THOSE OBTAINED BY A PLACEBO].
Topics: Aspirin; Biomedical Research; Chymotrypsin; Female; Humans; Hydrolases; Labor, Obstetric; Obstetrics | 1964 |
[CLINICAL EXPERIMENTATION WITH TH-2152 IN PAINFUL TENSION OF THE BREASTS DURING ESTABLISHMENT OF MILK FLOW].
Topics: Aspirin; Bicarbonates; Biomedical Research; Breast Feeding; Female; Gastric Mucosa; Humans; Infant, | 1964 |
[TRIALS OF TH-2152 ON THE ESTABLISHMENT OF MILK FLOW].
Topics: Aspirin; Bicarbonates; Biomedical Research; Breast Feeding; Female; Gastric Mucosa; Humans; Lactatio | 1964 |
[CLINICAL EXPERIMENTATION WITH TH-2152 IN GYNECOLOGY AND OBSTETRICS].
Topics: Analgesia; Aspirin; Bicarbonates; Biomedical Research; Dysmenorrhea; Female; Gynecology; Headache; H | 1964 |
TREATMENT OF POSTPARTUM PAIN WITH FIORINAL.
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Barbiturates; Biomedical Research; Caff | 1964 |
GROSS CONGENITAL MALFORMATIONS IN SIBLINGS OF CHILDREN WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT ERYTHROCYTES.
Topics: Abnormalities, Drug-Induced; Aspirin; Congenital Abnormalities; Erythrocytes; Glucosephosphate Dehyd | 1964 |
BLOOD SALICYLATE DURING PREGNANCY.
Topics: Animals; Aspirin; Blood Chemical Analysis; Female; Humans; Metabolism; Pregnancy; Pregnancy, Animal; | 1964 |
[PRENATAL PROTECTION OF THE FETUS AND PROBLEMS OF DRUG THERAPY IN PREGNANCY].
Topics: Adrenal Cortex Hormones; Aminopyrine; Anti-Bacterial Agents; Aspirin; Drug Therapy; Female; Fetal Di | 1964 |
EFFECT OF ACETYLSALICYLIC ACID ON FOETAL RATS.
Topics: Abnormalities, Drug-Induced; Aspirin; Caseins; Fetus; Pharmacology; Pregnancy; Rats; Research; Reser | 1964 |
CONTROLLED DOUBLE-BLIND EVALUATION OF THREE ANALGESIC MEDICATIONS FOR POSTPARTUM DISCOMFORT.
Topics: Analgesics; Aspirin; Azepines; Biomedical Research; Codeine; Double-Blind Method; Drug Therapy; Fema | 1965 |
TERATOGENIC ACTION OF SALICYLATES RELATED TO THE INHIBITION OF MUCOPOLYSACCHARIDE SYNTHESIS.
Topics: Abnormalities, Drug-Induced; Aspirin; Blood Vessels; Carbohydrate Metabolism; Glycosaminoglycans; Mi | 1965 |
ASPIRIN-INDUCED CLEFT LIP AND OTHER MALFORMATIONS IN MICE.
Topics: Abnormalities, Drug-Induced; Aspirin; Cleft Lip; Genetics; Mice; Pregnancy; Pregnancy, Animal; Resea | 1965 |
THE INFLUENCE OF DIET ON THE TOXICITY OF ACETYLSALICYLIC ACID.
Topics: Aspirin; Diet; Dietary Carbohydrates; Dietary Proteins; Magnesium; Pharmacology; Pregnancy; Pregnanc | 1964 |
EFFECT OF SOME THERAPEUTIC AGENTS ON THE DEVELOPING RAT FETUS.
Topics: Abnormalities, Drug-Induced; Animals; Antipyrine; Aspirin; Chloral Hydrate; Dimenhydrinate; Female; | 1965 |
EFFECTS OF ASPIRIN AND PHENYLBUTAZONE ON THE RABBIT BLASTOCYST.
Topics: Animals; Aspirin; Blastocyst; Embryo, Mammalian; Embryo, Nonmammalian; Female; Humans; Lagomorpha; M | 1965 |
[Prevention of preeclampsia].
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fetal Diseas | 2003 |
Effect of sairei-to combined with aspirin and prednisolone on four recurrent reproductive failure women who are positive for anti-phospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Drugs, | 2003 |
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, | 2003 |
Preventing diabetic retinopathy through control of systemic factors.
Topics: Anticoagulants; Aspirin; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Female; G | 2003 |
[Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Ferric Compounds; F | 2003 |
Aspirin prevents preeclampsia and complications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Randomiz | 2003 |
[Analysis of 8-isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR].
Topics: Adult; Arginine; Aspirin; Biomarkers; Case-Control Studies; Dinoprost; F2-Isoprostanes; Female; Feta | 2003 |
Pregnancy outcome in patients with a history of recurrent spontaneous miscarriages and documented thrombophilias.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Folic Acid; Heparin, Low-M | 2004 |
Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making.
Topics: Aspirin; Decision Making; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2004 |
Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; Hepari | 2004 |
Re: Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.
Topics: Arteries; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Uterus | 2004 |
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.
Topics: Adult; Aspirin; Autoimmune Diseases; Azathioprine; Cyclosporine; Dexamethasone; Female; Hemoglobins; | 2004 |
Antiphospholipid antibodies: a major advance in the management of recurrent abortion.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Hepari | 2004 |
[Plasma carbonyl group concentration in pregnant women with IUGR treated by L-arginine and acetylsalicylic acid].
Topics: Adult; Arginine; Aspirin; Biomarkers; Blood Proteins; Carbon; Case-Control Studies; Enzyme-Linked Im | 2004 |
Heparin/aspirin therapy for implantation failure in IVF cycles.
Topics: Antibodies, Antinuclear; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Embryo Implantation; | 2004 |
[Which abortion prevention should be chosen in the case of antiphospholipid syndrome?].
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Adult; Anticoagulants; Antiphospholipid Syndrome; As | 2004 |
Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage.
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome | 2004 |
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Glucocorticoids; | 2004 |
Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
Topics: Anticoagulants; Aspirin; Cell Line; Cell Movement; Dose-Response Relationship, Drug; Female; Heparin | 2004 |
Prescribing for thrombophilia--are we going to repeat mistakes of the past?
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 2004 |
Acute fatty liver of pregnancy after aspirin intake.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Component Transfusion; Diagnosis, Dif | 2004 |
[Prevention of gravid toxemia with magnesium].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dietary Supplements; Female; Humans; Magnes | 2004 |
Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Aspirin; Case-Control Studies; Delayed-Act | 2004 |
Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats.
Topics: Animals; Aspirin; Body Weight; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; | 2004 |
[Polycythemia vera and pregnancy].
Topics: Adult; Antisickling Agents; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hum | 2004 |
Kawasaki disease in a postpartum patient.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Femal | 2004 |
Management of ischaemic heart disease in women of child-bearing age.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Female; Fibrinolytic Agents; Humans; Hypoglycemic Agents; | 2004 |
Early treatment with low-dose aspirin is effective for the prevention of preeclampsia and related complications in high-risk patients selected by the analysis of their historic risk factors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnanc | 2005 |
Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; As | 2005 |
Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.
Topics: Abortion, Habitual; Anticoagulants; Apoptosis; Aspirin; Cell Line; Dose-Response Relationship, Drug; | 2005 |
Splenic infarction in a pregnant woman with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Aspirin; Cesarean Section; Drug Therap | 2005 |
[Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol].
Topics: Administration, Oral; Aspirin; Biomarkers; Blood Platelets; Dipyridamole; Embryo Loss; Endothelium; | 2004 |
Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study.
Topics: Abnormalities, Drug-Induced; Aspirin; Case-Control Studies; Cleft Lip; Cleft Palate; Female; Fetus; | 2005 |
Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Platelets; Cyclooxygenase 1; Edema; Estradiol; Female; Hum | 2005 |
Pregnancy after heart valve replacement--case report.
Topics: Adult; Anticoagulants; Aspirin; Cesarean Section; Female; Heart Valve Prosthesis; Heparin; Humans; M | 2004 |
A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies.
Topics: Adult; Aspirin; Clinical Protocols; Dose-Response Relationship, Drug; Drug Monitoring; Enoxaparin; F | 2005 |
Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
Topics: Abdominal Wall; Abnormalities, Drug-Induced; Alanine Transaminase; Animals; Aspartate Aminotransfera | 2005 |
Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology.
Topics: Abortion, Habitual; Adolescent; Adult; Aspirin; Drug Therapy, Combination; Female; Gestational Age; | 2005 |
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; | 2005 |
[Aspirin, paracetamol, ibuprofen: analgesics in the family medicine cabinet].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Contraind | 2005 |
Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Contraindications; Female; Heart Valve Prosthes | 2005 |
Minor physical anomalies are not increased in the offspring of mothers with systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenital Abnormalities; Fe | 2006 |
[Acute myocardial infarction complicating primary antiphospholipid syndrome after aspirin and steroids withdrawal].
Topics: Adrenal Cortex Hormones; Adult; Angioplasty, Balloon, Coronary; Antiphospholipid Syndrome; Aspirin; | 2005 |
[Strange pregnancy....].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Cardiov | 2005 |
Thromboembolic disease and air travel in pregnancy: a survey of advice given by obstetricians.
Topics: Aircraft; Aspirin; Exercise; Female; Heparin; Humans; Leg; Movement; Obstetrics; Physician's Role; P | 2004 |
Use of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Drug Monitoring; Edetic Acid; Female; Flow Cytom | 2005 |
Risk factors, prevention and treatment of hypertension in pregnancy.
Topics: Administration, Oral; Adult; Age Factors; Antihypertensive Agents; Antioxidants; Aspirin; Calcium Ch | 2005 |
Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies?
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Female; Heparin; Humans; Mass Screening; | 2005 |
Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndro
Topics: Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; HELLP Syndrom | 2005 |
Are low doses of enoxaparin with aspirin sufficient to guarantee good gestational outcome in women with heterozygote factor V Leiden mutation?
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor | 2007 |
Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cyclooxygenase Inhibitors; Female; Fetal Weight; Fetu | 2006 |
Anticardiolipin antibodies in Jamaican primiparae.
Topics: Adolescent; Adult; Antibodies, Anticardiolipin; Aspirin; Female; Humans; Jamaica; Parity; Platelet A | 2006 |
Aspirin therapy in preeclampsia: more questions than answers.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Research D | 2006 |
High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.
Topics: Anemia; Anemia, Diamond-Blackfan; Aspirin; Data Collection; Female; France; Germany; Humans; Pregnan | 2006 |
Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan.
Topics: Adolescent; Adult; Aspirin; Cesarean Section; Coronary Artery Bypass; Coronary Disease; Coronary Ves | 2006 |
Maternal and fetal complications of antiphospholipid syndrome: a case report with long-term follow-up.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Stu | 2006 |
[Recurrent miscarriage and thrombophilia].
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight | 2006 |
Dilatation of the abdominal umbilical vein is associated with increased risk of thrombotic complications.
Topics: Abdomen; Adult; Aspirin; Dilatation, Pathologic; Female; Fetal Diseases; Fibrinolytic Agents; Hepari | 2006 |
The natural course of women with recurrent fetal loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Enoxaparin; Female; Fibrinolyt | 2006 |
Thromboxane mediates neutrophil superoxide production in pregnancy.
Topics: Arachidonic Acid; Aspirin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; H | 2006 |
Meta-analysis of aspirin for the prevention of preeclampsia: do the main randomized controlled trials support an association between low-dose aspirin and a reduced risk of developing preeclampsia?
Topics: Aspirin; Female; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pre | 2006 |
Is there any scientific evidence for the prevention of preeclampsia with low-dose aspirin?: Meta-analysis versus randomized controlled trial to answer this question.
Topics: Aspirin; Female; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pre | 2006 |
Aspirin use and miscarriage risk.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies | 2006 |
[The total antioxidative activity measured by FRAP method in women with intrauterine growth restriction treated by L-arginine].
Topics: Adult; Arginine; Aspirin; Female; Fetal Blood; Fetal Growth Retardation; Humans; Nitric Oxide; Nitri | 2005 |
Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction.
Topics: Adult; Aspirin; Chemotherapy, Adjuvant; Cohort Studies; Endometrium; Estradiol; Female; Humans; Midd | 2006 |
Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Deriv | 2006 |
Periodic plateletpheresis during pregnancy in a high-risk patient with essential thrombocythemia.
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Aspirin; Blood Flow Velocity; Cesarean Section; Female | 2006 |
Successful pregnancy despite thrombotic thrombocytopenic purpura in the first trimester.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Component Transfusion; Dexamethasone; Female; Humans; Live | 2006 |
Prophylactic therapy for patients with reproductive failure who were positive for anti-phospholipid antibodies.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Drugs, Chinese H | 2006 |
[Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chorionic Villi; D | 2006 |
A case of stroke in pregnancy: the optimum management of such patients remains a challenge.
Topics: Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; P | 2006 |
Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Biomarkers; Coronary Artery D | 2006 |
Matching and the assumptions of standard frequentist statistics.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspiri | 2006 |
Interferon-alfa treatment of essential thrombocythemia during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Fetal Diseases; Humans; Immunolog | 2006 |
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.
Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 2007 |
Teratogenic effects of the interaction acetylsalicylic acid (ASA) and ethanol: morphologic and morphometric evaluation of the lingual epithelium in rat fetuses.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Respons | 2007 |
[Low dose of aspirin during pregnancy].
Topics: Abnormalities, Drug-Induced; Abortion, Habitual; Abortion, Spontaneous; Adult; Animals; Anti-Inflamm | 2007 |
Effect of prenatal administration of NSAIDs on the immune response in juvenile and adult rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Aspirin; Diclofenac; Enzyme-Li | 2007 |
[Spinal and epidural anaesthesia for caesarean section in patients with pre-eclampsia].
Topics: Analgesics; Anesthesia, Epidural; Anesthesia, Spinal; Antihypertensive Agents; Aspirin; Cesarean Sec | 2007 |
Atrial fibrillation in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Electrocardiography; Female; Flecainide | 2008 |
Light, electron microscopic and immunohistochemical study of the effect of low-dose aspirin during the proestrus phase on rat endometrium in the preimplantation period.
Topics: Animals; Aspirin; Blastocyst; Endometrium; Female; Immunohistochemistry; Microscopy; Microscopy, Ele | 2007 |
Aspirin for pre-eclampsia: compelling data on benefit and risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Female; Humans; Pre-Ecla | 2007 |
Matched designs--intuitively attractive, but the analysis can be problematic.
Topics: Abortion, Habitual; Adult; Aspirin; Drug Therapy, Combination; Female; Folic Acid; Humans; Matched-P | 2007 |
Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecul | 2007 |
Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders.
Topics: Adult; Aspirin; Cohort Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Estradi | 2008 |
Management of thrombophiliac problems during pregnancy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Pregnancy; | 2007 |
Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma.
Topics: Adult; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Nitric Oxide Donors; Pre-Eclampsia; P | 2007 |
Practical approach to treating essential thrombocythaemia: case studies.
Topics: Adult; Aspirin; Disease Management; Female; Humans; Hydroxyurea; Interferon-alpha; Leg Ulcer; Male; | 2007 |
Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization.
Topics: Abortion, Spontaneous; Aspirin; Dose-Response Relationship, Drug; Embryo Implantation; Evidence-Base | 2008 |
Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
Topics: Abruptio Placentae; Adult; Anticoagulants; Aspirin; Dalteparin; Drug Therapy, Combination; Female; F | 2007 |
Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Aspirin; Epoprostenol; Female; Humans; Placen | 2008 |
Antiplatelet agents for prevention of pre-eclampsia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Fetal Death; Humans; Infant Mortality; Inf | 2007 |
Modeling the effects of prenatal exposure to aspirin on the postnatal development of rat brain.
Topics: Animals; Animals, Newborn; Aspirin; Brain; Cyclooxygenase Inhibitors; Female; Models, Biological; Or | 2007 |
Pregnancy outcome in patients with patent foramen ovale and cerebral embolism.
Topics: Adult; Anticoagulants; Aspirin; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Heparin, Low-M | 2008 |
[Case report of a successful pregnancy following thrombolysis for acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Anticoagulants; Aspirin; Electrocardiography; Female; Fibrinolyt | 2007 |
Successful full-term pregnancies with assisted reproduction supported with prednisolone, acetylsalicylic acid and high progesterone doses in a lupus patient.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Anti-Inflammatory Agents; Aspirin; Female | 2007 |
Prescribing of NSAIDs and ASA during pregnancy; do we need to be more careful?
Topics: Abortion, Spontaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Congenit | 2008 |
Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Ant | 2008 |
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cohort Studies; Enoxaparin; Female | 2008 |
Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
Topics: Aspirin; Female; Fertilization in Vitro; Humans; Infertility; Ovarian Hyperstimulation Syndrome; Ovu | 2008 |
Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin.
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Echocardiography; Female; Fibrinolytic Agents; Fol | 2008 |
Improving the outcome of pregnancy in essential thrombocythaemia: The role of aspirin.
Topics: Adult; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, | 2008 |
[Stents, antiplatelet therapy, and surgery].
Topics: Adult; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Cesarean Section; Enoxaparin; Female | 2008 |
DBBF modified human placenta hemoglobin through the alpha chains.
Topics: Animals; Aspirin; Blood Substitutes; Enzyme Stability; Female; Hemoglobin A; Hemoglobins; Humans; Mu | 2008 |
Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Electrocardiography; Female; Humans | 2008 |
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 2008 |
[Does an additional administration of acetylsalicylic acid reduce the requirement of betamimetics in tocolytic treatment? (author's transl)].
Topics: Adrenergic beta-Agonists; Aspirin; Cervix Uteri; Drug Therapy, Combination; Ethanolamines; Female; F | 1981 |
Aspirin-induced psychoteratogenesis in rats as a function of embryonic age.
Topics: Analysis of Variance; Animals; Aspirin; Behavior, Animal; Female; Fetus; Gestational Age; Litter Siz | 1982 |
Fetal survival after prednisone suppression of maternal lupus-anticoagulant.
Topics: Adult; Antibodies, Antinuclear; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Fem | 1983 |
Effects of selected OTC medications on the unborn and newborn.
Topics: Abnormalities, Drug-Induced; Acetaminophen; Aspirin; Female; Fetus; Histamine H1 Antagonists; Humans | 1983 |
[Prophylaxis of thrombosis in surgical gynecology and obstetrics (author's transl)].
Topics: Adult; Aged; Aspirin; Bandages; Dextrans; Dose-Response Relationship, Drug; Early Ambulation; Female | 1980 |
Beta 2-microglobulin and other proteins as parameter for tubular function.
Topics: Acetaminophen; Amino Acid Sequence; Aspirin; beta 2-Microglobulin; Beta-Globulins; Female; Graft Rej | 1981 |
[Azulfidine/Salazopyrin therapy during pregnancy].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Colitis, Ulcerative; Crohn Disease; Female; Humans; I | 1981 |
[Antagonism of antifertility effect of gossypol by aspirin].
Topics: Animals; Aspirin; Contraceptive Agents, Male; Female; Fertility; Gossypol; Male; Mice; Pregnancy; Ra | 1983 |
[Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits].
Topics: Abnormalities, Drug-Induced; Animals; Antimalarials; Artemether; Artemisinins; Aspirin; Embryo, Mamm | 1984 |
Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report.
Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Female; Humans; Infa | 1983 |
Human vascular tissues produce thromboxane as well as prostacyclin.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Epoprostenol; Female; Humans; Mammary Arteries; | 1983 |
In vitro contractile responses of the uterus from 'restricted diet' rats to adrenoceptor agonists. Influence of cyclo-oxygenase inhibitors.
Topics: Animal Feed; Animals; Aspirin; Cyclooxygenase Inhibitors; Diet; Estrus; Female; In Vitro Techniques; | 1983 |
Prostaglandins and related compounds -- a general physiologic control system.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Diet; Epoprostenol; Fatty Acids; Female; Huma | 1983 |
Lupus anticoagulant in pregnancy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Chorea; Drug Therapy, Combination; | 1984 |
Maternal aspirin administration inhibits pulmonary arachidonic acid metabolism in fetal rabbits.
Topics: Animals; Arachidonic Acids; Aspirin; Chromatography, Thin Layer; Cyclooxygenase Inhibitors; Female; | 1984 |
Novel accessory skull bone in fetal rats after exposure to aspirin.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Gestational Age; Pregnancy; Rats; Rats, Inbre | 1984 |
Acute myocardial infarction in a thirty-six year old postpartum female.
Topics: Adult; Aspirin; Digoxin; Electrocardiography; Ergonovine; Female; Heart Aneurysm; Humans; Isosorbide | 1984 |
Menorrhagia. A symposium.
Topics: Adolescent; Adult; Aminocaproates; Anti-Inflammatory Agents; Antifibrinolytic Agents; Aspirin; Blood | 1984 |
Teratogenicity of aspirin and its metabolite, salicylic acid, in cultured rat embryos.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Embryo, Mammalian; Female; Organ Culture Techniques; | 1984 |
Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits.
Topics: Abnormalities, Drug-Induced; Adenosine Triphosphate; Anemia, Hemolytic; Animals; Antioxidants; Aspir | 1984 |
Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions.
Topics: Acetaminophen; Adult; Amino Acid Metabolism, Inborn Errors; Aspirin; Circadian Rhythm; Diabetes Mell | 1984 |
Thrombotic thrombocytopenic purpura mimicking toxemia of pregnancy.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Diagnosis, Differential; Dipyridamole; Female; Fetal Death; | 1984 |
Premenstrual exacerbation of asthma.
Topics: Adolescent; Adult; Aspirin; Asthma; Contraceptives, Oral; Female; Humans; Menstrual Cycle; Middle Ag | 1984 |
Prostaglandin synthesis in rat embryo tissue: the effect of non-steroidal anti-inflammatory drugs in vivo and ex vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents; Aspirin; Dinoprost; Embryo, Mammali | 1984 |
Possible role of prostaglandins in the regulation of food intake in the newborn rat.
Topics: Animals; Animals, Newborn; Animals, Suckling; Aspirin; Body Weight; Dinoprost; Dinoprostone; Eating; | 1984 |
Prostaglandins and ovarian factors as modulators of the negative inotropic action of histamine in the isolated rat uterus.
Topics: Animals; Aspirin; Depression, Chemical; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; E | 1984 |
Aspirin and maternal or neonatal hemostasis.
Topics: Aspirin; Female; Hemorrhage; Hemostasis; Humans; Infant, Newborn; Infant, Newborn, Diseases; Materna | 1983 |
Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration.
Topics: Animals; Aspirin; Blood Platelets; Female; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; | 1983 |
[Acetylsalicylic acid or paracetamol?].
Topics: Acetaminophen; Aspirin; Female; Humans; Maternal-Fetal Exchange; Pregnancy | 1983 |
[Distribution of salicylic acid and hydrolysis of acetylsalicylic acid in the human fetus in early pregnancy].
Topics: Aspirin; Female; Fetus; Humans; Hydrolysis; Maternal-Fetal Exchange; Pregnancy; Pregnancy Trimester, | 1983 |
[Relationship between the placental-fetal index (PFI) and the toxic and teratogenic effect in the fetuses of mothers treated with sedalgin during pregnancy].
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Caffeine; Codeine; Drug Combinations; Female; Fetus; | 1983 |
Teratogenesis study of o-toluenediamine in rats and rabbits.
Topics: 6-Aminonicotinamide; Abnormalities, Drug-Induced; Animals; Aspirin; Bone and Bones; Dose-Response Re | 1983 |
Placental transfer of acetylsalicylic acid (ASA) and salicylic acid (SA) in near-term ewes.
Topics: Animals; Aspirin; Female; Fetus; Gestational Age; Kinetics; Maternal-Fetal Exchange; Models, Biologi | 1983 |
Studies on the pharmacological bases of fetal toxicity of drugs (IV). Effect of endotoxin and starvation on serum protein binding of salicylic acid in pregnant rats.
Topics: Animals; Aspirin; Blood Proteins; Endotoxins; Fatty Acids, Nonesterified; Female; Fetus; Pregnancy; | 1983 |
Septic shock in obstetrics.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Disseminated Intravascular Coagulation; Dopamine; Emergenci | 1984 |
Teratological evaluation of trimethyl phosphite in the rat.
Topics: Abnormalities, Drug-Induced; Alkylating Agents; Animals; Aspirin; Dose-Response Relationship, Drug; | 1984 |
Placental drug transfer in near-term ewes: acetylsalicylic and salicylic acid.
Topics: Animals; Aspirin; Computers; Female; Isotope Labeling; Kinetics; Maternal-Fetal Exchange; Models, Bi | 1984 |
Hemostasis, Prostacyclin and Preeclampsia.
Topics: Aspirin; Dipyridamole; Epoprostenol; Female; Hemostasis; Humans; Imidazoles; Pre-Eclampsia; Pregnanc | 1982 |
[Aspirin-induced abnormality, liver damage induced by antibiotics, fatal drug reaction, and observation of the teeth].
Topics: Abnormalities, Drug-Induced; Adult; Anti-Bacterial Agents; Aspirin; Aurothioglucose; Chemical and Dr | 1980 |
[Delivery under general anesthesia with the sequence of althesin and lysine acetylsalicylate; a clinical contribution].
Topics: Adolescent; Adult; Alfaxalone Alfadolone Mixture; Anesthesia, General; Anesthesia, Intravenous; Anes | 1980 |
Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua.
Topics: Amnion; Aspirin; Cesarean Section; Chorion; Cyclooxygenase Inhibitors; Decidua; Extraembryonic Membr | 1981 |
[Effect of arachidonic acid on the secretion of milk caseins in vitro].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Caseins; Female; In Vitro Techniques; Lactati | 1982 |
Serum levels of free fatty acids in the first trimester of pregnancy: effect of acetylsalicylic acid.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Fatty Acids, Nonesterified; Female; Humans; Mid | 1982 |
Arachidonate metabolism in cultured human vascular endothelial cells. Evidence for two prostaglandin synthetic pathways sensitive to acetylsalicylic acid.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cells, | 1982 |
Influence of maternal drug metabolism on the fetal toxicity induced by acetylsalicylic acid.
Topics: Animals; Aspirin; Copper; Female; Fetus; Glucuronosyltransferase; Liver; Male; Maternal-Fetal Exchan | 1982 |
Alleviation of acetylsalicylic acid-induced fetal toxicity by calcium.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Body Weight; Calcium; Calcium Chloride; Drug Antagoni | 1983 |
Pregnancy in 20 patients with bioprosthetic valve replacement.
Topics: Adult; Aortic Valve; Aspirin; Bioprosthesis; Female; Fetus; Heart Valve Prosthesis; Humans; Mitral V | 1983 |
Combined embryotoxic action of toluene, a widely used industrial chemical, and acetylsalicylic acid (aspirin).
Topics: Abnormalities, Drug-Induced; Amniotic Fluid; Animals; Aspirin; Drug Interactions; Embryo, Mammalian; | 1983 |
Correction of pregnancy-related thrombocytopenia with aspirin without improvement in fetal outcome.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Fetal Death; Fetal Growth Retardation; Humans; Pl | 1983 |
Diagnosis and treatment of pregnancy induced platelet dysfunction.
Topics: Adult; Aspirin; Dexamethasone; Female; Humans; Plasma Substitutes; Platelet Aggregation; Pre-Eclamps | 1983 |
[Modification of implantation in rats and sows by oral administration of prostaglandin synthetase inhibitors. 5. Effects of acetylsalicylic acid and sodium salicylate on the litters of adult sows and gilts].
Topics: Administration, Oral; Animals; Aspirin; Female; Litter Size; Pregnancy; Sodium Salicylate; Swine | 1981 |
[Clinical study of the labour inhibiting effects an side effects of acetylsalicylic acid (ASA) (author's transl)].
Topics: Aspirin; Female; Fenoterol; Headache; Humans; Hyperventilation; Obstetric Labor, Premature; Pregnanc | 1981 |
Ankylosing spondylitis: the challenge of early diagnosis.
Topics: Adolescent; Adult; Aspirin; Female; Hip Prosthesis; HLA Antigens; HLA-B27 Antigen; Humans; Male; Pat | 1982 |
Role of arachidonic acid metabolites in the hypothalamic control of ovulation in the rat.
Topics: Acetaminophen; Animals; Arachidonic Acids; Aspirin; Female; Gonadotropin-Releasing Hormone; Hypothal | 1980 |
Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis.
Topics: Adult; Aspirin; Blood Coagulation Tests; Female; Fetus; Gestational Age; Hemoglobinometry; Hemorrhag | 1982 |
[Studies on the pharmacological bases of fetal toxicity of drugs. (I). Relation of fetal toxicity and tissue concentration of acetylsalicylic acid with pyrogen in pregnant rats].
Topics: Abnormalities, Drug-Induced; Adenosine Triphosphate; Animals; Aspirin; Body Weight; Drug Synergism; | 1982 |
Plasma carboxypeptidase activity and intolerance to acetylsalicylic acid unimpaired CP-N activity in ASA-intolerant individuals.
Topics: Aspirin; Carboxypeptidases; Drug Hypersensitivity; Female; Humans; Hydrogen-Ion Concentration; Lysin | 1982 |
Teratology study in Fischer 344 rats exposed to ethylene oxide by inhalation.
Topics: Animals; Aspirin; Ethylene Oxide; Female; Fetal Resorption; Gestational Age; Male; Pregnancy; Rats; | 1982 |
Teratogenic and reproductive effects of ethanol in Long-Evans rats.
Topics: Animals; Aspirin; Dieldrin; Ethanol; Female; Lactation; Male; Pregnancy; Rats; Reproduction; Teratog | 1982 |
Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Hydroxyurea; Pregnancy; Rats; Rats, Inbred F3 | 1982 |
Sodium salicylate teratogenicity in vitro.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Relationship, Drug; Female; In Vitro Te | 1982 |
[The course of pregnancy in patients with artificial valves].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Co | 1982 |
Fetal toxicity and hypocalcemia induced by acetylsalicylic acid analogues.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Fetus; Gentisates; Hydroxybenzoates; Hypocalc | 1982 |
Perinatal pharmacokinetics of acetylsalicylic acid.
Topics: Aspirin; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Obstetric Labor, Premature; Pregnan | 1982 |
[The effects of aspirin and acetaminophen during pregnancy on chromosomal structure in rat fetuses].
Topics: Acetaminophen; Animals; Aspirin; Chromosome Aberrations; Chromosome Disorders; Female; Fetus; Karyot | 1982 |
[Thrombotic thrombocytopenic purpura: report on 5 cases and current therapy concepts].
Topics: Adult; Aspirin; Dipyridamole; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Female | 1981 |
Seral, uterine and fetal salicylate concentrations after oral administration.
Topics: Administration, Oral; Adult; Aspirin; Endometrium; Female; Fetus; Humans; Kinetics; Maternal-Fetal E | 1981 |
Effect of indomethacin and aspirin on uterine activity in pregnant rats: comparison of circular and longitudinal muscle.
Topics: Animals; Aspirin; Endometrium; Female; Indomethacin; Myometrium; Organ Specificity; Pregnancy; Pregn | 1981 |
[Treatment of toxoplasmosis in obstetrics and gynecology].
Topics: Antiprotozoal Agents; Aspirin; Drug Therapy, Combination; Female; Humans; Leucomycins; Pregnancy; Pr | 1981 |
Record linkage for drug monitoring.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Computers; Delivery, Obstetric; Diarrhea; Digoxin; Drug-Related | 1981 |
[Control of implantation in rats and sows by peroral administration of prostaglandin synthetase inhibitors. 3. Effects of prostaglandin F2 alpha, progesterone/estrone, and acetylsalicylic acid on implantation and biochemical composition of amniotic fluid
Topics: Amniotic Fluid; Animals; Aspirin; Embryo Implantation; Estrone; Female; Fetus; Pregnancy; Progestero | 1981 |
[Control of implantation in rats and sows by peroral administration of prostaglandin synthetase inhibitors. 2. Effects of prostaglandin F2 alpha, progesterone/estrone, and acetylsalicylic acid on implantation and various biochemical parameters of amniotic
Topics: Acid Phosphatase; Albumins; Amniotic Fluid; Animals; Aspirin; Drug Implants; Embryo Implantation; Es | 1981 |
Aspirin-induced teratogenesis: a unique pattern of cell death and subsequent polydactyly in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cell Survival; Culture Techniques; Ectoderm; Female; | 1981 |
Effect of intrauterine administration of antiprostaglandin drugs on implantation in the rat.
Topics: Animals; Aspirin; Embryo Implantation; Female; Ibuprofen; Indomethacin; Injections; Pregnancy; Prost | 1981 |
Neonatal intracranial hemorrhage and maternal use of aspirin.
Topics: Acetaminophen; Aspirin; Cerebral Hemorrhage; Female; Gestational Age; Humans; Infant, Low Birth Weig | 1981 |
Maternal drug exposure and perinatal intracranial hemorrhage.
Topics: Aspirin; Cerebral Hemorrhage; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Dise | 1981 |
Evidence that vascular endothelial cells can induce the retraction of fibrin clots.
Topics: Animals; Aorta; Aspirin; Batroxobin; Cattle; Cells, Cultured; Clot Retraction; Endothelium; Female; | 1981 |
The placental transfer of acetylsalicylic acid in near-term ewes.
Topics: Animals; Aspirin; Carbon Radioisotopes; Chromatography, Thin Layer; Female; Fetus; Maternal-Fetal Ex | 1980 |
Adult Still's disease associated with pregnancy.
Topics: Adult; Arthritis, Juvenile; Aspirin; Female; Humans; Indomethacin; Prednisone; Pregnancy; Pregnancy | 1980 |
[ASA-triad syndrome in a 21-year-old woman in the 24th week of pregnancy].
Topics: Adult; Aspirin; Asthma; Drug Hypersensitivity; Female; Humans; Nasal Polyps; Pregnancy; Pregnancy Co | 1980 |
[Prostaglandin inhibitors and their use in the obstetrical and gynecological clinic].
Topics: Animals; Aspirin; Ethanol; Female; Fertility; Genital Diseases, Female; Humans; In Vitro Techniques; | 1980 |
Disseminated intravascular coagulation in toxaemia of pregnancy. Correction of the decreased platelet counts and raised levels of serum uric acid and fibrin(ogen) degradation products by aspirin.
Topics: Adult; Aspirin; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Produc | 1980 |
Clinical applications.
Topics: Abortion, Induced; Aspirin; Blood Pressure; Cardiovascular Diseases; Cervix Uteri; Digestive System; | 1980 |
Prediction of fetal drug concentrations.
Topics: Aspirin; Biological Availability; Female; Fetus; Humans; Kinetics; Maternal-Fetal Exchange; Models, | 1980 |
Effects of aspirin and related drugs in vitamin E-deficient rats.
Topics: Animals; Aspirin; Blood Cell Count; Female; Fetal Death; Hematocrit; Hemoglobins; Hemolysis; Male; P | 1980 |
[Pulmonary oedema as a complication of tocolytic therapy (author's transl)].
Topics: Adult; Aspirin; Autopsy; Betamethasone; Ethanolamines; Female; Fenoterol; Humans; Obstetric Labor, P | 1980 |
Effects of aspirin and acetaminophen in pregnancy and in the newborn.
Topics: Abnormalities, Drug-Induced; Acetaminophen; Animals; Aspirin; Blood Platelets; Female; Fetus; Humans | 1981 |
Aspirin-alcohol interaction in the production of cleft palate and limb malformations in the TO mouse.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cleft Palate; Drug Interactions; Ethanol; Female; Lim | 1995 |
The effect of aspirin and indomethacin on prostacyclin and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant.
Topics: Antibodies, Antiphospholipid; Aspirin; Epoprostenol; Female; Humans; Immunoglobulin G; Indomethacin; | 1995 |
Pregnancy complicated by cerebral venous thrombosis in Behçet's disease.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Behcet Syndrome; Cerebral Veins; Female; Heparin; Humans; M | 1995 |
The use of intravenous gammaglobulin, heparin and aspirin in the maintenance of pregnancy of freeze thawed embryo in a patient with lupus-type anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Cryopreservation; Drug Therapy, Combination; Embryo Trans | 1993 |
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
Topics: Acetylcholinesterase; Adult; alpha-Fetoproteins; Amniotic Fluid; Aspirin; Diseases in Twins; Ectoder | 1994 |
Clinical significance of anti-GM3 antibodies in recurrent pregnancy loss with elevated level of antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Therapy, Combination; Female; | 1995 |
A successful pregnancy in a woman with an elevated level of beta 2-glycoprotein I dependent anticardiolipin antibodies, despite a progressive thrombotic condition.
Topics: Adult; Antibodies, Anticardiolipin; Aspirin; beta 2-Glycoprotein I; Enzyme-Linked Immunosorbent Assa | 1995 |
Preconceptional counseling and intervention continued.
Topics: Aspirin; Counseling; Female; Fertilization; Humans; Pre-Eclampsia; Pregnancy; Randomized Controlled | 1995 |
Pre-eclampsia. III: The role of aspirin in prevention.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Risk Facto | 1994 |
Can low-dose acetylsalicylic acid cause disseminated intravascular coagulation?
Topics: Adult; Aspirin; Disseminated Intravascular Coagulation; Female; Fetal Growth Retardation; Humans; Po | 1995 |
[A case of pregnancy with essential thrombocythemia].
Topics: Adult; Aspirin; Dipyridamole; Female; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematolog | 1995 |
Conservative management of severe chronic hypertension in pregnancy.
Topics: Adult; Antihypertensive Agents; Aspirin; Chronic Disease; Female; Humans; Hypertension; Pregnancy; P | 1994 |
A prospective study on pregnancy risk of antiphospholipid antibodies in association with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Lupus Erythemato | 1995 |
Aspirin and prevention of preeclampsia. Position statement of the use of low-dose aspirin in pregnancy by the Australasian Society for the Study of Hypertension in Pregnancy.
Topics: Aspirin; Female; Humans; Patient Selection; Pre-Eclampsia; Pregnancy; Primary Prevention; Randomized | 1995 |
The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception.
Topics: Aspirin; Blood Flow Velocity; Buserelin; Cryopreservation; Female; Fertilization in Vitro; Follicle | 1994 |
[Effect of autoantibodies on women with infertility].
Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Aspirin; Embryonic and Fetal Developme | 1994 |
Effect of pre-treatment with aspirin on alcohol-induced neural tube defects in the TO mouse fetuses.
Topics: Anencephaly; Animals; Aspirin; Brain; Dose-Response Relationship, Drug; Embryonic and Fetal Developm | 1994 |
[May pre-eclampsia be prevented?].
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1995 |
CLASP: millstone or milestone?
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Multicenter Studies as Topic; Pre-Eclampsia; Preg | 1994 |
Influence of protein malnutrition on teratogenicity of acetylsalicylic acid in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Aspirin; Body Weight; Bone and Bones; Ca | 1994 |
Pregnancy and prosthetic heart valves.
Topics: Abnormalities, Drug-Induced; Aspirin; Bioprosthesis; Embryo, Mammalian; Female; Heart Valve Prosthes | 1994 |
How Swedish obstetricians manage hypertensive disorders in pregnancy. A questionnaire study.
Topics: Adult; Antihypertensive Agents; Aspirin; Diuretics; Female; Humans; Hypertension; Pre-Eclampsia; Pre | 1994 |
Antiphospholipid antibodies and pregnancy wastage.
Topics: Abortion, Habitual; Abortion, Spontaneous; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; | 1994 |
High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome.
Topics: Adult; Antibodies, Anti-Idiotypic; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; | 1994 |
Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Aspirin; Down-Regulation; Female; Heparin; Humans; | 1994 |
[Low-dosage acetylsalicylic acid as prevention. No documented effect in pre-eclampsia].
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1994 |
[The CLASP study--a clinical teaching-trick?].
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Publication Bias; Selection Bias | 1994 |
[Acetylsalicylic acid and pre-eclampsia/growth retardation (II)].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy | 1994 |
Low-dose aspirin in pregnancy.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1993 |
Aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Parity; Pregnancy; Pregnancy Compli | 1993 |
Aspirin in pregnancy.
Topics: Aspirin; Bias; Female; Fetal Growth Retardation; Humans; Hypertension; Pregnancy; Pregnancy Complica | 1993 |
Aspirin in pregnancy.
Topics: Aspirin; Docosahexaenoic Acids; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, P | 1993 |
Prevention of preeclampsia with low-dose aspirin.
Topics: Aspirin; Chi-Square Distribution; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy | 1994 |
Low-dose aspirin in pregnancy: changes in patterns of prescription in The Netherlands.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Netherlands; Pre-Eclampsia; Pregnan | 1993 |
The significance of experimental models of systemic lupus erythematosus and antiphospholipid syndrome induced by idiotypic manipulation.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antiphosp | 1994 |
Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome.
Topics: Abortion, Habitual; Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy | 1993 |
[Essential thrombocythemia and pregnancy].
Topics: Aspirin; Female; Humans; Hydroxyurea; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Out | 1994 |
Successful pregnancies in patients with antiphospholipid syndrome treated with low-dose aspirin.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; Humans; Methy | 1993 |
Aspirin and pre-eclampsia.
Topics: Aspirin; Female; Humans; Meta-Analysis as Topic; Pre-Eclampsia; Pregnancy | 1994 |
Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn.
Topics: Aspirin; Birth Weight; Cerebral Hemorrhage; Female; Fetal Blood; Fetal Growth Retardation; Gestation | 1993 |
Course of aPL in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Postpartum Period; | 1993 |
Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Aspirin; Female; Humans; Organ Culture Technique | 1993 |
[Effects of preimplantation treatment with aspirin and acetaminophen on blastocyst and fetus in rats].
Topics: Acetaminophen; Animals; Aspirin; Blastocyst; Embryonic and Fetal Development; Embryonic Development; | 1993 |
Pregnancy outcome in women with antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Immune System Dise | 1993 |
Secretion of lipid peroxides by the human placenta.
Topics: Aspirin; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Lipid Peroxides; Per | 1993 |
Increased platelet volume and aggregation precede the onset of preeclampsia.
Topics: Adult; Aspirin; Female; Humans; Longitudinal Studies; Platelet Aggregation; Platelet Count; Pre-Ecla | 1994 |
Severe intracranial hemorrhage in a term neonate associated with maternal acetylsalicylic acid ingestion.
Topics: Alcohol Drinking; Aspirin; Cerebral Hemorrhage; Female; Heartburn; Humans; Infant, Newborn; Male; Ma | 1993 |
Tumor necrosis factor alpha stimulates amnion prostaglandin biosynthesis primarily via an action on fatty acid cyclooxygenase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Amnion; Arachidonic Acid; Aspirin; Cells, | 1993 |
Branch retinal artery occlusion in pregnancy.
Topics: Adult; Aspirin; Female; Headache; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Recurr | 1994 |
The effect of low dose aspirin on bleeding times.
Topics: Anesthesia, Conduction; Aspirin; Bleeding Time; Female; Humans; Pregnancy | 1993 |
Antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnan | 1994 |
[Investigation of the association between autoantibodies and recurrent abortions].
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Autoantibodies; Female; Humans; Prednisone | 1993 |
Alpha 2b-interferon therapy and pregnancy--report of a case of essential thrombocythemia.
Topics: Adult; Aspirin; Female; Humans; Infant, Newborn; Infarction; Interferon alpha-2; Interferon-alpha; P | 1993 |
A clinical trial of a slow-release formulation of acetylsalicylic acid in patients at risk for preeclampsia.
Topics: Adult; Aspirin; Delayed-Action Preparations; Female; Fetal Blood; Humans; Indicators and Reagents; I | 1993 |
Hepatic infarction during pregnancy complicated by antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Female; Fetal Death; Humans; Infarction; Liver; Prednisol | 1993 |
Changes in platelet reactivity following aspirin treatment for pre-eclampsia.
Topics: Aspirin; Female; Fetal Growth Retardation; Gestational Age; Humans; Longitudinal Studies; Platelet A | 1993 |
Combined corticosteroid and aspirin treatment for the high risk lupus pregnancy.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Gestational Age; | 1993 |
Effect of prostaglandin synthesis inhibitors on spontaneous and endotoxin-induced abortion in mice.
Topics: Abortion, Spontaneous; Animals; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Female; Indomethac | 1993 |
[Retroplacental hematoma and uterine Doppler scan].
Topics: Adult; Aspirin; Birth Weight; Blood Flow Velocity; Diagnosis, Differential; Diastole; Female; Hemato | 1993 |
Roles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Topics: Animals; Arginine; Aspirin; Endothelium; Epoprostenol; Female; Humans; In Vitro Techniques; Neutroph | 1993 |
Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug | 1993 |
Lupus anticoagulant. Significance in habitual first-trimester abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Female; Fetal Death; Fetal Growth Retardation; Humans; Lupus Coa | 1993 |
Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; | 1993 |
Preventing preeclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1993 |
Angiotensin sensitivity predicts aspirin benefit in placental insufficiency.
Topics: Angiotensins; Aspirin; Female; Fetal Growth Retardation; Humans; Placental Insufficiency; Pregnancy; | 1993 |
Acetylsalicylic acid inhibits anticardiolipin antibody-induced platelet-activating factor (PAF) synthesis.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Cells, Cultured; Dose-Response Rela | 1993 |
Anticardiolipin syndrome, aspirin therapy and fetal malformation.
Topics: Abnormalities, Drug-Induced; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; | 1993 |
Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases.
Topics: Adult; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Prednisolone; Pregnancy; Pregnancy Comp | 1993 |
The effect of inhibition of prostaglandin F2 alpha synthesis on placental expulsion in the ewe.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dinoprost; Female; Labor, Obstetric; Lysi | 1993 |
Umbilical artery and ductal blood flow velocities in patients treated with aspirin and prednisone for presence of anticardiolipin antibody.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Blood Flow Velocity; Ductus Arteriosus; Fe | 1993 |
[Acetylsalicylic acid and pre-eclampsia/growth retardation].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy | 1993 |
Effects of maternal ingestion of low-dose aspirin on the fetal cardiovascular system.
Topics: Aspirin; Blood Flow Velocity; Coronary Circulation; Echocardiography, Doppler; Female; Fetus; Hemody | 1993 |
Toxic reaction to salicylate in a newborn infant: similarities to neonatal sepsis.
Topics: Aspirin; Diagnosis, Differential; Female; Fetus; Headache; Humans; Infant, Newborn; Infections; Pois | 1993 |
The lupus anticoagulant and pregnancy.
Topics: Adult; Aspirin; Female; Humans; Lupus Coagulation Inhibitor; Prednisone; Pregnancy; Pregnancy Compli | 1993 |
On the inhibitory effect of C17-sulfoconjugated catechol estrogens upon lipid peroxidation of rat liver microsomes.
Topics: Animals; Antioxidants; Aspirin; Bepridil; Biphenyl Compounds; Estrogens, Catechol; Female; Free Radi | 1995 |
Effects of low-dose aspirin therapy on plasma levels of polyunsaturated fatty acids: a preliminary investigation.
Topics: Adult; Aspirin; Fatty Acids, Unsaturated; Female; Humans; Hypertension; Pilot Projects; Pre-Eclampsi | 1995 |
Aspirin, interleukin-3 and the antiphospholipid syndrome.
Topics: Animals; Antiphospholipid Syndrome; Arachidonic Acid; Aspirin; Cyclooxygenase Inhibitors; Female; Hu | 1996 |
Low-dose aspirin therapy and placental pathology in women with poor prior pregnancy outcomes.
Topics: Adolescent; Adult; Aspirin; Drug Administration Schedule; Eclampsia; Female; Fetal Death; Humans; Pl | 1995 |
Uterine Doppler wave form and the prediction of the recurrence of pre-eclampsia and intra-uterine growth retardation in patients treated with low-dose aspirin.
Topics: Adult; Aspirin; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Follow-Up Studie | 1995 |
Maternal reproductive effects of oral salicylic acid in Sprague-Dawley rats.
Topics: Administration, Oral; Animals; Aspirin; Dose-Response Relationship, Drug; Embryonic and Fetal Develo | 1996 |
Perinatal morbidity in chronic hypertension.
Topics: Adult; Aspirin; Chronic Disease; Cohort Studies; Female; Fetal Death; Humans; Hypertension; Infant M | 1996 |
Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cocaine; Confounding | 1996 |
Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Female; Pregnancy; Prostaglandins; Rabbits; Tera | 1996 |
Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required.
Topics: Aspirin; Female; Genital Diseases, Female; Humans; Multicenter Studies as Topic; Platelet Aggregatio | 1996 |
Where next for prophylaxis against pre-eclampsia?
Topics: Aspirin; Calcium; Female; Fish Oils; Humans; Plant Oils; Platelet Aggregation Inhibitors; Pre-Eclamp | 1996 |
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women.
Topics: Aspirin; Female; Fetal Diseases; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Compl | 1996 |
Anesthesia with antiphospholipid antibodies: anesthetic management of a parturient with lupus anticoagulant and anticardiolipin antibody.
Topics: Adult; Anesthesia; Anesthesia, Obstetrical; Antibodies; Anticoagulants; Aspirin; Cardiolipins; Femal | 1996 |
[Should nitrogen monoxide replace aspirin in the prevention of preeclampsia?].
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Humans; Nitric Oxide; Pre-Eclampsia; Pregnancy | 1996 |
Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Kidney Diseases; Platelet Agg | 1995 |
Toxicity to transferred rat embryos after aspirin treatment during preimplantation stage in vivo.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Relationship, Drug; Embryo Implantation | 1996 |
Low-dose aspirin and recurrent miscarriage.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; Humans; | 1995 |
Placental thrombosis and second trimester miscarriage in association with activated protein C resistance.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Disorders; Factor Xa; Female; Humans; Placenta | 1996 |
[The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differ | 1995 |
Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases.
Topics: Adult; Aspirin; Female; Fibrinogen; Fibrinolytic Agents; Gestational Age; Hemoglobins; Heparin; Huma | 1996 |
Antiphospholipid antibodies, low-dose aspirin and pregnancy losses.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Female; Humans; Pregnancy | 1996 |
Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arachidonic A | 1996 |
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Cells, Cultured; Female; Humans; Interleukin-3; Leukocytes, Mono | 1996 |
5-Hydroxyeicosatetraenoic acid and human parturition.
Topics: Amniocentesis; Amnion; Amniotic Fluid; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cult | 1996 |
Use of aspirin in preeclampsia.
Topics: Aspirin; Cyclooxygenase Inhibitors; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; | 1995 |
Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required.
Topics: Aspirin; Female; Humans; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Cardiovas | 1996 |
Acetylsalicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy. Are they safe?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; | 1996 |
Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: results of a pilot study.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Drug Administration Schedule; D | 1996 |
Post tonsillitic erythema nodosum in pregnancy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Erythema Nodosum; Female; Humans; Pregnancy | 1996 |
Thrombotic thrombocytopenic purpura in pregnancy.
Topics: Aspirin; Female; Humans; Plasma Exchange; Pregnancy; Pregnancy Complications, Hematologic; Purpura, | 1996 |
Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Fema | 1997 |
Antiphospholipid (Hughes') syndrome.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Female; Fibrinolytic Agents; Heparin; Humans | 1997 |
Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion.
Topics: Angiotensin II; Antihypertensive Agents; Aspirin; Cells, Cultured; Cyclooxygenase Inhibitors; Dihydr | 1997 |
[Pregnancy in primary antiphospholipid syndrome. Proposal for a common management protocol].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid S | 1996 |
[Physiopathology of preeclampsia].
Topics: Arachidonic Acids; Aspirin; Blood Coagulation; Calcium; Cardiovascular System; Embryonic and Fetal D | 1996 |
Effects of aspirin and garlic on cyclooxygenase-induced chemiluminescence in human term placenta.
Topics: alpha-Linolenic Acid; Arachidonic Acid; Aspirin; Chorionic Villi; Cyclooxygenase Inhibitors; Female; | 1997 |
Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas.
Topics: Aspirin; Blood Platelets; Epoprostenol; Female; Free Radicals; Humans; In Vitro Techniques; Kinetics | 1995 |
[A case of antiphospholipid antibody syndrome successfully treated with prednisolone and low-dose aspirin, with subsequent normal pregnancy].
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; | 1997 |
[Initial evaluation of the ACL-Futura coagulation analyzer].
Topics: Acenocoumarol; Adult; Antithrombin III; Aspirin; Bilirubin; Blood Coagulation; Blood Coagulation Tes | 1996 |
Effect of diaspirin crosslinked hemoglobin on systemic and regional blood circulation in pregnant rats.
Topics: Animals; Aspirin; Blood Substitutes; Cerebrovascular Circulation; Coronary Circulation; Digestive Sy | 1997 |
Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; As | 1997 |
[Essential thrombocythemia in pregnancy. A case report and general considerations].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Infant, Newborn; Male; Plate | 1997 |
Autoantibodies and pregnancy loss.
Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Aspirin; Autoantibodies; Blood Coagulation; Fem | 1997 |
Medical prevention of pre-eclampsia.
Topics: Antihypertensive Agents; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1997 |
Aspirin induces increased expression of both prostaglandin H synthase-1 and prostaglandin H synthase-2 in cultured human placental trophoblast.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cycloheximide; | 1997 |
Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies.
Topics: Adrenal Cortex Hormones; Aging; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
Obstetric outcome in antiphospholipid syndrome.
Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; | 1997 |
Analgesics and the kidney: recommendations of the National Kidney Foundation for the use of analgesics.
Topics: Acetaminophen; Aged; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; | 1996 |
Antiphospholipid antibodies, infertility and recurrent miscarriage.
Topics: Abortion, Habitual; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combina | 1997 |
Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1997 |
Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin | 1997 |
[Effects of blastocyst deficiencies induced by aspirin treatment during preimplantation period in rats on development of embryos after implantation].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blastocyst; Embryo Implantation; Embryo L | 1996 |
Postpartum thrombosis in primary thrombocythaemia.
Topics: Adult; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytosis; Thr | 1997 |
Pregnancy in a patient with essential thrombocytosis.
Topics: Aspirin; Female; Humans; Ischemia; Placenta; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy C | 1997 |
Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera.
Topics: Anti-Inflammatory Agents; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Betameth | 1997 |
[Abortions caused by anticardiolipin antibodies: prevention by low-dose acetylsalicylic acid].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Autoimmu | 1997 |
Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Aspirin; Blood Pressure; Cel | 1997 |
The fetoplacental pressor effects of low-dose acetylsalicylic acid and angiotensin II in the ex vivo cotyledon model.
Topics: Angiotensin II; Aspirin; Blood Pressure; Female; Fetus; Humans; Perfusion; Placenta; Pregnancy | 1997 |
[Dosage of acetylsalicylic acid in the prevention and therapy of intrauterine growth retardation].
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pregnancy; Retrospective Studies | 1997 |
Prednisone and aspirin in women with recurrent fetal loss.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Female; Glucocorticoids; Humans; Prednisone; Pregnancy; | 1997 |
Hypothesis: antiphospholipid antibodies associated with congenital anomalies?
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Congeni | 1997 |
The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia.
Topics: Aspirin; Cells, Cultured; Cyclooxygenase Inhibitors; Female; Humans; Hydroxyeicosatetraenoic Acids; | 1998 |
Aspirin poisoning during pregnancy: increased fetal sensitivity.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Gas Analysis; Blood Glucose; Diu | 1998 |
[Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; | 1997 |
Low-dose aspirin for preeclampsia--the unresolved question.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Risk Factors | 1998 |
Immunosuppressive therapy for recurrent aborters with positive antiphospholipid antibodies and alteration of 6ketoPGF1 alpha/TXB2 ratio.
Topics: 6-Ketoprostaglandin F1 alpha; Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Aspirin; Drug | 1997 |
Aspirin pretreatment potentiates hyperthermia-induced teratogenesis in the mouse.
Topics: Animals; Aspirin; Body Temperature; Bone and Bones; Congenital Abnormalities; Female; Fever; Gestati | 1998 |
[Primary antiphospholipid syndrome in obstetrics. Apropos of 4 cases with fetal survival].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dipyridamole; D | 1996 |
Preventing intrauterine growth retardation with aspirin: does it work?
Topics: Aspirin; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Female; Fetal Growth Retardation; Huma | 1998 |
Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 1998 |
Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997;25(2):192-196.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; Aspirin; Female; Humans; Infant, | 1998 |
Increased ductal responsiveness to PGE2 after maternal treatment with aspirin and ibuprofen.
Topics: Administration, Oral; Animals; Animals, Newborn; Aspirin; Cesarean Section; Dinoprostone; Ductus Art | 1998 |
Titration of antiplatelet treatment in pregnant women at risk of preeclampsia.
Topics: Abortion, Spontaneous; Adult; Aspirin; Birth Weight; Female; Fetal Death; Fetal Growth Retardation; | 1998 |
Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996.
Topics: Adult; Anticoagulants; Aspirin; Cerebral Hemorrhage; Fatal Outcome; Female; Fertilization in Vitro; | 1998 |
Study strengthens case against using aspirin to prevent preeclampsia.
Topics: Aspirin; Clinical Trials as Topic; Female; Humans; Pre-Eclampsia; Pregnancy | 1998 |
[Indications for aspirin on the centennial of its discovery].
Topics: Adult; Aged; Alzheimer Disease; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; A | 1997 |
From the Centers for Disease Control and Prevention. Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996.
Topics: Adult; Anticoagulants; Aspirin; Cerebral Hemorrhage; Fatal Outcome; Female; Fertilization in Vitro; | 1998 |
A spontaneous induction of fetal membrane prostaglandin production precedes clinical labour.
Topics: Analysis of Variance; Aspirin; Culture Techniques; Cyclooxygenase Inhibitors; Dinoprostone; Endotoxi | 1998 |
Low-dose aspirin not for pre-eclampsia.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Incidence; Placebos; Platelet Activation; Platele | 1998 |
Early onset of parturition induced by acute alcohol exposure in C57BL/6J mice: role of uterine PGE and PGF2alpha.
Topics: Animals; Aspirin; Dinoprost; Ethanol; Female; Fetus; Labor, Obstetric; Mice; Mice, Inbred C57BL; Obs | 1997 |
Cutaneous vascular infarcts secondary to spontaneous platelet aggregation.
Topics: Adult; Aspirin; Female; Humans; Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; P | 1998 |
Recurrent abortion and moderate or strong antiphospholipid antibody production.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1998 |
Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
Topics: Aspirin; Drug Therapy, Combination; Female; Fetal Growth Retardation; Gestational Age; Heparin, Low- | 1998 |
Eleven myths of dentoalveolar surgery.
Topics: Alcoholic Beverages; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Blood C | 1998 |
Unilateral trigeminal and facial nerve palsies associated with epidural analgesia in labour.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthetics, Local; Anti-Inflammatory Agents, No | 1998 |
Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlopidine, and aspirin.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Aspirin; Blood Vessel Prosthesis Implantation; Coronary An | 1998 |
Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization.
Topics: Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Aspirin; Autoimmune Diseases; Dose-Res | 1998 |
Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
Topics: Abortion, Habitual; Adult; Aspirin; Busulfan; Female; Humans; Platelet Aggregation Inhibitors; Pregn | 1998 |
A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth.
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Fetal Moni | 1998 |
Effect of aspirin in pregnant women is dependent on increase in bleeding time.
Topics: Adult; Antihypertensive Agents; Arteries; Aspirin; Bleeding Time; Cohort Studies; Dose-Response Rela | 1999 |
Aspirin for preventing and treating pre-eclampsia.
Topics: Aspirin; Clinical Trials as Topic; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; P | 1999 |
Low-risk essential thrombocythaemia in patients younger than 40.
Topics: Adolescent; Adult; Aspirin; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; | 1999 |
Low-dose acetylsalicylic acid reduces the risk of preeclampsia in pregnant women at high risk for preeclampsia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Family Practice; Female; Humans; Pre-Eclamp | 1999 |
[Aspirin and the prevention of pre-eclampsia: focus in 1999].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Controlled Clinical Trials as Topic; Dise | 1999 |
[Treatment of integrated traditional and Western medicine in recurrent spontaneous abortion of immune abnormality type].
Topics: ABO Blood-Group System; Abortion, Habitual; Adult; Aspirin; Autoantibodies; Drug Therapy, Combinatio | 1997 |
Oxidative damage in fetal rat brain induced by ischemia and subsequent reperfusion. Relation to arachidonic acid peroxidation.
Topics: Animals; Arachidonic Acid; Aspirin; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Female | 1999 |
A randomised trial of low dose aspirin for primiparae in pregnancy (Golding)/Barbados low dose aspirin study in pregnancy (BLASP) (Rotchell et al.)
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Prenatal Care; R | 1999 |
Low dose aspirin for preventing and treating pre-eclampsia. Author of editorial did not criticise studies' methodology.
Topics: Antihypertensive Agents; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1999 |
Habitual abortions in 678 healthy patients: investigation and prevention.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibo | 1999 |
Too little, too late.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1999 |
Low dose aspirin for preventing and treating pre-eclampsia. Trials are needed to determine when treatment should be started.
Topics: Antihypertensive Agents; Aspirin; Clinical Trials as Topic; Female; Humans; Pre-Eclampsia; Pregnancy | 1999 |
[Favorable outcome of a subdural hematoma diagnosed in utero].
Topics: Adult; Aspirin; Female; Fetal Growth Retardation; Follow-Up Studies; Hematoma, Subdural; Humans; Inf | 1999 |
[Arterial hypertension of the pregnant woman].
Topics: Aspirin; Diagnosis, Differential; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Placenta D | 1999 |
Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study.
Topics: Absorptiometry, Photon; Adult; Antiphospholipid Syndrome; Aspirin; Bone Density; Bone Diseases, Meta | 1999 |
Warfarin or aspirin: both or others?
Topics: Aged; Anticoagulants; Aspirin; Embolism; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet | 1999 |
The effect of aspirin administration and parity on plasma salicylate concentrations and postpartum reproductive parameters in Brahman cows.
Topics: Animals; Aspirin; Body Weight; Cattle; Dinoprost; Estrus; Female; Parity; Postpartum Period; Pregnan | 1999 |
Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Topics: Adult; Anesthesia, Epidural; Aspirin; Cesarean Section; Chronic Disease; Double-Blind Method; Female | 1999 |
[Efficacy of the combined treatment with immunoglobulins and plasmapheresis in a pregnant woman with Rh alloimmunization and antiphospholipid antibodies].
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Combined Modality Therapy; Female; Fibrinolytic Agents; H | 1999 |
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies.
Topics: Adult; Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, | 1999 |
High-risk pregnancy in beta-thalassemia major women. Report of three cases.
Topics: Adult; Aspirin; beta-Thalassemia; Cardiomyopathy, Dilated; Deferoxamine; Female; Humans; Pregnancy; | 2000 |
The effect of oxytocin, prostaglandin E2 and acetylsalicylic acid on flow distribution and on the transfer of alanine, glucose and water in isolated perfused guinea pig placentae.
Topics: Alanine; Animals; Aspirin; Biological Transport, Active; Dinoprostone; Female; Glucose; Guinea Pigs; | 2000 |
Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study.
Topics: Antibodies, Anticardiolipin; Antibodies, Antinuclear; Aspirin; Autoantibodies; Embryo Transfer; Fema | 2000 |
Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.
Topics: Adolescent; Adult; Aged; Aspirin; Bacterial Toxins; Child; Child, Preschool; Clinical Trials as Topi | 1999 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free | 2000 |
The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.
Topics: Abortion, Habitual; Adult; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; | 2000 |
Aspirin and prevention of vascular complications: there are still indications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Female; Fetal Growth Re | 2000 |
Platelets induce human umbilical vein endothelial cell proliferation through P-selectin.
Topics: Aspirin; Blood Platelets; Cell Adhesion; Cell Division; Cell Line; Endothelium, Vascular; Female; Hu | 2000 |
Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Topics: 3' Untranslated Regions; Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; | 2000 |
Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial.
Topics: Aspirin; Drug Administration Schedule; Embryonic and Fetal Development; Female; Fetal Growth Retarda | 2000 |
Protection by free oxygen radical scavenging enzymes against salicylate-induced embryonic malformations in vitro.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Drug Interactions; Embryonic and Fetal Development; F | 2000 |
[Myocardial infarction, pregnancy and anesthesia].
Topics: Adrenergic beta-Antagonists; Adult; Analgesia, Obstetrical; Analgesia, Patient-Controlled; Analgesic | 2000 |
Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies.
Topics: Abortion, Spontaneous; Adult; Aspirin; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pl | 2000 |
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Topics: Adult; Anticoagulants; Aspirin; Asthma; Cephalosporins; Chondroitin Sulfates; Dermatan Sulfate; Drug | 2000 |
Choroidal neovascular membrane presenting as a complication of pre-eclampsia in a patient with the antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Choroidal Neovascularization; Female; Fluorescein Angiogr | 2000 |
Teratogenicity of edoferon kappa A, a molecule derived from salicylate, in cultured rat embryos: differences from salicylate and interaction with free oxygen radical scavenging enzymes.
Topics: Animals; Antioxidants; Aspirin; Culture Techniques; Dose-Response Relationship, Drug; Embryonic and | 2000 |
Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchodilator Agents; Extracorporeal Membrane Oxy | 2001 |
Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.
Topics: Abortion, Habitual; Aspirin; Female; Fetal Growth Retardation; Fetus; Heparin, Low-Molecular-Weight; | 2001 |
Late normalisation of uterine artery velocimetry in high risk pregnancy.
Topics: Arteries; Aspirin; Blood Flow Velocity; Dose-Response Relationship, Drug; Female; Fetal Death; Human | 2001 |
Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.
Topics: Adult; Anticoagulants; Aspirin; Brain Infarction; Drug Therapy, Combination; Female; Heart Valve Pro | 2001 |
Interactions in developmental toxicology: combined action of restraint stress, caffeine, and aspirin in pregnant mice.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Caffeine; Embryonic and Fetal Development; Female; Ma | 2001 |
Non-pregnant circulatory volume status predicts subsequent pregnancy outcome in normotensive thrombophilic formerly preeclamptic women.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Folic Acid; Gestational Age; HELLP Syndrome | 2001 |
Antiphospholipid antibodies in women at risk for preeclampsia.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; Blood Pressure; Enzyme-Li | 2001 |
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Fetal Death; Heparin; | 2001 |
Possible relevance of virus infection for development of analgesic idiosyncrasy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Drug Hypersensitivity; Female; Herp | 2001 |
Nonsteroidal anti-inflammatory drug-associated colitis with a histology of collagenous colitis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Collagen; Colonoscopy; Diarrhea; Fe | 2001 |
[Antibodies to phospholipids and ischemic disorders of cerebral circulation in young age].
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Antibodies, Antiphospholipid; Anticoagulants; Anti | 1997 |
Aspirin to treat obstetric manifestations of the antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2001 |
[Impaired maternal and fetal hemodynamics in the pathogenesis of gestosis].
Topics: Adolescent; Adult; Aspirin; Diagnosis, Differential; Female; Hemodynamics; Humans; Models, Theoretic | 2001 |
Enoxaparin treatment in women with mechanical heart valves during pregnancy.
Topics: Adult; Antibodies; Anticoagulants; Aspirin; Enoxaparin; Factor Xa; Female; Heart Valve Diseases; Hea | 2001 |
Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Base Pair Mismatch; Colorectal Neoplasms, | 2001 |
[Atrophic polychondritis and Hashimoto's thyroiditis: apropos of a case].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Follow-Up Studies; Humans; Infant, | 2001 |
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Female; Humans; Multiv | 2001 |
Fetal intracranial hemorrhage due to antenatal low dose aspirin intake.
Topics: Abnormalities, Drug-Induced; Adult; Aspirin; Cesarean Section; Dose-Response Relationship, Drug; Fem | 2001 |
Maternal medication use and risks of gastroschisis and small intestinal atresia.
Topics: Acetaminophen; Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Aspirin; Canada; Ephedrine; Fema | 2002 |
May-hegglin anomaly: the role of aspirin in the treatment of this rare platelet disorder in pregnancy.
Topics: Adult; Aspirin; Female; Humans; Inclusion Bodies; Platelet Aggregation Inhibitors; Pregnancy; Pregna | 2002 |
Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Gauche | 2002 |
[Contribution of diagnostic ultrasonography in cases of repeated embryonic implantation failure in fertilization in vitro].
Topics: Arteries; Aspirin; Embryo Implantation; Embryo Transfer; Female; Fertilization in Vitro; Humans; Lut | 2001 |
Antiphospholipid antibodies do not a syndrome make.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Diagnos | 2002 |
Liver and kidney ultrastructural changes caused by acetylsalicylic acid treatment during pregnancy in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Kidney; Liver; Pregnancy; Rats; R | 2002 |
Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Antithrombin III; Aspirin; Chondroitin Sulfates; Dermatan Sulfate; Drug Combi | 2002 |
[Course of pregnancy in a patient with systemic lupus erythematosus--case report].
Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Prednisone | 2002 |
Pregnancy outcome after suicide attempt by drug use: a Danish population-based study.
Topics: Abortion, Spontaneous; Acetaminophen; Adolescent; Adult; Aspirin; Child; Child, Preschool; Denmark; | 2002 |
A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; He | 2002 |
Four pregnancies in two patients with essential thrombocythaemia--a case report.
Topics: Adult; Aspirin; Combined Modality Therapy; Cyclooxygenase Inhibitors; Female; Fetal Death; Humans; H | 2002 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Aspirin; Controlled Clinical Trials as T | 2002 |
Aspirin and trauma--uncommon and preventable causes of intracranial haemorrhage in the newborn.
Topics: Adult; Aspirin; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Int | 2002 |
[Prevention of premature labor].
Topics: Adrenergic beta-Agonists; Aspirin; Female; Humans; Indomethacin; Obstetric Labor, Premature; Pregnan | 1975 |
Letter: Effect of sapirin on oestriol excretion in pregnancy.
Topics: Adult; Aspirin; Circadian Rhythm; Estriol; Female; Humans; Pregnancy | 1975 |
Letter: Aspirin and oestriol excretion.
Topics: Aspirin; Estriol; Female; Glucuronates; Humans; Pregnancy | 1975 |
Aspirin and congenital malformations.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Aspirin; Birth Weight; Female; Humans; Infant, | 1976 |
Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy.
Topics: Aspirin; Birth Weight; Black People; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, | 1976 |
Aspirin during pregnancy.
Topics: Aspirin; Female; Fetal Death; Fetus; Humans; Pregnancy | 1976 |
Disseminated intravascular coagulation induced by progesterone in the pregnant rat. Prevention by estogens.
Topics: Animals; Aspirin; Cortisone; Dicumarol; Diet; Disseminated Intravascular Coagulation; Estrogens; Fem | 1977 |
Aspirin for the treatment of recurrent toxaemia.
Topics: Adult; Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Recurrence; Th | 1978 |
Effect of aspirin on incidence of pre-eclampsia.
Topics: Aspirin; Female; Humans; Platelet Adhesiveness; Pre-Eclampsia; Pregnancy | 1979 |
Aspirin in pregnancy.
Topics: Aspirin; Drug Evaluation; Female; Humans; Pre-Eclampsia; Pregnancy | 1979 |
Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy.
Topics: Angiotensin II; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; In | 1978 |
[Prostaglandins and reproduction].
Topics: Animals; Aspirin; Corpus Luteum; Cricetinae; Cyclic AMP; Female; Gonadotropin-Releasing Hormone; Hum | 1975 |
[Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
Topics: Aspirin; Blood Platelets; Cyclic AMP; Depression, Chemical; Female; Humans; Platelet Adhesiveness; P | 1977 |
Diffuse metanephric adenoma after in utero aspirin intoxication. A unique case of progressive renal failure.
Topics: Aspirin; Female; Humans; Infant, Newborn; Kidney Neoplasms; Male; Maternal-Fetal Exchange; Pregnancy | 1979 |
The treatment of threatened premature labor by tocolytics, Ca++-Antagonists and anti-inflammatory drugs.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Aspirin; Calcium; Drug Therapy, Combina | 1975 |
Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy.
Topics: Arthritis; Aspirin; Female; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Kinetics; Maternal- | 1975 |
[General and local postoperative and postpartum therapy with BayroVas and BayroVas Gel].
Topics: Administration, Oral; Administration, Topical; Aspirin; Cicatrix; Drug Combinations; Ethanolamines; | 1975 |
[Effects of aspirin on pregnant women and fetus; tetracycline-induced esophageal ulcer; and re-evaluation of sulfa drugs, anti-inflammatory enzymes and vitamins].
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anemia; Anti-Inflammatory Agents; Aspirin; Esophagea | 1977 |
Salicylate toxicology.
Topics: Adolescent; Adult; Animals; Aspirin; Child; Child, Preschool; Drug Hypersensitivity; Female; Fetus; | 1977 |
Gastrointestinal and other side-effects from the use of aspirin and related drugs; biochemical studies on the mechanisms of gastrotoxicity.
Topics: Animals; Aspirin; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Guinea Pigs; Humans; Pregnanc | 1977 |
[Reproduction study of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101) in rats (II). Administration of M73101 during the period of major organogenesis (author's transl)].
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Behavior, An | 1979 |
[Reproduction study of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101) in rabbits. Administration of M73101 during the period of major organogenesis (author's transl)].
Topics: Abnormalities, Drug-Induced; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Weight; | 1979 |
[Neonatal hemorrhage due to maternal antiplatelet therapy].
Topics: Acute Disease; Aspirin; Dipyridamole; Female; Gastrointestinal Hemorrhage; Humans; Infant, Newborn; | 1979 |
Pathophysiologic considerations in peptic ulcer disease.
Topics: ABO Blood-Group System; Adrenal Cortex Hormones; Aspirin; Bicarbonates; Environment; Female; Gastric | 1979 |
Comparative distribution and embryotoxicity of acetylsalicylic acid in pregnant rats and rhesus monkeys.
Topics: Animals; Aspirin; Embryo, Mammalian; Female; Fetal Death; Fetal Resorption; Haplorhini; Macaca mulat | 1977 |
Pharmacology of the ductus arteriosus.
Topics: Aspirin; Chloroquine; Cyclooxygenase Inhibitors; Ductus Arteriosus; Ductus Arteriosus, Patent; Femal | 1978 |
Hemodynamic changes induced by blockers of prostaglandin synthesis in the fetal lamb in utero.
Topics: Animals; Aspirin; Cardiac Output; Cyclooxygenase Inhibitors; Female; Fetus; Gestational Age; Hemodyn | 1978 |
[Prevention of premature delivery with acetylsalicylic acid].
Topics: Adult; Aspirin; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Obstetric Labo | 1979 |
[Side effects of drug for thromboembolism prophylaxis. Results from the University Women's Clinic Freiburg/Br].
Topics: Adult; Anaphylaxis; Anticoagulants; Aspirin; Dextrans; Female; Hemorrhage; Heparin; Humans; Necrosis | 1979 |
The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function.
Topics: Adult; Aspirin; Blood Platelets; Cell Count; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans | 1979 |
Platelet life span in pregnancies resulting in small-for-gestational age infants.
Topics: Aspirin; Blood Platelets; Cell Survival; Female; Fetal Growth Retardation; Humans; Infant, Newborn; | 1979 |
[Influence of na-salicylate on uterine motility in labour (author's transl)].
Topics: Aspirin; Female; Humans; Labor, Obstetric; Pregnancy; Uterine Contraction | 1979 |
Vascular responsiveness to pressor agents during human pregnancy.
Topics: Aldosterone; Angiotensin II; Aspirin; Female; Hematocrit; Humans; Hypertension; Indomethacin; Pregna | 1979 |
Prostaglandins in the pathogenesis of the generalized Shwartzman reaction.
Topics: Animals; Aspirin; Bradykinin; Cortisone; Endotoxins; Female; Indomethacin; Male; Pregnancy; Prostagl | 1979 |
Aspirin and acetaminophen.
Topics: Acetaminophen; Antidotes; Arthritis, Juvenile; Aspirin; Child, Preschool; Female; Hemostasis; Humans | 1979 |
Aspirin: teratogenic evaluation in the dog.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dogs; Dose-Response Relationship, Drug; Female; Fetal | 1979 |
[Experimental model for the study of the teratogenic interaction of chemical agents and drugs (toluene and acetylsalicylic acid)].
Topics: Animals; Aspirin; Drug Interactions; Female; Models, Biological; Pregnancy; Rats; Teratogens; Toluen | 1979 |
Teratogenicity of therapeutic agents.
Topics: Abnormalities, Drug-Induced; Abnormalities, Radiation-Induced; Abortion, Induced; Anesthetics; Anima | 1979 |
Survival following thrombotic thrombocytopenic purpura in pregnancy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Transfusion; Blood Urea Nitrogen; Cesarean Section; D | 1977 |
Aspirin versus acetaminophen: a comparative view.
Topics: Acetaminophen; Aspirin; Child; Drug Labeling; Female; Humans; Pregnancy | 1978 |
Prostaglandin F in the fallopian tube secretion of the ewe.
Topics: Animals; Aspirin; Body Fluids; Estrus; Fallopian Tubes; Female; Pregnancy; Prostaglandins F; Protein | 1978 |
[Pharmacokinetic studies on the placental transfer of acetyl-salicylic acid intravenously administered in the prepartal period (proceedings)].
Topics: Aspirin; Female; Humans; Injections, Intravenous; Labor, Obstetric; Maternal-Fetal Exchange; Placent | 1977 |
[Results of labor-inhibiting treatment with high doses of intravenously administered acetylsalicylic acid (proceedings)].
Topics: Aspirin; Female; Humans; Infusions, Parenteral; Obstetric Labor, Premature; Pregnancy; Uterine Contr | 1977 |
PDAs, prostaglandins, and RLF.
Topics: Aspirin; Ductus Arteriosus, Patent; Female; Humans; Indomethacin; Infant, Newborn; Pregnancy; Prosta | 1978 |
Clinical importance of side-effects of drugs inhibiting platelet function.
Topics: Aspirin; Carbenicillin; Female; Hemorrhage; Humans; Nitrofurantoin; Penicillin G; Platelet Aggregati | 1977 |
Potentiation of methotrexate embryolethality by aspirin in rats.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Body Weight; Drug Synergism; Embryo, Mammalian; Femal | 1978 |
[The electrophoretic mobility of platelets. Short review of the literature and contribution with personal experience (author's transl)].
Topics: Adolescent; Adult; Aspirin; Blood Coagulation; Blood Platelets; Contraceptives, Oral; Diabetes Melli | 1978 |
Management of premature labor.
Topics: Aspirin; Bed Rest; Betamethasone; Estrogens; Ethanol; Female; Fetal Membranes, Premature Rupture; Gl | 1978 |
[Labor analgesia with lysine acetylsalicyclate. Evaluation of various respiratory, circulatory and hematological parameters in mothers and newborn infants].
Topics: Adult; Anesthesia, Obstetrical; Aspirin; Blood; Blood Circulation; Female; Fetus; Hemodynamics; Huma | 1978 |
Evaluation of the teratogenic potential of fresh-brewed coffee and caffeine in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Body Weight; Caffeine; Coffee; Cricetinae; Female; Le | 1978 |
Clinical pharmacokinetics of aspirin.
Topics: Absorption; Aspirin; Biotransformation; Child; Female; Humans; Infant, Newborn; Intestinal Absorptio | 1978 |
Ototoxic agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Aspirin; Child; Drug-Related Side Effects and Adver | 1978 |
Drugs and pregnancy.
Topics: Abnormalities, Drug-Induced; Aspirin; Embryo, Mammalian; Ethanol; Female; Fetus; Humans; Maternal-Fe | 1978 |
[Evaluation of various parameters of respiration, circulation and of the blood picture of mothers and newborn infants following treatment of labor pain with lysine acetylsalicylate].
Topics: Adolescent; Adult; Aspirin; Blood Cell Count; Female; Hematocrit; Hemodynamics; Hemoglobins; Humans; | 1978 |
[The therapeutic year].
Topics: Albuterol; Anti-Inflammatory Agents; Aspirin; Calcitonin; Colchicine; Drug Therapy; Endocrine System | 1976 |
[The effect of prostaglandin F2alpha on pregnancy in rats and attempts to counteract its abortifacient action].
Topics: Abortifacient Agents; Animals; Aspirin; Dose-Response Relationship, Drug; Female; Gestational Age; I | 1976 |
Effects of aspirin and acetaminophen on fetal and placental growth in rats.
Topics: Acetaminophen; Animals; Aspirin; Body Weight; Female; Fetus; Placenta; Pregnancy; Rats | 1977 |
The determination of aspirin levels in the presence of hyperbilirubinemia.
Topics: Aspirin; Blood Chemical Analysis; False Positive Reactions; Female; Humans; Infant, Newborn; Jaundic | 1977 |
Enhancement of aspirin-induced teratogenicity by food restriction in rats.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Body Weight; Female; Food Deprivation; Maternal-Fetal | 1977 |
Analogous effects of zinc deficiency and aspirin toxicity in the pregnant rat.
Topics: Aldosterone; Animals; Aspirin; Blood Coagulation; Calcium; Female; Fetal Death; Potassium; Pregnancy | 1977 |
[Effect of drug therapy during pregnancy on the clotting potential of the newborn].
Topics: Aspirin; Blood Coagulation Disorders; Drug-Related Side Effects and Adverse Reactions; Female; Hemos | 1977 |
A new hypothesis of itching in pregnancy.
Topics: Aspirin; Chlorpheniramine; Female; Humans; Liver Function Tests; Models, Biological; Pregnancy; Preg | 1977 |
The prevention of acute pulmonary embolism.
Topics: Adult; Anticoagulants; Aspirin; Dextrans; Early Ambulation; Female; Heparin; Humans; Leg; Postoperat | 1977 |
New uses for acetylsalicylic acid and other prostaglandin antagonists.
Topics: Aspirin; Crohn Disease; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Humans; Infant, Newbor | 1977 |
Serum aspirin esterase activity in women with habitual aspirin intake.
Topics: Adult; Aspirin; Carboxylic Ester Hydrolases; Female; Humans; Male; Methods; Pregnancy; Time Factors | 1977 |
Effect of aspirin on bleeding time during elective abortion.
Topics: Abortion, Induced; Acetaminophen; Adolescent; Adult; Aspirin; Blood Coagulation; Blood Coagulation D | 1976 |
Effect of L-glutamine on acetylsalicylic acid-induced gastric lesions in pregnant and non-pregnant rats.
Topics: Animals; Aspirin; Female; Gastric Mucosa; Glutamine; Pregnancy; Pregnancy, Animal; Rats; Stomach Ulc | 1976 |
Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero.
Topics: Animals; Aspirin; Blood Circulation; Blood Gas Analysis; Blood Pressure; Cardiac Output; Ductus Arte | 1976 |
The effect of prostaglandins on hypothalamic L-cystine arylamidase activity and on luteinizing hormone secretion in the rat.
Topics: Aminopeptidases; Animals; Aspirin; Cystine; Diestrus; Dose-Response Relationship, Drug; Estradiol; F | 1976 |
The effect of cortisone on the teratogenic action of acetylsalicylic acid and diphenylhydantoin in the mouse.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cleft Palate; Cortisone; Drug Administration Schedule | 1976 |
Intrauterine salicylate intoxication in a newborn. A case report.
Topics: Acetazolamide; Aspirin; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Maternal | 1976 |
Radioimmunoassay for urinary metabolites of prostaglandin F2alpha.
Topics: Animals; Aspirin; Estradiol; Estrus; Female; Guinea Pigs; Humans; Hysterectomy; Immune Sera; Immuniz | 1976 |
Corpus luteum function in the ewe: effect of PGF2alpha and prostaglandin synthetase inhibitors.
Topics: Acetates; Animals; Arachidonic Acids; Aspirin; Corpus Luteum; Dexamethasone; Estrus; Female; Flufena | 1976 |
[Effect of salicylates on the blood system of the fetus and the newborn under experimental conditions].
Topics: Animals; Aspirin; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Female; Fetal Blood; Hematopoies | 1976 |
Effect of acetyl salicylic acid & prostaglandins on the reproductive performance of female albino rats.
Topics: Animals; Aspirin; Female; Pregnancy; Prostaglandins E; Prostaglandins F; Rats; Reproduction | 1976 |
Influence of pregnancy on the development of various gastric lesions in rats.
Topics: Animals; Aspirin; Epinephrine; Female; Gastric Juice; Histamine; Lactation; Models, Biological; Preg | 1976 |
[Side and toxic effects of salicylates].
Topics: Aspirin; Chemical and Drug Induced Liver Injury; Female; Heart Diseases; Humans; Kidney Diseases; Ma | 1976 |
[Clinical evaluation of lysine acetylsalicylate in obstetrical analgesia].
Topics: Adult; Anesthesia, Obstetrical; Aspirin; Blood Coagulation; Cardiovascular System; Drug Evaluation; | 1976 |
Teratogenic effects of environmental agents on embryonic development.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anticonvulsants; Antide | 1975 |
[Aspirin at the table of the accused. Why?].
Topics: Aspirin; Female; Humans; Maternal-Fetal Exchange; Pregnancy | 1975 |
Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Disorders; Blood Donors; Blood P | 1975 |
Increased platelet aggregability in young patients with stroke. Diagnosis and therapy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cell Survival; Cerebrovascular Di | 1975 |
A clinical look at the problem of drugs in pregnancy and their effect on the fetus.
Topics: Abnormalities, Drug-Induced; Anesthesia, Obstetrical; Aspirin; Drug-Related Side Effects and Adverse | 1975 |
The effect of drugs on implantation in rats with an intrauterine device in one horn of the uterus.
Topics: Administration, Oral; Animals; Aspirin; Copulation; Embryo Implantation; Fallopian Tubes; Female; In | 1975 |
Effects of prenatal administration of acetylsalicylic acid in rats.
Topics: Animals; Animals, Newborn; Aspirin; Behavior, Animal; Body Weight; Female; Fetal Death; Pregnancy; P | 1975 |
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Hum | 1975 |
[Influence of acetylsalicylic acid on the course of pregnancy].
Topics: Animals; Aspirin; Cesarean Section; Depression, Chemical; Female; Humans; Infant Mortality; Obstetri | 1975 |
Analgesic abuse, ureteric obstruction, and retroperitoneal fibrosis.
Topics: Acetaminophen; Adult; Aged; Analgesia; Aspirin; Codeine; Female; Humans; Middle Aged; Phenacetin; Pr | 1975 |
The antagonism by anti-inflammatory analgesics of prostaglandin f 2 alpha-induced contractions of human and rabbit myometrium in vitro.
Topics: Abortion, Induced; Animals; Anti-Inflammatory Agents; Aspirin; Drug Antagonism; Female; Ibuprofen; I | 1975 |
[Aspirin and pregnancy].
Topics: Animals; Aspirin; Female; Fetal Death; Fetus; Humans; Pregnancy; Pregnancy Trimester, First; Pregnan | 1975 |
Inhibition of RNA synthesis by acetyl salicylate and actinomycin D during early development in the mouse.
Topics: Animals; Aspirin; Autoradiography; Breeding; Dactinomycin; Depression, Chemical; Female; Fetal Death | 1975 |
Simultaneous vasculitis in a mother and newborn infant.
Topics: Adult; Arthritis; Aspirin; Female; Gangrene; Gentamicins; Heparin; Humans; Infant, Newborn; Infant, | 1975 |
The efficacy and safety of intramuscularly administered 15(S) 15 methyl prostaglandin E2 methyl ester for induction of artificial abortion.
Topics: Abortion, Induced; Adolescent; Adult; Aspirin; Atropine; Diarrhea; Diphenoxylate; Drug Administratio | 1975 |
Embryotoxicity of solanine and aspirin in mice.
Topics: Abortion, Spontaneous; Animals; Aspirin; Drug Synergism; Female; Fetal Resorption; Fetus; Mice; Preg | 1976 |
Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome.
Topics: Adult; Aspirin; Female; Humans; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pre | 1992 |
Antiphospholipid antibodies in pregnancy.
Topics: Abortion, Habitual; Antibodies, Anticardiolipin; Aspirin; Female; Humans; Lupus Coagulation Inhibito | 1992 |
Prevention of miscarriage in antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Female; | 1992 |
[Recurrent loss of pregnancy in patients with anticardiolipin antibodies (ACAb)].
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Aspirin; Drug Therapy, Combination; Female; | 1992 |
Possible low-dose-aspirin-induced gastropathy.
Topics: Adult; Aspirin; Female; Humans; Peptic Ulcer; Pregnancy | 1992 |
Possible low-dose-aspirin-induced gastropathy.
Topics: Aspirin; Female; Gastric Mucosa; Humans; Pregnancy; Pregnancy Complications; Stomach Diseases | 1992 |
Treatment and outcome of unexplained recurrent spontaneous abortions in subclinical autoimmune disorders.
Topics: Abortion, Habitual; Antibodies, Antinuclear; Aspirin; Autoimmune Diseases; Female; Humans; Infant, N | 1992 |
Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects.
Topics: Aspirin; Bleeding Time; Blood Coagulation; Blood Platelets; Female; Humans; Pregnancy; Thrombelastog | 1992 |
Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; H | 1992 |
Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Enzym | 1992 |
Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast.
Topics: 6-Ketoprostaglandin F1 alpha; Arachidonic Acid; Aspirin; Chorionic Villi; Epoprostenol; Female; Huma | 1992 |
Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women.
Topics: Aspirin; Epoprostenol; Female; Humans; Lipid Peroxides; Pre-Eclampsia; Pregnancy; Radioimmunoassay; | 1992 |
Assessment of whole-blood spontaneous platelet aggregation during pregnancy using an impedance particle counter.
Topics: Adolescent; Adult; Aspirin; Electric Impedance; Female; Fetal Growth Retardation; Gestational Age; H | 1992 |
Lupus anticoagulant, paramyotonia congenita and pregnancy.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, Obstetrical; A | 1992 |
[Characteristics of thrombocyte metabolism in puerperae with massive blood loss and gestosis and possible ways of its metabolic correction].
Topics: Aspirin; Blood Platelets; Drug Combinations; Female; Glycogen; Humans; Lipid Peroxidation; Phospholi | 1992 |
Quadruplet pregnancy: contemporary management and outcome.
Topics: Adult; Aspirin; Bed Rest; Female; Humans; Hypertension; Infant, Newborn; Monitoring, Physiologic; Pr | 1992 |
[A trial of low-dose aspirin therapy in high-risk pregnancy].
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Calcium; Female; Fetal Death; Fetal Growth Retardation; Human | 1992 |
Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy.
Topics: Adult; Aspirin; Bleeding Time; Blood Component Transfusion; Blood Transfusion; Dipyridamole; Drug Th | 1992 |
The use of low dose aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy | 1992 |
Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients.
Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Female; Hum | 1992 |
[Prednisolone and aspirin therapy for habitual abortion associated with anti-cardiolipin antibody].
Topics: Abortion, Habitual; Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Cardiolipins; Drug Th | 1992 |
Prospective modulation of platelet function and volumes by aspirin and dipyridamole in an at-risk pregnancy.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Platelet Aggregation; Platelet Count; | 1992 |
Pathophysiology of neonatal subconjunctival hemorrhage.
Topics: Aspirin; Cesarean Section; Conjunctival Diseases; Delivery, Obstetric; Ecchymosis; Eye Hemorrhage; E | 1992 |
Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.
Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Cardiolipins; DNA; Female; Humans; Lupus Coag | 1992 |
Obstetric performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies.
Topics: Adrenal Cortex Hormones; Adult; Antiphospholipid Syndrome; Aspirin; Cardiolipins; Drug Therapy, Comb | 1992 |
Drugs in the womb: college student perceptions of maternal v. fetal rights.
Topics: Adult; Aspirin; Attitude; Beginning of Human Life; Civil Rights; Cocaine; Female; Fetal Alcohol Spec | 1992 |
Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dazmegrel (UK38485).
Topics: Adenosine Diphosphate; Aspirin; Collagen; Epinephrine; Female; Humans; Imidazoles; Platelet Aggregat | 1992 |
Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival.
Topics: Adult; Aspirin; Biomarkers; Dipyridamole; Female; Humans; Infant, Newborn; L-Lactate Dehydrogenase; | 1992 |
Low-dose-aspirin: treatment of the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia.
Topics: Aspirin; Blood Platelets; Endothelium, Vascular; Epoprostenol; Female; Humans; Pre-Eclampsia; Pregna | 1992 |
Aspirin, extradural anaesthesia and the MRC Collaborative Low-dose Aspirin Study in Pregnancy (CLASP)
Topics: Anesthesia, Epidural; Anesthesia, Obstetrical; Aspirin; Clinical Trials as Topic; Female; Hematoma, | 1992 |
Differential effects of prenatal and postnatal ACTH or nicotine exposure on 5-HT high affinity uptake in the neonatal rat brain.
Topics: Adrenocorticotropic Hormone; Animals; Animals, Newborn; Aspirin; Brain; Brain Stem; Female; Nicotine | 1991 |
The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin | 1991 |
Low-dose aspirin during pregnancy.
Topics: Aspirin; Birth Weight; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pregnancy | 1991 |
Role of thrombelastography in bleeding diatheses and regional anaesthesia.
Topics: Adult; Anesthesia, Conduction; Aspirin; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Pr | 1991 |
Low-dose aspirin and vascular response in pregnant patients sensitive to angiotensin II.
Topics: Angiotensin II; Aspirin; Blood Pressure; Drug Interactions; Female; Humans; Hypertension; Pregnancy; | 1991 |
Low-dose aspirin and nulliparae.
Topics: Aspirin; Female; Humans; Hypertension; Parity; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pr | 1991 |
Thrombelastography in pregnant patients on low-dose aspirin.
Topics: Aspirin; Blood Coagulation Disorders; Female; Humans; Pregnancy; Pregnancy Complications, Hematologi | 1991 |
Inhibition of isotretinoin teratogenicity by acetylsalicylic acid pretreatment in mice.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Female; Isotretinoin; Male; Mice; Mice, Inbred Strains; | 1992 |
Reversible effects of triamcinolone and lack of effects with aspirin or L-656,224 on external genitalia of male Sprague-Dawley rats exposed in utero.
Topics: Abnormalities, Drug-Induced; Animals; Arachidonic Acid; Aspirin; Benzofurans; Female; Fetal Death; G | 1991 |
Aspirin dose-dependently reduces alcohol-induced birth defects and prostaglandin E levels in mice.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Relationship, Drug; Ethanol; Female; Fe | 1991 |
Is pre-eclampsia preventable?
Topics: Aspirin; Female; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Thromboxane-A Sy | 1991 |
Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring.
Topics: Aspirin; Data Collection; Female; Fever; Finland; Heart Defects, Congenital; Humans; Infant, Newborn | 1991 |
Use of prescription drugs in the first trimester and congenital malformations.
Topics: Abnormalities, Drug-Induced; Aspirin; Contraceptives, Oral; Dicyclomine; Female; Humans; Infant, New | 1991 |
Idiopathic thrombocythemia and pregnancy; a case report.
Topics: Adult; Aspirin; Female; Humans; Melphalan; Pregnancy; Pregnancy Complications, Hematologic; Thromboc | 1991 |
Effect of ibuprofen on alcohol-induced teratogenesis in mice.
Topics: Abnormalities, Drug-Induced; Analysis of Variance; Animals; Aspirin; Body Weight; Ethanol; Female; F | 1991 |
Prophylactic aspirin treatment: the merits of timing. International Womb-to-Tomb Chronome Study Group.
Topics: Aspirin; Circadian Rhythm; Female; Humans; Hypertension; Myocardial Infarction; Pilot Projects; Preg | 1991 |
Subchorionic hematomas and the presence of autoantibodies.
Topics: Adult; Aspirin; Autoantibodies; Extraembryonic Membranes; Female; Hematoma; Humans; Prednisone; Preg | 1991 |
Thromboxane A2 synthesis in pregnancy-induced hypertension.
Topics: Adolescent; Adult; Aspirin; Evaluation Studies as Topic; Female; Humans; Hypertension; Platelet Acti | 1990 |
Essential thrombocythemia and complications of pregnancy.
Topics: Abortion, Incomplete; Aspirin; Female; Fetal Death; Humans; Pregnancy; Pregnancy Complications, Hema | 1991 |
Aspirin and extradural blocks.
Topics: Analgesia, Epidural; Analgesia, Obstetrical; Aspirin; Female; Hematoma, Epidural, Cranial; Humans; P | 1991 |
Increased platelet turnover in a patient with previous recurrent pre-eclampsia and failure of aspirin therapy. Case report.
Topics: Adult; Aspirin; Blood Platelets; Female; Humans; Platelet Activating Factor; Platelet Aggregation; P | 1991 |
Aspirin and pre-eclampsia.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1991 |
Treatment of severe pre-eclampsia by acetyl salicylic acid.
Topics: Adolescent; Adult; Albuminuria; Aspirin; Blood Pressure; Body Temperature; Edema; Female; Humans; Hy | 1991 |
Antiphospholipid antibodies in unselected patients with repeated abortion.
Topics: Abortion, Habitual; Adult; Antibodies; Aspirin; Autoimmunity; Blood Coagulation Factors; Female; Hum | 1990 |
[Aspirin and pregnancy].
Topics: Aspirin; Blood Coagulation Factors; Female; Fetal Death; Fetal Growth Retardation; Humans; Hypertens | 1990 |
Is human labour triggered by an increase in the rate of synthesis of prostaglandin G/H synthase?
Topics: Amnion; Aspirin; Chorion; Dinoprostone; Extraembryonic Membranes; Female; Humans; Labor Onset; Place | 1990 |
Transplacental cardiovascular effects of four popular analgesics in rats.
Topics: Acetaminophen; Analgesics; Animals; Aspirin; Cardiomegaly; Constriction, Pathologic; Ductus Arterios | 1990 |
[Fetal survival after the corticosteroid and low-dose aspirin regimen in a case of anti-phospholipid antibody syndrome].
Topics: Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Drug Therapy, Combination; Female; Fetal Death; | 1990 |
[Aspirin and pregnancy].
Topics: Adolescent; Aspirin; Child; Child Behavior Disorders; Female; Humans; Male; Pregnancy; Pregnancy Com | 1990 |
Chronobiologic approach to pregnancy-induced hypertension and individualized assessment of low-dose aspirin for pre-eclampsia prevention.
Topics: Adult; Aspirin; Blood Pressure; Chronobiology Phenomena; Female; Heart Rate; Humans; Hypertension; P | 1990 |
Women to have more say in births?
Topics: Acetaminophen; Aspirin; Codeine; Female; Humans; Pain; Pregnancy; Pregnancy Complications | 1990 |
[Prevention of pre-eclampsia with ASA--continuous caution is recommended].
Topics: Aspirin; Contraindications; Female; Humans; Pre-Eclampsia; Pregnancy | 1990 |
Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Analysis of Variance; Angiotensin II; Aspirin; Bloo | 1990 |
[Clinical study and therapy of systemic lupus erythematosus and pregnancy].
Topics: Antibodies, Antinuclear; Aspirin; Female; Heparin; Humans; Infant, Newborn; Kidney Function Tests; L | 1990 |
[Effect of low-dose aspirin therapy on utero-placental blood flow and malondialdehyde (MDA) as an indicator of its therapeutic effect].
Topics: Adult; Aspirin; Epoprostenol; Female; Fetal Growth Retardation; Humans; Malondialdehyde; Middle Aged | 1990 |
Aspirin to prevent pregnancy-induced hypertension.
Topics: Aspirin; Female; Hemostasis; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascula | 1990 |
Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Female; Hemolysis; Humans; Hypertension; Liver; Pregnancy; | 1990 |
From the National Institutes of Health.
Topics: Aspirin; Breast Neoplasms; Female; Fetal Diseases; Heart Defects, Congenital; Humans; Immunotherapy; | 1990 |
Research on heterocyclic compounds. XXVI. Antiinflammatory and related activities of some 2-phenylimidazo[1,2-b]pyridazines.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Carrageenan; | 1990 |
Ethanol increases PGE and thromboxane production in mouse pregnant uterine tissue.
Topics: Analysis of Variance; Animals; Aspirin; Ethanol; Female; Mice; Mice, Inbred C57BL; Pregnancy; Pregna | 1990 |
Plasma exchange and thrombotic thrombocytopenic purpura, the Indiana University Medical Center experience.
Topics: Adolescent; Adult; Aspirin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Plasma Excha | 1990 |
Miniaspirin in obstetrics.
Topics: Aspirin; Female; Humans; Pre-Eclampsia; Pregnancy | 1990 |
Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia.
Topics: Aspirin; Binding Sites; Chlorides; Female; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hype | 1990 |
Thromboembolic disease during pregnancy: problems with anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Blood Coagulation Factors; Female; Fibrinolysis; Heart Valve Prosthesis; He | 1990 |
Resorption of CBA/J x DBA/2 mouse conceptuses in CBA/J uteri correlates with failure of the feto-placental unit to suppress natural killer cell activity.
Topics: Animals; Aspirin; Female; Fetal Death; Fetal Resorption; Fetus; Gestational Age; Killer Cells, Natur | 1990 |
Amnion cell prostaglandin E2 stimulatory activity in chorion laeve-conditioned medium.
Topics: Amnion; Arachidonic Acids; Aspirin; Cells, Cultured; Chorion; Cycloheximide; Dinoprostone; Dose-Resp | 1990 |
Inhibition of the oxygen-induced contraction of the isolated human umbilical artery by indomethacin, flurbiprofen, aspirin and drugs modifying Ca2+ disposition.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1988 |
Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Biotransformation; Caffeic Acids; Cinnamates; Cyclic | 1989 |
Fetal loss treatment in patients with antiphospholipid antibodies.
Topics: Abortion, Habitual; Aspirin; Autoantibodies; Blood Coagulation Factors; Female; Humans; Lupus Coagul | 1989 |
Aspirin differentially affects thromboxane and prostacyclin production by trophoblast and villous core compartments of human placental villi.
Topics: Aspirin; Chorionic Villi; Epoprostenol; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Throm | 1989 |
Recurrent fetal loss with circulating lupus anticoagulant: report of 2 cases.
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation Factors; Drug Therapy, Combination; Female; Hu | 1989 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pr | 1989 |
Effects of aspirin and paracetamol on ATPases of human fetal brain: an in vitro study.
Topics: Acetaminophen; Adenosine Triphosphatases; Aspirin; Brain; Ca(2+) Mg(2+)-ATPase; Female; Fetus; Human | 1989 |
Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Blood Transfusion; Combined Modality Therapy; Dipyridamole; Drug Therapy, Combinatio | 1989 |
The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects.
Topics: Abnormalities, Drug-Induced; Aortic Coarctation; Aortic Valve Stenosis; Aspirin; Case-Control Studie | 1989 |
Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions.
Topics: Abortion, Habitual; Adult; Antibodies; Aspirin; Female; Heparin; Humans; Immunization, Passive; Infu | 1989 |
Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cleft Palate; Dealkylation; Dimethadione; Dose-Respon | 1989 |
Pregnancy loss with phospholipid antibodies: improved outcome with aspirin containing treatment.
Topics: Abortion, Spontaneous; Antibodies; Aspirin; Female; Fetal Death; Humans; Lupus Erythematosus, System | 1989 |
Fetal demise associated with lupus anticoagulant: clinical features and results of treatment.
Topics: Adult; Aspirin; Autoantibodies; Blood Coagulation; Dipyridamole; Female; Heparin; Humans; Immunosupp | 1989 |
Fibromuscular dysplasia of the carotid arteries complicating pregnancy.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Female; Fibromuscular Dysplasi | 1989 |
Thromboxane production in placentas of women with preeclampsia.
Topics: Aspirin; Female; Humans; Placenta; Pre-Eclampsia; Pregnancy; Thromboxane A2; Thromboxanes | 1989 |
Role of prostaglandins in alcohol teratogenesis.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Ethanol; Female; Indomethacin; Mice; Mice, Inbred C57 | 1989 |
Prevention of preeclampsia--a reality?
Topics: Aspirin; Female; Humans; Infant, Newborn; Neutropenia; Pre-Eclampsia; Pregnancy | 1989 |
Aspirin and pre-eclampsia.
Topics: Aspirin; Blood Platelets; Female; Humans; Placenta; Pre-Eclampsia; Pregnancy; Thromboxane A2 | 1986 |
Aspirin and pre-eclampsia.
Topics: Aspirin; Blood Platelets; Female; Humans; Platelet Count; Pre-Eclampsia; Pregnancy; Prospective Stud | 1986 |
Treatment of common minor ailments.
Topics: Acetaminophen; Antacids; Antiemetics; Aspirin; Dyspepsia; Female; Heartburn; Histamine H1 Antagonist | 1986 |
The potential relationship of maternal toxicity, general stress, and fetal outcome.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Corticosterone; Female; Heat-Shock Proteins; Humans; | 1987 |
Low-dose aspirin in pregnancy.
Topics: Aspirin; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Lupus Erythematosu | 1988 |
Prophylactic low-dose aspirin and dipyridamole in pregnancy.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Hum | 1988 |
Mitral valve prolapse and thromboembolic disease in pregnancy: a case report.
Topics: Adult; Aspirin; Brain Ischemia; Contraceptives, Oral; Dipyridamole; Drug Therapy, Combination; Embol | 1988 |
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.
Topics: Aspirin; Autoantibodies; Female; Fetal Death; Humans; Lupus Erythematosus, Systemic; Phospholipids; | 1989 |
[Multiple fetal losses caused by a circulating anticoagulant. Correction with a combination of aspirin and corticotherapy].
Topics: Abortion, Habitual; Adult; Aspirin; Blood Coagulation; Female; Humans; Immunoglobulins; Prednisolone | 1986 |
[Full term pregnancy and Soulier-Boffa syndrome].
Topics: Abortion, Habitual; Adult; Aspirin; Autoimmune Diseases; Drug Therapy, Combination; Female; Humans; | 1988 |
Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease.
Topics: Adult; Aspirin; Blood Coagulation Tests; Bucladesine; Epoprostenol; Female; Humans; Platelet Aggrega | 1987 |
The role of arachidonic acid metabolites in preeclampsia.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Epoprostenol; Female; Hemodynamics; Humans; Leukotriene | 1986 |
Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Aspirin; Cell Membrane; Cholera Toxin; Colforsi | 1987 |
Pharmacological management of an impending placental insufficiency.
Topics: Aspirin; Epoprostenol; Female; Gestational Age; Humans; Microcirculation; Placenta Diseases; Placent | 1988 |
Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Arteries; Aspirin; Epoprostenol; Female; Humans; Place | 1988 |
[Effect of aspirin and nordihydroguaiaretic acid on the secretion of milk caseins by the mammary epithelial cell].
Topics: Animals; Aspirin; Caseins; Catechols; Dinoprost; Epithelium; Exocytosis; Female; Lactation; Lipoxyge | 1986 |
Simple analgesics in pregnancy.
Topics: Acetaminophen; Analgesics; Aspirin; Female; Humans; Pregnancy | 1987 |
Low dose aspirin treatment in late pregnancy differentially inhibits cyclo-oxygenase in maternal platelets.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dose-Response Rel | 1987 |
Preeclampsia: platelets and antiplatelet therapy.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Diagnosis, Differential; Female; Fetus; Humans; Hyperte | 1988 |
Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.
Topics: Angiotensin II; Aspirin; Blood Pressure; Drug Administration Schedule; Drug Resistance; Female; Huma | 1988 |
[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Drug Therapy, Combination; | 1988 |
PGE measurement in mouse embryos and uterine/embryo tissue.
Topics: Analysis of Variance; Animals; Aspirin; Embryo, Mammalian; Female; In Vitro Techniques; Mice; Mice, | 1988 |
Treatment of habitual abortions associated with autoimmune abnormalities. A report of two cases.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Female; Heparin; Humans; Pr | 1988 |
Effects of aspirin-like drugs on mitogen-stimulated DNA synthesis of lymphocytes from pregnant rats and offspring.
Topics: Animals; Aspirin; Concanavalin A; DNA; Female; Lymphocyte Activation; Phytohemagglutinins; Pokeweed | 1988 |
Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age.
Topics: Age Factors; Aspirin; Data Collection; Female; Humans; Intelligence; Male; Pregnancy; Pregnancy Trim | 1988 |
[Mortality and morbidity of thromboembolism in drug prevention--5-year analysis].
Topics: Adenocarcinoma; Adult; Aspirin; Cesarean Section; Dihydroergotamine; Female; Genital Diseases, Femal | 1988 |
The effects of aspirin-like drugs on the nutritional status of pregnant rats and offspring.
Topics: Animals; Animals, Newborn; Aspirin; Female; Male; Nutritional Status; Pregnancy; Pregnancy, Animal; | 1988 |
Is there a prostaglandin involvement in the positive inotropic action of histamine in isolated pregnant rat uterus, apparently mediated via H1-receptors activation?
Topics: Alprostadil; Animals; Aspirin; Chlorpheniramine; Cimetidine; Dinoprost; Dinoprostone; Female; Histam | 1987 |
Bleeding.
Topics: Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Female; Hemorrhage; Hemostasis; Huma | 1987 |
Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans.
Topics: Adult; Aspirin; Epoprostenol; Female; Fetal Blood; Humans; Infant, Newborn; Pregnancy; Thromboxane A | 1986 |
Cardiovascular actions of dihydralazine as modified by dietary linoleic acid.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Pressure; Dietary Fats; Dihydralazine; Epoprostenol; Fatty | 1986 |
Subclinical autoimmune disease and recurrent spontaneous abortion.
Topics: Abortion, Habitual; Adult; Aspirin; Autoantibodies; Autoimmune Diseases; Cardiolipins; Cesarean Sect | 1986 |
Successful pregnancy after pharmacologic suppression of a circulating anticoagulant in a woman with previous pregnancy losses and pulmonary emboli. A case report.
Topics: Adult; Aspirin; Blood Coagulation; Female; Humans; Immunoglobulins; Infant, Newborn; Partial Thrombo | 1987 |
Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements.
Topics: Acetaminophen; Aspirin; Attention; Behavior; Female; Gestational Age; Humans; Intelligence; Maternal | 1987 |
Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Fetal Growth Retardation; Humans; Platelet | 1987 |
Platelet function in pregnancy induced hypertension following treatment with labetalol and low dose aspirin.
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Collagen; Dose-Response Relationship, Drug; | 1987 |
Serum salicylate levels in a breast fed infant.
Topics: Adult; Arthritis, Juvenile; Aspirin; Breast Feeding; Female; Humans; Infant; Milk, Human; Pregnancy; | 1987 |
In vitro effect of aspirin on NADPH producing pathway in developing human fetus.
Topics: Aspirin; Brain; Female; Fetus; Glucosephosphate Dehydrogenase; Heart; Humans; Male; Myocardium; NADP | 1987 |
The effect of acetylsalicylic acid and indomethacin on the catecholamine- and oxytocin-induced contractility and prostaglandin (6-keto-PGF1 alpha, PGF2 alpha)-production of human pregnant myometrial strips.
Topics: Aspirin; Epinephrine; Female; Humans; In Vitro Techniques; Indomethacin; Myometrium; Oxytocin; Pregn | 1987 |
Perinatal risk assessment for patent ductus arteriosus in premature infants.
Topics: Adolescent; Adult; Aspirin; Birth Weight; Ductus Arteriosus, Patent; Female; Histamine Antagonists; | 1986 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contracept | 1986 |
[Changes in the reaction of the cardiovascular system to angiotensin II in pregnancy modified by aspirin].
Topics: Angiotensin II; Animals; Aspirin; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; | 1986 |
Teratogenic effects on the CD-1 mouse embryo exposed to concurrent doses of ethanol and aspirin.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Bone and Bones; Drug Interactions; Ethanol; Female; M | 1986 |
Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy.
Topics: Angiotensin II; Aspirin; Blood Pressure; Female; Humans; Pregnancy; Time Factors | 1987 |
Cyclopia and maternal ingestion of salicylates.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Aspirin; Brain; Female; Humans; Infant, Newbor | 1986 |
The efflux from and the metabolism of 3H-norepinephrine in sow Graafian follicles. Variable involvement of some prostaglandins during two different stages of the sex cycle.
Topics: Alprostadil; Animals; Aspirin; Diestrus; Dinoprost; Dinoprostone; Estrus; Female; In Vitro Technique | 1985 |
Prescribing analgesics.
Topics: Acetaminophen; Aged; Analgesics; Anticoagulants; Aspirin; Child; Codeine; Diflunisal; Drug Hypersens | 1985 |
Progesterone and prostanoid production by bovine binucleate trophoblastic cells.
Topics: 6-Ketoprostaglandin F1 alpha; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Aspirin; Cattle; Cell | 1985 |
In vitro prostacyclin production by ovine uterine and systemic arteries. Effects of angiotensin II.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Arteries; Aspirin; Culture Techniques; Epopro | 1985 |
Effects of aspirin and alcohol on platelet thromboxane synthesis and vascular prostacyclin synthesis.
Topics: Aspirin; Blood Platelets; Epoprostenol; Ethanol; Female; Humans; Kinetics; Muscle, Smooth, Vascular; | 1985 |
Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions--effect of aspirin and salicylate.
Topics: Adenine; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cell Adhesion; Cells, Cultur | 1985 |
Obstetric complications associated with the lupus anticoagulant.
Topics: Abortion, Spontaneous; Aspirin; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fetal De | 1985 |
Platelet suppressive therapy in clinical medicine.
Topics: Aspirin; Blood Platelets; Female; Humans; Pre-Eclampsia; Pregnancy | 1986 |
Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment. Case report.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Humans; Pregnancy; Pregnancy Trimester, Se | 1986 |
Idiopathic thrombocythemia and pregnancy: report of a case.
Topics: Adult; Aspirin; Female; Hematologic Tests; Humans; Platelet Count; Postpartum Period; Pregnancy; Pre | 1985 |
The possible contribution of industrial chemicals (organic solvents) to the incidence of congenital defects caused by teratogenic drugs and consumer goods--an experimental study.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Benzene; Drug Synergism; Ethanol; Female; Fetus; Preg | 1985 |
Amniotic fluid embolism: prophylaxis with heparin and aspirin.
Topics: Animals; Aspirin; Embolism, Amniotic Fluid; Female; Heparin; Humans; Platelet Count; Pregnancy; Prem | 1985 |
Acute abstinence syndrome after epidural injection of butorphanol.
Topics: Adult; Anesthesia, Epidural; Aspirin; Blood Pressure; Butorphanol; Caffeine; Cesarean Section; Codei | 1985 |
Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy.
Topics: Acetaminophen; Adult; Anti-Bacterial Agents; Antiemetics; Aspirin; Dicyclomine; Doxylamine; Drug Com | 1985 |
Urticaria and angioedema: new insights and new entities.
Topics: Angioedema; Aspirin; Complement Activation; Female; Food Hypersensitivity; Humans; Mast Cells; Physi | 1985 |
Fatal in utero salicylism.
Topics: Aspirin; Female; Fetal Death; Gestational Age; Humans; Maternal-Fetal Exchange; Pregnancy; Suicide, | 1985 |
Thrombotic thrombocytopenic purpura in early pregnancy.
Topics: Adult; Aspirin; Combined Modality Therapy; Dipyridamole; Female; Gestational Age; Hematocrit; Humans | 1985 |
Nonsteroidal anti-inflammatory agents. A review of the literature.
Topics: Absorption; Anti-Inflammatory Agents; Aspirin; Diflunisal; Drug Interactions; Female; Fenoprofen; Ha | 1985 |
Anti-inflammatory therapy during pregnancy and lactation.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Female; Humans; I | 1985 |
Clinical-pharmacokinetic investigations of acetylsalicylic acid in cases of imminent premature delivery.
Topics: Amniotic Fluid; Aspirin; Female; Fetal Blood; Humans; Infant, Newborn; Kinetics; Obstetric Labor, Pr | 1985 |
Platelet aggregation by a specific human immunoglobulin preparation.
Topics: ABO Blood-Group System; Adenine Nucleotides; Adult; Antibodies; Antimycin A; Aspirin; Azathioprine; | 1970 |
Ototoxic drugs: a review of clinical aspects, histopathologic changes and mechanisms of action.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Aspirin; Chloroquine; Cochlea; Dihydrostreptomycin Su | 1971 |
Inhibition of prostaglandin release and the control of threatened abortion.
Topics: Abortion, Threatened; Aspirin; Blood Platelets; Female; Humans; Indomethacin; Lung; Obstetric Labor | 1971 |
Treatment of atherosclerosis and thrombosis with aspirin.
Topics: Adult; Age Factors; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Diabetes | 1972 |
Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour.
Topics: Adult; Aspirin; Birth Weight; Female; Humans; Infant, Newborn; Labor, Obstetric; Postpartum Hemorrha | 1973 |
Letter: Aspirin, prostaglandin, and gestation.
Topics: Animals; Arthritis; Aspirin; Embryo Implantation; Female; Humans; Pregnancy; Pregnancy Complications | 1974 |
Letter: Salicylates and pregnancy.
Topics: Abortion, Threatened; Animals; Aspirin; Drug Antagonism; Drug Evaluation; Female; Fetus; Humans; Obs | 1974 |
Puerperal thromboembolism and aspirin ingestion.
Topics: Aspirin; Female; Humans; Pregnancy; Puerperal Disorders; Thromboembolism | 1970 |
Effect of aspirin upon male mouse fertility.
Topics: Animals; Aspirin; Female; Fertility; Male; Mice; Pregnancy; Prostaglandin Antagonists; Prostaglandin | 1973 |
[Inhibition of premature labour--anti-inflammatory agents in the prevention of premature birth (author's transl)].
Topics: Administration, Oral; Anti-Inflammatory Agents; Aspirin; Blood Pressure; Blood Vessels; Drug Therapy | 1974 |
Editorial: Prostaglandins--tour d'horizon.
Topics: Abortion, Induced; Aspirin; Female; Humans; Indomethacin; Kidney; Natriuresis; Phenylbutazone; Pregn | 1974 |
Evaluation of thyroid status with "effective thyroxine ratio" (E.T.R.).
Topics: Adolescent; Adult; Aged; Aspirin; Depression, Chemical; Estrogens; Evaluation Studies as Topic; Fema | 1974 |
Teratology in the Macaca mulatta.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Clomiphene; Encephalocele; Female; Fetal Death; Haplo | 1968 |
[In vitro synthesis of progesterone in human cyclic corpus luteum: action of prostaglandin F2alpha].
Topics: Aspirin; Carbon Radioisotopes; Chorionic Gonadotropin; Corpus Luteum; Cyclic AMP; Drug Synergism; Fe | 1973 |
Congenital malformations in nonhuman primates: spontaneous and experimentally induced.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Aspirin; Congenital Abnormalities; Female; Haplor | 1967 |
The effect of anti-inflammatory drugs on the protein-binding of 11-hydroxysteroids in human plasma in vitro.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Arthritis, Rheumatoi | 1969 |
Role of antihistaminics in preventing systemic side effects of iron-dextran therapy.
Topics: Anemia, Hypochromic; Aspirin; Chlorpheniramine; Female; Histamine H1 Antagonists; Humans; Iron-Dextr | 1970 |
Some toxicological aspects of a nicotinamide-methylaminopyrazolone (Ra 101).
Topics: Abnormalities, Drug-Induced; Acetylcholine; Aminopyrine; Analgesics; Animals; Aspirin; Blood; Blood | 1970 |
Associations between drugs administered during pregnancy and congenital abnormalities of the fetus.
Topics: Abnormalities, Drug-Induced; Adult; Analgesics; Antacids; Antiemetics; Appetite Depressants; Ascorbi | 1971 |
Salicylate-induced foetal damage late in pregnancy. An experimental study in mice.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Carbon Isotopes; Coumarins; Female; | 1971 |
Aspirin and the reversal of antifertility effect of iproniazid in rats.
Topics: Animals; Aspirin; Corpus Luteum; Depression, Chemical; Embryo Implantation; Female; Fertility; Ipron | 1974 |
The susceptibility of the fetus and child to chemical pollutants. Special susceptibility of the fetal and neonatal hematopoietic system to chemical pollutants including drugs administered to the mother.
Topics: Abnormalities, Drug-Induced; Adenosine Diphosphate; Age Factors; Aspirin; Blood Platelets; Environme | 1974 |
Initiation of human parturition. I. Mechanism of action of arachidonic acid.
Topics: Abortifacient Agents; Abortion, Induced; Amniotic Fluid; Animals; Arachidonic Acids; Aspirin; Dogs; | 1974 |
[Quantitative analysis of the main metabolites of acetylsalicylic acid. Comparative analysis in the blood and milk of lactating women (author's transl)].
Topics: Aspirin; Breast Feeding; Female; Humans; Lactation; Milk, Human; Pregnancy; Puerperal Disorders; Thr | 1974 |
Treatment of sickle-cell disease.
Topics: Anemia, Sickle Cell; Anesthesia; Anticoagulants; Aspirin; Bicarbonates; Blood; Blood Flow Velocity; | 1974 |
Problems associated with the screening of drugs for possible teratogenic activity.
Topics: 2,4,5-Trichlorophenoxyacetic Acid; Abnormalities, Drug-Induced; Animals; Aspirin; Dose-Response Rela | 1974 |
[Embryotoxic and teratogenic effects of acetylsalicylic acid and an acetylsalicylic acid containing combination].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aspirin; Body Weight; Brain; Dose-Response | 1974 |
[Effect of an acetylsalicylic acid-quinidine-lithium-combination on the fertility of mice].
Topics: Administration, Oral; Animals; Animals, Newborn; Aspirin; Drug Combinations; Embryo, Mammalian; Fema | 1974 |
Leaning impairment from maternal salicylate treatment in rats.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Embryo, Mammalian; Female; Humans; | 1972 |
Development of aspirin hydrolase in fetal, newborn and adult tissues.
Topics: Abnormalities, Drug-Induced; Adenosine Diphosphate; Age Factors; Animals; Animals, Newborn; Aspirin; | 1973 |
The effect of anti-inflammatory drugs on parturition parameters in the rat.
Topics: Acetates; Animals; Aspirin; Cortisone; Depression, Chemical; Female; Fetal Death; Gestational Age; L | 1973 |
Naproxen. Proceedings from an International Medical Symposium presented by Syntex Corporation 7-8 May 1973, Geneva, Switzerland.
Topics: Adolescent; Adult; Aged; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspir | 1973 |
Letter to the editor: Non steroid anti-inflammatory drugs and pregnancy.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Female; Fetus; Homeostasis; Humans; Indomethacin | 1974 |
Aspirin and indomethacin prolong parturition in rats: evidence that prostaglandins contribute to expulsion of fetus.
Topics: Administration, Oral; Animals; Aspirin; Biological Assay; Chickens; Chromatography, Thin Layer; Fema | 1972 |
Delay of parturition in the rat by anti-inflammatory agents which inhibit the biosynthesis of prostaglandins.
Topics: Acetates; Administration, Oral; Animals; Anti-Inflammatory Agents; Aspirin; Cortisone; Depression, C | 1972 |
Effects on macaque embryos of drugs reported or suspected to be teratogenic to humans.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Aspirin; Cesarean Section; Embryo, Mammalian; Fem | 1972 |
Prostaglandins and aspirin.
Topics: Abortion, Spontaneous; Anti-Inflammatory Agents; Aspirin; Embryo Implantation; Female; Humans; Male; | 1972 |
Biochemical mechanisms of salicylate teratology in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Carbon Isotopes; Edetic Acid; Female; Fetus; Iron; Ir | 1973 |
[Clinical experiences with Fortalidon in painful conditions in gynecology and obstetrics].
Topics: Aminopyrine; Analgesics; Aspirin; Barbiturates; Caffeine; Codeine; Drug Combinations; Female; Genita | 1972 |
Acute polyarthritis.
Topics: Acute Disease; Arthritis, Rheumatoid; Aspirin; Blood Sedimentation; Diagnosis, Differential; Drainag | 1972 |
The influence of pregnancy on the acute toxicity of various compounds in mice.
Topics: Animals; Aspirin; Body Weight; Chlorpromazine; Colchicine; Female; Fetus; Folic Acid; Iron-Dextran C | 1972 |
Salicylate poisoning.
Topics: Adult; Aspirin; Female; Fetal Death; Humans; Poisoning; Pregnancy; Pregnancy Complications; Salicyla | 1973 |
Aspirin and indomethacin: effect on instillation-abortion time of mid-trimester hypertonic saline induced abortion.
Topics: Abortion, Induced; Adult; Amniotic Fluid; Aspirin; Depression, Chemical; Drug Interactions; Female; | 1973 |
Fluorescent properties of bovine serum albumin-bilirubin complex.
Topics: Alkylation; Animals; Aspirin; Bilirubin; Binding Sites; Binding, Competitive; Carrier Proteins; Catt | 1973 |
Whole-body autoradiography of late pregnant mice after intravenous injection of 14C-labelled salicylic acid and acetylsalicylic acid.
Topics: Animals; Aspirin; Autoradiography; Carbon Isotopes; Connective Tissue; Female; Fetus; Hydrolysis; In | 1973 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; | 1973 |
Physicochemical factors in maternal-fetal distribution of drugs.
Topics: Amphetamine; Aniline Compounds; Animals; Antipyrine; Aspirin; Atropine; Benzoates; Caffeine; Carbon | 1973 |
[Prostaglandins].
Topics: Abortion, Spontaneous; Animals; Aspirin; Drug Interactions; Female; Humans; Male; Pregnancy; Prostag | 1973 |
Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery.
Topics: Aspirin; Carbon Tetrachloride; Chromatography, Gas; Female; Gentisates; Glucuronates; Glycine; Human | 1974 |
Milk-ejecting activity induced by prostaglandin F2alpha.
Topics: Animals; Aspirin; Biological Assay; Breast; Breast Feeding; Dose-Response Relationship, Drug; Female | 1974 |
Letter: Aspirin and pregnancy.
Topics: Animals; Aspirin; Female; Fetus; Humans; Pregnancy; Pregnancy Complications; Rats | 1974 |
Pulmonary pressor effects of small amounts of bovine amniotic fluid.
Topics: Amniotic Fluid; Animals; Aorta; Aspirin; Blood Pressure; Cardiac Output; Cattle; Female; Gestational | 1974 |
[Studies of the interactions of clofibrate with the reproductive function].
Topics: 17-Ketosteroids; Animals; Animals, Newborn; Aspirin; Clofibrate; Estrogens; Estrus; Female; Fertilit | 1974 |
Drug toxicity in the animal fetus.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cats; Cricetinae; Dogs; Embryo, Mammalian; Female; Fe | 1967 |
Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.
Topics: Abnormalities, Drug-Induced; Aminopyrine; Analgesics; Anemia; Animals; Anti-Inflammatory Agents; Asp | 1970 |
[Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
Topics: ABO Blood-Group System; Amides; Analgesics; Antibodies; Antigens; Aspirin; Benzoates; Drug Hypersens | 1969 |
More on the effects of antenatally administered aspirin on aggregation of platelets of neonates.
Topics: Aspirin; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Platelet Adhesiveness; Pregnancy | 1972 |
[Acylpyrin in gynecology and obstetrics].
Topics: Aspirin; Female; Genital Diseases, Female; Humans; Pregnancy; Pregnancy Complications | 1972 |
[Therapy in decompression sickness and air embolism].
Topics: Abortion, Spontaneous; Adult; Air; Animals; Arteries; Aspirin; Blood Platelets; Capillaries; Child; | 1971 |
Salicylate-induced foetal damage during late pregnancy in mice: a comparison between sodium salicylate, acetylsalicylic acid and salicylsalicylic acid.
Topics: Animals; Aspirin; Female; Fetal Death; Gestational Age; Hemorrhage; Liver Glycogen; Mice; Pregnancy; | 1971 |
Aspirin and bleeding.
Topics: Advertising; Aspirin; Female; Hemorrhage; Humans; Infant, Newborn; Pregnancy; Television | 1971 |
The analgesic powder.
Topics: Abnormalities, Drug-Induced; Anemia; Aspirin; Blood Platelet Disorders; Female; Humans; Infant, Newb | 1971 |
[Stevens-Johnson syndrome. Review of 10 cases].
Topics: Adolescent; Adult; Aged; Aspirin; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; | 1971 |
The selective and differential vulnerability of the auditory system. In: Sensorineural hearing loss.
Topics: Aspirin; Auditory Pathways; Central Nervous System; Cochlea; Deafness; Diseases in Twins; Ear; Facia | 1970 |
Drugs and children.
Topics: Aminophylline; Aspirin; Atropine; Cardiomyopathies; Cataract; Child, Preschool; Chloramphenicol; Chl | 1968 |
Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis.
Topics: Aspirin; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Factor XII; Female; Gestationa | 1970 |
The value of physiotherapy in obstetrics.
Topics: Acetaminophen; Anesthesia, Obstetrical; Anesthetics, Local; Aspirin; Codeine; Conditioning, Psycholo | 1970 |
Salicylates and malformations.
Topics: Abnormalities, Drug-Induced; Aspirin; Central Nervous System; Clubfoot; Digestive System Abnormaliti | 1970 |
Acute puerperal mastitis. Evaluation of its management.
Topics: Abscess; Aspirin; Breast Feeding; Codeine; Cryosurgery; Delivery, Obstetric; Female; Fever; Humans; | 1970 |
Studies on the detection of adverse drug reactions in the newborn. I. Fetal exposure to maternal medication.
Topics: Antacids; Aspirin; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; | 1970 |
Teratogenic drugs--R.C.G.P. survey.
Topics: Abnormalities, Drug-Induced; Aspirin; Barbiturates; Female; Fetal Death; Hormones; Humans; Iron; Pre | 1970 |
Experimental teratology and pediatrics.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Congenital Abnormalities; Female; Fetal Diseases; Mam | 1970 |
Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Benzoates; Biotransformation; Female; Fetal Death; Fe | 1971 |
Mode of action of antirheumatic drugs.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Bilirubin; Binding Sites; Blood Proteins; Chloroquine; | 1971 |
Reduced passage of carbon-14-dieldrin to the fetal rat by phenobarbital but not by eight other drugs or dieldrin.
Topics: Administration, Oral; Ammonium Chloride; Animals; Aspirin; Bicarbonates; Brain; Brain Chemistry; Car | 1971 |
The effects of antenatal drug administration on aggregation of platelets of newborn infants.
Topics: Adenine Nucleotides; Aspirin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Collagen; | 1971 |
Goldenhar's syndrome and phocomelia. Case report and etiologic considerations.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Abortion, Threatened; Aspirin; Caffeine; Child | 1971 |
[Effect of several drugs on the fetus].
Topics: Abnormalities, Drug-Induced; Aminopyrine; Animals; Aspirin; Benzimidazoles; Chlorpromazine; Cortison | 1967 |
[On the question of release of fetus toxic effect through mangesium acetylosalicylate].
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Female; Fertility; Magnesium; Mice; | 1968 |
Experimental production of congenital cardiovascular malformations in rats by salicylate poisoning.
Topics: Abnormalities, Drug-Induced; Animals; Aorta; Aspirin; Dextrocardia; Female; Fetal Heart; Gestational | 1968 |
Pathogenesis of cleft lip and its relation to embryonic face shape in A-J and C57BL mice.
Topics: Animals; Aspirin; Cleft Lip; Face; Female; Lip; Maxillofacial Development; Mice; Nose; Pregnancy; Sp | 1968 |
[Acute anuric renal insufficiency with necrosing arteriolitis. Etiologic problems].
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Angioedema; Anuria; Arteritis; Arthritis; Aspirin; Dr | 1968 |
Reproduction studies on sodium meclofenamate in comparison to aspirin and phenylbutazone.
Topics: Abnormalities, Drug-Induced; Analgesics; Animals; Animals, Newborn; Anti-Inflammatory Agents; Aspiri | 1969 |
Salicylate exposure in the perinate.
Topics: Aspirin; Blood Proteins; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal | 1969 |
General considerations in the treatment of systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Allergens; Antimalarials; Aspirin; Contraception; Contraceptives, Oral; Fem | 1969 |
The use of non-narcotic analgesic drugs in postpartum patients.
Topics: Aspirin; Dextropropoxyphene; Female; Humans; Pain; Phenacetin; Pregnancy; Puerperal Disorders; Uteri | 1966 |
Experimental production of malformations due to acetyl salicylate and phenyl salicylate in rats.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Pregnancy; Pregnancy, Animal; Rats; Salicylat | 1966 |
Acute oral toxicity of various drugs in newborn rats after treatment of the dam during gestation.
Topics: Animals; Animals, Newborn; Aspirin; Dextroamphetamine; Female; Liver; Maternal-Fetal Exchange; Mepro | 1966 |